-DOCSTART- X X O

Glioma NNP O
tumor NN O
stem NN O
- : O
like IN O
cells NNS O
promote VBP O
tumor NN O
angiogenesis NN O
and CC O
vasculogenesis NN O
via IN O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
and CC O
stromal JJ O
- : O
derived VBN O
factor NN O
1 CD O
. . O

Cancer NNP O
stem NN O
cells NNS O
( -LRB- O
CSC NNP O
) -RRB- O
are VBP O
predicted VBN O
to TO O
be VB O
critical JJ O
drivers NNS O
of IN O
tumor NN O
progression NN O
due JJ O
to TO O
their PRP$ O
self NN O
- : O
renewal NN O
capacity NN O
and CC O
limitless JJ O
proliferative JJ O
potential NN O
. . O

An DT O
emerging VBG O
area NN O
of IN O
research NN O
suggests VBZ O
that IN O
CSC NNP O
may MD O
also RB O
support VB O
tumor NN O
progression NN O
by IN O
promoting VBG O
tumor NN O
angiogenesis NN O
. . O

To TO O
investigate VB O
how WRB O
CSC NNP O
contribute VB O
to TO O
tumor NN O
vascular JJ O
development NN O
, , O
we PRP O
used VBD O
an DT O
approach NN O
comparing NN O
tumor NN O
xenografts NNS O
of IN O
the DT O
C6 NNP B-NP
glioma NNP O
cell NN O
line NN O
containing VBG O
either CC O
a DT O
low JJ O
or CC O
a DT O
high JJ O
fraction NN O
of IN O
CSC NNP O
. . O

Compared VBN O
with IN O
CSC NNP O
- : O
low JJ O
tumors NNS O
, , O
CSC NNP O
- : O
high JJ O
tumors NNS O
exhibited VBD O
increased VBN O
microvessel NN O
density NN O
and CC O
blood NN O
perfusion NN O
and CC O
induced VBD O
increased VBN O
mobilization NN O
and CC O
tumor NN O
recruitment NN O
of IN O
bone NN O
marrow NN O
- : O
derived VBN O
endothelial JJ O
progenitor NN O
cells NNS O
( -LRB- O
EPC NNP O
) -RRB- O
. . O

CSC NNP O
- : O
high JJ O
C6 IN B-NP
cell NN O
cultures NNS O
also RB O
induced VBD O
higher JJR O
levels NNS O
of IN O
endothelial JJ O
cell NN O
proliferation NN O
and CC O
tubule JJ O
organization NN O
in IN O
vitro NN O
compared VBN O
with IN O
CSC NNP O
- : O
low JJ O
cultures NNS O
. . O

CSC NNP O
- : O
high JJ O
cultures NNS O
and CC O
tumors NNS O
expressed VBD O
increased VBN O
levels NNS O
of IN O
the DT O
proangiogenic JJ O
factors NNS O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
and CC O
stromal JJ O
- : O
derived VBN O
factor NN O
1 CD O
, , O
and CC O
when WRB O
signaling VBG O
by IN O
either DT O
factor NN O
was VBD O
blocked VBN O
, , O
all DT O
aspects NNS O
of IN O
angiogenesis NN O
observed VBN O
in IN O
CSC NNP O
- : O
high JJ O
cultures NNS O
and CC O
tumors NNS O
, , O
including VBG O
microvessel NN O
density NN O
, , O
perfusion NN O
, , O
EPC NNP O
mobilization NN O
/ NN O
recruitment NN O
, , O
and CC O
stimulation NN O
of IN O
endothelial JJ O
cell NN O
activity NN O
, , O
were VBD O
reduced VBN O
to TO O
levels NNS O
comparable JJ O
with IN O
those DT O
observed VBN O
in IN O
CSC NNP O
- : O
low JJ O
cultures NNS O
/ NN O
tumors NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
CSC NNP O
contribute VBP O
to TO O
tumor NN O
angiogenesis NN O
by IN O
promoting VBG O
both DT O
local JJ O
endothelial JJ O
cell NN O
activity NN O
and CC O
systemic JJ O
angiogenic JJ O
processes NNS O
involving VBG O
bone NN O
marrow NN O
- : O
derived VBN O
EPC NNP O
in IN O
a DT O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
- : O
dependent JJ O
and CC O
stromal JJ O
- : O
derived VBN O
factor NN O
1 LS O
- : O
dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Islet NNP O
endothelial JJ O
activation NN O
and CC O
oxidative JJ O
stress NN O
gene NN O
expression NN O
is VBZ O
reduced VBN O
by IN O
IL NNP O
- : O
1Ra JJ O
treatment NN O
in IN O
the DT O
type NN O
2 CD O
diabetic NN O
GK NN O
rat NN O
. . O

BACKGROUND NNP O
: : O
Inflammation NN O
followed VBN O
by IN O
fibrosis NN O
is VBZ O
a DT O
component NN O
of IN O
islet NN O
dysfunction NN O
in IN O
both DT O
rodent NN O
and CC O
human JJ O
type NN O
2 CD O
diabetes NN O
. . O

Because IN O
islet NN O
inflammation NN O
may MD O
originate VB O
from IN O
endothelial JJ O
cells NNS O
, , O
we PRP O
assessed VBD O
the DT O
expression NN O
of IN O
selected VBN O
genes NNS O
involved VBN O
in IN O
endothelial JJ O
cell NN O
activation NN O
in IN O
islets NNS O
from IN O
a DT O
spontaneous JJ O
model NN O
of IN O
type NN O
2 CD O
diabetes NN O
, , O
the DT O
Goto NNP O
- : O
Kakizaki NNP O
( -LRB- O
GK NN O
) -RRB- O
rat NN O
. . O

We PRP O
also RB O
examined VBD O
islet RB O
endotheliuml VB O
/ RP O
oxidative JJ O
stress NN O
( -LRB- O
OS RB O
) -RRB- O
/ VB O
inflammation NN O
- : O
related VBN O
gene NN O
expression NN O
, , O
islet NN O
vascularization NN O
and CC O
fibrosis NN O
after IN O
treatment NN O
with IN O
the DT O
interleukin JJ O
- : O
1 CD O
( -LRB- O
IL NNP O
- : O
1 CD O
) -RRB- O
receptor NN O
antagonist NN O
( -LRB- O
IL NNP O
- : O
1Ra CD O
) -RRB- O
. . O

METHODOLOGY NNP O
/ NNP O
PRINCIPAL NNP O
FINDINGS NNP O
: : O
Gene NNP O
expression NN O
was VBD O
analyzed VBN O
by IN O
quantitative JJ O
RT NNP O
- : O
PCR NN O
on IN O
islets NNS O
isolated VBN O
from IN O
10 CD O
- : O
week NN O
- : O
old JJ O
diabetic NN O
GK NNP O
and CC O
control NN O
Wistar NNP O
rats NNS O
. . O

Furthermore RB O
, , O
GK NNP O
rats NNS O
were VBD O
treated VBN O
s PRP O
. . O
c NN O
twice RB O
daily RB O
with IN O
IL NNP O
- : O
1Ra FW O
( -LRB- O
Kineret NNP O
, , O
Amgen NNP O
, , O
100 CD O
mg JJ O
/ NN O
kg NN O
/ JJ O
day NN O
) -RRB- O
or CC O
saline NN O
, , O
from IN O
4 CD O
weeks NNS O
of IN O
age NN O
onwards NNS O
( -LRB- O
onset NN O
of IN O
diabetes NNS O
) -RRB- O
. . O

Four CD O
weeks NNS O
later RB O
, , O
islet NN O
gene NN O
analysis NN O
and CC O
pancreas NNS O
immunochemistry NN O
were VBD O
performed VBN O
. . O

Thirty CD O
- : O
two CD O
genes NNS O
were VBD O
selected VBN O
encoding VBG O
molecules NNS O
involved VBN O
in IN O
endothelial JJ O
cell NN O
activation NN O
, , O
particularly RB O
fibrinolysis NN O
, , O
vascular JJ O
tone NN O
, , O
OS NNP O
, , O
angiogenesis NN O
and CC O
also RB O
inflammation NN O
. . O

All DT O
genes NNS O
except IN O
those DT O
encoding VBG O
angiotensinogen NN O
and CC O
epoxide NN O
hydrolase NN O
( -LRB- O
that WDT O
were VBD O
decreased VBN O
) -RRB- O
, , O
and CC O
12 CD O
- : O
lipoxygenase NN O
and CC O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
that WDT O
showed VBD O
no DT O
change NN O
) -RRB- O
, , O
were VBD O
significantly RB O
up RB O
- : O
regulated VBN O
in IN O
GK NNP O
islets NNS O
. . O

After IN O
IL NNP O
- : O
1Ra JJ O
treatment NN O
of IN O
GK NNP O
rats NNS O
in IN O
vivo NN O
, , O
most JJS O
selected VBN O
genes NNS O
implied VBN O
in IN O
endothelium NN O
/ IN O
OS NNP O
/ VBZ O
immune JJ O
cells NNS O
/ IN O
fibrosis NN O
were VBD O
significantly RB O
down IN O
- : O
regulated JJ O
. . O

IL NNP O
- : O
1Ra `` O
also RB O
improved VBN O
islet NN O
vascularization NN O
, , O
reduced VBN O
fibrosis NN O
and CC O
ameliorated VBD O
glycemia NN O
. . O

CONCLUSIONS NNS O
/ JJ O
SIGNIFICANCE NNP O
: : O
GK JJ O
rat NN O
islets NNS O
have VBP O
increased VBN O
mRNA JJ O
expression NN O
of IN O
markers NNS O
of IN O
early JJ O
islet NN O
endothelial NN O
cell NN O
activation NN O
, , O
possibly RB O
triggered VBN O
by IN O
several JJ O
metabolic JJ O
factors NNS O
, , O
and CC O
also RB O
some DT O
defense NN O
mechanisms NNS O
. . O

The DT O
beneficial JJ O
effect NN O
of IN O
IL NNP O
- : O
1Ra CD O
on IN O
most RBS O
islet IN O
endothelial JJ O
/ JJ O
OS NNS O
/ IN O
immune JJ O
cells NNS O
/ IN O
fibrosis NN O
parameters NNS O
analyzed VBD O
highlights NNS O
a DT O
major JJ O
endothelial JJ O
- : O
related JJ O
role NN O
for IN O
IL NNP O
- : O
1 CD O
in IN O
GK NNP O
islet NN O
alterations NNS O
. . O

Thus RB O
, , O
metabolically RB O
- : O
altered VBN O
islet NN O
endothelium NN O
might MD O
affect VB O
the DT O
beta JJ O
- : O
cell NN O
microenvironment NN O
and CC O
contribute VB O
to TO O
progressive JJ O
type NN O
2 CD O
diabetic NN O
beta NN O
- : O
cell NN O
dysfunction NN O
in IN O
GK NNP O
rats NNS O
. . O

Counteracting VBG O
islet NN O
endothelial JJ O
cell NN O
inflammation NN O
might MD O
be VB O
one CD O
way NN O
to TO O
ameliorate VB O
/ JJ O
prevent VB O
beta JJ O
- : O
cell NN O
dysfunction NN O
in IN O
type NN O
2 CD O
diabetes NN O
. . O

-DOCSTART- X X O

Cognitive JJ O
function NN O
and CC O
number NN O
of IN O
teeth NNS O
in IN O
a DT O
community NN O
- : O
dwelling NN O
elderly JJ O
population NN O
without IN O
dementia NN O
. . O

Although IN O
the DT O
number NN O
of IN O
sound NN O
or CC O
decayed VBN O
teeth NNS O
has VBZ O
been VBN O
reported VBN O
to TO O
be VB O
associated VBN O
with IN O
cognitive JJ O
function NN O
in IN O
elderly JJ O
populations NNS O
with IN O
dementia NN O
, , O
little RB O
is VBZ O
known VBN O
about IN O
this DT O
association NN O
in IN O
elderly JJ O
populations NNS O
without IN O
dementia NN O
. . O

We PRP O
evaluated VBZ O
this DT O
relationship NN O
, , O
with IN O
adjustment NN O
for IN O
confounding VBG O
factors NNS O
, , O
in IN O
Japanese JJ O
populations NNS O
of IN O
60 CD O
- : O
year NN O
- : O
old JJ O
( -LRB- O
n NN O
= SYM O
270 CD O
; : O
120 CD O
males NNS O
and CC O
150 CD O
females NNS O
) -RRB- O
and CC O
65 CD O
- : O
year NN O
- : O
old JJ O
( -LRB- O
n NN O
= SYM O
123 CD O
; : O
57 CD O
males NNS O
and CC O
66 CD O
females NNS O
) -RRB- O
individuals NNS O
residing VBG O
in IN O
Fukuoka NNP O
Prefecture NNP O
of IN O
Japan NNP O
. . O

Dental JJ O
examinations NNS O
were VBD O
performed VBN O
in IN O
all DT O
subjects NNS O
, , O
along IN O
with IN O
the DT O
Mini NNP O
- : O
mental JJ O
state NN O
examination NN O
( -LRB- O
MMSE NNP O
) -RRB- O
for IN O
assessing VBG O
cognitive JJ O
function NN O
. . O

Among IN O
the DT O
total NN O
of IN O
393 CD O
subjects NNS O
, , O
the DT O
mean JJ O
MMSE NNP O
score NN O
was VBD O
27 CD O
. . O
9 CD O
+ NN O
/ IN O
- : O
1 LS O
. . O
9 CD O
, , O
and CC O
391 CD O
subjects NNS O
scored VBD O
24 CD O
or CC O
higher JJR O
. . O

The DT O
mean JJ O
numbers NNS O
of IN O
sound JJ O
and CC O
decayed JJ O
teeth NNS O
were VBD O
12 CD O
. . O
0 CD O
+ NN O
/ NNS O
- : O
6 CD O
. . O
3 CD O
and CC O
0 CD O
. . O
5 CD O
+ NN O
/ IN O
- : O
1 LS O
. . O
2 CD O
, , O
respectively RB O
. . O

Associations NNS O
were VBD O
found VBN O
between IN O
the DT O
numbers NNS O
of IN O
sound JJ O
and CC O
decayed JJ O
teeth NNS O
and CC O
MMSE NNP O
in IN O
total JJ O
subjects NNS O
and CC O
males NNS O
, , O
but CC O
not RB O
in IN O
females NNS O
, , O
by IN O
multiple JJ O
regression NN O
analysis NN O
adjusted VBN O
for IN O
gender NN O
, , O
age NN O
, , O
level NN O
of IN O
education NN O
, , O
marital JJ O
status NN O
, , O
smoking NN O
, , O
alcohol NN O
drinking NN O
, , O
working VBG O
status NN O
, , O
systolic JJ O
blood NN O
pressure NN O
and CC O
blood NN O
glucose NN O
. . O

An DT O
association NN O
was VBD O
also RB O
found VBN O
between IN O
MMSE NNP O
and CC O
the DT O
number NN O
of IN O
sound JJ O
teeth NNS O
in IN O
a DT O
logistic JJ O
regression NN O
analysis NN O
. . O

In IN O
conclusion NN O
, , O
associations NNS O
were VBD O
found VBN O
between IN O
normal JJ O
- : O
range NN O
cognitive NN O
function NN O
and CC O
the DT O
numbers NNS O
of IN O
sound JJ O
and CC O
decayed JJ O
teeth NNS O
, , O
after IN O
adjustment NN O
for IN O
various JJ O
confounding JJ O
factors NNS O
, , O
in IN O
an DT O
elderly JJ O
Japanese JJ O
population NN O
. . O

-DOCSTART- X X O

Magnesium NNP O
for IN O
treatment NN O
of IN O
asthma NN O
in IN O
children NNS O
. . O

QUESTION NN O
: : O
Magnesium NNP O
is VBZ O
considered VBN O
adjuvant JJ O
therapy NN O
for IN O
moderate JJ O
to TO O
severe JJ O
asthma NN O
exacerbations NNS O
in IN O
adults NNS O
, , O
but CC O
can MD O
it PRP O
be VB O
used VBN O
to TO O
treat VB O
children NNS O
? . O

ANSWER NNP O
: : O
Magnesium NNP O
seems VBZ O
to TO O
be VB O
beneficial JJ O
in IN O
the DT O
treatment NN O
of IN O
moderate JJ O
to TO O
severe JJ O
asthma NN O
in IN O
children NNS O
. . O

It PRP O
is VBZ O
a DT O
safe JJ O
drug NN O
to TO O
administer VB O
, , O
but CC O
there EX O
have VBP O
been VBN O
minor JJ O
side NN O
effects NNS O
reported VBD O
, , O
such JJ O
as IN O
epigastric JJ O
or CC O
facial JJ O
warmth NN O
, , O
flushing NN O
, , O
pain NN O
and CC O
numbness NN O
at IN O
the DT O
infusion NN O
site NN O
, , O
dry JJ O
mouth NN O
, , O
malaise NN O
, , O
and CC O
hypotension NN O
. . O

Owing VBG O
to TO O
its PRP$ O
bronchodilating NN O
and CC O
anti NNS O
- : O
inflammatory JJ O
effects NNS O
, , O
magnesium NN O
is VBZ O
an DT O
encouraging JJ O
adjuvant JJ O
therapy NN O
for IN O
pediatric JJ O
patients NNS O
who WP O
do VBP O
not RB O
respond VB O
to TO O
conventional JJ O
treatment NN O
in IN O
acute JJ O
severe JJ O
exacerbations NNS O
. . O

Future JJ O
studies NNS O
should MD O
focus VB O
on IN O
establishing VBG O
the DT O
optimal JJ O
dosage NN O
for IN O
maximal JJ O
benefits NNS O
and CC O
the DT O
best JJS O
route NN O
of IN O
administration NN O
. . O

Magnesium NNP O
should MD O
also RB O
be VB O
considered VBN O
as IN O
a DT O
prophylactic JJ O
treatment NN O
. . O

-DOCSTART- X X O

AVE8062 NN O
: : O
a DT O
new JJ O
combretastatin NN O
derivative JJ O
vascular JJ O
disrupting NN O
agent NN O
. . O

Angiogenesis NNP O
has VBZ O
an DT O
essential JJ O
role NN O
in IN O
promoting VBG O
and CC O
supporting VBG O
tumor NN O
growth NN O
and CC O
it PRP O
is VBZ O
an DT O
important JJ O
therapeutic JJ O
target NN O
. . O

The DT O
tumor NN O
vascular JJ O
network NN O
is VBZ O
the DT O
result NN O
of IN O
pro FW O
- : O
angiogenic JJ O
and CC O
inhibitory JJ O
factors NNS O
as RB O
well RB O
as IN O
of IN O
the DT O
interaction NN O
between IN O
endothelial JJ O
cells NNS O
and CC O
extracellular JJ O
matrix NN O
. . O

Different JJ O
antiangiogenic JJ O
therapeutics NNS O
have VBP O
been VBN O
developed VBN O
to TO O
improve VB O
tumor NN O
control NN O
through IN O
vascular JJ O
- : O
targeting VBG O
agents NNS O
( -LRB- O
VTA NNP O
) -RRB- O
. . O

VTAs NNS O
can MD O
be VB O
divided VBN O
into IN O
two CD O
groups NNS O
: : O
antiangiogenic JJ O
agents NNS O
and CC O
vascular JJ O
- : O
disrupting VBG O
agents NNS O
( -LRB- O
VDAs NNS O
) -RRB- O
. . O

VTAs NNP O
inhibit VBP O
specific JJ O
factors NNS O
required VBN O
to TO O
induce VB O
and CC O
direct VB O
the DT O
angiogenic JJ O
process NN O
, , O
with IN O
major JJ O
activity NN O
against IN O
small JJ O
tumor NN O
masses NNS O
and CC O
at IN O
the DT O
tumor NN O
periphery NN O
, , O
encompassing VBG O
monoclonal JJ O
antibodies NNS O
and CC O
small JJ O
molecules NNS O
inhibitors NNS O
of IN O
the DT O
tyrosine NN O
kinase NN O
domain NN O
of IN O
the DT O
VEGF NN O
receptor NN O
. . O

VDAs NNP O
specifically RB O
target NN O
and CC O
destroy VB O
well RB O
- : O
established VBN O
tumor NN O
vessels NNS O
with IN O
ischemia NN O
and CC O
destruction NN O
of IN O
large JJ O
masses NNS O
with IN O
central JJ O
hemorrhagic NN O
necrosis NN O
and CC O
survival NN O
of IN O
a DT O
thin JJ O
peripheral JJ O
tumor NN O
layer NN O
. . O

VDAs NNS O
can MD O
be VB O
divided VBN O
into IN O
biologics NNS O
, , O
such JJ O
as IN O
ligand NN O
- : O
based VBN O
, , O
and CC O
small JJ O
- : O
molecule JJ O
agents NNS O
; : O
this DT O
second JJ O
group NN O
includes VBZ O
small JJ O
- : O
molecule NN O
VDAs NNS O
like IN O
flavonoids NNS O
, , O
such JJ O
as IN O
5 CD O
, , O
6 CD O
- : O
dimethylxanthenone NN O
- : O
4 LS O
- : O
acetic JJ O
acid NN O
( -LRB- O
DMXAA NNP O
) -RRB- O
, , O
and CC O
microtubule JJ O
- : O
destabilizing JJ O
agents NNS O
. . O

In IN O
this DT O
review NN O
we PRP O
will MD O
discuss VB O
the DT O
mechanism NN O
of IN O
action NN O
, , O
as RB O
well RB O
as IN O
the DT O
preclinical JJ O
and CC O
clinical JJ O
results NNS O
, , O
of IN O
one CD O
of IN O
the DT O
most RBS O
promising JJ O
antitubulin NN O
agents NNS O
: : O
the DT O
combretastatin NN O
A4 IN O
- : O
phosphate JJ O
derivative JJ O
, , O
AVE8062A NNP O
. . O

-DOCSTART- X X O

Targeting VBG O
TNF NNP O
for IN O
Treatment NNP O
of IN O
Cancer NNP O
and CC O
Autoimmunity NNP O
. . O

Tumor NN O
necrosis NN O
factor NN O
- : O
alpha NN O
( -LRB- O
TNF NNP O
- : O
alpha NN O
) -RRB- O
was VBD O
first RB O
isolated VBN O
two CD O
decades NNS O
ago RB O
as IN O
a DT O
macrophageproduced JJ O
protein NN O
that WDT O
can MD O
effectively RB O
kill VB O
tumor NN O
cells NNS O
. . O

TNF NNP O
- : O
alpha NN O
is VBZ O
also RB O
an DT O
essential JJ O
component NN O
of IN O
the DT O
immune JJ O
system NN O
and CC O
is VBZ O
required VBN O
for IN O
hematopoiesis NN O
, , O
for IN O
protection NN O
from IN O
bacterial JJ O
infection NN O
and CC O
for IN O
immune JJ O
cell NN O
- : O
mediated JJ O
cytotoxicity NN O
. . O

Extensive JJ O
research NN O
, , O
however RB O
, , O
has VBZ O
revealed VBN O
that IN O
TNF NNP O
- : O
alpha NN O
is VBZ O
one CD O
of IN O
the DT O
major JJ O
players NNS O
in IN O
tumor NN O
initiation NN O
, , O
proliferation NN O
, , O
invasion NN O
, , O
angiogenesis NN O
and CC O
metastasis NN O
. . O

The DT O
proinflammatory NN O
activities NNS O
link VBP O
TNF NNP O
- : O
alpha NN O
with IN O
a DT O
wide JJ O
variety NN O
of IN O
autoimmune JJ O
diseases NNS O
, , O
including VBG O
psoriasis NN O
, , O
inflammatory NN O
bowel NN O
disease NN O
, , O
rheumatoid NN O
arthritis NN O
, , O
systemic JJ O
sclerosis NN O
, , O
systemic JJ O
lupus FW O
erythematosus FW O
, , O
multiple JJ O
sclerosis NN O
, , O
diabetes NNS O
and CC O
ankylosing NN O
spondylitis NN O
. . O

Systemic JJ O
inhibitors NNS O
of IN O
TNF NNP O
such JJ O
as IN O
etanercept NN O
( -LRB- O
Enbrel NN O
) -RRB- O
( -LRB- O
a DT O
soluble JJ O
TNF NN O
receptor NN O
) -RRB- O
and CC O
infliximab NN O
( -LRB- O
Remicade NNP O
) -RRB- O
and CC O
adalimumab NN O
( -LRB- O
Humira NNP O
) -RRB- O
( -LRB- O
anti FW O
- : O
TNF NN O
antibodies NNS O
) -RRB- O
have VBP O
been VBN O
approved VBN O
for IN O
the DT O
treatment NN O
inflammatory NN O
bowel NN O
disease NN O
, , O
psoriasis NN O
and CC O
rheumatoid NN O
arthritis NN O
. . O

These DT O
drugs NNS O
, , O
however RB O
, , O
exhibit VBP O
severe JJ O
side NN O
effects NNS O
and CC O
are VBP O
expensive JJ O
. . O

Hence RB O
orally RB O
active JJ O
blockers NNS O
of IN O
TNF NNP O
- : O
alpha NN O
that WDT O
are VBP O
safe JJ O
, , O
efficacious JJ O
and CC O
inexpensive JJ O
are VBP O
urgently RB O
needed VBN O
. . O

Numerous JJ O
products NNS O
from IN O
fruits NNS O
, , O
vegetable NN O
and CC O
traditional JJ O
medicinal JJ O
plants NNS O
have VBP O
been VBN O
described VBN O
which WDT O
can MD O
suppress VB O
TNF NNP O
expression NN O
and CC O
TNF NNP O
signaling VBG O
but CC O
their PRP$ O
clinical JJ O
potential NN O
is VBZ O
yet RB O
uncertain JJ O
. . O

-DOCSTART- X X O

[ NNS O
Prognostic JJ O
significance NN O
of IN O
cellular JJ O
vascular JJ O
endothelial NN O
growth NN O
factor NN O
( -LRB- O
VEGF NN O
) -RRB- O
expression NN O
in IN O
the DT O
course NN O
of IN O
chronic JJ O
myeloid JJ O
leukaemia NN O
] . O

INTRODUCTION NN O
: : O
Increased VBN O
angiogenesis NN O
in IN O
bone NN O
marrow NN O
is VBZ O
one CD O
of IN O
the DT O
characteristics NNS O
of IN O
chronic JJ O
myeloid JJ O
leukaemia NN O
( -LRB- O
CML NNP O
) -RRB- O
, , O
a DT O
clonal JJ O
myeloproliferative JJ O
disorder NN O
that WDT O
expresses VBZ O
a DT O
chimeric JJ O
bcr NN O
/ IN O
abl JJ O
protein NN O
. . O

Vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
VEGF NN O
) -RRB- O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
potent JJ O
and CC O
a DT O
specific JJ O
regulator NN O
of IN O
angiogenesis NN O
which WDT O
principally RB O
targets VBZ O
endothelial JJ O
cells NNS O
and CC O
regulates VBZ O
several JJ O
of IN O
their PRP$ O
functions NNS O
, , O
including VBG O
mitogenesis NN O
, , O
permeability NN O
and CC O
migration NN O
. . O

The DT O
impact NN O
of IN O
elevated JJ O
VEGF NN O
expression NN O
on IN O
the DT O
course NN O
of IN O
chronic JJ O
myeloid JJ O
leukaemia NN O
is VBZ O
unknown JJ O
. . O

OBJECTIVE VBP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
the DT O
follow VBP O
- : O
up RB O
of IN O
VEGF NNP O
expression NN O
during IN O
the DT O
course NN O
of IN O
CML NNP O
. . O

METHODS NNS O
: : O
We PRP O
studied VBD O
VEGF NNP O
expression NN O
of IN O
85 CD O
CML NNP O
patients NNS O
( -LRB- O
median JJ O
age NN O
50 CD O
years NNS O
, , O
range NN O
16 CD O
- : O
75 CD O
years NNS O
) -RRB- O
. . O

At IN O
the DT O
commencement NN O
of IN O
the DT O
study NN O
, , O
29 CD O
patients NNS O
were VBD O
in IN O
chronic JJ O
phase NN O
( -LRB- O
CP CD O
) -RRB- O
, , O
25 CD O
in IN O
an DT O
accelerated VBN O
phase NN O
( -LRB- O
AP NNP O
) -RRB- O
, , O
and CC O
31 CD O
in IN O
the DT O
blast NN O
crisis NN O
( -LRB- O
BC NNP O
) -RRB- O
. . O

The DT O
temporal JJ O
expression NN O
( -LRB- O
percentage NN O
positivity NN O
per IN O
1000 CD O
analysed JJ O
cells NNS O
) -RRB- O
VEGF RB O
proteins VBZ O
over IN O
the DT O
course NN O
of IN O
CML NNP O
were VBD O
studied VBN O
using VBG O
the DT O
immunohistochemical JJ O
technique NN O
utilizing VBG O
relevant JJ O
monoclonal JJ O
antibodies NNS O
. . O

It PRP O
was VBD O
correlated VBN O
with IN O
the DT O
laboratory NN O
( -LRB- O
Hb NNP O
, , O
WBC NNP O
and CC O
platelet NN O
counts NNS O
, , O
and CC O
the DT O
percentage NN O
of IN O
blasts NNS O
) -RRB- O
and CC O
clinical JJ O
parameters NNS O
( -LRB- O
organomegaly NN O
, , O
duration NN O
of IN O
CP CD O
, , O
AP NNP O
, , O
and CC O
BC NNP O
) -RRB- O
of IN O
disease NN O
progression NN O
. . O

RESULTS NNS O
: : O
The DT O
expression NN O
ofVEGF IN O
protein NN O
was VBD O
most JJS O
pronounced VBN O
in IN O
AP NNP O
( -LRB- O
ANOVA NNP O
, , O
p NN O
= SYM O
0 CD O
. . O
033 CD O
) -RRB- O
. . O

The DT O
level NN O
of IN O
VEGF NNP O
expression NN O
correlated VBD O
inversely RB O
with IN O
the DT O
degree NN O
of IN O
splenomegaly RB O
( -LRB- O
Pearson NNP O
, , O
r NN O
= SYM O
- : O
0 CD O
. . O
400 CD O
, , O
p NN O
= SYM O
0 CD O
. . O
011 CD O
) -RRB- O
. . O

High JJ O
expression NN O
of IN O
VEGF NNP O
correlated VBD O
with IN O
a DT O
shorter JJR O
overall JJ O
survival NN O
( -LRB- O
log NN O
rank NN O
, , O
p NN O
= SYM O
0 CD O
. . O
042 CD O
) -RRB- O
. . O

CONCLUSION NN O
: : O
Immunohistochemically NNP O
confirmed VBD O
significance NN O
of IN O
the DT O
expression NN O
of IN O
VEGF NNP O
in IN O
dependence NN O
of IN O
the DT O
CML NNP O
stage NN O
could MD O
be VB O
of IN O
clinical JJ O
importance NN O
in IN O
deciding VBG O
on IN O
the DT O
timing NN O
therapy NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
VEGF NNP O
plays VBZ O
a DT O
role NN O
in IN O
the DT O
biology NN O
of IN O
CML NNP O
and CC O
that DT O
VEGF NNP O
inhibitors NNS O
should MD O
be VB O
investigated VBN O
in IN O
CML NNP O
. . O

-DOCSTART- X X O

Pbx1 NNP O
is VBZ O
a DT O
downstream NN O
target NN O
of IN O
Evi NNP O
- : O
1 CD O
in IN O
hematopoietic JJ O
stem NN O
/ NN O
progenitors NNS O
and CC O
leukemic JJ O
cells NNS O
. . O

Ecotropic NNP O
viral JJ O
integration NN O
site NN O
- : O
1 CD O
( -LRB- O
Evi NNP O
- : O
1 CD O
) -RRB- O
is VBZ O
a DT O
nuclear JJ O
transcription NN O
factor NN O
, , O
which WDT O
is VBZ O
essential JJ O
for IN O
the DT O
proliferation NN O
/ IN O
maintenance NN O
of IN O
hematopoietic JJ O
stem NN O
cells NNS O
( -LRB- O
HSCs NNS O
) -RRB- O
. . O

Aberrant JJ O
expression NN O
of IN O
Evi NNP O
- : O
1 CD O
has VBZ O
been VBN O
frequently RB O
found VBN O
in IN O
myeloid JJ O
leukemia NN O
, , O
and CC O
is VBZ O
associated VBN O
with IN O
a DT O
poor JJ O
patient NN O
survival NN O
. . O

Recently RB O
, , O
we PRP O
reported VBD O
candidate NN O
target NN O
genes NNS O
of IN O
Evi NNP O
- : O
1 CD O
shared VBN O
in IN O
HSCs NNP O
and CC O
leukemic JJ O
cells NNS O
using VBG O
gene NN O
expression NN O
profiling NN O
analysis NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
identified VBD O
Pbx1 NNP O
, , O
a DT O
proto NN O
- : O
oncogene NN O
in IN O
hematopoietic JJ O
malignancy NN O
, , O
as IN O
a DT O
target NN O
gene NN O
of IN O
Evi NNP O
- : O
1 CD O
. . O

Overexpression IN O
of IN O
Evi NNP O
- : O
1 CD O
increased VBN O
Pbx1 CD O
expression NN O
in IN O
hematopoietic JJ O
stem NN O
/ IN O
progenitor NN O
cells NNS O
. . O

An DT O
analysis NN O
of IN O
the DT O
Pbx1 NNP O
promoter NN O
region NN O
revealed VBD O
that IN O
Evi NNP O
- : O
1 CD O
upregulates NNS O
Pbx1 JJ O
transcription NN O
. . O

Furthermore RB O
, , O
reduction NN O
of IN O
Pbx1 JJ O
levels NNS O
through IN O
RNAi NNP O
- : O
mediated JJ O
knockdown NN O
significantly RB O
inhibited VBD O
Evi NNP O
- : O
1 LS O
- : O
induced VBN O
transformation NN O
. . O

In IN O
contrast NN O
, , O
knockdown NN O
of IN O
Pbx1 NNP O
did VBD O
not RB O
impair NN O
bone NN O
marrow NN O
transformation NN O
by IN O
E2A NNP O
/ NNP O
HLF NNP O
or CC O
AML1 NNP O
/ NNP O
ETO NNP O
, , O
suggesting VBG O
that IN O
Pbx1 NNP O
is VBZ O
specifically RB O
required VBN O
for IN O
the DT O
maintenance NN O
of IN O
bone NN O
marrow NN O
transformation NN O
mediated VBN O
by IN O
Evi NNP O
- : O
1 CD O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
Pbx1 NNP O
is VBZ O
a DT O
target NN O
gene NN O
of IN O
Evi NNP O
- : O
1 CD O
involved VBN O
in IN O
Evi NNP O
- : O
1 LS O
- : O
mediated JJ O
leukemogenesis NN O
. . O

-DOCSTART- X X O

Inducible JJ O
nitric JJ O
oxide NN O
synthase NN O
modulates NNS O
angiogenesis NN O
in IN O
ischemic JJ O
hindlimb NN O
of IN O
rat NN O
. . O

BACKGROUND NNP O
: : O
Angiogenesis NNP O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
maintaining VBG O
adequate JJ O
oxygen NN O
delivery NN O
, , O
and CC O
nitric JJ O
oxide NN O
( -LRB- O
NO DT O
) -RRB- O
is VBZ O
a DT O
potential JJ O
regulator NN O
of IN O
angiogenesis NN O
. . O

NO DT O
is VBZ O
synthesized VBN O
through IN O
three CD O
isoforms NNS O
of IN O
NO DT O
synthase NN O
( -LRB- O
NOS NNP O
) -RRB- O
. . O

It PRP O
is VBZ O
hypothesized VBN O
that IN O
the DT O
NO RB O
derived VBN O
from IN O
inducible JJ O
NOS NNS O
( -LRB- O
iNOS NNS O
) -RRB- O
may MD O
promote VB O
survival NN O
of IN O
ischemic JJ O
tissue NN O
through IN O
angiogenesis NN O
. . O

To TO O
test VB O
this DT O
hypothesis NN O
, , O
we PRP O
investigated VBD O
the DT O
effect NN O
of IN O
iNOS JJ O
deficiency NN O
( -LRB- O
by IN O
L NNP O
- : O
NIL NN O
) -RRB- O
on IN O
angiogenesis NN O
in IN O
a DT O
hindlimb JJ O
ischemia NN O
model NN O
. . O

METHODS NNS O
: : O
Thirty CD O
- : O
two CD O
male JJ O
wistar NN O
rats NNS O
randomly RB O
divided VBN O
into IN O
four CD O
groups NNS O
. . O

In IN O
groups NNS O
1 CD O
& CC O
2 CD O
, , O
hindlimb NN O
ischemia NN O
was VBD O
induced VBN O
by IN O
ligation NN O
of IN O
femoral JJ O
artery NN O
and CC O
they PRP O
received VBD O
L NNP O
- : O
NIL NN O
and CC O
saline NN O
respectively RB O
. . O

The DT O
animals NNS O
in IN O
groups NNS O
3 CD O
and CC O
4 CD O
also RB O
received VBN O
L NNP O
- : O
NIL NN O
and CC O
saline NN O
respectively RB O
without IN O
surgical JJ O
procedure NN O
. . O

After IN O
21 CD O
days NNS O
, , O
the DT O
serum NN O
concentration NN O
of IN O
nitrite JJ O
, , O
capillary NN O
density NN O
and CC O
expression NN O
of IN O
HIF1alpha NNP O
were VBD O
determined VBN O
. . O

RESULTS NNS O
: : O
Serum NN O
nitrite JJ O
levels NNS O
were VBD O
significantly RB O
lower JJR O
in IN O
L NNP O
- : O
NIL JJ O
groups NNS O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

The DT O
capillary NN O
density NN O
in IN O
group NN O
1 CD O
( -LRB- O
ischemia NN O
+ NN O
L NNP O
- : O
NIL NN O
) -RRB- O
was VBD O
significantly RB O
different JJ O
from IN O
group NN O
2 CD O
( -LRB- O
ischemia NN O
+ JJ O
saline NN O
) -RRB- O
; : O
group NN O
1 CD O
: : O
360 CD O
. . O
33 CD O
+ NN O
/ NN O
- : O
77 CD O
. . O
02 CD O
, , O
group NN O
2 CD O
: : O
549 CD O
+ NN O
/ NN O
- : O
81 CD O
. . O
85 CD O
/ NN O
mm2 CD O
, , O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O
In IN O
addition NN O
, , O
expression NN O
of IN O
HIF1alpha NNP O
was VBD O
significantly RB O
increased VBN O
in IN O
ischemic JJ O
groups NNS O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

CONCLUSION NN O
: : O
Selective JJ O
inhibition NN O
of IN O
iNOS NNS O
by IN O
L NNP O
- : O
NIL NNP O
inhibits VBZ O
angiogenesis NN O
in IN O
a DT O
hindlimb JJ O
ischemic JJ O
rat NN O
model NN O
. . O

In IN O
addition NN O
, , O
ischemia NN O
induces VBZ O
expression NN O
of IN O
HIF1alpha NNP O
in IN O
hypoxic JJ O
tissue NN O
. . O

-DOCSTART- X X O

Tumor NN O
Angiogenesis NNP O
: : O
Initiation NNP O
and CC O
Targeting NNP O
- : O
Therapeutic JJ O
Targeting NN O
of IN O
an DT O
FGF NNP O
- : O
Binding JJ O
Protein NNP O
, , O
an DT O
Angiogenic NNP O
Switch NNP O
Molecule NNP O
, , O
and CC O
Indicator NNP O
of IN O
Early NNP O
Stages NNP O
of IN O
Gastrointestinal NNP O
Adenocarcinomas NNP O
- : O
. . O

Tumor NN O
angiogenesis NN O
has VBZ O
been VBN O
related VBN O
to TO O
the DT O
initiation NN O
as RB O
well RB O
as IN O
progression NN O
toward IN O
more RBR O
aggressive JJ O
behavior NN O
of IN O
human JJ O
tumors NNS O
. . O

In IN O
particular JJ O
, , O
the DT O
activity NN O
of IN O
angiogenic JJ O
factors NNS O
is VBZ O
crucial JJ O
for IN O
tumor NN O
progression NN O
. . O

We PRP O
previously RB O
characterized VBD O
a DT O
secreted JJ O
fibroblast JJ O
growth NN O
factor NN O
- : O
binding JJ O
protein NN O
( -LRB- O
FGF NN O
- : O
BP NNP O
) -RRB- O
as IN O
a DT O
chaperone NN O
molecule NN O
, , O
which WDT O
binds VBZ O
to TO O
various JJ O
FGFs NNS O
, , O
enhances NNS O
FGF IN O
- : O
mediated JJ O
biochemical JJ O
and CC O
biologic JJ O
events NNS O
and CC O
importantly RB O
is VBZ O
a DT O
crucial JJ O
rate NN O
- : O
limiting VBG O
factor NN O
for IN O
tumor NN O
- : O
dependent JJ O
angiogenesis NN O
. . O

We PRP O
generated VBD O
monoclonal JJ O
antibodies NNS O
that IN O
target NN O
FGF IN O
- : O
BP NNP O
protein NN O
and CC O
used VBD O
them PRP O
as IN O
a DT O
tool NN O
to TO O
evaluate VB O
frequency NN O
and CC O
pattern NN O
of IN O
FGF NNP O
- : O
BP NNP O
expression NN O
during IN O
the DT O
malignant JJ O
progression NN O
of IN O
pancreas NNS O
and CC O
colorectal JJ O
carcinoma NN O
in IN O
archival JJ O
tissue NN O
samples NNS O
. . O

We PRP O
found VBD O
that IN O
FGF NNP O
- : O
BP NNP O
is VBZ O
dramatically RB O
upregulated VBN O
during IN O
the DT O
initiation NN O
of IN O
colorectal NN O
and CC O
pancreatic JJ O
adenocarcinoma NN O
. . O

Crucial JJ O
genetic JJ O
events NNS O
underlying VBG O
the DT O
initiation NN O
and CC O
progression NN O
of IN O
colorectal JJ O
and CC O
pancreatic JJ O
adenocarcinoma NN O
with IN O
a DT O
particular JJ O
focus NN O
on IN O
the DT O
modulation NN O
of IN O
angiogenesis NN O
and CC O
antiangiogenic JJ O
therapies NNS O
are VBP O
discussed VBN O
. . O

We PRP O
propose VBP O
that IN O
the DT O
upregulation NN O
of IN O
the DT O
secreted VBN O
FGF NNP O
- : O
BP NNP O
protein NN O
during IN O
early JJ O
phases NNS O
of IN O
pancreas NNS O
and CC O
colon NN O
cancer NN O
could MD O
make VB O
this DT O
protein NN O
a DT O
possible JJ O
serum NN O
marker NN O
indicating VBG O
the DT O
presence NN O
of IN O
high JJ O
- : O
risk NN O
premalignant NN O
lesions NNS O
. . O

Furthermore RB O
, , O
the DT O
biological JJ O
activity NN O
of IN O
FGF NNP O
- : O
BP NNP O
is VBZ O
neutralized VBN O
by IN O
monoclonal JJ O
antibodies NNS O
suggesting VBG O
the DT O
potential JJ O
for IN O
antibody NN O
- : O
based VBN O
therapeutic JJ O
targeting VBG O
. . O

-DOCSTART- X X O

Range NNP O
of IN O
motion NN O
limitation NN O
after IN O
rotator NN O
cuff NN O
repair NN O
. . O

HYPOTHESIS NNP O
: : O

This DT O
study NN O
was VBD O
conducted VBN O
to TO O
identify VB O
preoperative JJ O
factors NNS O
correlating VBG O
with IN O
limited JJ O
motion NN O
after IN O
rotator NN O
cuff NN O
repair NN O
( -LRB- O
RCR NN O
) -RRB- O
and CC O
to TO O
evaluate VB O
the DT O
affect VBP O
of IN O
loss NN O
of IN O
motion NN O
on IN O
outcome NN O
. . O

We PRP O
hypothesized VBD O
that IN O
patients NNS O
with IN O
preoperative JJ O
ROM NNP O
loss NN O
, , O
diabetes NNS O
, , O
and CC O
workman NN O
' '' O
s PRP O
compensation NN O
claims NNS O
would MD O
exhibit VB O
postoperative JJ O
ROM NNP O
loss NN O
at IN O
3 CD O
months NNS O
. . O

MATERIAL NNP O
AND CC O
METHODS NNP O
: : O

Preoperative JJ O
and CC O
postoperative JJ O
evaluations NNS O
, , O
including VBG O
outcomes NNS O
assessment NN O
and CC O
physical JJ O
examination NN O
parameters NNS O
, , O
were VBD O
reviewed VBN O
for IN O
345 CD O
patients NNS O
who WP O
underwent VBD O
RCR NNP O
. . O

Correlations NNS O
between IN O
demographic JJ O
, , O
physical JJ O
examination NN O
, , O
and CC O
surgical JJ O
variables NNS O
and CC O
postoperative JJ O
limitation NN O
of IN O
motion NN O
and CC O
need NN O
for IN O
capsular JJ O
release NN O
were VBD O
determined VBN O
. . O

RESULTS NNS O
: : O

At IN O
3 CD O
- : O
month NN O
follow VB O
- : O
up RP O
, , O
mean VB O
active JJ O
forward RB O
elevation NN O
( -LRB- O
AFE NNP O
) -RRB- O
, , O
active JJ O
external JJ O
rotation NN O
( -LRB- O
AER NNP O
) -RRB- O
, , O
and CC O
passive JJ O
internal JJ O
rotation NN O
( -LRB- O
PIR NN O
) -RRB- O
were VBD O
90 CD O
% NN O
, , O
78 CD O
% NN O
, , O
and CC O
80 CD O
% NN O
of IN O
the DT O
contralateral JJ O
side NN O
. . O

Limitation NN O
of IN O
preoperative JJ O
motion NN O
correlated VBN O
with IN O
limitation NN O
of IN O
postoperative JJ O
AFE NNS O
, , O
AER NNP O
, , O
and CC O
PIR NNP O
( -LRB- O
P NNP O
< NNP O
. . O
001 CD O
) -RRB- O
. . O

Forty CD O
- : O
seven CD O
patients NNS O
considered VBD O
clinically VBG O
stiff JJ O
were VBD O
followed VBN O
at IN O
1 CD O
year NN O
postoperatively RB O
. . O

Three CD O
patients NNS O
required VBD O
arthroscopic JJ O
capsular JJ O
release NN O
for IN O
persistent JJ O
range NN O
of IN O
motion NN O
loss NN O
. . O

CONCLUSION NN O
: : O

Early RB O
postoperative JJ O
limitation NN O
of IN O
motion NN O
after IN O
RCR NNP O
is VBZ O
associated VBN O
with IN O
restricted JJ O
preoperative JJ O
motion NN O
. . O

Other JJ O
factors NNS O
, , O
including VBG O
diabetes NNS O
mellitus JJ O
and CC O
worker NN O
' '' O
s VBZ O
compensation NN O
claim NN O
, , O
are VBP O
also RB O
associated VBN O
with IN O
range NN O
of IN O
motion NN O
loss NN O
. . O

Most RBS O
shoulders NNS O
with IN O
early JJ O
motion NN O
loss NN O
recover VBP O
motion NN O
and CC O
rarely RB O
require VBP O
capsular JJ O
release NN O
. . O

-DOCSTART- X X O

[ JJ O
Effect NN O
of IN O
osteopontin NN O
silencing NN O
by IN O
lentivirus NN O
- : O
mediated JJ O
delivery NN O
of IN O
siRNA NN O
on IN O
glioma NN O
cell NN O
invasion NN O
and CC O
apoptosis NN O
] NN O
. . O

OBJECTIVE CD O
: : O
To TO O
investigate VB O
the DT O
effect NN O
of IN O
osteopontin NN O
silencing NN O
on IN O
the DT O
invasion NN O
and CC O
apoptosis NN O
of IN O
U251 NNP B-NP
cells NNS O
. . O

METHODS NNP O
: : O
The DT O
invasion NN O
, , O
apoptosis NN O
and CC O
levels NNS O
of IN O
uPA NNP O
, , O
MMP NNP O
- : O
2 CD O
and CC O
MMP NNP O
- : O
9 CD O
were VBD O
determined VBN O
by IN O
invasion NN O
assay NN O
, , O
flow NN O
cytometry NN O
, , O
Western JJ O
blot NN O
and CC O
real JJ O
- : O
time NN O
fluorescence NN O
quantitative JJ O
PCR NN O
respectively RB O
. . O

RESULTS NNS O
: : O
Osteopontin NNP O
small JJ O
interference NN O
RNA NNP O
( -LRB- O
siRNA NN O
) -RRB- O
inhibited VBD O
osteopontin JJ O
expression NN O
and CC O
cell NN O
invasion NN O
, , O
promoted VBN O
apoptosis NN O
in IN O
U251 NNP B-NP
cells NNS O
. . O

In IN O
addition NN O
, , O
the DT O
expression NN O
of IN O
Bcl NNP O
- : O
2 CD O
, , O
uPA NNP O
, , O
MMP NNP O
- : O
2 CD O
and CC O
MMP NNP O
- : O
9 CD O
was VBD O
decreased VBN O
, , O
while IN O
Bax NNP O
level NN O
was VBD O
elevated VBN O
. . O

CONCLUSION NN O
: : O
Osteopontin NNP O
siRNA NNS O
can MD O
inhibit VB O
U251 IN B-NP
cells NNS O
invasion NN O
via IN O
the DT O
down RP O
- : O
regulation NN O
of IN O
uPA NNP O
, , O
MMP NNP O
- : O
2 CD O
and CC O
MMP NNP O
- : O
9 CD O
levels NNS O
, , O
and CC O
promote VBP O
apoptosis NN O
through IN O
induction NN O
of IN O
Bax NNP O
expression NN O
and CC O
inhibition NN O
of IN O
Bcl JJ O
2 CD O
level NN O
. . O

It PRP O
suggests VBZ O
that IN O
osteopontin NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
human JJ O
glioma NN O
progression NN O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
hypoxia NN O
in IN O
2 CD O
- : O
butoxyethanol NN O
- : O
induced VBN O
hemangiosarcoma NN O
. . O

To TO O
understand VB O
the DT O
molecular JJ O
mechanisms NNS O
underlying VBG O
compound NN O
- : O
induced JJ O
hemangiosarcomas NN O
in IN O
mice NNS O
, , O
and CC O
therefore RB O
, , O
their PRP$ O
human JJ O
relevance NN O
, , O
a DT O
systems NNS O
biology NN O
approach NN O
was VBD O
undertaken VBN O
using VBG O
transcriptomics NNS O
and CC O
Causal VB O
Network NNP O
Modeling NNP O
from IN O
mice NNS O
treated VBN O
with IN O
2 CD O
- : O
butoxyethanol NN O
( -LRB- O
2 LS O
- : O
BE VB O
) -RRB- O
. . O

2 LS O
- : O
BE NN O
is VBZ O
a DT O
hemolytic JJ O
agent NN O
that WDT O
induces VBZ O
hemangiosarcomas NNS O
in IN O
mice NNS O
. . O

We PRP O
hypothesized VBD O
that IN O
the DT O
hemolysis NN O
induced VBN O
by IN O
2 CD O
- : O
BE NN O
would MD O
result VB O
in IN O
local JJ O
tissue NN O
hypoxia NN O
, , O
a DT O
well RB O
- : O
documented VBN O
trigger NN O
for IN O
endothelial JJ O
cell NN O
proliferation NN O
leading VBG O
to TO O
hemangiosarcoma NN O
. . O

Gene NNP O
expression NN O
data NNS O
from IN O
bone NN O
marrow NN O
( -LRB- O
BM NNP O
) -RRB- O
, , O
liver NN O
, , O
and CC O
spleen NN O
of IN O
mice NNS O
exposed VBN O
to TO O
a DT O
single JJ O
dose NN O
( -LRB- O
4 CD O
h NN O
) -RRB- O
or CC O
seven CD O
daily JJ O
doses NNS O
of IN O
2 CD O
- : O
BE NN O
were VBD O
used VBN O
to TO O
develop VB O
a DT O
mechanistic JJ O
model NN O
of IN O
hemangiosarcoma NN O
. . O

The DT O
resulting VBG O
mechanistic JJ O
model NN O
confirms VBZ O
previous JJ O
work NN O
proposing VBG O
that IN O
2 CD O
- : O
BE VB O
induces VBZ O
macrophage VB O
activation NN O
and CC O
inflammation NN O
in IN O
the DT O
liver NN O
. . O

In IN O
addition NN O
, , O
the DT O
model NN O
supports VBZ O
local JJ O
tissue NN O
hypoxia NN O
in IN O
the DT O
liver NN O
and CC O
spleen NN O
, , O
coupled VBN O
with IN O
increased JJ O
erythropoeitin NN O
signaling NN O
and CC O
erythropoiesis NN O
in IN O
the DT O
spleen JJ O
and CC O
BM NNP O
, , O
and CC O
suppression NN O
of IN O
mechanisms NNS O
that WDT O
contribute VBP O
to TO O
genomic JJ O
stability NN O
, , O
events NNS O
that WDT O
could MD O
be VB O
contributing VBG O
factors NNS O
to TO O
hemangiosarcoma NN O
formation NN O
. . O

Finally RB O
, , O
an DT O
immunohistochemistry NN O
method NN O
( -LRB- O
Hypoxyprobe NNP O
) -RRB- O
demonstrated VBD O
that IN O
tissue NN O
hypoxia NN O
was VBD O
present JJ O
in IN O
the DT O
spleen JJ O
and CC O
BM NNP O
. . O

Together RB O
, , O
the DT O
results NNS O
of IN O
this DT O
study NN O
identify VB O
molecular JJ O
mechanisms NNS O
that WDT O
initiate VBP O
hemangiosarcoma NN O
, , O
a DT O
key JJ O
step NN O
in IN O
understanding VBG O
safety NN O
concerns NNS O
that WDT O
can MD O
impact VB O
drug NN O
decision NN O
processes VBZ O
, , O
and CC O
identified VBD O
hypoxia NN O
as IN O
a DT O
possible JJ O
contributing VBG O
factor NN O
for IN O
2 CD O
- : O
BE VB O
- : O
induced VBN O
hemangiosarcoma NN O
in IN O
mice NNS O
. . O

-DOCSTART- X X O

Magnitude NNP O
of IN O
malate JJ O
- : O
aspartate NN O
reduced VBN O
nicotinamide JJ O
adenine IN O
dinucleotide NN O
shuttle NN O
activity NN O
in IN O
intact JJ O
respiring JJ O
tumor NN O
cells NNS O
. . O

Measurements NNS O
of IN O
respiration NN O
, , O
CO2 NNP O
and CC O
lactate NN O
production NN O
, , O
and CC O
changes NNS O
in IN O
the DT O
levels NNS O
of IN O
various JJ O
key JJ O
metabolites NNS O
of IN O
the DT O
glycolytic JJ O
sequence NN O
and CC O
tricarboxylic JJ O
acid NN O
cycle NN O
were VBD O
made VBN O
on IN O
five CD O
lines NNS O
of IN O
rodent NN O
ascites VBZ O
tumor NN O
cells NNS O
( -LRB- O
two CD O
strains NNS O
of IN O
Ehrlich NNP O
ascites VBZ O
tumor NN O
cells NNS O
, , O
Krebs NNP B-NP
II NNP I-NP
carcinoma NN O
, , O
AS IN B-NP
- : I-NP
30D JJ I-NP
carcinoma NN O
, , O
and CC O
L1210 JJ B-NP
cells NNS O
) -RRB- O
incubated VBN O
aerobically RB O
in IN O
the DT O
presence NN O
of IN O
uniformly RB O
labeled VBN O
D LS O
- : O
[ JJ O
14C JJ O
] NN O
glucose NN O
. . O

From IN O
these DT O
data NNS O
, , O
as RB O
well RB O
as IN O
earlier JJR O
evidence NN O
demonstrating VBG O
that IN O
the DT O
reduced JJ O
nicotinamide JJ O
adenine NN O
dinucleotide NN O
( -LRB- O
NADH NNP O
) -RRB- O
shuttle NN O
in IN O
these DT O
cells NNS O
requires VBZ O
a DT O
transaminase JJ O
step NN O
and CC O
is VBZ O
thus RB O
identified VBN O
as IN O
the DT O
malate NN O
- : O
aspartate NN O
shuttle NN O
( -LRB- O
W NNP O
. . O
V NNP O
. . O
V NNP O
. . O
Greenhouse NNP O
and CC O
A DT O
. . O
L NNP O
. . O
Lehninger NNP O
, , O
Cancer NNP O
Res NNP O
. . O
, , O
36 CD O
: : O
1392 CD O
- : O
1396 CD O
, , O
1976 CD O
) -RRB- O
, , O
metabolic JJ O
flux NN O
diagrams NNS O
were VBD O
constructed VBN O
for IN O
the DT O
five CD O
cell NN O
lines NNS O
. . O

These DT O
diagrams NNS O
show VBP O
the DT O
relative JJ O
rates NNS O
of IN O
glycolysis NN O
, , O
the DT O
tricarboxylic JJ O
acid NN O
cycle NN O
, , O
electron NN O
transport NN O
, , O
and CC O
the DT O
malate JJ O
- : O
aspartate NN O
shuttle NN O
in IN O
these DT O
tumors NNS O
. . O

Large JJ O
amounts NNS O
of IN O
cytosolic JJ O
NADH NNP O
were VBD O
oxidized VBN O
by IN O
the DT O
mitochondrial JJ O
respiratory NN O
chain NN O
via IN O
the DT O
NADH NNP O
shuttle NN O
, , O
comprising VBG O
anywhere RB O
from IN O
about IN O
20 CD O
to TO O
80 CD O
% NN O
of IN O
the DT O
total JJ O
flow NN O
of IN O
reducing VBG O
equivalents NNS O
to TO O
oxygen NN O
in IN O
these DT O
tumors NNS O
. . O

Calculations NNS O
of IN O
the DT O
sources NNS O
of IN O
energy NN O
for IN O
adenosine JJ O
triphosphate NN O
synthesis NN O
indicated VBD O
that IN O
on IN O
the DT O
average NN O
about IN O
one CD O
- : O
third JJ O
of IN O
the DT O
respiratory NN O
adenosine NN O
triphosphate NN O
is VBZ O
generated VBN O
by IN O
electron NN O
flow NN O
originating VBG O
from IN O
cytosolic JJ O
NADH NNP O
via IN O
the DT O
malate NN O
- : O
aspartate NN O
shuttle NN O
. . O

-DOCSTART- X X O

AKT2 NN O
is VBZ O
a DT O
downstream NN O
target NN O
of IN O
metabotropic JJ O
glutamate NN O
receptor NN O
1 CD O
( -LRB- O
Grm1 NNP O
) -RRB- O
. . O

We PRP O
reported VBD O
earlier RBR O
on IN O
the DT O
oncogenic JJ O
properties NNS O
of IN O
Grm1 NNP O
by IN O
demonstrating VBG O
that DT O
stable JJ O
Grm1 NNP O
- : O
mouse NN O
- : O
melanocytic JJ O
clones NNS O
proliferate VBP O
in IN O
the DT O
absence NN O
of IN O
growth NN O
supplement NN O
and CC O
anchorage NN O
in IN O
vitro NN O
. . O

In IN O
addition NN O
, , O
these DT O
clones NNS O
also RB O
exhibit VBP O
aggressive JJ O
tumorigenic JJ O
phenotypes NNS O
in IN O
vivo NN O
with IN O
short JJ O
latency NN O
in IN O
tumor NN O
formation NN O
in IN O
both DT O
immunodeficient JJ O
and CC O
syngeneic JJ O
mice NNS O
. . O

We PRP O
also RB O
detected VBD O
strong JJ O
activation NN O
of IN O
AKT NNP O
in IN O
allograft NN O
tumors NNS O
specifically RB O
AKT2 IN O
as IN O
the DT O
predominant JJ O
isoform NN O
involved VBN O
. . O

In IN O
parallel RB O
, , O
we PRP O
assessed VBD O
several JJ O
human JJ O
melanoma NN O
biopsy NN O
samples NNS O
and CC O
found VBD O
again RB O
that IN O
AKT2 NNP O
was VBD O
the DT O
predominantly RB O
activated VBN O
AKT NNP O
in IN O
these DT O
human JJ O
melanoma NN O
biopsies NNS O
. . O

In IN O
cultured JJ O
stable JJ O
Grm1 NNP O
- : O
mouse NN O
- : O
melanocytic JJ O
clones NNS O
, , O
as RB O
well RB O
as IN O
an DT O
metabotropic NN O
glutamate NN O
receptor NN O
1 CD O
( -LRB- O
Grm1 NNP O
) -RRB- O
expressing VBG O
human NN O
melanoma NN O
cell NN O
line NN O
, , O
C8161 NNP B-NP
, , O
stimulation NN O
of IN O
Grm1 NNP O
by IN O
its PRP$ O
agonist NN O
led VBD O
to TO O
the DT O
activation NN O
of IN O
AKT NNP O
, , O
while IN O
preincubation NN O
with IN O
Grm1 NNP O
- : O
antagonist NN O
abolished VBD O
Grm1 NNP O
- : O
agonist JJ O
- : O
induced JJ O
AKT NNP O
activation NN O
. . O

In IN O
addition NN O
, , O
a DT O
reduction NN O
in IN O
tumor NN O
volume NN O
of IN O
Grm1 NNP O
- : O
mouse NN O
- : O
melanocytic JJ O
- : O
allografts NNS O
was VBD O
detected VBN O
in IN O
the DT O
presence NN O
of IN O
small JJ O
interfering NN O
AKT2 IN O
RNA NNP O
( -LRB- O
siAKT2 NN O
) -RRB- O
. . O

Taken VBN O
together RB O
, , O
these DT O
results NNS O
showed VBD O
that IN O
, , O
in IN O
addition NN O
to TO O
the DT O
MAPK NNP O
pathway NN O
previously RB O
reported VBD O
being VBG O
a DT O
downstream NN O
target NN O
of IN O
stimulated VBN O
Grm1 NNP O
, , O
AKT2 NNP O
is VBZ O
another DT O
downstream NN O
target NN O
in IN O
Grm1 NNP O
mediated JJ O
melanocyte NN O
transformation NN O
. . O

-DOCSTART- X X O

Pancreatic JJ O
endocrine NN O
tumors NNS O
: : O
expression NN O
profiling NN O
evidences VBZ O
a DT O
role NN O
for IN O
AKT NNP O
- : O
mTOR NN O
pathway NN O
. . O

PURPOSE NNP O
: : O
We PRP O
investigated VBD O
the DT O
global JJ O
gene NN O
expression NN O
in IN O
a DT O
large JJ O
panel NN O
of IN O
pancreatic JJ O
endocrine NN O
tumors NNS O
( -LRB- O
PETs NNS O
) -RRB- O
aimed VBN O
at IN O
identifying VBG O
new JJ O
potential JJ O
targets NNS O
for IN O
therapy NN O
and CC O
biomarkers NNS O
to TO O
predict VB O
patient JJ O
outcome NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
Using VBG O
a DT O
custom NN O
microarray NN O
, , O
we PRP O
analyzed VBD O
72 CD O
primary JJ O
PETs NN O
, , O
seven CD O
matched VBD O
metastases NNS O
, , O
and CC O
10 CD O
normal JJ O
pancreatic JJ O
samples NNS O
. . O

Relevant NNP O
differentially RB O
expressed VBD O
genes NNS O
were VBD O
validated VBN O
by IN O
either DT O
quantitative JJ O
real JJ O
- : O
time NN O
polymerase NN O
chain NN O
reaction NN O
or CC O
immunohistochemistry NN O
on IN O
tissue NN O
microarrays NNS O
. . O

RESULTS NNS O
: : O
Our PRP$ O
data NNS O
showed VBD O
that IN O
: : O
tuberous JJ O
sclerosis NN O
2 CD O
( -LRB- O
TSC2 NN O
) -RRB- O
and CC O
phosphatase NN O
and CC O
tensin NN O
homolog NN O
( -LRB- O
PTEN NNS O
) -RRB- O
were VBD O
downregulated JJ O
in IN O
most JJS O
of IN O
the DT O
primary JJ O
tumors NNS O
, , O
and CC O
their PRP$ O
low JJ O
expression NN O
was VBD O
significantly RB O
associated VBN O
with IN O
shorter JJR O
disease NN O
- : O
free JJ O
and CC O
overall JJ O
survival NN O
; : O
somatostatin NN O
receptor NN O
2 CD O
( -LRB- O
SSTR2 NN O
) -RRB- O
was VBD O
absent JJ O
or CC O
very RB O
low JJ O
in IN O
insulinomas NNS O
compared VBN O
with IN O
nonfunctioning NN O
tumors NNS O
; : O
and CC O
expression NN O
of IN O
fibroblast JJ O
growth NN O
factor NN O
13 CD O
( -LRB- O
FGF13 NN O
) -RRB- O
gene NN O
was VBD O
significantly RB O
associated VBN O
with IN O
the DT O
occurrence NN O
of IN O
liver NN O
metastasis NN O
and CC O
shorter JJR O
disease NN O
- : O
free JJ O
survival NN O
. . O

TSC2 NNP O
and CC O
PTEN NNP O
are VBP O
two CD O
key JJ O
inhibitors NNS O
of IN O
the DT O
Akt NNP O
/ NNP O
mammalian JJ O
target NN O
of IN O
rapamycin NN O
( -LRB- O
mTOR NN O
) -RRB- O
pathway NN O
and CC O
the DT O
specific JJ O
inhibition NN O
of IN O
mTOR NN O
with IN O
rapamycin NN O
or CC O
RAD001 CD O
inhibited JJ O
cell NN O
proliferation NN O
of IN O
PET NN O
cell NN O
lines NNS O
. . O

CONCLUSION NN O
: : O
Our PRP$ O
results NNS O
strongly RB O
support VB O
a DT O
role NN O
for IN O
PI3K NNP O
/ NNP O
Akt NNP O
/ NNP O
mTOR NN O
pathway NN O
in IN O
PET NNP O
, , O
which WDT O
ties VBZ O
in IN O
with IN O
the DT O
fact NN O
that IN O
mTOR JJ O
inhibitors NNS O
have VBP O
reached VBN O
phase NN O
III NNP O
trials NNS O
in IN O
neuroendocrine JJ O
tumors NNS O
. . O

The DT O
finding NN O
of IN O
differential JJ O
SSTR NNP O
expression NN O
raises VBZ O
the DT O
potential NN O
for IN O
SSTR NNP O
expression NN O
to TO O
be VB O
evaluated VBN O
as IN O
a DT O
marker NN O
of IN O
response NN O
to TO O
somatostatin NN O
analogs NNS O
. . O

Finally RB O
, , O
we PRP O
identified VBD O
FGF13 PRP O
as IN O
a DT O
new JJ O
prognostic JJ O
marker NN O
that WDT O
predicted VBD O
poorer JJR O
outcome NN O
in IN O
patients NNS O
who WP O
were VBD O
clinically RB O
considered VBN O
free JJ O
from IN O
disease NN O
. . O

-DOCSTART- X X O

Neural JJ O
network NN O
analysis NN O
of IN O
spectroscopic JJ O
data NNS O
of IN O
lycopene NN O
and CC O
beta JJ O
- : O
carotene NN O
content NN O
in IN O
food NN O
samples NNS O
compared VBN O
to TO O
HPLC VB O
- : O
UV NN O
- : O
vis FW O
. . O

In IN O
this DT O
study NN O
a DT O
neural JJ O
network NN O
( -LRB- O
NN NNP O
) -RRB- O
model NN O
was VBD O
designed VBN O
to TO O
predict VB O
lycopene NN O
and CC O
beta JJ O
- : O
carotene NN O
concentrations NNS O
in IN O
food NN O
samples NNS O
, , O
combined VBN O
with IN O
a DT O
simple NN O
and CC O
fast JJ O
technique NN O
, , O
such JJ O
as IN O
UV NN O
- : O
vis FW O
spectroscopy NN O
. . O

The DT O
measurement NN O
of IN O
the DT O
absorbance NN O
at IN O
446 CD O
and CC O
502 CD O
nm NN O
of IN O
different JJ O
beta NN O
- : O
carotene NN O
and CC O
lycopene VB O
standard JJ O
mixtures NNS O
was VBD O
used VBN O
to TO O
optimize VB O
a DT O
neural JJ O
network NN O
based VBN O
on IN O
a DT O
multilayer NN O
perceptron NN O
( -LRB- O
MLP NNP O
) -RRB- O
( -LRB- O
learning NN O
and CC O
verification NN O
process NN O
) -RRB- O
. . O

Then RB O
, , O
for IN O
validation NN O
purposes NNS O
, , O
the DT O
optimized JJ O
NN NNP O
has VBZ O
been VBN O
applied VBN O
to TO O
determine VB O
the DT O
concentration NN O
of IN O
both DT O
compounds NNS O
in IN O
food NN O
samples NNS O
( -LRB- O
fresh JJ O
tomato NN O
, , O
tomato NN O
concentrate NN O
, , O
tomato DT O
sauce NN O
, , O
ketchup NN O
, , O
tomato NN O
juice NN O
, , O
watermelon NN O
, , O
medlar JJ O
, , O
green JJ O
pepper NN O
, , O
and CC O
carrots NNS O
) -RRB- O
, , O
comparing VBG O
the DT O
NN JJ O
results NNS O
with IN O
the DT O
known VBN O
values NNS O
of IN O
these DT O
compounds NNS O
obtained VBN O
by IN O
analytical JJ O
techniques NNS O
( -LRB- O
UV NN O
- : O
vis FW O
and CC O
HPLC NNP O
) -RRB- O
. . O

It PRP O
was VBD O
concluded VBN O
that IN O
when WRB O
the DT O
MLP NNP O
- : O
NN NN O
is VBZ O
used VBN O
within IN O
the DT O
range NN O
studied VBN O
, , O
the DT O
optimized JJ O
NN NNP O
is VBZ O
able JJ O
to TO O
estimate VB O
the DT O
beta JJ O
- : O
carotene NN O
and CC O
lycopene NN O
concentrations NNS O
in IN O
food NN O
samples NNS O
with IN O
an DT O
adequate JJ O
accuracy NN O
, , O
solving VBG O
the DT O
UV NN O
- : O
vis FW O
interference NN O
of IN O
beta JJ O
- : O
carotene NN O
and CC O
lycopene NN O
. . O

-DOCSTART- X X O

Effectiveness NN O
of IN O
different JJ O
approaches NNS O
for IN O
establishing VBG O
cisplatin NN O
- : O
induced VBN O
cochlear JJ O
lesions NNS O
in IN O
mice NNS O
. . O

CONCLUSIONS NNS O
: : O

Mouse NN O
cochleae NNS O
are VBP O
highly RB O
resistant JJ O
to TO O
systemically RB O
administered VBN O
cisplatin NN O
. . O

However RB O
, , O
cochlear JJ O
lesions NNS O
can MD O
be VB O
produced VBN O
effectively RB O
in IN O
mice NNS O
when WRB O
cisplatin NN O
is VBZ O
applied VBN O
locally RB O
through IN O
the DT O
round JJ O
window NN O
niche NN O
or CC O
tympanum NN O
. . O

OBJECTIVE CD O
: : O

To TO O
explore VB O
the DT O
optimal JJ O
approach NN O
for IN O
creating VBG O
cisplatin JJ O
- : O
induced JJ O
cochlear NN O
lesions NNS O
in IN O
mice NNS O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O
: : O

Cisplatin NNP O
was VBD O
administered VBN O
to TO O
adult NN O
C57BL IN O
/ NNS O
6J CC O
mice NNS O
via IN O
four CD O
approaches NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
transtympanic NN O
injection NN O
, , O
( -LRB- O
2 CD O
) -RRB- O
round VBP O
window NN O
niche NN O
injection NN O
, , O
( -LRB- O
3 CD O
) -RRB- O
intraperitoneal NN O
injection NN O
( -LRB- O
i FW O
. . O
p NN O
. . O
) -RRB- O
at IN O
4 CD O
mg NN O
/ NN O
kg NN O
/ JJ O
day NN O
for IN O
4 CD O
consecutive JJ O
days NNS O
, , O
and CC O
( -LRB- O
4 CD O
) -RRB- O
one CD O
15 CD O
mg NN O
/ NN O
kg NN O
dose NN O
i NN O
. . O
p NN O
. . O

The DT O
hearing NN O
was VBD O
monitored VBN O
using VBG O
frequency NN O
- : O
specific JJ O
auditory NN O
brainstem NN O
responses NNS O
( -LRB- O
ABRs NNS O
) -RRB- O
and CC O
distortion NN O
- : O
product NN O
otoacoustic JJ O
emissions NNS O
( -LRB- O
DPOAEs NNP O
) -RRB- O
. . O

Cochlear JJ O
pathology NN O
was VBD O
observed VBN O
in IN O
cochleograms NNS O
with IN O
Harris NNP O
' POS O
hematoxylin NN O
staining NN O
. . O

RESULTS NNS O
: : O

Cisplatin NNP O
applied VBD O
systemically RB O
did VBD O
not RB O
cause VB O
any DT O
significant JJ O
ABR NN O
threshold NN O
elevation NN O
across IN O
the DT O
frequencies NNS O
tested VBN O
( -LRB- O
2 LS O
- : O
32 CD O
kHz NN O
) -RRB- O
, , O
whereas IN O
local JJ O
application NN O
of IN O
cisplatin NN O
through IN O
the DT O
round JJ O
window NN O
niche NN O
or CC O
tympanum NN O
resulted VBD O
in IN O
significant JJ O
ABR NNP O
threshold NN O
elevations NNS O
from IN O
high JJ O
to TO O
medium JJ O
frequencies NNS O
. . O

The DT O
functional JJ O
changes NNS O
were VBD O
consistent JJ O
with IN O
the DT O
cochlear NN O
pathology NN O
across IN O
groups NNS O
. . O

-DOCSTART- X X O

[ JJ O
Reconstruction NNP O
of IN O
hepatic JJ O
artery NN O
in IN O
adult NN O
to TO O
adult NN O
living NN O
donor NN O
liver NN O
transplantation NN O
in IN O
104 CD O
patients NNS O
] RB O
. . O

OBJECTIVE CD O
: : O

To TO O
report VB O
the DT O
experience NN O
of IN O
hepatic JJ O
artery NN O
reconstruction NN O
with IN O
adult NN O
- : O
to TO O
- : O
adult NN O
living NN O
donor NN O
liver NN O
transplantation NN O
( -LRB- O
ALDLT NNP O
) -RRB- O
using VBG O
right NN O
lobe NN O
liver NN O
grafts NNS O
. . O

METHODS NNS O
: : O

From IN O
January NNP O
2002 CD O
to TO O
August NNP O
2007 CD O
, , O
104 CD O
patients NNS O
underwent JJ O
ALDLT NNP O
using VBG O
right JJ O
lobe NN O
grafts NNS O
. . O

Hepatic JJ O
arteries NNS O
of IN O
donors NNS O
and CC O
recipients NNS O
were VBD O
assessed VBN O
carefully RB O
with IN O
spiral JJ O
CT NNP O
angiography NN O
and CC O
DSA NNP O
before IN O
ALDLT NNP O
. . O

All DT O
patients NNS O
underwent VBD O
reconstruction NNP O
of IN O
hepatic JJ O
artery NN O
between IN O
right NN O
lobe NN O
liver NN O
grafts NNS O
of IN O
donor NN O
and CC O
recipient NN O
which WDT O
included VBD O
the DT O
anastomosis NN O
between IN O
right JJ O
hepatic JJ O
artery NN O
of IN O
donors NNS O
and CC O
recipients NNS O
; : O
the DT O
reconstruction NN O
of IN O
right JJ O
hepatic JJ O
artery NN O
between IN O
donor NN O
grafts NNS O
and CC O
left VBD O
hepatic JJ O
artery NN O
of IN O
recipients NNS O
; : O
interpositional JJ O
bypass IN O
using VBG O
autogenous JJ O
saphenous JJ O
vein NN O
and CC O
cryopreserved VBD O
iliac JJ O
artery NN O
between IN O
right JJ O
hepatic JJ O
artery NN O
of IN O
donors NNS O
and CC O
hepatic JJ O
artery NN O
, , O
common JJ O
hepatic JJ O
artery NN O
and CC O
abdominal JJ O
aorta NN O
of IN O
recipients NNS O
. . O

The DT O
microsurgical JJ O
technique NN O
was VBD O
employed VBN O
under IN O
the DT O
magnification NN O
of IN O
3 CD O
. . O
5 CD O
times NNS O
and CC O
operative JJ O
microscope NN O
of IN O
5 CD O
- : O
10 CD O
times NNS O
. . O

RESULTS NNS O
: : O

In IN O
these DT O
series NN O
, , O
HAT NNP O
occurred VBD O
in IN O
2 CD O
recipients NNS O
at IN O
Days NNS O
1 CD O
and CC O
7 CD O
post NN O
- : O
ALDLT NNP O
( -LRB- O
1 CD O
. . O
9 CD O
% NN O
) -RRB- O
. . O

Both DT O
were VBD O
revascularized VBN O
with IN O
autogenous JJ O
saphenous JJ O
vein NN O
between IN O
right JJ O
hepatic JJ O
artery NN O
of IN O
donor NN O
and CC O
abdominal JJ O
aorta NN O
of IN O
recipient NN O
. . O

HAT NN O
occurred VBD O
in IN O
1 CD O
recipient NN O
at IN O
Days NNP O
90 CD O
post NN O
- : O
ALDLT NNP O
, , O
but CC O
no DT O
symptom NN O
was VBD O
presented VBN O
. . O

There EX O
was VBD O
no DT O
severe JJ O
complication NN O
and CC O
mortality NN O
related VBN O
to TO O
hepatic JJ O
artery NN O
reconstruction NN O
in IN O
recipients NNS O
. . O

No DT O
HAT NN O
, , O
hepatic JJ O
artery NN O
stenosis NN O
and CC O
aneurysm NN O
occurred VBD O
during IN O
the DT O
follow VBP O
- : O
up RP O
period NN O
of IN O
2 CD O
- : O
60 CD O
months NNS O
. . O

The DT O
1 CD O
, , O
2 CD O
and CC O
3 CD O
- : O
year NN O
survival NN O
rates NNS O
were VBD O
89 CD O
. . O
3 CD O
% NN O
, , O
76 CD O
. . O
0 CD O
% NN O
and CC O
69 CD O
. . O
3 CD O
% NN O
respectively RB O
. . O

CONCLUSION NN O
: : O

Careful JJ O
evaluation NN O
of IN O
hepatic JJ O
artery NN O
condition NN O
and CC O
using VBG O
microsurgical JJ O
techniques NNS O
are VBP O
important JJ O
for IN O
safer JJR O
arterial NN O
reconstruction NN O
and CC O
a DT O
long JJ O
- : O
term NN O
patency NN O
of IN O
hepatic JJ O
artery NN O
in IN O
living VBG O
donor NN O
liver NN O
transplantation NN O
in IN O
adults NNS O
using VBG O
right JJ O
lobe NN O
liver NN O
grafts NNS O
. . O

-DOCSTART- X X O

ICAM NNP O
- : O
3 CD O
enhances NNS O
the DT O
migratory JJ O
and CC O
invasive JJ O
potential NN O
of IN O
human JJ O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
cells NNS O
by IN O
inducing VBG O
MMP NNP O
- : O
2 CD O
and CC O
MMP NNP O
- : O
9 CD O
via IN O
Akt NNP O
and CC O
CREB NNP O
. . O

We PRP O
have VBP O
previously RB O
reported VBN O
that IN O
intercellular JJ O
adhesion NN O
molecule NN O
- : O
3 CD O
( -LRB- O
ICAM NN O
- : O
3 CD O
) -RRB- O
is VBZ O
associated VBN O
with IN O
an DT O
increase NN O
of IN O
cellular JJ O
radio NN O
- : O
resistance NN O
and CC O
cancer NN O
cell NN O
proliferation NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
hypothesized VBD O
that IN O
ICAM NNP O
- : O
3 LS O
has VBZ O
an DT O
additional JJ O
effect NN O
on IN O
cancer NN O
cell NN O
migration NN O
and CC O
invasion NN O
because IN O
molecules NNS O
induced VBN O
by IN O
ICAM NNP O
- : O
3 CD O
are VBP O
known VBN O
as IN O
regulators NNS O
of IN O
cell NN O
migration NN O
and CC O
invasion NN O
. . O

To TO O
examine VB O
this DT O
hypothesis NN O
, , O
we PRP O
used VBD O
NCI NNP B-NP
- : I-NP
H1299 CD I-NP
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
( -LRB- O
NSCLC NNP O
) -RRB- O
cell NN O
line NN O
( -LRB- O
p53 NN O
and CC O
PTEN NNP O
null JJ O
cell NN O
) -RRB- O
and CC O
constructed VBD O
an DT O
ICAM NN O
- : O
3 LS O
- : O
over IN O
- : O
expressing VBG O
stable JJ O
transfectant NN O
, , O
which WDT O
exhibited VBD O
increased VBN O
cell NN O
migration NN O
and CC O
invasion NN O
. . O

The DT O
increased VBD O
migration NN O
and CC O
invasion NN O
resulted VBD O
from IN O
up IN O
- : O
regulation NN O
of IN O
expression NN O
and CC O
activities NNS O
of IN O
MMP NNP O
- : O
2 CD O
and CC O
MMP NNP O
- : O
9 CD O
. . O

ICAM NNP O
- : O
3 LS O
also RB O
increased VBN O
Akt NNP O
phosphorylation NN O
, , O
which WDT O
caused VBD O
an DT O
increase NN O
in IN O
cellular JJ O
migration NN O
/ VBN O
invasion NN O
and CC O
MMP NNP O
activities NNS O
. . O

Activity NN O
of IN O
several JJ O
transcriptional JJ O
factors NNS O
located VBN O
downstream RB O
in IN O
the DT O
Akt NNP O
pathway NN O
was VBD O
also RB O
tested VBN O
, , O
and CC O
constitutive JJ O
activation NN O
of IN O
adenosine NN O
3 CD O
' '' O
, , O
5 CD O
' POS O
- : O
monophosphate JJ O
response NN O
element NN O
- : O
binding JJ O
protein NN O
( -LRB- O
CREB NN O
) -RRB- O
by IN O
ICAM NNP O
- : O
3 CD O
was VBD O
detected VBN O
. . O

Blockage NNP O
of IN O
the DT O
Akt NNP O
pathway NN O
attenuated VBD O
CREB NNP O
activation NN O
, , O
and CC O
a DT O
decrease NN O
in IN O
CREB NNP O
expression NN O
reduced VBN O
cellular JJ O
migration NN O
/ VBN O
invasion NN O
and CC O
activity NN O
of IN O
MMPs NNP O
. . O

This DT O
result NN O
indicates VBZ O
that IN O
CREB NNP O
functions NNS O
in IN O
the DT O
signaling VBG O
pathway NN O
between IN O
Akt NNP O
and CC O
MMP NNP O
. . O

We PRP O
also RB O
showed VBD O
ICAM NNP O
- : O
3 LS O
- : O
induced VBN O
cell NN O
migration NN O
and CC O
invasion NN O
in IN O
NCI NNP B-NP
- : I-NP
H460 CD I-NP
NSCLC NNP O
cells NNS O
( -LRB- O
wild JJ O
- : O
type NN O
p53 NN O
and CC O
PTEN JJ O
cell NN O
) -RRB- O
through IN O
the DT O
same JJ O
signaling NN O
pathway NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
findings NNS O
suggest VBP O
that IN O
ICAM NNP O
- : O
3 CD O
stimulates NNS O
cancer NN O
cell NN O
migration NN O
/ VBN O
invasion NN O
via IN O
ICAM NNP O
- : O
3 CD O
/ NN O
Akt NNP O
/ NNP O
CREB NNP O
/ NNP O
MMP NNP O
pathway NN O
regardless RB O
of IN O
p53 NN O
and CC O
PTEN NNS O
status NN O
, , O
and CC O
this DT O
reflects VBZ O
the DT O
possibility NN O
that IN O
ICAM NNP O
- : O
3 CD O
could MD O
be VB O
considered VBN O
as IN O
a DT O
candidate NN O
for IN O
anti NNS O
- : O
cancer NN O
drug NN O
development NN O
and CC O
as IN O
a DT O
cancer NN O
diagnostic JJ O
marker NN O
. . O

-DOCSTART- X X O

Phenolic JJ O
fraction NN O
of IN O
tobacco NN O
smoke NN O
condensate VB O
potentiates NNS O
benzo IN O
[ VBG O
a DT O
] SYM O
pyerene JJ O
diol NN O
epoxide NN O
- : O
induced VBN O
cell NN O
transformation NN O
: : O
role NN O
of IN O
protein NN O
kinase NN O
C NNP O
. . O

In IN O
this DT O
study NN O
we PRP O
separated VBD O
weakly RB O
acidic JJ O
phenolic JJ O
components NNS O
from IN O
other JJ O
neutral JJ O
, , O
acidic JJ O
and CC O
basic JJ O
components NNS O
of IN O
tobacco NN O
smoke NN O
condensate VB O
( -LRB- O
TSC NNP O
) -RRB- O
and CC O
observed VBD O
that IN O
phenolic JJ O
fraction NN O
of IN O
TSC NNP O
significantly RB O
increased VBD O
the DT O
number NN O
of IN O
colonies NNS O
of IN O
promotion NN O
- : O
sensitive JJ O
JB6 IN B-NP
Cl41 NNP I-NP
cells NNS O
that WDT O
showed VBD O
anchorage NN O
- : O
independent JJ O
growth NN O
on IN O
soft JJ O
agar NN O
in IN O
response NN O
to TO O
BPDE NNP O
( -LRB- O
an DT O
ultimate JJ O
carcinogen NN O
produced VBN O
by IN O
metabolic JJ O
activation NN O
of IN O
the DT O
PAH NNP O
benzo NN O
[ VBD O
a DT O
] JJ O
pyrene NN O
) -RRB- O
. . O

Anchorage NNP O
- : O
independent JJ O
cell NN O
growth NN O
is VBZ O
indicative JJ O
of IN O
cell NN O
transformation NN O
resulting VBG O
in IN O
acquisition NN O
of IN O
tumorigenic JJ O
potential NN O
. . O

In IN O
order NN O
to TO O
understand VB O
the DT O
underlying JJ O
mechanism NN O
by IN O
which WDT O
TSC NNP O
phenolic JJ O
fraction NN O
potentiates VBZ O
BPDE NNP O
- : O
induced JJ O
tumorigenicity NN O
, , O
we PRP O
examined VBD O
its PRP$ O
effect NN O
on IN O
the DT O
activation NN O
of IN O
two CD O
transcription NN O
factors NNS O
AP NNP O
- : O
1 CD O
and CC O
NF NNP O
- : O
kappaB NN O
which WDT O
are VBP O
known VBN O
to TO O
be VB O
influenced VBN O
by IN O
established VBN O
tumor NN O
promoter NN O
TPA NNP O
. . O

BPDE NNP O
treatment NN O
caused VBD O
induction NN O
of IN O
both DT O
AP NNP O
- : O
1 CD O
and CC O
NF NNP O
- : O
kappaB NN O
activity NN O
as IN O
determined VBN O
by IN O
luciferase NN O
reporter NN O
assay NN O
and CC O
only RB O
NF NNP O
- : O
kappaB NN O
induction NN O
in IN O
response NN O
to TO O
BPDE NNP O
was VBD O
significantly RB O
attenuated VBN O
by IN O
TSC NNP O
phenolic JJ O
fraction NN O
whereas IN O
AP NNP O
- : O
1 CD O
induction NN O
remains VBZ O
unaltered JJ O
. . O

Attenuation NN O
of IN O
NF NNP O
- : O
kappaB NN O
activation NN O
by IN O
TSC NNP O
phenolic JJ O
fraction NN O
was VBD O
associated VBN O
with IN O
significant JJ O
decrease NN O
of IN O
intracellular JJ O
PKC NNP O
substrate NN O
phosphorylation NN O
in IN O
BPDE NNP O
treated VBD O
cells NNS O
. . O

Non FW O
- : O
specific JJ O
PKC JJ O
inhibitors NNS O
staurosporine JJ O
and CC O
bisindolylmaleimide JJ O
II NNP O
as RB O
well RB O
as IN O
inhibitors NNS O
specific JJ O
to TO O
conventional JJ O
PKCs NNS O
( -LRB- O
Go6976 NNP O
) -RRB- O
and CC O
PKC NNP O
- : O
delta NN O
( -LRB- O
rottlerin NN O
) -RRB- O
attenuated VBN O
NF NNP O
- : O
kappaB NN O
activation NN O
in IN O
BPDE NNP O
treated VBD O
cells NNS O
to TO O
a DT O
varying VBG O
degree NN O
indicating VBG O
a DT O
possible JJ O
link NN O
between IN O
PKC NNP O
down IN O
- : O
regulation NN O
and CC O
the DT O
attenuation NN O
of IN O
NF NNP O
- : O
kappaB NN O
activity NN O
by IN O
TSC NNP O
phenolic JJ O
fraction NN O
. . O

Treatment NNP O
of IN O
cells NNS O
with IN O
PKC NNP O
inhibitors NNS O
also RB O
potentiated VBD O
anchorage NN O
- : O
independent JJ O
growth NN O
of IN O
BPDE NNP O
treated VBD O
cells NNS O
on IN O
soft JJ O
agar NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
a DT O
possible JJ O
role NN O
of IN O
PKC NNP O
down IN O
- : O
regulation NN O
in IN O
potentiation NN O
of IN O
BPDE NNP O
- : O
induced VBN O
tumorogenicity NN O
by IN O
TSC NNP O
phenolic JJ O
fraction NN O
. . O

-DOCSTART- X X O

Costs NNS O
of IN O
hip NN O
fracture NN O
. . O

Rehabilitation NN O
of IN O
180 CD O
patients NNS O
in IN O
primary JJ O
health NN O
care NN O
. . O

Costs NNS O
related VBN O
to TO O
functional JJ O
status NN O
were VBD O
calculated VBN O
for IN O
180 CD O
consecutive JJ O
hip NN O
fracture NN O
patients NNS O
( -LRB- O
mean JJ O
age NN O
78 CD O
years NNS O
) -RRB- O
who WP O
were VBD O
admitted VBN O
from IN O
their PRP$ O
own JJ O
home NN O
and CC O
rehabilitated VBN O
in IN O
primary JJ O
health NN O
care NN O
. . O

Within IN O
4 CD O
months NNS O
after IN O
the DT O
fracture NN O
, , O
75 CD O
percent NN O
of IN O
the DT O
patients NNS O
had VBD O
been VBN O
discharged VBN O
to TO O
their PRP$ O
own JJ O
home NN O
, , O
9 CD O
percent NN O
were VBD O
dead JJ O
, , O
and CC O
the DT O
short JJ O
- : O
term NN O
medical JJ O
treatment NN O
costs NNS O
per IN O
patient NN O
were VBD O
SEK NNP O
43 CD O
, , O
000 CD O
, , O
whereas IN O
the DT O
total NN O
costs NNS O
including VBG O
communal JJ O
help NN O
and CC O
costs NNS O
for IN O
living VBG O
accommodations NNS O
after IN O
discharge NN O
were VBD O
twice RB O
as RB O
high JJ O
. . O

The DT O
total JJ O
costs NNS O
per IN O
patient NN O
for IN O
long JJ O
- : O
term NN O
medical JJ O
treatment NN O
( -LRB- O
from IN O
4 CD O
months NNS O
up IN O
to TO O
3 CD O
years NNS O
after IN O
fracture NN O
) -RRB- O
were VBD O
7 CD O
percent NN O
of IN O
the DT O
short JJ O
- : O
term NN O
medical JJ O
treatment NN O
costs NNS O
. . O

Patients NNS O
with IN O
a DT O
cervical JJ O
fracture NN O
discharged VBD O
to TO O
their PRP$ O
own JJ O
home NN O
and CC O
with IN O
good JJ O
functional JJ O
status NN O
consumed VBN O
only RB O
one CD O
fifth NN O
of IN O
the DT O
resources NNS O
that IN O
patients NNS O
with IN O
a DT O
trochanteric JJ O
fracture NN O
discharged VBD O
to TO O
institutional JJ O
care NN O
and CC O
who WP O
had VBD O
reduced VBN O
functional JJ O
status NN O
consumed VBN O
. . O

A DT O
substantial JJ O
part NN O
of IN O
the DT O
costs NNS O
can MD O
be VB O
saved VBN O
by IN O
improved JJ O
organization NN O
of IN O
rehabilitation NN O
after IN O
discharge NN O
from IN O
the DT O
hospital NN O
. . O

A DT O
further JJ O
cost NN O
reduction NN O
would MD O
require VB O
a DT O
combination NN O
of IN O
technologic NN O
, , O
social JJ O
, , O
and CC O
organizational JJ O
changes NNS O
aimed VBN O
at IN O
early JJ O
discharge NN O
and CC O
continued VBD O
follow VB O
- : O
up RP O
in IN O
primary JJ O
health NN O
care NN O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
p53 NN O
in IN O
glucose NN O
metabolism NN O
. . O

The DT O
p53 NN O
protein NN O
functions NNS O
to TO O
prevent VB O
tumour NN O
development NN O
by IN O
inhibiting VBG O
the DT O
outgrowth NN O
of IN O
stressed VBN O
or CC O
damaged VBN O
cells NNS O
. . O

In IN O
addition NN O
to TO O
well RB O
established VBN O
functions NNS O
to TO O
block VB O
cell NN O
proliferation NN O
, , O
recent JJ O
studies NNS O
have VBP O
revealed VBN O
a DT O
role NN O
for IN O
p53 NN O
in IN O
the DT O
regulation NN O
of IN O
pathways NNS O
involved VBN O
in IN O
glucose NN O
metabolism NN O
. . O

The DT O
metabolic JJ O
functions NNS O
of IN O
p53 NN O
resist VBP O
the DT O
shift NN O
to TO O
glycolysis NN O
that WDT O
is VBZ O
characteristically RB O
seen VBN O
in IN O
cancers NNS O
, , O
and CC O
also RB O
help VB O
cells NNS O
adapt VB O
to TO O
and CC O
survive VB O
limited JJ O
periods NNS O
of IN O
metabolic JJ O
stress NN O
. . O

Such JJ O
activities NNS O
of IN O
p53 NN O
would MD O
not RB O
only RB O
help VB O
to TO O
prevent VB O
cancer NN O
development NN O
, , O
but CC O
might MD O
also RB O
contribute VB O
to TO O
non FW O
- : O
tumour NN O
related VBN O
roles NNS O
for IN O
p53 NN O
, , O
such JJ O
as IN O
in IN O
the DT O
regulation NN O
of IN O
longevity NN O
. . O

These DT O
new JJ O
functions NNS O
of IN O
p53 NN O
are VBP O
providing VBG O
interesting JJ O
possibilities NNS O
for IN O
the DT O
development NN O
of IN O
novel NN O
therapies NNS O
. . O

-DOCSTART- X X O

14 CD O
- : O
3 LS O
- : O
3zeta JJ O
Overexpression NNP O
and CC O
abnormal JJ O
beta NN O
- : O
catenin NN O
expression NN O
are VBP O
associated VBN O
with IN O
poor JJ O
differentiation NN O
and CC O
progression NN O
in IN O
stage NN O
I PRP O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
14 CD O
- : O
3 CD O
- : O
3zeta NN O
interacted VBN O
with IN O
other JJ O
key JJ O
cellular JJ O
proteins NNS O
involved VBN O
in IN O
the DT O
tumor NN O
development NN O
and CC O
progression NN O
. . O

Knowledge NN O
of IN O
14 CD O
- : O
3 LS O
- : O
3zeta JJ O
and CC O
beta JJ O
- : O
catenin NN O
expression NN O
and CC O
clinical JJ O
significance NN O
in IN O
the DT O
same JJ O
tumor NN O
tissues NNS O
is VBZ O
limited VBN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
expression NN O
and CC O
significance NN O
of IN O
14 CD O
- : O
3 LS O
- : O
3zeta JJ O
and CC O
beta JJ O
- : O
catenin NN O
in IN O
stage NN O
I PRP O
non FW O
- : O
small JJ O
- : O
cell NN O
lung NN O
cancer NN O
( -LRB- O
NSCLC NNP O
) -RRB- O
. . O

Specimens NNP O
of IN O
NSCLC NNP O
and CC O
adjacent JJ O
normal JJ O
lung NN O
tissues NNS O
were VBD O
collected VBN O
from IN O
110 CD O
patients NNS O
. . O

The DT O
expressions NNS O
of IN O
14 CD O
- : O
3 LS O
- : O
3zeta JJ O
and CC O
beta JJ O
- : O
catenin NN O
were VBD O
detected VBN O
by IN O
western JJ O
blotting NN O
, , O
double JJ O
labeling NN O
immunofluorescence NN O
, , O
confocal JJ O
laser NN O
scanning NN O
microscopy NN O
and CC O
immunohistochemistry NN O
. . O

The DT O
expression NN O
of IN O
14 CD O
- : O
3 LS O
- : O
3zeta NN O
was VBD O
upregulated VBN O
in IN O
stage NN O
I PRP O
NSCLC RB O
. . O

Further RB O
, , O
the DT O
overexpression NN O
of IN O
14 CD O
- : O
3 LS O
- : O
3zeta JJ O
correlated JJ O
with IN O
histological JJ O
grades NNS O
, , O
lymph NN O
node NN O
metastasis NN O
and CC O
poor JJ O
clinical JJ O
outcome NN O
. . O

Abnormal JJ O
expression NN O
of IN O
beta JJ O
- : O
catenin NN O
was VBD O
significantly RB O
correlated VBN O
with IN O
poor JJ O
differentiation NN O
and CC O
lymph NN O
node NN O
metastasis NN O
. . O

Abnormal JJ O
beta JJ O
- : O
catenin NN O
expression NN O
was VBD O
associated VBN O
significantly RB O
with IN O
positive JJ O
14 CD O
- : O
3 LS O
- : O
3zeta JJ O
expression NN O
. . O

In IN O
conclusion NN O
, , O
14 CD O
- : O
3 LS O
- : O
3zeta JJ O
and CC O
beta JJ O
- : O
catenin NN O
might MD O
have VB O
an DT O
important JJ O
role NN O
in IN O
development NN O
, , O
progression NN O
and CC O
metastatic JJ O
process NN O
of IN O
NSCLC NNP O
. . O

14 CD O
- : O
3 CD O
- : O
3zeta NN O
might MD O
be VB O
used VBN O
as IN O
prognostic JJ O
biomarkers NNS O
for IN O
NSCLC NNP O
. . O

-DOCSTART- X X O

A DT O
randomized JJ O
pilot NN O
study NN O
of IN O
the DT O
Engaging NNP O
Moms NNP O
Program NNP O
for IN O
family NN O
drug NN O
court NN O
. . O

In IN O
response NN O
to TO O
the DT O
need NN O
for IN O
effective JJ O
drug NN O
court NN O
interventions NNS O
, , O
the DT O
effectiveness NN O
of IN O
the DT O
Engaging NNP O
Moms NNP O
Program NNP O
( -LRB- O
EMP NNP O
) -RRB- O
versus NN O
Intensive NNP O
Case NNP O
Management NNP O
Services NNP O
( -LRB- O
ICMS NNP O
) -RRB- O
on IN O
multiple JJ O
outcomes NNS O
for IN O
mothers NNS O
enrolled VBD O
in IN O
family NN O
drug NN O
court NN O
was VBD O
investigated VBN O
. . O

In IN O
this DT O
intent NN O
- : O
to TO O
- : O
treat NN O
study NN O
, , O
mothers NNS O
( -LRB- O
N NNP O
= SYM O
62 CD O
) -RRB- O
were VBD O
randomly RB O
assigned VBN O
to TO O
either DT O
usual JJ O
drug NN O
court NN O
care NN O
or CC O
the DT O
Engaging NNP O
Moms NNP O
drug NN O
court NN O
program NN O
. . O

Mothers NNS O
were VBD O
assessed VBN O
at IN O
intake NN O
and CC O
3 CD O
, , O
6 CD O
, , O
12 CD O
, , O
and CC O
18 CD O
months NNS O
following VBG O
intake NN O
. . O

Results NNS O
indicated VBD O
that IN O
at IN O
18 CD O
months NNS O
post IN O
drug NN O
court NN O
enrollment NN O
, , O
77 CD O
% NN O
of IN O
mothers NNS O
assigned VBN O
to TO O
EMP NNP O
versus IN O
55 CD O
% NN O
of IN O
mothers NNS O
assigned VBN O
to TO O
ICMS NNP O
had VBD O
positive JJ O
child NN O
welfare NN O
dispositions NNS O
. . O

There EX O
were VBD O
statistically RB O
significant JJ O
time NN O
effects NNS O
for IN O
both DT O
intervention NN O
groups NNS O
on IN O
multiple JJ O
outcomes NNS O
including VBG O
substance NN O
use NN O
, , O
mental JJ O
health NN O
, , O
parenting NN O
practices NNS O
, , O
and CC O
family NN O
functioning NN O
. . O

EMP NNP O
showed VBD O
equal JJ O
or CC O
better JJR O
improvement NN O
than IN O
ICMS NNP O
on IN O
all DT O
outcomes NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
EMP NNP O
in IN O
family NN O
drug NN O
court NN O
is VBZ O
a DT O
viable JJ O
and CC O
promising JJ O
intervention NN O
approach NN O
to TO O
reduce VB O
maternal JJ O
addiction NN O
and CC O
child NN O
maltreatment NN O
. . O

-DOCSTART- X X O

Hormonal NNP O
regulation NN O
and CC O
distinct JJ O
functions NNS O
of IN O
semaphorin NN O
- : O
3B NN O
and CC O
semaphorin NN O
- : O
3F NN O
in IN O
ovarian JJ O
cancer NN O
. . O

Semaphorins NNP O
comprise NN O
a DT O
family NN O
of IN O
molecules NNS O
that IN O
influence NN O
neuronal JJ O
growth NN O
and CC O
guidance NN O
. . O

Class NN O
- : O
3 CD O
semaphorins NNS O
, , O
semaphorin VBG O
- : O
3B FW O
( -LRB- O
SEMA3B NN O
) -RRB- O
and CC O
semaphorin VB O
- : O
3F FW O
( -LRB- O
SEMA3F NN O
) -RRB- O
, , O
illustrate VBP O
their PRP$ O
effects NNS O
by IN O
forming VBG O
a DT O
complex JJ O
with IN O
neuropilins NNS O
( -LRB- O
NP NNP O
- : O
1 CD O
or CC O
NP NNP O
- : O
2 CD O
) -RRB- O
and CC O
plexins NNS O
. . O

We PRP O
examined VBD O
the DT O
status NN O
and CC O
regulation NN O
of IN O
semaphorins NNS O
and CC O
their PRP$ O
receptors NNS O
in IN O
human JJ O
ovarian NN O
cancer NN O
cells NNS O
. . O

A DT O
significantly RB O
reduced VBN O
expression NN O
of IN O
SEMA3B NNP O
( -LRB- O
83 CD O
kDa NN O
) -RRB- O
, , O
SEMA3F FW O
( -LRB- O
90 CD O
kDa NN O
) -RRB- O
, , O
and CC O
plexin VB O
- : O
A3 NNP O
was VBD O
observed VBN O
in IN O
ovarian JJ O
cancer NN O
cell NN O
lines NNS O
when WRB O
compared VBN O
with IN O
normal JJ O
human JJ O
ovarian NN O
surface NN O
epithelial JJ O
cells NNS O
. . O

The DT O
expression NN O
of IN O
NP NNP O
- : O
1 CD O
, , O
NP NNP O
- : O
2 CD O
, , O
and CC O
plexin VB O
- : O
A1 NNP O
was VBD O
not RB O
altered VBN O
in IN O
human JJ O
ovarian NN O
surface NN O
epithelial NN O
and CC O
ovarian JJ O
cancer NN O
cells NNS O
. . O

The DT O
decreased VBD O
expression NN O
of IN O
SEMA3B NNP O
, , O
SEMA3F NNP O
, , O
and CC O
plexin VB O
- : O
A3 NN O
was VBD O
confirmed VBN O
in IN O
stage NN O
3 CD O
ovarian NN O
tumors NNS O
. . O

The DT O
treatment NN O
of IN O
ovarian JJ O
cancer NN O
cells NNS O
with IN O
luteinizing VBG O
hormone NN O
, , O
follicle NN O
- : O
stimulating NN O
hormone NN O
, , O
and CC O
estrogen NN O
induced VBD O
a DT O
significant JJ O
upregulation NN O
of IN O
SEMA3B NNP O
, , O
whereas IN O
SEMA3F NNP O
was VBD O
upregulated VBN O
only RB O
by IN O
estrogen NN O
. . O

Cotreatment NN O
of IN O
cell NN O
lines NNS O
with IN O
a DT O
hormone NN O
and CC O
its PRP$ O
specific JJ O
antagonist NN O
blocked VBD O
the DT O
effect NN O
of IN O
the DT O
hormone NN O
. . O

Ectopic JJ O
expression NN O
of IN O
SEMA3B NNP O
or CC O
SEMA3F NNP O
reduced VBD O
soft JJ O
- : O
agar JJ O
colony NN O
formation NN O
, , O
adhesion NN O
, , O
and CC O
cell NN O
invasion NN O
of IN O
ovarian JJ O
cancer NN O
cell NN O
cultures NNS O
. . O

Forced VBN O
expression NN O
of IN O
SEMA3B NNP O
, , O
but CC O
not RB O
SEMA3F NNP O
, , O
inhibited VBD O
viability NN O
of IN O
ovarian JJ O
cancer NN O
cells NNS O
. . O

Overexpression IN O
of IN O
SEMA3B NNP O
and CC O
SEMA3F NNP O
reduced VBD O
focal JJ O
adhesion NN O
kinase NN O
phosphorylation NN O
and CC O
matrix NN O
metalloproteinase NN O
- : O
2 CD O
and CC O
matrix NN O
metalloproteinase NN O
- : O
9 CD O
expression NN O
in IN O
ovarian JJ O
cancer NN O
cells NNS O
. . O

Forced VBN O
expression NN O
of IN O
SEMA3F NNP O
, , O
but CC O
not RB O
SEMA3B NNP O
in IN O
ovarian JJ O
cancer NN O
cells NNS O
, , O
significantly RB O
inhibited VBD O
endothelial JJ O
cell NN O
tube NN O
formation NN O
. . O

Collectively RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
loss NN O
of IN O
SEMA3 JJ O
expression NN O
could MD O
be VB O
a DT O
hallmark NN O
of IN O
cancer NN O
progression NN O
. . O

Furthermore RB O
, , O
gonadotropin NNP O
- : O
and CC O
/ NN O
or CC O
estrogen NN O
- : O
mediated JJ O
maintenance NN O
of IN O
SEMA3 JJ O
expression NN O
could MD O
control VB O
ovarian JJ O
cancer NN O
angiogenesis NN O
and CC O
metastasis NN O
. . O

-DOCSTART- X X O

Tobacco NNP O
smoke NN O
promotes VBZ O
lung NN O
tumorigenesis NN O
by IN O
triggering VBG O
IKKbeta NNP O
- : O
and CC O
JNK1 NNP O
- : O
dependent JJ O
inflammation NN O
. . O

Chronic JJ O
exposure NN O
to TO O
tobacco NN O
smoke NN O
, , O
which WDT O
contains VBZ O
over IN O
60 CD O
tumor NN O
- : O
initiating NN O
carcinogens NNS O
, , O
is VBZ O
the DT O
major JJ O
risk NN O
factor NN O
for IN O
development NN O
of IN O
lung NN O
cancer NN O
, , O
accounting NN O
for IN O
a DT O
large JJ O
portion NN O
of IN O
cancer NN O
- : O
related VBN O
deaths NNS O
worldwide JJ O
. . O

It PRP O
is VBZ O
well RB O
established VBN O
that IN O
tobacco NN O
smoke NN O
is VBZ O
a DT O
tumor NN O
initiator NN O
, , O
but CC O
we PRP O
asked VBD O
whether IN O
it PRP O
also RB O
acts VBZ O
as IN O
a DT O
tumor NN O
promoter NN O
once RB O
malignant JJ O
initiation NN O
, , O
such JJ O
as IN O
caused VBN O
by IN O
K NNP O
- : O
ras VBD O
activation NN O
, , O
has VBZ O
taken VBN O
place NN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
repetitive JJ O
exposure NN O
to TO O
tobacco NN O
smoke NN O
promotes VBZ O
tumor NN O
development NN O
both DT O
in IN O
carcinogen NN O
- : O
treated VBN O
mice NNS O
and CC O
in IN O
transgenic JJ O
mice NNS O
undergoing VBG O
sporadic JJ O
K NNP O
- : O
ras VBD O
activation NN O
in IN O
lung NN O
epithelial NN O
cells NNS O
. . O

Tumor NN O
promotion NN O
is VBZ O
due JJ O
to TO O
induction NN O
of IN O
inflammation NN O
that IN O
results NNS O
in IN O
enhanced JJ O
pneumocyte NN O
proliferation NN O
and CC O
is VBZ O
abrogated VBN O
by IN O
IKKbeta NNP O
ablation NN O
in IN O
myeloid JJ O
cells NNS O
or CC O
inactivation NN O
of IN O
JNK1 NNP O
. . O

-DOCSTART- X X O

Killing NNP O
tumor NN O
cells NNS O
through IN O
their PRP$ O
surface NN O
beta NN O
( -LRB- O
2 CD O
) -RRB- O
- : O
microglobulin NN O
or CC O
major JJ O
histocompatibility NN O
complex NN O
class NN O
I PRP O
molecules NNS O
. . O

Targeted NNP O
antibody NN O
- : O
based VBN O
therapy NN O
has VBZ O
been VBN O
used VBN O
successfully RB O
to TO O
treat VB O
cancers NNS O
. . O

Recent JJ O
studies NNS O
have VBP O
demonstrated VBN O
that IN O
tumor NN O
cells NNS O
treated VBN O
with IN O
antibodies NNS O
specific JJ O
for IN O
beta NN O
( -LRB- O
2 CD O
) -RRB- O
- : O
microglobulin NN O
( -LRB- O
beta NN O
( -LRB- O
2 CD O
) -RRB- O
M NNP O
) -RRB- O
or CC O
major JJ O
histocompatibility NN O
complex NN O
( -LRB- O
MHC NNP O
) -RRB- O
class NN O
I PRP O
molecules NNS O
undergo VBP O
apoptosis NN O
in IN O
vitro NN O
and CC O
in IN O
vivo FW O
( -LRB- O
mouse NN O
models NNS O
) -RRB- O
. . O

Antibodies NNS O
against IN O
beta NN O
( -LRB- O
2 CD O
) -RRB- O
M NNP O
or CC O
MHC NNP O
class NN O
I PRP O
induce VB O
tumor NN O
cell NN O
apoptosis NN O
by IN O
1 CD O
) -RRB- O
recruiting VBG O
MHC RB O
class NN O
I PRP O
molecules NNS O
to TO O
lipid VB O
rafts NNS O
and CC O
activating VBG O
LYN NNP O
kinase NN O
and CC O
the DT O
signal NN O
- : O
transducing NN O
enzyme NN O
phospholipase NN O
C LS O
- : O
gamma2 SYM O
- : O
dependent JJ O
c SYM O
- : O
Jun NNP O
N NNP O
- : O
terminal NN O
kinase NN O
signaling VBG O
pathway NN O
and CC O
2 CD O
) -RRB- O
expelling VBG O
interleukin RB O
6 CD O
and CC O
insulin NN O
- : O
like IN O
growth NN O
factor NN O
1 CD O
receptors NNS O
out IN O
of IN O
lipid JJ O
rafts NNS O
and CC O
inhibiting VBG O
the DT O
growth NN O
and CC O
survival NN O
factor NN O
- : O
induced VBN O
activation NN O
of IN O
the DT O
phosphatidylinositol NN O
3 CD O
- : O
kinase NN O
/ NN O
Akt NNP O
and CC O
extracellular JJ O
signal NN O
- : O
related VBN O
kinase NN O
pathways NNS O
. . O

Consequently RB O
, , O
mitochondrial JJ O
integrity NN O
is VBZ O
compromised VBN O
, , O
and CC O
the DT O
caspase NN O
- : O
9 CD O
- : O
dependent JJ O
cascade NN O
is VBZ O
activated VBN O
in IN O
treated VBN O
tumor NN O
cells NNS O
. . O

However RB O
, , O
although IN O
beta JJ O
( -LRB- O
2 CD O
) -RRB- O
M NNP O
and CC O
MHC NNP O
class NN O
I PRP O
are VBP O
expressed VBN O
on IN O
normal JJ O
hematopoietic JJ O
cells NNS O
, , O
which WDT O
is VBZ O
a DT O
potential JJ O
safety NN O
concern NN O
, , O
the DT O
monoclonal JJ O
antibodies NNS O
were VBD O
selective JJ O
to TO O
tumor NN O
cells NNS O
and CC O
did VBD O
not RB O
damage NN O
normal JJ O
cells NNS O
in IN O
vitro NN O
or CC O
in IN O
human JJ O
- : O
like IN O
mouse NN O
models NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
targeting VBG O
beta NN O
( -LRB- O
2 CD O
) -RRB- O
M NNP O
or CC O
MHC NNP O
class NN O
I PRP O
by IN O
using VBG O
antibodies NNS O
or CC O
other JJ O
agents NNS O
offers VBZ O
a DT O
potential JJ O
therapeutic JJ O
approach NN O
for IN O
beta NN O
( -LRB- O
2 CD O
) -RRB- O
M NNP O
/ NNP O
MHC NNP O
class NN O
I PRP O
- : O
expressing VBG O
malignancies NNS O
. . O

Cancer NNP O
2010 CD O
. . O

( -LRB- O
c NN O
) -RRB- O
2010 CD O
American NNP O
Cancer NNP O
Society NNP O
. . O

-DOCSTART- X X O

Further JJ O
Characterization NNP O
of IN O
Activin NNP O
A DT O
- : O
induced VBN O
IgA NNP O
Response NN O
in IN O
Murine NNP O
B NNP O
Lymphocytes NNP O
. . O

We PRP O
have VBP O
recently RB O
shown VBN O
that IN O
activin NN O
A DT O
, , O
a DT O
member NN O
of IN O
TGF NNP O
- : O
beta JJ O
superfamily NN O
, , O
stimulates NNS O
mouse NN O
B NNP O
cells NNS O
to TO O
express VB O
IgA NNP O
isotype NN O
but CC O
other JJ O
isotypes NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
further RB O
characterized VBD O
effects NNS O
of IN O
activin NN O
A DT O
on IN O
B NNP O
cell NN O
growth NN O
and CC O
IgA NNP O
expression NN O
. . O

We PRP O
found VBD O
that IN O
activin IN O
A DT O
did VBD O
not RB O
have VB O
effect NN O
on IN O
LPS NNP O
- : O
stimulated VBD O
cell NN O
viability NN O
. . O

In IN O
parallel RB O
, , O
CFSE JJ O
staining NN O
analysis NN O
revealed VBD O
that IN O
activin IN O
A DT O
did VBD O
not RB O
alter VB O
cell NN O
division NN O
. . O

An DT O
increase NN O
of IN O
IgA NNP O
secretion NN O
by IN O
activin JJ O
A DT O
was VBD O
completely RB O
abrogated VBN O
by IN O
anti NNS O
- : O
activin NN O
A DT O
Ab CD O
but CC O
not RB O
by IN O
anti NNS O
- : O
TGFbeta1 CD O
Ab CD O
. . O

In IN O
the DT O
same JJ O
conditions NNS O
, , O
no DT O
other JJ O
isotypes NNS O
are VBP O
significantly RB O
affected VBN O
by IN O
each DT O
antibody NN O
treatment NN O
. . O

Finally RB O
, , O
activin IN O
A DT O
, , O
as IN O
similar JJ O
to TO O
TGF VB O
- : O
beta1 NN O
, , O
increased VBD O
IgA NNP O
secretion NN O
by IN O
mesenteric JJ O
lymph NN O
node NN O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
activin NN O
A DT O
can MD O
specifically RB O
stimulate VB O
IgA DT O
response NN O
, , O
independent JJ O
of IN O
TGF NNP O
- : O
beta NN O
in IN O
the DT O
gut NN O
. . O

-DOCSTART- X X O

Posterior NNP O
stabilization NN O
of IN O
the DT O
cervical JJ O
spine NN O
with IN O
hook NN O
plates NNS O
. . O

Hook NNP O
- : O
plate NN O
fixation NN O
is VBZ O
designed VBN O
for IN O
posterior JJ O
cervical JJ O
stabilization NN O
from IN O
C2 NNP O
to TO O
C7 VB O
. . O

Indications NNS O
remain VBP O
the DT O
same JJ O
as IN O
for IN O
standard JJ O
posterior JJ O
fixations NNS O
. . O

The DT O
prime JJ O
indications NNS O
are VBP O
discoligamentous JJ O
injuries NNS O
. . O

The DT O
plates NNS O
are VBP O
hooked JJ O
under IN O
the DT O
lower JJR O
laminas NNS O
and CC O
attached VBN O
to TO O
the DT O
articular JJ O
masses NNS O
of IN O
the DT O
upper JJ O
vertebra NN O
by IN O
oblique JJ O
screws NNS O
. . O

An DT O
H NNP O
- : O
graft NN O
is VBZ O
placed VBN O
between IN O
the DT O
spinous JJ O
processes NNS O
. . O

The DT O
vertebrae NNS O
are VBP O
compressed VBN O
together RB O
by IN O
the DT O
plates NNS O
at IN O
three CD O
points NNS O
, , O
the DT O
facet NN O
joints NNS O
, , O
and CC O
graft NN O
. . O

The DT O
resulting VBG O
pre NN O
- : O
stressed VBN O
system NN O
is VBZ O
stable JJ O
in IN O
all DT O
directions NNS O
. . O

A DT O
protocol NN O
for IN O
safe JJ O
reduction NN O
of IN O
cervical JJ O
dislocations NNS O
is VBZ O
observed VBN O
. . O

Of IN O
70 CD O
patients NNS O
treated VBN O
from IN O
1979 CD O
to TO O
1986 CD O
, , O
51 CD O
were VBD O
examined VBN O
12 CD O
- : O
54 CD O
months NNS O
after IN O
surgery NN O
. . O

All DT O
fusions NNS O
consolidated VBN O
. . O

Two CD O
neurologic JJ O
complications NNS O
not RB O
attributable JJ O
to TO O
the DT O
fixation NN O
occurred VBD O
. . O

Other JJ O
major JJ O
complications NNS O
were VBD O
not RB O
seen VBN O
. . O

-DOCSTART- X X O

Comment NN O
on IN O
" `` O
Why WRB O
reduced VBD O
- : O
form NN O
regression NN O
models NNS O
of IN O
health NN O
effects NNS O
versus IN O
exposures NNS O
should MD O
not RB O
replace VB O
QRA NNP O
: : O
livestock NN O
production NN O
and CC O
infant NN O
mortality NN O
as IN O
an DT O
example NN O
, , O
" `` O
by IN O
Louis NNP O
Anthony NNP O
( -LRB- O
Tony NNP O
) -RRB- O
Cox NNP O
, , O
Jr NNP O
. . O
, , O
Risk NNP O
Analysis NNP O
2009 CD O
, , O
Vol NNP O
. . O

29 CD O
, , O
No RB O
. . O
12 CD O
. . O

While IN O
a DT O
recent JJ O
paper NN O
by IN O
Cox NNP O
in IN O
this DT O
journal NN O
uses VBZ O
as IN O
its PRP$ O
motivating NN O
factor NN O
the DT O
benefits NNS O
of IN O
quantitative JJ O
risk NN O
assessment NN O
, , O
its PRP$ O
content NN O
is VBZ O
entirely RB O
devoted VBN O
to TO O
critiquing JJ O
Sneeringer NNP O
' POS O
s PRP O
article NN O
in IN O
the DT O
American NNP O
Journal NNP O
of IN O
Agricultural NNP O
Economics NNP O
. . O

Cox NNP O
' POS O
s VBZ O
two CD O
main JJ O
critiques NNS O
of IN O
Sneeringer NNP O
are VBP O
fundamentally RB O
flawed JJ O
and CC O
misrepresent VB O
the DT O
original JJ O
article NN O
. . O

Cox NNP O
posits NNS O
that IN O
Sneeringer NNP O
did VBD O
A DT O
and CC O
B NNP O
, , O
and CC O
then RB O
argues VBZ O
why WRB O
A DT O
and CC O
B NNP O
are VBP O
incorrect JJ O
. . O

However RB O
, , O
Sneeringer NNP O
in IN O
fact NN O
did VBD O
C NNP O
and CC O
D NNP O
; : O
thus RB O
critiques NNS O
of IN O
A NNP O
and CC O
B NNP O
are VBP O
not RB O
applicable JJ O
to TO O
Sneeringer NNP O
' POS O
s PRP O
analysis NN O
. . O

-DOCSTART- X X O

Dose NNP O
- : O
and CC O
time NN O
- : O
dependent JJ O
effects NNS O
of IN O
doxorubicin NN O
on IN O
cytotoxicity NN O
, , O
cell NN O
cycle NN O
and CC O
apoptotic JJ O
cell NN O
death NN O
in IN O
human JJ O
colon NN O
cancer NN O
cells NNS O
. . O

The DT O
cytostatic JJ O
drug NN O
doxorubicin NN O
is VBZ O
a DT O
well RB O
- : O
known VBN O
chemotherapeutic NN O
agent NN O
which WDT O
is VBZ O
used VBN O
in IN O
treatment NN O
of IN O
a DT O
wide JJ O
variety NN O
of IN O
cancers NNS O
. . O

A DT O
key JJ O
factor NN O
in IN O
the DT O
response NN O
of IN O
cancer NN O
cells NNS O
to TO O
chemotherapeutic JJ O
drugs NNS O
is VBZ O
the DT O
activation NN O
of IN O
the DT O
apoptotic JJ O
pathway NN O
, , O
a DT O
pathway NN O
that WDT O
is VBZ O
often RB O
impaired VBN O
in IN O
chemoresistant NN O
colon NN O
cancer NN O
cells NNS O
. . O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
doxorubicin NN O
in IN O
Hct NNP B-NP
- : I-NP
116 CD I-NP
human JJ O
colon NN O
carcinoma NN O
cells NNS O
in IN O
order NN O
to TO O
clarify VB O
if IN O
a DT O
time NN O
/ IN O
concentration NN O
range NN O
for IN O
optimal JJ O
doxorubicin SYM O
- : O
induced JJ O
apoptosis NN O
exists VBZ O
. . O

We PRP O
compared VBD O
a DT O
treatment NN O
schedule NN O
were VBD O
cells NNS O
were VBD O
bolus JJ O
incubated VBN O
for IN O
3h JJ O
with IN O
doxorubicin NN O
followed VBN O
by IN O
24h JJ O
in IN O
drug NN O
- : O
free JJ O
medium NN O
, , O
with IN O
a DT O
continuous JJ O
doxorubicin NN O
treatment NN O
schedule NN O
for IN O
24h JJ O
. . O

Bolus NNP O
incubation NN O
was VBD O
carried VBN O
out RP O
to TO O
determine VB O
effects NNS O
of IN O
doxorubicin NN O
accumulated VBN O
during IN O
the DT O
first JJ O
3h NN O
, , O
whereas IN O
continuous JJ O
incubation NN O
allowed VBN O
further RB O
( -LRB- O
continuous JJ O
) -RRB- O
exposure NN O
to TO O
doxorubicin VB O
. . O

We PRP O
found VBD O
that IN O
bolus NN O
( -LRB- O
3h JJ O
) -RRB- O
treatment NN O
with IN O
doxorubicin NN O
resulted VBN O
in IN O
a DT O
dose NN O
- : O
dependent JJ O
decrease NN O
of IN O
viable JJ O
cells NNS O
and CC O
concomitant JJ O
increase NN O
of IN O
apoptosis NN O
. . O

Additionally RB O
, , O
bolus NN O
( -LRB- O
3h NN O
) -RRB- O
doxorubicin NN O
incubation NN O
led VBD O
to TO O
phosphorylation NN O
of IN O
p53 NN O
at IN O
serine NN O
392 CD O
, , O
induction NN O
of IN O
p21 NN O
, , O
G2 NNP O
arrest NN O
and CC O
increase NN O
of IN O
proapoptotic JJ O
protein NN O
Bax NNP O
. . O

In IN O
contrast NN O
, , O
continuous JJ O
( -LRB- O
24h JJ O
) -RRB- O
treatment NN O
with IN O
doxorubicin NN O
reduced VBN O
the DT O
number NN O
of IN O
living VBG O
cells NNS O
with IN O
no DT O
parallel JJ O
raise NN O
in IN O
the DT O
amount NN O
of IN O
dead JJ O
cells NNS O
. . O

Continuous JJ O
( -LRB- O
24h JJ O
) -RRB- O
treatment NN O
with IN O
5 CD O
microM NNS O
doxorubicin RB O
resulted VBD O
in IN O
cell NN O
cycle NN O
arrest NN O
in IN O
G0 DT O
/ JJ O
G1 NNP O
phase NN O
that WDT O
was VBD O
neither DT O
accompanied VBN O
by IN O
phosphorylation NN O
and CC O
activation NN O
of IN O
p53 NN O
nor CC O
enhanced JJ O
expression NN O
of IN O
p21 NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
doxorubicin NN O
is VBZ O
able JJ O
to TO O
induce VB O
cell NN O
death NN O
by IN O
apoptosis NN O
only RB O
at IN O
particular JJ O
dose NN O
and CC O
treatment NN O
conditions NNS O
and CC O
imply VB O
a DT O
completely RB O
different JJ O
cellular JJ O
response NN O
following VBG O
bolus JJ O
or CC O
continuous JJ O
exposure NN O
to TO O
doxorubicin VB O
. . O

-DOCSTART- X X O

p24 DT O
family NN O
type NN O
1 CD O
transmembrane NN O
proteins NNS O
are VBP O
required VBN O
for IN O
insulin NN O
biosynthesis NN O
and CC O
secretion NN O
in IN O
pancreatic JJ O
beta JJ O
- : O
cells NNS O
. . O

The DT O
p24 NNS O
protein NN O
family NN O
have VBP O
multiple JJ O
functions NNS O
in IN O
protein NN O
transport NN O
in IN O
the DT O
early JJ O
secretory NN O
pathway NN O
. . O

In IN O
this DT O
study NN O
we PRP O
examined VBD O
the DT O
role NN O
of IN O
p24 DT O
proteins NNS O
in IN O
insulin NN O
transport NN O
. . O

Several JJ O
members NNS O
were VBD O
detected VBN O
in IN O
insulinoma NN O
cell NN O
lines NNS O
and CC O
rat NN O
islets NNS O
and CC O
expression NN O
levels NNS O
positively RB O
correlated VBN O
with IN O
insulin NN O
abundance NN O
, , O
particularly RB O
for IN O
p24delta1 NN O
and CC O
p24beta1 NN O
. . O

Knocking VBG O
down IN O
p24delta1 NNS O
in IN O
insulinoma NN O
cell NN O
lines NNS O
, , O
which WDT O
also RB O
resulted VBD O
in IN O
the DT O
concomitant JJ O
knock NN O
- : O
down IN O
of IN O
other JJ O
family NN O
members NNS O
, , O
impaired VBN O
glucose NN O
- : O
stimulated VBN O
insulin NN O
secretion NN O
, , O
decreased VBN O
total JJ O
cellular JJ O
insulin NN O
content NN O
and CC O
reduced VBD O
proinsulin NN O
biosynthesis NN O
. . O

There EX O
was VBD O
no DT O
effect NN O
on IN O
overall JJ O
protein NN O
biosynthesis NN O
or CC O
ER NNP O
stress NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
p24delta1 NN O
and CC O
possibly RB O
other JJ O
p24 IN O
family NN O
proteins NNS O
are VBP O
required VBN O
for IN O
normal JJ O
insulin NN O
biosynthesis NN O
and CC O
subsequent JJ O
secretion NN O
in IN O
pancreatic JJ O
beta JJ O
- : O
cells NNS O
. . O

-DOCSTART- X X O

Absence NN O
of IN O
microbiota NN O
( -LRB- O
germ NN O
- : O
free JJ O
conditions NNS O
) -RRB- O
accelerates VBZ O
the DT O
atherosclerosis NN O
in IN O
ApoE NNP O
- : O
deficient JJ O
mice NNS O
fed VBN O
standard NN O
low JJ O
cholesterol NN O
diet NN O
. . O

AIM NNP O
: : O

The DT O
aim NN O
of IN O
our PRP$ O
work NN O
was VBD O
to TO O
determine VB O
the DT O
influence NN O
of IN O
intestinal JJ O
bacteria NNS O
on IN O
the DT O
development NN O
of IN O
atherosclerotic JJ O
lesions NNS O
using VBG O
apolipoprotein NN O
E NNP O
( -LRB- O
ApoE NNP O
) -RRB- O
- : O
deficient JJ O
knockout NN O
mice NNS O
. . O

METHODS NNS O
: : O

The DT O
experiments NNS O
were VBD O
performed VBN O
on IN O
ApoE NNP O
- : O
/ VB O
- : O
- : O
deficient JJ O
mouse NN O
strain NN O
C57BL IN O
/ NN O
6 CD O
, , O
bred VBD O
under IN O
germ NN O
- : O
free JJ O
( -LRB- O
GF NN O
) -RRB- O
conditions NNS O
for IN O
two CD O
generations NNS O
or CC O
under IN O
conventional JJ O
conditions NNS O
with IN O
defined VBN O
microflora NN O
( -LRB- O
CV NN O
) -RRB- O
. . O

The DT O
mice NNS O
were VBD O
fed VBN O
a DT O
standard NN O
low JJ O
cholesterol NN O
diet NN O
or CC O
cholesterol NN O
- : O
rich JJ O
diet NN O
for IN O
3 CD O
- : O
4 CD O
months NNS O
. . O

We PRP O
studied VBD O
the DT O
development NN O
of IN O
advanced JJ O
lesions NNS O
in IN O
the DT O
thoracic JJ O
and CC O
abdominal JJ O
aorta NN O
by IN O
histological JJ O
, , O
morphometric JJ O
and CC O
immunohistological JJ O
methods NNS O
. . O

RESULTS NNS O
: : O

Conventionally RB O
reared VBD O
ApoE NNP O
- : O
/ SYM O
- : O
mice NNS O
( -LRB- O
containing VBG O
no DT O
pathogenic JJ O
intestinal JJ O
microbiota NN O
) -RRB- O
and CC O
fed VBD O
a DT O
standard NN O
low JJ O
cholesterol NN O
diet NN O
in IN O
contrast NN O
to TO O
a DT O
high JJ O
cholesterol NN O
diet NN O
did VBD O
not RB O
develop VB O
atherosclerotic JJ O
aortic JJ O
plaques NNS O
. . O

In IN O
contrast NN O
, , O
ApoE NNP O
- : O
/ SYM O
- : O
mice NNS O
reared VBD O
under IN O
germfree JJ O
conditions NNS O
for IN O
2 CD O
generations NNS O
and CC O
fed VBN O
a DT O
low JJ O
cholesterol NN O
diet NN O
exhibited VBD O
atherosclerotic JJ O
plaques NNS O
in IN O
the DT O
aorta NN O
. . O

Characteristic NNP O
lipid VBD O
deposition NN O
with IN O
foam NN O
cells NNS O
and CC O
macrophages NNS O
was VBD O
found VBN O
in IN O
their PRP$ O
arterial JJ O
walls NNS O
. . O

CONCLUSION NN O
: : O

In IN O
contrast NN O
to TO O
the DT O
absence NN O
of IN O
atherosclerotic JJ O
plaques NNS O
in IN O
conventionally RB O
reared VBN O
ApoE NNP O
- : O
deficient JJ O
mice NNS O
, , O
germ NN O
- : O
free JJ O
ApoE NNP O
- : O
/ SYM O
- : O
mice NNS O
consuming VBG O
the DT O
same JJ O
low JJ O
cholesterol NN O
standard NN O
diet NN O
developed VBD O
atherosclerotic JJ O
plaques NNS O
in IN O
the DT O
aorta NN O
. . O

Differences NNS O
in IN O
atherosclerotic JJ O
plaques NNS O
between IN O
GF NNP O
and CC O
CV NNP O
ApoE NNP O
- : O
/ SYM O
- : O
mice NNS O
are VBP O
not RB O
so RB O
apparent JJ O
when WRB O
mice NNS O
are VBP O
fed VBN O
a DT O
high JJ O
cholesterol NN O
diet NN O
. . O

Our PRP$ O
findings NNS O
thus RB O
document VB O
the DT O
protective JJ O
effect NN O
of IN O
microbiota NN O
( -LRB- O
commensal JJ O
bacteria NNS O
) -RRB- O
on IN O
atherosclerosis NN O
development NN O
. . O

-DOCSTART- X X O

Lactate NNP O
- : O
dehydrogenase NN O
5 CD O
is VBZ O
overexpressed VBN O
in IN O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
and CC O
correlates NNS O
with IN O
the DT O
expression NN O
of IN O
the DT O
transketolase NN O
- : O
like IN O
protein NN O
1 CD O
. . O

AIMS NNP O
: : O
As IN O
one CD O
of IN O
the DT O
five CD O
lactate NN O
dehydrogenase NN O
( -LRB- O
LDH NNP O
) -RRB- O
isoenzymes VBZ O
, , O
LDH5 NNP O
has VBZ O
the DT O
highest JJS O
efficiency NN O
to TO O
catalyze VB O
pyruvate JJ O
transformation NN O
to TO O
lactate VB O
. . O

LDH5 DT O
overexpression NN O
in IN O
cancer NN O
cells NNS O
induces VBZ O
an DT O
upregulated JJ O
glycolytic NN O
metabolism NN O
and CC O
reduced VBD O
dependence NN O
on IN O
the DT O
presence NN O
of IN O
oxygen NN O
. . O

Here RB O
we PRP O
analyzed VBD O
LDH5 DT O
protein NN O
expression NN O
in IN O
a DT O
well RB O
characterized VBN O
large JJ O
cohort NN O
of IN O
primary JJ O
lung NN O
cancers NNS O
in IN O
correlation NN O
to TO O
clinico VB O
- : O
pathological JJ O
data NNS O
and CC O
its PRP$ O
possible JJ O
impact NN O
on IN O
patient NN O
survival NN O
. . O

METHODS NNS O
: : O
Primary JJ O
lung NN O
cancers NNS O
( -LRB- O
n NN O
= SYM O
269 CD O
) -RRB- O
and CC O
non JJ O
neoplastic JJ O
lung NN O
tissue NN O
( -LRB- O
n NN O
= SYM O
35 CD O
) -RRB- O
were VBD O
tested VBN O
for IN O
LDH5 NNP O
expression NN O
by IN O
immunohistochemistry NN O
using VBG O
a DT O
polyclonal JJ O
LDH5 CD O
antibody NN O
( -LRB- O
ab53010 IN O
) -RRB- O
. . O

The DT O
results NNS O
of IN O
LDH5 DT O
expression NN O
were VBD O
correlated VBN O
to TO O
clinico VB O
- : O
pathological JJ O
data NNS O
as RB O
well RB O
as IN O
to TO O
patient NN O
' POS O
s PRP O
survival NN O
. . O

In IN O
addition NN O
, , O
the DT O
results NNS O
of IN O
the DT O
previously RB O
tested VBN O
transketolase NN O
like IN O
1 CD O
protein NN O
( -LRB- O
TKTL1 NN O
) -RRB- O
expression NN O
were VBD O
correlated VBN O
to TO O
LDH5 VB O
expression NN O
. . O

RESULTS NNS O
: : O
89 CD O
. . O
5 CD O
% NN O
( -LRB- O
n NN O
= SYM O
238 CD O
) -RRB- O
of IN O
NSCLC NNP O
revealed VBD O
LDH5 DT O
expression NN O
whereas IN O
LDH5 DT O
expression NN O
was VBD O
not RB O
detected VBN O
in IN O
non NN O
neoplastic JJ O
lung NN O
tissues NNS O
( -LRB- O
n NN O
= SYM O
34 CD O
) -RRB- O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
0001 CD O
) -RRB- O
. . O

LDH5 DT O
overexpression NNP O
was VBD O
associated VBN O
with IN O
histological JJ O
type NN O
( -LRB- O
adenocarcinoma NN O
= SYM O
57 CD O
% NN O
, , O
squamous JJ O
cell NN O
carcinoma NN O
= SYM O
45 CD O
% NN O
, , O
large JJ O
cell NN O
carcinoma NN O
= SYM O
46 CD O
% NN O
, , O
p NN O
= SYM O
0 CD O
. . O
006 CD O
) -RRB- O
. . O

No DT O
significant JJ O
correlation NN O
could MD O
be VB O
detected VBN O
with IN O
regard NN O
to TO O
TNM NNP O
- : O
stage NN O
, , O
grading NN O
or CC O
survival NN O
. . O

A DT O
two CD O
sided JJ O
correlation NN O
between IN O
the DT O
expression NN O
of IN O
TKTL1 NNP O
and CC O
LDH5 NNP O
could MD O
be VB O
shown VBN O
( -LRB- O
p NN O
= SYM O
0 CD O
. . O
002 CD O
) -RRB- O
within IN O
the DT O
overall JJ O
cohort NN O
as RB O
well RB O
as IN O
for IN O
each DT O
grading NN O
and CC O
pN NN O
group NN O
. . O

A DT O
significant JJ O
correlation NN O
between IN O
LDH5 NNP O
and CC O
TKTL1 NNP O
within IN O
each DT O
histologic NN O
tumortype NN O
could MD O
not RB O
be VB O
revealed VBN O
. . O

CONCLUSIONS NNS O
: : O
LDH5 NNP O
is VBZ O
overexpressed VBN O
in IN O
NSCLC NNP O
and CC O
could MD O
hence RB O
serve VB O
as IN O
an DT O
additional JJ O
marker NN O
for IN O
malignancy NN O
. . O

Furthermore RB O
, , O
LDH5 PRP O
correlates VBZ O
positively RB O
with IN O
the DT O
prognostic JJ O
marker NN O
TKTL1 NNP O
. . O

Our PRP$ O
results NNS O
confirm VBP O
a DT O
close JJ O
link NN O
between IN O
the DT O
two CD O
metabolic JJ O
enzymes NNS O
and CC O
indicate VBP O
an DT O
alteration NN O
in IN O
the DT O
glucose NN O
metabolism NN O
in IN O
the DT O
process NN O
of IN O
malignant JJ O
transformation NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
KISS1 NNP O
and CC O
MMP NNP O
- : O
9 CD O
in IN O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
and CC O
their PRP$ O
relations NNS O
to TO O
metastasis NN O
and CC O
survival NN O
. . O

KISS1 NNP O
and CC O
matrix NN O
metalloproteinase NN O
- : O
9 CD O
( -LRB- O
MMP NNP O
- : O
9 CD O
) -RRB- O
may MD O
play VB O
important JJ O
roles NNS O
as IN O
metastasis NN O
suppressor NN O
and CC O
metastasis NN O
promoter NN O
genes NNS O
, , O
respectively RB O
, , O
in IN O
a DT O
variety NN O
of IN O
malignancies NNS O
. . O

However RB O
, , O
there EX O
is VBZ O
little JJ O
information NN O
about IN O
their PRP$ O
possible JJ O
roles NNS O
in IN O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
( -LRB- O
NSCLC NNP O
) -RRB- O
. . O

The DT O
goals NNS O
of IN O
this DT O
study NN O
were VBD O
to TO O
determine VB O
the DT O
mRNA NN O
and CC O
protein NN O
expressions NNS O
of IN O
KISS1 NNP O
and CC O
MMP NNP O
- : O
9 CD O
in IN O
NSCLC NNP O
and CC O
their PRP$ O
relations NNS O
to TO O
metastasis NN O
and CC O
prognosis NN O
. . O

The DT O
mRNA NN O
and CC O
protein NN O
expressions NNS O
of IN O
KISS1 NNP O
and CC O
of IN O
MMP NNP O
- : O
9 CD O
protein NN O
were VBD O
detected VBN O
by IN O
in IN O
situ FW O
hybridization NN O
and CC O
immunohistochemistry NN O
respectively RB O
in IN O
85 CD O
cases NNS O
of IN O
NSCLC NNP O
, , O
and CC O
their PRP$ O
matched VBN O
lymph NN O
node NN O
metastases NNS O
. . O

Expressions NNS O
of IN O
KISS1 NNP O
mRNA NN O
and CC O
protein NN O
were VBD O
significantly RB O
higher JJR O
in IN O
low JJ O
TNM NNP O
stages NNS O
of IN O
NSCLC NNP O
( -LRB- O
I PRP O
- : O
II NNP O
) -RRB- O
compared VBN O
to TO O
more RBR O
advanced JJ O
stages NNS O
( -LRB- O
III NNP O
- : O
IV NNP O
) -RRB- O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

Moreover RB O
, , O
in IN O
advanced JJ O
TNM NNP O
stages NNS O
, , O
cases NNS O
without IN O
metastasis NN O
had VBD O
higher JJR O
KISS1 NNP O
gene NN O
expression NN O
compared VBN O
to TO O
those DT O
with IN O
lymph NN O
node NN O
metastasis NN O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

In IN O
contrast NN O
, , O
MMP NNP O
- : O
9 CD O
expression NN O
was VBD O
higher JJR O
in IN O
stage NN O
III NNP O
- : O
IV NNP O
NSCLC NNP O
cases NNS O
compared VBN O
to TO O
stage VB O
I PRP O
- : O
II NNP O
tumors NNS O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
and CC O
higher JJR O
in IN O
NSCLC NNP O
cases NNS O
with IN O
metastasis NN O
than IN O
those DT O
without IN O
metastasis NN O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

There EX O
was VBD O
negative JJ O
correction NN O
between IN O
KISS1 NNP O
and CC O
MMP NNP O
- : O
9 CD O
protein NN O
expression NN O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
01 CD O
) -RRB- O
. . O

The DT O
5 CD O
- : O
year NN O
survival NN O
rate NN O
in IN O
cases NNS O
with IN O
higher JJR O
KISS1 JJ O
protein NN O
expression NN O
was VBD O
significantly RB O
higher JJR O
than IN O
in IN O
those DT O
with IN O
low JJ O
expression NN O
( -LRB- O
20 CD O
. . O
9 CD O
vs NN O
. . O
2 CD O
. . O
4 CD O
% NN O
, , O
p NN O
< NN O
0 CD O
. . O
01 CD O
) -RRB- O
. . O

However RB O
, , O
the DT O
5 CD O
- : O
year NN O
survival NN O
rate NN O
of IN O
patients NNS O
with IN O
high JJ O
MMP NNP O
- : O
9 CD O
protein NN O
expression NN O
were VBD O
lower JJR O
than IN O
those DT O
with IN O
low JJ O
expression NN O
( -LRB- O
19 CD O
vs NN O
. . O
4 CD O
. . O
7 CD O
% NN O
, , O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
KISS1 NNP O
and CC O
MMP NNP O
- : O
9 CD O
may MD O
serve VB O
as IN O
potential JJ O
prognostic NN O
and CC O
therapeutic JJ O
markers NNS O
in IN O
lung NN O
cancer NN O
. . O

-DOCSTART- X X O

Is VBZ O
the DT O
elimination NN O
of IN O
HIV PRP$ O
infection NN O
within IN O
reach NN O
in IN O
the DT O
United NNP O
States NNP O
? . O

Lessons NNS O
from IN O
an DT O
epidemiologic NN O
transmission NN O
model NN O
. . O

Recent JJ O
estimates NNS O
show VBP O
that IN O
the DT O
transmission NN O
rate NN O
of IN O
human JJ O
immunodeficiency NN O
virus NN O
( -LRB- O
HIV NNP O
) -RRB- O
in IN O
the DT O
U NNP O
. . O
S NNP O
. . O
has VBZ O
substantially RB O
decreased VBN O
. . O

This DT O
raises VBZ O
the DT O
question NN O
, , O
is VBZ O
elimination NN O
of IN O
HIV NNP O
infection NN O
in IN O
the DT O
nation NN O
feasible NN O
in IN O
the DT O
foreseeable JJ O
future NN O
? . O

We PRP O
demonstrate VBP O
that IN O
if IN O
the DT O
HIV NNP O
transmission NN O
rate NN O
were VBD O
reduced VBN O
by IN O
50 CD O
% NN O
, , O
then RB O
the DT O
reproductive JJ O
rate NN O
of IN O
HIV NNP O
infection NN O
would MD O
drop VB O
below IN O
unity NN O
and CC O
lead NN O
to TO O
eventual JJ O
elimination NN O
of IN O
infection NN O
. . O

In IN O
recent JJ O
congressional JJ O
testimony NN O
, , O
the DT O
director NN O
of IN O
the DT O
Centers NNPS O
for IN O
Disease NNP O
Control NNP O
and CC O
Prevention NNP O
and CC O
others NNS O
asserted VBD O
that IN O
the DT O
HIV NNP O
transmission NN O
rate NN O
can MD O
be VB O
halved VBN O
by IN O
2020 CD O
, , O
if IN O
not RB O
earlier JJR O
, , O
provided VBN O
sufficient JJ O
investment NN O
is VBZ O
made VBN O
toward IN O
achieving VBG O
this DT O
goal NN O
. . O

We PRP O
assert VBP O
that IN O
if IN O
adequate JJ O
investment NN O
is VBZ O
made VBN O
and CC O
the DT O
transmission NN O
rate NN O
is VBZ O
in IN O
fact NN O
lowered VBN O
by IN O
50 CD O
% NN O
, , O
then RB O
the DT O
HIV NNP O
reproductive NN O
rate NN O
would MD O
fall VB O
below IN O
unity NN O
, , O
setting VBG O
the DT O
stage NN O
for IN O
eventual JJ O
elimination NN O
of IN O
HIV NNP O
infection NN O
in IN O
the DT O
U NNP O
. . O
S NNP O
. . O

-DOCSTART- X X O

Loss NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
in IN O
gastric JJ O
carcinoma NN O
. . O

BACKGROUND NNP O
: : O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
, , O
encoding VBG O
a DT O
ubiquitin NN O
ligase NN O
, , O
maps NNS O
to TO O
4q32 CD O
and CC O
has VBZ O
been VBN O
implicated VBN O
as IN O
a DT O
tumor NN O
suppressor NN O
gene NN O
and CC O
therapeutic JJ O
target NN O
in IN O
many JJ O
tumor NN O
types NNS O
. . O

Mutations NNS O
in IN O
colonic JJ O
adenomas NNS O
, , O
and CC O
the DT O
frequent JJ O
losses NNS O
on IN O
4q JJ O
described VBN O
in IN O
gastric JJ O
cancer NN O
prompt JJ O
speculation NN O
about IN O
the DT O
role NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
in IN O
gastric JJ O
carcinogenesis NN O
. . O

METHODS NNS O
: : O
We PRP O
assessed VBD O
the DT O
role NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
in IN O
gastric JJ O
cancer NN O
, , O
through IN O
loss NN O
of IN O
heterozygosity NN O
( -LRB- O
LOH NNP O
) -RRB- O
and CC O
multiplex JJ O
ligation NN O
- : O
dependent JJ O
probe NN O
amplification NN O
( -LRB- O
MLPA NNP O
) -RRB- O
on IN O
47 CD O
flow NN O
- : O
sorted JJ O
gastric JJ O
carcinomas NNS O
including VBG O
early JJ O
- : O
onset NN O
gastric JJ O
cancers NNS O
( -LRB- O
EOGC NN O
) -RRB- O
and CC O
xenografted VBD O
conventional JJ O
gastric JJ O
carcinomas NNS O
. . O

Ploidy JJ O
analysis NN O
was VBD O
carried VBN O
out RP O
on IN O
39 CD O
EOGCs NNS O
and CC O
immunohistochemistry NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
and CC O
its PRP$ O
substrates NNS O
c SYM O
- : O
myc NN O
, , O
c SYM O
- : O
jun NN O
, , O
Notch NN O
and CC O
cyclin NN O
E NNP O
was VBD O
performed VBN O
on IN O
204 NNS O
gastric JJ O
carcinomas NNS O
using VBG O
tissue NN O
microarrays NNS O
( -LRB- O
TMAs NN O
) -RRB- O
. . O

Sequence NN O
analysis NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
was VBD O
carried VBN O
out RP O
on IN O
gastric JJ O
carcinoma NN O
cell NN O
lines NNS O
and CC O
xenografts NNS O
. . O

RESULTS NNS O
: : O
Loss NN O
of IN O
heterozygosity NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
occurred VBD O
in IN O
32 CD O
% NN O
of IN O
EOGCs NNP O
, , O
and CC O
correlated VBD O
with IN O
loss NN O
of IN O
expression NN O
in IN O
26 CD O
% NN O
. . O

Loss NN O
of IN O
expression NN O
was VBD O
frequent JJ O
in IN O
both DT O
EOGC NNP O
and CC O
conventional JJ O
gastric JJ O
cancers NNS O
. . O

No DT O
CDC4 NNP O
/ NNP O
FBXW7 IN O
mutations NNS O
were VBD O
found VBN O
and CC O
loss NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
did VBD O
not RB O
correlate VB O
with IN O
ploidy JJ O
status NN O
. . O

There EX O
was VBD O
a DT O
significant JJ O
correlation NN O
between IN O
loss NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
expression NN O
and CC O
upregulation NN O
of IN O
c NNS O
- : O
myc NN O
. . O

CONCLUSION NN O
: : O
Loss NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 NNP O
appears VBZ O
to TO O
play VB O
a DT O
role NN O
in IN O
both DT O
EOGC NNP O
and CC O
conventional JJ O
gastric JJ O
carcinogenesis NN O
, , O
and CC O
c SYM O
- : O
myc JJ O
overexpression NN O
is VBZ O
likely JJ O
to TO O
be VB O
an DT O
important JJ O
oncogenic JJ O
consequence NN O
of IN O
CDC4 NNP O
/ NNP O
FBXW7 IN O
loss NN O
. . O

-DOCSTART- X X O

Pain NNP O
assessment NN O
by IN O
continuous JJ O
EEG NN O
: : O
association NN O
between IN O
subjective JJ O
perception NN O
of IN O
tonic JJ O
pain NN O
and CC O
peak JJ O
frequency NN O
of IN O
alpha NN O
oscillations NNS O
during IN O
stimulation NN O
and CC O
at IN O
rest NN O
. . O

Recordings NNS O
of IN O
neurophysiological JJ O
brain NN O
responses NNS O
to TO O
noxious JJ O
stimuli NNS O
have VBP O
been VBN O
traditionally RB O
based VBN O
on IN O
short JJ O
stimuli NNS O
, , O
in IN O
the DT O
order NN O
of IN O
milliseconds NNS O
, , O
which WDT O
induce VB O
distinct JJ O
event NN O
- : O
related JJ O
potentials NNS O
( -LRB- O
ERPs NNS O
) -RRB- O
. . O

However RB O
, , O
using VBG O
such JJ O
stimuli NNS O
in IN O
the DT O
experimental JJ O
setting NN O
is VBZ O
disadvantageous JJ O
as IN O
they PRP O
are VBP O
too RB O
brief JJ O
to TO O
faithfully RB O
simulate JJ O
clinical JJ O
pain NN O
. . O

We PRP O
aimed VBD O
at IN O
utilizing VBG O
continuous JJ O
EEG NN O
to TO O
investigate VB O
the DT O
properties NNS O
of IN O
peak NN O
alpha NN O
frequency NN O
( -LRB- O
PAF NN O
) -RRB- O
as IN O
an DT O
objective JJ O
cortical JJ O
measure NN O
associated VBN O
with IN O
subjective JJ O
perception NN O
of IN O
tonic JJ O
pain NN O
. . O

Five CD O
minute JJ O
long JJ O
continuous JJ O
EEG NN O
was VBD O
recorded VBN O
in IN O
18 CD O
healthy JJ O
volunteers NNS O
under IN O
: : O
( -LRB- O
i FW O
) -RRB- O
resting VBG O
- : O
state NN O
; : O
( -LRB- O
ii NNS O
) -RRB- O
innocuous JJ O
temperature NN O
; : O
and CC O
( -LRB- O
iii NN O
) -RRB- O
psychophysically RB O
- : O
anchored VBN O
noxious JJ O
temperature NN O
. . O

Numerical JJ O
pain NN O
scores NNS O
( -LRB- O
NPSs NN O
) -RRB- O
collected VBN O
during IN O
the DT O
application NN O
of IN O
tonic JJ O
noxious JJ O
stimuli NNS O
were VBD O
tested VBN O
for IN O
correlation NN O
with IN O
peak JJ O
frequencies NNS O
of IN O
alpha NN O
power NN O
- : O
curves NNS O
derived VBN O
from IN O
central JJ O
, , O
temporal JJ O
and CC O
frontal JJ O
electrodes NNS O
. . O

NPSs NNP O
and CC O
PAFs NNP O
remained VBD O
stable JJ O
throughout IN O
the DT O
recording NN O
conditions NNS O
( -LRB- O
RM NN O
- : O
ANOVAs NNS O
; : O
Ps NNS O
> VBP O
0 CD O
. . O
51 CD O
) -RRB- O
. . O

In IN O
the DT O
noxious JJ O
condition NN O
, , O
PAFs NNP O
obtained VBD O
at IN O
the DT O
bilateral JJ O
temporal JJ O
scalp NN O
were VBD O
correlated VBN O
with IN O
NPSs NNP O
( -LRB- O
Ps NNPS O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

Moreover RB O
, , O
resting VBG O
- : O
state NN O
PAFs NNS O
recorded VBD O
at IN O
the DT O
bilateral JJ O
temporal JJ O
scalp NN O
were VBD O
correlated VBN O
with IN O
NPSs NNP O
reported VBD O
during IN O
the DT O
noxious JJ O
condition NN O
( -LRB- O
Ps NNPS O
< NNP O
0 CD O
. . O
01 CD O
) -RRB- O
. . O

These DT O
psychophysical JJ O
- : O
neurophysiological JJ O
relations NNS O
attest NN O
to TO O
the DT O
properties NNS O
of IN O
PAF NNP O
as IN O
a DT O
novel NN O
cortical JJ O
objective JJ O
measure NN O
of IN O
subjective JJ O
perception NN O
of IN O
tonic JJ O
pain NN O
. . O

Moreover RB O
, , O
resting VBG O
- : O
state NN O
PAFs NNS O
might MD O
hold VB O
inherent JJ O
pain NN O
modulation NN O
attributes VBZ O
, , O
possibly RB O
enabling VBG O
the DT O
prediction NN O
of IN O
individual JJ O
responsiveness NN O
to TO O
prolonged JJ O
pain NN O
. . O

The DT O
relevance NN O
of IN O
PAF NNP O
to TO O
the DT O
neural JJ O
processing NN O
of IN O
tonic JJ O
pain NN O
may MD O
indicate VB O
its PRP$ O
potential JJ O
to TO O
advance VB O
pain NN O
research NN O
as RB O
well RB O
as IN O
clinical JJ O
pain NN O
characterization NN O
. . O

-DOCSTART- X X O

Acoustic JJ O
trauma NN O
evokes VBZ O
hyperactivity NN O
and CC O
changes NNS O
in IN O
gene NN O
expression NN O
in IN O
guinea NN O
- : O
pig NN O
auditory NN O
brainstem NN O
. . O

Hearing VBG O
loss NN O
from IN O
acoustic JJ O
trauma NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
tinnitus NN O
. . O

Animal JJ O
models NNS O
using VBG O
acoustic JJ O
trauma NN O
have VBP O
demonstrated VBN O
hyperactivity NN O
in IN O
central JJ O
auditory NN O
pathways NNS O
, , O
which WDT O
has VBZ O
been VBN O
suggested VBN O
as IN O
a DT O
substrate NN O
for IN O
tinnitus NN O
. . O

We PRP O
used VBD O
a DT O
guinea NN O
- : O
pig NN O
model NN O
of IN O
unilateral JJ O
acoustic JJ O
trauma NN O
. . O

Within IN O
the DT O
same JJ O
animals NNS O
, , O
measurements NNS O
of IN O
peripheral JJ O
hearing NN O
loss NN O
, , O
spontaneous JJ O
activity NN O
of IN O
single JJ O
neurons NNS O
in IN O
the DT O
inferior JJ O
colliculus NN O
and CC O
gene NN O
expression NN O
in IN O
cochlear JJ O
nucleus JJ O
and CC O
inferior JJ O
colliculus NN O
were VBD O
combined VBN O
, , O
acutely RB O
and CC O
after IN O
recovery NN O
from IN O
acoustic JJ O
trauma NN O
. . O

Genes NNS O
investigated VBD O
related VBN O
to TO O
inhibitory JJ O
( -LRB- O
GABA NNP O
- : O
A DT O
receptor NN O
subunit NN O
alpha NN O
1 CD O
; : O
glycine NN O
receptor NN O
subunit NN O
alpha NN O
1 CD O
) -RRB- O
and CC O
excitatory JJ O
neurotransmission NN O
( -LRB- O
glutamate NN O
decarboxylase NN O
1 CD O
; : O
glutamate NN O
receptor NN O
AMPA NNP O
subunit NN O
alpha NN O
2 CD O
; : O
glutamate NN O
receptor NN O
NMDA NNP O
subunit NN O
1 CD O
) -RRB- O
, , O
regulation NN O
of IN O
transmitter NN O
release NN O
( -LRB- O
member NN O
of IN O
RAB NNP O
family NN O
of IN O
small JJ O
GTPase NNP O
; : O
RAB3 NNP O
GTPase NNP O
activating VBG O
protein NN O
subunit NN O
1 CD O
) -RRB- O
and CC O
neuronal JJ O
excitability NN O
( -LRB- O
potassium NN O
channel NN O
subfamily NN O
K NNP O
member NN O
15 CD O
) -RRB- O
. . O

Acoustic JJ O
trauma NN O
resulted VBD O
in IN O
unilateral JJ O
hearing NN O
loss NN O
and CC O
hyperactivity NN O
bilaterally RB O
in IN O
inferior JJ O
colliculus NN O
. . O

Changes NNS O
in IN O
expression NN O
of IN O
different JJ O
mRNAs NNS O
were VBD O
observed VBN O
in IN O
ipsilateral JJ O
cochlear NN O
nucleus NN O
and CC O
in IN O
ipsi FW O
- : O
and CC O
contralateral JJ O
inferior JJ O
colliculus NN O
, , O
immediately RB O
after IN O
acoustic JJ O
trauma NN O
, , O
and CC O
after IN O
2 CD O
and CC O
4 CD O
weeks NNS O
' POS O
recovery NN O
. . O

Gene NNP O
expression NN O
was VBD O
generally RB O
reduced VBN O
immediately RB O
after IN O
trauma NN O
, , O
followed VBN O
by IN O
a DT O
return NN O
to TO O
near VB O
normal JJ O
levels NNS O
or CC O
over IN O
- : O
expression NN O
as IN O
recovery NN O
time NN O
increased VBN O
. . O

Different JJ O
mechanisms NNS O
appear VBP O
to TO O
underlie VB O
the DT O
spontaneous JJ O
hyperactivity NN O
observed VBD O
. . O

There EX O
is VBZ O
evidence NN O
of IN O
down IN O
- : O
regulation NN O
of IN O
genes NNS O
associated VBN O
with IN O
neuronal JJ O
inhibition NN O
in IN O
the DT O
contralateral JJ O
inferior JJ O
colliculus NN O
, , O
whereas IN O
in IN O
ipsilateral JJ O
cochlear JJ O
nucleus JJ O
, , O
competing VBG O
actions NNS O
of IN O
inhibitory JJ O
and CC O
excitatory JJ O
systems NNS O
seem VBP O
to TO O
play VB O
a DT O
major JJ O
role NN O
in IN O
determining VBG O
overall JJ O
excitability NN O
. . O

-DOCSTART- X X O

Telomere NNP O
/ NNP O
telomerase NN O
interplay NN O
in IN O
virus NN O
- : O
driven VBN O
and CC O
virus NN O
- : O
independent JJ O
lymphomagenesis NN O
: : O
pathogenic JJ O
and CC O
clinical JJ O
implications NNS O
. . O

Telomerase NNP O
is VBZ O
a DT O
ribonucleoprotein NN O
complex JJ O
critically RB O
involved VBN O
in IN O
extending VBG O
and CC O
maintaining VBG O
telomeres NNS O
. . O

Unlike IN O
the DT O
majority NN O
of IN O
somatic JJ O
cells NNS O
, , O
in IN O
which WDT O
hTERT NN O
and CC O
telomerase NN O
activity NN O
are VBP O
generally RB O
silent JJ O
, , O
normal JJ O
lymphocytes NNS O
show VBP O
transient JJ O
physiological JJ O
hTERT JJ O
expression NN O
and CC O
telomerase NN O
activity NN O
according VBG O
to TO O
their PRP$ O
differentiation NN O
/ IN O
activation NN O
status NN O
. . O

During IN O
lymphomagenesis NN O
, , O
induction NN O
of IN O
persistent JJ O
telomerase NN O
expression NN O
and CC O
activity NN O
may MD O
occur VB O
before IN O
or CC O
after IN O
telomere JJ O
shortening NN O
, , O
as IN O
a DT O
consequence NN O
of IN O
the DT O
different JJ O
mechanisms NNS O
through IN O
which WDT O
transforming VBG O
factors NNS O
/ JJ O
agents NNS O
may MD O
activate VB O
telomerase NN O
. . O

Available JJ O
data NNS O
indicate VBP O
that IN O
the DT O
timing NN O
of IN O
telomerase NN O
activation NN O
may MD O
allow VB O
the DT O
distinction NN O
of IN O
two CD O
different JJ O
lymphomagenetic JJ O
models NNS O
: : O
( -LRB- O
i NN O
) -RRB- O
an DT O
early JJ O
activation NN O
of IN O
telomerase NN O
via IN O
exogenous JJ O
regulators NNS O
of IN O
hTERT NN O
, , O
along IN O
with IN O
an DT O
increased VBN O
lymphocyte NN O
growth NN O
and CC O
a DT O
subsequent JJ O
selection NN O
of IN O
cells NNS O
with IN O
increased VBN O
transforming NN O
potential NN O
may MD O
characterize VB O
several JJ O
virus NN O
- : O
related VBN O
lymphoid NN O
malignancies NNS O
; : O
( -LRB- O
ii NNS O
) -RRB- O
a DT O
progressive JJ O
shortening NN O
of IN O
telomeres NNS O
, , O
leading VBG O
to TO O
genetic JJ O
instability NN O
which WDT O
favors VBZ O
a DT O
subsequent JJ O
activation NN O
of IN O
telomerase NN O
via IN O
endogenous JJ O
regulators NNS O
may MD O
occur VB O
in IN O
most JJS O
virus NN O
- : O
unrelated JJ O
lymphoid NN O
tumors NNS O
. . O

These DT O
models NNS O
may MD O
have VB O
clinically RB O
relevant JJ O
implications NNS O
, , O
particularly RB O
for IN O
the DT O
tailoring NN O
of IN O
therapeutic JJ O
strategies NNS O
targeting VBG O
telomerase NN O
. . O

-DOCSTART- X X O

Angiogenesis NNP O
inhibitors VBZ O
: : O
current JJ O
strategies NNS O
and CC O
future JJ O
prospects NNS O
. . O

Angiogenesis NNP O
has VBZ O
become VBN O
an DT O
attractive JJ O
target NN O
for IN O
drug NN O
therapy NN O
because IN O
of IN O
its PRP$ O
key JJ O
role NN O
in IN O
tumor NN O
growth NN O
. . O

An DT O
extensive JJ O
array NN O
of IN O
compounds NNS O
is VBZ O
currently RB O
in IN O
preclinical JJ O
development NN O
, , O
with IN O
many JJ O
now RB O
entering VBG O
the DT O
clinic NN O
and CC O
/ NN O
or CC O
achieving VBG O
approval NN O
from IN O
the DT O
US NNP O
Food NNP O
and CC O
Drug NNP O
Administration NNP O
. . O

Several JJ O
regulatory JJ O
and CC O
signaling VBG O
molecules NNS O
governing VBG O
angiogenesis NN O
are VBP O
of IN O
interest NN O
, , O
including VBG O
growth NN O
factors NNS O
( -LRB- O
eg NN O
, , O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
, , O
platelet NN O
- : O
derived VBN O
growth NN O
factor NN O
, , O
fibroblast JJ O
growth NN O
factor NN O
, , O
and CC O
epidermal JJ O
growth NN O
factor NN O
) -RRB- O
, , O
receptor NN O
tyrosine NN O
kinases NNS O
, , O
and CC O
transcription NN O
factors NNS O
such JJ O
as IN O
hypoxia NN O
inducible JJ O
factor NN O
, , O
as RB O
well RB O
as IN O
molecules NNS O
involved VBN O
in IN O
mitogen NN O
- : O
activated JJ O
protein NN O
kinase NN O
( -LRB- O
MAPK NN O
) -RRB- O
and CC O
phosphoinositide VB O
3 CD O
- : O
kinase NN O
( -LRB- O
PI3K NN O
) -RRB- O
signaling VBG O
. . O

Pharmacologic NNP O
agents NNS O
have VBP O
been VBN O
identified VBN O
that IN O
target NN O
these DT O
pathways NNS O
, , O
yet RB O
for IN O
some DT O
agents NNS O
( -LRB- O
notably RB O
thalidomide NN O
) -RRB- O
, , O
an DT O
understanding NN O
of IN O
the DT O
specific JJ O
mechanisms NNS O
of IN O
antitumor JJ O
action NN O
has VBZ O
proved VBN O
elusive JJ O
. . O

The DT O
following VBG O
review NN O
describes VBZ O
key JJ O
molecular JJ O
mechanisms NNS O
and CC O
novel NN O
therapies NNS O
that WDT O
are VBP O
on IN O
the DT O
horizon NN O
for IN O
antiangiogenic JJ O
tumor NN O
therapy NN O
. . O

-DOCSTART- X X O

A DT O
generative JJ O
model NN O
for IN O
image NN O
segmentation NN O
based VBN O
on IN O
label NN O
fusion NN O
. . O

We PRP O
propose VBP O
a DT O
nonparametric JJ O
, , O
probabilistic JJ O
model NN O
for IN O
the DT O
automatic JJ O
segmentation NN O
of IN O
medical JJ O
images NNS O
, , O
given VBN O
a DT O
training NN O
set NN O
of IN O
images NNS O
and CC O
corresponding JJ O
label NN O
maps NNS O
. . O

The DT O
resulting VBG O
inference NN O
algorithms NNS O
rely VBP O
on IN O
pairwise NN O
registrations NNS O
between IN O
the DT O
test NN O
image NN O
and CC O
individual JJ O
training NN O
images NNS O
. . O

The DT O
training NN O
labels NNS O
are VBP O
then RB O
transferred VBN O
to TO O
the DT O
test NN O
image NN O
and CC O
fused VBD O
to TO O
compute VB O
the DT O
final JJ O
segmentation NN O
of IN O
the DT O
test NN O
subject NN O
. . O

Such JJ O
label NN O
fusion NN O
methods NNS O
have VBP O
been VBN O
shown VBN O
to TO O
yield VB O
accurate JJ O
segmentation NN O
, , O
since IN O
the DT O
use NN O
of IN O
multiple JJ O
registrations NNS O
captures NNS O
greater JJR O
inter NN O
- : O
subject JJ O
anatomical JJ O
variability NN O
and CC O
improves VBZ O
robustness NN O
against IN O
occasional JJ O
registration NN O
failures NNS O
. . O

To TO O
the DT O
best JJS O
of IN O
our PRP$ O
knowledge NN O
, , O
this DT O
manuscript NN O
presents VBZ O
the DT O
first JJ O
comprehensive JJ O
probabilistic JJ O
framework NN O
that WDT O
rigorously RB O
motivates VBZ O
label NN O
fusion NN O
as IN O
a DT O
segmentation NN O
approach NN O
. . O

The DT O
proposed VBN O
framework NN O
allows VBZ O
us PRP O
to TO O
compare VB O
different JJ O
label NN O
fusion NN O
algorithms NNS O
theoretically RB O
and CC O
practically RB O
. . O

In IN O
particular JJ O
, , O
recent JJ O
label NN O
fusion NN O
or CC O
multiatlas NNS O
segmentation NN O
algorithms NNS O
are VBP O
interpreted VBN O
as IN O
special JJ O
cases NNS O
of IN O
our PRP$ O
framework NN O
. . O

We PRP O
conduct VBP O
two CD O
sets NNS O
of IN O
experiments NNS O
to TO O
validate VB O
the DT O
proposed VBN O
methods NNS O
. . O

In IN O
the DT O
first JJ O
set NN O
of IN O
experiments NNS O
, , O
we PRP O
use VBP O
39 CD O
brain NN O
MRI NNP O
scans VBZ O
- : O
with IN O
manually RB O
segmented VBN O
white JJ O
matter NN O
, , O
cerebral JJ O
cortex NN O
, , O
ventricles NNS O
and CC O
subcortical JJ O
structures NNS O
- : O
to TO O
compare VB O
different JJ O
label NN O
fusion NN O
algorithms NNS O
and CC O
the DT O
widely RB O
- : O
used VBN O
FreeSurfer NNP O
whole NN O
- : O
brain NN O
segmentation NN O
tool NN O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
the DT O
proposed JJ O
framework NN O
yields VBZ O
more RBR O
accurate JJ O
segmentation NN O
than IN O
FreeSurfer NNP O
and CC O
previous JJ O
label NN O
fusion NN O
algorithms NNS O
. . O

In IN O
a DT O
second JJ O
experiment NN O
, , O
we PRP O
use VBP O
brain NN O
MRI NNP O
scans NNS O
of IN O
282 CD O
subjects NNS O
to TO O
demonstrate VB O
that IN O
the DT O
proposed VBN O
segmentation NN O
tool NN O
is VBZ O
sufficiently RB O
sensitive JJ O
to TO O
robustly RB O
detect VB O
hippocampal NN O
volume NN O
changes NNS O
in IN O
a DT O
study NN O
of IN O
aging VBG O
and CC O
Alzheimer NNP O
' POS O
s PRP O
Disease NN O
. . O

-DOCSTART- X X O

Yellow JJ O
- : O
green JJ O
52 CD O
. . O
3W IN O
laser NN O
at IN O
556nm JJ O
based VBN O
on IN O
frequency NN O
doubling NN O
of IN O
a DT O
diode NN O
side NN O
- : O
pumped VBD O
Q NNP O
- : O
switched VBD O
Nd NNP O
: : O
YAG NNP O
laser NN O
. . O

We PRP O
demonstrate VBP O
a DT O
high JJ O
- : O
power NN O
556nm RP O
yellow JJ O
- : O
green JJ O
laser NN O
generated VBN O
by IN O
intracavity NN O
frequency NN O
doubling NN O
of IN O
a DT O
diode NN O
side NN O
- : O
pumped VBD O
Nd NNP O
: : O
YAG NNP O
laser NN O
at IN O
1112nm JJ O
. . O

A DT O
symmetrical JJ O
L NNP O
- : O
shaped VBN O
flat JJ O
- : O
flat JJ O
cavity NN O
was VBD O
employed VBN O
to TO O
implement VB O
efficient JJ O
operation NN O
of IN O
the DT O
low JJ O
- : O
gain NN O
1112nm IN O
transition NN O
and CC O
to TO O
achieve VB O
good JJ O
power NN O
scalability NN O
. . O

The DT O
coatings NNS O
of IN O
the DT O
cavity NN O
mirrors NNS O
were VBD O
carefully RB O
designed VBN O
to TO O
optimize VB O
the DT O
performance NN O
of IN O
the DT O
laser NN O
, , O
and CC O
a DT O
92W JJ O
continuous JJ O
wave NN O
laser NN O
output NN O
at IN O
1112nm PRP O
was VBD O
achieved VBN O
when WRB O
the DT O
pumping VBG O
power NN O
of IN O
the DT O
laser NN O
diodes NNS O
reached VBD O
960W NNP O
. . O

By IN O
intracavity NN O
frequency NN O
doubling NN O
of IN O
the DT O
fundamental JJ O
laser NN O
in IN O
a DT O
lithium JJ O
triborate NN O
crystal NN O
, , O
the DT O
maximum JJ O
power NN O
of IN O
the DT O
frequency NN O
- : O
doubled VBD O
output NN O
at IN O
556nm PRP O
was VBD O
found VBN O
to TO O
be VB O
as RB O
high JJ O
as IN O
52 CD O
. . O
3W '' O
with IN O
a DT O
pulse NN O
repetition NN O
frequency NN O
of IN O
10kHz CD O
. . O

This DT O
corresponds NNS O
to TO O
an DT O
optical JJ O
- : O
to TO O
- : O
optical JJ O
conversion NN O
efficiency NN O
of IN O
about IN O
5 CD O
. . O
4 CD O
% NN O
. . O

-DOCSTART- X X O

Betulin NNP O
induces VBZ O
mitochondrial JJ O
cytochrome NN O
c NN O
release NN O
associated VBN O
apoptosis NN O
in IN O
human JJ O
cancer NN O
cells NNS O
. . O

We PRP O
examined VBD O
whether IN O
betulin NN O
, , O
a DT O
naturally RB O
abundant JJ O
compound NN O
, , O
has VBZ O
anticancer VBN O
functions NNS O
in IN O
human JJ O
cancer NN O
cells NNS O
. . O

The DT O
results NNS O
showed VBD O
that IN O
betulin IN O
significantly RB O
inhibited VBN O
cell NN O
viability NN O
in IN O
cervix NN O
carcinoma NN O
HeLa NNP B-NP
cells NNS O
, , O
hepatoma NN O
HepG2 IN B-NP
cells NNS O
, , O
lung NN O
adenocarcinoma NN O
A549 IN B-NP
cells NNS O
, , O
and CC O
breast NN O
cancer NN O
MCF NNP B-NP
- : I-NP
7 CD I-NP
cells NNS O
with IN O
IC NN O
( -LRB- O
50 CD O
) -RRB- O
values NNS O
ranging VBG O
from IN O
10 CD O
to TO O
15 CD O
microg NN O
/ NN O
mL NN O
. . O

While IN O
betulin NN O
exhibited VBD O
only RB O
moderate JJ O
anticancer NN O
activity NN O
in IN O
other JJ O
human JJ O
cancer NN O
cells NNS O
such JJ O
as IN O
hepatoma NN O
SK JJ B-NP
- : I-NP
HEP JJ I-NP
- : I-NP
1 CD I-NP
cells NNS O
, , O
prostate JJ O
carcinoma NN O
PC NN B-NP
- : I-NP
3 CD I-NP
, , O
and CC O
lung NN O
carcinoma NN O
NCI NNP B-NP
- : I-NP
H460 CD I-NP
, , O
with IN O
IC NN O
( -LRB- O
50 CD O
) -RRB- O
values NNS O
ranging VBG O
from IN O
20 CD O
to TO O
60 CD O
microg NN O
/ NN O
mL NN O
, , O
it PRP O
showed VBD O
minor JJ O
growth NN O
inhibition NN O
in IN O
human JJ O
erythroleukemia NN O
K562 NN B-NP
cells NNS O
( -LRB- O
IC NN O
( -LRB- O
50 CD O
) -RRB- O
> VBZ O
100 CD O
microg NN O
/ JJ O
mL NN O
) -RRB- O
. . O

We PRP O
further RB O
investigated VBD O
the DT O
mechanism NN O
of IN O
anticancer NN O
activity NN O
by IN O
betulin NN O
, , O
using VBG O
HeLa NNP B-NP
cells NNS O
as IN O
an DT O
experimental JJ O
model NN O
. . O

Betulin NNP O
( -LRB- O
10 CD O
microg NN O
/ JJ O
mL NN O
) -RRB- O
induces VBZ O
apoptotic JJ O
cell NN O
death NN O
, , O
as IN O
evidenced VBN O
by IN O
morphological JJ O
characteristics NNS O
such JJ O
as IN O
membrane NN O
phosphatidylserine NN O
translocation NN O
, , O
nuclear JJ O
condensation NN O
/ IN O
fragmentation NN O
, , O
and CC O
apoptotic JJ O
body NN O
formation NN O
. . O

A DT O
kinetics NNS O
analysis NN O
showed VBD O
that IN O
the DT O
depolarization NN O
of IN O
mitochondrial JJ O
membrane NN O
potential NN O
and CC O
the DT O
release NN O
of IN O
mitochondrial JJ O
cytochrome NN O
c NNS O
occurred VBD O
as RB O
early RB O
as IN O
30 CD O
min NN O
after IN O
treatment NN O
with IN O
betulin NN O
. . O

Betulin NNP O
, , O
unlike IN O
its PRP$ O
chemical JJ O
derivative JJ O
betulinic NN O
acid NN O
, , O
did VBD O
not RB O
directly RB O
trigger VB O
mitochondrial JJ O
cytochrome NN O
c NN O
release NN O
in IN O
isolated JJ O
mitochondria NNS O
. . O

Importantly RB O
, , O
Bax NNP O
and CC O
Bak NNP O
were VBD O
rapidly RB O
translocated VBN O
to TO O
the DT O
mitochondria NN O
30 CD O
min NN O
after IN O
betulin NN O
treatment NN O
. . O

The DT O
sequential JJ O
activation NN O
of IN O
caspase NN O
- : O
9 CD O
and CC O
caspase VB O
- : O
3 CD O
/ NN O
- : O
7 CD O
and CC O
the DT O
cleavage NN O
of IN O
poly NN O
( -LRB- O
ADP NNP O
- : O
ribose NN O
) -RRB- O
polymerase NN O
( -LRB- O
PARP NNP O
) -RRB- O
were VBD O
observed VBN O
behind IN O
those DT O
mitochondrial JJ O
events NNS O
. . O

Furthermore RB O
, , O
specific JJ O
downregulation NN O
of IN O
either DT O
caspase NN O
- : O
9 CD O
, , O
Bax NNP O
, , O
or CC O
Bak NNP O
by IN O
siRNA NN O
effectively RB O
reduced VBD O
PARP NNP O
cleavage NN O
and CC O
caspase NN O
- : O
3 CD O
activation NN O
. . O

Taken VBN O
together RB O
, , O
the DT O
lines NNS O
of IN O
evidence NN O
demonstrate VBP O
that IN O
betulin IN O
triggers NNS O
apoptosis NN O
of IN O
human JJ O
cancer NN O
cells NNS O
through IN O
the DT O
intrinsic JJ O
apoptotic JJ O
pathway NN O
. . O

-DOCSTART- X X O

Relationship NN O
and CC O
prognostic JJ O
significance NN O
of IN O
SPARC NNP O
and CC O
VEGF NNP O
protein NN O
expression NN O
in IN O
colon NN O
cancer NN O
. . O

BACKGROUND NNP O
: : O
SPARC NNP O
( -LRB- O
secreted VBN O
protein NN O
, , O
acidic NN O
and CC O
rich JJ O
in IN O
cysteine NN O
) -RRB- O
is VBZ O
closely RB O
related VBN O
with IN O
the DT O
progress NN O
, , O
invasion NN O
and CC O
metastasis NN O
of IN O
malignant JJ O
tumor NN O
and CC O
angiogenesis NN O
. . O

METHODS NNS O
: : O
Using VBG O
human JJ O
colon NN O
adenocarcinoma NN O
tissues NNS O
( -LRB- O
hereinafter RB O
referred VBN O
to TO O
as IN O
colon NN O
cancer NN O
) -RRB- O
and CC O
their PRP$ O
corresponding JJ O
non FW O
- : O
diseased JJ O
colon NN O
from IN O
114 CD O
patients NNS O
' POS O
biopsies NNS O
, , O
the DT O
expression NN O
of IN O
SPARC NNP O
and CC O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
VEGF NN O
) -RRB- O
were VBD O
investigated VBN O
by IN O
immunohistochemistry NN O
staining VBG O
to TO O
assessment NN O
the DT O
relationship NN O
between IN O
SPARC NNP O
and CC O
VEGF NNP O
, , O
as RB O
well RB O
as IN O
their PRP$ O
prognostic JJ O
significance NN O
in IN O
patients NNS O
. . O

Evaluation NN O
of IN O
VEGF NN O
expression NN O
level NN O
with IN O
the DT O
same JJ O
tissues NNS O
was VBD O
used VBN O
to TO O
establish VB O
the DT O
antigenic JJ O
profiles NNS O
, , O
and CC O
the DT O
marker NN O
of IN O
CD34 NNP O
staining NN O
was VBD O
used VBN O
as IN O
an DT O
indicator NN O
of IN O
microvessel NN O
density NN O
( -LRB- O
MVD NNP O
) -RRB- O
. . O

RESULTS NNS O
: : O
SPARC NNP O
expression NN O
was VBD O
mainly RB O
in IN O
the DT O
stromal JJ O
cells NNS O
surrounding VBG O
the DT O
colon NN O
cancer NN O
, , O
and CC O
was VBD O
significant JJ O
difference NN O
in IN O
those DT O
tissues NNS O
with IN O
the DT O
lymph NN O
node NN O
metastasis NN O
and CC O
differentiation NN O
degree NN O
of IN O
tumor NN O
. . O

Expression NN O
of IN O
SPARC NNP O
was VBD O
significantly RB O
correlated VBN O
with IN O
the DT O
expression NN O
of IN O
VEGF NNP O
and CC O
MVD NNP O
in IN O
colon NN O
cancer NN O
tissues NNS O
. . O

Patients NNS O
with IN O
low JJ O
or CC O
absence NN O
expressing VBG O
SPARC NNP O
had VBD O
significantly RB O
worse JJR O
overall JJ O
survival NN O
and CC O
disease NN O
- : O
free JJ O
survival NN O
in IN O
a DT O
Single NNP O
Factor NNP O
Analysis NNP O
; : O
Cox NNP O
Regression NNP O
Analysis NNP O
, , O
SPARC NNP O
emerged VBD O
as IN O
an DT O
overall JJ O
survival NN O
and CC O
disease NN O
- : O
free JJ O
survival NN O
independent JJ O
prognostic JJ O
factor NN O
for IN O
colon NN O
cancer NN O
. . O

CONCLUSION NN O
: : O
The DT O
low JJ O
expression NN O
or CC O
absence NN O
of IN O
stromal JJ O
SPARC NNP O
was VBD O
an DT O
independent JJ O
prognostic JJ O
factor NN O
for IN O
poor JJ O
prognosis NN O
of IN O
colon NN O
cancer NN O
. . O

SPARC NNP O
maybe RB O
involved VBD O
in IN O
the DT O
regulation NN O
of IN O
anti NNS O
- : O
angiogenesis NN O
by IN O
which WDT O
it PRP O
may MD O
serve VB O
as IN O
a DT O
novel NN O
target NN O
for IN O
colon NN O
cancer NN O
treatment NN O
as RB O
well RB O
as IN O
a DT O
novel NN O
distinctive JJ O
marker NN O
. . O

-DOCSTART- X X O

Prognostic JJ O
significance NN O
of IN O
TRAIL NNP O
signaling VBG O
molecules NNS O
in IN O
stage NN O
II NNP O
and CC O
III NNP O
colorectal JJ O
cancer NN O
. . O

PURPOSE NNP O
: : O

We PRP O
previously RB O
found VBD O
that IN O
cellular JJ O
FLICE NNP O
- : O
inhibitory JJ O
protein NN O
( -LRB- O
c SYM O
- : O
FLIP NN O
) -RRB- O
, , O
caspase JJ O
8 CD O
, , O
and CC O
tumor NN O
necrosis NN O
factor NN O
- : O
related VBN O
apoptosis NN O
- : O
inducing NN O
ligand NN O
( -LRB- O
TRAIL NN O
) -RRB- O
receptor NN O
2 CD O
( -LRB- O
DR5 NN O
) -RRB- O
are VBP O
major JJ O
regulators NNS O
of IN O
cell NN O
viability NN O
and CC O
chemotherapy NN O
- : O
induced VBN O
apoptosis NN O
in IN O
colorectal JJ O
cancer NN O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
determined VBD O
the DT O
prognostic JJ O
significance NN O
of IN O
c NNS O
- : O
FLIP NN O
, , O
caspase NN O
8 CD O
, , O
TRAIL NN O
and CC O
DR5 DT O
expression NN O
in IN O
tissues NNS O
from IN O
patients NNS O
with IN O
stage NN O
II NNP O
and CC O
III NNP O
colorectal JJ O
cancer NN O
. . O

EXPERIMENTAL NNP O
DESIGN NNP O
: : O

Tissue NN O
microarrays NNS O
were VBD O
constructed VBN O
from IN O
matched VBN O
normal JJ O
and CC O
tumor NN O
tissue NN O
derived VBN O
from IN O
patients NNS O
( -LRB- O
n NN O
= SYM O
253 CD O
) -RRB- O
enrolled VBD O
in IN O
a DT O
phase NN O
III NNP O
trial NN O
of IN O
adjuvant NN O
5 CD O
- : O
fluorouracil NN O
- : O
based VBN O
chemotherapy NN O
versus NN O
postoperative JJ O
observation NN O
alone RB O
. . O

TRAIL NN O
, , O
DR5 NNP O
, , O
caspase NN O
8 CD O
, , O
and CC O
c SYM O
- : O
FLIP JJ O
expression NN O
levels NNS O
were VBD O
determined VBN O
by IN O
immunohistochemistry NN O
. . O

RESULTS NNS O
: : O

Colorectal JJ O
tumors NNS O
displayed VBD O
significantly RB O
higher JJR O
expression NN O
levels NNS O
of IN O
c SYM O
- : O
FLIP NN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
, , O
caspase JJ O
8 CD O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
01 CD O
) -RRB- O
, , O
and CC O
DR5 NNP O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
, , O
but CC O
lower JJR O
levels NNS O
of IN O
TRAIL NN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
compared VBN O
with IN O
matched VBN O
normal JJ O
tissue NN O
. . O

In IN O
univariate JJ O
analysis NN O
, , O
higher JJR O
TRAIL NN O
expression NN O
in IN O
the DT O
tumor NN O
was VBD O
associated VBN O
with IN O
worse JJR O
overall JJ O
survival NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
026 CD O
) -RRB- O
, , O
with IN O
a DT O
trend NN O
to TO O
decreased VBN O
relapse NN O
- : O
free JJ O
survival NN O
( -LRB- O
RFS NNP O
; : O
P NNP O
= SYM O
0 CD O
. . O
06 CD O
) -RRB- O
, , O
and CC O
higher JJR O
tumor NN O
c SYM O
- : O
FLIP JJ O
expression NN O
was VBD O
associated VBN O
with IN O
a DT O
significantly RB O
decreased VBN O
RFS NNP O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
015 CD O
) -RRB- O
. . O

Using VBG O
multivariate JJ O
predictive NN O
modeling VBG O
for IN O
RFS NNS O
in IN O
all DT O
patients NNS O
and CC O
including VBG O
all DT O
biomarkers NNS O
, , O
age NN O
, , O
treatment NN O
, , O
and CC O
stage NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
model NN O
was VBD O
significant JJ O
when WRB O
the DT O
mean JJ O
tumor NN O
c SYM O
- : O
FLIP JJ O
expression NN O
score NN O
and CC O
disease NN O
stage NN O
were VBD O
included VBN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

As IN O
regards NNS O
overall JJ O
survival NN O
, , O
the DT O
overall JJ O
model NN O
was VBD O
predictive JJ O
when WRB O
both DT O
TRAIL NNP O
expression NN O
and CC O
disease NN O
stage NN O
were VBD O
included VBN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

CONCLUSIONS NNS O
: : O

High NNP O
c SYM O
- : O
FLIP NN O
and CC O
TRAIL NN O
expression NN O
may MD O
be VB O
independent JJ O
adverse JJ O
prognostic JJ O
markers NNS O
in IN O
stage NN O
II NNP O
and CC O
III NNP O
colorectal JJ O
cancer NN O
and CC O
might MD O
identify VB O
patients NNS O
most RBS O
at IN O
risk NN O
of IN O
relapse NN O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
Bax NNP O
inhibitor IN O
- : O
1 LS O
( -LRB- O
BI JJR O
- : O
1 CD O
) -RRB- O
induces VBZ O
cell NN O
transformation NN O
in IN O
NIH3T3 NNP B-NP
cells NNS O
. . O

BI JJR O
- : O
1 CD O
( -LRB- O
Bax NNP O
inhibitor VB O
- : O
1 CD O
) -RRB- O
, , O
an DT O
apoptosis NN O
- : O
inhibiting JJ O
gene NN O
belonging VBG O
to TO O
the DT O
Bcl NNP O
- : O
2 CD O
protein NN O
family NN O
, , O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
mitochondrial JJ O
apoptosis NN O
pathway NN O
to TO O
suppress VB O
Bax NNP O
- : O
induced JJ O
apoptosis NN O
. . O

To TO O
investigate VB O
the DT O
potential JJ O
role NN O
of IN O
BI JJR O
- : O
1 CD O
in IN O
promoting VBG O
cell NN O
growth NN O
and CC O
tumorigenesis NN O
, , O
in IN O
the DT O
present JJ O
study NN O
we PRP O
overexpressed VBD O
the DT O
BI JJR O
- : O
1 CD O
gene NN O
in IN O
NIH3T3 NNP B-NP
cells NNS O
using VBG O
the DT O
lentivirus NN O
- : O
mediated JJ O
gene NN O
expression NN O
system NN O
. . O

Our PRP$ O
in IN O
vitro NN O
studies NNS O
showed VBD O
that IN O
NIH3T3 NNP B-NP
cells NNS O
overexpressing VBG O
BI JJR O
- : O
1 CD O
displayed VBN O
a DT O
significantly RB O
higher JJR O
growth NN O
rate NN O
and CC O
formed VBD O
more JJR O
and CC O
larger JJR O
colonies NNS O
than IN O
the DT O
control NN O
cells NNS O
. . O

In IN O
addition NN O
, , O
our PRP$ O
in IN O
vivo JJ O
studies NNS O
indicated VBD O
that IN O
the DT O
lenti NNS O
- : O
BI JJR O
- : O
1 LS O
- : O
infected JJ O
cells NNS O
formed VBN O
obvious JJ O
tumours NNS O
, , O
while IN O
no DT O
tumours NNS O
were VBD O
formed VBN O
by IN O
the DT O
control NN O
cells NNS O
after IN O
subcutaneously RB O
injected VBN O
into IN O
nude JJ O
mice NNS O
. . O

These DT O
results NNS O
strongly RB O
suggested VBD O
that IN O
the DT O
BI JJR O
- : O
1 CD O
gene NN O
might MD O
play VB O
a DT O
crucial JJ O
role NN O
in IN O
neoplastic JJ O
genesis NN O
and CC O
development NN O
. . O

-DOCSTART- X X O

Structure NN O
of IN O
human JJ O
hemoglobin NN O
messenger NN O
RNA NNP O
and CC O
its PRP$ O
relation NN O
to TO O
hemoglobinopathies NNS O
. . O

1 CD O
. . O

One CD O
- : O
fifth JJ O
to TO O
1 CD O
/ CD O
4 CD O
of IN O
globin NN O
mRNA NN O
is VBZ O
untranslated JJ O
sequence NN O
other JJ O
than IN O
polyadenylic JJ O
acid NN O
. . O

2 CD O
. . O

The DT O
untranslated JJ O
sequences NNS O
of IN O
mRNA NNS O
vary VBP O
markedly RB O
in IN O
their PRP$ O
sequence NN O
and CC O
in IN O
their PRP$ O
length NN O
. . O

3 CD O
. . O

Globin NNP O
mRNAs RB O
demonstrate VBP O
a DT O
marked JJ O
bias NN O
in IN O
codon NN O
selection NN O
. . O

4 CD O
. . O

Viral NNP O
mRNA NN O
shows VBZ O
a DT O
quite RB O
different JJ O
pattern NN O
of IN O
codon NN O
selection NN O
; : O
therefore RB O
, , O
the DT O
selection NN O
of IN O
codons NNS O
is VBZ O
not RB O
uniform JJ O
for IN O
all DT O
mRNAs NNS O
functioning VBG O
in IN O
animal NN O
cells NNS O
. . O

5 CD O
. . O

Elongated VBN O
hemoglobin NN O
chains NNS O
can MD O
be VB O
accounted VBN O
for IN O
by IN O
frame NN O
- : O
shift NN O
mutations NNS O
, , O
or CC O
point NN O
mutations NNS O
within IN O
the DT O
normal JJ O
termination NN O
codon NN O
. . O

The DT O
additional JJ O
amino NN O
acids NNS O
are VBP O
then RB O
coded VBN O
for IN O
by IN O
sequences NNS O
that WDT O
are VBP O
normally RB O
untranslated VBN O
. . O

6 CD O
. . O

Certain NNP O
hemoglobin NN O
deletion NN O
mutants NNS O
occur VBP O
at IN O
sites NNS O
where WRB O
there EX O
are VBP O
partially RB O
reiterated VBD O
sequences NNS O
within IN O
the DT O
heomoglobin NN O
messenger NN O
RNA NNP O
. . O

-DOCSTART- X X O

Anti NNP O
- : O
metastasis NN O
effects NNS O
of IN O
gallic JJ O
acid NN O
on IN O
gastric JJ O
cancer NN O
cells NNS O
involves VBZ O
inhibition NN O
of IN O
NF NNP O
- : O
kappaB NN O
activity NN O
and CC O
downregulation NN O
of IN O
PI3K NNP O
/ NNP O
AKT NNP O
/ , O
small JJ O
GTPase NNP O
signals NNS O
. . O

Polyphenols NNS O
are VBP O
natural JJ O
antioxidants NNS O
that WDT O
are VBP O
thought VBN O
to TO O
contribute VB O
to TO O
prevention NN O
of IN O
cardiovascular JJ O
disease NN O
and CC O
malignancy NN O
. . O

Although IN O
many JJ O
studies NNS O
have VBP O
been VBN O
carried VBN O
out RP O
to TO O
investigate VB O
the DT O
chemopreventive JJ O
role NN O
of IN O
flavonoids NNS O
, , O
less JJR O
attention NN O
has VBZ O
been VBN O
focused VBN O
on IN O
phenolic JJ O
acids NNS O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
aim NN O
was VBD O
to TO O
investigate VB O
the DT O
effect NN O
of IN O
phenolic JJ O
acids NNS O
found VBD O
abundantly RB O
in IN O
vegetables NNS O
, , O
i FW O
. . O
e NN O
. . O
gallic JJ O
acid NN O
( -LRB- O
GA NNP O
) -RRB- O
, , O
caffeic JJ O
acid NN O
( -LRB- O
CA NNP O
) -RRB- O
and CC O
protocatechuic JJ O
acid NN O
( -LRB- O
PCA NNP O
) -RRB- O
, , O
on IN O
the DT O
inhibition NN O
of IN O
gastric JJ O
adenocarcinoma NN O
( -LRB- O
AGS NNP O
) -RRB- O
cell NN O
metastasis NN O
. . O

The DT O
results NNS O
showed VBD O
0 CD O
. . O
01 CD O
mM NN O
GA NNP O
induced VBD O
the DT O
same JJ O
level NN O
of IN O
cell NN O
toxicity NN O
as IN O
4 CD O
. . O
0mM IN O
PCA NNP O
. . O

Using VBG O
wound NN O
- : O
healing NN O
assay NN O
and CC O
Boyden NNP O
chamber NN O
assay NN O
, , O
GA NNP O
had VBD O
potent JJ O
inhibitory JJ O
effects NNS O
on IN O
AGS NNP O
cell NN O
migration NN O
. . O

The DT O
expression NN O
of IN O
MMP NNP O
- : O
2 CD O
/ NN O
9 CD O
of IN O
AGS NNP O
cells NNS O
was VBD O
inhibited VBN O
by IN O
2 CD O
. . O
0 CD O
microM NN O
of IN O
GA NNP O
. . O

It PRP O
is VBZ O
possible JJ O
that IN O
the DT O
suppressive JJ O
effect NN O
of IN O
GA NNP O
on IN O
MMP NNP O
- : O
2 CD O
/ NN O
9 CD O
might MD O
involve VB O
the DT O
inhibition NN O
of IN O
NF NNP O
- : O
kappaB NN O
activity NN O
. . O

Multiple JJ O
proteins NNS O
involved VBN O
in IN O
metastasis NN O
and CC O
the DT O
cytoskeletal NN O
reorganization NN O
signal NN O
pathway NN O
, , O
including VBG O
Ras NNP O
, , O
Cdc42 NNP O
, , O
Rac1 NNP O
, , O
RhoA NNP O
, , O
RhoB NNP O
, , O
PI3K NNP O
and CC O
p38MAPK JJ O
, , O
were VBD O
also RB O
inhibited VBN O
by IN O
GA NNP O
. . O

Furthermore RB O
, , O
immunoreactivity NN O
assay NN O
of IN O
cytoskeletal NN O
F NNP O
- : O
actin NN O
demonstrated VBD O
a DT O
significant JJ O
inhibitory JJ O
effect NN O
of IN O
GA NNP O
treatment NN O
. . O

In IN O
conclusion NN O
, , O
GA NNP O
may MD O
have VB O
the DT O
potential JJ O
to TO O
be VB O
an DT O
effective JJ O
agent NN O
for IN O
prevention NN O
and CC O
treatment NN O
of IN O
gastric JJ O
cancer NN O
metastasis NN O
. . O

-DOCSTART- X X O

1 CD O
, , O
4 CD O
- : O
phenylenebis NNS O
( -LRB- O
methylene NN O
) -RRB- O
selenocyanate NN O
, , O
but CC O
not RB O
selenomethionine VB O
, , O
inhibits VBZ O
androgen NN O
receptor NN O
and CC O
Akt NNP O
signaling VBG O
in IN O
human JJ O
prostate NN O
cancer NN O
cells NNS O
. . O

The DT O
lack NN O
of IN O
treatment NN O
for IN O
worried JJ O
- : O
well RB O
patients NNS O
with IN O
high JJ O
- : O
grade NN O
prostatic JJ O
intraepithelial JJ O
neoplasia NN O
combined VBN O
with IN O
issues NNS O
of IN O
recurrence NN O
and CC O
hormone NN O
resistance NN O
in IN O
prostate NN O
cancer NN O
survivors NNS O
remains VBZ O
a DT O
major JJ O
public JJ O
health NN O
obstacle NN O
. . O

The DT O
long JJ O
latency NN O
of IN O
prostate NN O
cancer NN O
development NN O
provides VBZ O
an DT O
opportunity NN O
to TO O
intervene VB O
with IN O
agents NNS O
of IN O
known VBN O
mechanisms NNS O
at IN O
various JJ O
stages NNS O
of IN O
disease NN O
progression NN O
. . O

A DT O
number NN O
of IN O
signaling VBG O
cascades NNS O
have VBP O
been VBN O
shown VBN O
to TO O
play VB O
important JJ O
roles NNS O
in IN O
prostate NN O
cancer NN O
development NN O
and CC O
progression NN O
, , O
including VBG O
the DT O
androgen NN O
receptor NN O
( -LRB- O
AR NN O
) -RRB- O
and CC O
phosphatidylinositol NN O
3 LS O
- : O
kinase NN O
/ NN O
Akt IN O
signaling VBG O
pathways NNS O
. . O

Crosstalk NN O
between IN O
these DT O
two CD O
pathways NNS O
is VBZ O
also RB O
thought VBN O
to TO O
contribute VB O
to TO O
progression NN O
and CC O
hormone NN O
- : O
refractory JJ O
prostate NN O
disease NN O
. . O

Our PRP$ O
initial JJ O
investigations NNS O
show VBP O
that IN O
the DT O
naturally RB O
occurring VBG O
organoselenium NN O
compound NN O
selenomethionine NN O
( -LRB- O
SM NNP O
) -RRB- O
and CC O
the DT O
synthetic NN O
1 CD O
, , O
4 CD O
- : O
phenylenebis NNS O
( -LRB- O
methylene NN O
) -RRB- O
selenocyanate VBP O
( -LRB- O
p NN O
- : O
XSC NNS O
) -RRB- O
can MD O
inhibit VB O
human JJ O
prostate NN O
cancer NN O
cell NN O
viability NN O
; : O
however RB O
, , O
in IN O
contrast NN O
to TO O
SM NNP O
, , O
p NN O
- : O
XSC NNP O
is VBZ O
active JJ O
at IN O
physiologically RB O
relevant JJ O
doses NNS O
. . O

In IN O
the DT O
current JJ O
investigation NN O
, , O
we PRP O
show VBP O
that IN O
p NN O
- : O
XSC NNP O
, , O
but CC O
not RB O
an DT O
equivalent JJ O
dose NN O
of IN O
SM NNP O
, , O
alters NNS O
molecular JJ O
targets NNS O
and CC O
induces VBZ O
apoptosis NN O
in IN O
androgen NN O
- : O
responsive JJ O
LNCaP NNP B-NP
and CC O
androgen NN O
- : O
independent JJ O
LNCaP NNP B-NP
C4 NNP I-NP
- : I-NP
2 CD I-NP
human JJ O
prostate NN O
cancer NN O
cells NNS O
. . O

p VB O
- : O
XSC NNP O
effectively RB O
inhibits VBZ O
AR NN O
expression NN O
and CC O
transcriptional JJ O
activity NN O
in IN O
both DT O
cell NN O
lines NNS O
. . O

p VB O
- : O
XSC NNP O
also RB O
decreases VBZ O
Akt NNP O
phosphorylation NN O
as RB O
well RB O
as IN O
Akt NNP O
- : O
specific JJ O
phosphorylation NN O
of IN O
the DT O
AR NN O
. . O

Inhibition NN O
of IN O
Akt NNP O
, , O
however RB O
, , O
does VBZ O
not RB O
fully RB O
attenuate VB O
p NN O
- : O
XSC NNP O
- : O
mediated JJ O
downregulation NN O
of IN O
AR NN O
activity NN O
, , O
suggesting VBG O
that IN O
inhibition NN O
of IN O
AR NN O
signaling VBG O
by IN O
p NN O
- : O
XSC NNP O
does VBZ O
not RB O
occur VB O
solely RB O
through IN O
alterations NNS O
in IN O
the DT O
phosphatidylinositol NN O
3 CD O
- : O
kinase NN O
/ NN O
Akt NN O
survival NN O
pathway NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
p NN O
- : O
XSC NNP O
inhibits VBZ O
multiple JJ O
signaling VBG O
pathways NNS O
in IN O
prostate NN O
cancer NN O
, , O
likely JJ O
accounting NN O
for IN O
the DT O
downstream NN O
effects NNS O
on IN O
proliferation NN O
and CC O
apoptosis NN O
. . O

-DOCSTART- X X O

Listerine NN O
: : O
past NN O
, , O
present JJ O
and CC O
future JJ O
- : O
- : O
a DT O
test NN O
of IN O
thyme NN O
. . O

Listerine NN O
, , O
a DT O
mouthrinse NN O
composed VBN O
of IN O
a DT O
mixture NN O
of IN O
essential JJ O
oils NNS O
, , O
was VBD O
created VBN O
in IN O
1879 CD O
and CC O
was VBD O
originally RB O
formulated VBN O
as IN O
a DT O
surgical JJ O
antiseptic NN O
. . O

In IN O
spite NN O
of IN O
its PRP$ O
known VBN O
antimicrobial JJ O
properties NNS O
it PRP O
was VBD O
thought VBN O
of IN O
as IN O
a DT O
product NN O
in IN O
search NN O
of IN O
a DT O
use NN O
and CC O
promoted VBD O
as IN O
a DT O
deterrent NN O
for IN O
halitosis NN O
and CC O
as IN O
a DT O
floor NN O
cleaner JJR O
. . O

In IN O
the DT O
last JJ O
several JJ O
years NNS O
Listerine NNP O
has VBZ O
emerged VBN O
as IN O
a DT O
bona NN O
fide JJ O
therapeutic JJ O
agent NN O
for IN O
reduction NN O
of IN O
plaque JJ O
induced JJ O
oral JJ O
diseases NNS O
. . O

In IN O
contrast NN O
to TO O
the DT O
inconsistent JJ O
history NN O
of IN O
Listerine NNP O
, , O
systemic JJ O
antibiotics NNS O
discovered VBN O
in IN O
the DT O
1940 CD O
' POS O
s PRP O
were VBD O
heralded VBN O
as IN O
miracle NN O
drugs NNS O
. . O

However RB O
, , O
the DT O
value NN O
of IN O
prophylactic JJ O
usage NN O
of IN O
antibiotics NNS O
has VBZ O
come VBN O
under IN O
scrutiny NN O
as IN O
a DT O
result NN O
of IN O
increasing VBG O
resistance NN O
and CC O
adverse JJ O
reactions NNS O
. . O

Moreover RB O
, , O
reports NNS O
by IN O
both DT O
American NNP O
and CC O
British JJ O
professional JJ O
societies NNS O
have VBP O
led VBN O
to TO O
a DT O
re NN O
- : O
evaluation NN O
of IN O
the DT O
relative JJ O
risks NNS O
associated VBN O
with IN O
plaque NN O
induced VBN O
bacteremia NN O
when WRB O
twice JJ O
- : O
yearly JJ O
visits NNS O
to TO O
dental JJ O
professionals NNS O
are VBP O
compared VBN O
to TO O
daily JJ O
activities NNS O
. . O

These DT O
new JJ O
recommendations NNS O
and CC O
revelations NNS O
open VBP O
the DT O
door NN O
for IN O
local JJ O
antimicrobial JJ O
approaches NNS O
to TO O
reduce VB O
the DT O
challenge NN O
of IN O
plaque NN O
- : O
induced VBN O
bacteremias NNS O
. . O

These DT O
issues NNS O
will MD O
be VB O
discussed VBN O
in IN O
the DT O
context NN O
of IN O
Listerine NNP O
, , O
its PRP$ O
intricate JJ O
and CC O
complicated JJ O
past JJ O
, , O
and CC O
its PRP$ O
connection NN O
to TO O
current JJ O
uses NNS O
in IN O
oral JJ O
health NN O
and CC O
beyond IN O
. . O

-DOCSTART- X X O

Ventral NNP O
and CC O
dorsal JJ O
striatal JJ O
dopamine NN O
efflux NN O
and CC O
behavior NN O
in IN O
rats NNS O
with IN O
simple JJ O
vs NN O
. . O
co VB O
- : O
morbid NN O
histories NNS O
of IN O
cocaine NN O
sensitization NN O
and CC O
neonatal JJ O
ventral JJ O
hippocampal NN O
lesions NNS O
. . O

UNLABELLED VBD O
: : O

RATIONAL NNP O
: : O
Exposing NNP O
animal NN O
models NNS O
of IN O
mental JJ O
illness NN O
to TO O
addictive JJ O
drugs NNS O
provides VBZ O
an DT O
approach NN O
to TO O
understanding VBG O
the DT O
neural JJ O
etiology NN O
of IN O
dual JJ O
diagnosis NN O
disorders NNS O
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
neonatal JJ O
ventral JJ O
hippocampal NN O
lesions NNS O
( -LRB- O
NVHL NN O
) -RRB- O
in IN O
rats NNS O
produce VBP O
features NNS O
of IN O
both DT O
schizophrenia NN O
and CC O
addiction NN O
vulnerability NN O
. . O

OBJECTIVE CD O
: : O

This DT O
study NN O
investigated VBD O
ventral JJ O
and CC O
dorsal JJ O
striatal JJ O
dopamine NN O
( -LRB- O
DA NNP O
) -RRB- O
efflux NN O
in IN O
NVHL NNP O
rats NNS O
combined VBN O
with IN O
behavioral JJ O
sensitization NN O
to TO O
cocaine NN O
. . O

METHODS NNS O
: : O

Adult NN O
NVHL NNP O
vs IN O
. . O
SHAM NNP O
- : O
operated VBD O
rats NNS O
underwent IN O
a DT O
5 CD O
- : O
day NN O
injection NN O
series NN O
of IN O
cocaine NN O
( -LRB- O
15 CD O
mg NN O
/ NN O
kg NN O
/ JJ O
day NN O
) -RRB- O
vs NN O
. . O
saline NN O
. . O

One CD O
week NN O
later RB O
, , O
rats NNS O
were VBD O
cannulated VBN O
in IN O
nucleus JJ O
accumbens NNS O
SHELL NNP O
, , O
CORE NNP O
, , O
or CC O
caudate VB O
- : O
putamen NNS O
. . O

Another DT O
week NN O
later RB O
, , O
in IN O
vivo JJ O
microdialysis NN O
sampled VBN O
DA NNP O
during IN O
locomotor NN O
testing NN O
in IN O
which WDT O
a DT O
single JJ O
cocaine NN O
injection NN O
( -LRB- O
15 CD O
mg NN O
/ JJ O
kg NN O
) -RRB- O
was VBD O
delivered VBN O
. . O

RESULTS NNS O
: : O

NVHLs NNS O
and CC O
cocaine NN O
history NN O
significantly RB O
increased VBD O
behavioral JJ O
activation NN O
approximately RB O
2 CD O
- : O
fold NN O
over IN O
SHAM NNP O
- : O
saline NN O
history NN O
rats NNS O
. . O

DA NNP O
efflux NN O
curves NNS O
corresponded VBD O
time NN O
dependently RB O
with IN O
the DT O
cocaine NN O
injection NN O
and CC O
locomotor NN O
curves NNS O
and CC O
varied VBN O
significantly RB O
by IN O
striatal JJ O
region NN O
: : O
Baseline NNP O
DA NNP O
levels NNS O
increased VBD O
5 CD O
- : O
fold NN O
while IN O
cocaine NN O
- : O
stimulated VBN O
DA NNP O
efflux NN O
decreased VBN O
by IN O
half NN O
across IN O
a DT O
ventral NN O
to TO O
dorsal JJ O
striatal JJ O
gradient NN O
. . O

However RB O
, , O
NVHLs NNP O
, , O
prior JJ O
cocaine NN O
history NN O
, , O
and CC O
individual JJ O
differences NNS O
in IN O
behavior NN O
were VBD O
not RB O
underpinned VBN O
by IN O
differential JJ O
DA NNP O
efflux NN O
overall JJ O
or CC O
within IN O
any DT O
striatal JJ O
region NN O
. . O

CONCLUSION NN O
: : O

Differences NNS O
in IN O
ventral JJ O
/ NNS O
dorsal JJ O
striatal JJ O
DA NNP O
efflux NN O
are VBP O
not RB O
present JJ O
in IN O
and CC O
are VBP O
not RB O
required VBN O
for IN O
producing VBG O
differential JJ O
levels NNS O
of IN O
acute JJ O
cocaine NN O
- : O
induced JJ O
behavioral JJ O
activation NN O
in IN O
NVHLs NNP O
with IN O
and CC O
without IN O
a DT O
behaviorally RB O
sensitizing VBG O
cocaine NN O
history NN O
. . O

These DT O
findings NNS O
suggest VBP O
other JJ O
neurotransmitter NN O
systems NNS O
, , O
and CC O
alterations NNS O
in IN O
striatal JJ O
network NN O
function NN O
post NN O
- : O
synaptic JJ O
to TO O
DA NNP O
transmission NN O
are VBP O
more RBR O
important JJ O
to TO O
understanding VBG O
the DT O
interactive JJ O
effects NNS O
of IN O
addictive JJ O
drugs NNS O
and CC O
mental JJ O
illness NN O
. . O

-DOCSTART- X X O

Adenovirus NNP O
5 CD O
E1A NNP O
enhances NNS O
histone NN O
deacetylase NN O
inhibitors NNS O
- : O
induced JJ O
apoptosis NN O
through IN O
Egr NNP O
- : O
1 LS O
- : O
mediated JJ O
Bim NNP O
upregulation NN O
. . O

Histone NN O
deacetylase NN O
inhibitors NNS O
( -LRB- O
HDACi NN O
) -RRB- O
are VBP O
potent JJ O
anti NNS O
- : O
cancer NN O
agents NNS O
for IN O
variety NN O
of IN O
cancer NN O
types NNS O
. . O

Suberoylanilide JJ O
hydroxamic JJ O
acid NN O
( -LRB- O
SAHA NNP O
) -RRB- O
has VBZ O
been VBN O
approved VBN O
as IN O
a DT O
drug NN O
to TO O
treat VB O
cutaneous JJ O
T NNP O
cell NN O
lymphoma NN O
, , O
and CC O
the DT O
combination NN O
of IN O
HDACi NNP O
and CC O
other JJ O
agents NNS O
have VBP O
been VBN O
actively RB O
tested VBN O
in IN O
many JJ O
clinical JJ O
trials NNS O
. . O

Adenovirus NNP O
5 CD O
early JJ O
region NN O
1A IN O
( -LRB- O
E1A NN O
) -RRB- O
has VBZ O
been VBN O
shown VBN O
to TO O
exhibit VB O
high JJ O
tumor NN O
suppressor NN O
activity NN O
, , O
and CC O
gene NN O
therapy NN O
using VBG O
E1A PRP O
has VBZ O
been VBN O
tested VBN O
in IN O
clinical JJ O
trials NNS O
. . O

Here RB O
, , O
we PRP O
showed VBD O
that IN O
proapoptotic JJ O
activity NN O
of IN O
HDACi NNP O
was VBD O
robustly RB O
enhanced VBN O
by IN O
E1A NNP O
in IN O
multiple JJ O
cancer NN O
cells NNS O
, , O
but CC O
not RB O
in IN O
normal JJ O
cells NNS O
. . O

Moreover RB O
, , O
we PRP O
showed VBD O
that IN O
combination NN O
of IN O
E1A NNP O
gene NN O
therapy NN O
and CC O
SAHA NNP O
showed VBD O
high JJ O
therapeutic JJ O
efficacy NN O
with IN O
low JJ O
toxicity NN O
in IN O
vivo JJ O
ovarian JJ O
and CC O
breast NN O
xenograft NN O
models NNS O
. . O

SAHA NNP O
downregulated VBD O
Bcl NNP O
- : O
XL NNP O
and CC O
upregulated JJ O
proapoptotic JJ O
BH3 NNS O
- : O
only JJ O
protein NN O
Bim NNP O
, , O
whose WP$ O
expression NN O
was VBD O
further RB O
enhanced VBN O
by IN O
E1A NNP O
in IN O
cancer NN O
cells NNS O
. . O

These DT O
alterations NNS O
of IN O
Bcl NNP O
- : O
2 CD O
family NN O
proteins NNS O
were VBD O
critical JJ O
for IN O
apoptosis NN O
induced VBN O
by IN O
the DT O
combination NN O
in IN O
cancer NN O
cells NNS O
. . O

SAHA NNP O
enhanced VBD O
acetylation NN O
of IN O
histone NN O
H3 . O
in IN O
Bim NNP O
promoter NN O
region NN O
, , O
while IN O
E1A NNP O
upregulated NNP O
Egr NNP O
- : O
1 CD O
, , O
which WDT O
was VBD O
directly RB O
involved VBN O
in IN O
Bim NNP O
transactivation NN O
. . O

Together RB O
, , O
our PRP$ O
results NNS O
provide VBP O
not RB O
only RB O
a DT O
novel JJ O
insight NN O
into IN O
the DT O
mechanisms NNS O
underlying VBG O
anti FW O
- : O
tumor NN O
activity NN O
of IN O
E1A NNP O
, , O
but CC O
also RB O
a DT O
rationale NN O
for IN O
the DT O
combined VBN O
HDACi NNP O
and CC O
E1A NNP O
gene NN O
therapy NN O
in IN O
future JJ O
clinical JJ O
trials NNS O
. . O

-DOCSTART- X X O

Sanguinarine NNP O
induces VBZ O
apoptosis NN O
of IN O
human JJ O
osteosarcoma NN O
cells NNS O
through IN O
the DT O
extrinsic JJ O
and CC O
intrinsic JJ O
pathways NNS O
. . O

The DT O
quaternary JJ O
benzo JJ O
[ NN O
c NNS O
] SYM O
phenanthridine JJ O
alkaloid JJ O
sanguinarine NN O
inhibits VBZ O
the DT O
proliferation NN O
of IN O
cancerous JJ O
cells NNS O
from IN O
different JJ O
origins NNS O
, , O
including VBG O
lung NN O
, , O
breast NN O
, , O
pancreatic JJ O
and CC O
colon NN O
, , O
but CC O
nothing NN O
is VBZ O
known VBN O
of IN O
its PRP$ O
effects NNS O
on IN O
osteosarcoma NN O
, , O
a DT O
primary JJ O
malignant JJ O
bone NN O
tumour NN O
. . O

We PRP O
have VBP O
found VBN O
that IN O
sanguinarine NN O
alters NNS O
the DT O
morphology NN O
and CC O
reduces VBZ O
the DT O
viability NN O
of IN O
MG NNP B-NP
- : I-NP
63 CD I-NP
and CC O
SaOS NNP B-NP
- : I-NP
2 CD I-NP
human NN O
osteosarcoma NN O
cell NN O
lines NNS O
in IN O
concentration NN O
- : O
and CC O
time NN O
- : O
dependent JJ O
manner NN O
. . O

Incubation NNP O
with IN O
1 CD O
micromol NN O
/ NN O
L NNP O
sanguinarine NN O
for IN O
4 CD O
and CC O
24h JJ O
killed VBN O
more RBR O
efficiently RB O
MG NNP B-NP
- : I-NP
63 CD I-NP
cells NNS O
than IN O
SaOS NNP B-NP
- : I-NP
2 CD I-NP
cells NNS O
, , O
while IN O
incubation NN O
with IN O
5 CD O
micromol NN O
/ NN O
L NNP O
sanguinarine NN O
killed VBD O
almost RB O
100 CD O
% NN O
of IN O
both DT O
cell NN O
populations NNS O
within IN O
24h JJ O
. . O

This DT O
treatment NN O
also RB O
changed VBD O
the DT O
mitochondrial JJ O
membrane NN O
potential NN O
in IN O
both DT O
MG NNP B-NP
- : I-NP
63 CD I-NP
and CC O
SaOS NNP B-NP
- : I-NP
2 CD I-NP
cells NNS O
within IN O
1h JJ O
, , O
caused VBD O
chromatin NN O
condensation NN O
and CC O
the DT O
formation NN O
of IN O
apoptotic JJ O
bodies NNS O
. . O

It PRP O
activated VBD O
multicaspases NNS O
, , O
and CC O
increased VBD O
the DT O
activities NNS O
of IN O
caspase NN O
- : O
8 CD O
and CC O
caspase VB O
- : O
9 CD O
in IN O
both DT O
MG NNP B-NP
- : I-NP
63 CD I-NP
and CC O
SaOS NNP B-NP
- : I-NP
2 CD I-NP
cells NNS O
. . O

These DT O
data NNS O
highlight NN O
sanguinarine NN O
as IN O
a DT O
novel JJ O
potential JJ O
agent NN O
for IN O
bone NN O
cancer NN O
therapy NN O
. . O

-DOCSTART- X X O

Using VBG O
a DT O
web NN O
- : O
based VBN O
orthopaedic JJ O
clinic NN O
in IN O
the DT O
curricular JJ O
teaching NN O
of IN O
a DT O
German JJ O
university NN O
hospital NN O
: : O
analysis NN O
of IN O
learning VBG O
effect NN O
, , O
student NN O
usage NN O
and CC O
reception NN O
. . O

PURPOSE NNP O
: : O

Modern JJ O
teaching VBG O
concepts NNS O
for IN O
undergraduate JJ O
medical JJ O
students NNS O
in IN O
Germany NNP O
include VBP O
problem NN O
based VBN O
learning VBG O
as IN O
a DT O
major JJ O
component NN O
of IN O
the DT O
new JJ O
licensing NN O
regulations NNS O
for IN O
physicians NNS O
. . O

Here RB O
we PRP O
describe VBP O
the DT O
usage NN O
of IN O
a DT O
web NN O
- : O
based VBN O
virtual JJ O
outpatient NN O
clinic NN O
in IN O
the DT O
teaching NN O
curriculum NN O
of IN O
undergraduate JJ O
medical JJ O
students NNS O
, , O
its PRP$ O
effect NN O
on IN O
learning VBG O
success NN O
, , O
and CC O
student NN O
reception NN O
. . O

METHODS NNS O
: : O

Fifth JJ O
year NN O
medial JJ O
students NNS O
were VBD O
requested VBN O
to TO O
examine VB O
7 CD O
virtual JJ O
orthopaedic NN O
patients NNS O
which WDT O
had VBD O
been VBN O
created VBN O
by IN O
the DT O
authors NNS O
using VBG O
the DT O
Inmedea NNP O
- : O
Simulator NN O
. . O

They PRP O
also RB O
had VBD O
to TO O
take VB O
a DT O
multiple JJ O
- : O
choice NN O
examination NN O
on IN O
two CD O
different JJ O
occasions NNS O
and CC O
their PRP$ O
utilisation NN O
of IN O
the DT O
simulator NN O
was VBD O
analysed JJ O
subjectively RB O
and CC O
objectively RB O
. . O

RESULTS NNS O
: : O

One CD O
hundred CD O
and CC O
sixty CD O
students NNS O
took VBD O
part NN O
in IN O
the DT O
study NN O
. . O

The DT O
average JJ O
age NN O
was VBD O
24 CD O
. . O
9 CD O
years NNS O
, , O
60 CD O
% NN O
were VBD O
female JJ O
. . O

Most JJS O
of IN O
the DT O
participants NNS O
studied VBD O
on IN O
their PRP$ O
own JJ O
using VBG O
their PRP$ O
private JJ O
computer NN O
with IN O
a DT O
fast JJ O
internet NN O
- : O
connection NN O
at IN O
home NN O
. . O

The DT O
average JJ O
usage NN O
time NN O
was VBD O
263 CD O
min NN O
, , O
most JJS O
of IN O
the DT O
students NNS O
worked VBD O
with IN O
the DT O
system NN O
in IN O
the DT O
afternoon NN O
, , O
although IN O
a DT O
considerable JJ O
number NN O
used VBN O
it PRP O
late RB O
in IN O
the DT O
night NN O
. . O

Regarding VBG O
learning VBG O
success NN O
, , O
we PRP O
found VBD O
that IN O
the DT O
examination NN O
results NNS O
were VBD O
significantly RB O
better JJR O
after IN O
using VBG O
the DT O
system NN O
( -LRB- O
7 CD O
. . O
66 CD O
versus JJ O
8 CD O
. . O
37 CD O
, , O
p NN O
< NN O
0 CD O
. . O
0001 CD O
) -RRB- O
. . O

Eighty CD O
percent NN O
of IN O
the DT O
students NNS O
enjoyed VBD O
dealing VBG O
with IN O
the DT O
virtual JJ O
patients NNS O
emphasizing VBG O
the DT O
completeness NN O
of IN O
patient JJ O
cases NNS O
, , O
the DT O
artistic JJ O
graphic JJ O
design NN O
and CC O
the DT O
expert JJ O
comments NNS O
available JJ O
, , O
as RB O
well RB O
as IN O
the DT O
good JJ O
applicability NN O
to TO O
real JJ O
cases NNS O
. . O

Eighty CD O
- : O
seven CD O
percent NN O
of IN O
the DT O
students NNS O
graded VBD O
the DT O
virtual JJ O
orthopaedic JJ O
clinic NN O
as IN O
appropriate JJ O
to TO O
teach VB O
orthopaedic JJ O
content NN O
. . O

CONCLUSION NN O
: : O

Using VBG O
the DT O
Inmedea NNP O
- : O
Simulator NN O
is VBZ O
an DT O
effective JJ O
method NN O
to TO O
enhance VB O
students NNS O
' POS O
learning NN O
efficacy NN O
. . O

The DT O
way NN O
the DT O
system NN O
was VBD O
used VBN O
by IN O
the DT O
students NNS O
emphasises VBZ O
the DT O
advantages NNS O
of IN O
the DT O
internet JJ O
- : O
like IN O
free JJ O
time NN O
management NN O
and CC O
the DT O
implementation NN O
of IN O
multimedia NNS O
- : O
based VBN O
content NN O
. . O

-DOCSTART- X X O

Constitutively RB O
nuclear JJ O
FOXO3a NN O
localization NN O
predicts VBZ O
poor JJ O
survival NN O
and CC O
promotes VBZ O
Akt NNP O
phosphorylation NN O
in IN O
breast NN O
cancer NN O
. . O

BACKGROUND NNP O
: : O
The DT O
PI3K JJ O
- : O
Akt JJ O
signal NN O
pathway NN O
plays VBZ O
a DT O
key JJ O
role NN O
in IN O
tumorigenesis NN O
and CC O
the DT O
development NN O
of IN O
drug NN O
- : O
resistance NN O
. . O

Cytotoxic JJ O
chemotherapy NN O
resistance NN O
is VBZ O
linked VBN O
to TO O
limited JJ O
therapeutic JJ O
options NNS O
and CC O
poor JJ O
prognosis NN O
. . O

METHODOLOGY NNP O
/ NNP O
PRINCIPAL NNP O
FINDINGS NNP O
: : O
Examination NNP O
of IN O
FOXO3a NNP O
and CC O
phosphorylated JJ O
- : O
Akt NN O
( -LRB- O
P NNP O
- : O
Akt NN O
) -RRB- O
expression NN O
in IN O
breast NN O
cancer NN O
tissue NN O
microarrays NNS O
showed VBD O
nuclear JJ O
FOXO3a NNP O
was VBD O
associated VBN O
with IN O
lymph NN O
node NN O
positivity NN O
( -LRB- O
p NN O
= SYM O
0 CD O
. . O
052 CD O
) -RRB- O
, , O
poor JJ O
prognosis NN O
( -LRB- O
p NN O
= SYM O
0 CD O
. . O
014 CD O
) -RRB- O
, , O
and CC O
P NNP O
- : O
Akt JJ O
expression NN O
in IN O
invasive JJ O
ductal JJ O
carcinoma NN O
. . O

Using VBG O
tamoxifen JJ O
and CC O
doxorubicin JJ O
- : O
sensitive JJ O
and CC O
- : O
resistant JJ O
breast NN O
cancer NN O
cell NN O
lines NNS O
as IN O
models NNS O
, , O
we PRP O
found VBD O
that IN O
doxorubicin JJ O
- : O
but CC O
not RB O
tamoxifen VB O
- : O
resistance NN O
is VBZ O
associated VBN O
with IN O
nuclear JJ O
accumulation NN O
of IN O
FOXO3a NN O
, , O
consistent JJ O
with IN O
the DT O
finding VBG O
that IN O
sustained VBN O
nuclear JJ O
FOXO3a NN O
is VBZ O
associated VBN O
with IN O
poor JJ O
prognosis NN O
. . O

We PRP O
also RB O
established VBD O
that IN O
doxorubicin NN O
treatment NN O
induces VBZ O
proliferation NN O
arrest NN O
and CC O
FOXO3a JJ O
nuclear JJ O
relocation NN O
in IN O
sensitive JJ O
breast NN O
cancer NN O
cells NNS O
. . O

Induction NN O
of IN O
FOXO3a JJ O
activity NN O
in IN O
doxorubicin JJ O
- : O
sensitive JJ O
MCF NNP B-NP
- : I-NP
7 CD I-NP
cells NNS O
was VBD O
sufficient JJ O
to TO O
promote VB O
Akt NNP O
phosphorylation NN O
and CC O
arrest NN O
cell NN O
proliferation NN O
. . O

Conversely RB O
, , O
knockdown NN O
of IN O
endogenous JJ O
FOXO3a JJ O
expression NN O
reduced VBD O
PI3K JJ O
/ NN O
Akt NNP O
activity NN O
. . O

Using VBG O
MDA NNP B-NP
- : I-NP
MB SYM I-NP
- : I-NP
231 CD I-NP
cells NNS O
, , O
in IN O
which WDT O
FOXO3a JJ O
activity NN O
can MD O
be VB O
induced VBN O
by IN O
4 CD O
- : O
hydroxytamoxifen NN O
, , O
we PRP O
showed VBD O
that IN O
FOXO3a NNP O
induction NN O
up IN O
- : O
regulates VBZ O
PI3K JJ O
- : O
Akt JJ O
activity NN O
and CC O
enhanced JJ O
doxorubicin NN O
resistance NN O
. . O

However RB O
FOXO3a DT O
induction NN O
has VBZ O
little JJ O
effect NN O
on IN O
cell NN O
proliferation NN O
, , O
indicating VBG O
that IN O
FOXO3a NNP O
or CC O
its PRP$ O
downstream NN O
activity NN O
is VBZ O
deregulated VBN O
in IN O
the DT O
cytotoxic JJ O
drug NN O
resistant JJ O
breast NN O
cancer NN O
cells NNS O
. . O

Thus RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
sustained VBN O
FOXO3a NN O
activation NN O
can MD O
enhance VB O
hyperactivation NN O
of IN O
the DT O
PI3K NNP O
/ NNP O
Akt NNP O
pathway NN O
. . O

CONCLUSIONS NNS O
/ JJ O
SIGNIFICANCE NNP O
: : O
Together RB O
these DT O
data NNS O
suggest VBP O
that IN O
lymph NN O
node NN O
metastasis NN O
and CC O
poor JJ O
survival NN O
in IN O
invasive JJ O
ductal JJ O
breast NN O
carcinoma NN O
are VBP O
linked VBN O
to TO O
an DT O
uncoupling NN O
of IN O
the DT O
Akt NNP O
- : O
FOXO3a JJ O
signaling NN O
axis NN O
. . O

In IN O
these DT O
breast NN O
cancers NNS O
activated VBN O
Akt RB O
fails VBZ O
to TO O
inactivate VB O
and CC O
re VB O
- : O
localize NN O
FOXO3a NN O
to TO O
the DT O
cytoplasm NN O
, , O
and CC O
nuclear JJ O
- : O
targeted VBN O
FOXO3a NN O
does VBZ O
not RB O
induce VB O
cell NN O
death NN O
or CC O
cell NN O
cycle NN O
arrest NN O
. . O

As IN O
such JJ O
, , O
sustained JJ O
nuclear JJ O
FOXO3a NN O
expression NN O
in IN O
breast NN O
cancer NN O
may MD O
culminate VB O
in IN O
cancer NN O
progression NN O
and CC O
the DT O
development NN O
of IN O
an DT O
aggressive JJ O
phenotype NN O
similar JJ O
to TO O
that DT O
observed VBN O
in IN O
cytotoxic JJ O
chemotherapy NN O
resistant JJ O
breast NN O
cancer NN O
cell NN O
models NNS O
. . O

-DOCSTART- X X O

The DT O
neural JJ O
stem NN O
cell NN O
fate NN O
determinant NN O
TLX NNP O
promotes VBZ O
tumorigenesis NN O
and CC O
genesis NN O
of IN O
cells NNS O
resembling VBG O
glioma DT O
stem NN O
cells NNS O
. . O

A DT O
growing VBG O
body NN O
of IN O
evidence NN O
indicates VBZ O
that IN O
deregulation NN O
of IN O
stem NN O
cell NN O
fate NN O
determinants NNS O
is VBZ O
a DT O
hallmark NN O
of IN O
many JJ O
types NNS O
of IN O
malignancies NNS O
. . O

The DT O
neural JJ O
stem NN O
cell NN O
fate NN O
determinant NN O
TLX NNP O
plays VBZ O
a DT O
pivotal JJ O
role NN O
in IN O
neurogenesis NN O
in IN O
the DT O
adult NN O
brain NN O
by IN O
maintaining VBG O
neural JJ O
stem NN O
cells NNS O
. . O

Here RB O
, , O
we PRP O
report VBP O
a DT O
tumorigenic JJ O
role NN O
of IN O
TLX NNP O
in IN O
brain NN O
tumor NN O
initiation NN O
and CC O
progression NN O
. . O

Increased VBN O
TLX NNP O
expression NN O
was VBD O
observed VBN O
in IN O
a DT O
number NN O
of IN O
glioma NN O
cells NNS O
and CC O
glioma VBD O
stem NN O
cells NNS O
, , O
and CC O
correlated VBD O
with IN O
poor JJ O
survival NN O
of IN O
patients NNS O
with IN O
gliomas NNP O
. . O

Ectopic JJ O
expression NN O
of IN O
TLX NNP O
in IN O
the DT O
U87MG NNP B-NP
glioma NNP O
cell NN O
line NN O
and CC O
Ink4a NNP O
/ NNP O
Arf NNP O
- : O
deficient JJ O
mouse NN O
astrocytes NNS O
( -LRB- O
Ink4a DT O
/ NN O
Arf NNP O
( -LRB- O
- : O
/ JJ O
- : O
) -RRB- O
astrocytes NNS O
) -RRB- O
induced VBN O
cell NN O
proliferation NN O
with IN O
a DT O
concomitant JJ O
increase NN O
in IN O
cyclin NN O
D NNP O
expression NN O
, , O
and CC O
accelerated VBD O
foci NNS O
formation NN O
in IN O
soft JJ O
agar NN O
and CC O
tumor NN O
formation NN O
in IN O
in IN O
vivo JJ O
transplantation NN O
assays VBZ O
. . O

Furthermore RB O
, , O
overexpression IN O
of IN O
TLX NNP O
in IN O
Ink4a NNP O
/ NNP O
Arf NNP O
( -LRB- O
- : O
/ JJ O
- : O
) -RRB- O
astrocytes VBZ O
inhibited JJ O
cell NN O
migration NN O
and CC O
invasion NN O
and CC O
promoted VBD O
neurosphere RB O
formation NN O
and CC O
Nestin NNP O
expression NN O
, , O
which WDT O
are VBP O
hallmark JJ O
characteristics NNS O
of IN O
glioma NN O
stem NN O
cells NNS O
, , O
under IN O
stem NN O
cell NN O
culture NN O
conditions NNS O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
TLX NNP O
is VBZ O
involved VBN O
in IN O
glioma NN O
stem NN O
cell NN O
genesis NN O
and CC O
represents VBZ O
a DT O
potential JJ O
therapeutic JJ O
target NN O
for IN O
this DT O
type NN O
of IN O
malignancy NN O
. . O

-DOCSTART- X X O

Actin NNP O
- : O
sequestering NN O
protein NN O
, , O
thymosin NN O
beta NN O
- : O
4 CD O
, , O
is VBZ O
a DT O
novel JJ O
hypoxia NN O
responsive JJ O
regulator NN O
. . O

Angiogenesis NNP O
is VBZ O
induced VBN O
by IN O
soluble JJ O
factors NNS O
such JJ O
as IN O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
VEGF NN O
) -RRB- O
released VBN O
from IN O
tumor NN O
cells NNS O
in IN O
hypoxia NN O
. . O

It PRP O
enhances VBZ O
solid JJ O
tumor NN O
growth NN O
and CC O
provides VBZ O
an DT O
ability NN O
to TO O
establish VB O
metastasis NN O
at IN O
peripheral JJ O
sites NNS O
by IN O
tumor NN O
cell NN O
migration NN O
. . O

Thymosin DT O
beta NN O
- : O
4 CD O
( -LRB- O
TB4 NN O
) -RRB- O
is VBZ O
an DT O
actin NN O
- : O
sequestering NN O
protein NN O
to TO O
control VB O
cytoskeletal JJ O
reorganization NN O
. . O

Here RB O
, , O
we PRP O
investigated VBD O
whether IN O
angiogenesis NN O
and CC O
tumor NN O
metastasis NN O
are VBP O
dependent JJ O
on IN O
hypoxia NN O
conditioning NN O
- : O
induced VBN O
TB4 DT O
expression NN O
in IN O
B16F10 CD B-NP
melanoma NN O
cells NNS O
. . O

TB4 DT O
expression NN O
in IN O
B16F10 CD B-NP
cells NNS O
was VBD O
increased VBN O
by IN O
hypoxia NN O
conditioning NN O
in IN O
a DT O
time NN O
- : O
dependent JJ O
manner NN O
. . O

In IN O
addition NN O
, , O
we PRP O
found VBD O
an DT O
increase NN O
of IN O
angiogenesis NN O
and CC O
HIF NN O
- : O
1alpha WDT O
expression NN O
in IN O
TB4 NNP O
- : O
transgenic JJ O
( -LRB- O
Tg NN O
) -RRB- O
mice NNS O
as IN O
compared VBN O
to TO O
wildtype JJ O
mice NNS O
. . O

When WRB O
wound VBN O
healing NN O
assay NN O
was VBD O
used VBN O
to TO O
assess VB O
in IN O
vitro NN O
tumor NN O
cell NN O
migration NN O
, , O
hypoxia NN O
conditioning NN O
for IN O
1 CD O
h NN O
enhanced VBN O
B16F10 CD B-NP
cell NN O
migration NN O
. . O

When WRB O
TB4 DT O
expression NN O
in IN O
B16F10 CD B-NP
cells NNS O
was VBD O
inhibited VBN O
by IN O
the DT O
infection NN O
with IN O
small JJ O
hairpin NN O
( -LRB- O
sh NN O
) -RRB- O
RNA NNP O
of IN O
TB4 NNP O
cloned VBD O
in IN O
lentiviral JJ O
vector NN O
, , O
tumor NN O
cell NN O
migration NN O
was VBD O
retarded VBN O
. . O

In IN O
addition NN O
, , O
hypoxia NN O
conditioning NN O
- : O
induced VBN O
tumor NN O
cell NN O
migration NN O
was VBD O
reduced VBN O
by IN O
the DT O
infection NN O
of IN O
lentiviral JJ O
shRNA NN O
of IN O
TB4 NNP O
. . O

HIF NN O
- : O
1alpha CD O
stabilization NN O
and CC O
the DT O
expression NN O
of IN O
VEGF NNP O
isoform VBP O
165 CD O
and CC O
121 CD O
in IN O
hypoxia NN O
were VBD O
also RB O
reduced VBN O
by IN O
the DT O
infection NN O
of IN O
lentiviral JJ O
shRNA NN O
of IN O
TB4 NNP O
in IN O
B16F10 CD B-NP
cells NNS O
. . O

We PRP O
also RB O
found VBD O
an DT O
increase NN O
of IN O
tumor NN O
growth NN O
and CC O
lung NN O
metastasis NN O
count NN O
in IN O
TB4 CD O
- : O
Tg NN O
mice NNS O
as IN O
compared VBN O
to TO O
wildtype JJ O
mice NNS O
. . O

Collectively RB O
, , O
hypoxia NN O
conditioning NN O
induced JJ O
tumor NN O
cell NN O
migration NN O
by IN O
TB4 DT O
expression NN O
- : O
dependent JJ O
HIF NN O
- : O
1alpha CD O
stabilization NN O
. . O

It PRP O
suggests VBZ O
that IN O
TB4 NNP O
could MD O
be VB O
a DT O
hypoxia NN O
responsive JJ O
regulator NN O
to TO O
control VB O
tumor NN O
cell NN O
migration NN O
in IN O
angiogenesis NN O
and CC O
tumor NN O
metastasis NN O
. . O

-DOCSTART- X X O

Acute JJ O
ablation NN O
of IN O
Langerhans NNP O
cells NNS O
enhances VBZ O
skin NN O
immune JJ O
responses NNS O
. . O

Understanding VBG O
the DT O
function NN O
of IN O
Langerhans NNP O
cells NNS O
( -LRB- O
LCs NNS O
) -RRB- O
in IN O
vivo NN O
has VBZ O
been VBN O
complicated VBN O
by IN O
conflicting JJ O
results NNS O
from IN O
LC NNP O
- : O
deficient JJ O
mice NNS O
. . O

Human JJ O
Langerin NNP O
- : O
DTA NNP O
mice NNS O
constitutively RB O
lack VBP O
LCs JJ O
and CC O
develop VB O
exaggerated JJ O
contact NN O
hypersensitivity NN O
( -LRB- O
CHS NNP O
) -RRB- O
responses NNS O
. . O

Murine NNP O
Langerin NNP O
- : O
diphtheria NN O
toxin NN O
receptor NN O
( -LRB- O
DTR NN O
) -RRB- O
mice NNS O
allow VBP O
for IN O
the DT O
inducible JJ O
elimination NN O
of IN O
LCs NNP O
and CC O
Langerin NNP O
( -LRB- O
+ NN O
) -RRB- O
dermal JJ O
dendritic NN O
cells NNS O
( -LRB- O
dDCs NNS O
) -RRB- O
after IN O
administration NN O
of IN O
diphtheria NNS O
toxin NN O
, , O
which WDT O
results VBZ O
in IN O
reduced JJ O
CHS NNP O
. . O

When WRB O
Langerin NNP O
( -LRB- O
+ NN O
) -RRB- O
dDCs NNS O
have VBP O
partially RB O
repopulated VBN O
the DT O
skin NN O
but CC O
LCs NNS O
are VBP O
still RB O
absent JJ O
, , O
CHS NNP O
returns VBZ O
to TO O
normal JJ O
. . O

Thus RB O
, , O
LCs NNPS O
appear VBP O
to TO O
be VB O
suppressive JJ O
in IN O
human JJ O
Langerin NNP O
- : O
DTA NNP O
mice NNS O
and CC O
redundant NN O
in IN O
murine NN O
Langerin NNP O
- : O
DTR NN O
mice NNS O
. . O

To TO O
determine VB O
whether IN O
inducible JJ O
versus JJ O
constitutive JJ O
LC NNP O
ablation NN O
explains VBZ O
these DT O
results NNS O
, , O
we PRP O
engineered VBN O
human NN O
Langerin NNP O
- : O
DTR NN O
mice NNS O
in IN O
which WDT O
diphtheria NN O
toxin NN O
ablates NNS O
LCs NNS O
without IN O
affecting VBG O
Langerin NNP O
( -LRB- O
+ NN O
) -RRB- O
dDCs NNS O
. . O

The DT O
inducible JJ O
ablation NN O
of IN O
LCs NNS O
in IN O
human JJ O
Langerin NNP O
- : O
DTR NN O
mice NNS O
resulted VBD O
in IN O
increased JJ O
CHS NNP O
. . O

Thus RB O
, , O
LC NNP O
- : O
mediated JJ O
suppression NN O
does VBZ O
not RB O
require VB O
their PRP$ O
absence NN O
during IN O
ontogeny JJ O
or CC O
during IN O
the DT O
steady JJ O
- : O
state NN O
and CC O
is VBZ O
consistent JJ O
with IN O
a DT O
model NN O
in IN O
which WDT O
LCs NNP O
actively RB O
suppress VB O
Ag VBG O
- : O
specific JJ O
CHS NNP O
responses NNS O
. . O

-DOCSTART- X X O

Skin NNP O
deep JJ O
and CC O
deeper JJR O
: : O
multiple NN O
pathways NNS O
in IN O
basal JJ O
cell NN O
carcinogenesis NN O
. . O

This DT O
perspective NN O
places VBZ O
the DT O
report NN O
by IN O
Villani NNP O
et NNP O
al NN O
. . O
that WDT O
appears VBZ O
in IN O
this DT O
issue NN O
of IN O
the DT O
journal NN O
( -LRB- O
beginning VBG O
on IN O
page NN O
1222 CD O
) -RRB- O
in IN O
the DT O
context NN O
of IN O
recent JJ O
work NN O
showing VBG O
an DT O
intersection NN O
between IN O
two CD O
important JJ O
developmental JJ O
pathways NNS O
implicated VBN O
in IN O
oncogenesis NN O
: : O
the DT O
hedgehog NN O
and CC O
insulin NN O
- : O
like IN O
growth NN O
factor NN O
( -LRB- O
IGF NN O
) -RRB- O
pathways NNS O
. . O

Villani NNP O
et NNP O
al NN O
. . O
define VB O
a DT O
key JJ O
role NN O
for IN O
the DT O
IGF NNP O
regulatory JJ O
protein NN O
Igfbp2 NN O
in IN O
a DT O
genetic JJ O
model NN O
of IN O
basal JJ O
cell NN O
carcinogenesis NN O
driven VBN O
by IN O
targeted JJ O
constitutive JJ O
activation NN O
of IN O
hedgehog NN O
signaling NN O
. . O

Placed NNP O
in IN O
the DT O
framework NN O
of IN O
other JJ O
recently RB O
published VBN O
work NN O
, , O
the DT O
observations NNS O
of IN O
Villani NNP O
et NNP O
al NN O
. . O
both DT O
raise VBP O
questions NNS O
about IN O
the DT O
cell NN O
of IN O
origin NN O
for IN O
basal NN O
cell NN O
cancers NNS O
and CC O
define VB O
additional JJ O
putative JJ O
therapeutic JJ O
and CC O
preventive JJ O
targets NNS O
for IN O
this DT O
disease NN O
. . O

-DOCSTART- X X O

Brick1 NNP O
is VBZ O
an DT O
essential JJ O
regulator NN O
of IN O
actin NN O
cytoskeleton NN O
required VBN O
for IN O
embryonic JJ O
development NN O
and CC O
cell NN O
transformation NN O
. . O

Brick1 NNP O
( -LRB- O
Brk1 NNP O
) -RRB- O
is VBZ O
the DT O
less RBR O
- : O
studied VBD O
component NN O
of IN O
the DT O
Wave NNP O
/ NNP O
Scar NNP O
pathway NN O
involved VBN O
in IN O
the DT O
branched JJ O
nucleation NN O
of IN O
actin NN O
fibers NNS O
. . O

The DT O
clinical JJ O
relevance NN O
of IN O
Brk1 NNP O
is VBZ O
emphasized VBN O
by IN O
correlative JJ O
data NNS O
showing VBG O
that IN O
Von FW O
Hippel NNP O
- : O
Lindau NNP O
( -LRB- O
VHL NN O
) -RRB- O
patients NNS O
that WDT O
also RB O
lose VBP O
the DT O
BRK1 NNP O
gene NN O
are VBP O
protected VBN O
against IN O
the DT O
development NN O
of IN O
tumors NNS O
. . O

This DT O
contrasts VBZ O
with IN O
recent JJ O
evidence NN O
suggesting VBG O
that IN O
the DT O
Wave NNP O
complex NN O
may MD O
function VB O
as IN O
an DT O
invasion NN O
suppressor NN O
in IN O
epithelial NN O
cancers NNS O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
downregulation NN O
of IN O
Brk1 JJ O
results NNS O
in IN O
abnormal JJ O
actin NN O
stress NN O
fiber NN O
formation NN O
and CC O
vinculin NN O
distribution NN O
and CC O
loss NN O
of IN O
Arp2 NNP O
/ NNP O
3 CD O
and CC O
Wave NNP O
proteins VBZ O
at IN O
the DT O
cellular JJ O
protrusions NNS O
. . O

Brk1 NNP O
is VBZ O
required VBN O
for IN O
cell NN O
proliferation NN O
and CC O
cell NN O
transformation NN O
by IN O
oncogenes NNS O
. . O

In IN O
addition NN O
, , O
Brk1 NNP O
downregulation NN O
results NNS O
in IN O
defective JJ O
directional JJ O
migration NN O
and CC O
invasive JJ O
growth NN O
in IN O
renal JJ O
cell NN O
carcinoma NN O
cells NNS O
as RB O
well RB O
as IN O
in IN O
other JJ O
tumor NN O
cell NN O
types NNS O
. . O

Finally RB O
, , O
genetic JJ O
ablation NN O
of IN O
Brk1 JJ O
results NNS O
in IN O
dramatic JJ O
defects NNS O
in IN O
embryo NN O
compaction NN O
and CC O
development NN O
, , O
suggesting VBG O
an DT O
essential JJ O
role NN O
for IN O
this DT O
protein NN O
in IN O
actin NN O
dynamics NNS O
. . O

Thus RB O
, , O
genetic JJ O
loss NN O
or CC O
inhibition NN O
of IN O
BRK1 NNP O
is VBZ O
likely JJ O
to TO O
be VB O
protective JJ O
against IN O
tumor NN O
development NN O
due JJ O
to TO O
proliferation NN O
and CC O
motility NN O
defects NNS O
in IN O
affected JJ O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
proenkephalin NN O
- : O
A DT O
- : O
derivative JJ O
Met NNP O
- : O
enkephalin SYM O
- : O
Arg JJ O
- : O
Gly JJ O
- : O
Leu NNP O
is VBZ O
not RB O
present JJ O
in IN O
the DT O
feline NN O
species NNS O
. . O

No DT O
opioid JJ O
octapeptide NN O
Met NNP O
- : O
enkephalin SYM O
- : O
Arg JJ O
- : O
Gly JJ O
- : O
Leu NNP O
was VBD O
detected VBN O
either CC O
in IN O
the DT O
brain NN O
or CC O
in IN O
the DT O
adrenal JJ O
gland NN O
of IN O
the DT O
cat NN O
using VBG O
a DT O
specific JJ O
radioimmunoassay NN O
. . O

Whereas IN O
it PRP O
was VBD O
possible JJ O
to TO O
determine VB O
the DT O
Met NNP O
- : O
enkephalin NN O
and CC O
Leu NNP O
- : O
enkephalin NN O
contents NNS O
. . O

The DT O
Met NNP O
- : O
enkephalin NN O
versus NN O
Leu NNP O
- : O
enkephalin NN O
concentration NN O
ratio NN O
was VBD O
around IN O
five CD O
in IN O
each DT O
area NN O
of IN O
the DT O
brain NN O
assayed VBD O
. . O

The DT O
presence NN O
of IN O
authentic JJ O
Met NNP O
- : O
enkephalin NN O
and CC O
Leu NNP O
- : O
enkephalin NN O
was VBD O
confirmed VBN O
by IN O
high JJ O
performance NN O
liquid NN O
chromatography NN O
analysis NN O
. . O

All DT O
in IN O
all DT O
, , O
these DT O
data NNS O
seem VBP O
to TO O
indicate VB O
that IN O
the DT O
cat NN O
proenkephalin NN O
is VBZ O
partly RB O
different JJ O
from IN O
that DT O
previously RB O
analysed VBN O
in IN O
mammalian JJ O
species NNS O
including VBG O
humans NNS O
, , O
rats NNS O
and CC O
cows NNS O
. . O

-DOCSTART- X X O

Ras NNP O
- : O
association NN O
domain NN O
family NN O
1C JJ O
protein NN O
promotes NNS O
breast NN O
cancer NN O
cell NN O
migration NN O
and CC O
attenuates NNS O
apoptosis NN O
. . O

BACKGROUND NNP O
: : O
The DT O
Ras NNP O
association NN O
domain NN O
family NN O
1 CD O
( -LRB- O
RASSF1 NN O
) -RRB- O
gene NN O
is VBZ O
a DT O
Ras NNP O
effector NN O
encoding VBG O
two CD O
major JJ O
mRNA NNS O
forms NNS O
, , O
RASSF1A NNP O
and CC O
RASSF1C NNP O
, , O
derived VBN O
by IN O
alternative JJ O
promoter NN O
selection NN O
and CC O
alternative JJ O
mRNA JJ O
splicing NN O
. . O

RASSF1A NNP O
is VBZ O
a DT O
tumor NN O
suppressor NN O
gene NN O
. . O

However RB O
, , O
very RB O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
function NN O
of IN O
RASSF1C NNP O
both CC O
in IN O
normal JJ O
and CC O
transformed VBD O
cells NNS O
. . O

METHODS NNS O
: : O
Gene NNP O
silencing NN O
and CC O
over IN O
- : O
expression NN O
techniques NNS O
were VBD O
used VBN O
to TO O
modulate VB O
RASSF1C JJ O
expression NN O
in IN O
human JJ O
breast NN O
cancer NN O
cells NNS O
. . O

Affymetrix NNP O
- : O
microarray NN O
analysis NN O
was VBD O
performed VBN O
using VBG O
T47D NNP B-NP
cells NNS O
over IN O
- : O
expressing VBG O
RASSF1C NNP O
to TO O
identify VB O
RASSF1C DT O
target NN O
genes NNS O
. . O

RT NNP O
- : O
PCR NN O
and CC O
western JJ O
blot NN O
techniques NNS O
were VBD O
used VBN O
to TO O
validate VB O
target NN O
gene NN O
expression NN O
. . O

Cell NNP O
invasion NN O
and CC O
apoptosis NN O
assays . O
were VBD O
also RB O
performed VBN O
. . O

RESULTS NNS O
: : O
In IN O
this DT O
article NN O
, , O
we PRP O
report VBP O
the DT O
effects NNS O
of IN O
altering VBG O
RASSF1C JJ O
expression NN O
in IN O
human JJ O
breast NN O
cancer NN O
cells NNS O
. . O

We PRP O
found VBD O
that IN O
silencing VBG O
RASSF1C NNP O
mRNA NN O
in IN O
breast NN O
cancer NN O
cell NN O
lines NNS O
( -LRB- O
MDA NNP B-NP
- : I-NP
MB231 CD I-NP
and CC O
T47D NNP B-NP
) -RRB- O
caused VBD O
a DT O
small JJ O
but CC O
significant JJ O
decrease NN O
in IN O
cell NN O
proliferation NN O
. . O

Conversely RB O
, , O
inducible JJ O
over IN O
- : O
expression NN O
of IN O
RASSF1C JJ O
in IN O
breast NN O
cancer NN O
cells NNS O
( -LRB- O
MDA NNP B-NP
- : I-NP
MB231 CD I-NP
and CC O
T47D NNP B-NP
) -RRB- O
resulted VBD O
in IN O
a DT O
small JJ O
increase NN O
in IN O
cell NN O
proliferation NN O
. . O

We PRP O
also RB O
report VBP O
on IN O
the DT O
identification NN O
of IN O
novel NN O
RASSF1C NNP O
target NN O
genes NNS O
. . O

RASSF1C VB O
down IN O
- : O
regulates VBZ O
several JJ O
pro FW O
- : O
apoptotic JJ O
and CC O
tumor NN O
suppressor NN O
genes NNS O
and CC O
up IN O
- : O
regulates VBZ O
several JJ O
growth NN O
promoting VBG O
genes NNS O
in IN O
breast NN O
cancer NN O
cells NNS O
. . O

We PRP O
further JJ O
show NN O
that IN O
down IN O
- : O
regulation NN O
of IN O
caspase NN O
3 CD O
via IN O
overexpression NN O
of IN O
RASSF1C JJ O
reduces VBZ O
breast NN O
cancer NN O
cells NNS O
' POS O
sensitivity NN O
to TO O
the DT O
apoptosis NN O
inducing NN O
agent NN O
, , O
etoposide NN O
. . O

Furthermore RB O
, , O
we PRP O
found VBD O
that IN O
RASSF1C NNP O
over IN O
- : O
expression NN O
enhances NNS O
T47D IN B-NP
cell NN O
invasion NN O
/ VBZ O
migration NN O
in IN O
vitro NN O
. . O

CONCLUSION NN O
: : O
Together RB O
, , O
our PRP$ O
findings NNS O
suggest VBP O
that IN O
RASSF1C NNP O
, , O
unlike IN O
RASSF1A NNP O
, , O
is VBZ O
not RB O
a DT O
tumor NN O
suppressor NN O
, , O
but CC O
instead RB O
may MD O
play VB O
a DT O
role NN O
in IN O
stimulating VBG O
metastasis NN O
and CC O
survival NN O
in IN O
breast NN O
cancer NN O
cells NNS O
. . O

-DOCSTART- X X O

Androgen NNP O
stimulates NNS O
glycolysis NN O
for IN O
de FW O
novo FW O
lipid VBD O
synthesis NN O
by IN O
increasing VBG O
the DT O
activities NNS O
of IN O
hexokinase NN O
2 CD O
and CC O
6 CD O
- : O
phosphofructo SYM O
- : O
2 LS O
- : O
kinase NN O
/ NN O
fructose NN O
- : O
2 CD O
, , O
6 CD O
- : O
bisphosphatase NN O
2 CD O
in IN O
prostate NN O
cancer NN O
cells NNS O
. . O

Up IN O
- : O
regulation NN O
of IN O
lipogenesis NN O
by IN O
androgen NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
characteristic JJ O
metabolic JJ O
features NNS O
of IN O
LNCaP JJ B-NP
prostate NN O
cancer NN O
cells NNS O
. . O

The DT O
present JJ O
study NN O
revealed VBD O
that IN O
androgen NN O
increases NNS O
glucose NN O
utilization NN O
for IN O
de FW O
novo FW O
lipogenesis NN O
in IN O
LNCaP NNP B-NP
cells NNS O
through IN O
the DT O
activation NN O
of IN O
HK2 NNP O
( -LRB- O
hexokinase NN O
2 CD O
) -RRB- O
and CC O
activation NN O
of IN O
the DT O
cardiac JJ O
isoform NN O
of IN O
PFKFB2 NN O
( -LRB- O
6 CD O
- : O
phosphofructo SYM O
- : O
2 LS O
- : O
kinase NN O
/ NN O
fructose NN O
- : O
2 CD O
, , O
6 CD O
- : O
bisphosphatase NN O
) -RRB- O
. . O

Activation NN O
of IN O
PKA NNP O
( -LRB- O
cAMP NN O
- : O
dependent JJ O
protein NN O
kinase NN O
) -RRB- O
by IN O
androgen NN O
increased VBN O
phosphorylation NN O
of IN O
CREB NNP O
[ NNP O
CRE NNP O
( -LRB- O
cAMP VBP O
- : O
response NN O
element NN O
) -RRB- O
- : O
binding JJ O
protein NN O
] NN O
, , O
which WDT O
in IN O
turn NN O
bound VBD O
to TO O
CRE VB O
on IN O
the DT O
promoter NN O
of IN O
the DT O
HK2 NNP O
gene NN O
resulting VBG O
in IN O
transcriptional JJ O
activation NN O
of IN O
the DT O
HK2 NNP O
gene NN O
. . O

Up IN O
- : O
regulation NN O
of IN O
PFKFB2 JJ O
expression NN O
was VBD O
mediated VBN O
by IN O
the DT O
direct JJ O
binding NN O
of IN O
ligand NN O
- : O
activated VBN O
androgen NN O
receptor NN O
to TO O
the DT O
PFKFB2 NN O
promoter NN O
. . O

The DT O
activated JJ O
PI3K NN O
( -LRB- O
phosphoinositide NN O
3 CD O
- : O
kinase NN O
) -RRB- O
/ VBZ O
Akt JJ O
signalling NN O
pathway NN O
in IN O
LNCaP NNP B-NP
cells NNS O
contributes VBZ O
to TO O
the DT O
phosphorylation NN O
of IN O
PFKFB2 NN O
at IN O
Ser466 NNP O
and CC O
Ser483 NNP O
, , O
resulting VBG O
in IN O
the DT O
constitutive JJ O
activation NN O
of IN O
PFK NNP O
- : O
2 CD O
( -LRB- O
6 CD O
- : O
phosphofructo SYM O
- : O
2 LS O
- : O
kinase NN O
) -RRB- O
activity NN O
. . O

Glucose DT O
uptake NN O
and CC O
lipogenesis NN O
were VBD O
severely RB O
blocked VBN O
by IN O
knocking VBG O
- : O
down IN O
of IN O
PFKFB2 NN O
using VBG O
siRNA NN O
( -LRB- O
small JJ O
interfering NN O
RNA NN O
) -RRB- O
or CC O
by IN O
inhibition NN O
of IN O
PFK NNP O
- : O
2 CD O
activity NN O
with IN O
LY294002 NNP O
treatment NN O
. . O

Taken VBN O
together RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
induction NN O
of IN O
de FW O
novo FW O
lipid VBD O
synthesis NN O
by IN O
androgen NN O
requires VBZ O
the DT O
transcriptional JJ O
up IN O
- : O
regulation NN O
of IN O
HK2 NNP O
and CC O
PFKFB2 NNP O
, , O
and CC O
phosphorylation NN O
of IN O
PFKFB2 NN O
generated VBN O
by IN O
the DT O
PI3K NNP O
/ NNP O
Akt NNP O
signalling NN O
pathway NN O
to TO O
supply VB O
the DT O
source NN O
for IN O
lipogenesis NN O
from IN O
glucose NN O
in IN O
prostate NN O
cancer NN O
cells NNS O
. . O

-DOCSTART- X X O

Expression NNP O
profiling NN O
in IN O
progressive JJ O
stages NNS O
of IN O
fumarate JJ O
- : O
hydratase JJ O
deficiency NN O
: : O
the DT O
contribution NN O
of IN O
metabolic JJ O
changes NNS O
to TO O
tumorigenesis NN O
. . O

Hereditary RB O
leiomyomatosis NN O
and CC O
renal JJ O
cell NN O
carcinoma NN O
( -LRB- O
HLRCC NNP O
) -RRB- O
is VBZ O
caused VBN O
by IN O
mutations NNS O
in IN O
the DT O
Krebs NNP O
cycle NN O
enzyme NN O
fumarate JJ O
hydratase NN O
( -LRB- O
FH NNP O
) -RRB- O
. . O

It PRP O
has VBZ O
been VBN O
proposed VBN O
that IN O
" `` O
pseudohypoxic JJ O
" '' O
stabilization NN O
of IN O
hypoxia NN O
- : O
inducible JJ O
factor NN O
- : O
alpha NN O
( -LRB- O
HIF NNP O
- : O
alpha NN O
) -RRB- O
by IN O
fumarate JJ O
accumulation NN O
contributes VBZ O
to TO O
tumorigenesis VB O
in IN O
HLRCC NNP O
. . O

We PRP O
hypothesized VBD O
that IN O
an DT O
additional JJ O
direct JJ O
consequence NN O
of IN O
FH NNP O
deficiency NN O
is VBZ O
the DT O
establishment NN O
of IN O
a DT O
biosynthetic JJ O
milieu NN O
. . O

To TO O
investigate VB O
this DT O
hypothesis NN O
, , O
we PRP O
isolated VBD O
primary JJ O
mouse NN O
embryonic NN O
fibroblast NN O
( -LRB- O
MEF NN O
) -RRB- O
lines NNS O
from IN O
Fh1 NNP O
- : O
deficient JJ O
mice NNS O
. . O

As IN O
predicted VBN O
, , O
these DT O
MEFs NNS O
upregulated JJ O
Hif NNP O
- : O
1alpha CD O
and CC O
HIF NNP O
target NN O
genes NNS O
directly RB O
as IN O
a DT O
result NN O
of IN O
FH NNP O
deficiency NN O
. . O

In IN O
addition NN O
, , O
detailed JJ O
metabolic JJ O
assessment NN O
of IN O
these DT O
MEFs NNS O
confirmed VBD O
their PRP$ O
dependence NN O
on IN O
glycolysis NN O
, , O
and CC O
an DT O
elevated JJ O
rate NN O
of IN O
lactate NN O
efflux NN O
, , O
associated VBN O
with IN O
the DT O
upregulation NN O
of IN O
glycolytic JJ O
enzymes NNS O
known VBN O
to TO O
be VB O
associated VBN O
with IN O
tumorigenesis NN O
. . O

Correspondingly NNP O
, , O
Fh1 NNP O
- : O
deficient JJ O
benign JJ O
murine NN O
renal JJ O
cysts NNS O
and CC O
an DT O
advanced JJ O
human JJ O
HLRCC NNP O
- : O
related VBN O
renal JJ O
cell NN O
carcinoma NN O
manifested VBD O
a DT O
prominent JJ O
and CC O
progressive JJ O
increase NN O
in IN O
the DT O
expression NN O
of IN O
HIF NNP O
- : O
alpha NN O
target NN O
genes NNS O
and CC O
in IN O
genes NNS O
known VBN O
to TO O
be VB O
relevant JJ O
to TO O
tumorigenesis NN O
and CC O
metastasis NN O
. . O

In IN O
accord NN O
with IN O
our PRP$ O
hypothesis NN O
, , O
in IN O
a DT O
variety NN O
of IN O
different JJ O
FH NNP O
- : O
deficient JJ O
tissues NNS O
, , O
including VBG O
a DT O
novel JJ O
murine NN O
model NN O
of IN O
Fh1 NNS O
- : O
deficient JJ O
smooth JJ O
muscle NN O
, , O
we PRP O
show VBP O
a DT O
striking JJ O
and CC O
progressive JJ O
upregulation NN O
of IN O
a DT O
tumorigenic JJ O
metabolic JJ O
profile NN O
, , O
as IN O
manifested VBN O
by IN O
increased VBN O
PKM2 NN O
and CC O
LDHA NNP O
protein NN O
. . O

Based VBN O
on IN O
the DT O
models NNS O
assessed VBN O
herein RB O
, , O
we PRP O
infer VBP O
that IN O
that DT O
FH NNP O
deficiency NN O
compels VBZ O
cells NNS O
to TO O
adopt VB O
an DT O
early JJ O
, , O
reversible JJ O
, , O
and CC O
progressive JJ O
protumorigenic JJ O
metabolic NN O
milieu NN O
that WDT O
is VBZ O
reminiscent JJ O
of IN O
that DT O
driving VBG O
the DT O
Warburg NNP O
effect NN O
. . O

Targets NNS O
identified VBN O
in IN O
these DT O
novel JJ O
and CC O
diverse JJ O
FH NNP O
- : O
deficient NN O
models NNS O
represent VBP O
excellent JJ O
potential JJ O
candidates NNS O
for IN O
further JJ O
mechanistic JJ O
investigation NN O
and CC O
therapeutic JJ O
metabolic JJ O
manipulation NN O
in IN O
tumors NNS O
. . O

-DOCSTART- X X O

Role NNP O
of IN O
stromal JJ O
myofibroblasts NNS O
in IN O
invasive JJ O
breast NN O
cancer NN O
: : O
stromal JJ O
expression NN O
of IN O
alpha NN O
- : O
smooth JJ O
muscle NN O
actin NN O
correlates VBZ O
with IN O
worse JJR O
clinical JJ O
outcome NN O
. . O

BACKGROUND NNP O
: : O
Recently RB O
, , O
the DT O
desmoplastic JJ O
reaction NN O
has VBZ O
been VBN O
implicated VBN O
as IN O
having VBG O
an DT O
important JJ O
function NN O
in IN O
epithelial NN O
solid JJ O
tumor NN O
biology NN O
. . O

There EX O
have VBP O
been VBN O
no DT O
reports NNS O
showing VBG O
the DT O
relativity NN O
of IN O
invasive JJ O
breast NN O
cancer NN O
and CC O
the DT O
desmoplastic JJ O
reaction NN O
by IN O
a DT O
quantitative JJ O
analysis NN O
of IN O
the DT O
myofibroblasts NNS O
that WDT O
were VBD O
an DT O
important JJ O
player NN O
in IN O
the DT O
desmoplastic JJ O
reaction NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
immunohistochemically RB O
investigate VB O
the DT O
correlation NN O
between IN O
the DT O
desmoplastic JJ O
reaction NN O
and CC O
the DT O
clinicopathology NN O
of IN O
invasive JJ O
breast NN O
cancer NN O
. . O

METHODS NNP O
: : O
The DT O
study NN O
included VBD O
60 CD O
patients NNS O
with IN O
a DT O
known VBN O
prognosis NN O
of IN O
invasive JJ O
breast NN O
cancer NN O
. . O

We PRP O
quantified VBD O
the DT O
expression NN O
of IN O
alpha NN O
- : O
SMA NNP O
as IN O
a DT O
marker NN O
of IN O
myofibroblasts NNS O
in IN O
the DT O
invasive JJ O
breast NN O
cancer NN O
. . O

After IN O
staining VBG O
samples NNS O
for IN O
alpha NN O
- : O
SMA NNP O
, , O
their PRP$ O
expression NN O
was VBD O
extracted VBN O
and CC O
quantified VBN O
as IN O
a DT O
relative JJ O
percentage NN O
by IN O
computer NN O
- : O
assisted VBN O
image NN O
analysis NN O
. . O

RESULTS NNS O
: : O
There EX O
was VBD O
relatively RB O
wide JJ O
variation NN O
in IN O
the DT O
expression NN O
of IN O
alpha NN O
- : O
SMA NNP O
with IN O
the DT O
percentage NN O
of IN O
the DT O
area NN O
from IN O
0 CD O
. . O
68 CD O
to TO O
28 CD O
. . O
15 CD O
% NN O
( -LRB- O
mean JJ O
8 CD O
. . O
48 CD O
+ NN O
/ NN O
- : O
5 CD O
. . O
40 CD O
% NN O
) -RRB- O
. . O

The DT O
metastasis NN O
group NN O
showed VBD O
significantly RB O
higher JJR O
alpha NN O
- : O
SMA NNP O
expression NN O
compared VBN O
with IN O
the DT O
no NN O
metastasis NN O
group NN O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

When WRB O
the DT O
patients NNS O
were VBD O
divided VBN O
into IN O
two CD O
groups NNS O
according VBG O
to TO O
their PRP$ O
alpha NN O
- : O
SMA NNP O
expression NN O
using VBG O
a DT O
cutoff NN O
point NN O
at IN O
the DT O
mean JJ O
value NN O
of IN O
8 CD O
. . O
48 CD O
% NN O
, , O
the DT O
high JJ O
alpha NN O
- : O
SMA NNP O
group NN O
had VBD O
a DT O
significantly RB O
poorer JJR O
overall JJ O
survival NN O
rate NN O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

Multivariate VB O
analysis NN O
demonstrated VBN O
that IN O
alpha NN O
- : O
SMA NNP O
and CC O
lymph NN O
node NN O
metastasis NN O
were VBD O
identified VBN O
as IN O
independent JJ O
predictive JJ O
factors NNS O
of IN O
metastasis NN O
. . O

CONCLUSION NN O
: : O
Myofibroblasts NNS O
represent VBP O
an DT O
important JJ O
prognostic JJ O
factor NN O
for IN O
invasive JJ O
growth NN O
that WDT O
is VBZ O
translated VBN O
into IN O
a DT O
poor JJ O
clinical JJ O
prognosis NN O
for IN O
patients NNS O
with IN O
invasive JJ O
breast NN O
cancer NN O
. . O

-DOCSTART- X X O

A DT O
STAT3 NNPS O
- : O
mediated JJ O
metabolic JJ O
switch NN O
is VBZ O
involved VBN O
in IN O
tumour NN O
transformation NN O
and CC O
STAT3 VBD O
addiction NN O
. . O

The DT O
pro FW O
- : O
oncogenic JJ O
transcription NN O
factor NN O
STAT3 NNP O
is VBZ O
constitutively RB O
activated VBN O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
tumours NNS O
that WDT O
often RB O
become VBP O
addicted JJ O
to TO O
its PRP$ O
activity NN O
, , O
but CC O
no DT O
unifying JJ O
view NN O
of IN O
a DT O
core NN O
function NN O
determining VBG O
this DT O
widespread JJ O
STAT3 NNP O
- : O
dependence NN O
has VBZ O
yet RB O
emerged VBN O
. . O

We PRP O
show VBP O
here RB O
that IN O
constitutively RB O
active JJ O
STAT3 NNS O
acts VBZ O
as IN O
a DT O
master NN O
regulator NN O
of IN O
cell NN O
metabolism NN O
, , O
inducing VBG O
aerobic JJ O
glycolysis NN O
and CC O
down IN O
- : O
regulating JJ O
mitochondrial JJ O
activity NN O
both CC O
in IN O
primary JJ O
fibroblasts NNS O
and CC O
in IN O
STAT3 NNP O
- : O
dependent JJ O
tumour NN O
cell NN O
lines NNS O
. . O

As IN O
a DT O
result NN O
, , O
cells NNS O
are VBP O
protected VBN O
from IN O
apoptosis NN O
and CC O
senescence NN O
while IN O
becoming VBG O
highly RB O
sensitive JJ O
to TO O
glucose VB O
deprivation NN O
. . O

We PRP O
show VBP O
that IN O
enhanced JJ O
glycolysis NN O
is VBZ O
dependent JJ O
on IN O
HIF NNP O
- : O
1alpha RP O
up IN O
- : O
regulation NN O
, , O
while IN O
reduced VBN O
mitochondrial JJ O
activity NN O
is VBZ O
HIF NNP O
- : O
1alpha SYM O
- : O
independent JJ O
and CC O
likely JJ O
caused VBN O
by IN O
STAT3 NNP O
- : O
mediated VBN O
down IN O
- : O
regulation NN O
of IN O
mitochondrial JJ O
proteins NNS O
. . O

The DT O
induction NN O
of IN O
aerobic JJ O
glycolysis NN O
is VBZ O
an DT O
important JJ O
component NN O
of IN O
STAT3 NNP O
pro FW O
- : O
oncogenic JJ O
activities NNS O
, , O
since IN O
inhibition NN O
of IN O
STAT3 NNP O
tyrosine NN O
phosphorylation NN O
in IN O
the DT O
tumour NN O
cell NN O
lines NNS O
down IN O
- : O
regulates VBZ O
glycolysis NN O
prior RB O
to TO O
leading VBG O
to TO O
growth NN O
arrest NN O
and CC O
cell NN O
death NN O
, , O
both DT O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

We PRP O
propose VBP O
that IN O
this DT O
novel NN O
, , O
central JJ O
metabolic JJ O
role NN O
is VBZ O
at IN O
the DT O
core NN O
of IN O
the DT O
addiction NN O
for IN O
STAT3 NNS O
shown VBN O
by IN O
so RB O
many JJ O
biologically RB O
different JJ O
tumours NNS O
. . O

-DOCSTART- X X O

The DT O
disintegrin NN O
- : O
like IN O
and CC O
cysteine VB O
- : O
rich JJ O
domains NNS O
of IN O
ADAM NNP O
- : O
9 CD O
mediate JJ O
interactions NNS O
between IN O
melanoma NN O
cells NNS O
and CC O
fibroblasts NNS O
. . O

A DT O
characteristic NN O
of IN O
malignant JJ O
cells NNS O
is VBZ O
their PRP$ O
capacity NN O
to TO O
invade VB O
their PRP$ O
surrounding VBG O
and CC O
to TO O
metastasize VB O
to TO O
distant JJ O
organs NNS O
. . O

During IN O
these DT O
processes NNS O
, , O
proteolytic JJ O
activities NNS O
of IN O
tumor NN O
and CC O
stromal JJ O
cells NNS O
modify VB O
the DT O
extracellular JJ O
matrix NN O
to TO O
produce VB O
a DT O
microenvironment NN O
suitable JJ O
for IN O
their PRP$ O
growth NN O
and CC O
migration NN O
. . O

In IN O
recent JJ O
years NNS O
the DT O
family NN O
of IN O
ADAM NNP O
proteases NNS O
has VBZ O
been VBN O
ascribed VBN O
important JJ O
roles NNS O
in IN O
these DT O
processes NNS O
. . O

ADAM NNP O
- : O
9 CD O
is VBZ O
expressed VBN O
in IN O
human NN O
melanoma NN O
at IN O
the DT O
tumor NN O
- : O
stroma JJ O
border NN O
where WRB O
direct JJ O
or CC O
indirect JJ O
interactions NNS O
between IN O
tumor NN O
cells NNS O
and CC O
fibroblasts NNS O
occur VBP O
. . O

To TO O
analyze VB O
the DT O
role NN O
of IN O
ADAM NNP O
- : O
9 CD O
for IN O
the DT O
interaction NN O
between IN O
melanoma NN O
cells NNS O
and CC O
stromal JJ O
fibroblasts NNS O
, , O
we PRP O
produced VBD O
the DT O
recombinant JJ O
disintegrin NN O
- : O
like IN O
and CC O
cysteine VB O
- : O
rich JJ O
domain NN O
of IN O
ADAM NNP O
- : O
9 CD O
( -LRB- O
DC NNP O
- : O
9 CD O
) -RRB- O
. . O

Melanoma NNP O
cells NNS O
and CC O
human JJ O
fibroblasts NNS O
adhered VBD O
to TO O
immobilized VB O
DC NNP O
- : O
9 CD O
in IN O
a DT O
Mn NNP O
( -LRB- O
2 CD O
+ NN O
) -RRB- O
- : O
dependent JJ O
fashion NN O
suggesting VBG O
an DT O
integrin NN O
- : O
mediated JJ O
process NN O
. . O

Inhibition NN O
studies NNS O
showed VBD O
that IN O
adhesion NN O
of IN O
fibroblasts NNS O
was VBD O
mediated VBN O
by IN O
several JJ O
beta1 CD O
integrin NN O
receptors NNS O
independent JJ O
of IN O
the DT O
RGD NNP O
and CC O
ECD NNP O
recognition NN O
motif NN O
. . O

Furthermore RB O
, , O
interaction NN O
of IN O
fibroblasts NNS O
and CC O
high JJ O
invasive JJ O
melanoma NN O
cells NNS O
with IN O
soluble JJ O
recombinant NN O
DC NNP O
- : O
9 CD O
resulted VBN O
in IN O
enhanced JJ O
expression NN O
of IN O
MMP NNP O
- : O
1 CD O
and CC O
MMP NNP O
- : O
2 CD O
. . O

Silencing NN O
of IN O
ADAM NNP O
- : O
9 CD O
in IN O
melanoma NN O
cells NNS O
significantly RB O
reduced VBD O
cell NN O
adhesion NN O
to TO O
fibroblasts NNS O
. . O

Ablation NNP O
of IN O
ADAM NNP O
- : O
9 CD O
in IN O
fibroblasts NNS O
almost RB O
completely RB O
abolished VBN O
these DT O
cellular JJ O
interactions NNS O
and CC O
melanoma NN O
cell NN O
invasion NN O
in IN O
vitro NN O
. . O

In IN O
summary NN O
, , O
these DT O
results NNS O
suggest VBP O
that IN O
ADAM NNP O
- : O
9 CD O
expression NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
mediating VBG O
cell NN O
- : O
cell NN O
contacts NNS O
between IN O
fibroblasts NNS O
and CC O
melanoma NN O
cells NNS O
and CC O
that IN O
these DT O
interactions NNS O
contribute VBP O
to TO O
proteolytic JJ O
activities NNS O
required VBN O
during IN O
invasion NN O
of IN O
melanoma NN O
cells NNS O
. . O

-DOCSTART- X X O

Influences NNS O
on IN O
the DT O
pharmacokinetics NNS O
of IN O
oxycodone NN O
: : O
a DT O
multicentre JJ O
cross NN O
- : O
sectional JJ O
study NN O
in IN O
439 CD O
adult NN O
cancer NN O
patients NNS O
. . O

OBJECTIVE CD O
: : O

Oxycodone NNP O
is VBZ O
widely RB O
used VBN O
for IN O
the DT O
treatment NN O
of IN O
cancer NN O
pain NN O
, , O
but CC O
little RB O
is VBZ O
known VBN O
of IN O
its PRP$ O
pharmacokinetics NNS O
in IN O
cancer NN O
pain NN O
patients NNS O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
explore VB O
the DT O
relationships NNS O
between IN O
ordinary JJ O
patient NN O
characteristics NNS O
and CC O
serum NN O
concentrations NNS O
of IN O
oxycodone NN O
and CC O
the DT O
ratios NNS O
noroxycodone , O
or CC O
oxymorphone NN O
/ NN O
oxycodone NN O
in IN O
cancer NN O
patients NNS O
. . O

METHODS NNS O
: : O

Four CD O
hundred CD O
and CC O
thirty CD O
- : O
nine CD O
patients NNS O
using VBG O
oral JJ O
oxycodone NN O
for IN O
cancer NN O
pain NN O
were VBD O
included VBN O
. . O

The DT O
patients NNS O
' POS O
characteristics NNS O
( -LRB- O
sex NN O
, , O
age NN O
, , O
body NN O
mass NN O
index NN O
[ NN O
BMI NNP O
] NNP O
, , O
Karnofsky NNP O
performance NN O
status NN O
, , O
" '' O
time NN O
since IN O
starting VBG O
opioids NNS O
" `` O
, , O
" '' O
oxycodone CD O
total JJ O
daily JJ O
dose NN O
" '' O
, , O
" '' O
time NN O
from IN O
last JJ O
oxycodone NN O
dose NN O
" '' O
, , O
use NN O
of IN O
CYP3A4 NNP O
inducer NN O
/ IN O
inhibitor NN O
, , O
" `` O
use VB O
of IN O
systemic JJ O
steroids NNS O
" `` O
, , O
" `` O
number NN O
of IN O
medications NNS O
taken VBN O
in IN O
the DT O
last JJ O
24 CD O
h NN O
" '' O
, , O
glomerular JJ O
filtration NN O
rate NN O
( -LRB- O
GFR NN O
) -RRB- O
and CC O
albumin NN O
serum NN O
concentrations NNS O
) -RRB- O
influence NN O
on IN O
oxycodone NN O
serum NN O
concentrations NNS O
or CC O
metabolite NN O
/ IN O
oxycodone JJ O
ratios NNS O
were VBD O
explored VBN O
by IN O
multiple JJ O
regression NN O
analyses NNS O
. . O

RESULTS NNS O
: : O

Sex NN O
, , O
CYP3A4 NNP O
inducers NNS O
/ IN O
inhibitors NNS O
, , O
total JJ O
daily JJ O
dose NN O
, , O
and CC O
" `` O
time NN O
from IN O
last JJ O
oxycodone NN O
dose NN O
" '' O
predicted VBD O
oxycodone CD O
concentrations NNS O
. . O

CYP3A4 NNP O
inducers NNS O
, , O
total JJ O
daily JJ O
dose NN O
, , O
and CC O
" `` O
number NN O
of IN O
medications NNS O
taken VBN O
in IN O
the DT O
last JJ O
24 CD O
h NN O
" '' O
predicted VBD O
the DT O
oxymorphone NN O
/ IN O
oxycodone CD O
ratio NN O
. . O

Total JJ O
daily JJ O
dose NN O
, , O
" '' O
time NN O
from IN O
last JJ O
dose NN O
to TO O
blood NN O
sample NN O
" '' O
, , O
albumin NN O
, , O
sex NN O
, , O
CYP3A4 IN O
inducers NNS O
/ IN O
inhibitors NNS O
, , O
steroids NNS O
, , O
BMI NNP O
and CC O
GFR NNP O
predicted VBD O
the DT O
noroxycodone JJ O
/ JJ O
oxycodone NN O
ratio NN O
. . O

CONCLUSION NN O
: : O

Women NNS O
had VBD O
lower JJR O
oxycodone NN O
serum NN O
concentrations NNS O
than IN O
men NNS O
. . O

CYP3A4 DT O
inducers NNS O
/ IN O
inhibitors NNS O
should MD O
be VB O
used VBN O
with IN O
caution NN O
as IN O
these DT O
are VBP O
predicted VBN O
to TO O
have VB O
a DT O
significant JJ O
impact NN O
on IN O
oxycodone NN O
pharmacokinetics NNS O
. . O

Other JJ O
characteristics NNS O
explained VBD O
only RB O
minor JJ O
parts NNS O
of IN O
the DT O
variability NN O
of IN O
the DT O
outcomes NNS O
. . O

-DOCSTART- X X O

Emerging VBG O
metabolic JJ O
targets NNS O
in IN O
cancer NN O
therapy NN O
. . O

Cancer NNP O
cells NNS O
are VBP O
different JJ O
from IN O
normal JJ O
cells NNS O
in IN O
their PRP$ O
metabolic JJ O
properties NNS O
. . O

Normal JJ O
cells NNS O
mostly RB O
rely VBP O
on IN O
mitochondrial JJ O
oxidative JJ O
phosphorylation NN O
to TO O
produce VB O
energy NN O
. . O

In IN O
contrast NN O
, , O
cancer NN O
cells NNS O
depend VBP O
mostly RB O
on IN O
glycolysis NN O
, , O
the DT O
aerobic JJ O
breakdown NN O
of IN O
glucose NN O
into IN O
ATP NNP O
. . O

This DT O
altered JJ O
energy NN O
dependency NN O
is VBZ O
known VBN O
as IN O
the DT O
" `` O
Warburg NNP O
effect NN O
" '' O
and CC O
is VBZ O
a DT O
hallmark NN O
of IN O
cancer NN O
cells NNS O
. . O

In IN O
recent JJ O
years NNS O
, , O
investigating VBG O
the DT O
metabolic JJ O
changes NNS O
within IN O
cancer NN O
cells NNS O
has VBZ O
been VBN O
a DT O
rapidly RB O
growing VBG O
area NN O
. . O

Emerging VBG O
evidence NN O
shows VBZ O
that IN O
oncogenes NNS O
that IN O
drive NN O
the DT O
cancer NN O
- : O
promoting VBG O
signals NNS O
also RB O
drive VBP O
the DT O
altered JJ O
metabolism NN O
. . O

Although IN O
the DT O
exact JJ O
mechanisms NNS O
underlying VBG O
the DT O
Warburg NNP O
effect NN O
are VBP O
unclear JJ O
, , O
the DT O
existing VBG O
evidence NN O
suggests VBZ O
that IN O
increased VBN O
glycolysis NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
support NN O
malignant JJ O
behavior NN O
of IN O
cancer NN O
cells NNS O
. . O

A DT O
thorough JJ O
understanding NN O
of IN O
the DT O
unique JJ O
metabolism NN O
of IN O
cancer NN O
cells NNS O
will MD O
help VB O
to TO O
design VB O
of IN O
more JJR O
effective JJ O
drugs NNS O
targeting VBG O
metabolic JJ O
pathways NNS O
, , O
which WDT O
will MD O
greatly RB O
impact VB O
the DT O
capacity NN O
to TO O
effectively RB O
treat VB O
cancer NN O
patients NNS O
. . O

Here RB O
we PRP O
provide VBP O
an DT O
overview NN O
of IN O
the DT O
current JJ O
understanding NN O
of IN O
the DT O
Warburg NNP O
effect NN O
upon IN O
tumor NN O
cell NN O
growth NN O
and CC O
survival NN O
, , O
and CC O
discussion NN O
on IN O
the DT O
potential JJ O
metabolic JJ O
targets NNS O
for IN O
cancer NN O
therapy NN O
. . O

-DOCSTART- X X O

MTSS1 NNP O
: : O
a DT O
multifunctional JJ O
protein NN O
and CC O
its PRP$ O
role NN O
in IN O
cancer NN O
invasion NN O
and CC O
metastasis NN O
. . O

MTSS1 NNP O
( -LRB- O
metastasis NN O
suppressor NN O
- : O
1 CD O
) -RRB- O
was VBD O
first RB O
identified VBN O
as IN O
a DT O
metastasis NN O
suppressor NN O
missing VBG O
in IN O
metastatic JJ O
bladder NN O
carcinoma NN O
cell NN O
lines NNS O
. . O

The DT O
down IN O
- : O
regulation NN O
of IN O
MTSS1 NNP O
that WDT O
may MD O
be VB O
caused VBN O
by IN O
DNA NNP O
methylation NN O
was VBD O
also RB O
observed VBN O
in IN O
many JJ O
other JJ O
types NNS O
of IN O
cancer NN O
. . O

While IN O
accumlating VBG O
evidence NN O
for IN O
the DT O
function NN O
of IN O
MTSS1 JJ O
support NN O
the DT O
concept NN O
that IN O
it PRP O
is VBZ O
unlikely JJ O
to TO O
be VB O
a DT O
metastasis NN O
suppressor NN O
, , O
but CC O
actually RB O
acts VBZ O
as IN O
a DT O
scaffold JJ O
protein NN O
that IN O
interacts NNS O
with IN O
multiple JJ O
partners NNS O
to TO O
regulate VB O
actin NN O
dynamics NNS O
. . O

It PRP O
has VBZ O
also RB O
been VBN O
demonstrated VBN O
that IN O
MTSS1 NNP O
is VBZ O
involved VBN O
in IN O
the DT O
Shh NNP O
signaling VBG O
pathway NN O
in IN O
the DT O
developing VBG O
hair NN O
follicle NN O
and CC O
in IN O
basal JJ O
cell NN O
carcinomas NNS O
of IN O
the DT O
skin NN O
. . O

Such JJ O
evidence NN O
indicates VBZ O
that IN O
MTSS1 NNP O
as IN O
a DT O
multiple JJ O
functional JJ O
molecular JJ O
player NN O
and CC O
has VBZ O
an DT O
important JJ O
role NN O
in IN O
development NN O
, , O
carcinogenesis NN O
and CC O
metastasis NN O
. . O

However RB O
, , O
the DT O
biochemical JJ O
mechanisms NNS O
by IN O
which WDT O
MTSS1 NNP O
functions VBZ O
in IN O
cells NNS O
and CC O
the DT O
physiological JJ O
role NN O
of IN O
this DT O
protein NN O
in IN O
animals NNS O
remain VBP O
largely RB O
unknown JJ O
. . O

In IN O
this DT O
review NN O
, , O
we PRP O
will MD O
discuss VB O
the DT O
current JJ O
knowledge NN O
of IN O
MTSS1 NNP O
' POS O
s PRP O
role NN O
in IN O
cancer NN O
metastasis NN O
, , O
carcinogenesis NN O
, , O
and CC O
development NN O
. . O

The DT O
clinical JJ O
significance NN O
of IN O
MTSS1 NNP O
will MD O
also RB O
be VB O
discussed VBN O
. . O

-DOCSTART- X X O

Geometric NNP O
correlations NNS O
and CC O
breakdown NN O
of IN O
mesoscopic NN O
universality NN O
in IN O
spin NN O
transport NN O
. . O

We PRP O
construct VB O
a DT O
unified VBN O
semiclassical JJ O
theory NN O
of IN O
charge NN O
and CC O
spin VB O
transport NN O
in IN O
chaotic JJ O
ballistic JJ O
and CC O
disordered JJ O
diffusive JJ O
mesoscopic NN O
systems NNS O
with IN O
spin NN O
- : O
orbit NN O
interaction NN O
. . O

Neglecting JJ O
dynamic JJ O
effects NNS O
of IN O
spin NN O
- : O
orbit NN O
interaction NN O
, , O
we PRP O
reproduce VB O
the DT O
random JJ O
matrix NN O
theory NN O
results NNS O
that IN O
the DT O
spin NN O
conductance NN O
fluctuates NNS O
universally RB O
around IN O
zero CD O
average NN O
. . O

Incorporating VBG O
these DT O
effects NNS O
into IN O
the DT O
theory NN O
, , O
we PRP O
show VBP O
that IN O
geometric JJ O
correlations NNS O
generate VBP O
finite JJ O
average JJ O
spin NN O
conductances NNS O
, , O
but CC O
that IN O
they PRP O
do VBP O
not RB O
affect VB O
the DT O
charge NN O
conductance NN O
to TO O
leading VBG O
order NN O
. . O

The DT O
theory NN O
, , O
which WDT O
is VBZ O
confirmed VBN O
by IN O
numerical JJ O
transport NN O
calculations NNS O
, , O
allows VBZ O
us PRP O
to TO O
investigate VB O
the DT O
entire JJ O
range NN O
from IN O
the DT O
weak JJ O
to TO O
the DT O
previously RB O
unexplored JJ O
strong JJ O
spin NN O
- : O
orbit NN O
regime NN O
, , O
where WRB O
the DT O
spin NN O
rotation NN O
time NN O
is VBZ O
shorter JJR O
than IN O
the DT O
momentum NN O
relaxation NN O
time NN O
. . O

-DOCSTART- X X O

Development NNP O
and CC O
validation NN O
of IN O
an DT O
approach NN O
to TO O
produce VB O
large JJ O
- : O
scale NN O
quantities NNS O
of IN O
CpG NNP O
- : O
methylated VBD O
plasmid JJ O
DNA NN O
. . O

The DT O
prokaryotic JJ O
CpG NN O
- : O
specific JJ O
DNA NN O
methylase NN O
from IN O
Spiroplasma NNP O
, , O
SssI NNP O
methylase NN O
, , O
has VBZ O
been VBN O
extensively RB O
used VBN O
to TO O
methylate VB O
plasmid JJ O
DNA NN O
in IN O
vitro NN O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
methylation NN O
in IN O
vertebrate JJ O
systems NNS O
. . O

Currently RB O
available JJ O
methods NNS O
to TO O
produce VB O
CpG NNP O
- : O
methylated VBD O
plasmid JJ O
DNA NN O
have VBP O
certain JJ O
limitations NNS O
and CC O
cannot NN O
generate VBP O
large JJ O
quantities NNS O
of IN O
methylated JJ O
DNA NN O
without IN O
cost NN O
or CC O
problems NNS O
of IN O
purity NN O
. . O

Here RB O
we PRP O
describe VBP O
an DT O
approach NN O
in IN O
which WDT O
the DT O
SssI NN O
methylase NN O
gene NN O
has VBZ O
been VBN O
introduced VBN O
into IN O
the DT O
Escherichia NNP O
coli NNS O
bacterial JJ O
genome NN O
under IN O
the DT O
control NN O
of IN O
an DT O
inducible JJ O
promoter NN O
. . O

Plasmid NNP O
DNA NNP O
propagated VBD O
in IN O
this DT O
bacterium NN O
under IN O
conditions NNS O
which WDT O
induce VB O
the DT O
methylase NN O
gene NN O
result NN O
in IN O
significant JJ O
( -LRB- O
> RB O
90 CD O
% NN O
) -RRB- O
CpG NNP O
methylation NN O
. . O

Methylated NNP O
DNA NNP O
produced VBN O
by IN O
this DT O
approach NN O
behaves VBZ O
similarly RB O
to TO O
methylated JJ O
DNA NN O
produced VBN O
in IN O
vitro NN O
using VBG O
the DT O
purified VBN O
methylase NN O
. . O

The DT O
approach NN O
is VBZ O
scalable JJ O
allowing VBG O
for IN O
the DT O
production NN O
of IN O
milligram NN O
quantities NNS O
of IN O
methylated JJ O
plasmid JJ O
DNA NN O
. . O

-DOCSTART- X X O

Dissecting VBG O
genetic JJ O
networks NNS O
underlying VBG O
complex JJ O
phenotypes NNS O
: : O
the DT O
theoretical JJ O
framework NN O
. . O

Great JJ O
progress NN O
has VBZ O
been VBN O
made VBN O
in IN O
genetic JJ O
dissection NN O
of IN O
quantitative JJ O
trait NN O
variation NN O
during IN O
the DT O
past JJ O
two CD O
decades NNS O
, , O
but CC O
many JJ O
studies NNS O
still RB O
reveal VBP O
only RB O
a DT O
small JJ O
fraction NN O
of IN O
quantitative JJ O
trait NN O
loci NNS O
( -LRB- O
QTLs NNS O
) -RRB- O
, , O
and CC O
epistasis NN O
remains VBZ O
elusive JJ O
. . O

We PRP O
integrate VB O
contemporary JJ O
knowledge NN O
of IN O
signal NN O
transduction NN O
pathways NNS O
with IN O
principles NNS O
of IN O
quantitative JJ O
and CC O
population NN O
genetics NNS O
to TO O
characterize VB O
genetic JJ O
networks NNS O
underlying VBG O
complex JJ O
traits NNS O
, , O
using VBG O
a DT O
model NN O
founded VBD O
upon IN O
one CD O
- : O
way NN O
functional JJ O
dependency NN O
of IN O
downstream NN O
genes NNS O
on IN O
upstream JJ O
regulators NNS O
( -LRB- O
the DT O
principle NN O
of IN O
hierarchy NN O
) -RRB- O
and CC O
mutual JJ O
functional JJ O
dependency NN O
among IN O
related JJ O
genes NNS O
( -LRB- O
functional JJ O
genetic JJ O
units NNS O
, , O
FGU NNP O
) -RRB- O
. . O

Both DT O
simulated VBN O
and CC O
real JJ O
data NNS O
suggest VBP O
that IN O
complementary JJ O
epistasis NN O
contributes VBZ O
greatly RB O
to TO O
quantitative JJ O
trait NN O
variation NN O
, , O
and CC O
obscures VBZ O
the DT O
phenotypic JJ O
effects NNS O
of IN O
many JJ O
' '' O
downstream NN O
' '' O
loci NNS O
in IN O
pathways NNS O
. . O

The DT O
mathematical JJ O
relationships NNS O
between IN O
the DT O
main JJ O
effects NNS O
and CC O
epistatic JJ O
effects NNS O
of IN O
genes NNS O
acting VBG O
at IN O
different JJ O
levels NNS O
of IN O
signaling VBG O
pathways NNS O
were VBD O
established VBN O
using VBG O
the DT O
quantitative NN O
and CC O
population NN O
genetic JJ O
parameters NNS O
. . O

Both DT O
loss NN O
of IN O
function NN O
and CC O
" `` O
co VB O
- : O
adapted VBN O
" `` O
gene NN O
complexes NNS O
formed VBN O
by IN O
multiple JJ O
alleles NNS O
with IN O
differentiated JJ O
functions NNS O
( -LRB- O
effects NNS O
) -RRB- O
are VBP O
predicted VBN O
to TO O
be VB O
frequent JJ O
types NNS O
of IN O
allelic JJ O
diversity NN O
at IN O
loci NNS O
that IN O
contribute VBP O
to TO O
the DT O
genetic JJ O
variation NN O
of IN O
complex JJ O
traits NNS O
in IN O
populations NNS O
. . O

Downstream NNP O
FGUs NNS O
appear VBP O
to TO O
be VB O
more RBR O
vulnerable JJ O
to TO O
loss NN O
of IN O
function NN O
than IN O
their PRP$ O
upstream JJ O
regulators NNS O
, , O
but CC O
this DT O
vulnerability NN O
is VBZ O
apparently RB O
compensated VBN O
by IN O
different JJ O
FGUs NNS O
of IN O
similar JJ O
functions NNS O
. . O

Other JJ O
predictions NNS O
from IN O
the DT O
model NN O
may MD O
account VB O
for IN O
puzzling JJ O
results NNS O
regarding VBG O
responses NNS O
to TO O
selection NN O
, , O
genotype JJ O
by IN O
environment NN O
interaction NN O
, , O
and CC O
the DT O
genetic JJ O
basis NN O
of IN O
heterosis NN O
. . O

-DOCSTART- X X O

Ras NNP O
p21 VB O
onco IN O
- : O
protein NN O
in IN O
the DT O
sera NN O
of IN O
mice NNS O
carrying VBG O
an DT O
experimentally RB O
induced JJ O
tumor NN O
and CC O
in IN O
human JJ O
cancer NN O
patients NNS O
. . O

We PRP O
have VBP O
established VBN O
a DT O
model NN O
system NN O
to TO O
detect VB O
the DT O
presence NN O
of IN O
ras JJ O
p21 NNS O
in IN O
the DT O
sera NN O
of IN O
Balb NNP O
/ NNP O
c NN O
mice NNS O
carrying VBG O
tumors NNS O
induced VBN O
by IN O
a DT O
mouse NN O
cell NN O
line NN O
transformed VBN O
with IN O
the DT O
Harvey NNP O
murine NN O
sarcoma NN O
virus NN O
in IN O
the DT O
presence NN O
of IN O
a DT O
helper NN O
Friend NNP O
murine NN O
leukemia NN O
virus NN O
. . O

As IN O
determined VBN O
by IN O
ELISA NNP O
and CC O
immunoblot NN O
assays VBZ O
, , O
ras VBD O
p21 NNS O
in IN O
the DT O
serum NN O
increased VBN O
with IN O
increased JJ O
tumor NN O
growth NN O
. . O

Since IN O
ras NNS O
genes NNS O
have VBP O
been VBN O
found VBN O
to TO O
be VB O
frequently RB O
activated VBN O
in IN O
human JJ O
tumours NNS O
, , O
we PRP O
examined VBD O
the DT O
levels NNS O
of IN O
ras NNS O
p21 VBP O
in IN O
the DT O
sera NN O
of IN O
a DT O
variety NN O
of IN O
human JJ O
cancer NN O
patients NNS O
. . O

In IN O
only RB O
3 CD O
out IN O
of IN O
13 CD O
cases NNS O
, , O
representing VBG O
patients NNS O
with IN O
adenocarcinomas NNS O
of IN O
the DT O
stomach NN O
receiving VBG O
chemotherapy NN O
, , O
was VBD O
ras JJ O
p21 IN O
detected VBN O
at IN O
elevated JJ O
levels NNS O
, , O
whereas IN O
in IN O
patients NNS O
with IN O
the DT O
following VBG O
types NNS O
of IN O
cancer NN O
no DT O
substantial JJ O
change NN O
in IN O
serum NN O
ras NNS O
p21 . O
was VBD O
observed VBN O
; : O
nine CD O
with IN O
breast NN O
, , O
5 CD O
colon NN O
, , O
5 CD O
lung NN O
, , O
5 CD O
ovarian NN O
and CC O
5 CD O
hepatocellular JJ O
carcinomas NNS O
. . O

-DOCSTART- X X O

Serum NN O
soluble JJ O
vascular JJ O
adhesion NN O
protein NN O
- : O
1 CD O
is VBZ O
a DT O
valuable JJ O
prognostic JJ O
marker NN O
in IN O
gastric JJ O
cancer NN O
. . O

BACKGROUND NNP O
: : O
Vascular NNP O
adhesion NN O
protein NN O
- : O
1 CD O
( -LRB- O
VAP NNP O
- : O
1 CD O
) -RRB- O
regulates VBZ O
leukocyte JJ O
tissue NN O
infiltration NN O
. . O

Elevated VBN O
serum NN O
soluble NN O
VAP NNP O
- : O
1 CD O
( -LRB- O
sVAP NN O
- : O
1 CD O
) -RRB- O
levels NNS O
occur VBP O
in IN O
certain JJ O
diseases NNS O
having VBG O
an DT O
inflammatory JJ O
component NN O
. . O

We PRP O
previously RB O
showed VBD O
in IN O
colorectal NN O
cancer NN O
that WDT O
sVAP VBP O
- : O
1 CD O
expression NN O
is VBZ O
significantly RB O
higher JJR O
relative JJ O
to TO O
controls NNS O
, , O
and CC O
this DT O
decreased VBN O
expression NN O
is VBZ O
associated VBN O
with IN O
poor JJ O
prognosis NN O
and CC O
lymph NN O
node NN O
and CC O
liver NN O
metastasis NN O
. . O

However RB O
, , O
sVAP JJ O
- : O
1 CD O
expression NN O
has VBZ O
not RB O
been VBN O
described VBN O
for IN O
gastric JJ O
cancer NN O
. . O

This DT O
study NN O
determines VBZ O
the DT O
relationship NN O
between IN O
preoperative JJ O
serum NN O
sVAP NNS O
- : O
1 CD O
levels NNS O
and CC O
clinicopathological JJ O
features NNS O
and CC O
prognosis NN O
in IN O
gastric JJ O
cancer NN O
. . O

METHODS NNS O
: : O
Preoperative JJ O
serum NN O
was VBD O
collected VBN O
from IN O
107 CD O
gastric JJ O
cancer NN O
patients NNS O
and CC O
33 CD O
normal JJ O
controls NNS O
. . O

sVAP JJ O
- : O
1 CD O
levels NNS O
were VBD O
assayed VBN O
by IN O
enzyme JJ O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
. . O

RESULTS NNS O
: : O
The DT O
mean JJ O
sVAP JJ O
- : O
1 CD O
level NN O
for IN O
cancer NN O
patients NNS O
was VBD O
significantly RB O
higher JJR O
relative JJ O
to TO O
controls NNS O
, , O
and CC O
decreased VBD O
with IN O
disease NN O
progression NN O
. . O

Tumor NN O
size NN O
, , O
serosal NN O
invasion NN O
, , O
lymph NN O
node NN O
metastasis NN O
, , O
peritoneal JJ O
dissemination NN O
, , O
and CC O
TNM NNP O
classification NN O
was VBD O
significantly RB O
correlated VBN O
with IN O
sVAP JJ O
- : O
1 CD O
level NN O
. . O

sVAP JJ O
- : O
1 CD O
is VBZ O
also RB O
an DT O
independent JJ O
predictive JJ O
marker NN O
for IN O
lymph NN O
node NN O
metastasis NN O
. . O

Patients NNS O
having VBG O
low JJ O
sVAP NNS O
- : O
1 CD O
levels NNS O
had VBD O
significantly RB O
poorer JJR O
prognosis NN O
relative JJ O
to TO O
patients NNS O
having VBG O
elevated VBN O
sVAP JJ O
- : O
1 CD O
in IN O
all DT O
or CC O
stages NNS O
I PRP O
- : O
III NNP O
gastric NNP O
cancer NN O
patients NNS O
, , O
respectively RB O
. . O

CONCLUSIONS NNS O
: : O
Low NNP O
sVAP VBP O
- : O
1 CD O
levels NNS O
are VBP O
associated VBN O
with IN O
poor JJ O
prognosis NN O
in IN O
gastric JJ O
cancer NN O
. . O

Determining VBG O
sVAP JJ O
- : O
1 CD O
levels NNS O
may MD O
be VB O
valuable JJ O
for IN O
predicting VBG O
prognosis NN O
and CC O
lymph NN O
node NN O
metastasis NN O
. . O

-DOCSTART- X X O

Diallyl NNP O
trisulfide NN O
( -LRB- O
DATS NNP O
) -RRB- O
inhibits VBZ O
mouse NN O
colon NN O
tumor NN O
in IN O
mouse NN O
CT NN B-NP
- : I-NP
26 CD I-NP
cells NNS O
allograft IN O
model NN O
in IN O
vivo NN O
. . O

Our PRP$ O
earlier JJR O
studies NNS O
showed VBD O
that IN O
DATS NNP O
induced VBD O
apoptosis NN O
in IN O
human JJ O
colon NN O
cancer NN O
HT29 . B-NP
and CC O
colo JJ B-NP
205 CD I-NP
cell NN O
lines NNS O
in IN O
vitro NN O
. . O

However RB O
, , O
there EX O
is VBZ O
no DT O
report NN O
to TO O
show VB O
that IN O
DATS NNP O
induced VBD O
apoptosis NN O
in IN O
vitro NN O
and CC O
inhibited JJ O
CT26 IN B-NP
cancer NN O
cells NNS O
in IN O
vivo RB O
on IN O
a DT O
murine NN O
allograft VBN O
animal NN O
model NN O
. . O

In IN O
vitro NN O
studies NNS O
, , O
the DT O
results NNS O
indicated VBD O
that IN O
DATS NNP O
induced VBD O
morphological JJ O
changes NNS O
and CC O
induction NN O
of IN O
apoptosis NN O
in IN O
CT26 NNP B-NP
cells NNS O
. . O

In IN O
vivo JJ O
studies NNS O
, , O
CT26 IN B-NP
cancer NN O
cells NNS O
were VBD O
implanted VBN O
into IN O
BALB NNP O
/ NNP O
c NN O
mice NNS O
and CC O
groups NNS O
of IN O
mice NNS O
were VBD O
treated VBN O
with IN O
vehicle NN O
, , O
DATS NNP O
( -LRB- O
10 CD O
and CC O
50 CD O
mg JJ O
/ JJ O
kg NN O
of IN O
body NN O
weight NN O
) -RRB- O
. . O

DATS NNS O
were VBD O
injected VBN O
once RB O
per IN O
four CD O
days NNS O
intraperitoneally RB O
( -LRB- O
i FW O
. . O
p NN O
. . O
) -RRB- O
, , O
with IN O
treatment NN O
starting VBG O
4 CD O
weeks NNS O
prior JJ O
to TO O
cells NNS O
inoculation NN O
. . O

Treatment NNP O
with IN O
vehicle NN O
or CC O
with IN O
10 CD O
and CC O
50 CD O
mg JJ O
/ JJ O
kg NN O
of IN O
DATS NNP O
resulted VBD O
in IN O
a DT O
reduction NN O
in IN O
tumor NN O
volume NN O
and CC O
weight NN O
. . O

Tumor NN O
volume NN O
and CC O
total JJ O
hemoglobin NN O
in IN O
allograft NN O
mice NNS O
treated VBN O
with IN O
50 CD O
mg JJ O
/ NN O
kg NN O
DATS NNS O
were VBD O
significantly RB O
smaller JJR O
than IN O
that DT O
in IN O
the DT O
control NN O
group NN O
. . O

These DT O
findings NNS O
indicated VBD O
that IN O
DATS NNP O
inhibits VBZ O
tumor NN O
growth NN O
in IN O
an DT O
allograft VBN O
animal NN O
model NN O
. . O

Thus RB O
, , O
DATS NNP O
may MD O
represent VB O
a DT O
colon NN O
cancer NN O
preventive JJ O
agent NN O
and CC O
can MD O
be VB O
used VBN O
in IN O
the DT O
future NN O
. . O

-DOCSTART- X X O

Metabolic NNP O
regulation NN O
by IN O
p53 NN O
. . O

We PRP O
are VBP O
increasingly RB O
aware JJ O
that IN O
cellular JJ O
metabolism NN O
plays VBZ O
a DT O
vital JJ O
role NN O
in IN O
diseases NNS O
such JJ O
as IN O
cancer NN O
, , O
and CC O
that DT O
p53 NN O
is VBZ O
an DT O
important JJ O
regulator NN O
of IN O
metabolic JJ O
pathways NNS O
. . O

By IN O
transcriptional JJ O
activation NN O
and CC O
other JJ O
means NNS O
, , O
p53 NN O
is VBZ O
able JJ O
to TO O
contribute VB O
to TO O
the DT O
regulation NN O
of IN O
glycolysis NN O
, , O
oxidative JJ O
phosphorylation NN O
, , O
glutaminolysis NN O
, , O
insulin NN O
sensitivity NN O
, , O
nucleotide JJ O
biosynthesis NN O
, , O
mitochondrial JJ O
integrity NN O
, , O
fatty JJ O
acid NN O
oxidation NN O
, , O
antioxidant JJ O
response NN O
, , O
autophagy NN O
and CC O
mTOR NN O
signalling NN O
. . O

The DT O
ability NN O
to TO O
positively RB O
and CC O
negatively RB O
regulate VB O
many JJ O
of IN O
these DT O
pathways NNS O
, , O
combined VBN O
with IN O
feedback NN O
signalling NN O
from IN O
these DT O
pathways NNS O
to TO O
p53 NN O
, , O
demonstrates VBZ O
the DT O
reciprocal JJ O
and CC O
flexible JJ O
nature NN O
of IN O
the DT O
regulation NN O
, , O
facilitating VBG O
a DT O
diverse JJ O
range NN O
of IN O
responses NNS O
to TO O
metabolic JJ O
stress NN O
. . O

Intriguingly RB O
, , O
metabolic JJ O
stress NN O
triggers VBZ O
primarily RB O
an DT O
adaptive JJ O
( -LRB- O
rather RB O
than IN O
pro FW O
- : O
apoptotic JJ O
) -RRB- O
p53 NN O
response NN O
, , O
and CC O
p53 NN O
is VBZ O
emerging VBG O
as IN O
an DT O
important JJ O
regulator NN O
of IN O
metabolic JJ O
homeostasis NN O
. . O

A DT O
better JJR O
understanding NN O
of IN O
how WRB O
p53 NN O
coordinates VBZ O
metabolic JJ O
adaptation NN O
will MD O
facilitate VB O
the DT O
identification NN O
of IN O
novel JJ O
therapeutic JJ O
targets NNS O
and CC O
will MD O
also RB O
illuminate VB O
the DT O
wider JJR O
role NN O
of IN O
p53 NN O
in IN O
human JJ O
biology NN O
. . O

-DOCSTART- X X O

Use NN O
of IN O
DNA NNP O
microarray NN O
and CC O
small JJ O
animal NN O
positron NN O
emission NN O
tomography NN O
in IN O
preclinical JJ O
drug NN O
evaluation NN O
of IN O
RAF265 NNP O
, , O
a DT O
novel NN O
B NNP O
- : O
Raf NNP O
/ NNP O
VEGFR NNP O
- : O
2 CD O
inhibitor NN O
. . O

Positron NNP O
emission NN O
tomography NN O
( -LRB- O
PET NN O
) -RRB- O
imaging NN O
has VBZ O
become VBN O
a DT O
useful JJ O
tool NN O
for IN O
assessing VBG O
early JJ O
biologic NN O
response NN O
to TO O
cancer NN O
therapy NN O
and CC O
may MD O
be VB O
particularly RB O
useful JJ O
in IN O
the DT O
development NN O
of IN O
new JJ O
cancer NN O
therapeutics NNS O
. . O

RAF265 CD O
, , O
a DT O
novel NN O
B NNP O
- : O
Raf NNP O
/ , O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
receptor NN O
- : O
2 CD O
inhibitor NN O
, , O
was VBD O
evaluated VBN O
in IN O
the DT O
preclinical JJ O
setting NN O
for IN O
its PRP$ O
ability NN O
to TO O
inhibit VB O
the DT O
uptake NN O
of IN O
PET NNP O
tracers NNS O
in IN O
the DT O
A375M NNP B-NP
( -LRB- O
B NNP O
- : O
Raf NNP O
( -LRB- O
V600E NN O
) -RRB- O
) -RRB- O
human JJ O
melanoma NN O
cell NN O
line NN O
. . O

RAF265 CD O
inhibited VBN O
2 CD O
- : O
deoxy NN O
- : O
2 LS O
- : O
[ NN O
( -LRB- O
18 CD O
) -RRB- O
F NNP O
] SYM O
fluoro FW O
- : O
d SYM O
- : O
glucose NN O
( -LRB- O
FDG NN O
) -RRB- O
accumulation NN O
in IN O
cell NN O
culture NN O
at IN O
28 CD O
hours NNS O
in IN O
a DT O
dose NN O
- : O
dependent JJ O
manner NN O
. . O

RAF265 PRP O
also RB O
inhibited VBD O
FDG NNP O
accumulation NN O
in IN O
tumor NN O
xenografts NNS O
after IN O
1 CD O
day NN O
of IN O
drug NN O
treatment NN O
. . O

This DT O
decrease NN O
persisted VBD O
for IN O
the DT O
remaining VBG O
2 CD O
weeks NNS O
of IN O
treatment NN O
. . O

DNA NNP O
microarray NN O
analysis NN O
of IN O
treated VBN O
tumor NN O
xenografts NNS O
revealed VBD O
significantly RB O
decreased VBN O
expression NN O
of IN O
genes NNS O
regulating VBG O
glucose NN O
and CC O
thymidine NN O
metabolism NN O
and CC O
revealed VBD O
changes NNS O
in IN O
apoptotic JJ O
genes NNS O
, , O
suggesting VBG O
that IN O
the DT O
imaging NN O
tracers NNS O
FDG NNP O
, , O
3 CD O
- : O
deoxy NN O
- : O
3 LS O
- : O
[ NN O
( -LRB- O
18 CD O
) -RRB- O
F NNP O
] NNP O
fluorothymidine NN O
, , O
and CC O
annexin IN O
V NNP O
could MD O
serve VB O
as IN O
potential JJ O
imaging NN O
biomarkers NNS O
for IN O
RAF265 NNP O
therapy NN O
monitoring NN O
. . O

We PRP O
concluded VBD O
that IN O
RAF265 PRP O
is VBZ O
highly RB O
efficacious JJ O
in IN O
this DT O
xenograft NN O
model NN O
of IN O
human JJ O
melanoma NN O
and CC O
decreases VBZ O
glucose NN O
metabolism NN O
as IN O
measured VBN O
by IN O
DNA NNP O
microarray NN O
analysis NN O
, , O
cell NN O
culture NN O
assays VBZ O
, , O
and CC O
small JJ O
animal NN O
FDG NNP O
PET NNP O
scans NNS O
as RB O
early RB O
as IN O
1 CD O
day NN O
after IN O
treatment NN O
. . O

Our PRP$ O
results NNS O
support VBP O
the DT O
use NN O
of IN O
FDG NNP O
PET NNP O
in IN O
clinical JJ O
trials NNS O
with IN O
RAF265 NNP O
to TO O
assess VB O
early JJ O
tumor NN O
response NN O
. . O

DNA NNP O
microarray NN O
analysis NN O
and CC O
small JJ O
animal NN O
PET NN O
studies NNS O
may MD O
be VB O
used VBN O
as IN O
complementary JJ O
technologies NNS O
in IN O
drug NN O
development NN O
. . O

DNA NNP O
microarray NN O
analysis NN O
allows VBZ O
for IN O
analysis NN O
of IN O
drug NN O
effects NNS O
on IN O
multiple JJ O
pathways NNS O
linked VBN O
to TO O
cancer NN O
and CC O
can MD O
suggest VB O
corresponding JJ O
imaging NN O
tracers NNS O
for IN O
further JJ O
analysis NN O
as IN O
biomarkers NNS O
of IN O
tumor NN O
response NN O
. . O

-DOCSTART- X X O

Predictive JJ O
value NN O
of IN O
serum NN O
carbohydrate NN O
antigen RB O
19 CD O
- : O
9 CD O
in IN O
malignant JJ O
intraductal JJ O
papillary NN O
mucinous JJ O
neoplasms NNS O
. . O

BACKGROUND NNP O
: : O

The DT O
goal NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
evaluate VB O
the DT O
predictive JJ O
value NN O
of IN O
serum NN O
carbohydrate NN O
antigen RB O
19 CD O
- : O
9 CD O
( -LRB- O
CA NNP O
19 CD O
- : O
9 CD O
) -RRB- O
in IN O
the DT O
diagnosis NN O
of IN O
malignant JJ O
intraductal JJ O
papillary NN O
mucinous JJ O
neoplasms NNS O
of IN O
pancreas NNS O
( -LRB- O
IPMNs NNS O
) -RRB- O
. . O

METHODS NNS O
: : O

Eighty CD O
- : O
six CD O
patients NNS O
with IN O
pathological JJ O
diagnosis NN O
of IN O
IPMNs NNP O
in IN O
Zhongshan NNP O
Hospital NNP O
between IN O
March NNP O
1999 CD O
and CC O
November NNP O
2008 CD O
were VBD O
retrospectively RB O
reviewed VBN O
. . O

Data NNP O
reflecting VBG O
clinical JJ O
characteristics NNS O
, , O
tumor NN O
marker NN O
level NN O
, , O
and CC O
prognosis NN O
were VBD O
collected VBN O
. . O

The DT O
potential JJ O
predictive JJ O
value NN O
of IN O
CA NNP O
19 CD O
- : O
9 CD O
was VBD O
analyzed VBN O
by IN O
receiver NN O
operating NN O
characteristic NN O
( -LRB- O
ROC NNP O
) -RRB- O
curve NN O
. . O

RESULTS NNS O
: : O

Eighty CD O
- : O
six CD O
consecutive JJ O
patients NNS O
with IN O
IPMNs NNP O
all DT O
underwent JJ O
surgical JJ O
intervention NN O
. . O

A DT O
high JJ O
level NN O
of IN O
CA NNP O
19 CD O
- : O
9 CD O
or CC O
carcinoembryonic JJ O
antigen NN O
( -LRB- O
CEA NN O
) -RRB- O
was VBD O
associated VBN O
with IN O
more JJR O
advanced JJ O
stage NN O
of IN O
malignant JJ O
IPMNs NNS O
. . O

Carbohydrate NNP O
antigen RB O
19 CD O
- : O
9 CD O
was VBD O
significant JJ O
for IN O
judging VBG O
malignant JJ O
IPMNs NNS O
in IN O
the DT O
binary JJ O
logistic JJ O
regression NN O
model NN O
( -LRB- O
p NN O
= SYM O
0 CD O
. . O
047 CD O
) -RRB- O
. . O

The DT O
hazard NN O
ratio NN O
was VBD O
1 CD O
. . O
014 CD O
, , O
whose WP$ O
95 CD O
. . O
0 CD O
% NN O
confidence NN O
interval NN O
was VBD O
0 CD O
. . O
91 CD O
- : O
1 CD O
. . O
028 CD O
. . O

Receiver NN O
operating VBG O
characteristic JJ O
analysis NN O
showed VBD O
that IN O
the DT O
serum NN O
CA NNP O
19 CD O
- : O
9 CD O
level NN O
had VBD O
good JJ O
predictive JJ O
value NN O
for IN O
malignant JJ O
or CC O
invasive JJ O
IPMNs NNS O
, , O
postoperative JJ O
survival NN O
, , O
and CC O
disease NN O
- : O
specific JJ O
recurrence NN O
. . O

The DT O
area NN O
under IN O
the DT O
curve NN O
( -LRB- O
AUC NNP O
) -RRB- O
was VBD O
0 CD O
. . O
856 CD O
, , O
0 CD O
. . O
893 CD O
, , O
0 CD O
. . O
815 CD O
, , O
and CC O
0 CD O
. . O
857 CD O
( -LRB- O
p NN O
< NN O
0 CD O
. . O
05 CD O
) -RRB- O
, , O
respectively RB O
. . O

According VBG O
to TO O
the DT O
follow VBP O
- : O
up RB O
, , O
mean JJ O
survival NN O
time NN O
for IN O
groups NNS O
with IN O
CA NNP O
19 CD O
- : O
9 CD O
> NN O
63 CD O
. . O
60 CD O
U NNP O
/ NNP O
ml NN O
was VBD O
dramatically RB O
shorter JJR O
than IN O
that IN O
for IN O
groups NNS O
with IN O
CA NNP O
19 CD O
- : O
9 CD O
< CD O
= SYM O
63 CD O
. . O
60 CD O
U NNP O
/ NN O
ml NN O
( -LRB- O
57 CD O
. . O
38 CD O
+ NN O
/ IN O
- : O
2 LS O
. . O
85 CD O
versus NN O
29 CD O
. . O
24 CD O
+ NN O
/ NNS O
- : O
5 CD O
. . O
82 CD O
[ NNP O
months NNS O
] SYM O
; : O
p NN O
< NN O
0 CD O
. . O
01 CD O
) -RRB- O
. . O

CONCLUSIONS NNS O
: : O

Serum NN O
CA NNP O
19 CD O
- : O
9 CD O
level NN O
has VBZ O
good JJ O
predictive JJ O
value NN O
for IN O
malignant JJ O
or CC O
invasive JJ O
IPMNs NNS O
. . O

Patients NNS O
with IN O
CA NNP O
19 CD O
- : O
9 CD O
> NN O
63 CD O
. . O
60 CD O
U NNP O
/ NNP O
ml NN O
had VBD O
poor JJ O
postoperative JJ O
prognosis NN O
in IN O
IPMNs NNP O
. . O

Preoperative JJ O
abnormal JJ O
serum NN O
CA NNP O
19 CD O
- : O
9 CD O
might MD O
be VB O
predictive JJ O
for IN O
an DT O
aggressive JJ O
surgical JJ O
intervention NN O
in IN O
IPMNs NNP O
. . O

-DOCSTART- X X O

Saliva NNP O
proteins NNS O
of IN O
vector NN O
Culicoides . O
modify VB O
structure NN O
and CC O
infectivity NN O
of IN O
bluetongue NN O
virus NN O
particles NNS O
. . O

Bluetongue NNP O
virus NN O
( -LRB- O
BTV NNP O
) -RRB- O
and CC O
epizootic JJ O
haemorrhagic JJ O
disease NN O
virus NN O
( -LRB- O
EHDV NN O
) -RRB- O
are VBP O
related VBN O
orbiviruses NNS O
, , O
transmitted VBN O
between IN O
their PRP$ O
ruminant JJ O
hosts NNS O
primarily RB O
by IN O
certain JJ O
haematophagous JJ O
midge NN O
vectors NNS O
( -LRB- O
Culicoides NNPS O
spp NN O
. . O
) -RRB- O
. . O

The DT O
larger JJR O
of IN O
the DT O
BTV NNP O
outer JJ O
- : O
capsid JJ O
proteins NNS O
, , O
' '' O
VP2 NNP O
' '' O
, , O
can MD O
be VB O
cleaved VBN O
by IN O
proteases NNS O
( -LRB- O
including VBG O
trypsin NN O
or CC O
chymotrypsin NN O
) -RRB- O
, , O
forming VBG O
infectious JJ O
subviral JJ O
particles NNS O
( -LRB- O
ISVP NNP O
) -RRB- O
which WDT O
have VBP O
enhanced VBN O
infectivity NN O
for IN O
adult NN O
Culicoides NNS O
, , O
or CC O
KC NN O
cells NNS O
( -LRB- O
a DT O
cell NN O
- : O
line NN O
derived VBN O
from IN O
C NNP O
. . O
sonorensis NN O
) -RRB- O
. . O

We PRP O
demonstrate VBP O
that IN O
VP2 NNP O
present NN O
on IN O
purified VBN O
virus NN O
particles NNS O
from IN O
3 CD O
different JJ O
BTV NN O
strains NNS O
can MD O
also RB O
be VB O
cleaved VBN O
by IN O
treatment NN O
with IN O
saliva NN O
from IN O
adult NN O
Culicoides NNS O
. . O

The DT O
saliva NN O
proteins VBZ O
from IN O
C NNP O
. . O
sonorensis NN O
( -LRB- O
a DT O
competent JJ O
BTV NN O
vector NN O
) -RRB- O
, , O
cleaved JJ O
BTV NNP O
- : O
VP2 VBP O
more RBR O
efficiently RB O
than IN O
those DT O
from IN O
C NNP O
. . O
nubeculosus NN O
( -LRB- O
a DT O
less JJR O
competent JJ O
/ NN O
non FW O
- : O
vector NN O
species NNS O
) -RRB- O
. . O

Electrophoresis NNP O
and CC O
mass JJ O
spectrometry NN O
identified VBN O
a DT O
trypsin NN O
- : O
like IN O
protease NN O
in IN O
C NNP O
. . O
sonorensis NN O
saliva NN O
, , O
which WDT O
was VBD O
significantly RB O
reduced VBN O
or CC O
absent JJ O
from IN O
C NNP O
. . O
nubeculosus IN O
saliva NN O
. . O

Incubating VBG O
purified VBN O
BTV NNP O
- : O
1 CD O
with IN O
C NNP O
. . O
sonorensis NN O
saliva NN O
proteins VBZ O
also RB O
increased VBN O
their PRP$ O
infectivity NN O
for IN O
KC NN O
cells NNS O
~ IN O
10 CD O
fold NN O
, , O
while IN O
infectivity NN O
for IN O
BHK NNP B-NP
cells NNS O
was VBD O
reduced VBN O
by IN O
2 CD O
- : O
6 CD O
fold NN O
. . O

Treatment NNP O
of IN O
an DT O
' '' O
eastern JJ O
' '' O
strain NN O
of IN O
EHDV NNP O
- : O
2 CD O
with IN O
saliva NN O
proteins NNS O
of IN O
either DT O
C NNP O
. . O
sonorensis NN O
or CC O
C NNP O
. . O
nubeculosus '' O
cleaved VBD O
VP2 NNP O
, , O
but CC O
a DT O
' `` O
western JJ O
' '' O
strain NN O
of IN O
EHDV NNP O
- : O
2 CD O
remained VBN O
unmodified JJ O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
temperature NN O
, , O
strain NN O
of IN O
virus NN O
and CC O
protein NN O
composition NN O
of IN O
Culicoides NNPS O
saliva FW O
( -LRB- O
particularly RB O
its PRP$ O
protease NN O
content NN O
which WDT O
is VBZ O
dependent JJ O
upon IN O
vector JJ O
species NNS O
) -RRB- O
, , O
can MD O
all DT O
play VB O
a DT O
significant JJ O
role NN O
in IN O
the DT O
efficiency NN O
of IN O
VP2 NNP O
cleavage NN O
, , O
influencing VBG O
virus NN O
infectivity NN O
. . O

Saliva NNP O
of IN O
several JJ O
other JJ O
arthropod NN O
species NNS O
has VBZ O
previously RB O
been VBN O
shown VBN O
to TO O
increase VB O
transmission NN O
, , O
infectivity NN O
and CC O
virulence NN O
of IN O
certain JJ O
arboviruses NNS O
, , O
by IN O
modulating VBG O
and CC O
/ NNS O
or CC O
suppressing VBG O
the DT O
mammalian JJ O
immune JJ O
response NN O
. . O

The DT O
findings NNS O
presented VBD O
here RB O
, , O
however RB O
, , O
demonstrate VBP O
a DT O
novel NN O
mechanism NN O
by IN O
which WDT O
proteases NNS O
in IN O
Culicoides NNS O
saliva NN O
can MD O
also RB O
directly RB O
modify VB O
the DT O
orbivirus NNP O
particle NN O
structure NN O
, , O
leading VBG O
to TO O
increased VB O
infectivity NN O
specifically RB O
for IN O
Culicoides NNP O
cells NNS O
and CC O
, , O
in IN O
turn NN O
, , O
efficiency NN O
of IN O
transmission NN O
to TO O
the DT O
insect NN O
vector NN O
. . O

-DOCSTART- X X O

Systematic JJ O
proteomic JJ O
analysis NN O
of IN O
human JJ O
hepotacellular JJ O
carcinoma NN O
cells NNS O
reveals VBZ O
molecular JJ O
pathways NNS O
and CC O
networks NNS O
involved VBN O
in IN O
metastasis NN O
. . O

Systematic JJ O
proteomic JJ O
studying VBG O
of IN O
the DT O
mechanism NN O
of IN O
hepatocellular JJ O
carcinoma NN O
( -LRB- O
HCC NNP O
) -RRB- O
metastasis NN O
remains VBZ O
challenging VBG O
. . O

We PRP O
performed VBD O
comparative JJ O
proteomic JJ O
and CC O
pathway NN O
analysis NN O
of IN O
four CD O
human JJ O
metastatic JJ O
HCC NNP O
cell NN O
lines NNS O
to TO O
identify VB O
metastasis NN O
- : O
associated JJ O
proteins NNS O
. . O

These DT O
HCC NNP O
cell NN O
lines NNS O
had VBD O
a DT O
similar JJ O
genetic JJ O
background NN O
but CC O
with IN O
an DT O
increasing VBG O
potential NN O
of IN O
metastasis NN O
. . O

Using VBG O
a DT O
combination NN O
of IN O
two CD O
dimensional JJ O
electrophoresis NN O
( -LRB- O
2 LS O
- : O
DE VBD O
) -RRB- O
and CC O
MALDI NNP O
- : O
TOF NN O
mass NN O
spectrometry NN O
, , O
a DT O
total NN O
of IN O
125 CD O
proteins NNS O
and CC O
their PRP$ O
post NN O
- : O
translational JJ O
modification NN O
forms NNS O
or CC O
isoforms NNS O
were VBD O
found VBN O
to TO O
be VB O
differentially RB O
expressed VBN O
in IN O
the DT O
cell NN O
lines NNS O
. . O

Among IN O
them PRP O
, , O
29 CD O
were VBD O
gradually RB O
up IN O
- : O
regulated JJ O
whereas IN O
17 CD O
were VBD O
down RB O
- : O
regulated VBN O
with IN O
increasing VBG O
metastatic JJ O
potential NN O
. . O

Instead RB O
of IN O
a DT O
traditional JJ O
single JJ O
- : O
gene NN O
readout NN O
, , O
global JJ O
bioinformatics NNS O
analysis NN O
was VBD O
carried VBN O
out RP O
, , O
which WDT O
revealed VBD O
that IN O
the DT O
glycolysis NN O
pathway NN O
was VBD O
the DT O
most JJS O
significantly RB O
enriched VBD O
pathway NN O
. . O

The DT O
heat NN O
shock NN O
proteins NNS O
( -LRB- O
HSPs NNS O
) -RRB- O
centered VBN O
and CC O
NF NNP O
- : O
kappaB NN O
centered VBN O
networks NNS O
were VBD O
also RB O
enriched VBN O
in IN O
the DT O
result NN O
, , O
which WDT O
may MD O
imply VB O
the DT O
key JJ O
function NN O
of IN O
inflaming VBG O
on IN O
metastasis NN O
. . O

Meanwhile RB O
, , O
knockdown NN O
of IN O
HDGF NNP O
, , O
an DT O
up RB O
- : O
regulated JJ O
protein NN O
and CC O
a DT O
target NN O
of IN O
NF NNP O
- : O
kappaB NN O
, , O
induced VBN O
cell NN O
apoptosis NN O
in IN O
the DT O
metastatic JJ O
HCC NNP O
cells NNS O
. . O

This DT O
work NN O
provides VBZ O
a DT O
demonstration NN O
that IN O
a DT O
combination NN O
of IN O
bioinformatics NNS O
and CC O
comparative JJ O
proteomics NNS O
can MD O
help VB O
in IN O
finding VBG O
out RP O
potential JJ O
biomarkers NNS O
associated VBN O
with IN O
HCC NNP O
metastasis NN O
on IN O
the DT O
level NN O
of IN O
pathways NNS O
. . O

-DOCSTART- X X O

Roles NNP O
of IN O
brca2 CD O
( -LRB- O
fancd1 NN O
) -RRB- O
in IN O
oocyte NN O
nuclear JJ O
architecture NN O
, , O
gametogenesis NN O
, , O
gonad NN O
tumors NNS O
, , O
and CC O
genome JJ O
stability NN O
in IN O
zebrafish NN O
. . O

Mild NNP O
mutations NNS O
in IN O
BRCA2 NNP O
( -LRB- O
FANCD1 NN O
) -RRB- O
cause NN O
Fanconi NNS O
anemia NN O
( -LRB- O
FA NNP O
) -RRB- O
when WRB O
homozygous JJ O
, , O
while IN O
severe JJ O
mutations NNS O
cause VBP O
common JJ O
cancers NNS O
including VBG O
breast NN O
, , O
ovarian JJ O
, , O
and CC O
prostate NN O
cancers NNS O
when WRB O
heterozygous JJ O
. . O

Here RB O
we PRP O
report VBP O
a DT O
zebrafish NN O
brca2 IN O
insertional JJ O
mutant JJ O
that DT O
shares NNS O
phenotypes NNS O
with IN O
human JJ O
patients NNS O
and CC O
identifies VBZ O
a DT O
novel NN O
brca2 IN O
function NN O
in IN O
oogenesis NN O
. . O

Experiments NNS O
showed VBD O
that IN O
mutant JJ O
embryos NNS O
and CC O
mutant JJ O
cells NNS O
in IN O
culture NN O
experienced VBN O
genome JJ O
instability NN O
, , O
as IN O
do VBP O
cells NNS O
in IN O
FA NNP O
patients NNS O
. . O

In IN O
wild JJ O
- : O
type NN O
zebrafish NN O
, , O
meiotic JJ O
cells NNS O
expressed VBN O
brca2 JJ O
; : O
and CC O
, , O
unexpectedly RB O
, , O
transcripts NNS O
in IN O
oocytes NNS O
localized VBN O
asymmetrically RB O
to TO O
the DT O
animal NN O
pole NN O
. . O

In IN O
juvenile JJ O
brca2 NN O
mutants NNS O
, , O
oocytes NNS O
failed VBD O
to TO O
progress VB O
through IN O
meiosis NN O
, , O
leading VBG O
to TO O
female JJ O
- : O
to TO O
- : O
male JJ O
sex NN O
reversal NN O
. . O

Adult NN O
mutants NNS O
became VBD O
sterile JJ O
males NNS O
due JJ O
to TO O
the DT O
meiotic JJ O
arrest NN O
of IN O
spermatocytes NNS O
, , O
which WDT O
then RB O
died VBD O
by IN O
apoptosis NN O
, , O
followed VBN O
by IN O
neoplastic JJ O
proliferation NN O
of IN O
gonad JJ O
somatic JJ O
cells NNS O
that WDT O
was VBD O
similar JJ O
to TO O
neoplasia NN O
observed VBD O
in IN O
ageing VBG O
dead JJ O
end NN O
( -LRB- O
dnd NN O
) -RRB- O
- : O
knockdown JJ O
males NNS O
, , O
which WDT O
lack VBP O
germ JJ O
cells NNS O
. . O

The DT O
construction NN O
of IN O
animals NNS O
doubly RB O
mutant JJ O
for IN O
brca2 NN O
and CC O
the DT O
apoptotic JJ O
gene NN O
tp53 NN O
( -LRB- O
p53 NN O
) -RRB- O
rescued VBN O
brca2 CD O
- : O
dependent JJ O
sex NN O
reversal NN O
. . O

Double NNP O
mutants NNS O
developed VBD O
oocytes NNS O
and CC O
became VBD O
sterile JJ O
females NNS O
that WDT O
produced VBD O
only RB O
aberrant JJ O
embryos NNS O
and CC O
showed VBD O
elevated JJ O
risk NN O
for IN O
invasive JJ O
ovarian JJ O
tumors NNS O
. . O

Oocytes NNS O
in IN O
double JJ O
- : O
mutant JJ O
females NNS O
showed VBD O
normal JJ O
localization NN O
of IN O
brca2 NN O
and CC O
pou5f1 VBD O
transcripts NNS O
to TO O
the DT O
animal NN O
pole NN O
and CC O
vasa NN O
transcripts NNS O
to TO O
the DT O
vegetal NN O
pole NN O
, , O
but CC O
had VBD O
a DT O
polarized JJ O
rather RB O
than IN O
symmetrical JJ O
nucleus NN O
with IN O
the DT O
distribution NN O
of IN O
nucleoli NNS O
and CC O
chromosomes NNS O
to TO O
opposite JJ O
nuclear JJ O
poles NNS O
; : O
this DT O
result NN O
revealed VBD O
a DT O
novel JJ O
role NN O
for IN O
Brca2 NNP O
in IN O
establishing VBG O
or CC O
maintaining VBG O
oocyte JJ O
nuclear JJ O
architecture NN O
. . O

Mutating VBG O
tp53 NN O
did VBD O
not RB O
rescue VB O
the DT O
infertility NN O
phenotype NN O
in IN O
brca2 NN O
mutant JJ O
males NNS O
, , O
suggesting VBG O
that IN O
brca2 NN O
plays VBZ O
an DT O
essential JJ O
role NN O
in IN O
zebrafish NN O
spermatogenesis NN O
. . O

Overall RB O
, , O
this DT O
work NN O
verified VBN O
zebrafish NN O
as IN O
a DT O
model NN O
for IN O
the DT O
role NN O
of IN O
Brca2 NNP O
in IN O
human JJ O
disease NN O
and CC O
uncovered VBD O
a DT O
novel JJ O
function NN O
of IN O
Brca2 NNP O
in IN O
vertebrate JJ O
oocyte JJ O
nuclear JJ O
architecture NN O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
Id NN O
- : O
1 CD O
by IN O
FGF NNP O
- : O
2 CD O
involves VBZ O
activity NN O
of IN O
EGR NNP O
- : O
1 CD O
and CC O
sensitizes VBZ O
neuroblastoma NN O
cells NNS O
to TO O
cell NN O
death NN O
. . O

Inhibitor NN O
of IN O
differentiation NN O
- : O
1 CD O
( -LRB- O
Id NN O
- : O
1 CD O
) -RRB- O
is VBZ O
a DT O
member NN O
of IN O
helix NN O
- : O
loop NN O
- : O
helix NN O
( -LRB- O
HLH NNP O
) -RRB- O
family NN O
of IN O
proteins NNS O
that WDT O
regulate VB O
gene NN O
transcription NN O
through IN O
their PRP$ O
inhibitory JJ O
binding NN O
to TO O
basic JJ O
- : O
HLH NNP O
transcription NN O
factors NNS O
. . O

Similarly RB O
to TO O
other JJ O
members NNS O
of IN O
this DT O
family NN O
, , O
Id NNP O
- : O
1 CD O
is VBZ O
involved VBN O
in IN O
the DT O
repression NN O
of IN O
cell NN O
differentiation NN O
and CC O
activation NN O
of IN O
cell NN O
growth NN O
. . O

The DT O
dual JJ O
function NN O
of IN O
Id NN O
- : O
1 CD O
, , O
inhibition NN O
of IN O
differentiation NN O
, , O
and CC O
stimulation NN O
of IN O
cell NN O
proliferation NN O
, , O
might MD O
be VB O
interdependent JJ O
, , O
as IN O
cell NN O
differentiation NN O
is VBZ O
generally RB O
coupled VBN O
with IN O
the DT O
exit NN O
from IN O
the DT O
cell NN O
cycle NN O
. . O

Fibroblast JJ O
growth NN O
factor NN O
- : O
2 CD O
( -LRB- O
FGF NN O
- : O
2 CD O
) -RRB- O
has VBZ O
been VBN O
reported VBN O
to TO O
play VB O
multiple JJ O
roles NNS O
in IN O
different JJ O
biological JJ O
processes NNS O
during IN O
development NN O
of IN O
the DT O
central JJ O
nervous JJ O
system NN O
( -LRB- O
CNS NNP O
) -RRB- O
. . O

In IN O
addition NN O
, , O
FGF NNP O
- : O
2 CD O
has VBZ O
been VBN O
described VBN O
to TO O
induce VB O
" `` O
neuronal JJ O
- : O
like IN O
" `` O
differentiation NN O
and CC O
trigger NN O
apoptosis NN O
in IN O
neuroblastoma NN O
SK JJ B-NP
- : I-NP
N NNP I-NP
- : I-NP
MC NNP I-NP
cells NNS O
. . O

Although IN O
regulation NN O
of IN O
Id NN O
- : O
1 CD O
protein NN O
by IN O
several JJ O
mitogenic JJ O
factors NNS O
is VBZ O
well RB O
- : O
established VBN O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
role NN O
of IN O
FGF NNP O
- : O
2 CD O
in IN O
the DT O
regulation NN O
of IN O
Id NN O
- : O
1 CD O
. . O

Using VBG O
human JJ O
neuroblastoma NN O
cell NN O
line NN O
, , O
SK JJ B-NP
- : I-NP
N NNP I-NP
- : I-NP
MC NNP I-NP
, , O
we PRP O
found VBD O
that IN O
treatment NN O
of IN O
these DT O
cells NNS O
with IN O
FGF NNP O
- : O
2 CD O
resulted VBN O
in IN O
early JJ O
induction NN O
of IN O
both DT O
Id NN O
- : O
1 CD O
mRNA NN O
and CC O
protein NN O
. . O

The DT O
induction NN O
occurs VBZ O
within IN O
1 CD O
h NN O
from IN O
FGF NNP O
- : O
2 CD O
treatment NN O
and CC O
is VBZ O
mediated VBN O
by IN O
ERK1 NNP O
/ NNP O
2 CD O
pathway NN O
, , O
which WDT O
in IN O
turn NN O
stimulates NNS O
expression NN O
of IN O
the DT O
early JJ O
growth NN O
response NN O
- : O
1 CD O
( -LRB- O
Egr NNP O
- : O
1 CD O
) -RRB- O
transcription NN O
factor NN O
. . O

We PRP O
also RB O
demonstrate VBP O
direct JJ O
interaction NN O
of IN O
Egr NNP O
- : O
1 CD O
with IN O
Id NN O
- : O
1 CD O
promoter NN O
in IN O
vitro NN O
and CC O
in IN O
cell NN O
culture NN O
. . O

Finally RB O
, , O
inhibition NN O
of IN O
Id NN O
- : O
1 CD O
expression NN O
results NNS O
in IN O
G NNP O
( -LRB- O
2 CD O
) -RRB- O
/ NN O
M NNP O
accumulation NN O
of IN O
FGF NNP O
- : O
2 LS O
- : O
treated VBN O
cells NNS O
and CC O
delayed VBN O
cell NN O
death NN O
. . O

-DOCSTART- X X O

Vimentin NNP O
is VBZ O
preferentially RB O
expressed VBN O
in IN O
human JJ O
breast NN O
carcinomas NNS O
with IN O
low JJ O
estrogen NN O
receptor NN O
and CC O
high JJ O
Ki FW O
- : O
67 CD O
growth NN O
fraction NN O
. . O

Vimentin NNP O
expression NN O
, , O
growth NN O
fractions NNS O
( -LRB- O
GF NN O
) -RRB- O
, , O
and CC O
estrogen NN O
receptor NN O
( -LRB- O
ER NN O
) -RRB- O
levels NNS O
were VBD O
determined VBN O
for IN O
90 CD O
untreated JJ O
primary JJ O
breast NN O
carcinomas NNS O
. . O

Coexpression NNP O
of IN O
keratin NN O
and CC O
vimentin NN O
was VBD O
found VBN O
in IN O
approximately RB O
20 CD O
% NN O
of IN O
the DT O
tumors NNS O
regardless RB O
of IN O
menopausal JJ O
status NN O
. . O

Vimentin NNP O
was VBD O
expressed VBN O
preferentially RB O
in IN O
tumor NN O
cells NNS O
of IN O
high JJ O
- : O
grade NN O
ductal JJ O
breast NN O
carcinomas NNS O
( -LRB- O
15 CD O
of IN O
28 CD O
histologic NN O
grade NN O
3 CD O
vs NN O
. . O
0 CD O
of IN O
40 CD O
grades NNS O
1 CD O
and CC O
2 CD O
) -RRB- O
. . O

Vimentin NNP O
expression NN O
was VBD O
found VBN O
preferentially RB O
in IN O
tumors NNS O
with IN O
high JJ O
GF NN O
( -LRB- O
greater JJR O
than IN O
15 CD O
% NN O
Ki NNP O
- : O
67 CD O
positive JJ O
by IN O
immunoperoxidase JJ O
staining NN O
) -RRB- O
and CC O
low JJ O
ER NN O
levels NNS O
( -LRB- O
less RBR O
than IN O
60 CD O
fmols NNS O
/ IN O
mg JJ O
protein NN O
by IN O
a DT O
monoclonal JJ O
enzyme JJ O
immunoassay NN O
) -RRB- O
. . O

Sixty CD O
- : O
eight CD O
percent NN O
of IN O
tumors NNS O
in IN O
this DT O
group NN O
were VBD O
vimentin RB O
positive JJ O
and CC O
88 CD O
% NN O
of IN O
all DT O
vimentin NN O
- : O
positive JJ O
tumors NNS O
fell VBD O
into IN O
this DT O
category NN O
. . O

More JJR O
than IN O
50 CD O
% NN O
of IN O
the DT O
tumor NN O
cells NNS O
coexpressed VBN O
vimentin RB O
and CC O
keratin NN O
. . O

Thus RB O
, , O
vimentin IN O
expression NN O
may MD O
be VB O
helpful JJ O
in IN O
identifying VBG O
a DT O
substantial JJ O
subset NN O
of IN O
ER NNP O
- : O
independent JJ O
breast NN O
carcinomas NNS O
with IN O
poor JJ O
prognostic JJ O
indicators NNS O
. . O

-DOCSTART- X X O

High NNP O
- : O
mobility NN O
group NN O
A2 IN O
protein NN O
modulates NNS O
hTERT VBP O
transcription NN O
to TO O
promote VB O
tumorigenesis NN O
. . O

The DT O
high JJ O
- : O
mobility NN O
group NN O
A2 NNP O
gene NN O
( -LRB- O
HMGA2 CD O
) -RRB- O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
frequently RB O
amplified VBN O
genes NNS O
in IN O
human JJ O
cancers NNS O
. . O

However RB O
, , O
functions NNS O
of IN O
HMGA2 NN O
in IN O
tumorigenesis NN O
are VBP O
not RB O
fully RB O
understood VBN O
due JJ O
to TO O
limited JJ O
knowledge NN O
of IN O
its PRP$ O
targets NNS O
in IN O
tumor NN O
cells NNS O
. . O

Our PRP$ O
study NN O
reveals VBZ O
a DT O
novel NN O
link NN O
between IN O
HMGA2 NNP O
and CC O
the DT O
regulation NN O
of IN O
human NN O
telomerase NN O
reverse NN O
transcriptase NN O
( -LRB- O
hTERT NN O
) -RRB- O
, , O
the DT O
catalytic JJ O
subunit NN O
of IN O
telomerase NN O
, , O
which WDT O
offers VBZ O
critical JJ O
insight NN O
into IN O
how WRB O
HMGA2 PRP O
contributes VBZ O
to TO O
tumorigenesis VB O
. . O

The DT O
expression NN O
of IN O
HMGA2 NNP O
modulates VBZ O
the DT O
expression NN O
of IN O
hTERT NN O
, , O
resulting VBG O
in IN O
cells NNS O
with IN O
enhanced JJ O
telomerase NN O
activities NNS O
and CC O
increased VBD O
telomere JJ O
length NN O
. . O

Treatment NNP O
with IN O
suberoylanilide NN O
hydroxamide NN O
( -LRB- O
SAHA NNP O
) -RRB- O
, , O
a DT O
histone NN O
deacetylase NN O
( -LRB- O
HDAC NNP O
) -RRB- O
inhibitor NN O
, , O
causes VBZ O
dose NN O
- : O
dependent JJ O
hTERT JJ O
reporter NN O
activation NN O
, , O
mimicking VBG O
HMGA2 IN O
overexpression NN O
. . O

By IN O
interacting VBG O
with IN O
Sp1 NNP O
, , O
HMGA2 NNP O
interferes VBZ O
with IN O
the DT O
recruitment NN O
of IN O
HDAC2 NNP O
to TO O
the DT O
hTERT JJ O
proximal JJ O
promoter NN O
, , O
enhancing VBG O
localized VBN O
histone NN O
H3 IN O
- : O
K9 IN O
acetylation NN O
and CC O
thereby RB O
stimulating VBG O
hTERT JJ O
expression NN O
and CC O
telomerase NN O
activity NN O
. . O

Moreover RB O
, , O
HMGA2 IN O
knockdown VBN O
by IN O
short JJ O
hairpin NN O
HMGA2 . O
in IN O
HepG2 CD B-NP
cells NNS O
leads VBZ O
to TO O
progressive JJ O
telomere JJ O
shortening NN O
and CC O
a DT O
concurrent JJ O
decrease NN O
of IN O
steady JJ O
- : O
state NN O
hTERT NN O
mRNA NN O
levels NNS O
, , O
attenuating VBG O
their PRP$ O
ability NN O
to TO O
form VB O
colonies NNS O
in IN O
soft JJ O
agar NN O
. . O

Importantly RB O
, , O
HMGA2 NNP O
partially RB O
replaces VBZ O
the DT O
function NN O
of IN O
hTERT NN O
during IN O
the DT O
tumorigenic JJ O
transformation NN O
of IN O
normal JJ O
human JJ O
fibroblasts NNS O
. . O

These DT O
findings NNS O
are VBP O
potentially RB O
clinically RB O
relevant JJ O
, , O
because IN O
HMGA2 NNP O
expression NN O
is VBZ O
reported VBN O
to TO O
be VB O
upregulated VBN O
in IN O
a DT O
number NN O
of IN O
human JJ O
cancers NNS O
as IN O
telomere JJ O
maintenance NN O
is VBZ O
essential JJ O
for IN O
tumorigenesis NN O
. . O

-DOCSTART- X X O

3 LS O
- : O
[ NN O
( -LRB- O
Methyl NNP O
- : O
carbamo NN O
- : O
yl NN O
) -RRB- O
amino IN O
] SYM O
- : O
1H VB O
- : O
isoindolium NN O
chloride NN O
. . O

The DT O
title NN O
compound JJ O
, , O
C NNP O
( -LRB- O
10 CD O
) -RRB- O
H NNP O
( -LRB- O
12 CD O
) -RRB- O
N NNP O
( -LRB- O
3 CD O
) -RRB- O
O UH O
( -LRB- O
+ NN O
) -RRB- O
. . O
Cl NNP O
( -LRB- O
- : O
) -RRB- O
, , O
is VBZ O
a DT O
derivative JJ O
of IN O
o IN O
- : O
phthaldehyde NN O
and CC O
methyl NN O
- : O
thio SYM O
- : O
urea NN O
. . O

The DT O
mol NN O
- : O
ecules NNS O
form VBP O
dimers NNS O
through IN O
intra JJ O
- : O
and CC O
inter NN O
- : O
molecular JJ O
N NNP O
- : O
H NNP O
. . O
. . O
. . O
O UH O
hydrogen NN O
bonds NNS O
. . O

The DT O
dimers NNS O
are VBP O
further RB O
linked VBN O
into IN O
chains NNS O
through IN O
one CD O
C LS O
- : O
H NNP O
. . O
. . O
. . O
Cl NNP O
and CC O
two CD O
N NNP O
- : O
H NNP O
. . O
. . O
. . O
Cl NNP O
hydrogen NN O
bonds NNS O
. . O

-DOCSTART- X X O

mirAct NN O
: : O
a DT O
web NN O
tool NN O
for IN O
evaluating VBG O
microRNA NN O
activity NN O
based VBN O
on IN O
gene NN O
expression NN O
data NNS O
. . O

MicroRNAs NNP O
( -LRB- O
miRNAs NN O
) -RRB- O
are VBP O
critical JJ O
regulators NNS O
in IN O
the DT O
complex JJ O
cellular JJ O
networks NNS O
. . O

The DT O
mirAct JJ O
web NN O
server NN O
( -LRB- O
http NN O
: : O
/ NN O
/ NN O
sysbio NN O
. . O
ustc NN O
. . O
edu NN O
. . O
cn '' O
/ VBZ O
software NN O
/ JJ O
mirAct NN O
) -RRB- O
is VBZ O
a DT O
tool NN O
designed VBN O
to TO O
investigate VB O
miRNA NN O
activity NN O
based VBN O
on IN O
gene NN O
- : O
expression NN O
data NNS O
by IN O
using VBG O
the DT O
negative JJ O
regulation NN O
relationship NN O
between IN O
miRNAs NNS O
and CC O
their PRP$ O
target NN O
genes NNS O
. . O

mirAct NN O
supports VBZ O
multiple JJ O
- : O
class NN O
data NNS O
and CC O
enables VBZ O
clustering VBG O
analysis NN O
based VBN O
on IN O
computationally RB O
determined VBN O
miRNA NN O
activity NN O
. . O

Here RB O
, , O
we PRP O
describe VBP O
the DT O
framework NN O
of IN O
mirAct NN O
, , O
demonstrate VB O
its PRP$ O
performance NN O
by IN O
comparing VBG O
with IN O
other JJ O
similar JJ O
programs NNS O
and CC O
exemplify VB O
its PRP$ O
applications NNS O
using VBG O
case NN O
studies NNS O
. . O

-DOCSTART- X X O

Non FW O
- : O
heart NN O
- : O
beating VBG O
organ NN O
donation NN O
in IN O
Italy NNP O
. . O

In IN O
2007 CD O
the DT O
non FW O
- : O
heart NN O
- : O
beating VBG O
organ NN O
donation NN O
( -LRB- O
NHBD NNP O
) -RRB- O
" `` O
Programma FW O
Alba NNP O
" '' O
( -LRB- O
Sunrise NN O
Programme NN O
) -RRB- O
started VBN O
in IN O
Pavia NNP O
, , O
Italy NNP O
. . O

The DT O
initial JJ O
plan NN O
was VBD O
to TO O
cut VB O
down RP O
waiting VBG O
list NN O
for IN O
kidney NN O
transplantation NN O
, , O
while IN O
its PRP$ O
final JJ O
aim NN O
is VBZ O
to TO O
shorten VB O
organ NN O
transplantation NN O
waiting VBG O
lists NNS O
. . O

When WRB O
compared VBN O
to TO O
European JJ O
countries NNS O
and CC O
the DT O
USA NNP O
, , O
the DT O
Italian JJ O
NHBD NNP O
program NN O
has VBZ O
taken VBN O
longer RB O
to TO O
get VB O
established VBN O
. . O

Initially RB O
Italian JJ O
physicians NNS O
were VBD O
not RB O
entirely RB O
aware JJ O
of IN O
the DT O
NHBD NNP O
organ NN O
viability NN O
for IN O
transplantation NN O
, , O
furthermore RB O
ethical JJ O
issues NNS O
and CC O
the DT O
need NN O
to TO O
regulate VB O
medical JJ O
requirements NNS O
to TO O
Italian JJ O
law NN O
slowed VBD O
down IN O
the DT O
NHBD NNP O
program NN O
. . O

In IN O
particular JJ O
, , O
Italian JJ O
legislation NN O
provides VBZ O
for IN O
death NN O
ascertainment NN O
after IN O
irreversible JJ O
cardiac NN O
arrest NN O
, , O
20 CD O
- : O
minute NN O
flat JJ O
electrocardiogram NN O
. . O

This DT O
no DT O
- : O
touch NN O
period NN O
is VBZ O
longer RBR O
when WRB O
compared VBN O
to TO O
worldwide JJ O
legislation NN O
, , O
and CC O
organ NN O
viability NN O
has VBZ O
been VBN O
a DT O
main JJ O
concern NN O
for IN O
Italian NNP O
transplant NN O
doctors NNS O
over IN O
the DT O
years NNS O
. . O

However RB O
, , O
recent JJ O
data NNS O
let VB O
up RP O
to TO O
40 CD O
- : O
minute NN O
warm JJ O
ischemia NN O
time NN O
to TO O
preserve VB O
organ NN O
viability NN O
; : O
this DT O
has VBZ O
encouraged VBN O
Pavia NNP O
' POS O
s PRP O
group NN O
to TO O
establish VB O
the DT O
NHBD NNP O
" `` O
Programma FW O
Alba NNP O
" '' O
. . O

It PRP O
was VBD O
designed VBN O
according VBG O
to TO O
Italian JJ O
legislation NN O
from IN O
death NN O
diagnosis NN O
to TO O
graft VB O
placement NN O
, , O
from IN O
this DT O
perspective NN O
must MD O
the DT O
significant JJ O
role NN O
of IN O
the DT O
Transplant NNP O
coordinator NN O
be VB O
recognized VBN O
. . O

Since IN O
2007 CD O
seven CD O
kidneys NNS O
have VBP O
been VBN O
gathered VBN O
from IN O
seven CD O
NHBD NNP O
. . O

Of IN O
these DT O
, , O
six CD O
NHBD NNP O
kidneys NNS O
have VBP O
been VBN O
transplanted VBN O
. . O

Currently RB O
, , O
four CD O
patients NNS O
are VBP O
out IN O
of IN O
dialysis NN O
. . O

This DT O
report NN O
is VBZ O
a DT O
detailed JJ O
description NN O
of IN O
NHBD NNP O
" '' O
Programma NNP O
Alba NNP O
" '' O
and CC O
its PRP$ O
preliminary JJ O
results NNS O
. . O

-DOCSTART- X X O

KISS1 NNP O
methylation NN O
and CC O
expression NN O
as IN O
tumor NN O
stratification NN O
biomarkers NNS O
and CC O
clinical JJ O
outcome NN O
prognosticators NNS O
for IN O
bladder NN O
cancer NN O
patients NNS O
. . O

KISS1 NNP O
is VBZ O
a DT O
metastasis NN O
suppressor NN O
gene NN O
that WDT O
is VBZ O
lost VBN O
in IN O
several JJ O
malignancies NNS O
, , O
including VBG O
bladder NN O
cancer NN O
. . O

We PRP O
tested VBD O
the DT O
epigenetic JJ O
silencing NN O
hypothesis NN O
and CC O
evaluated VBN O
the DT O
biological JJ O
influence NN O
of IN O
KISS1 NNP O
methylation NN O
on IN O
its PRP$ O
expression NN O
and CC O
clinical JJ O
relevance NN O
in IN O
bladder NN O
cancer NN O
. . O

KISS1 NNP O
hypermethylation NN O
was VBD O
frequent JJ O
in IN O
bladder NN O
cancer NN O
cells NNS O
analyzed VBN O
by IN O
methylation NN O
- : O
specific JJ O
PCR NN O
and CC O
bisulfite NN O
sequencing NN O
and CC O
was VBD O
associated VBN O
with IN O
low JJ O
gene NN O
expression NN O
, , O
being VBG O
restored VBN O
in IN O
vitro NN O
by IN O
demethylating VBG O
azacytidine NN O
. . O

Hypermethylation NNP O
was VBD O
also RB O
frequently RB O
observed VBN O
in IN O
a DT O
large JJ O
series NN O
of IN O
bladder NN O
tumors NNS O
( -LRB- O
83 CD O
. . O
1 CD O
% NN O
, , O
n RB O
= SYM O
804 CD O
) -RRB- O
. . O

KISS1 NNP O
methylation NN O
was VBD O
associated VBN O
with IN O
increasing VBG O
stage NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
001 CD O
) -RRB- O
and CC O
tumor NN O
grade NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
010 CD O
) -RRB- O
. . O

KISS1 NNP O
methylation NN O
was VBD O
associated VBN O
with IN O
low JJ O
KISS1 NNP O
transcript NN O
expression NN O
by IN O
quantitative JJ O
RT NNP O
- : O
PCR NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
037 CD O
) -RRB- O
. . O

KISS1 DT O
transcript NN O
expression NN O
was VBD O
also RB O
associated VBN O
with IN O
histopathological JJ O
tumor NN O
stage NN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
0005 CD O
) -RRB- O
. . O

Low NNP O
transcript NN O
expression NN O
alone RB O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
003 CD O
) -RRB- O
or CC O
combined VBN O
with IN O
methylation NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
019 CD O
) -RRB- O
was VBD O
associated VBN O
with IN O
poor JJ O
disease NN O
- : O
specific JJ O
survival NN O
( -LRB- O
n RB O
= SYM O
205 CD O
) -RRB- O
. . O

KISS1 DT O
transcript NN O
expression NN O
remained VBD O
an DT O
independent JJ O
prognosticator NN O
in IN O
multivariate JJ O
analyses NNS O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
017 CD O
) -RRB- O
. . O

KISS1 NNP O
hypermethylation NN O
was VBD O
identified VBN O
in IN O
bladder NN O
cancer NN O
, , O
providing VBG O
a DT O
potential JJ O
mechanistic JJ O
explanation NN O
( -LRB- O
epigenetic JJ O
silencing NN O
) -RRB- O
for IN O
the DT O
observed JJ O
loss NN O
of IN O
KISS1 NNP O
in IN O
uroepithelial JJ O
malignancies NNS O
. . O

Associations NNP O
of IN O
KISS1 NNP O
methylation NN O
and CC O
its PRP$ O
expression NN O
with IN O
histopathological JJ O
variables NNS O
and CC O
poor JJ O
survival NN O
suggest VBP O
the DT O
utility NN O
of IN O
incorporating VBG O
KISS1 NNP O
measurement NN O
using VBG O
paraffin NN O
- : O
embedded VBN O
material NN O
for IN O
tumor NN O
stratification NN O
and CC O
clinical JJ O
outcome NN O
prognosis NN O
of IN O
patients NNS O
with IN O
uroepithelial JJ O
neoplasias NNS O
. . O

-DOCSTART- X X O

Oscillatory NNP O
alpha NN O
- : O
band NN O
mechanisms NNS O
and CC O
the DT O
deployment NN O
of IN O
spatial JJ O
attention NN O
to TO O
anticipated JJ O
auditory NN O
and CC O
visual JJ O
target NN O
locations NNS O
: : O
supramodal JJ O
or CC O
sensory JJ O
- : O
specific JJ O
control NN O
mechanisms NNS O
? . O

Oscillatory NNP O
alpha NN O
- : O
band NN O
activity NN O
( -LRB- O
8 CD O
- : O
15 CD O
Hz NN O
) -RRB- O
over IN O
parieto NN O
- : O
occipital NN O
cortex NN O
in IN O
humans NNS O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
suppression NN O
of IN O
processing VBG O
for IN O
inputs NNS O
at IN O
to TO O
- : O
be VB O
- : O
ignored VBN O
regions NNS O
of IN O
space NN O
, , O
with IN O
increased VBN O
alpha NN O
- : O
band NN O
power NN O
observed VBN O
over IN O
cortex JJ O
contralateral JJ O
to TO O
locations NNS O
expected VBN O
to TO O
contain VB O
distractors NNS O
. . O

It PRP O
is VBZ O
unclear JJ O
whether IN O
similar JJ O
processes NNS O
operate VBP O
during IN O
deployment NN O
of IN O
spatial JJ O
attention NN O
in IN O
other JJ O
sensory JJ O
modalities NNS O
. . O

Evidence NN O
from IN O
lesion NN O
patients NNS O
suggests VBZ O
that IN O
parietal NN O
regions NNS O
house NN O
supramodal JJ O
representations NNS O
of IN O
space NN O
. . O

The DT O
parietal NN O
lobes NNS O
are VBP O
prominent JJ O
generators NNS O
of IN O
alpha NN O
oscillations NNS O
, , O
raising VBG O
the DT O
possibility NN O
that IN O
alpha NN O
is VBZ O
a DT O
neural JJ O
signature NN O
of IN O
supramodal NN O
spatial JJ O
attention NN O
. . O

Furthermore RB O
, , O
when WRB O
spatial JJ O
attention NN O
is VBZ O
deployed VBN O
within IN O
vision NN O
, , O
processing NN O
of IN O
task NN O
- : O
irrelevant JJ O
auditory NN O
inputs NNS O
at IN O
attended VBN O
locations NNS O
is VBZ O
also RB O
enhanced VBN O
, , O
pointing VBG O
to TO O
automatic JJ O
links NNS O
between IN O
spatial JJ O
deployments NNS O
across IN O
senses NNS O
. . O

Here RB O
, , O
we PRP O
asked VBD O
whether IN O
lateralized JJ O
alpha NN O
- : O
band NN O
activity NN O
is VBZ O
also RB O
evident JJ O
in IN O
a DT O
purely RB O
auditory JJ O
spatial JJ O
- : O
cueing NN O
task NN O
and CC O
whether IN O
it PRP O
had VBD O
the DT O
same JJ O
underlying JJ O
generator NN O
configuration NN O
as IN O
in IN O
a DT O
purely RB O
visuospatial JJ O
task NN O
. . O

If IN O
common JJ O
to TO O
both DT O
sensory JJ O
systems NNS O
, , O
this DT O
would MD O
provide VB O
strong JJ O
support NN O
for IN O
" `` O
supramodal JJ O
" '' O
attention NN O
theory NN O
. . O

Alternately RB O
, , O
alpha NN O
- : O
band NN O
differences NNS O
between IN O
auditory JJ O
and CC O
visual JJ O
tasks NNS O
would MD O
support VB O
a DT O
sensory JJ O
- : O
specific JJ O
account NN O
. . O

Lateralized JJ O
shifts NNS O
in IN O
alpha NN O
- : O
band NN O
activity NN O
were VBD O
indeed RB O
observed VBN O
during IN O
a DT O
purely RB O
auditory JJ O
spatial JJ O
task NN O
. . O

Crucially RB O
, , O
there EX O
were VBD O
clear JJ O
differences NNS O
in IN O
scalp NN O
topographies NNS O
of IN O
this DT O
alpha NN O
activity NN O
depending VBG O
on IN O
the DT O
sensory JJ O
system NN O
within IN O
which WDT O
spatial JJ O
attention NN O
was VBD O
deployed VBN O
. . O

Findings NNS O
suggest VBP O
that IN O
parietally RB O
generated VBN O
alpha NN O
- : O
band NN O
mechanisms NNS O
are VBP O
central JJ O
to TO O
attentional JJ O
deployments NNS O
across IN O
modalities NNS O
but CC O
that IN O
they PRP O
are VBP O
invoked VBN O
in IN O
a DT O
sensory JJ O
- : O
specific JJ O
manner NN O
. . O

The DT O
data NNS O
support VBP O
an DT O
" `` O
interactivity NN O
account NN O
, , O
" '' O
whereby WRB O
a DT O
supramodal NN O
system NN O
interacts NNS O
with IN O
sensory JJ O
- : O
specific JJ O
control NN O
systems NNS O
during IN O
deployment NN O
of IN O
spatial JJ O
attention NN O
. . O

-DOCSTART- X X O

[ JJ O
Expression NNP O
of IN O
Merlin NNP O
protein NN O
in IN O
non JJ O
- : O
small JJ O
cell NN O
lung NN O
carcinoma NN O
and CC O
the DT O
clinical JJ O
significance NN O
] NN O
. . O

OBJECTIVE CD O
: : O
To TO O
determine VB O
the DT O
expression NN O
and CC O
clinical JJ O
significance NN O
of IN O
Merlin NNP O
protein NN O
in IN O
non JJ O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
( -LRB- O
NSCLC NNP O
) -RRB- O
. . O

METHODS NNP O
: : O
The DT O
expression NN O
of IN O
Merlin NNP O
protein NN O
in IN O
45 CD O
cases NNS O
of IN O
NSCLC NNP O
and CC O
adjacent JJ O
tissue NN O
of IN O
NSCLC NNP O
and CC O
normal JJ O
lung NN O
tissue NN O
was VBD O
checked VBN O
by IN O
immunohistochemistry NN O
. . O

The DT O
relation NN O
between IN O
the DT O
expression NN O
of IN O
Merlin NNP O
protein NN O
and CC O
the DT O
multiple JJ O
factors NNS O
of IN O
pathological JJ O
type NN O
, , O
gender NN O
, , O
P NNP O
- : O
TNM NNP O
stage NN O
, , O
differentiation NN O
and CC O
lymph NN O
node NN O
metastasis NN O
was VBD O
analyzed VBN O
. . O

RESULTS NNS O
: : O
The DT O
expression NN O
rates NNS O
of IN O
Merlin NNP O
protein NN O
in IN O
NSCLC NNP O
and CC O
normal JJ O
lung NN O
tissue NN O
sections NNS O
were VBD O
73 CD O
. . O
33 CD O
% NN O
and CC O
15 CD O
. . O
56 CD O
% NN O
, , O
respectively RB O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

The DT O
expression NN O
of IN O
Merlin NNP O
protein NN O
was VBD O
not RB O
associated VBN O
with IN O
the DT O
pathological JJ O
type NN O
, , O
gender NN O
, , O
P NNP O
- : O
TNM NNP O
stage NN O
, , O
differentiation NN O
and CC O
lymph NN O
node NN O
metastasis NN O
( -LRB- O
P NNP O
> NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

CONCLUSION NN O
: : O
Merlin NNP O
protein NN O
might MD O
contribute VB O
to TO O
the DT O
initiation NN O
of IN O
metastasis NN O
of IN O
NSCLC NNP O
. . O

-DOCSTART- X X O

The DT O
members NNS O
of IN O
an DT O
Epstein NNP O
- : O
Barr NNP O
virus NN O
microRNA NN O
cluster NN O
cooperate VBP O
to TO O
transform VB O
B NNP O
lymphocytes NNS O
. . O

Epstein NNP O
- : O
Barr NNP O
virus NN O
( -LRB- O
EBV NN O
) -RRB- O
transforms VBZ O
B NNP O
lymphocytes NNS O
through IN O
the DT O
expression NN O
of IN O
the DT O
latent JJ O
viral JJ O
proteins NNS O
EBNA NNP O
and CC O
latent JJ O
membrane NN O
protein NN O
( -LRB- O
LMP NNP O
) -RRB- O
. . O

Recently RB O
, , O
it PRP O
has VBZ O
become VBN O
apparent JJ O
that IN O
microRNAs NNS O
( -LRB- O
miRNAs NN O
) -RRB- O
also RB O
contribute VBP O
to TO O
EBV NNP O
' POS O
s PRP O
oncogenic JJ O
properties NNS O
; : O
recombinant JJ O
EBVs NNS O
that WDT O
lack VBP O
the DT O
BHRF1 NNP O
miRNA NN O
cluster NN O
display NN O
a DT O
reduced VBN O
ability NN O
to TO O
transform VB O
B NNP O
lymphocytes NNS O
in IN O
vitro NN O
. . O

Furthermore RB O
, , O
infected JJ O
cells NNS O
evince IN O
a DT O
marked JJ O
upregulation NN O
of IN O
the DT O
EBNA NNP O
genes NNS O
. . O

Using VBG O
recombinant JJ O
viruses NNS O
that WDT O
lack VBP O
only RB O
one CD O
member NN O
of IN O
the DT O
cluster NN O
, , O
we PRP O
now RB O
show VBP O
that IN O
all DT O
three CD O
BHRF1 CD O
miRNAs NNS O
contribute VBP O
to TO O
B NNP O
- : O
cell NN O
transformation NN O
. . O

Recombinants NNS O
that WDT O
lacked VBD O
miR NN O
- : O
BHRF1 CD O
- : O
2 CD O
or CC O
miR CD O
- : O
BHRF1 CD O
- : O
3 CD O
displayed VBN O
enhanced VBN O
EBNA NNS O
expression NN O
initiated VBN O
at IN O
the DT O
Cp NNP O
and CC O
Wp NNP O
promoters NNS O
. . O

Interestingly RB O
, , O
we PRP O
find VBP O
that IN O
the DT O
deletion NN O
of IN O
miR NN O
- : O
BHRF1 CD O
- : O
2 CD O
reduced VBN O
the DT O
expression NN O
level NN O
of IN O
miR NN O
- : O
BHRF1 SYM O
- : O
3 CD O
and CC O
possibly RB O
that IN O
of IN O
miR NN O
- : O
BHRF1 SYM O
- : O
1 CD O
, , O
demonstrating VBG O
that IN O
the DT O
expression NN O
of IN O
one CD O
miRNA NN O
can MD O
potentiate VB O
the DT O
expression NN O
of IN O
other JJ O
miRNAs NNS O
located VBN O
in IN O
the DT O
same JJ O
cluster NN O
. . O

Therefore RB O
, , O
the DT O
phenotypic JJ O
traits NNS O
of IN O
the DT O
miR NN O
- : O
BHRF1 CD O
- : O
2 CD O
null JJ O
mutant NN O
could MD O
result VB O
partly RB O
from IN O
reduced VBN O
miR NN O
- : O
BHRF1 SYM O
- : O
1 CD O
and CC O
miR CD O
- : O
BHRF1 CD O
- : O
3 CD O
expression NN O
levels NNS O
. . O

Nevertheless RB O
, , O
using VBG O
an DT O
miR NN O
- : O
BHRF1 SYM O
- : O
1 CD O
and CC O
miR CD O
- : O
BHRF1 CD O
- : O
3 CD O
double JJ O
mutant NN O
, , O
we PRP O
could MD O
directly RB O
assess VB O
and CC O
confirm VB O
the DT O
contribution NN O
of IN O
miR NN O
- : O
BHRF1 CD O
- : O
2 CD O
to TO O
B LS O
- : O
cell NN O
transformation NN O
. . O

Furthermore RB O
, , O
we PRP O
found VBD O
that IN O
the DT O
potentiating JJ O
effect NN O
of IN O
miR NN O
- : O
BHRF1 CD O
- : O
2 CD O
on IN O
miR NN O
- : O
BHRF1 SYM O
- : O
3 CD O
synthesis NN O
can MD O
be VB O
reproduced VBN O
with IN O
simple JJ O
expression NN O
plasmids NNS O
, , O
provided VBN O
that IN O
both DT O
miRNAs NNS O
are VBP O
processed VBN O
from IN O
the DT O
same JJ O
transcript NN O
. . O

Therefore RB O
, , O
this DT O
enhancing NN O
effect NN O
does VBZ O
not RB O
result VB O
from IN O
an DT O
idiosyncrasy NN O
of IN O
the DT O
EBV NNP O
genome NN O
but CC O
rather RB O
reflects VBZ O
a DT O
general JJ O
property NN O
of IN O
these DT O
miRNAs NNS O
. . O

This DT O
study NN O
highlights IN O
the DT O
advantages NNS O
of IN O
arranging VBG O
the DT O
BHRF1 NNP O
miRNAs NN O
in IN O
clusters NNS O
: : O
it PRP O
allows VBZ O
the DT O
synchronous JJ O
and CC O
synergistic JJ O
expression NN O
of IN O
genetic JJ O
elements NNS O
that WDT O
cooperate VBP O
to TO O
transform VB O
their PRP$ O
target NN O
cells NNS O
. . O

-DOCSTART- X X O

Hedgehog NNP O
signaling VBG O
: : O
networking VBG O
to TO O
nurture VB O
a DT O
promalignant JJ O
tumor NN O
microenvironment NN O
. . O

In IN O
addition NN O
to TO O
its PRP$ O
role NN O
in IN O
embryonic JJ O
development NN O
, , O
the DT O
Hedgehog NNP O
pathway NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
an DT O
active JJ O
participant NN O
in IN O
cancer NN O
development NN O
, , O
progression NN O
, , O
and CC O
metastasis NN O
. . O

Although IN O
this DT O
pathway NN O
is VBZ O
activated VBN O
by IN O
autocrine NN O
signaling VBG O
by IN O
Hedgehog NNP O
ligands NNS O
, , O
it PRP O
can MD O
also RB O
initiate VB O
paracrine NN O
signaling VBG O
with IN O
cells NNS O
in IN O
the DT O
microenvironment NN O
. . O

This DT O
creates VBZ O
a DT O
network NN O
of IN O
Hedgehog NNP O
signaling NN O
that WDT O
determines VBZ O
the DT O
malignant JJ O
behavior NN O
of IN O
the DT O
tumor NN O
cells NNS O
. . O

As IN O
a DT O
result NN O
of IN O
paracrine NN O
signal NN O
transmission NN O
, , O
the DT O
effects NNS O
of IN O
Hedgehog NNP O
signaling VBG O
most JJS O
profoundly RB O
influence VB O
the DT O
stromal JJ O
cells NNS O
that WDT O
constitute VBP O
the DT O
tumor NN O
microenvironment NN O
. . O

The DT O
stromal JJ O
cells NNS O
in IN O
turn NN O
produce VBP O
factors NNS O
that WDT O
nurture NN O
the DT O
tumor NN O
. . O

Thus RB O
, , O
such JJ O
a DT O
resonating NN O
cross NN O
- : O
talk NN O
can MD O
amplify VB O
Hedgehog NNP O
signaling VBG O
, , O
resulting VBG O
in IN O
molecular JJ O
chatter NN O
that IN O
overall JJ O
promotes NNS O
tumor NN O
progression NN O
. . O

Inhibitors NNS O
of IN O
Hedgehog NNP O
signaling NN O
have VBP O
been VBN O
the DT O
subject NN O
of IN O
intense JJ O
research NN O
. . O

Several JJ O
of IN O
these DT O
inhibitors NNS O
are VBP O
currently RB O
being VBG O
evaluated VBN O
in IN O
clinical JJ O
trials NNS O
. . O

Here RB O
, , O
we PRP O
review VBP O
the DT O
role NN O
of IN O
the DT O
Hedgehog NNP O
pathway NN O
in IN O
the DT O
signature NN O
characteristics NNS O
of IN O
cancer NN O
cells NNS O
that WDT O
determine VBP O
tumor NN O
development NN O
, , O
progression NN O
, , O
and CC O
metastasis NN O
. . O

This DT O
review NN O
condenses VBZ O
the DT O
latest JJS O
findings NNS O
on IN O
the DT O
signaling VBG O
pathways NNS O
that WDT O
are VBP O
activated VBN O
and CC O
/ VBN O
or CC O
regulated VBN O
by IN O
molecules NNS O
generated VBN O
from IN O
Hedgehog NNP O
signaling VBG O
in IN O
cancer NN O
and CC O
cites VBZ O
promising VBG O
clinical JJ O
interventions NNS O
. . O

Finally RB O
, , O
we PRP O
discuss VBP O
future JJ O
directions NNS O
for IN O
identifying VBG O
the DT O
appropriate JJ O
patients NNS O
for IN O
therapy NN O
, , O
developing VBG O
reliable JJ O
markers NNS O
of IN O
efficacy NN O
of IN O
treatment NN O
, , O
and CC O
combating VBG O
resistance NN O
to TO O
Hedgehog NNP O
pathway NN O
inhibitors NNS O
. . O

-DOCSTART- X X O

Analysis NN O
of IN O
molecular JJ O
aberrations NNS O
of IN O
Wnt NNP O
pathway NN O
gladiators NNS O
in IN O
colorectal JJ O
cancer NN O
in IN O
the DT O
Kashmiri NNP O
population NN O
. . O

The DT O
development NN O
and CC O
progression NN O
of IN O
colorectal NN O
cancer NN O
( -LRB- O
CRC NNP O
) -RRB- O
is VBZ O
a DT O
multi JJ O
- : O
step NN O
process NN O
, , O
and CC O
the DT O
Wnt NNP O
pathways NNS O
with IN O
its PRP$ O
two CD O
molecular JJ O
gladiators NNS O
adenomatous JJ O
polyposis NN O
coli NNS O
( -LRB- O
APC NN O
) -RRB- O
and CC O
beta JJ O
- : O
catenin NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
transforming VBG O
a DT O
normal JJ O
tissue NN O
into IN O
a DT O
malignant JJ O
one CD O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
aimed VBD O
to TO O
investigate VB O
the DT O
role NN O
of IN O
aberrations NNS O
in IN O
the DT O
APC NNP O
and CC O
beta JJ O
- : O
catenin NN O
genes NNS O
in IN O
the DT O
pathogenesis NN O
of IN O
CRC NNP O
in IN O
the DT O
Kashmir NNP O
valley NN O
, , O
and CC O
to TO O
correlate VB O
it PRP O
with IN O
various JJ O
clinicopathological JJ O
variables NNS O
. . O

We PRP O
examined VBD O
the DT O
paired VBN O
tumour NN O
and CC O
normal JJ O
- : O
tissue NN O
specimens NNS O
of IN O
86 CD O
CRC NNP O
patients NNS O
for IN O
the DT O
occurrence NN O
of IN O
aberrations NNS O
in IN O
the DT O
mutation NN O
cluster NN O
region NN O
( -LRB- O
MCR NNP O
) -RRB- O
of IN O
the DT O
APC NNP O
gene NN O
and CC O
exon NN O
3 CD O
of IN O
the DT O
beta JJ O
- : O
catenin NN O
gene NN O
by IN O
polymerase NN O
chain NN O
reaction NN O
- : O
single JJ O
- : O
strand JJ O
conformation NN O
polymorphism NN O
( -LRB- O
PCR FW O
- : O
SSCP NNS O
) -RRB- O
and CC O
/ NNP O
or CC O
PCR NNP O
- : O
direct JJ O
sequencing NN O
. . O

Analysis NN O
of IN O
promoter NN O
hypermethylation NN O
of IN O
the DT O
APC NNP O
gene NN O
was VBD O
also RB O
carried VBN O
out RP O
using VBG O
methylation NN O
- : O
specific JJ O
PCR NN O
( -LRB- O
MS NNP O
- : O
PCR NN O
) -RRB- O
. . O

The DT O
overall JJ O
mutation NN O
rate NN O
of IN O
the DT O
MCR NNP O
of IN O
the DT O
APC NNP O
gene NN O
among IN O
86 CD O
CRC JJ O
cases NNS O
was VBD O
12 CD O
. . O
8 CD O
per IN O
cent NN O
( -LRB- O
11 CD O
of IN O
86 CD O
) -RRB- O
. . O

Promoter NNP O
hypermethylation NN O
of IN O
APC NNP O
was VBD O
observed VBN O
in IN O
54 CD O
. . O
65 CD O
per IN O
cent NN O
( -LRB- O
47 CD O
of IN O
86 CD O
) -RRB- O
of IN O
cases NNS O
. . O

Furthermore RB O
, , O
we PRP O
found VBD O
a DT O
significant JJ O
association NN O
between IN O
tumour NN O
location NN O
, , O
tumour NN O
grade NN O
and CC O
node VBD O
status NN O
and CC O
the DT O
methylation NN O
status NN O
of IN O
the DT O
APC NNP O
gene NN O
( -LRB- O
p NN O
< NN O
= SYM O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

Although IN O
the DT O
number NN O
of IN O
mutations NNS O
in IN O
the DT O
APC NNP O
and CC O
beta JJ O
- : O
catenin NN O
genes NNS O
in IN O
our PRP$ O
CRC NNP O
cases NNS O
was VBD O
very RB O
low JJ O
, , O
the DT O
study NN O
confirms VBZ O
the DT O
role NN O
of IN O
epigenetic JJ O
gene NN O
silencing NN O
of IN O
the DT O
pivotal JJ O
molecular JJ O
gladiator NN O
, , O
APC NNP O
, , O
of IN O
the DT O
Wnt NNP O
pathway NN O
in IN O
the DT O
development NN O
of IN O
CRC NNP O
in IN O
the DT O
Kashmiri NNP O
population NN O
. . O

-DOCSTART- X X O

Massive JJ O
osteolysis NN O
in IN O
a DT O
dog NN O
resembling NN O
Gorham NNP O
' POS O
s PRP O
disease NN O
in IN O
humans NNS O
. . O

An DT O
eight CD O
- : O
month NN O
- : O
old JJ O
mixed JJ O
- : O
breed NN O
dog NN O
was VBD O
presented VBN O
with IN O
a DT O
history NN O
of IN O
sudden JJ O
onset NN O
pelvic JJ O
limb NN O
lameness NN O
. . O

Radiographic NNP O
and CC O
computed VBN O
tomographic JJ O
examinations NNS O
demonstrated VBD O
an DT O
osteolytic JJ O
process NN O
involving VBG O
the DT O
lumbar NN O
spine NN O
and CC O
pelvis NN O
. . O

A DT O
comprehensive JJ O
work NN O
- : O
up RP O
including VBG O
serial JJ O
radiographic JJ O
skeletal NN O
survey NN O
, , O
biopsy JJ O
, , O
routine JJ O
laboratory NN O
investigation NN O
and CC O
evaluation NN O
of IN O
parathyroid NN O
hormone NN O
( -LRB- O
PTH NNP O
) -RRB- O
and CC O
25 CD O
- : O
hydroxy JJ O
- : O
vitamin NN O
D NN O
levels NNS O
failed VBD O
to TO O
reveal VB O
any DT O
underlying VBG O
cause NN O
for IN O
the DT O
osteolysis NN O
. . O

Conservative JJ O
treatment NN O
using VBG O
the DT O
bisphosphonate JJ O
drug NN O
alendronate NN O
and CC O
oral JJ O
analgesic NN O
medications NNS O
resulted VBD O
in IN O
a DT O
return NN O
to TO O
nearly RB O
normal JJ O
long RB O
- : O
term NN O
function NN O
, , O
despite IN O
massive JJ O
lumbar NN O
and CC O
pelvic JJ O
osteolysis NN O
. . O

The DT O
clinical JJ O
, , O
radiological JJ O
and CC O
histopathological JJ O
features NNS O
in IN O
this DT O
dog NN O
are VBP O
reported VBN O
, , O
and CC O
similarities NNS O
with IN O
the DT O
human JJ O
condition NN O
known VBN O
as IN O
Gorham NNP O
' POS O
s PRP O
disease NN O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Correlation NN O
of IN O
lymphatic JJ O
vessel NN O
density NN O
and CC O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
with IN O
nodal JJ O
metastasis NN O
in IN O
papillary NN O
thyroid NN O
microcarcinoma NN O
. . O

BACKGROUND NNP O
: : O
The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
not RB O
only RB O
the DT O
intratumoral JJ O
and CC O
peritumoral JJ O
lymphatic JJ O
vessel NN O
density NN O
( -LRB- O
ILD NNP O
and CC O
PLD NNP O
) -RRB- O
but CC O
also RB O
the DT O
expression NN O
of IN O
vascular JJ O
endothelial JJ O
growth NN O
factors NNS O
( -LRB- O
VEGFs NNS O
) -RRB- O
and CC O
to TO O
test VB O
their PRP$ O
correlation NN O
with IN O
regional JJ O
lymph NN O
nodal NN O
metastases NNS O
in IN O
papillary NN O
thyroid NN O
microcarcinoma NN O
( -LRB- O
PTMC NNP O
) -RRB- O
. . O

METHODS NNS O
: : O
A DT O
clinicopathologic NN O
data NNS O
review NN O
was VBD O
performed VBN O
in IN O
60 CD O
patients NNS O
with IN O
PTMC NNP O
treated VBD O
with IN O
total JJ O
thyroidectomies NNS O
involving VBG O
neck NN O
dissections NNS O
. . O

The DT O
patterns NNS O
of IN O
lymphatic JJ O
vessels NNS O
, , O
the DT O
expression NN O
of IN O
VEGFs NNP O
, , O
and CC O
their PRP$ O
correlation NN O
with IN O
neck NN O
metastases NNS O
were VBD O
assessed VBN O
. . O

RESULTS NNS O
: : O
PLD NNP O
was VBD O
significantly RB O
higher JJR O
than IN O
ILD NNP O
( -LRB- O
p NN O
< NN O
. . O
001 CD O
) -RRB- O
. . O

Patients NNS O
with IN O
high JJ O
PLD NN O
( -LRB- O
> JJ O
8 CD O
. . O
0 CD O
) -RRB- O
showed VBD O
higher JJR O
rates NNS O
of IN O
neck NN O
metastases NNS O
than IN O
low JJ O
PLD NNP O
( -LRB- O
< NN O
= SYM O
8 CD O
. . O
0 CD O
) -RRB- O
( -LRB- O
74 CD O
. . O
0 CD O
% NN O
vs JJ O
46 CD O
. . O
8 CD O
% NN O
, , O
p NN O
= SYM O
. . O
03 CD O
) -RRB- O
. . O

Univariate NNP O
and CC O
multivariate JJ O
analyses NNS O
revealed VBD O
high JJ O
PLD NN O
as IN O
the DT O
only JJ O
independent JJ O
variable JJ O
predictive NN O
of IN O
neck NN O
metastasis NN O
. . O

The DT O
expression NN O
of IN O
VEGFs NNP O
did VBD O
not RB O
correlate VB O
with IN O
either DT O
lymphatic JJ O
density NN O
or CC O
neck NN O
metastasis NN O
. . O

CONCLUSIONS NNS O
: : O
PLD NNP O
may MD O
be VB O
of IN O
potential JJ O
benefit NN O
in IN O
the DT O
prediction NN O
of IN O
neck NN O
metastasis NN O
in IN O
PTMC NNP O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
autophagy NN O
potentiates VBZ O
the DT O
antitumor JJ O
effect NN O
of IN O
the DT O
multikinase JJ O
inhibitor NN O
sorafenib NN O
in IN O
hepatocellular JJ O
carcinoma NN O
. . O

Multikinase VB O
inhibitor NN O
sorafenib NN O
inhibits VBZ O
proliferation NN O
and CC O
angiogenesis NN O
of IN O
tumors NNS O
by IN O
suppressing VBG O
the DT O
Raf NNP O
/ NNP O
MEK NNP O
/ NNP O
ERK NNP O
signaling VBG O
pathway NN O
and CC O
VEGF NN O
receptor NN O
tyrosine NN O
kinase NN O
. . O

It PRP O
significantly RB O
prolongs VBZ O
median JJ O
survival NN O
of IN O
patients NNS O
with IN O
advanced JJ O
hepatocellular JJ O
carcinoma NN O
( -LRB- O
HCC NNP O
) -RRB- O
but CC O
the DT O
response NN O
is VBZ O
disease NN O
- : O
stabilizing VBG O
and CC O
cytostatic JJ O
rather RB O
than IN O
one CD O
of IN O
tumor NN O
regression NN O
. . O

To TO O
examine VB O
the DT O
mechanisms NNS O
underlying VBG O
the DT O
relative JJ O
resistance NN O
in IN O
HCC NNP O
, , O
we PRP O
investigated VBD O
the DT O
role NN O
of IN O
autophagy NN O
, , O
an DT O
evolutionarily RB O
conserved VBN O
self NN O
- : O
digestion NN O
pathway NN O
, , O
in IN O
hepatoma NN O
cells NNS O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
. . O

Sorafenib NNP O
treatment NN O
led VBD O
to TO O
accumulation NN O
of IN O
autophagosomes NNS O
as IN O
evidenced VBN O
by IN O
conversion NN O
from IN O
LC3 JJ O
- : O
I PRP O
to TO O
LC3 VB O
- : O
II NNP O
observed VBN O
by IN O
immunoblot NN O
in IN O
Huh7 NNP B-NP
, , O
HLF NNP B-NP
and CC O
PLC NNP B-NP
/ NNP I-NP
PRF NNP I-NP
/ VBD I-NP
5 CD I-NP
cells NNS O
. . O

This DT O
induction NN O
was VBD O
due JJ O
to TO O
activation NN O
of IN O
autophagic JJ O
flux NN O
, , O
as IN O
there EX O
was VBD O
further JJ O
increase NN O
in IN O
LC3 JJ O
- : O
II NNP O
expression NN O
upon IN O
treatment NN O
with IN O
lysosomal JJ O
inhibitors NNS O
, , O
clear JJ O
decline NN O
of IN O
the DT O
autophagy NN O
substrate NN O
p62 NN O
, , O
and CC O
an DT O
mRFP JJ O
- : O
GFP JJ O
- : O
LC3 JJ O
fluorescence NN O
change NN O
in IN O
sorafenib NN O
- : O
treated VBN O
hepatoma NN O
cells NNS O
. . O

Sorafenib NNP O
inhibited VBD O
the DT O
mammalian JJ O
target NN O
of IN O
rapamycin NN O
complex NN O
1 CD O
and CC O
its PRP$ O
inhibition NN O
led VBD O
to TO O
accumulation NN O
of IN O
LC3 JJ O
- : O
II NNP O
. . O

Pharmacological JJ O
inhibition NN O
of IN O
autophagic JJ O
flux NN O
by IN O
chloroquine NN O
increased VBN O
apoptosis NN O
and CC O
decreased VBD O
cell NN O
viability NN O
in IN O
hepatoma NN O
cells NNS O
. . O

siRNA NNS O
- : O
mediated JJ O
knockdown NN O
of IN O
the DT O
ATG7 NNP O
gene NN O
also RB O
sensitized VBD O
hepatoma NN O
cells NNS O
to TO O
sorafenib NNS O
. . O

Finally RB O
, , O
sorafenib JJ O
induced JJ O
autophagy NN O
in IN O
Huh7 CD B-NP
xenograft NN O
tumors NNS O
in IN O
nude JJ O
mice NNS O
and CC O
coadministration NN O
with IN O
chloroquine NN O
significantly RB O
suppressed VBD O
tumor NN O
growth NN O
compared VBN O
with IN O
sorafenib NN O
alone RB O
. . O

In IN O
conclusion NN O
, , O
sorafenib JJ O
administration NN O
induced VBD O
autophagosome JJ O
formation NN O
and CC O
enhanced JJ O
autophagic JJ O
activity NN O
, , O
which WDT O
conferred VBD O
a DT O
survival NN O
advantage NN O
to TO O
hepatoma NN O
cells NNS O
. . O

Concomitant NNP O
inhibition NN O
of IN O
autophagy NN O
may MD O
be VB O
an DT O
attractive JJ O
strategy NN O
for IN O
unlocking VBG O
the DT O
antitumor JJ O
potential NN O
of IN O
sorafenib NN O
in IN O
HCC NNP O
. . O

-DOCSTART- X X O

Desensitization NNP O
of IN O
prostaglandin NN O
F2 IN O
alpha NN O
- : O
stimulated VBN O
inositol NN O
phosphate NN O
generation NN O
in IN O
NIH NNP B-NP
- : I-NP
3T3 CD I-NP
fibroblasts NNS O
transformed VBN O
by IN O
overexpression NN O
of IN O
normal JJ O
c SYM O
- : O
Ha SYM O
- : O
ras FW O
- : O
1 CD O
, , O
c SYM O
- : O
Ki FW O
- : O
ras FW O
- : O
2 CD O
and CC O
c SYM O
- : O
N NNP O
- : O
ras VBD O
genes NNS O
. . O

The DT O
stimulation NN O
of IN O
inositol NN O
phosphate NN O
generation NN O
in IN O
control NN O
and CC O
ras NNS O
- : O
gene NN O
- : O
transformed VBN O
NIH NNP B-NP
- : I-NP
3T3 CD I-NP
cells NNS O
by IN O
prostaglandin JJ O
F2 NN O
alpha NN O
( -LRB- O
PGF2 JJ O
alpha NN O
) -RRB- O
was VBD O
investigated VBN O
. . O

Compared VBN O
with IN O
the DT O
control NN O
cells NNS O
, , O
a DT O
desensitization NN O
of IN O
the DT O
response NN O
was VBD O
observed VBN O
in IN O
cells NNS O
transformed VBN O
by IN O
the DT O
overexpression NN O
of IN O
N NNP O
- : O
, , O
Ha NNP O
- : O
, , O
or CC O
Ki NNP O
- : O
ras JJ O
genes NNS O
. . O

This DT O
desensitization NN O
was VBD O
without IN O
effect NN O
upon IN O
the DT O
concentration NN O
causing VBG O
half JJ O
- : O
maximal JJ O
effect NN O
( -LRB- O
EC50 NNP O
) -RRB- O
, , O
dissociation NN O
constant JJ O
( -LRB- O
Kd NN O
) -RRB- O
or CC O
number NN O
of IN O
PGF2 NNP O
alpha NN O
receptors NNS O
. . O

Inhibition NN O
of IN O
PG NNP O
synthesis NN O
was VBD O
without IN O
effect NN O
upon IN O
desensitization NN O
, , O
demonstrating VBG O
that IN O
the DT O
effect NN O
was VBD O
not RB O
agonist JJ O
- : O
induced VBN O
. . O

Desensitization NNP O
could MD O
be VB O
induced VBN O
in IN O
NIH NNP B-NP
- : I-NP
3T3 CD I-NP
cells NNS O
by IN O
culturing VBG O
under IN O
conditions NNS O
where WRB O
the DT O
cells NNS O
were VBD O
all RB O
in IN O
the DT O
exponential JJ O
growth NN O
phase NN O
, , O
or CC O
by IN O
a DT O
12 CD O
h NN O
exposure NN O
to TO O
a DT O
C LS O
- : O
kinase NN O
- : O
activating NN O
phorbol NN O
ester NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
desensitization NN O
of IN O
certain JJ O
agonist JJ O
- : O
induced JJ O
inositol NN O
phospholipid JJ O
responses NNS O
in IN O
ras NNS O
- : O
transformed VBN O
cells NNS O
is VBZ O
a DT O
consequence NN O
of IN O
increased VBN O
cell NN O
proliferation NN O
and CC O
associated JJ O
amplification NN O
in IN O
C NNP O
- : O
kinase NN O
activity NN O
and CC O
is VBZ O
an DT O
indirect JJ O
consequence NN O
of IN O
transformation NN O
by IN O
ras NNS O
. . O

-DOCSTART- X X O

Sunitinib NNP O
induces VBZ O
apoptosis NN O
in IN O
pheochromocytoma NN O
tumor NN O
cells NNS O
by IN O
inhibiting VBG O
VEGFR2 NNP O
/ NNP O
Akt NNP O
/ NNP O
mTOR NN O
/ IN O
S6K1 NNP O
pathways NNS O
through IN O
modulation NN O
of IN O
Bcl NNP O
- : O
2 CD O
and CC O
BAD NNP O
. . O

Sunitinib NNP O
is VBZ O
an DT O
oral JJ O
multitargeted JJ O
receptor NN O
tyrosine NN O
kinase NN O
inhibitor NN O
with IN O
antiangiogenic JJ O
and CC O
antitumor JJ O
activity NN O
that IN O
mainly RB O
targets VBZ O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
receptors NNS O
( -LRB- O
VEGFRs NNS O
) -RRB- O
. . O

Very RB O
recently RB O
, , O
sunitinib NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
an DT O
active JJ O
agent NN O
for IN O
the DT O
treatment NN O
of IN O
malignant JJ O
pheochromocytomas NNS O
. . O

However RB O
, , O
it PRP O
is VBZ O
unclear JJ O
whether IN O
sunitinib NN O
acts VBZ O
only RB O
through IN O
an DT O
antiangiogenic JJ O
mechanism NN O
or CC O
whether IN O
it PRP O
may MD O
also RB O
directly RB O
target VB O
tumor NN O
cells NNS O
. . O

Sunitinib NNP O
markedly RB O
induced VBD O
apoptosis NN O
of IN O
PC12 CD B-NP
cells NNS O
in IN O
a DT O
dose NN O
- : O
dependent JJ O
and CC O
time NN O
- : O
dependent JJ O
manner NN O
. . O

Furthermore RB O
, , O
in IN O
support NN O
of IN O
these DT O
findings NNS O
, , O
we PRP O
found VBD O
that IN O
sunitinib NN O
induced VBN O
a DT O
reduction NN O
in IN O
the DT O
expression NN O
of IN O
the DT O
antiapoptotic JJ O
molecule NN O
Bcl NNP O
- : O
2 CD O
as RB O
well RB O
as IN O
dephosphorylation NN O
of IN O
the DT O
proapoptotic JJ O
molecule NN O
BAD NN O
, , O
which WDT O
results VBZ O
in IN O
the DT O
activation NN O
of IN O
BAD NN O
in IN O
these DT O
cells NNS O
. . O

Consistent JJ O
with IN O
these DT O
apoptotic JJ O
effects NNS O
, , O
our PRP$ O
results NNS O
showed VBD O
that IN O
sunitinib NN O
inhibited VBD O
phosphorylation NN O
of IN O
Akt NNP O
and CC O
mTOR NN O
and CC O
was VBD O
followed VBN O
by IN O
a DT O
reduction NN O
of IN O
S6K1 NNP O
, , O
which WDT O
is VBZ O
a DT O
well RB O
- : O
known VBN O
target NN O
of IN O
mTOR NN O
. . O

Knockdown NNP O
of IN O
VEGFR NNP O
- : O
2 CD O
attenuated VBN O
the DT O
sunitinib NN O
- : O
induced VBN O
effects NNS O
, , O
including VBG O
apoptosis NN O
and CC O
inhibition NN O
of IN O
signaling VBG O
pathways NNS O
such JJ O
as IN O
the DT O
phosphorylation NN O
of IN O
Akt NNP O
as RB O
well RB O
as IN O
mTOR NN O
, , O
and CC O
Bcl NNP O
- : O
2 CD O
, , O
which WDT O
confirmed VBD O
that IN O
these DT O
effects NNS O
could MD O
be VB O
mediated VBN O
by IN O
VEGFR NNP O
- : O
2 CD O
. . O

In IN O
addition NN O
, , O
silencing NN O
of IN O
S6K1 NNP O
induced VBD O
apoptosis NN O
accompanied VBN O
by IN O
a DT O
decrease NN O
in IN O
the DT O
phosphorylation NN O
of IN O
BAD NNP O
and CC O
Bcl NNP O
- : O
2 CD O
, , O
similar JJ O
to TO O
that DT O
observed VBN O
with IN O
sunitinib JJ O
treatment NN O
. . O

Thus RB O
, , O
these DT O
results NNS O
together RB O
suggest VBP O
that IN O
sunitinib NN O
initially RB O
exerts VBZ O
its PRP$ O
apoptotic JJ O
effect NN O
through IN O
the DT O
inhibition NN O
of IN O
VEGFR NNP O
- : O
2 CD O
, , O
which WDT O
, , O
when WRB O
followed VBN O
by IN O
reduction NN O
of IN O
its PRP$ O
downstream NN O
effectors NNS O
, , O
including VBG O
Akt NNP O
/ NNP O
mTOR NN O
/ IN O
S6K1 NNP O
, , O
may MD O
lead VB O
to TO O
inhibition NN O
of IN O
the DT O
antiapoptotic JJ O
molecule NN O
Bcl NNP O
- : O
2 CD O
and CC O
activation NN O
of IN O
the DT O
proapoptotic JJ O
molecule NN O
BAD NN O
in IN O
PC12 CD B-NP
cells NNS O
. . O

However RB O
, , O
PC12 NN B-NP
cells NNS O
do VBP O
not RB O
precisely RB O
reflect VB O
the DT O
pathogenesis NN O
of IN O
malignant JJ O
cells NNS O
. . O

Therefore RB O
, , O
we PRP O
confirmed VBD O
the DT O
key NN O
findings NNS O
by IN O
replicating VBG O
these DT O
experiments NNS O
in IN O
human JJ O
neuroblastoma NN O
SK JJ B-NP
- : I-NP
N NN I-NP
- : I-NP
SH NNS I-NP
cells NNS O
. . O

-DOCSTART- X X O

Development NNP O
of IN O
a DT O
mouse NN O
model NN O
for IN O
lymph NN O
node NN O
metastasis NN O
with IN O
endometrial JJ O
cancer NN O
. . O

Controlling VBG O
lymph NN O
node NN O
metastasis NN O
is VBZ O
currently RB O
a DT O
key JJ O
issue NN O
in IN O
cancer NN O
therapy NN O
. . O

Lymph NNP O
node NN O
metastasis NN O
is VBZ O
one CD O
of IN O
the DT O
most RBS O
important JJ O
prognostic JJ O
factors NNS O
in IN O
various JJ O
types NNS O
of IN O
cancers NNS O
, , O
including VBG O
endometrial JJ O
cancer NN O
. . O

Vascular JJ O
endothelial JJ O
growth NN O
factor NN O
- : O
C NNP O
( -LRB- O
VEGF NNP O
- : O
C NN O
) -RRB- O
plays VBZ O
a DT O
crucial JJ O
role NN O
in IN O
lymphangiogenesis NN O
, , O
and CC O
is VBZ O
implicated VBN O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
lymph NN O
node NN O
metastasis NN O
. . O

To TO O
evaluate VB O
the DT O
role NN O
of IN O
VEGF NNP O
- : O
C NNP O
in IN O
lymph NN O
node NN O
metastasis NN O
, , O
we PRP O
developed VBD O
an DT O
animal NN O
model NN O
by IN O
using VBG O
an DT O
endometrial JJ O
cancer NN O
cell NN O
line NN O
, , O
HEC1A NNP B-NP
. . O

This DT O
cell NN O
line NN O
is VBZ O
not RB O
invasive JJ O
by IN O
nature NN O
and CC O
secretes NNS O
moderate JJ O
amounts NNS O
of IN O
VEGF NNP O
- : O
C NNP O
; : O
intrauterine JJ O
injection NN O
of IN O
HEC1A NNP B-NP
cells NNS O
into IN O
Balb NNP O
/ NNP O
c NN O
nude JJ O
mice NNS O
resulted VBN O
in IN O
uterine JJ O
cancer NN O
with IN O
lymph NN O
node NN O
metastasis NN O
after IN O
8 CD O
weeks NNS O
. . O

To TO O
analyze VB O
the DT O
contribution NN O
of IN O
VEGF NNP O
- : O
C NNP O
to TO O
lymph VB O
node NN O
metastasis NN O
, , O
its PRP$ O
corresponding JJ O
gene NN O
was VBD O
stably RB O
introduced VBN O
into IN O
HEC1A JJ B-NP
cells NNS O
( -LRB- O
HEC1A PRP B-NP
/ VB O
VEGF NNP O
- : O
C NNP O
) -RRB- O
, , O
which WDT O
then RB O
produced VBD O
more JJR O
than IN O
10 CD O
times NNS O
the DT O
amount NN O
of IN O
VEGF NNP O
- : O
C NNP O
. . O

The DT O
number NN O
of IN O
lymph NN O
node NN O
metastases NNS O
was VBD O
significantly RB O
higher JJR O
in IN O
HEC1A NNP B-NP
/ NNP I-NP
VEGF NNP I-NP
- : I-NP
C NNP I-NP
cells NNS O
than IN O
in IN O
HEC1A CD B-NP
cells NNS O
( -LRB- O
3 CD O
. . O
2 CD O
vs NN O
1 CD O
. . O
1 CD O
nodes VBZ O
/ VBN O
animal NN O
, , O
respectively RB O
) -RRB- O
. . O

Augmented JJ O
lymphangiogenesis NN O
was VBD O
observed VBN O
within IN O
tumors NNS O
when WRB O
HEC1A PRP B-NP
/ VBD I-NP
VEGF NNP I-NP
- : I-NP
C NNP I-NP
cells NNS O
were VBD O
inoculated VBN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
VEGF NNP O
- : O
C NNP O
plays VBZ O
a DT O
critical JJ O
role NN O
in IN O
lymph NN O
node NN O
metastasis NN O
, , O
in IN O
addition NN O
to TO O
serving VBG O
as IN O
a DT O
platform NN O
to TO O
test VB O
the DT O
efficacy NN O
of IN O
various JJ O
therapeutic JJ O
modalities NNS O
against IN O
lymph NN O
node NN O
metastasis NN O
. . O

-DOCSTART- X X O

[ NN O
Rubella NNP O
in IN O
Poland NNP O
in IN O
2009 CD O
] NN O
. . O

In IN O
Poland NNP O
, , O
7 CD O
, , O
587 CD O
cases NNS O
of IN O
rubella NN O
were VBD O
registered VBN O
in IN O
2009 CD O
( -LRB- O
incidence NN O
19 CD O
. . O
9 CD O
per IN O
100 CD O
, , O
000 CD O
population NN O
) -RRB- O
. . O

According VBG O
to TO O
a DT O
new JJ O
rubella NN O
case NN O
definition NN O
, , O
introduced VBN O
in IN O
2009 CD O
, , O
7 CD O
( -LRB- O
0 CD O
. . O
1 CD O
% NN O
) -RRB- O
cases NNS O
were VBD O
classified VBN O
as IN O
confirmed JJ O
cases NNS O
, , O
30 CD O
( -LRB- O
0 CD O
. . O
4 CD O
% NN O
) -RRB- O
as IN O
probable JJ O
. . O

One CD O
case NN O
of IN O
congenital JJ O
rubella NN O
syndrome NN O
was VBD O
reported VBN O
. . O

The DT O
incidence NN O
in IN O
men NNS O
( -LRB- O
26 CD O
. . O
6 CD O
) -RRB- O
was VBD O
1 CD O
. . O
9 CD O
- : O
times NNS O
higher JJR O
than IN O
in IN O
women NNS O
( -LRB- O
13 CD O
. . O
6 CD O
) -RRB- O
. . O

The DT O
highest JJS O
incidence NN O
was VBD O
observed VBN O
in IN O
children NNS O
aged VBN O
7 CD O
and CC O
8 CD O
years NNS O
( -LRB- O
180 CD O
. . O
3 CD O
and CC O
175 CD O
. . O
6 CD O
, , O
respectively RB O
) -RRB- O
. . O

No DT O
rubella NN O
deaths NNS O
were VBD O
registered VBN O
. . O

An DT O
improvement NN O
of IN O
laboratory NN O
diagnosis NN O
of IN O
reported JJ O
cases NNS O
is VBZ O
necessary JJ O
to TO O
assess VB O
the DT O
impact NN O
of IN O
2 CD O
- : O
dose NN O
immunization NN O
implemented VBN O
in IN O
2003 CD O
on IN O
rubella NN O
epidemiology NN O
in IN O
Poland NNP O
. . O

-DOCSTART- X X O

Burns NNP O
from IN O
hot JJ O
wheat NN O
bags NNS O
: : O
a DT O
public JJ O
safety NN O
issue NN O
. . O

Introduction NN O
: : O
Wheat NN O
bags NNS O
are VBP O
therapeutic JJ O
devices NNS O
that WDT O
are VBP O
heated VBN O
in IN O
microwaves NNS O
and CC O
commonly RB O
used VBN O
to TO O
provide VB O
relief NN O
from IN O
muscle NN O
and CC O
joint JJ O
pain NN O
. . O

The DT O
Royal NNP O
Adelaide NNP O
Hospital NNP O
Burns NNP O
Unit NNP O
has VBZ O
observed VBN O
a DT O
number NN O
of IN O
patients NNS O
with IN O
significant JJ O
burn NN O
injuries NNS O
resulting VBG O
from IN O
their PRP$ O
use NN O
. . O

Despite IN O
their PRP$ O
dangers NNS O
, , O
the DT O
products NNS O
come VBP O
with IN O
limited JJ O
safety NN O
information NN O
. . O

Methods NNS O
: : O
Data NNP O
were VBD O
collected VBN O
from IN O
the DT O
Burns NNP O
Unit NN O
database NN O
for IN O
all DT O
patients NNS O
admitted VBD O
with IN O
burns NNS O
due JJ O
to TO O
hot JJ O
wheat NN O
bags NNS O
from IN O
2004 CD O
to TO O
2009 CD O
. . O

This DT O
was VBD O
analyzed VBN O
to TO O
determine VB O
the DT O
severity NN O
of IN O
the DT O
burn NN O
injury NN O
and CC O
identify VB O
any DT O
predisposing NN O
factors NNS O
. . O

An DT O
experimental JJ O
study NN O
was VBD O
performed VBN O
to TO O
measure VB O
the DT O
temperature NN O
of IN O
wheat NN O
bags NNS O
when WRB O
heated VBN O
to TO O
determine VB O
their PRP$ O
potential JJ O
for IN O
causing VBG O
thermal JJ O
injury NN O
. . O

Results NNS O
: : O
11 CD O
patients NNS O
were VBD O
admitted VBN O
with IN O
burns NNS O
due JJ O
to TO O
hot JJ O
wheat NN O
bags NNS O
. . O

The DT O
median JJ O
age NN O
was VBD O
52 CD O
years NNS O
and CC O
the DT O
mean JJ O
total JJ O
body NN O
surface NN O
area NN O
was VBD O
1 CD O
. . O
1 CD O
% NN O
. . O

All DT O
burns NNS O
were VBD O
either RB O
deep JJ O
dermal NN O
( -LRB- O
45 CD O
. . O
5 CD O
% NN O
) -RRB- O
or CC O
full JJ O
thickness NN O
( -LRB- O
54 CD O
. . O
5 CD O
% NN O
) -RRB- O
. . O

Ten CD O
patients NNS O
required VBD O
operative JJ O
management NN O
. . O

Predisposing NN O
factors NNS O
( -LRB- O
eg NN O
, , O
neuropathy NN O
) -RRB- O
to TO O
thermal DT O
injury NN O
were VBD O
identified VBN O
in IN O
7 CD O
patients NNS O
. . O

The DT O
experimental JJ O
study NN O
showed VBD O
that IN O
hot JJ O
wheat NN O
bags NNS O
reached VBD O
temperatures NNS O
of IN O
57 CD O
. . O
3degreesC IN O
( -LRB- O
135 CD O
. . O
1degreesF IN O
) -RRB- O
when WRB O
heated VBN O
according VBG O
to TO O
instructions NNS O
, , O
63 CD O
. . O
3degreesC IN O
( -LRB- O
145 CD O
. . O
9degreesF IN O
) -RRB- O
in IN O
a DT O
1000 CD O
W NNP O
microwave NN O
and CC O
69 CD O
. . O
6degreesC IN O
( -LRB- O
157 CD O
. . O
3degreesF NN O
) -RRB- O
on IN O
reheating VBG O
. . O

Conclusions NNS O
: : O
Hot JJ O
wheat NN O
bags NNS O
cause VB O
serious JJ O
burn NN O
injury NN O
. . O

When WRB O
heated VBN O
improperly RB O
, , O
they PRP O
can MD O
reach VB O
temperatures NNS O
high RB O
enough RB O
to TO O
cause VB O
epidermal JJ O
necrosis NN O
in IN O
a DT O
short JJ O
period NN O
of IN O
time NN O
. . O

Patients NNS O
with IN O
impaired JJ O
temperature NN O
sensation NN O
are VBP O
particularly RB O
at IN O
risk NN O
. . O

There EX O
should MD O
be VB O
greater JJR O
public JJ O
awareness NN O
of IN O
the DT O
dangers NNS O
of IN O
wheat NN O
bag NN O
use NN O
and CC O
more JJR O
specific JJ O
safety NN O
warnings NNS O
on IN O
the DT O
products NNS O
. . O

-DOCSTART- X X O

IL NNP O
- : O
17F JJ O
deficiency NN O
inhibits VBZ O
small JJ O
intestinal JJ O
tumorigenesis NN O
in IN O
ApcMin NNP O
/ NNP O
+ NNP O
mice NNS O
. . O

IL NNP O
- : O
17 CD O
plays NNS O
an DT O
important JJ O
role NN O
in IN O
gut NN O
homeostasis NN O
. . O

However RB O
, , O
the DT O
role NN O
of IN O
IL NNP O
- : O
17F CD O
in IN O
intestinal JJ O
tumorigenesis NN O
has VBZ O
not RB O
been VBN O
addressed VBN O
. . O

Here RB O
we PRP O
demonstrate VBP O
that IN O
ablation NN O
of IN O
IL NNP O
- : O
17F `` O
significantly RB O
inhibits VBZ O
spontaneous JJ O
intestinal JJ O
tumorigenesis NN O
in IN O
the DT O
small JJ O
intestine NN O
of IN O
Apc NNP O
( -LRB- O
Min NNP O
/ NN O
+ NN O
) -RRB- O
mice NNS O
. . O

IL NNP O
- : O
17F JJ O
ablation NN O
decreased VBN O
IL NNP O
- : O
1beta JJ O
and CC O
Cox NNP O
- : O
2 CD O
expression NN O
as RB O
well RB O
as IN O
IL NNP O
- : O
17 CD O
receptor NN O
C NNP O
( -LRB- O
IL NNP O
- : O
17RC JJ O
) -RRB- O
expression NN O
, , O
which WDT O
were VBD O
increased VBN O
in IN O
tumors NNS O
from IN O
Apc NNP O
( -LRB- O
Min NNP O
/ NN O
+ NN O
) -RRB- O
mice NNS O
. . O

Lack NN O
of IN O
IL NNP O
- : O
17F PRP O
did VBD O
not RB O
reverse VB O
the DT O
splenomegaly JJ O
but CC O
partially RB O
restored VBN O
thymic JJ O
atrophy NN O
, , O
suggesting VBG O
a DT O
local JJ O
effect NN O
of IN O
IL NNP O
- : O
17F CD O
in IN O
the DT O
intestine NN O
. . O

IL NNP O
- : O
17F CD O
deficient NN O
Apc NNP O
( -LRB- O
Min NNP O
/ NN O
+ NN O
) -RRB- O
mice NNS O
showed VBD O
a DT O
significant JJ O
decrease NN O
in IN O
immune JJ O
cell NN O
infiltration NN O
in IN O
the DT O
lamina NN O
propria NN O
. . O

Interestingly RB O
, , O
the DT O
expression NN O
of IN O
IL NNP O
- : O
17A CD O
from IN O
CD4 NNP O
T NNP O
cells NNS O
in IN O
the DT O
lamina NN O
propria NN O
remains VBZ O
unchanged JJ O
in IN O
the DT O
absence NN O
of IN O
IL NNP O
- : O
17F CD O
. . O

Collectively RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
the DT O
proinflammatory NN O
and CC O
essential JJ O
role NN O
of IN O
IL NNP O
- : O
17F CD O
to TO O
develop VB O
spontaneous JJ O
intestinal JJ O
tumorigenesis NN O
in IN O
Apc NNP O
( -LRB- O
Min NNP O
/ NN O
+ NN O
) -RRB- O
mice NNS O
in IN O
the DT O
presence NN O
of IN O
IL NNP O
- : O
17A CD O
. . O

-DOCSTART- X X O

Curcumin NNP O
inhibits VBZ O
metastatic JJ O
progression NN O
of IN O
breast NN O
cancer NN O
cell NN O
through IN O
suppression NN O
of IN O
urokinase JJ O
- : O
type NN O
plasminogen NN O
activator NN O
by IN O
NF NNP O
- : O
kappa NN O
B NNP O
signaling VBG O
pathways RB O
. . O

Curcumin NNP O
( -LRB- O
1 CD O
, , O
7 CD O
- : O
bis NNS O
( -LRB- O
4 LS O
- : O
hydroxy JJ O
- : O
3 LS O
- : O
methoxyphenyl NN O
) -RRB- O
- : O
1 CD O
, , O
6 CD O
- : O
heptadiene NN O
- : O
3 CD O
, , O
5 CD O
- : O
dione NN O
) -RRB- O
, , O
is VBZ O
extracted VBN O
from IN O
the DT O
plant NN O
Curcuma NNP O
longa NN O
. . O

It PRP O
was VBD O
recently RB O
reported VBN O
for IN O
its PRP$ O
anticancer JJ O
effect NN O
on IN O
several JJ O
types NNS O
of IN O
cancer NN O
cells NNS O
in IN O
vitro NN O
however RB O
, , O
the DT O
molecular JJ O
mechanisms NNS O
of IN O
this DT O
anticancer NN O
effect NN O
are VBP O
not RB O
fully RB O
understood VBN O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
we PRP O
evaluated VBD O
the DT O
effects NNS O
of IN O
curcumin NN O
on IN O
human JJ O
mammary NN O
epithelial NN O
carcinoma NN O
MCF NNP B-NP
- : I-NP
7 CD I-NP
cells NNS O
. . O

Cells NNS O
were VBD O
treated VBN O
with IN O
curcumin NN O
and CC O
examined VBD O
for IN O
cell NN O
viability NN O
by IN O
MTT NNP O
assay NN O
. . O

The DT O
cells NNS O
invasion NN O
was VBD O
demonstrated VBN O
by IN O
transwell NN O
assay NN O
. . O

The DT O
binding JJ O
activity NN O
of IN O
NF NNP O
- : O
kappaB NN O
to TO O
DNA NNP O
was VBD O
examined VBN O
in IN O
nuclear JJ O
extracts NNS O
using VBG O
Trans NNP O
- : O
AM VBP O
NF NNP O
- : O
kappaB NN O
ELISA NNP O
kit NN O
. . O

Western JJ O
blot NN O
was VBD O
performed VBN O
to TO O
detect VB O
the DT O
effect NN O
of IN O
curcumin NN O
on IN O
the DT O
expression NN O
of IN O
uPA NNP O
. . O

Our PRP$ O
results NNS O
showed VBD O
that IN O
curcumin NN O
dose NN O
- : O
dependently RB O
inhibited VBN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
the DT O
proliferation NN O
of IN O
MCF NNP B-NP
- : I-NP
7 CD I-NP
cells NNS O
. . O

Meanwhile RB O
, , O
the DT O
adhesion NN O
and CC O
invasion NN O
ability NN O
of IN O
MCF NNP B-NP
- : I-NP
7 CD I-NP
cells NNS O
were VBD O
sharply RB O
inhibited VBN O
when WRB O
treated VBN O
with IN O
different JJ O
concentrations NNS O
of IN O
curcumin NN O
. . O

Curcumin NNP O
also RB O
significantly RB O
decreased VBD O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
the DT O
expression NN O
of IN O
uPA NNP O
and CC O
NF NNP O
- : O
kappaB NN O
DNA NN O
binding NN O
activity NN O
, , O
respectively RB O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
curcumin NN O
inhibits VBZ O
the DT O
adhesion NN O
and CC O
invasion NN O
of IN O
MCF NNP B-NP
- : I-NP
7 CD I-NP
cells NNS O
through IN O
down IN O
- : O
regulating VBG O
the DT O
protein NN O
expression NN O
of IN O
uPA NNP O
via IN O
of IN O
NF NNP O
- : O
kappaB NN O
activation NN O
. . O

Accordingly RB O
, , O
the DT O
therapeutic JJ O
potential NN O
of IN O
curcumin NN O
for IN O
breast NN O
cancer NN O
deserves VBZ O
further JJ O
study NN O
. . O

-DOCSTART- X X O

Aglycon NNP O
of IN O
rhizochalin NN O
from IN O
the DT O
Rhizochalina NNP O
incrustata NN O
induces VBZ O
apoptosis NN O
via IN O
activation NN O
of IN O
AMP NNP O
- : O
activated JJ O
protein NN O
kinase NN O
in IN O
HT NNP B-NP
- : I-NP
29 CD I-NP
colon NN O
cancer NN O
cells NNS O
. . O

Rhizochalin NNP O
is VBZ O
a DT O
two CD O
- : O
headed VBN O
sphingolipid JJ O
- : O
like IN O
compound NN O
isolated VBN O
from IN O
the DT O
sponge NN O
Rhizochalina NNP O
incrustata NN O
. . O

It PRP O
has VBZ O
been VBN O
reported VBN O
that IN O
rhizocalin NN O
and CC O
its PRP$ O
derivates NNS O
have VBP O
a DT O
chemopreventive NN O
and CC O
chemotherapeutic JJ O
effect NN O
. . O

However RB O
, , O
the DT O
molecular JJ O
mechanism NN O
of IN O
these DT O
effects NNS O
is VBZ O
not RB O
understood VBN O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
that IN O
aglycon NN O
of IN O
rhizochalin NN O
( -LRB- O
AglRhz NNP O
) -RRB- O
from IN O
the DT O
Rhizochalina NNP O
incrustata NN O
induces VBZ O
AMP NNP O
- : O
activated JJ O
protein NN O
kinase NN O
( -LRB- O
AMPK NNP O
) -RRB- O
phosphorylation NN O
, , O
and CC O
thereby RB O
inhibits VBZ O
mammalian JJ O
target NN O
of IN O
rapamycin NN O
( -LRB- O
mTOR NN O
) -RRB- O
- : O
p70S6 VB O
kinase NN O
- : O
extracellular JJ O
signal NN O
- : O
regulated JJ O
kinase NN O
( -LRB- O
ERK NN O
) -RRB- O
signaling VBG O
and CC O
activator NN O
protein NN O
1 CD O
( -LRB- O
AP NNP O
- : O
1 CD O
) -RRB- O
activity NN O
via IN O
phosphorylation NN O
of IN O
Raptor NNP O
in IN O
HT NNP B-NP
- : I-NP
29 CD I-NP
cells NNS O
. . O

In IN O
addition NN O
, , O
AglRhz NNP O
induced VBD O
activation NN O
of IN O
caspase NN O
- : O
3 CD O
and CC O
poly NN O
( -LRB- O
ADP NNP O
- : O
ribose NN O
) -RRB- O
polymerase NN O
( -LRB- O
PARP NNP O
) -RRB- O
, , O
and CC O
DNA NNP O
fragmentation NN O
in IN O
HT NNP B-NP
- : I-NP
29 CD I-NP
cells NNS O
, , O
leads VBZ O
to TO O
induction NN O
of IN O
apoptosis NN O
as RB O
well RB O
as IN O
suppression NN O
of IN O
tumorigenicity NN O
of IN O
HT NNP B-NP
- : I-NP
29 CD I-NP
cells NNS O
. . O

Notably RB O
, , O
AglRhz NNP O
inhibits VBZ O
insulin NN O
- : O
like IN O
growth NN O
factor NN O
( -LRB- O
IGF NN O
) -RRB- O
- : O
1 CD O
- : O
induced VBN O
AP NNP O
- : O
1 CD O
activity NN O
and CC O
cell NN O
transformation NN O
in IN O
JB6 NNP B-NP
Cl41 NNP I-NP
cells NNS O
. . O

Overall RB O
, , O
our PRP$ O
findings NNS O
identify VBP O
AMPK NNP O
as IN O
an DT O
important JJ O
target NN O
protein NN O
for IN O
mediating VBG O
the DT O
anti NNS O
- : O
tumor NN O
properties NNS O
of IN O
AglRhz NNP O
in IN O
HT NNP B-NP
- : I-NP
29 CD I-NP
colon NN O
cancer NN O
cells NNS O
and CC O
have VBP O
important JJ O
implication NN O
for IN O
sponges NNS O
, , O
the DT O
most RBS O
important JJ O
marine NN O
source NN O
, , O
in IN O
colon NN O
cancer NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
thymidylate JJ O
synthase NN O
and CC O
dihydropyrimidine NN O
dehydrogenase NN O
in IN O
primary JJ O
oral JJ O
squamous JJ O
cell NN O
carcinoma NN O
and CC O
corresponding JJ O
metastases NNS O
in IN O
cervical JJ O
lymph NN O
nodes NNS O
: : O
association NN O
with IN O
the DT O
metastasis NN O
suppressor NN O
CD82 NNS O
. . O

Thymidylate JJ O
synthase NN O
( -LRB- O
TS NNS O
) -RRB- O
and CC O
dihydropyrimidine JJ O
dehydrogenase NN O
( -LRB- O
DPD NNP O
) -RRB- O
are VBP O
5 CD O
- : O
fluorouracil NN O
( -LRB- O
5 CD O
- : O
FU NNS O
) -RRB- O
metabolizing VBG O
enzymes NNS O
and CC O
are VBP O
involved VBN O
in IN O
the DT O
sensitivity NN O
of IN O
carcinoma NN O
patients NNS O
to TO O
5 CD O
- : O
FU NNP O
. . O

Although IN O
5 CD O
- : O
FU NN O
is VBZ O
often RB O
used VBN O
for IN O
the DT O
treatment NN O
of IN O
oral JJ O
carcinoma NN O
, , O
there EX O
has VBZ O
not RB O
been VBN O
any DT O
investigation NN O
into IN O
the DT O
expression NN O
of IN O
these DT O
enzymes NNS O
in IN O
metastatic JJ O
lymph NN O
nodes NNS O
or CC O
of IN O
their PRP$ O
roles NNS O
in IN O
the DT O
effectiveness NN O
of IN O
5 CD O
- : O
FU NN O
in IN O
treating VBG O
lymph NN O
node NN O
- : O
metastatic JJ O
cancer NN O
. . O

Oral NNP O
squamous JJ O
cell NN O
carcinoma NN O
( -LRB- O
OSCC NNP O
) -RRB- O
often RB O
metastasizes VBZ O
to TO O
the DT O
lymph NN O
nodes NNS O
, , O
and CC O
these DT O
enzymes NNS O
may MD O
be VB O
significant JJ O
in IN O
the DT O
survival NN O
of IN O
patients NNS O
with IN O
this DT O
disease NN O
. . O

This DT O
study NN O
investigated VBD O
the DT O
expression NN O
of IN O
TS NNS O
and CC O
DPD NNP O
in IN O
cervical JJ O
lymph NN O
node NN O
metastases NNS O
and CC O
its PRP$ O
relationship NN O
with IN O
primary JJ O
OSCC NNP O
, , O
as RB O
well RB O
as IN O
the DT O
interaction NN O
between IN O
these DT O
enzymes NNS O
and CC O
Kangai NNP O
1 CD O
( -LRB- O
KAI1 IN O
/ JJ O
CD82 NN O
) -RRB- O
which WDT O
is VBZ O
a DT O
metastasis NN O
suppressor NN O
protein NN O
. . O

Surgical JJ O
specimens NNS O
from IN O
20 CD O
cases NNS O
of IN O
OSCC NNP O
with IN O
lymph NN O
node NN O
metastasis NN O
, , O
20 CD O
cases NNS O
of IN O
OSCC NNP O
without IN O
lymph NN O
node NN O
metastasis NN O
, , O
and CC O
10 CD O
cases NNS O
of IN O
normal JJ O
mucosa NN O
were VBD O
examined VBN O
by IN O
immunohistochemistry NN O
. . O

The DT O
relationship NN O
between IN O
TS NNS O
and CC O
DPD NNP O
expression NN O
and CC O
clinicopathological JJ O
data NNS O
was VBD O
analyzed VBN O
. . O

TS NNS O
and CC O
DPD NNP O
proteins NNS O
were VBD O
overexpressed VBN O
in IN O
primary JJ O
OSCC NNS O
compared VBN O
to TO O
that DT O
in IN O
normal JJ O
mucosa NN O
. . O

TS NNS O
expression NN O
of IN O
the DT O
primary JJ O
oral JJ O
cancer NN O
cells NNS O
in IN O
the DT O
group NN O
with IN O
lymph NN O
node NN O
metastasis NN O
was VBD O
higher JJR O
than IN O
that DT O
of IN O
those DT O
without IN O
. . O

DPD NNP O
expression NN O
did VBD O
not RB O
significantly RB O
correlate VB O
with IN O
the DT O
occurrence NN O
of IN O
lymph NN O
node NN O
metastasis NN O
, , O
nor CC O
was VBD O
it PRP O
different JJ O
between IN O
primary JJ O
oral JJ O
cancer NN O
cells NNS O
and CC O
cervical JJ O
metastases NNS O
. . O

CD82 DT O
expression NN O
was VBD O
significantly RB O
reduced VBN O
in IN O
lymph NN O
node NN O
metastases NNS O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
TS NNS O
and CC O
CD82 NN O
may MD O
be VB O
of IN O
great JJ O
value NN O
in IN O
assessing VBG O
lymph NN O
node NN O
metastasis NN O
of IN O
OSCC NNP O
, , O
and CC O
could MD O
be VB O
taken VBN O
as IN O
new JJ O
targets NNS O
for IN O
therapy NN O
of IN O
metastatic JJ O
OSCC NNP O
. . O

-DOCSTART- X X O

c SYM O
- : O
MYC JJ O
functions NNS O
as IN O
a DT O
molecular JJ O
switch NN O
to TO O
alter VB O
the DT O
response NN O
of IN O
human JJ O
mammary NN O
epithelial NN O
cells NNS O
to TO O
oncostatin NNP O
M NNP O
. . O

Cytokines NNS O
play VBP O
an DT O
important JJ O
role NN O
in IN O
creating VBG O
an DT O
inflammatory NN O
microenvironment NN O
, , O
which WDT O
is VBZ O
now RB O
considered VBN O
a DT O
hallmark NN O
of IN O
cancer NN O
. . O

Although IN O
tumor NN O
cells NNS O
can MD O
exploit VB O
cytokine JJ O
signaling NN O
to TO O
promote VB O
growth NN O
, , O
invasion NN O
, , O
and CC O
metastasis NN O
, , O
the DT O
response NN O
of IN O
normal JJ O
and CC O
premalignant JJ O
epithelial NN O
cells NNS O
to TO O
cytokines NNS O
present JJ O
in IN O
a DT O
developing VBG O
tumor NN O
microenvironment NN O
remains VBZ O
unclear JJ O
. . O

Oncostatin NNP O
M NNP O
( -LRB- O
OSM NNP O
) -RRB- O
, , O
an DT O
IL NN O
- : O
6 CD O
family NN O
cytokine NN O
responsible JJ O
for IN O
STAT3 NNP O
activation NN O
, , O
has VBZ O
been VBN O
implicated VBN O
in IN O
cancer NN O
development NN O
, , O
progression NN O
, , O
invasion NN O
, , O
and CC O
metastasis NN O
. . O

Paradoxically NNP O
, , O
OSM NNP O
can MD O
also RB O
suppress VB O
the DT O
growth NN O
of IN O
normal JJ O
cells NNS O
and CC O
certain JJ O
tumor NN O
- : O
derived VBN O
cell NN O
lines NNS O
. . O

Using VBG O
isogenic JJ O
human NN O
mammary NN O
epithelial NN O
cells NNS O
( -LRB- O
HMEC NNP O
) -RRB- O
at IN O
different JJ O
stages NNS O
of IN O
neoplastic JJ O
transformation NN O
, , O
we PRP O
found VBD O
that IN O
OSM NNP O
signaling VBG O
suppressed JJ O
c SYM O
- : O
MYC JJ O
expression NN O
and CC O
engaged VBD O
a DT O
p16 FW O
- : O
and CC O
p53 NN O
- : O
independent JJ O
growth NN O
arrest NN O
that WDT O
required VBD O
STAT3 NNP O
activity NN O
. . O

Inhibition NN O
of IN O
STAT3 NNP O
activation NN O
by IN O
expressing VBG O
a DT O
dominant JJ O
- : O
negative JJ O
STAT3 JJ O
protein NN O
or CC O
a DT O
STAT3 NNPS O
- : O
shRNA NN O
prevented VBD O
the DT O
OSM NNP O
- : O
mediated JJ O
arrest NN O
. . O

In IN O
addition NN O
, , O
expression NN O
of IN O
c NNS O
- : O
MYC NNS O
from IN O
a DT O
constitutive JJ O
promoter NN O
also RB O
abrogated VBD O
the DT O
STAT3 NNPS O
- : O
mediated JJ O
arrest NN O
, , O
and CC O
strikingly RB O
, , O
cooperated VBD O
with IN O
OSM NNP O
to TO O
promote VB O
anchorage NN O
- : O
independent JJ O
growth NN O
( -LRB- O
AIG NNP O
) -RRB- O
, , O
a DT O
property NN O
associated VBN O
with IN O
malignant JJ O
transformation NN O
. . O

Cooperative JJ O
transformation NN O
by IN O
c NNS O
- : O
MYC NNS O
and CC O
OSM NNP O
required VBD O
PI3K NNP O
and CC O
AKT NNP O
signaling NN O
, , O
showing VBG O
the DT O
importance NN O
of IN O
multiple JJ O
signaling NN O
pathways NNS O
downstream NN O
of IN O
the DT O
OSM NNP O
receptor NN O
in IN O
defining VBG O
the DT O
cellular JJ O
response NN O
to TO O
cytokines NNS O
. . O

These DT O
findings NNS O
identify VBP O
c SYM O
- : O
MYC NNS O
as IN O
an DT O
important JJ O
molecular JJ O
switch NN O
that WDT O
alters VBZ O
the DT O
cellular JJ O
response NN O
to TO O
OSM NNP O
- : O
mediated JJ O
signaling NN O
from IN O
tumor NN O
suppressive NN O
to TO O
tumor NN O
promoting VBG O
. . O

-DOCSTART- X X O

PTHrP JJ O
drives NNS O
breast NN O
tumor NN O
initiation NN O
, , O
progression NN O
, , O
and CC O
metastasis NN O
in IN O
mice NNS O
and CC O
is VBZ O
a DT O
potential JJ O
therapy NN O
target NN O
. . O

Parathyroid NNP O
hormone NN O
- : O
related JJ O
protein NN O
( -LRB- O
PTHrP NN O
) -RRB- O
is VBZ O
a DT O
secreted JJ O
factor NN O
expressed VBD O
in IN O
almost RB O
all DT O
normal JJ O
fetal NN O
and CC O
adult NN O
tissues NNS O
. . O

It PRP O
is VBZ O
involved VBN O
in IN O
a DT O
wide JJ O
range NN O
of IN O
developmental JJ O
and CC O
physiological JJ O
processes NNS O
, , O
including VBG O
serum NN O
calcium NN O
regulation NN O
. . O

PTHrP NNP O
is VBZ O
also RB O
associated VBN O
with IN O
the DT O
progression NN O
of IN O
skeletal NN O
metastases NNS O
, , O
and CC O
its PRP$ O
dysregulated JJ O
expression NN O
in IN O
advanced VBN O
cancers NNS O
causes VBZ O
malignancy JJ O
- : O
associated JJ O
hypercalcemia NN O
. . O

Although IN O
PTHrP NNP O
is VBZ O
frequently RB O
expressed VBN O
by IN O
breast NN O
tumors NNS O
and CC O
other JJ O
solid JJ O
cancers NNS O
, , O
its PRP$ O
effects NNS O
on IN O
tumor NN O
progression NN O
are VBP O
unclear JJ O
. . O

Here RB O
, , O
we PRP O
demonstrate VBP O
in IN O
mice NNS O
pleiotropic JJ O
involvement NN O
of IN O
PTHrP NNP O
in IN O
key JJ O
steps NNS O
of IN O
breast NN O
cancer NN O
- : O
it PRP O
influences VBZ O
the DT O
initiation NN O
and CC O
progression NN O
of IN O
primary JJ O
tumors NNS O
and CC O
metastases NNS O
. . O

Pthrp NNP O
ablation NN O
in IN O
the DT O
mammary JJ O
epithelium NN O
of IN O
the DT O
PyMT NNP O
- : O
MMTV NNP O
breast NN O
cancer NN O
mouse NN O
model NN O
caused VBD O
a DT O
delay NN O
in IN O
primary JJ O
tumor NN O
initiation NN O
, , O
inhibited VBD O
tumor NN O
progression NN O
, , O
and CC O
reduced VBD O
metastasis NN O
to TO O
distal VB O
sites NNS O
. . O

Mechanistically RB O
, , O
it PRP O
reduced VBD O
expression NN O
of IN O
molecular JJ O
markers NNS O
of IN O
cell NN O
proliferation NN O
( -LRB- O
Ki67 IN O
) -RRB- O
and CC O
angiogenesis NN O
( -LRB- O
factor NN O
VIII NNP O
) -RRB- O
, , O
antiapoptotic JJ O
factor NN O
Bcl NNP O
- : O
2 CD O
, , O
cell NN O
- : O
cycle NN O
progression NN O
regulator NN O
cyclin NN O
D1 NNP O
, , O
and CC O
survival NN O
factor NN O
AKT1 NNP O
. . O

PTHrP NNP O
also RB O
influenced VBD O
expression NN O
of IN O
the DT O
adhesion NN O
factor NN O
CXCR4 NNP O
, , O
and CC O
coexpression NN O
of IN O
PTHrP NNP O
and CC O
CXCR4 NNP O
was VBD O
crucial JJ O
for IN O
metastatic JJ O
spread NN O
. . O

Importantly RB O
, , O
PTHrP NNP O
- : O
specific JJ O
neutralizing JJ O
antibodies NNS O
slowed VBD O
the DT O
progression NN O
and CC O
metastasis NN O
of IN O
human JJ O
breast NN O
cancer NN O
xenografts NNS O
. . O

Our PRP$ O
data NNS O
identify VBP O
what WP O
we PRP O
believe VBP O
to TO O
be VB O
new JJ O
functions NNS O
for IN O
PTHrP NN O
in IN O
several JJ O
key JJ O
steps NNS O
of IN O
breast NN O
cancer NN O
and CC O
suggest VBP O
that IN O
PTHrP NNP O
may MD O
constitute VB O
a DT O
novel JJ O
target NN O
for IN O
therapeutic JJ O
intervention NN O
. . O

-DOCSTART- X X O

Aquaporins NNS O
in IN O
human JJ O
breast NN O
cancer NN O
: : O
identification NN O
and CC O
involvement NN O
in IN O
carcinogenesis NN O
of IN O
breast NN O
cancer NN O
. . O

BACKGROUND NNP O
AND CC O
OBJECTIVES NNP O
: : O
Aquaporins NNP O
( -LRB- O
AQPs NNS O
) -RRB- O
play VBP O
important JJ O
roles NNS O
in IN O
water NN O
and CC O
glycerol NN O
transport NN O
. . O

Recently RB O
, , O
the DT O
role NN O
of IN O
AQPs NNS O
in IN O
human JJ O
carcinogenesis NN O
has VBZ O
become VBN O
an DT O
area NN O
of IN O
great JJ O
interest NN O
. . O

However RB O
, , O
little JJ O
is VBZ O
known VBN O
about IN O
the DT O
function NN O
of IN O
AQPs NNS O
in IN O
human JJ O
breast NN O
cancer NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
expression NN O
profile NN O
of IN O
AQPs NNS O
in IN O
human JJ O
breast NN O
cancer NN O
and CC O
its PRP$ O
significance NN O
. . O

METHODS NNS O
: : O
In IN O
this DT O
study NN O
, , O
we PRP O
screened VBD O
the DT O
expression NN O
profile NN O
of IN O
AQP0 DT O
- : O
12 CD O
in IN O
breast NN O
cancer NN O
tissues NNS O
and CC O
corresponding JJ O
normal JJ O
tissues NNS O
by IN O
RT NNP O
- : O
PCR NN O
, , O
Western JJ O
blotting NN O
and CC O
immunohistochemistry NN O
. . O

RESULTS NNS O
: : O
AQP1 NNP O
, , O
3 LS O
- : O
5 CD O
, , O
and CC O
10 CD O
- : O
12 CD O
were VBD O
expressed VBN O
in IN O
human JJ O
breast NN O
cancer NN O
and CC O
/ NN O
or CC O
normal JJ O
breast NN O
tissues NNS O
, , O
and CC O
AQP1 NNP O
and CC O
3 CD O
- : O
5 CD O
exhibited VBN O
differential JJ O
expression NN O
. . O

AQP1 NNP O
was VBD O
expressed VBN O
in IN O
cell NN O
membranes NNS O
and CC O
its PRP$ O
expression NN O
was VBD O
higher JJR O
in IN O
cancer NN O
than IN O
that WDT O
in IN O
normal JJ O
tissues NNS O
. . O

AQP4 NNP O
was VBD O
expressed VBN O
in IN O
the DT O
cell NN O
membrane NN O
and CC O
cytoplasm NN O
and CC O
was VBD O
detected VBN O
markedly RB O
stronger JJR O
in IN O
normal JJ O
than IN O
in IN O
cancer NN O
tissues NNS O
. . O

AQP5 DT O
was VBD O
expressed VBN O
mainly RB O
in IN O
cell NN O
membranes NNS O
in IN O
carcinoma NN O
tissues NNS O
, , O
but CC O
was VBD O
almost RB O
absent JJ O
in IN O
normal JJ O
breast NN O
tissues NNS O
. . O

Expression NN O
of IN O
AQP5 NNP O
was VBD O
associated VBN O
with IN O
cellular JJ O
differentiation NN O
, , O
lymph NN O
node NN O
invasion NN O
, , O
and CC O
clinicopathological JJ O
staging NN O
. . O

CONCLUSIONS NNS O
: : O
These DT O
observations NNS O
suggested VBD O
that IN O
several JJ O
subtypes NNS O
of IN O
the DT O
AQP NNP O
family NN O
play VBP O
a DT O
role NN O
in IN O
human JJ O
breast NN O
carcinogenesis NN O
. . O

-DOCSTART- X X O

Absence NN O
of IN O
antisperm JJ O
antibodies NNS O
in IN O
anejaculatory JJ O
men NNS O
. . O

Antisperm JJ O
antibodies NNS O
were VBD O
assessed VBN O
in IN O
the DT O
serum NN O
samples NNS O
of IN O
73 CD O
men NNS O
unable JJ O
to TO O
ejaculate VB O
naturally RB O
and CC O
on IN O
the DT O
sperm NN O
cells NNS O
of IN O
13 CD O
of IN O
these DT O
men NNS O
. . O

None NN O
of IN O
the DT O
serum NN O
samples NNS O
were VBD O
found VBN O
to TO O
be VB O
positive JJ O
by IN O
sperm NN O
agglutination NN O
or CC O
sperm NN O
immobilization NN O
methods NNS O
and CC O
antibodies NNS O
were VBD O
detected VBN O
by IN O
an DT O
immunobead JJ O
assay NN O
on IN O
the DT O
sperm NN O
cells NNS O
of IN O
one CD O
of IN O
the DT O
13 CD O
men NNS O
examined VBD O
. . O

-DOCSTART- X X O

Research NNP O
and CC O
discovery NN O
of IN O
the DT O
first JJ O
human NN O
cancer NN O
virus NN O
, , O
HTLV NNP O
- : O
1 CD O
. . O

Human JJ O
T NNP O
- : O
cell NN O
lymphoma NN O
virus NN O
( -LRB- O
HTLV NN O
) -RRB- O
- : O
1 CD O
was VBD O
the DT O
first JJ O
human JJ O
retrovirus NN O
to TO O
be VB O
discovered VBN O
. . O

It PRP O
has VBZ O
been VBN O
recognized VBN O
as IN O
the DT O
cause NN O
of IN O
adult NN O
T NNP O
- : O
cell NN O
leukemia NN O
( -LRB- O
ATL NNP O
) -RRB- O
. . O

In IN O
addition NN O
to TO O
giving VBG O
a DT O
historical JJ O
perspective NN O
on IN O
HTLV NNP O
- : O
1 CD O
and CC O
other JJ O
retrovirus NN O
research NN O
, , O
this DT O
paper NN O
discusses VBZ O
the DT O
origin NN O
of IN O
HTLV NNP O
- : O
1 CD O
; : O
the DT O
modes NNS O
of IN O
transmission NN O
and CC O
global JJ O
epidemiology NN O
of IN O
HTLV NNP O
- : O
1 CD O
infection NN O
; : O
the DT O
genome NN O
of IN O
HTLV NNP O
- : O
1 CD O
and CC O
the DT O
mechanism NN O
of IN O
HTLV NNP O
- : O
1 LS O
- : O
induced VBN O
leukemogenesis NN O
; : O
the DT O
role NN O
of IN O
HTLV NNP O
- : O
1 CD O
in IN O
other JJ O
diseases NNS O
, , O
and CC O
recent JJ O
breakthroughs NNS O
in IN O
ATL NNP O
therapy NN O
. . O

-DOCSTART- X X O

Relationship NN O
between IN O
of IN O
blood NN O
flow NN O
, , O
glucose NN O
metabolism NN O
, , O
protein NN O
synthesis NN O
, , O
glucose NN O
and CC O
ATP NNP O
content NN O
in IN O
experimentally RB O
- : O
induced JJ O
glioma NN O
( -LRB- O
RG1 NNP O
2 CD O
. . O
2 CD O
) -RRB- O
of IN O
rat NN O
brain NN O
. . O

In IN O
experimental JJ O
RG1 NN O
2 CD O
. . O
2 CD O
glioma NN O
of IN O
rat NN O
brain NN O
, , O
local JJ O
blood NN O
flow NN O
, , O
glucose DT O
utilization NN O
, , O
protein NN O
synthesis NN O
, , O
glucose NN O
and CC O
ATP NNP O
content NN O
were VBD O
measured VBN O
by IN O
means NNS O
of IN O
triple JJ O
tracer NN O
autoradiography NN O
and CC O
bioluminescence NN O
technique NN O
, , O
respectively RB O
, , O
to TO O
determine VB O
hemodynamic JJ O
and CC O
metabolic JJ O
thresholds NNS O
for IN O
local JJ O
tumor NN O
energy NN O
failure NN O
. . O

Perfusion NNP O
thresholds NNS O
were VBD O
estimated VBN O
at IN O
tumor NN O
blood NN O
flow NN O
values NNS O
of IN O
69 CD O
. . O
0 CD O
+ NN O
/ NNS O
- : O
0 CD O
. . O
1 CD O
ml NN O
/ IN O
100 CD O
g NN O
/ NN O
min NN O
( -LRB- O
estimate NN O
+ NN O
/ IN O
- : O
standard JJ O
error NN O
) -RRB- O
and CC O
of IN O
69 CD O
+ NN O
/ NNS O
- : O
7 CD O
. . O
1 CD O
ml NN O
/ IN O
100 CD O
g NN O
/ NN O
min NN O
for IN O
the DT O
beginning NN O
of IN O
the DT O
decline NN O
in IN O
regional JJ O
ATP NNP O
and CC O
glucose NN O
content NN O
, , O
respectively RB O
. . O

Metabolic NNP O
thresholds NNS O
were VBD O
derived VBN O
at IN O
tumor NN O
glucose NN O
utilization NN O
values NNS O
of IN O
70 CD O
. . O
6 CD O
+ NN O
/ NN O
- : O
8 CD O
. . O
3 CD O
mumol NN O
/ IN O
100 CD O
g NN O
/ NN O
min NN O
for IN O
reduced JJ O
protein NN O
synthesis NN O
, , O
of IN O
55 CD O
. . O
0 CD O
+ NN O
/ NNS O
- : O
0 CD O
. . O
2 CD O
mumol NN O
/ IN O
100 CD O
g NN O
/ NN O
min NN O
for IN O
the DT O
decrease NN O
in IN O
glucose NN O
content NN O
, , O
and CC O
34 CD O
. . O
7 CD O
+ NN O
/ NN O
- : O
4 CD O
. . O
7 CD O
mumol NN O
/ IN O
100 CD O
g NN O
/ NN O
min NN O
for IN O
decline NN O
in IN O
ATP NNP O
content NN O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
blood NN O
flow NN O
limits NNS O
glucose NN O
supply NN O
to TO O
tumor NN O
tissue NN O
at IN O
much RB O
higher JJR O
flow NN O
rates NNS O
than IN O
in IN O
normal JJ O
brain NN O
which WDT O
, , O
in IN O
turn NN O
, , O
is VBZ O
associated VBN O
with IN O
a DT O
decrease NN O
in IN O
tumor NN O
glucose NN O
utilization NN O
. . O

A DT O
reduction NN O
and CC O
not RB O
an DT O
increase NN O
in IN O
tumor NN O
glucose NN O
availability NN O
could MD O
be VB O
a DT O
more RBR O
appropriate JJ O
strategy NN O
for IN O
the DT O
induction NN O
of IN O
energy NN O
failure NN O
in IN O
tumors NNS O
. . O

-DOCSTART- X X O

Selective JJ O
inhibition NN O
of IN O
nuclear JJ O
factor NN O
- : O
kappaB NN O
by IN O
nuclear JJ O
factor NN O
- : O
kappaB NN O
essential JJ O
modulator NN O
- : O
binding JJ O
domain NN O
peptide NN O
suppresses VBZ O
the DT O
metastasis NN O
of IN O
highly RB O
metastatic JJ O
oral JJ O
squamous JJ O
cell NN O
carcinoma NN O
. . O

Nuclear NNP O
factor NN O
- : O
kappaB NN O
( -LRB- O
NF NNP O
- : O
kappaB NN O
) -RRB- O
activation NN O
contributes VBZ O
to TO O
the DT O
development NN O
of IN O
metastasis NN O
, , O
thus RB O
leading VBG O
to TO O
a DT O
poor JJ O
prognosis NN O
in IN O
many JJ O
cancers NNS O
, , O
including VBG O
OSCC NNP O
. . O

However RB O
, , O
little JJ O
in IN O
vivo JJ O
experimental JJ O
data NNS O
are VBP O
available JJ O
about IN O
the DT O
effects NNS O
of IN O
NF NNP O
- : O
kappaB NN O
inhibition NN O
on IN O
OSCC NNP O
metastasis NN O
. . O

OSCC NNP B-NP
sublines NNS O
were VBD O
established VBN O
from IN O
a DT O
GFP NNP O
- : O
expressing VBG O
parental JJ O
cell NN O
line NN O
, , O
GSAS NNP B-NP
, , O
and CC O
designated VBD O
GSAS NNP B-NP
/ NNP O
N3 NNP O
and CC O
N5 NNP O
according VBG O
to TO O
the DT O
in IN O
vivo JJ O
passage NN O
number NN O
after IN O
cervical JJ O
lymph NN O
node NN O
metastasis NN O
by IN O
a DT O
serial JJ O
orthotopic JJ O
transplantation NN O
model NN O
. . O

In IN O
vitro NN O
migration NN O
and CC O
invasion NN O
were VBD O
assessed VBN O
in IN O
these DT O
cells NNS O
, , O
and CC O
the DT O
NF NNP O
- : O
kappaB NN O
activities NNS O
and CC O
expression NN O
of IN O
NF NNP O
- : O
kappaB FW O
- : O
regulated VBN O
metastasis NN O
- : O
related VBN O
molecules NNS O
were VBD O
also RB O
examined VBN O
. . O

In IN O
in IN O
vivo JJ O
experiments NNS O
, , O
the DT O
metastasis NN O
and CC O
survival NN O
of IN O
tumor NN O
- : O
engrafted VBN O
mice NNS O
were VBD O
monitored VBN O
. . O

Furthermore RB O
, , O
the DT O
effects NNS O
of IN O
a DT O
selective JJ O
NF NNP O
- : O
kappaB NN O
inhibitor NN O
, , O
NEMO NNP O
- : O
binding JJ O
domain NN O
( -LRB- O
NBD NNP O
) -RRB- O
peptide NN O
, , O
on IN O
metastasis NN O
in IN O
GSAS NNP B-NP
/ NNP O
N5 . O
- : O
engrafted VBN O
mice NNS O
were VBD O
assessed VBN O
, , O
and CC O
engrafted JJ O
tongue NN O
tumors NNS O
were VBD O
immunohistochemically RB O
examined VBN O
. . O

Highly NNP O
metastatic JJ O
GSAS NNP B-NP
/ NNP O
N3 NNP O
and CC O
N5 NNP O
cells NNS O
showed VBD O
an DT O
enhanced JJ O
NF NNP O
- : O
kappaB NN O
activity NN O
, , O
thus RB O
contributing VBG O
to TO O
increased VB O
migration NN O
, , O
invasion NN O
, , O
and CC O
a DT O
poor JJ O
prognosis NN O
compared VBN O
with IN O
the DT O
parent NN O
cells NNS O
. . O

Furthermore RB O
, , O
the DT O
expression NN O
levels NNS O
of IN O
NF NNP O
- : O
kappaB FW O
- : O
regulated VBN O
metastasis NN O
- : O
related VBN O
molecules NNS O
, , O
such JJ O
as IN O
fibronectin NNS O
, , O
beta1 IN O
integrin NN O
, , O
MMP NNP O
- : O
1 CD O
, , O
- : O
2 CD O
, , O
- : O
9 CD O
, , O
and CC O
- : O
14 CD O
, , O
and CC O
VEGF NNP O
- : O
C NNP O
, , O
were VBD O
upregulated VBN O
in IN O
the DT O
highly RB O
metastatic JJ O
cells NNS O
. . O

The DT O
NBD NNP O
peptide NN O
suppressed VBD O
metastasis NN O
and CC O
tongue NN O
tumor NN O
growth NN O
in IN O
GSAS NNP B-NP
/ , O
N5 DT O
- : O
inoculated VBN O
mice NNS O
, , O
and CC O
was VBD O
accompanied VBN O
by IN O
the DT O
downregulation NN O
of IN O
the DT O
NF NNP O
- : O
kappaB FW O
- : O
regulated VBN O
metastasis NN O
- : O
related VBN O
molecules NNS O
in IN O
engrafted JJ O
tongue NN O
tumors NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
selective JJ O
inhibition NN O
of IN O
NF NNP O
- : O
kappaB NN O
activation NN O
by IN O
NBD NNP O
peptide NN O
may MD O
provide VB O
an DT O
effective JJ O
approach NN O
for IN O
the DT O
treatment NN O
of IN O
highly RB O
metastatic JJ O
OSCC NNP O
. . O

-DOCSTART- X X O

beta JJ O
- : O
catenin NN O
signaling VBG O
controls NNS O
metastasis NN O
in IN O
Braf NNP O
- : O
activated JJ O
Pten NNP O
- : O
deficient JJ O
melanomas NN O
. . O

Malignant JJ O
melanoma NN O
is VBZ O
characterized VBN O
by IN O
frequent JJ O
metastasis NN O
, , O
however RB O
, , O
specific JJ O
changes NNS O
that IN O
regulate VB O
this DT O
process NN O
have VBP O
not RB O
been VBN O
clearly RB O
delineated VBN O
. . O

Although IN O
it PRP O
is VBZ O
well RB O
known VBN O
that IN O
Wnt NNP O
signaling NN O
is VBZ O
frequently RB O
dysregulated VBN O
in IN O
melanoma NN O
, , O
the DT O
functional JJ O
implications NNS O
of IN O
this DT O
observation NN O
are VBP O
unclear JJ O
. . O

By IN O
modulating VBG O
beta JJ O
- : O
catenin NN O
levels NNS O
in IN O
a DT O
mouse NN O
model NN O
of IN O
melanoma NN O
that WDT O
is VBZ O
based VBN O
on IN O
melanocyte NN O
- : O
specific JJ O
Pten JJ O
loss NN O
and CC O
Braf NNP O
( -LRB- O
V600E NN O
) -RRB- O
mutation NN O
, , O
we PRP O
demonstrate VBP O
that IN O
beta JJ O
- : O
catenin NN O
is VBZ O
a DT O
central JJ O
mediator NN O
of IN O
melanoma NN O
metastasis NN O
to TO O
the DT O
lymph NN O
nodes NNS O
and CC O
lungs NNS O
. . O

In IN O
addition NN O
to TO O
altering VBG O
metastasis NN O
, , O
beta JJ O
- : O
catenin NN O
levels NNS O
control VBP O
tumor NN O
differentiation NN O
and CC O
regulate VB O
both DT O
MAPK NNP O
/ NNP O
Erk NNP O
and CC O
PI3K NNP O
/ NNP O
Akt NNP O
signaling NN O
. . O

Highly NNP O
metastatic JJ O
tumors NNS O
with IN O
beta JJ O
- : O
catenin NN O
stabilization NN O
are VBP O
very RB O
similar JJ O
to TO O
a DT O
subset NN O
of IN O
human JJ O
melanomas NN O
. . O

Together RB O
these DT O
findings NNS O
establish VBP O
Wnt JJ O
signaling NN O
as IN O
a DT O
metastasis NN O
regulator NN O
in IN O
melanoma NN O
. . O

-DOCSTART- X X O

Impaired VBN O
CK1 JJ O
delta NN O
activity NN O
attenuates NNS O
SV40 VBP O
- : O
induced VBN O
cellular JJ O
transformation NN O
in IN O
vitro NN O
and CC O
mouse NN O
mammary NN O
carcinogenesis NN O
in IN O
vivo NN O
. . O

Simian NNP O
virus NN O
40 CD O
( -LRB- O
SV40 NN O
) -RRB- O
is VBZ O
a DT O
powerful JJ O
tool NN O
to TO O
study VB O
cellular JJ O
transformation NN O
in IN O
vitro NN O
, , O
as RB O
well RB O
as IN O
tumor NN O
development NN O
and CC O
progression NN O
in IN O
vivo NN O
. . O

Various JJ O
cellular JJ O
kinases NNS O
, , O
among IN O
them PRP O
members NNS O
of IN O
the DT O
CK1 NNP O
family NN O
, , O
play VB O
an DT O
important JJ O
role NN O
in IN O
modulating VBG O
the DT O
transforming NN O
activity NN O
of IN O
SV40 NNP O
, , O
including VBG O
the DT O
transforming JJ O
activity NN O
of IN O
T NNP O
- : O
Ag NNP O
, , O
the DT O
major JJ O
transforming JJ O
protein NN O
of IN O
SV40 NN O
, , O
itself PRP O
. . O

Here RB O
we PRP O
characterized VBD O
the DT O
effects NNS O
of IN O
mutant JJ O
CK1delta NNP O
variants NNS O
with IN O
impaired JJ O
kinase NN O
activity NN O
on IN O
SV40 DT O
- : O
induced VBN O
cell NN O
transformation NN O
in IN O
vitro NN O
, , O
and CC O
on IN O
SV40 DT O
- : O
induced VBN O
mammary JJ O
carcinogenesis NN O
in IN O
vivo NN O
in IN O
a DT O
transgenic JJ O
/ NN O
bi NN O
- : O
transgenic JJ O
mouse NN O
model NN O
. . O

CK1delta NNP O
mutants NNS O
exhibited VBD O
a DT O
reduced JJ O
kinase NN O
activity NN O
compared VBN O
to TO O
wtCK1delta JJ O
in IN O
in IN O
vitro NN O
kinase NN O
assays VBZ O
. . O

Molecular JJ O
modeling JJ O
studies NNS O
suggested VBD O
that IN O
mutation NN O
N172D NN O
, , O
located VBN O
within IN O
the DT O
substrate JJ O
binding JJ O
region NN O
, , O
is VBZ O
mainly RB O
responsible JJ O
for IN O
impaired JJ O
mutCK1delta JJ O
activity NN O
. . O

When WRB O
stably RB O
over IN O
- : O
expressed VBN O
in IN O
maximal NN O
transformed VBN O
SV NNP B-NP
- : I-NP
52 CD I-NP
cells NNS O
, , O
CK1delta NNP O
mutants NNS O
induced VBD O
reversion NN O
to TO O
a DT O
minimal JJ O
transformed VBN O
phenotype NN O
by IN O
dominant JJ O
- : O
negative JJ O
interference NN O
with IN O
endogenous JJ O
wtCK1delta NN O
. . O

To TO O
characterize VB O
the DT O
effects NNS O
of IN O
CK1delta NNP O
on IN O
SV40 DT O
- : O
induced VBN O
mammary JJ O
carcinogenesis NN O
, , O
we PRP O
generated VBD O
transgenic JJ O
mice NNS O
expressing VBG O
mutant JJ O
CK1delta NNP O
under IN O
the DT O
control NN O
of IN O
the DT O
whey NN O
acidic JJ O
protein NN O
( -LRB- O
WAP NNP O
) -RRB- O
gene NN O
promoter NN O
, , O
and CC O
crossed VBD O
them PRP O
with IN O
SV40 DT O
transgenic JJ O
WAP NNP O
- : O
T NNP O
- : O
antigen NN O
( -LRB- O
WAP NNP O
- : O
T NNP O
) -RRB- O
mice NNS O
. . O

Both DT O
WAP NNP O
- : O
T NNP O
mice NNS O
as RB O
well RB O
as IN O
WAP NNP O
- : O
mutCK1delta JJ O
/ NN O
WAP NNP O
- : O
T NNP O
bi FW O
- : O
transgenic JJ O
mice NNS O
developed JJ O
breast NN O
cancer NN O
. . O

However RB O
, , O
tumor NN O
incidence NN O
was VBD O
lower JJR O
and CC O
life NN O
span NN O
was VBD O
significantly RB O
longer RB O
in IN O
WAP NNP O
- : O
mutCK1delta JJ O
/ NN O
WAP NNP O
- : O
T NNP O
bi FW O
- : O
transgenic JJ O
animals NNS O
. . O

The DT O
reduced VBD O
CK1delta NNP O
activity NN O
did VBD O
not RB O
affect VB O
early JJ O
lesion NN O
formation NN O
during IN O
tumorigenesis NN O
, , O
suggesting VBG O
that IN O
impaired JJ O
CK1delta NN O
activity NN O
reduces VBZ O
the DT O
probability NN O
for IN O
outgrowth NN O
of IN O
in IN O
situ FW O
carcinomas NNS O
to TO O
invasive VB O
carcinomas NNS O
. . O

The DT O
different JJ O
tumorigenic JJ O
potential NN O
of IN O
SV40 NNP O
in IN O
WAP NNP O
- : O
T NNP O
and CC O
WAP NNP O
- : O
mutCK1delta JJ O
/ NN O
WAP NNP O
- : O
T NNP O
tumors NNS O
was VBD O
also RB O
reflected VBN O
by IN O
a DT O
significantly RB O
different JJ O
expression NN O
of IN O
various JJ O
genes NNS O
known VBN O
to TO O
be VB O
involved VBN O
in IN O
tumor NN O
progression NN O
, , O
specifically RB O
of IN O
those DT O
involved VBN O
in IN O
wnt NN O
- : O
signaling NN O
and CC O
DNA NN O
repair NN O
. . O

Our PRP$ O
data NNS O
show VBP O
that IN O
inactivating JJ O
mutations NNS O
in IN O
CK1delta NNP O
impair NN O
SV40 . O
- : O
induced VBN O
cellular JJ O
transformation NN O
in IN O
vitro NN O
and CC O
mouse NN O
mammary NN O
carcinogenesis NN O
in IN O
vivo NN O
. . O

-DOCSTART- X X O

Mitochondrial NNP O
apoptosis NN O
and CC O
FAK NNP O
signaling VBG O
disruption NN O
by IN O
a DT O
novel NN O
histone NN O
deacetylase NN O
inhibitor NN O
, , O
HTPB NNP O
, , O
in IN O
antitumor NN O
and CC O
antimetastatic JJ O
mouse NN O
models NNS O
. . O

BACKGROUND NNP O
: : O
Compound NNP O
targeting VBG O
histone NN O
deacetylase NN O
( -LRB- O
HDAC NNP O
) -RRB- O
represents VBZ O
a DT O
new JJ O
era NN O
in IN O
molecular JJ O
cancer NN O
therapeutics NNS O
. . O

However RB O
, , O
effective JJ O
HDAC NNP O
inhibitors NNS O
for IN O
the DT O
treatment NN O
of IN O
solid JJ O
tumors NNS O
remain VBP O
to TO O
be VB O
developed VBN O
. . O

METHODOLOGY NNP O
/ NNP O
PRINCIPAL NNP O
FINDINGS NNP O
: : O
Here RB O
, , O
we PRP O
propose VBP O
a DT O
novel NN O
HDAC NNP O
inhibitor VBD O
, , O
N NNP O
- : O
Hydroxy JJ O
- : O
4 CD O
- : O
( -LRB- O
4 LS O
- : O
phenylbutyryl NN O
- : O
amino IN O
) -RRB- O
benzamide IN O
( -LRB- O
HTPB NN O
) -RRB- O
, , O
as IN O
a DT O
potential JJ O
chemotherapeutic NN O
drug NN O
for IN O
solid JJ O
tumors NNS O
. . O

The DT O
HDAC NNP O
inhibition NN O
of IN O
HTPB NNP O
was VBD O
confirmed VBN O
using VBG O
HDAC NNP O
activity NN O
assay NN O
. . O

The DT O
antiproliferative JJ O
and CC O
anti JJ O
- : O
migratory JJ O
mechanisms NNS O
of IN O
HTPB NNP O
were VBD O
investigated VBN O
by IN O
cell NN O
proliferation NN O
, , O
flow NN O
cytometry NN O
, , O
DNA NNP O
ladder NN O
, , O
caspase NN O
activity NN O
, , O
Rho NNP O
activity NN O
, , O
F NNP O
- : O
actin NN O
polymerization NN O
, , O
and CC O
gelatin NNP O
- : O
zymography NN O
for IN O
matrix NN O
metalloproteinases NNS O
( -LRB- O
MMPs NNS O
) -RRB- O
. . O

Mice NNP O
with IN O
tumor NN O
xenograft NN O
and CC O
experimental JJ O
metastasis NN O
model NN O
were VBD O
used VBN O
to TO O
evaluate VB O
effects NNS O
on IN O
tumor NN O
growth NN O
and CC O
metastasis NN O
. . O

Our PRP$ O
results NNS O
indicated VBD O
that IN O
HTPB NNP O
was VBD O
a DT O
pan NN O
- : O
HDAC NNP O
inhibitor NN O
in IN O
suppressing VBG O
cell NN O
viability NN O
specifically RB O
of IN O
lung NN O
cancer NN O
cells NNS O
but CC O
not RB O
of IN O
the DT O
normal JJ O
lung NN O
cells NNS O
. . O

Upon IN O
HTPB NNP O
treatment NN O
, , O
cell NN O
cycle NN O
arrest NN O
was VBD O
induced JJ O
and CC O
subsequently RB O
led VBD O
to TO O
mitochondria NNS O
- : O
mediated JJ O
apoptosis NN O
. . O

HTPB NNP O
disrupted VBD O
F NNP O
- : O
actin NN O
dynamics NNS O
via IN O
downregulating VBG O
RhoA NNP O
activity NN O
. . O

Moreover RB O
, , O
HTPB NNP O
inhibited VBD O
activity NN O
of IN O
MMP2 NNP O
and CC O
MMP9 NNP O
, , O
reduced VBN O
integrin NN O
- : O
beta1 CD O
/ NN O
focal JJ O
adhesion NN O
complex NN O
formation NN O
and CC O
decreased VBD O
pericellular JJ O
poly NN O
- : O
fibronectin NN O
assemblies NNS O
. . O

Finally RB O
, , O
intraperitoneal JJ O
injection NN O
or CC O
oral JJ O
administration NN O
of IN O
HTPB NNP O
efficiently RB O
inhibited VBD O
A549 DT B-NP
xenograft NN O
tumor NN O
growth NN O
in IN O
vivo NN O
without IN O
side NN O
effects NNS O
. . O

HTPB NN O
delayed VBD O
lung NN O
metastasis NN O
of IN O
4T1 JJ B-NP
mouse NN O
breast NN O
cancer NN O
cells NNS O
. . O

Acetylation NN O
of IN O
histone NN O
and CC O
non JJ O
- : O
histone NN O
proteins NNS O
, , O
induction NN O
of IN O
apoptotic JJ O
- : O
related JJ O
proteins NNS O
and CC O
de FW O
- : O
phosphorylation NN O
of IN O
focal JJ O
adhesion NN O
kinase NN O
were VBD O
confirmed VBN O
in IN O
treated VBN O
mice NNS O
. . O

CONCLUSIONS NNS O
/ JJ O
SIGNIFICANCE NNP O
: : O
These DT O
results NNS O
suggested VBD O
that IN O
intrinsic JJ O
apoptotic JJ O
pathway NN O
may MD O
involve VB O
in IN O
anti NNS O
- : O
tumor NN O
growth NN O
effects NNS O
of IN O
HTPB NN O
in IN O
lung NN O
cancer NN O
cells NNS O
. . O

HTPB NNP O
significantly RB O
suppresses VBZ O
tumor NN O
metastasis NN O
partly RB O
through IN O
inhibition NN O
of IN O
integrin NN O
- : O
beta1 CD O
/ NN O
FAK NNP O
/ NNP O
MMP NNP O
/ NNP O
RhoA NNP O
/ NNP O
F NNP O
- : O
actin NN O
pathways NNS O
. . O

We PRP O
have VBP O
provided VBN O
convincing VBG O
preclinical JJ O
evidence NN O
that IN O
HTPB NNP O
is VBZ O
a DT O
potent JJ O
HDAC NNP O
targeted JJ O
inhibitor NN O
and CC O
is VBZ O
thus RB O
a DT O
promising JJ O
candidate NN O
for IN O
lung NN O
cancer NN O
chemotherapy NN O
. . O

-DOCSTART- X X O

Inactivation NN O
of IN O
androgen NN O
- : O
induced VBN O
regulator NN O
ARD1 NN O
inhibits VBZ O
androgen NN O
receptor NN O
acetylation NN O
and CC O
prostate NN O
tumorigenesis NN O
. . O

Androgen NN O
signaling VBG O
through IN O
androgen NN O
receptor NN O
( -LRB- O
AR NN O
) -RRB- O
is VBZ O
critical JJ O
for IN O
prostate NN O
tumorigenesis NN O
. . O

Given VBN O
that IN O
AR NN O
- : O
mediated VBN O
gene NN O
regulation NN O
is VBZ O
enhanced VBN O
by IN O
AR NN O
coregulators NNS O
, , O
inactivation NN O
of IN O
those DT O
coregulators NNS O
is VBZ O
emerging VBG O
as IN O
a DT O
promising JJ O
therapy NN O
for IN O
prostate NN O
cancer NN O
( -LRB- O
PCa NN O
) -RRB- O
. . O

Here RB O
, , O
we PRP O
show VBP O
that IN O
the DT O
N NNP O
- : O
acetyltransferase NN O
arrest NN O
- : O
defect NN O
1 CD O
protein NN O
( -LRB- O
ARD1 NN O
) -RRB- O
functions VBZ O
as IN O
a DT O
unique JJ O
AR NN O
regulator NN O
in IN O
PCa NNP O
cells NNS O
. . O

ARD1 NN O
is VBZ O
up RB O
- : O
regulated VBN O
in IN O
human JJ O
PCa NN O
cell NN O
lines NNS O
and CC O
primary JJ O
tumor NN O
biopsies NNS O
. . O

The DT O
expression NN O
of IN O
ARD1 NNP O
was VBD O
augmented VBN O
by IN O
treatment NN O
with IN O
synthetic JJ O
androgen NN O
( -LRB- O
R1881 NN O
) -RRB- O
unless IN O
AR NN O
is VBZ O
deficient JJ O
or CC O
is VBZ O
inhibited VBN O
by IN O
AR NN O
- : O
specific JJ O
siRNA NN O
or CC O
androgen NN O
inhibitor NN O
bicalutamide NN O
( -LRB- O
Casodex NNP O
) -RRB- O
. . O

Depletion NNP O
of IN O
ARD1 NNP O
by IN O
shRNA DT O
suppressed VBN O
PCa NNP O
cell NN O
proliferation NN O
, , O
anchorage NN O
- : O
independent JJ O
growth NN O
, , O
and CC O
xenograft NN O
tumor NN O
formation NN O
in IN O
SCID NNP O
mice NNS O
, , O
suggesting VBG O
that IN O
AR NN O
- : O
dependent JJ O
ARD1 JJ O
expression NN O
is VBZ O
biologically RB O
germane JJ O
. . O

Notably RB O
, , O
ARD1 NNP O
was VBD O
critical JJ O
for IN O
transcriptionally RB O
regulating VBG O
a DT O
number NN O
of IN O
AR NN O
target NN O
genes NNS O
that WDT O
are VBP O
involved VBN O
in IN O
prostate NN O
tumorigenesis NN O
. . O

Furthermore RB O
, , O
ARD1 NNP O
interacted VBD O
physically RB O
with IN O
and CC O
acetylated VBD O
the DT O
AR NN O
protein NN O
in IN O
vivo NN O
and CC O
in IN O
vitro NN O
. . O

Because IN O
AR NN O
- : O
ARD1 NN O
interaction NN O
facilitated VBD O
the DT O
AR NN O
binding NN O
to TO O
its PRP$ O
targeted JJ O
promoters NNS O
for IN O
gene NN O
transcription NN O
, , O
we PRP O
propose VBP O
that IN O
ARD1 JJ O
functions NNS O
as IN O
a DT O
unique JJ O
AR NN O
regulator NN O
and CC O
forms NNS O
a DT O
positive JJ O
feedback NN O
loop NN O
for IN O
AR NN O
- : O
dependent JJ O
prostate NN O
tumorigenesis NN O
. . O

Disruption NN O
of IN O
AR NN O
- : O
ARD1 NN O
interactions NNS O
may MD O
be VB O
a DT O
potent JJ O
intervention NN O
for IN O
androgen NN O
- : O
dependent JJ O
PCa JJ O
therapy NN O
. . O

-DOCSTART- X X O

The DT O
role NN O
of IN O
Hes NNP O
genes NNS O
in IN O
intestinal JJ O
development NN O
, , O
homeostasis NN O
and CC O
tumor NN O
formation NN O
. . O

Notch NN O
signaling VBG O
regulates VBZ O
intestinal JJ O
development NN O
, , O
homeostasis NN O
and CC O
tumorigenesis NN O
, , O
but CC O
its PRP$ O
precise JJ O
downstream NN O
mechanism NN O
remains VBZ O
largely RB O
unknown JJ O
. . O

Here RB O
we PRP O
found VBD O
that IN O
inactivation NN O
of IN O
the DT O
Notch NNP O
effectors NNS O
Hes1 NNP O
, , O
Hes3 NNP O
and CC O
Hes5 NNP O
, , O
but CC O
not RB O
Hes1 NNP O
alone RB O
, , O
led VBN O
to TO O
reduced VBN O
cell NN O
proliferation NN O
, , O
increased VBN O
secretory NN O
cell NN O
formation NN O
and CC O
altered JJ O
intestinal JJ O
structures NNS O
in IN O
adult NN O
mice NNS O
. . O

However RB O
, , O
in IN O
Apc NNP O
mutation NN O
- : O
induced VBN O
intestinal JJ O
tumors NNS O
, , O
inactivation NN O
of IN O
Hes1 NNP O
alone RB O
was VBD O
sufficient JJ O
for IN O
reducing VBG O
tumor NN O
cell NN O
proliferation NN O
and CC O
inducing NN O
differentiation NN O
of IN O
tumor NN O
cells NNS O
into IN O
all DT O
types NNS O
of IN O
intestinal JJ O
epithelial NN O
cells NNS O
, , O
but CC O
without IN O
affecting VBG O
the DT O
homeostasis NN O
of IN O
normal JJ O
crypts NNS O
owing VBG O
to TO O
genetic JJ O
redundancy NN O
. . O

These DT O
results NNS O
indicated VBD O
that IN O
Hes NNP O
genes NNS O
cooperatively RB O
regulate VB O
intestinal JJ O
development NN O
and CC O
homeostasis NN O
and CC O
raised VBD O
the DT O
possibility NN O
that IN O
Hes1 NNP O
is VBZ O
a DT O
promising JJ O
target NN O
to TO O
induce VB O
the DT O
differentiation NN O
of IN O
tumor NN O
cells NNS O
. . O

-DOCSTART- X X O

Activation NN O
- : O
induced VBN O
cytidine NN O
deaminase NN O
in IN O
antibody NN O
diversification NN O
and CC O
chromosome NN O
translocation NN O
. . O

DNA NNP O
damage NN O
, , O
rearrangement NN O
, , O
and CC O
mutation NN O
of IN O
the DT O
human JJ O
genome NN O
are VBP O
the DT O
basis NN O
of IN O
carcinogenesis NN O
and CC O
thought VBD O
to TO O
be VB O
avoided VBN O
at IN O
all DT O
costs NNS O
. . O

An DT O
exception NN O
is VBZ O
the DT O
adaptive JJ O
immune JJ O
system NN O
where WRB O
lymphocytes NNS O
utilize VBP O
programmed VBN O
DNA NNP O
damage NN O
to TO O
effect NN O
antigen RB O
receptor NN O
diversification NN O
. . O

Both DT O
B NNP O
and CC O
T NNP O
lymphocytes NNS O
diversify VB O
their PRP$ O
antigen JJ O
receptors NNS O
through IN O
RAG1 NNP O
/ NNP O
2 CD O
mediated JJ O
recombination NN O
, , O
but CC O
B NNP O
cells NNS O
undergo VBP O
two CD O
additional JJ O
processes NNS O
- : O
- : O
somatic JJ O
hypermutation NN O
( -LRB- O
SHM NNP O
) -RRB- O
and CC O
class NN O
- : O
switch NN O
recombination NN O
( -LRB- O
CSR NNP O
) -RRB- O
, , O
both DT O
initiated VBN O
by IN O
activation NN O
- : O
induced VBN O
cytidine NN O
deaminase NN O
( -LRB- O
AID NNP O
) -RRB- O
. . O

AID NNP O
deaminates VBZ O
cytidines NNS O
in IN O
DNA NNP O
resulting VBG O
in IN O
U NNP O
: : O
G NNP O
mismatches NNS O
that WDT O
are VBP O
processed VBN O
into IN O
point NN O
mutations NNS O
in IN O
SHM NNP O
or CC O
double VB O
- : O
strand NN O
breaks NNS O
in IN O
CSR NNP O
. . O

Although IN O
AID NNP O
activity NN O
is VBZ O
focused VBN O
at IN O
Immunoglobulin NNP O
( -LRB- O
Ig NN O
) -RRB- O
gene NN O
loci NNS O
, , O
it PRP O
also RB O
targets VBZ O
a DT O
wide JJ O
array NN O
of IN O
non FW O
- : O
Ig VB O
genes NNS O
including VBG O
oncogenes NNS O
associated VBN O
with IN O
lymphomas NNS O
. . O

Here RB O
, , O
we PRP O
review VBP O
the DT O
molecular JJ O
basis NN O
of IN O
AID NNP O
regulation NN O
, , O
targeting VBG O
, , O
and CC O
initiation NN O
of IN O
CSR NNP O
and CC O
SHM NNP O
, , O
as RB O
well RB O
as IN O
AID NNP O
' POS O
s PRP O
role NN O
in IN O
generating VBG O
chromosome NN O
translocations NNS O
that WDT O
contribute VBP O
to TO O
lymphomagenesis NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
HER2 NNP O
and CC O
bradykinin NN O
B1 IN O
receptors NNS O
in IN O
precursor NN O
lesions NNS O
of IN O
gallbladder NN O
carcinoma NN O
. . O

AIM NNP O
: : O
To TO O
determine VB O
the DT O
expression NN O
of IN O
HER2 NNP O
and CC O
bradykinin NN O
B NNP O
( -LRB- O
1 CD O
) -RRB- O
receptors NNS O
( -LRB- O
B NNP O
( -LRB- O
1 CD O
) -RRB- O
R NN O
) -RRB- O
in IN O
the DT O
two CD O
pathogenic JJ O
models NNS O
of IN O
gallbladder NN O
cancer NN O
: : O
the DT O
metaplasia NN O
- : O
dysplasia SYM O
- : O
carcinoma NN O
and CC O
the DT O
adenoma NN O
- : O
carcinoma NN O
pathways NNS O
. . O

METHODS NNS O
: : O
Receptor JJ O
proteins NNS O
were VBD O
visualized VBN O
by IN O
immunohistochemistry NN O
on IN O
5 CD O
- : O
mum NN O
sections NNS O
of IN O
paraffin JJ O
- : O
embedded VBN O
tissue NN O
. . O

Expression NN O
of IN O
both DT O
receptors NNS O
was VBD O
studied VBN O
in IN O
biopsy NN O
samples NNS O
from IN O
92 CD O
patients NNS O
( -LRB- O
6 CD O
males NNS O
and CC O
86 CD O
females NNS O
; : O
age NN O
ranging VBG O
from IN O
28 CD O
to TO O
86 CD O
years NNS O
, , O
mean VBP O
56 CD O
years NNS O
) -RRB- O
. . O

High NNP O
HER2 NNP O
expression NN O
in IN O
specimens NNS O
was VBD O
additionally RB O
investigated VBN O
by IN O
fluorescence NN O
in IN O
situ FW O
hybridization NN O
. . O

Cell NNP O
proliferation NN O
in IN O
each DT O
sample NN O
was VBD O
assessed VBN O
by IN O
using VBG O
the DT O
Ki NNP O
- : O
67 CD O
proliferation NN O
marker NN O
. . O

RESULTS NNS O
: : O
HER2 NN O
receptor NN O
protein NN O
was VBD O
absent JJ O
in IN O
adenomas NNS O
and CC O
in IN O
normal JJ O
gallbladder NN O
epithelium NN O
. . O

On IN O
the DT O
contrary NN O
, , O
there EX O
was VBD O
intense JJ O
staining NN O
for IN O
HER2 NNP O
on IN O
the DT O
basolateral JJ O
membrane NN O
of IN O
epithelial JJ O
cells NNS O
of IN O
intestinal JJ O
metaplasia NN O
( -LRB- O
22 CD O
/ RB O
24 CD O
; : O
91 CD O
. . O
7 CD O
% NN O
) -RRB- O
and CC O
carcinoma NN O
in IN O
situ FW O
( -LRB- O
9 CD O
/ NN O
10 CD O
; : O
90 CD O
% NN O
) -RRB- O
, , O
the DT O
lesions NNS O
that WDT O
displayed VBD O
a DT O
significantly RB O
high JJ O
proliferation NN O
index NN O
. . O

Protein NNP O
up IN O
- : O
regulation NN O
of IN O
HER2 NNP O
in IN O
the DT O
epithelium NN O
with IN O
metaplasia NN O
or CC O
carcinoma NN O
in IN O
situ NN O
was VBD O
not RB O
accompanied VBN O
by IN O
HER2 NNP O
gene NN O
amplification NN O
. . O

A DT O
similar JJ O
result NN O
was VBD O
observed VBN O
in IN O
invasive JJ O
carcinomas NNS O
( -LRB- O
0 CD O
/ NN O
12 CD O
) -RRB- O
. . O

The DT O
B NNP O
( -LRB- O
1 CD O
) -RRB- O
R NN O
distribution NN O
pattern NN O
mirrored VBN O
that IN O
of IN O
HER2 PRP O
except IN O
that IN O
B NNP O
( -LRB- O
1 CD O
) -RRB- O
R NN O
was VBD O
additionally RB O
observed VBN O
in IN O
the DT O
adenomas NNS O
. . O

The DT O
B NNP O
( -LRB- O
1 CD O
) -RRB- O
R NN O
appeared VBD O
either CC O
as IN O
cytoplasmic JJ O
dots NNS O
or CC O
labeling NN O
on IN O
the DT O
apical JJ O
cell NN O
membrane NN O
of IN O
the DT O
cells NNS O
composing VBG O
the DT O
epithelia NN O
with IN O
intestinal JJ O
metaplasia NN O
( -LRB- O
24 CD O
/ RB O
24 CD O
; : O
100 CD O
% NN O
) -RRB- O
and CC O
carcinoma NN O
in IN O
situ FW O
( -LRB- O
10 CD O
/ NN O
10 CD O
; : O
100 CD O
% NN O
) -RRB- O
and CC O
in IN O
the DT O
epithelial JJ O
cells NNS O
of IN O
adenomas NNS O
. . O

In IN O
contrast NN O
, , O
both DT O
HER2 NNP O
( -LRB- O
4 CD O
/ RB O
12 CD O
; : O
33 CD O
% NN O
) -RRB- O
and CC O
B NNP O
( -LRB- O
1 CD O
) -RRB- O
R NN O
( -LRB- O
1 CD O
/ NN O
12 CD O
; : O
8 CD O
. . O
3 CD O
% NN O
) -RRB- O
showed VBD O
a DT O
low JJ O
expression NN O
in IN O
invasive JJ O
gallbladder NN O
carcinomas NNS O
. . O

CONCLUSION NN O
: : O
The DT O
up IN O
- : O
regulation NN O
of IN O
HER2 NNP O
and CC O
B NNP O
( -LRB- O
1 CD O
) -RRB- O
R NN O
in IN O
precursor NN O
lesions NNS O
of IN O
gallbladder NN O
carcinoma NN O
suggests VBZ O
cross VB O
- : O
talk NN O
between IN O
these DT O
two CD O
receptors NNS O
that WDT O
may MD O
be VB O
of IN O
importance NN O
in IN O
the DT O
modulation NN O
of IN O
cell NN O
proliferation NN O
in IN O
gallbladder NN O
carcinogenesis NN O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
basic JJ O
fibroblast JJ O
growth NN O
factor NN O
in IN O
normal JJ O
human JJ O
tissues NNS O
. . O

The DT O
distribution NN O
of IN O
basic JJ O
fibroblast JJ O
growth NN O
factor NN O
( -LRB- O
bFGF NN O
) -RRB- O
was VBD O
studied VBN O
immunohistochemically RB O
in IN O
fresh JJ O
frozen JJ O
sections NNS O
of IN O
normal JJ O
human JJ O
tissues NNS O
. . O

Immunodetection NNP O
was VBD O
performed VBN O
with IN O
a DT O
specific JJ O
anti NNS O
- : O
bFGF NN O
mouse NN O
monoclonal JJ O
antibody NN O
that WDT O
was VBD O
found VBN O
to TO O
react VB O
with IN O
recombinant JJ O
human JJ O
bFGF NN O
in IN O
Western JJ O
blot NN O
analysis NN O
, , O
and CC O
to TO O
specifically RB O
neutralize VB O
the DT O
mitogenic JJ O
activity NN O
of IN O
bFGF NN O
on IN O
bovine NN O
vascular JJ O
endothelial JJ O
cells NNS O
. . O

Expression NN O
of IN O
bFGF NN O
on IN O
normal JJ O
human JJ O
tissues NNS O
was VBD O
ubiquitously RB O
detected VBN O
in IN O
the DT O
basement NN O
membranes NNS O
of IN O
all DT O
size NN O
blood NN O
vessels NNS O
, , O
but CC O
was VBD O
not RB O
found VBN O
in IN O
epidermal JJ O
or CC O
epithelial JJ O
basement NN O
membranes NNS O
of IN O
a DT O
variety NN O
of IN O
tissues NNS O
tested VBN O
. . O

Intensity NNP O
and CC O
patterns NNS O
of IN O
localization NN O
in IN O
blood NN O
vessels NNS O
was VBD O
consistent JJ O
in IN O
various JJ O
tissues NNS O
, , O
but CC O
varied VBN O
among IN O
different JJ O
regions NNS O
of IN O
the DT O
vascular JJ O
bed NN O
. . O

Whereas IN O
homogeneous JJ O
and CC O
intense JJ O
immunoreactivity NN O
were VBD O
observed VBN O
in IN O
large JJ O
and CC O
intermediate JJ O
size NN O
blood NN O
vessels NNS O
, , O
heterogeneity NN O
of IN O
expression NN O
was VBD O
found VBN O
in IN O
capillaries NNS O
. . O

The DT O
most RBS O
intense JJ O
immunoreactivity NN O
was VBD O
observed VBN O
in IN O
branching NN O
capillaries NNS O
. . O

Endothelial NNP O
cell NN O
staining NN O
was VBD O
heterogeneous JJ O
and CC O
varied VBN O
in IN O
different JJ O
regions NNS O
. . O

Strong JJ O
staining NN O
for IN O
bFGF NN O
was VBD O
also RB O
found VBN O
in IN O
cardiac JJ O
muscle NN O
fibers NNS O
, , O
smooth JJ O
muscle NN O
cells NNS O
of IN O
mid JJ O
- : O
size NN O
blood NN O
vessels NNS O
, , O
the DT O
gut NN O
and CC O
the DT O
myometrium NN O
, , O
in IN O
central JJ O
nervous JJ O
system NN O
neurons NNS O
and CC O
cerebellar NN O
Purkinje NNP O
cells NNS O
, , O
and CC O
on IN O
epithelial JJ O
cells NNS O
of IN O
the DT O
bronchi NN O
, , O
colon NN O
, , O
endometrium NN O
, , O
and CC O
sweat NN O
gland NN O
ducts NNS O
of IN O
the DT O
skin NN O
. . O

The DT O
presence NN O
of IN O
bFGF NN O
in IN O
the DT O
extracellular JJ O
compartment NN O
of IN O
a DT O
diverse JJ O
variety NN O
of IN O
organs NNS O
may MD O
play VB O
a DT O
role NN O
in IN O
angiogenesis NN O
. . O

However RB O
, , O
the DT O
function NN O
of IN O
bFGF NN O
in IN O
parenchymal JJ O
cells NNS O
remains VBZ O
to TO O
be VB O
determined VBN O
. . O

-DOCSTART- X X O

Incidence NNP O
of IN O
BRAF NNP O
p NN O
. . O
Val600Glu '' O
and CC O
p VB O
. . O
Val600Lys NNP O
mutations NNS O
in IN O
a DT O
consecutive JJ O
series NN O
of IN O
183 CD O
metastatic JJ O
melanoma NN O
patients NNS O
from IN O
a DT O
high JJ O
incidence NN O
region NN O
. . O

AIM NNP O
: : O
Approximately RB O
40 CD O
- : O
60 CD O
% NN O
of IN O
melanomas NNS O
from IN O
Caucasian NNP O
populations NNS O
carry VBP O
activating VBG O
mutations NNS O
in IN O
the DT O
BRAF NNP O
oncogene NNP O
, , O
with IN O
the DT O
most RBS O
common JJ O
being VBG O
the DT O
p NN O
. . O
Val600Glu FW O
( -LRB- O
V600E NN O
) -RRB- O
hotspot NN O
mutation NN O
in IN O
exon NN O
15 CD O
. . O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
was VBD O
to TO O
investigate VB O
the DT O
frequency NN O
of IN O
the DT O
less RBR O
common JJ O
p NN O
. . O
Val600Lys '' O
( -LRB- O
V600K NN O
) -RRB- O
mutation NN O
in IN O
metastatic JJ O
melanoma NN O
from IN O
a DT O
high JJ O
incidence NN O
region NN O
. . O

METHOD NNP O
: : O
Dideoxy JJ O
sequencing NN O
and CC O
fluorescent JJ O
single JJ O
strand JJ O
conformation NN O
analysis NN O
were VBD O
used VBN O
to TO O
screen VB O
for IN O
mutations NNS O
in IN O
exon JJ O
15 CD O
of IN O
BRAF NNP O
in IN O
183 CD O
cases NNS O
of IN O
metastatic JJ O
melanoma NN O
. . O

RESULTS NNS O
: : O
The DT O
overall JJ O
incidence NN O
of IN O
BRAF NN O
mutation NN O
( -LRB- O
89 CD O
/ NN O
183 CD O
, , O
49 CD O
% NN O
) -RRB- O
was VBD O
very RB O
similar JJ O
to TO O
other JJ O
large JJ O
studies NNS O
of IN O
Caucasian NNP O
populations NNS O
. . O

However RB O
, , O
the DT O
frequency NN O
of IN O
the DT O
p NN O
. . O
Val600Lys '' O
mutation NN O
was VBD O
higher JJR O
than IN O
in IN O
most JJS O
other JJ O
studies NNS O
and CC O
comprised VBN O
almost RB O
one CD O
- : O
third JJ O
of IN O
all DT O
BRAF NNP O
mutations NNS O
in IN O
our PRP$ O
cohort NN O
( -LRB- O
27 CD O
/ NN O
89 CD O
, , O
30 CD O
% NN O
) -RRB- O
. . O

CONCLUSION NN O
: : O
BRAF NN O
p NN O
. . O
Val600Lys '' O
mutations NNS O
were VBD O
present JJ O
at IN O
a DT O
relatively RB O
high JJ O
frequency NN O
in IN O
this DT O
cohort NN O
of IN O
metastatic JJ O
melanoma NN O
patients NNS O
( -LRB- O
27 CD O
/ NN O
183 CD O
, , O
15 CD O
% NN O
) -RRB- O
. . O

Assays NNP O
used VBD O
to TO O
screen VB O
for IN O
BRAF NNP O
mutations NNS O
in IN O
the DT O
clinic NN O
should MD O
be VB O
robust JJ O
enough RB O
to TO O
detect VB O
the DT O
p NN O
. . O
Val600Lys NNP O
mutation NN O
, , O
as IN O
this DT O
may MD O
have VB O
therapeutic JJ O
implications NNS O
. . O

-DOCSTART- X X O

[ NN O
Biotechnological NNP O
and CC O
biomedical JJ O
aspects NNS O
of IN O
production NN O
and CC O
study NN O
of IN O
metal NN O
cation NN O
- : O
phospholipid JJ O
complexes NNS O
] RB O
. . O

Problems NNS O
relating VBG O
to TO O
the DT O
technology NN O
of IN O
a DT O
phospholipid JJ O
preparation NN O
from IN O
natural JJ O
materials NNS O
, , O
liposome JJ O
production NN O
, , O
and CC O
studies NNS O
into IN O
the DT O
mechanisms NNS O
of IN O
interaction NN O
between IN O
metal NN O
( -LRB- O
trace NN O
elements NNS O
) -RRB- O
cations NNS O
and CC O
model NN O
bilayer NN O
lipid VBN O
membranes NNS O
are VBP O
discussed VBN O
. . O

The DT O
proposed JJ O
technology NN O
of IN O
extraction NN O
allows VBZ O
for IN O
preparation NN O
of IN O
phospholipids NNS O
utilizable JJ O
for IN O
liposome JJ O
formation NN O
. . O

The DT O
cation NN O
specificity NN O
of IN O
lipid JJ O
bilayers NNS O
is VBZ O
found VBN O
to TO O
be VB O
determined VBN O
by IN O
the DT O
presence NN O
of IN O
anionic JJ O
phosphate NN O
adsorption NN O
sites NNS O
on IN O
their PRP$ O
surface NN O
. . O

-DOCSTART- X X O

Overexpression NNP O
confers VBZ O
an DT O
oncogenic JJ O
potential NN O
upon IN O
the DT O
eph NN O
gene NN O
. . O

The DT O
eph NN O
gene NN O
encodes VBZ O
a DT O
putative JJ O
receptor NN O
tyrosine NN O
kinase NN O
for IN O
an DT O
as RB O
yet RB O
unknown JJ O
ligand NN O
. . O

Some DT O
human JJ O
cancer NN O
cells NNS O
have VBP O
been VBN O
found VBN O
to TO O
overexpress NNP O
eph NN O
mRNAs NNS O
without IN O
gene NN O
amplification NN O
. . O

We PRP O
show VBP O
here RB O
that IN O
NIH3T3 NNP B-NP
cells NNS O
acquire VB O
tumorigenic JJ O
ability NN O
in IN O
nude JJ O
mice NNS O
and CC O
make VB O
colonies NNS O
in IN O
soft JJ O
agar NN O
with IN O
a DT O
viral JJ O
LTR NNP O
( -LRB- O
Long NNP O
Terminal NNP O
Repeat NN O
) -RRB- O
- : O
driven VBN O
artificial JJ O
expression NN O
of IN O
the DT O
eph NN O
gene NN O
to TO O
a DT O
high JJ O
level NN O
. . O

This DT O
result NN O
supports VBZ O
the DT O
alleged VBN O
contribution NN O
of IN O
overexpressed JJ O
receptor NN O
tyrosine NN O
kinases NNS O
to TO O
cell NN O
transformation NN O
. . O

-DOCSTART- X X O

The DT O
enlarging VBG O
clinical JJ O
spectrum NN O
of IN O
Lyme JJ O
disease NN O
: : O
Lyme JJ O
cerebral JJ O
vasculitis NN O
, , O
a DT O
new JJ O
disease NN O
entity NN O
. . O

The DT O
case NN O
of IN O
a DT O
patient NN O
with IN O
cerebral JJ O
vasculitis NN O
with IN O
a DT O
right JJ O
thalamic IN O
infarct NN O
associated VBN O
with IN O
cerebral JJ O
spinal JJ O
fluid NN O
Lyme NNP O
disease NN O
is VBZ O
presented VBN O
. . O

This DT O
entity NN O
has VBZ O
not RB O
been VBN O
described VBN O
in IN O
the DT O
United NNP O
States NNP O
, , O
and CC O
only RB O
one CD O
similar JJ O
case NN O
in IN O
the DT O
world NN O
literature NN O
could MD O
be VB O
found VBN O
. . O

The DT O
patient NN O
presented VBD O
with IN O
a DT O
progressive JJ O
headache NN O
and CC O
subsequent JJ O
development NN O
of IN O
grand JJ O
mal JJ O
seizure NN O
activity NN O
. . O

Lyme NNP O
disease NN O
has VBZ O
been VBN O
associated VBN O
with IN O
cranial JJ O
nerve NN O
palsies NNS O
, , O
peripheral JJ O
and CC O
cranial JJ O
radiculopathies NNS O
, , O
aseptic JJ O
meningitis NN O
, , O
encephalitic NN O
symptoms NNS O
, , O
chorea NN O
, , O
and CC O
demyelinating VBG O
polyneuropathy NN O
presenting VBG O
like IN O
Guillain NNP O
- : O
Barre NNP O
syndrome NN O
. . O

These DT O
syndromes NNS O
can MD O
occur VB O
separately RB O
or CC O
in IN O
combination NN O
. . O

Stroke NNP O
and CC O
strokelike JJ O
syndromes NNS O
have VBP O
been VBN O
attributed VBN O
to TO O
Lyme VB O
disease NN O
. . O

The DT O
literature NN O
concerning VBG O
the DT O
neurologic NN O
manifestations NNS O
of IN O
Lyme NNP O
disease NN O
is VBZ O
reviewed VBN O
. . O

-DOCSTART- X X O

Amplification NN O
of IN O
mineralocorticoid JJ O
activity NN O
of IN O
aldosterone NN O
by IN O
18 CD O
- : O
hydroxy JJ O
- : O
corticosterone NN O
and CC O
18 CD O
- : O
hydroxy JJ O
- : O
19 CD O
- : O
nor CC O
- : O
corticosterone NN O
in IN O
adrenalectomized JJ O
rats NNS O
. . O

A DT O
combination NN O
of IN O
aldosterone NN O
( -LRB- O
1 CD O
micrograms NNS O
) -RRB- O
with IN O
either DT O
18 CD O
- : O
OH SYM O
- : O
corticosterone NN O
( -LRB- O
1 CD O
micrograms NNS O
) -RRB- O
or CC O
18 CD O
- : O
OH NNS O
- : O
19 CD O
- : O
norcorticosterone NN O
( -LRB- O
1 CD O
micrograms NNS O
) -RRB- O
injected VBN O
to TO O
adrenalectomized DT O
rats NNS O
indicated VBD O
an DT O
amplification NN O
of IN O
mineralocorticoid JJ O
activity NN O
as IN O
expressed VBN O
by IN O
Na NNP O
/ NNP O
K NNP O
ratio NN O
in IN O
urine NN O
. . O

Without IN O
aldosterone DT O
their PRP$ O
mineralocorticoid JJ O
potency NN O
was VBD O
negligible JJ O
. . O

-DOCSTART- X X O

Alterations NNP O
in IN O
carbohydrate NN O
metabolism NN O
in IN O
canine CD O
lymphoma NN O
. . O

Following VBG O
an DT O
overnight JJ O
fast JJ O
, , O
blood NN O
samples NNS O
were VBD O
obtained VBN O
from IN O
14 CD O
dogs NNS O
with IN O
previously RB O
untreated JJ O
lymphoma NN O
before IN O
and CC O
5 CD O
, , O
15 CD O
, , O
30 CD O
, , O
45 CD O
, , O
60 CD O
, , O
and CC O
90 CD O
minutes NNS O
following VBG O
an DT O
intravenous JJ O
challenge NN O
with IN O
500 CD O
mg NN O
/ IN O
kg JJ O
dextrose NN O
. . O

Samples NNS O
were VBD O
assayed VBN O
for IN O
glucose NN O
, , O
lactate NN O
, , O
and CC O
insulin NN O
concentrations NNS O
and CC O
compared VBN O
statistically RB O
with IN O
ten CD O
control NN O
dogs NNS O
of IN O
similar JJ O
weight NN O
and CC O
age NN O
undergoing VBG O
an DT O
identical JJ O
dextrose NN O
challenge NN O
. . O

Dogs NNS O
with IN O
lymphoma NN O
had VBD O
similar JJ O
glucose NN O
tolerance NN O
curves NNS O
when WRB O
compared VBN O
with IN O
controls NNS O
. . O

Lactate NNP O
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0 CD O
. . O
001 CD O
) -RRB- O
at IN O
baseline NN O
and CC O
all DT O
time NN O
periods NNS O
of IN O
the DT O
glucose NN O
tolerance NN O
test NN O
in IN O
dogs NNS O
with IN O
lymphoma NN O
when WRB O
compared VBN O
with IN O
controls NNS O
. . O

Rise NN O
in IN O
lactate NN O
concentrations NNS O
over IN O
baseline NN O
levels NNS O
in IN O
the DT O
first JJ O
30 CD O
minutes NNS O
of IN O
the DT O
glucose NN O
tolerance NN O
test NN O
were VBD O
significantly RB O
higher JJR O
in IN O
dogs NNS O
with IN O
lymphoma NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
011 CD O
) -RRB- O
. . O

Insulin NNP O
concentrations NNS O
were VBD O
significantly RB O
higher JJR O
( -LRB- O
P NNP O
less RBR O
than IN O
0 CD O
. . O
001 CD O
) -RRB- O
at IN O
baseline NN O
and CC O
at IN O
the DT O
5 CD O
- : O
, , O
45 CD O
- : O
, , O
60 CD O
- : O
, , O
and CC O
90 CD O
- : O
minute JJ O
time NN O
periods NNS O
of IN O
the DT O
glucose NN O
tolerance NN O
test NN O
in IN O
dogs NNS O
with IN O
lymphoma NN O
. . O

Rise NN O
in IN O
insulin NN O
concentrations NNS O
over IN O
baseline NN O
in IN O
the DT O
first JJ O
5 CD O
minutes NNS O
of IN O
the DT O
glucose NN O
tolerance NN O
test NN O
were VBD O
also RB O
significantly RB O
greater JJR O
in IN O
dogs NNS O
with IN O
lymphoma NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
021 CD O
) -RRB- O
. . O

These DT O
results NNS O
indicate VBP O
carbohydrate NN O
metabolism NN O
is VBZ O
altered VBN O
in IN O
dogs NNS O
with IN O
lymphoma NN O
. . O

Many JJ O
of IN O
these DT O
alterations NNS O
parallel VBP O
those DT O
observed JJ O
in IN O
human JJ O
patients NNS O
suffering VBG O
from IN O
cancer NN O
cachexia NN O
making VBG O
canine CD O
lymphoma NN O
a DT O
potential JJ O
model NN O
for IN O
further JJ O
study NN O
of IN O
the DT O
pathogenesis NN O
and CC O
therapy NN O
of IN O
cancer NN O
cachexia NN O
. . O

-DOCSTART- X X O

Retinal NNP O
revascularisation NN O
in IN O
diabetic JJ O
retinopathy NN O
. . O

The DT O
case NN O
history NN O
of IN O
a DT O
33 CD O
- : O
year NN O
- : O
old JJ O
diabetic JJ O
patient NN O
who WP O
has VBZ O
had VBN O
diabetes NNS O
for IN O
24 CD O
years NNS O
is VBZ O
presented VBN O
. . O

When WRB O
first JJ O
seen VBN O
in IN O
1975 CD O
he PRP O
had VBD O
bilateral JJ O
proliferative JJ O
retinopathy NN O
with IN O
new JJ O
vessels NNS O
in IN O
the DT O
retinal JJ O
periphery NN O
. . O

He PRP O
had VBD O
large JJ O
areas NNS O
of IN O
capillary NN O
non FW O
- : O
perfusion NN O
lateral JJ O
to TO O
the DT O
macula NN O
in IN O
the DT O
right JJ O
eye NN O
associated VBN O
with IN O
the DT O
new JJ O
vessels NNS O
. . O

Nine CD O
years NNS O
later RB O
, , O
after IN O
extensive JJ O
repeated VBD O
photocoagulation NN O
, , O
revascularisation NN O
of IN O
large JJ O
areas NNS O
previously RB O
not RB O
perfused VBN O
were VBD O
seen VBN O
. . O

The DT O
vessels NNS O
are VBP O
in IN O
the DT O
plane NN O
of IN O
the DT O
retina NN O
and CC O
do VBP O
not RB O
have VB O
the DT O
appearance NN O
of IN O
new JJ O
vessels NNS O
. . O

-DOCSTART- X X O

Members NNS O
of IN O
the DT O
src NN O
and CC O
ras VBD O
oncogene IN O
families NNS O
supplant VBP O
the DT O
epidermal JJ O
growth NN O
factor NN O
requirement NN O
of IN O
BALB NNP O
/ NNP O
MK NNP O
- : O
2 CD O
keratinocytes NNS O
and CC O
induce VB O
distinct JJ O
alterations NNS O
in IN O
their PRP$ O
terminal JJ O
differentiation NN O
program NN O
. . O

BALB NNP O
- : O
/ NN O
MK NN O
- : O
2 CD O
mouse NN O
epidermal NN O
keratinocytes VBZ O
required VBN O
epidermal JJ O
growth NN O
factor NN O
for IN O
proliferation NN O
and CC O
terminally RB O
differentiated JJ O
in IN O
response NN O
to TO O
high JJ O
Ca2 IN O
+ JJ O
concentration NN O
. . O

Infection NN O
with IN O
retroviruses NNS O
containing VBG O
transforming JJ O
genes NNS O
of IN O
the DT O
src NN O
and CC O
ras VBD O
oncogene IN O
families NNS O
led VBD O
to TO O
rapid JJ O
loss NN O
of IN O
epidermal JJ O
growth NN O
factor NN O
dependence NN O
, , O
in IN O
some DT O
cases NNS O
, , O
accompanied VBN O
by IN O
alterations NNS O
in IN O
cellular JJ O
morphology NN O
. . O

The DT O
virus NN O
- : O
altered JJ O
cells NNS O
continued VBN O
to TO O
proliferate VB O
in IN O
the DT O
presence NN O
of IN O
high JJ O
levels NNS O
of IN O
extracellular JJ O
calcium NN O
but CC O
exhibited VBD O
alterations NNS O
in IN O
normal JJ O
keratinocyte NN O
terminal NN O
differentiation NN O
that WDT O
appear VBP O
to TO O
be VB O
specific JJ O
to TO O
the DT O
particular JJ O
oncogene NN O
. . O

These DT O
alterations NNS O
bore VBD O
similarities NNS O
to TO O
abnormalities NNS O
in IN O
differentiation NN O
observed VBD O
in IN O
naturally RB O
occurring VBG O
squamous JJ O
epithelial NN O
malignancies NNS O
. . O

-DOCSTART- X X O

Experimental JJ O
drug NN O
therapy NN O
of IN O
peritumoral JJ O
brain NN O
edema NN O
. . O

Four CD O
drugs NNS O
with IN O
potential JJ O
anti NNS O
- : O
peritumoral JJ O
brain NN O
edema NN O
activity NN O
were VBD O
studied VBN O
using VBG O
the DT O
VX2 NNP O
rabbit NN O
brain NN O
tumor NN O
model NN O
. . O

Meclofenamate NNP O
and CC O
indomethacin NN O
were VBD O
tested VBN O
in IN O
an DT O
attempt NN O
to TO O
confirm VB O
recent JJ O
reports NNS O
of IN O
anti NNS O
- : O
edema NN O
activity NN O
in IN O
non JJ O
steroidal JJ O
anti NNS O
- : O
inflammatory NN O
drugs NNS O
( -LRB- O
NSAID NN O
' '' O
s PRP O
) -RRB- O
. . O

The DT O
' '' O
angiostatic JJ O
' '' O
steroids NNS O
17 CD O
hydroxyprogesterone NN O
and CC O
epicortisol NN O
were VBD O
tested VBN O
because IN O
of IN O
their PRP$ O
lack NN O
of IN O
glucocorticoid JJ O
and CC O
mineralocorticoid JJ O
effects NNS O
and CC O
their PRP$ O
structural JJ O
similarity NN O
to TO O
glucocorticoids NNS O
. . O

The DT O
protein NN O
and CC O
water NN O
component NN O
of IN O
brain NN O
edema NN O
were VBD O
indirectly RB O
quantitated VBN O
. . O

None NN O
of IN O
the DT O
test NN O
drugs NNS O
demonstrated VBD O
significant JJ O
anti NNS O
- : O
edema NN O
activity NN O
. . O

This DT O
work NN O
does VBZ O
not RB O
confirm VB O
reports NNS O
that IN O
NSAID NNP O
' POS O
s PRP O
have VBP O
anti DT O
- : O
edema NN O
activity NN O
and CC O
suggests VBZ O
that IN O
there EX O
may MD O
be VB O
no DT O
correlation NN O
between IN O
' '' O
angiostatic JJ O
' '' O
and CC O
anti NNS O
- : O
edema NN O
activity NN O
in IN O
certain JJ O
steroid JJ O
compounds NNS O
. . O

-DOCSTART- X X O

Gastric NNP O
microcirculatory NN O
change NN O
and CC O
development NN O
of IN O
acute JJ O
gastric JJ O
mucosal NN O
lesions NNS O
( -LRB- O
stress NN O
ulcer NN O
) -RRB- O
. . O

Concerning VBG O
the DT O
pathogenesis NN O
of IN O
acute JJ O
gastric JJ O
mucosal NN O
lesions NNS O
, , O
gastric JJ O
microcirculatory NN O
change NN O
has VBZ O
drawn VBN O
attention NN O
as IN O
an DT O
important JJ O
factor NN O
. . O

In IN O
view NN O
of IN O
this DT O
fact NN O
, , O
gastric JJ O
mucosal NN O
blood NN O
flow NN O
and CC O
microvascular JJ O
structure NN O
were VBD O
investigated VBN O
in IN O
normal JJ O
and CC O
in IN O
burn NN O
stressed VBD O
rats NNS O
. . O

Moreover RB O
, , O
alterations NNS O
in IN O
acid NN O
and CC O
pepsin NN O
activities NNS O
in IN O
by IN O
morphological JJ O
and CC O
biochemical JJ O
procedures NNS O
in IN O
order NN O
to TO O
evaluate VB O
the DT O
relationship NN O
between IN O
defensive JJ O
and CC O
aggressive JJ O
factors NNS O
of IN O
the DT O
gastric JJ O
mucosa NN O
. . O

Gastric NNP O
mucosal NN O
blood NN O
flow VBP O
decreased VBN O
significantly RB O
in IN O
early JJ O
period NN O
after IN O
induction NN O
of IN O
stress NN O
( -LRB- O
p NN O
less JJR O
than IN O
0 CD O
. . O
01 CD O
) -RRB- O
. . O

The DT O
incidence NN O
of IN O
ulceration NN O
showed VBD O
a DT O
correlative JJ O
relation NN O
with IN O
the DT O
decrease NN O
of IN O
mucosal NN O
blood NN O
flow NN O
. . O

Reduction NN O
of IN O
blood NN O
flow NN O
in IN O
burn NN O
was VBD O
due JJ O
to TO O
opening NN O
of IN O
arteriovenular JJ O
shunt NN O
and CC O
it PRP O
appeared VBD O
that IN O
this DT O
was VBD O
responsible JJ O
for IN O
mucosal NN O
ischemia NN O
and CC O
congestion NN O
. . O

Following VBG O
the DT O
decrease NN O
of IN O
blood NN O
flow NN O
, , O
acid NN O
output NN O
was VBD O
lower JJR O
in IN O
stress NN O
than IN O
that IN O
in IN O
control NN O
. . O

Finally RB O
, , O
the DT O
results NNS O
of IN O
these DT O
studies NNS O
demonstrated VBD O
the DT O
importance NN O
of IN O
defensive JJ O
factors NNS O
. . O

The DT O
reduction NN O
of IN O
mucosal NN O
blood NN O
flow NN O
resulted VBD O
in IN O
the DT O
sequence NN O
of IN O
events NNS O
that WDT O
led VBD O
to TO O
formation NN O
of IN O
acute JJ O
gastric JJ O
mucosal NN O
lesion NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
a DT O
small JJ O
region NN O
of IN O
the DT O
v FW O
- : O
fos JJ O
gene NN O
product NN O
that WDT O
is VBZ O
sufficient JJ O
for IN O
transforming VBG O
potential JJ O
and CC O
growth NN O
- : O
stimulating JJ O
activity NN O
. . O

To TO O
analyze VB O
the DT O
structure NN O
- : O
function NN O
relationship NN O
for IN O
the DT O
v NN O
- : O
fos JJ O
protein NN O
, , O
we PRP O
constructed VBD O
in IN O
- : O
frame NN O
insertion NN O
and CC O
deletion NN O
mutants NNS O
of IN O
the DT O
v FW O
- : O
fos JJ O
gene NN O
carried VBN O
by IN O
FBJ NNP O
- : O
MuSV NNP O
, , O
and CC O
expressed VBD O
them PRP O
in IN O
chicken NN O
primary JJ O
cells NNS O
using VBG O
retrovirus NN O
vectors NNS O
. . O

We PRP O
assessed VBD O
the DT O
effects NNS O
of IN O
these DT O
mutations NNS O
on IN O
the DT O
ability NN O
of IN O
the DT O
v FW O
- : O
fos JJ O
protein NN O
to TO O
transform VB O
chicken NN O
embryo NN O
fibroblasts NNS O
and CC O
to TO O
stimulate VB O
cellular JJ O
proliferation NN O
of IN O
chicken NN O
neuroretinal JJ O
cells NNS O
. . O

The DT O
mutant NN O
which WDT O
retains VBZ O
only RB O
the DT O
central JJ O
region NN O
of IN O
the DT O
v FW O
- : O
fos JJ O
protein NN O
( -LRB- O
Met111 FW O
- : O
Ile206 PRP O
) -RRB- O
have VBP O
both DT O
activities NNS O
, , O
but CC O
the DT O
mutants NNS O
which WDT O
have VBP O
deletions NNS O
in IN O
this DT O
region NN O
, , O
and CC O
one CD O
of IN O
the DT O
mutants NNS O
that WDT O
has VBZ O
a DT O
four CD O
amino IN O
acid NN O
insertion NN O
in IN O
it PRP O
, , O
lost VBD O
both DT O
activities NNS O
. . O

The DT O
central JJ O
region NN O
that WDT O
is VBZ O
sufficient JJ O
for IN O
these DT O
activities NNS O
includes VBZ O
the DT O
evolutionarily RB O
highly RB O
conserved VBN O
region NN O
among IN O
human JJ O
, , O
mouse NN O
and CC O
chicken NN O
c SYM O
- : O
fos JJ O
proteins NNS O
. . O

Additionally RB O
, , O
this DT O
sequence NN O
shares NNS O
some DT O
homology NN O
with IN O
the DT O
DNA NNP O
binding NN O
domain NN O
of IN O
GCN4 NNP O
and CC O
c SYM O
- : O
jun NN O
protein NN O
. . O

The DT O
truncated JJ O
fos JJ O
protein NN O
that WDT O
contains VBZ O
only JJ O
part NN O
of IN O
the DT O
central JJ O
region NN O
is VBZ O
not RB O
phosphorylated VBN O
in IN O
chicken NN O
embryo NN O
fibroblasts NNS O
, , O
indicating VBG O
that IN O
phosphorylation NN O
of IN O
the DT O
fos JJ O
protein NN O
is VBZ O
not RB O
necessary JJ O
for IN O
the DT O
transforming NN O
activity NN O
. . O

-DOCSTART- X X O

Inhibition NN O
by IN O
retinoic JJ O
acid NN O
of IN O
type NN O
IV NNP O
collagenolysis NN O
and CC O
invasion NN O
through IN O
reconstituted JJ O
basement NN O
membrane NN O
by IN O
metastatic JJ O
rat NN O
mammary JJ O
adenocarcinoma NN O
cells NNS O
. . O

The DT O
activity NN O
of IN O
type NN O
IV NNP O
collagenase NN O
, , O
which WDT O
enables VBZ O
tumor NN O
cells NNS O
to TO O
degrade VB O
collagen NN O
type NN O
IV NNP O
found VBD O
in IN O
the DT O
subendothelial JJ O
basement NN O
membrane NN O
, , O
has VBZ O
been VBN O
correlated VBN O
with IN O
the DT O
metastatic JJ O
potential NN O
in IN O
several JJ O
tumor NN O
types NNS O
, , O
including VBG O
the DT O
rat NN O
13762NF IN B-NP
mammary JJ O
adenocarcinoma NN O
cell NN O
line NN O
and CC O
its PRP$ O
clones NNS O
. . O

In IN O
this DT O
study NN O
, , O
we PRP O
examined VBD O
whether IN O
all DT O
- : O
trans NNS O
- : O
retinoic JJ O
acid NN O
( -LRB- O
all DT O
- : O
trans NNS O
- : O
RA NNP O
) -RRB- O
and CC O
other JJ O
retinoids NNS O
, , O
which WDT O
exhibit VBP O
antitumor JJ O
activity NN O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
, , O
affect VB O
the DT O
collagenolytic JJ O
activity NN O
of IN O
metastatic JJ O
rat NN O
13762NF IN B-NP
mammary JJ O
adenocarcinoma NN O
cells NNS O
. . O

Cells NNP O
of IN O
the DT O
highly RB O
metastatic JJ O
lung NN O
- : O
colonizing NN O
clone NN O
MTF7 NNP B-NP
. . I-NP
T35 '' I-NP
. . I-NP
3 CD I-NP
, , O
derived VBN O
from IN O
the DT O
13762NF JJ B-NP
cell NN O
line NN O
, , O
were VBD O
treated VBN O
for IN O
3 CD O
days NNS O
with IN O
0 CD O
. . O
1 CD O
, , O
1 CD O
, , O
or CC O
10 CD O
microM NNS O
all DT O
- : O
trans NNS O
- : O
RA NNP O
, , O
harvested VBN O
, , O
and CC O
seeded VBD O
on IN O
[ NNP O
3H NNP O
] SYM O
proline VB O
- : O
labeled VBN O
extracellular JJ O
matrix NN O
deposited VBN O
by IN O
cultured JJ O
rat NN O
lung NN O
endothelial NN O
cells NNS O
or CC O
on IN O
a DT O
film NN O
of IN O
purified VBN O
[ NN O
3H . O
] SYM O
proline VB O
- : O
labeled VBN O
type NN O
IV NNP O
collagen NN O
. . O

The DT O
amount NN O
of IN O
radioactivity NN O
released VBN O
into IN O
the DT O
medium NN O
during IN O
the DT O
subsequent JJ O
24 CD O
to TO O
72 CD O
h NN O
was VBD O
measured VBN O
, , O
and CC O
it PRP O
was VBD O
found VBN O
that IN O
all DT O
- : O
trans NNS O
- : O
RA NNP O
treatment NN O
inhibited VBD O
degradation NN O
of IN O
extracellular JJ O
matrix NN O
and CC O
type NN O
IV NNP O
collagen NN O
by IN O
50 CD O
to TO O
60 CD O
% NN O
. . O

This DT O
effect NN O
was VBD O
observed VBN O
whether IN O
the DT O
cells NNS O
had VBD O
been VBN O
treated VBN O
with IN O
all DT O
- : O
trans NNS O
- : O
RA NNP O
in IN O
serum NN O
- : O
free JJ O
medium NN O
or CC O
in IN O
medium NN O
supplemented VBN O
with IN O
heat NN O
- : O
inactivated JJ O
or CC O
acid NN O
- : O
treated VBN O
fetal NN O
bovine NN O
serum NN O
. . O

The DT O
growth NN O
of IN O
the DT O
cells NNS O
was VBD O
not RB O
inhibited VBN O
under IN O
these DT O
conditions NNS O
, , O
except IN O
after IN O
treatment NN O
with IN O
10 CD O
microM NNS O
all DT O
- : O
trans NNS O
- : O
RA NNP O
in IN O
serum NN O
- : O
free JJ O
medium NN O
. . O

The DT O
reduction NN O
in IN O
collagenolytic JJ O
activity NN O
was VBD O
observed VBN O
in IN O
viable JJ O
cells NNS O
as RB O
well RB O
as IN O
in IN O
conditioned VBN O
medium NN O
. . O

A DT O
24 CD O
- : O
h JJ O
exposure NN O
of IN O
cells NNS O
to TO O
all DT O
- : O
trans NNS O
- : O
RA NNP O
was VBD O
sufficient JJ O
to TO O
cause VB O
a DT O
30 CD O
% NN O
decrease NN O
in IN O
the DT O
collagenolytic JJ O
activity NN O
, , O
and CC O
this DT O
inhibitory JJ O
effect NN O
was VBD O
reversible JJ O
. . O

The DT O
direct JJ O
addition NN O
of IN O
all DT O
- : O
trans NNS O
- : O
RA NNP O
to TO O
conditioned VBN O
medium NN O
had VBD O
no DT O
effect NN O
on IN O
secreted JJ O
collagenase NN O
activity NN O
. . O

The DT O
apparent JJ O
molecular JJ O
weights NNS O
of IN O
the DT O
collagenolytic JJ O
enzymes NNS O
were VBD O
determined VBN O
by IN O
electrophoresis NN O
of IN O
cell NN O
extracts NNS O
and CC O
concentrated VBD O
conditioned VBN O
medium NN O
in IN O
type NN O
IV NNP O
collagen NN O
- : O
embedded VBN O
polyacrylamide NN O
gels NNS O
followed VBN O
by IN O
renaturation NN O
and CC O
activation NN O
of IN O
the DT O
enzymes NNS O
within IN O
the DT O
gels NNS O
. . O

Two CD O
major JJ O
type NN O
IV NNP O
collagenolytic JJ O
metalloproteinases NNS O
exhibiting VBG O
molecular JJ O
weights NNS O
of IN O
64 CD O
, , O
000 CD O
and CC O
88 CD O
, , O
000 CD O
, , O
respectively RB O
, , O
were VBD O
detected VBN O
by IN O
this DT O
method NN O
. . O

These DT O
two CD O
enzymes NNS O
were VBD O
also RB O
found VBN O
to TO O
have VB O
specificity NN O
for IN O
gelatin NN O
. . O

The DT O
Mr NNP O
64 CD O
, , O
000 CD O
enzyme NN O
could MD O
be VB O
extracted VBN O
from IN O
viable JJ O
cells NNS O
( -LRB- O
presumably RB O
from IN O
the DT O
cell NN O
membrane NN O
) -RRB- O
by IN O
2 CD O
% NN O
1 CD O
- : O
butanol NN O
. . O

Treatment NNP O
with IN O
all DT O
- : O
trans NNS O
- : O
RA NNP O
decreased VBD O
the DT O
level NN O
of IN O
these DT O
enzymes NNS O
in IN O
the DT O
cellular JJ O
, , O
cell NN O
membrane NN O
, , O
and CC O
conditioned VBD O
medium JJ O
compartments NNS O
. . O
( -LRB- O
ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Type JJ O
- : O
A DT O
cholecystokinin NN O
receptors NNS O
in IN O
CHP212 NNP B-NP
neuroblastoma NN O
cells NNS O
: : O
evidence NN O
for IN O
association NN O
with IN O
G NNP O
protein NN O
and CC O
activation NN O
of IN O
phosphoinositide NN O
hydrolysis NN O
. . O

125I CD O
- : O
Bolton NNP O
Hunter NNP O
- : O
cholecystokinin NN O
octapeptide NN O
( -LRB- O
BH FW O
- : O
CCK8 NNS O
) -RRB- O
and CC O
( -LRB- O
- : O
) -RRB- O
- : O
[ JJ O
3H JJ O
] SYM O
L NNP O
- : O
364718 CD O
membrane NN O
binding NN O
assays WDT O
were VBD O
used VBN O
to TO O
identify VB O
and CC O
characterize VB O
cholecystokinin NN O
( -LRB- O
CCK NN O
) -RRB- O
receptors NNS O
in IN O
CHP212 JJ B-NP
human JJ O
neuroblastoma NN O
cells NNS O
. . O

The DT O
ligand NN O
binding NN O
properties NNS O
of IN O
CCK NNP O
receptors NNS O
in IN O
these DT O
cells NNS O
are VBP O
similar JJ O
to TO O
those DT O
found VBN O
in IN O
pancreas NNS O
( -LRB- O
CCK NN O
- : O
A DT O
sites NNS O
) -RRB- O
and CC O
differ VB O
from IN O
the DT O
predominant JJ O
type NN O
of IN O
CCK NNP O
binding NN O
site NN O
found VBN O
in IN O
brain NN O
( -LRB- O
CCK NN O
- : O
B NN O
sites NNS O
) -RRB- O
. . O

The DT O
specific JJ O
binding NN O
of IN O
125I CD O
- : O
BH VB O
- : O
CCK8 : O
but CC O
not RB O
( -LRB- O
- : O
) -RRB- O
- : O
[ JJ O
3H JJ O
] SYM O
L NNP O
- : O
364718 CD O
was VBD O
reduced VBN O
by IN O
the DT O
metabolically NN O
stable JJ O
GTP NNP O
analog NN O
guanosine NN O
5 CD O
' '' O
- : O
( -LRB- O
beta NN O
- : O
delta NN O
- : O
imido NN O
) -RRB- O
trisphosphate NN O
. . O

A DT O
substantial JJ O
difference NN O
in IN O
the DT O
Bmax NNP O
for IN O
the DT O
radiolabeled JJ O
agonist NN O
( -LRB- O
125I CD O
- : O
BH SYM O
- : O
CCK8 NNS O
) -RRB- O
and CC O
antagonist NN O
[ NN O
( -LRB- O
- : O
) -RRB- O
- : O
[ JJ O
3H JJ O
] SYM O
L NNP O
- : O
364718 CD O
] NN O
was VBD O
noted VBN O
. . O

These DT O
observations NNS O
are VBP O
consistent JJ O
with IN O
CCK NNP O
receptors NNS O
existing VBG O
in IN O
guanine CD O
nucleotide JJ O
- : O
binding JJ O
protein NN O
- : O
coupled VBN O
and CC O
- : O
uncoupled JJ O
states NNS O
. . O

Similar JJ O
to TO O
its PRP$ O
action NN O
in IN O
pancreatic JJ O
acinar NN O
cells NNS O
, , O
CCK8 IN O
( -LRB- O
S NNP O
) -RRB- O
stimulated VBD O
the DT O
accumulation NN O
of IN O
[ JJ O
3H NNP O
] SYM O
inositol NN O
phosphates VBZ O
in IN O
cells NNS O
prelabeled VBN O
with IN O
[ NNP O
3H NNP O
] SYM O
myo FW O
- : O
inositol NN O
( -LRB- O
EC50 NNP O
= SYM O
3 CD O
. . O
2 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
4 CD O
nM NN O
; : O
maximum JJ O
response NN O
= SYM O
4 CD O
. . O
5 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
4 CD O
x NN O
basal NN O
) -RRB- O
. . O

The DT O
intrinsic JJ O
activity NN O
of IN O
CCK NNP O
analogues NNS O
in IN O
stimulating NN O
phosphoinositide NN O
hydrolysis NN O
was VBD O
substantially RB O
less JJR O
than IN O
their PRP$ O
reported VBN O
intrinsic JJ O
activity NN O
in IN O
stimulating NN O
phosphoinositide NN O
hydrolysis NN O
in IN O
pancreatic JJ O
acinar NN O
cells NNS O
. . O

The DT O
CHP212 NNP B-NP
neuroblastoma NN O
cell NN O
may MD O
serve VB O
as IN O
a DT O
useful JJ O
model NN O
for IN O
the DT O
recently RB O
reported VBN O
CCK NN O
- : O
A DT O
binding NN O
site NN O
found VBN O
in IN O
the DT O
central JJ O
nervous JJ O
system NN O
. . O

-DOCSTART- X X O

Energy NNP O
supply NN O
of IN O
the DT O
mitotic JJ O
cell NN O
cycle NN O
and CC O
the DT O
Na NNP O
+ NNP O
/ NNP O
H NNP O
+ . O
- : O
antiport NN O
in IN O
ascites NNS O
tumors NNS O
. . O

The DT O
activation NN O
of IN O
Na NNP O
+ NNP O
transport NN O
is VBZ O
due JJ O
to TO O
the DT O
exchange NN O
of IN O
protons NNS O
formed VBN O
via IN O
glucose NN O
conversion NN O
into IN O
lactate NN O
for IN O
Na NNP O
+ NNP O
, , O
i NN O
. . O
e NN O
. . O
, , O
to TO O
the DT O
stimulation NN O
of IN O
the DT O
Na NNP O
+ NNP O
/ NNP O
H NNP O
+ . O
- : O
antiport NN O
. . O

Experimental JJ O
results NNS O
and CC O
theoretical JJ O
calculations NNS O
suggest VBP O
that IN O
in IN O
glucose NN O
- : O
containing VBG O
medium NN O
the DT O
Na NNP O
+ NNP O
transport NN O
increases NNS O
from IN O
0 CD O
. . O
75 CD O
to TO O
1 CD O
. . O
78 CD O
pmol NN O
/ JJ O
hour NN O
per IN O
cell NN O
. . O

The DT O
permeability NN O
of IN O
plasma NN O
membranes NNS O
for IN O
K NNP O
+ NNP O
increases VBZ O
2 CD O
. . O
75 CD O
fold NN O
, , O
while IN O
the DT O
passive JJ O
flux NN O
of IN O
Na NNP O
+ NNP O
diminishes VBZ O
. . O

The DT O
intensity NN O
of IN O
O2 CD O
adsorption NN O
by IN O
ascites NNS O
tumor NN O
cells NNS O
does VBZ O
not RB O
practically RB O
depend VB O
on IN O
the DT O
monovalent NN O
cation NN O
concentration NN O
gradient NN O
between IN O
the DT O
cells NNS O
and CC O
the DT O
culture NN O
medium NN O
, , O
whereas IN O
the DT O
rate NN O
of IN O
glycolysis NN O
decreases VBZ O
simultaneously RB O
with IN O
the DT O
diminution NN O
of IN O
the DT O
concentration NN O
gradient NN O
. . O

In IN O
synchronized JJ O
cultures NNS O
at IN O
the DT O
beginning NN O
of IN O
the DT O
mitotic JJ O
cycle NN O
, , O
the DT O
bulk NN O
of IN O
ATP NNP O
resynthesized VBD O
via IN O
glycolysis NN O
is VBZ O
utilized VBN O
for IN O
the DT O
synthesis NN O
of IN O
biopolymers NNS O
, , O
whereas IN O
that IN O
at IN O
the DT O
end NN O
of IN O
the DT O
S NNP O
- : O
phase NN O
and CC O
in IN O
the DT O
G2 JJ O
- : O
phase NN O
is VBZ O
utilized VBN O
for IN O
cation NN O
transport NN O
across IN O
plasma NN O
membranes NNS O
. . O

From IN O
35 CD O
to TO O
100 CD O
% NN O
of IN O
the DT O
whole JJ O
amount NN O
of IN O
ATP NNP O
resynthesized VBD O
via IN O
glycolysis NN O
is VBZ O
utilized VBN O
for IN O
transport NN O
purposes NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
the DT O
observed JJ O
increase NN O
in IN O
the DT O
Na NNP O
+ NNP O
/ NNP O
K NNP O
+ NNP O
ratio NN O
in IN O
ascites NNS O
tumor NN O
cells NNS O
is VBZ O
connected VBN O
with IN O
their PRP$ O
enhanced VBN O
ability NN O
to TO O
synthesize VB O
lactic JJ O
acid NN O
. . O

Presumably RB O
, , O
glycolysis NN O
is VBZ O
one CD O
of IN O
the DT O
regulatory JJ O
mechanisms NNS O
of IN O
intracellular JJ O
ratios NNS O
of IN O
monovalent JJ O
cations NNS O
. . O

-DOCSTART- X X O

Endoscopic NNP O
injection NN O
therapy NN O
for IN O
acute JJ O
upper JJ O
GI JJ O
bleeding NN O
. . O

In IN O
summary NN O
, , O
we PRP O
have VBP O
found VBN O
this DT O
technique NN O
to TO O
be VB O
useful JJ O
in IN O
patients NNS O
in IN O
whom WP O
coagulation NN O
therapy NN O
is VBZ O
not RB O
possible JJ O
or CC O
effective JJ O
. . O

It PRP O
must MD O
still RB O
be VB O
considered VBN O
a DT O
technique NN O
which WDT O
is VBZ O
undergoing VBG O
evaluation NN O
. . O

Prospective JJ O
randomized JJ O
trials NNS O
comparing VBG O
this DT O
therapy NN O
with IN O
other JJ O
currently RB O
available JJ O
therapies NNS O
such JJ O
a DT O
electrocoagulation NN O
, , O
laser NN O
and CC O
conservative JJ O
management NN O
must MD O
be VB O
completed VBN O
to TO O
firmly RB O
define VB O
its PRP$ O
place NN O
in IN O
treatment NN O
strategy NN O
for IN O
acute JJ O
upper JJ O
GI JJ O
bleeding NN O
. . O

-DOCSTART- X X O

Screening VBG O
method NN O
for IN O
insecticidal JJ O
activity NN O
using VBG O
first JJ O
instars NNS O
of IN O
black JJ O
blow NN O
fly NN O
( -LRB- O
Diptera NNP O
: : O
Calliphoridae NNP O
) -RRB- O
. . O

A DT O
bioassay NN O
method NN O
suitable JJ O
for IN O
rapid JJ O
mass NN O
screening NN O
of IN O
fermentation NN O
and CC O
synthetic JJ O
organic JJ O
compounds NNS O
for IN O
insecticidal JJ O
activity NN O
is VBZ O
described VBN O
. . O

The DT O
test NN O
, , O
which WDT O
uses VBZ O
first JJ O
instars NNS O
of IN O
susceptible JJ O
black JJ O
blow NN O
fly NN O
, , O
Phormia NNP O
regina NN O
( -LRB- O
Meigen NNP O
) -RRB- O
, , O
in IN O
a DT O
bovine NN O
serum NN O
medium NN O
, , O
detects VBZ O
insecticidal JJ O
activity NN O
with IN O
reproducible JJ O
results NNS O
. . O

It PRP O
is VBZ O
capable JJ O
of IN O
selecting VBG O
the DT O
most RBS O
active JJ O
compound NN O
in IN O
structure NN O
- : O
activity NN O
relationships NNS O
by IN O
minimum JJ O
effective JJ O
dose NN O
concentration NN O
studies NNS O
. . O

The DT O
bioassay NN O
system NN O
is VBZ O
easy JJ O
to TO O
operate VB O
and CC O
requires VBZ O
only RB O
a DT O
minute JJ O
quantity NN O
of IN O
chemical JJ O
compound NN O
. . O

-DOCSTART- X X O

Osteonectin NNP O
transcript NN O
and CC O
metastatic JJ O
behavior NN O
in IN O
v FW O
- : O
Ki FW O
- : O
ras NNS O
transformed VBN O
fibroblasts NNS O
. . O

Osteonectin NNP O
is VBZ O
one CD O
of IN O
the DT O
major JJ O
non FW O
- : O
collagenous JJ O
proteins NNS O
of IN O
bone NN O
. . O

However RB O
, , O
its PRP$ O
transcript NN O
has VBZ O
been VBN O
found VBN O
in IN O
many JJ O
soft JJ O
, , O
extracellular JJ O
matrix NN O
- : O
producing VBG O
tissues NNS O
; : O
an DT O
osteonectin NN O
- : O
related JJ O
protein NN O
was VBD O
detected VBN O
in IN O
tumor NN O
basement NN O
membrane NN O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
expression NN O
of IN O
osteonectin NNP O
gene NN O
in IN O
fresh JJ O
BALB NNP B-NP
/ NN I-NP
c NN I-NP
fibroblasts NNS O
transformed VBN O
by IN O
v NN O
- : O
Ki FW O
- : O
ras NNS O
. . O

Transformed NNP O
cells NNS O
exhibited VBD O
lower JJR O
levels NNS O
of IN O
RNA NNP O
as IN O
compared VBN O
with IN O
normal JJ O
fibroblasts NNS O
. . O

The DT O
transformed VBD O
cells NNS O
were VBD O
cloned VBN O
after IN O
in IN O
vivo JJ O
tumorigenic JJ O
assay NN O
, , O
and CC O
4 CD O
clones NNS O
were VBD O
analyzed VBN O
for IN O
osteonectin NN O
expression NN O
by IN O
Northern NNP O
blots NNS O
. . O

Two CD O
of IN O
them PRP O
were VBD O
selected VBN O
for IN O
high JJ O
or CC O
low JJ O
osteonectin NN O
expression NN O
and CC O
tested VBN O
in IN O
vivo NN O
in IN O
spontaneous JJ O
and CC O
artificial JJ O
metastasis NN O
assays VBZ O
. . O

High NNP O
osteonectin NNP O
expression NN O
was VBD O
correlated VBN O
with IN O
high JJ O
lung NN O
colonization NN O
. . O

When WRB O
10 CD O
( -LRB- O
5 CD O
) -RRB- O
cells NNS O
were VBD O
injected VBN O
i RB O
. . O
v NN O
. . O
, , O
median JJ O
colony NN O
value NN O
was VBD O
55 CD O
and CC O
20 CD O
in IN O
higher JJR O
expressor NN O
vs NN O
. . O
lower JJR O
expressor NN O
respectively RB O
( -LRB- O
p NN O
less JJR O
than IN O
0 CD O
. . O
005 CD O
) -RRB- O
. . O

Spontaneous JJ O
metastasis NN O
indicates VBZ O
a DT O
possible JJ O
reverse NN O
correlation NN O
. . O

Our PRP$ O
data NNS O
align JJ O
osteonectin NN O
with IN O
other JJ O
matrix NN O
- : O
components NNS O
and CC O
adhesion NN O
molecules NNS O
in IN O
affecting VBG O
potential JJ O
metastatic JJ O
spreading VBG O
of IN O
transformed VBN O
cells NNS O
. . O

-DOCSTART- X X O

Early RB O
post VB O
- : O
mortem NN O
metabolism NN O
and CC O
muscle NN O
shortening NN O
in IN O
the DT O
Pectoralis NNP O
major JJ O
muscle NN O
of IN O
broiler NN O
chickens NNS O
. . O

Three CD O
experiments NNS O
were VBD O
conducted VBN O
to TO O
examine VB O
the DT O
effects NNS O
of IN O
sodium NN O
pentobarbital NN O
( -LRB- O
SP NNP O
) -RRB- O
, , O
iodoacetate NN O
( -LRB- O
IO NN O
) -RRB- O
, , O
tubocurarine FW O
( -LRB- O
TC NNP O
) -RRB- O
, , O
and CC O
surgical JJ O
denervation NN O
( -LRB- O
DN NN O
) -RRB- O
on IN O
early JJ O
rigor NN O
development NN O
in IN O
broiler NN O
breast NN O
muscle NN O
. . O

In IN O
Experiment NNP O
1 CD O
, , O
birds NNS O
were VBD O
either DT O
anesthetized JJ O
or CC O
not RB O
with IN O
SP NNP O
before IN O
receiving VBG O
an DT O
injection NN O
of IN O
IO NN O
or CC O
TC NNP O
or CC O
maintained VBN O
as IN O
noninjected JJ O
controls NNS O
. . O

Experiment NN O
2 CD O
was VBD O
identical JJ O
except IN O
that IN O
a DT O
treatment NN O
of IN O
denervation NN O
of IN O
the DT O
breast NN O
muscle NN O
was VBD O
added VBN O
. . O

Experiment NN O
3 CD O
was VBD O
conducted VBN O
to TO O
contrast NN O
birds NNS O
at IN O
1 CD O
day NN O
( -LRB- O
DN1 NN O
) -RRB- O
and CC O
3 CD O
days NNS O
( -LRB- O
DN3 NN O
) -RRB- O
denervation NN O
prior RB O
to TO O
slaughter NN O
to TO O
nonoperated JJ O
controls NNS O
. . O

Measurements NNS O
of IN O
muscle NN O
lactate NN O
, , O
ATP NNP O
, , O
R NN O
value NN O
( -LRB- O
ratio NN O
of IN O
inosine NN O
to TO O
adenine VB O
nucleotides NNS O
) -RRB- O
, , O
pH RB O
, , O
sarcomere JJ O
lengths NNS O
, , O
and CC O
shear NN O
were VBD O
used VBN O
to TO O
evaluate VB O
treatment NN O
effects NNS O
. . O

Results NNS O
for IN O
Experiment NN O
1 CD O
showed VBD O
no DT O
significant JJ O
differences NNS O
among IN O
treatment NN O
and CC O
control NN O
groups NNS O
for IN O
ATP NNP O
and CC O
lactate NN O
contents NNS O
, , O
R NN O
values NNS O
, , O
or CC O
sarcomere JJ O
lengths NNS O
; : O
however RB O
, , O
significantly RB O
lower JJR O
pH NNS O
and CC O
higher JJR O
shear NN O
values NNS O
were VBD O
observed VBN O
for IN O
control NN O
birds NNS O
. . O

In IN O
Experiment NN O
2 CD O
, , O
no DT O
significant JJ O
differences NNS O
were VBD O
observed VBN O
among IN O
the DT O
treatment NN O
groups NNS O
for IN O
ATP NNP O
, , O
R NN O
values NNS O
, , O
or CC O
sarcomere JJ O
lengths NNS O
. . O

However RB O
, , O
lactate NN O
and CC O
shear NN O
values NNS O
were VBD O
significantly RB O
lower JJR O
, , O
and CC O
pH RB O
higher JJR O
, , O
for IN O
the DT O
DN NNP O
and CC O
SP NNP O
treated VBD O
birds NNS O
. . O

Experiment NN O
3 CD O
resulted VBD O
in IN O
lower JJR O
lactate NN O
and CC O
higher JJR O
pH NNS O
values NNS O
for IN O
the DT O
DN3 JJ O
treatment NN O
in IN O
comparison NN O
with IN O
both DT O
DN1 NNP O
and CC O
control NN O
groups NNS O
. . O

Results NNS O
of IN O
these DT O
studies NNS O
indicate VBP O
that IN O
the DT O
use NN O
of IN O
SP NNP O
and CC O
DN NNP O
can MD O
be VB O
used VBN O
to TO O
alter VB O
the DT O
early JJ O
profiles NNS O
of IN O
rigor NN O
development NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
hypertension NN O
and CC O
sympathetic JJ O
denervation NN O
on IN O
cerebral JJ O
blood NN O
flow NN O
in IN O
newborn JJ O
pigs NNS O
. . O

To TO O
investigate VB O
the DT O
potential JJ O
role NN O
of IN O
sympathetic JJ O
nerves NNS O
in IN O
preventing VBG O
pronounced JJ O
increases NNS O
in IN O
cerebral JJ O
blood NN O
flow NN O
, , O
we PRP O
evaluated VBD O
the DT O
effects NNS O
of IN O
abrupt JJ O
hypertension NN O
on IN O
the DT O
cerebral JJ O
circulation NN O
of IN O
newborn JJ O
pigs NNS O
with IN O
intact JJ O
cerebral JJ O
sympathetic JJ O
innervation NN O
and CC O
after IN O
cerebral JJ O
sympathetic JJ O
denervation NN O
. . O

Epinephrine NNP O
infusion NN O
was VBD O
used VBN O
to TO O
induce VB O
abrupt JJ O
increases NNS O
in IN O
mean JJ O
( -LRB- O
+ RB O
/ VB O
- : O
SEM NNP O
) -RRB- O
arterial NN O
pressure NN O
( -LRB- O
innervated JJ O
pigs NNS O
, , O
62 CD O
+ NN O
/ NN O
- : O
3 CD O
mm CD O
of IN O
Hg NNP O
to TO O
115 CD O
+ NN O
/ NN O
- : O
3 CD O
mm CD O
of IN O
Hg NNP O
; : O
denervated VBN O
pigs NNS O
, , O
71 CD O
+ NN O
/ IN O
- : O
4 LS O
mm CD O
of IN O
Hg NNP O
to TO O
132 CD O
+ NN O
/ IN O
- : O
4 LS O
mm CD O
of IN O
Hg NNP O
) -RRB- O
that WDT O
remained VBD O
increased VBN O
for IN O
the DT O
3 CD O
minutes NNS O
of IN O
the DT O
study NN O
. . O

Abrupt NNP O
hypertension NN O
increased VBD O
blood NN O
flow NN O
to TO O
all DT O
brain NN O
regions NNS O
. . O

In IN O
denervated VBN O
pigs NNS O
, , O
the DT O
increased VBN O
flow NN O
to TO O
the DT O
cerebrum NN O
was VBD O
prolonged VBN O
, , O
compared VBN O
with IN O
that DT O
in IN O
pigs NNS O
with IN O
intact JJ O
sympathetic JJ O
innervation NN O
. . O

Differences NNS O
between IN O
pigs NNS O
of IN O
the DT O
innervated JJ O
and CC O
denervated JJ O
groups NNS O
were VBD O
not RB O
apparent JJ O
, , O
with IN O
respect NN O
to TO O
blood NN O
flow NN O
to TO O
any DT O
other JJ O
region NN O
( -LRB- O
caudate VB O
region NN O
, , O
brain NN O
stem NN O
, , O
cerebellum NN O
) -RRB- O
. . O

In IN O
newborn JJ O
pigs NNS O
, , O
sympathetic JJ O
nerves NNS O
may MD O
attenuate VB O
hypertension NN O
- : O
induced VBN O
increases NNS O
in IN O
blood NN O
flow NN O
to TO O
the DT O
cerebrum NN O
, , O
but CC O
do VBP O
not RB O
appear VB O
to TO O
affect VB O
flow NN O
to TO O
the DT O
rest NN O
of IN O
the DT O
brain NN O
. . O

-DOCSTART- X X O

[ NN O
Tumor NN O
metastasis NN O
and CC O
the DT O
fibrinolytic JJ O
system NN O
] NN O
. . O

Metastatic NNP O
spread NN O
of IN O
malignant JJ O
tumor NN O
appears VBZ O
to TO O
correlate VB O
with IN O
activation NN O
of IN O
the DT O
fibrolytic JJ O
system NN O
. . O

The DT O
role NN O
of IN O
fibrinolysis NN O
in IN O
growth NN O
and CC O
metastasis NN O
was VBD O
examined VBN O
in IN O
Lewis NNP O
lung NN O
carcinoma NN O
of IN O
mice NNS O
. . O

The DT O
inhibition NN O
of IN O
fibrinolysis NN O
or CC O
proteases NNS O
decreased VBD O
the DT O
primary JJ O
tumor NN O
growth NN O
and CC O
pulmonary JJ O
metastasis NN O
, , O
whereas IN O
the DT O
activation NN O
of IN O
fibrinolysis NN O
or CC O
proteases NNS O
increased VBD O
the DT O
number NN O
of IN O
metastatic JJ O
foci NNS O
in IN O
the DT O
lung NN O
. . O

Electronmicroscopically RB O
, , O
thrombus NN O
formation NN O
in IN O
the DT O
primary JJ O
site NN O
prevented VBN O
tumor NN O
invasion NN O
and CC O
metastasis NN O
formation NN O
. . O

Plasminogen NN O
activator NN O
( -LRB- O
PA NNP O
) -RRB- O
content NN O
of IN O
excised JJ O
tumors NNS O
was VBD O
determined VBN O
by IN O
SDS NNP O
- : O
PAGE NN O
, , O
and CC O
major JJ O
PA NNP O
was VBD O
found VBN O
to TO O
be VB O
urokinase JJ O
( -LRB- O
UK NN O
) -RRB- O
type NN O
. . O

Immunohistochemical NNP O
study NN O
with IN O
specific JJ O
antisera NN O
was VBD O
done VBN O
. . O

When WRB O
tumor NN O
cells NNS O
possessed VBN O
a DT O
high JJ O
level NN O
of IN O
UK NNP O
, , O
laminin NN O
and CC O
type NN O
IV NNP O
collagen NN O
, , O
components NNS O
of IN O
the DT O
basement NN O
membrane NN O
, , O
disappeared VBD O
from IN O
tumor NN O
tissues NNS O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
PA NNP O
through IN O
protease NN O
cascade NN O
plays VBZ O
a DT O
role NN O
in IN O
tumor NN O
invasion NN O
and CC O
metastasis NN O
. . O

Clinically RB O
, , O
patients NNS O
with IN O
advanced JJ O
cancer NN O
are VBP O
usually RB O
in IN O
a DT O
hypercoagulable JJ O
state NN O
with IN O
elevated JJ O
fibrinogen NN O
, , O
and CC O
fibrin NNS O
deposition NN O
around IN O
tumor NN O
mass NN O
is VBZ O
a DT O
serious JJ O
problem NN O
in IN O
cancer NN O
chemotherapy NN O
. . O

UK NNP O
infusion NN O
prior RB O
to TO O
5 CD O
- : O
fluorouracil NN O
increased VBN O
tissue NN O
concentration NN O
of IN O
antitumor JJ O
agent NN O
. . O

However RB O
, , O
development NN O
of IN O
consumption NN O
coagulopathy NN O
characterized VBN O
by IN O
progression NN O
from IN O
hypercoagulable JJ O
state NN O
to TO O
disseminated JJ O
intravascular JJ O
coagulation NN O
has VBZ O
also RB O
been VBN O
found VBN O
in IN O
several JJ O
cases NNS O
. . O

-DOCSTART- X X O

[ NN O
Intraepithelial NNP O
neoplasm NN O
of IN O
the DT O
uterine NN O
cervix NN O
and CC O
angiogenesis NN O
: : O
morphologic NN O
study NN O
] . O

Thirty CD O
uterine NN O
cervix NN O
specimens NNS O
sampled VBN O
following VBG O
conization NN O
or CC O
total JJ O
hysterectomy NN O
were VBD O
studied VBN O
using VBG O
histology NN O
, , O
histoenzymology NN O
( -LRB- O
vessel NN O
phosphatase NN O
alkaline NN O
activity NN O
) -RRB- O
, , O
and CC O
immunohistochemistry NN O
( -LRB- O
demonstration NN O
of IN O
laminin NN O
and CC O
type NN O
IV NNP O
collagen NN O
in IN O
epithelium NN O
and CC O
vessel NN O
basement NN O
membranes NNS O
) -RRB- O
. . O

Pathologic NNP O
conditions NNS O
included VBD O
dystrophia NN O
, , O
moderate JJ O
dysplasia NN O
, , O
severe JJ O
dysplasia NN O
, , O
and CC O
intraepithelial JJ O
carcinoma NN O
. . O

Results NNS O
were VBD O
compared VBN O
to TO O
findings NNS O
in IN O
a DT O
control NN O
group NN O
. . O

We PRP O
found VBD O
that IN O
the DT O
severity NN O
of IN O
vascular JJ O
abnormalities NNS O
correlated VBD O
positively RB O
with IN O
the DT O
severity NN O
of IN O
histologic NN O
epithelial NN O
lesions NNS O
; : O
this DT O
finding NN O
is VBZ O
consistent JJ O
with IN O
colposcopic JJ O
results NNS O
. . O

Anarchic JJ O
angiogenesis NN O
with IN O
large JJ O
, , O
moniliform NN O
, , O
tortuous JJ O
vessels NNS O
was VBD O
seen VBN O
in IN O
severe JJ O
dysplasias NNS O
and CC O
carcinomas NNS O
. . O

The DT O
vascular JJ O
anomalies NNS O
seem VBP O
to TO O
precede VB O
the DT O
development NN O
of IN O
histologic NN O
lesions NNS O
in IN O
some DT O
instances NNS O
. . O

Histogenesis NN O
of IN O
the DT O
abnormal JJ O
vessels NNS O
may MD O
involve VB O
production NN O
of IN O
an DT O
angiogenic JJ O
factor NN O
by IN O
the DT O
cancerized JJ O
epithelia NN O
. . O

-DOCSTART- X X O

Glycolysis NNP O
and CC O
glutaminolysis NN O
in IN O
perifused JJ O
Ehrlich NNP O
ascites VBZ O
tumour JJ O
cells NNS O
. . O

A DT O
perifusion NN O
system NN O
was VBD O
designed VBN O
in IN O
order NN O
to TO O
study VB O
glucose NN O
and CC O
glutamine NN O
metabolism NN O
by IN O
freshly RB O
harvested VBN O
Ehrlich NNP O
ascites VBZ O
tumour JJ O
cells NNS O
in IN O
steady JJ O
state NN O
conditions NNS O
. . O

Cells NNP O
were VBD O
perifused VBN O
in IN O
the DT O
presence NN O
of IN O
5 CD O
mM NN O
glucose NN O
, , O
0 CD O
. . O
5 CD O
mM NN O
glutamine NN O
or CC O
5 CD O
mM JJ O
glucose NN O
and CC O
0 CD O
. . O
5 CD O
mM NN O
glutamine NN O
. . O

The DT O
results NNS O
in IN O
steady JJ O
state NN O
reveal VBP O
that IN O
both DT O
substrates NNS O
glucose NN O
and CC O
glutamine NN O
are VBP O
continuously RB O
wasted VBN O
by IN O
tumour JJ O
cells NNS O
, , O
excreting VBG O
two CD O
moles NNS O
of IN O
lactate NN O
per IN O
mol NN O
of IN O
glucose NN O
and CC O
one CD O
mol NN O
of IN O
glutamate NN O
and CC O
ammonia NN O
per IN O
mol NN O
of IN O
glutamine NN O
consumed VBN O
into IN O
the DT O
medium NN O
. . O

Glutamine NN O
consumption NN O
in IN O
the DT O
presence NN O
of IN O
glucose NN O
was VBD O
higher JJR O
than IN O
with IN O
glutamine NN O
alone RB O
. . O

-DOCSTART- X X O

Invagination NN O
of IN O
the DT O
otic JJ O
placode NN O
: : O
normal JJ O
development NN O
and CC O
experimental JJ O
manipulation NN O
. . O

The DT O
inner JJ O
ear NN O
forms NNS O
from IN O
paired JJ O
ectodermal JJ O
primordia NN O
that IN O
lie NN O
to TO O
either DT O
side NN O
of IN O
the DT O
developing VBG O
hindbrain NN O
. . O

Initially RB O
each DT O
primordium NN O
forms VBZ O
a DT O
shallow JJ O
depression NN O
in IN O
the DT O
ectodermal JJ O
surface NN O
. . O

Invagination NN O
to TO O
form VB O
an DT O
otic JJ O
pit NN O
coincides VBZ O
with IN O
the DT O
formation NN O
of IN O
several JJ O
deep JJ O
folds NNS O
in IN O
the DT O
epithelial JJ O
surface NN O
. . O

An DT O
initial JJ O
fold NN O
appears VBZ O
parallel RB O
to TO O
the DT O
embryonic JJ O
axis NN O
and CC O
at IN O
the DT O
junction NN O
of IN O
the DT O
rhombencephalon NN O
with IN O
somitomeric JJ O
mesoderm NN O
. . O

This DT O
is VBZ O
followed VBN O
by IN O
formation NN O
of IN O
cranial JJ O
and CC O
caudal JJ O
folds NNS O
perpendicular JJ O
to TO O
the DT O
axis NN O
and CC O
minor JJ O
folds NNS O
that WDT O
are VBP O
within IN O
the DT O
pit NN O
formed VBN O
by IN O
earlier JJR O
folding NN O
. . O

The DT O
central JJ O
region NN O
of IN O
the DT O
otic JJ O
primordium NN O
remains VBZ O
in IN O
close JJ O
apposition NN O
to TO O
the DT O
lateral JJ O
surface NN O
of IN O
the DT O
neural JJ O
tube NN O
during IN O
the DT O
process NN O
of IN O
fold NN O
formation NN O
, , O
until IN O
the DT O
otic JJ O
pit NN O
becomes VBZ O
quite RB O
deep JJ O
. . O

At IN O
that DT O
time NN O
, , O
mesenchymal VB O
cells NNS O
penetrate VB O
between IN O
the DT O
two CD O
layers NNS O
. . O

Experimental JJ O
analysis NN O
of IN O
invagination NN O
supports VBZ O
the DT O
conclusion NN O
that IN O
otic JJ O
invagination NN O
is VBZ O
controlled VBN O
differently RB O
from IN O
that IN O
of IN O
similar JJ O
organ NN O
primordia NN O
, , O
such JJ O
as IN O
the DT O
eye NN O
and CC O
thyroid NN O
. . O

Whereas IN O
these DT O
other JJ O
primordia NN O
can MD O
be VB O
stimulated VBN O
to TO O
undergo VB O
normal JJ O
morphogenetic JJ O
shape NN O
changes NNS O
precociously RB O
by IN O
treatments NNS O
that IN O
presumably RB O
activate JJ O
motile JJ O
processes NNS O
in IN O
the DT O
cytoskeleton NN O
, , O
the DT O
same JJ O
conditions NNS O
have VBP O
little JJ O
effect NN O
on IN O
the DT O
otic JJ O
placode NN O
. . O

Similarly RB O
, , O
neither DT O
inhibitors NNS O
of IN O
calcium NN O
transport NN O
nor CC O
inactivators NNS O
of IN O
calmodulin NN O
activity NN O
prevent VBP O
otic JJ O
pit NN O
formation NN O
, , O
while IN O
these DT O
drugs NNS O
block NN O
invagination NN O
of IN O
other JJ O
primordia NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
otic JJ O
invagination NN O
may MD O
be VB O
caused VBN O
by IN O
changes NNS O
in IN O
the DT O
surrounding VBG O
tissues NNS O
rather RB O
than IN O
by IN O
an DT O
activation NN O
of IN O
motility NN O
within IN O
the DT O
primordium NN O
. . O

-DOCSTART- X X O

Anaplastic JJ O
and CC O
sarcomatoid JJ O
carcinoma NN O
of IN O
the DT O
small JJ O
intestine NN O
: : O
a DT O
clinicopathologic NN O
study NN O
. . O

Carcinomas NNP O
involving VBG O
the DT O
jejunum NN O
and CC O
ileum NN O
are VBP O
rare JJ O
tumors NNS O
. . O

During IN O
a DT O
review NN O
of IN O
small JJ O
intestinal JJ O
neoplasms NNS O
, , O
six CD O
primary JJ O
carcinomas NNS O
of IN O
jejunum NN O
or CC O
ileum NN O
with IN O
an DT O
anaplastic JJ O
and CC O
sarcomatoid JJ O
histology NN O
were VBD O
identified VBN O
. . O

At IN O
presentation NN O
, , O
three CD O
of IN O
the DT O
patients NNS O
had VBD O
symptoms NNS O
related VBN O
to TO O
metastatic JJ O
disease NN O
and CC O
three CD O
had VBD O
symptoms NNS O
referable JJ O
to TO O
the DT O
local JJ O
tumor NN O
. . O

The DT O
tumors NNS O
were VBD O
large JJ O
( -LRB- O
greater JJR O
than IN O
4 CD O
. . O
5 CD O
cm NN O
in IN O
diameter NN O
) -RRB- O
, , O
usually RB O
endophytic JJ O
masses NNS O
composed VBN O
of IN O
large JJ O
cells NNS O
with IN O
eosinophilic JJ O
cytoplasm NN O
, , O
anaplastic JJ O
nuclei NNS O
, , O
and CC O
prominent JJ O
nucleoli NNS O
. . O

In IN O
many JJ O
areas NNS O
, , O
the DT O
cells NNS O
had VBD O
a DT O
spindled JJ O
configuration NN O
. . O

Mucin NNP O
positivity NN O
was VBD O
identified VBN O
in IN O
all DT O
six CD O
cases NNS O
. . O

Electron NNP O
microscopic NN O
findings NNS O
in IN O
two CD O
cases NNS O
were VBD O
indicative JJ O
of IN O
epithelial JJ O
differentiation NN O
. . O

The DT O
tumors NNS O
behaved VBD O
aggressively RB O
; : O
all DT O
five CD O
patients NNS O
for IN O
whom WP O
there EX O
was VBD O
clinical JJ O
follow VB O
- : O
up RP O
died VBD O
of IN O
metastases NNS O
within IN O
40 CD O
months NNS O
. . O

The DT O
six CD O
anaplastic JJ O
and CC O
sarcomatoid JJ O
carcinomas NNS O
were VBD O
compared VBN O
with IN O
29 CD O
typical JJ O
adenocarcinomas NNS O
arising VBG O
in IN O
the DT O
jejunum NN O
or CC O
ileum NN O
. . O

Only RB O
two CD O
of IN O
the DT O
latter JJ O
group NN O
had VBD O
symptoms NNS O
referable VBG O
to TO O
distant JJ O
metastases NNS O
at IN O
presentation NN O
. . O

These DT O
tumors NNS O
also RB O
tended VBN O
to TO O
be VB O
smaller JJR O
at IN O
presentation NN O
( -LRB- O
11 CD O
tumors NNS O
were VBD O
less JJR O
than IN O
4 CD O
cm NN O
in IN O
greatest JJS O
dimension NN O
) -RRB- O
. . O

Of IN O
25 CD O
patients NNS O
with IN O
typical JJ O
adenocarcinomas NNS O
who WP O
had VBD O
acceptable JJ O
follow VB O
- : O
up RP O
, , O
18 CD O
( -LRB- O
72 CD O
% NN O
) -RRB- O
died VBN O
of IN O
disease NN O
and CC O
five CD O
( -LRB- O
20 CD O
% NN O
) -RRB- O
were VBD O
alive JJ O
with IN O
no DT O
evidence NN O
of IN O
disease NN O
after IN O
5 CD O
years NNS O
. . O

We PRP O
conclude VBP O
that IN O
anaplastic JJ O
and CC O
sarcomatoid JJ O
carcinoma NN O
is VBZ O
a DT O
rare JJ O
variant NN O
of IN O
small JJ O
intestinal JJ O
carcinoma NN O
with IN O
an DT O
aggressive JJ O
clinical JJ O
course NN O
. . O

-DOCSTART- X X O

Time NN O
course NN O
of IN O
transmitter NN O
action NN O
at IN O
the DT O
sympathetic JJ O
neuroeffector NN O
junction NN O
in IN O
rodent NN O
vascular JJ O
and CC O
non JJ O
- : O
vascular JJ O
smooth JJ O
muscle NN O
. . O

1 CD O
. . O

Transmitter NNP O
release NN O
from IN O
sympathetic JJ O
postganglionic JJ O
nerve NN O
terminals NNS O
innervating VBG O
the DT O
guinea NN O
- : O
pig NN O
and CC O
mouse NN O
vas NNS O
deferens NNS O
and CC O
the DT O
rat NN O
tail NN O
artery NN O
has VBZ O
been VBN O
studied VBN O
in IN O
vitro NN O
by IN O
focal JJ O
extracellular JJ O
recording NN O
with IN O
particular JJ O
emphasis NN O
on IN O
the DT O
time NN O
course NN O
of IN O
transmitter NN O
action NN O
underlying VBG O
the DT O
intracellular JJ O
potential JJ O
changes NNS O
. . O

2 CD O
. . O

In IN O
the DT O
absence NN O
of IN O
stimulation NN O
, , O
spontaneous JJ O
excitatory NN O
junction NN O
currents NNS O
( -LRB- O
SEJCs NNS O
) -RRB- O
were VBD O
recorded VBN O
with IN O
amplitudes NNS O
up IN O
to TO O
500 CD O
microV NN O
and CC O
durations NNS O
between IN O
40 CD O
and CC O
100 CD O
ms NNS O
. . O

SEJCs NNS O
were VBD O
unaffected JJ O
by IN O
the DT O
competitive JJ O
alpha NN O
- : O
adrenoceptor NN O
antagonist NN O
prazosin NN O
but CC O
blocked VBN O
by IN O
alpha NN O
, , O
beta JJ O
- : O
methylene NN O
ATP IN O
which WDT O
desensitizes VBZ O
P2 CD O
- : O
purinoceptors NNS O
. . O

3 CD O
. . O

During IN O
trains NNS O
of IN O
supramaximal JJ O
stimuli NNS O
at IN O
0 CD O
. . O
1 LS O
- : O
4 CD O
Hz JJ O
stimulus NN O
locked VBN O
excitatory NN O
junction NN O
currents NNS O
( -LRB- O
EJCs NNS O
) -RRB- O
were VBD O
evoked VBN O
intermittently RB O
from IN O
the DT O
population NN O
of IN O
varicosities NNS O
located VBN O
under IN O
the DT O
suction NN O
electrode NN O
. . O

4 CD O
. . O

SEJCs NNS O
were VBD O
similar JJ O
in IN O
amplitude NN O
and CC O
time NN O
course NN O
to TO O
EJCs NNP O
evoked VBN O
by IN O
low JJ O
- : O
frequency NN O
stimulation NN O
in IN O
the DT O
same JJ O
attachment NN O
in IN O
all DT O
three CD O
tissues NNS O
. . O

5 CD O
. . O

SEJCs NNS O
recorded VBD O
using VBG O
either CC O
a DT O
conventional JJ O
AC NNP O
amplifier NN O
or CC O
a DT O
patch NN O
clamp NN O
amplifier NN O
had VBD O
the DT O
same JJ O
time NN O
course NN O
. . O

6 CD O
. . O

These DT O
studies NNS O
show VBP O
that IN O
the DT O
time NN O
course NN O
of IN O
the DT O
current JJ O
underlying VBG O
the DT O
excitatory NN O
junction NN O
potential NN O
is VBZ O
brief JJ O
and CC O
essentially RB O
the DT O
same JJ O
in IN O
three CD O
different JJ O
tissues NNS O
. . O

The DT O
prolonged JJ O
time NN O
course NN O
of IN O
the DT O
excitatory NN O
junction NN O
potential NN O
in IN O
different JJ O
tissues NNS O
can MD O
be VB O
accounted VBN O
for IN O
by IN O
the DT O
passive JJ O
membrane NN O
properties NNS O
. . O

-DOCSTART- X X O

Phase NNP O
II NNP O
trial NN O
with IN O
D NNP O
- : O
Trp JJ O
- : O
6 CD O
- : O
LH VB O
- : O
RH NNP O
in IN O
prostatic JJ O
carcinoma NN O
: : O
comparison NN O
with IN O
other JJ O
hormonal JJ O
agents NNS O
. . O

Various JJ O
approaches NNS O
to TO O
hormonal JJ O
treatment NN O
of IN O
prostate NN O
carcinoma NN O
are VBP O
discussed VBN O
. . O

Eighty CD O
- : O
one CD O
patients NNS O
with IN O
prostatic JJ O
carcinoma NN O
, , O
eight CD O
with IN O
stage NN O
B NNP O
, , O
nine CD O
with IN O
stage NN O
C NNP O
, , O
and CC O
64 CD O
with IN O
stage NN O
D NNP O
disease NN O
, , O
were VBD O
treated VBN O
subcutaneously RB O
daily RB O
for IN O
3 CD O
months NNS O
with IN O
the DT O
LH NNP O
- : O
RH NNP O
agonist NN O
D LS O
- : O
Trp JJ O
- : O
6 CD O
- : O
LH VB O
- : O
RH NNP O
( -LRB- O
Decapeptyl NNP O
) -RRB- O
in IN O
order NN O
to TO O
evaluate VB O
the DT O
incidence NN O
of IN O
remissions NNS O
according VBG O
to TO O
WHO WP O
recommendations NNS O
for IN O
oncologic NNP O
trials NNS O
. . O

The DT O
findings NNS O
were VBD O
compared VBN O
to TO O
those DT O
obtained VBN O
with IN O
other JJ O
hormonal JJ O
therapies NNS O
of IN O
prostatic JJ O
carcinoma NN O
according VBG O
to TO O
the DT O
statistical JJ O
method NN O
of IN O
" `` O
expected VBN O
response NN O
rate NN O
" `` O
as IN O
adapted VBN O
by IN O
Lee NNP O
and CC O
Wesley NNP O
for IN O
phase NN O
II NNP O
trials NNS O
. . O

Treatment NNP O
with IN O
D NNP O
- : O
Trp JJ O
- : O
6 CD O
- : O
LH VB O
- : O
RH NNP O
greatly RB O
reduced VBD O
serum NN O
LH NNP O
and CC O
testosterone NN O
levels NNS O
without IN O
raising VBG O
serum NN O
prolactin NN O
. . O

After IN O
1 CD O
- : O
2 CD O
weeks NNS O
of IN O
therapy NN O
, , O
there EX O
was VBD O
relief NN O
of IN O
subjective JJ O
symptoms NNS O
and CC O
a DT O
reversal NN O
of IN O
the DT O
signs NNS O
of IN O
prostatism NN O
as RB O
well RB O
as IN O
a DT O
marked JJ O
decrease NN O
in IN O
bone NN O
pain NN O
. . O

At IN O
90 CD O
days NNS O
52 CD O
patients NNS O
had VBD O
complete JJ O
relief NN O
of IN O
prostatism NN O
and CC O
21 CD O
had VBD O
only RB O
mild JJ O
signs NNS O
and CC O
symptoms NNS O
. . O

Seventy NN O
patients NNS O
were VBD O
experiencing VBG O
no DT O
bone NN O
pain NN O
and CC O
an DT O
additional JJ O
six CD O
had VBD O
only RB O
mild JJ O
pain NN O
. . O

Prostatic JJ O
size NN O
, , O
evaluated VBN O
by IN O
rectal JJ O
examination NN O
and CC O
transabdominal JJ O
ultrasonography NN O
, , O
reverted VBD O
to TO O
normal JJ O
in IN O
26 CD O
. . O
4 CD O
% NN O
of IN O
patients NNS O
( -LRB- O
complete JJ O
remission NN O
) -RRB- O
and CC O
was VBD O
reduced VBN O
by IN O
more JJR O
than IN O
50 CD O
% NN O
in IN O
an DT O
additional JJ O
17 CD O
. . O
6 CD O
% NN O
( -LRB- O
partial JJ O
remission NN O
) -RRB- O
, , O
the DT O
overall JJ O
rate NN O
of IN O
complete JJ O
plus CC O
partial JJ O
regression NN O
of IN O
prostatic JJ O
enlargement NN O
being VBG O
44 CD O
% NN O
. . O

Scans NNPS O
showed VBD O
a DT O
major JJ O
improvement NN O
of IN O
bone NN O
lesions NNS O
in IN O
14 CD O
. . O
8 CD O
% NN O
of IN O
cases NNS O
. . O

This DT O
response NN O
increased VBD O
to TO O
37 CD O
% NN O
after IN O
more RBR O
than IN O
6 CD O
months NNS O
of IN O
follow VB O
- : O
up RB O
. . O

Prostatic JJ O
acid NN O
phosphatase NN O
levels NNS O
were VBD O
decreased VBN O
by IN O
more JJR O
than IN O
50 CD O
% NN O
in IN O
61 CD O
% NN O
of IN O
the DT O
patients NNS O
, , O
but CC O
this DT O
test NN O
appears VBZ O
to TO O
be VB O
a DT O
less RBR O
valid JJ O
marker NN O
than IN O
the DT O
lipid JJ O
- : O
associated JJ O
sialic JJ O
acid NN O
( -LRB- O
LASA NNP O
) -RRB- O
. . O

The DT O
increase NN O
in IN O
LASA NNP O
before IN O
treatment NN O
and CC O
a DT O
reduction NN O
after IN O
treatment NN O
can MD O
frequently RB O
be VB O
correlated VBN O
with IN O
the DT O
objective JJ O
volume NN O
of IN O
the DT O
neoplasms NNS O
. . O

No DT O
flare NN O
- : O
up IN O
of IN O
the DT O
disease NN O
was VBD O
encountered VBN O
, , O
and CC O
there EX O
were VBD O
no DT O
side NN O
effects NNS O
except IN O
for IN O
impotence NN O
. . O

Statistical NNP O
analyses NNS O
of IN O
results NNS O
by IN O
the DT O
method NN O
of IN O
Lee NNP O
and CC O
Wesley NNP O
indicated VBD O
that IN O
the DT O
incidence NN O
of IN O
complete JJ O
and CC O
partial JJ O
regression NN O
( -LRB- O
CR VBD O
and CC O
PR NNP O
) -RRB- O
observed VBD O
with IN O
D LS O
- : O
Trp JJ O
- : O
6 CD O
- : O
LH VB O
- : O
RH NNP O
was VBD O
not RB O
significantly RB O
different JJ O
from IN O
that DT O
recorded VBN O
in IN O
previous JJ O
studies NNS O
for IN O
another DT O
LH NNP O
- : O
RH NNP O
analog NN O
, , O
Buserelin NNP O
. . O

However RB O
, , O
CR VBD O
and CC O
PR NNP O
obtained VBD O
with IN O
D LS O
- : O
Trp JJ O
- : O
6 CD O
- : O
LH VB O
- : O
RH FW O
( -LRB- O
44 CD O
% NN O
) -RRB- O
were VBD O
significantly RB O
higher JJR O
than IN O
with IN O
subcapsular JJ O
orchiectomy NN O
( -LRB- O
22 CD O
% NN O
) -RRB- O
. . O

Hormonal NNP O
effects NNS O
and CC O
some DT O
other JJ O
actions NNS O
of IN O
D NNP O
- : O
Trp JJ O
- : O
6 CD O
- : O
LH VB O
- : O
RH NNP O
were VBD O
compared VBN O
and CC O
contrasted VBN O
with IN O
those DT O
produced VBN O
by IN O
castration NN O
, , O
estrogens NNS O
, , O
antiandrogens NNS O
, , O
and CC O
progestogens NNS O
. . O
( -LRB- O
ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

On IN O
the DT O
mechanism NN O
of IN O
glycolysis NN O
stimulation NN O
by IN O
neutral JJ O
detergents NNS O
in IN O
3T3 CD B-NP
and CC O
Ehrlich NNP O
ascites VBZ O
tumor NN O
cells NNS O
. . O

Glycolysis NNP O
of IN O
3T3 CD B-NP
and CC O
Ehrlich NNP O
ascites VBZ O
tumor NN O
cells NNS O
was VBD O
greatly RB O
enhanced VBN O
by IN O
Nonidet NN O
P NNP O
- : O
40 CD O
or CC O
Triton NNP O
X NNP O
- : O
100 CD O
at IN O
about IN O
100 CD O
micrograms NNS O
/ IN O
mg JJ O
cell NN O
protein NN O
. . O

This DT O
enhanced JJ O
glycolysis NN O
was VBD O
partly RB O
sensitive JJ O
to TO O
rutamycin NNS O
and CC O
partly RB O
sensitive JJ O
to TO O
ouabain RB O
, , O
suggesting VBG O
that IN O
the DT O
detergent NN O
released VBD O
the DT O
control NN O
of IN O
the DT O
ATPase NNP O
of IN O
the DT O
mitochondria NN O
and CC O
of IN O
the DT O
plasma NN O
membrane NN O
Na NNP O
+ NNP O
K NNP O
+ NNP O
- : O
ATPase NN O
. . O

Nonidet NN O
P NNP O
- : O
40 CD O
had VBD O
no DT O
effect NN O
on IN O
glycolysis NN O
in IN O
cell NN O
- : O
free JJ O
extracts NNS O
from IN O
Ehrlich NNP O
ascites VBZ O
tumor NN O
cells NNS O
to TO O
which WDT O
soluble JJ O
mitochondrial NN O
ATPase NNP O
was VBD O
added VBN O
. . O

Measuring NN O
ouabain RB O
- : O
sensitive JJ O
22Na JJ O
efflux NN O
and CC O
using VBG O
ouabain JJ O
- : O
sensitive JJ O
lactate NN O
production NN O
as IN O
a DT O
measure NN O
of IN O
ATP NNP O
hydrolysis NN O
by IN O
the DT O
Na NNP O
+ NNP O
K NNP O
+ NNP O
pump NN O
, , O
it PRP O
was VBD O
shown VBN O
that IN O
Nonidet NN O
P NNP O
- : O
40 CD O
greatly RB O
decreased VBD O
the DT O
efficiency NN O
of IN O
the DT O
Na NNP O
+ NNP O
K NNP O
+ NNP O
pump NN O
. . O

Quercetin NNP O
increased VBD O
the DT O
efficiency NN O
of IN O
pumping VBG O
in IN O
EAT NN O
cells NNS O
both CC O
in IN O
the DT O
absence NN O
and CC O
presence NN O
of IN O
the DT O
detergent NN O
. . O

-DOCSTART- X X O

Elevated VBN O
levels NNS O
of IN O
diacylglycerol NN O
and CC O
decreased VBD O
phorbol NN O
ester NN O
sensitivity NN O
in IN O
ras NNS O
- : O
transformed VBN O
fibroblasts NNS O
. . O

Diacylglycerol NNP O
( -LRB- O
DG NN O
) -RRB- O
plays VBZ O
a DT O
central JJ O
role NN O
in IN O
phospholipid JJ O
metabolism NN O
and CC O
is VBZ O
an DT O
endogenous JJ O
activator NN O
of IN O
protein NN O
kinase NN O
C NNP O
. . O

We PRP O
have VBP O
suggested VBN O
that IN O
constitutive JJ O
activation NN O
of IN O
this DT O
kinase NN O
is VBZ O
one CD O
mechanism NN O
by IN O
which WDT O
oncogenes NNS O
transform VB O
cells NNS O
. . O

The DT O
ras FW O
- : O
encoded JJ O
proteins NNS O
are VBP O
similar JJ O
to TO O
regulatory JJ O
G NNP O
- : O
proteins NNS O
and CC O
are VBP O
candidates NNS O
for IN O
the DT O
unknown JJ O
G NNP O
- : O
protein NN O
that WDT O
modulates VBZ O
phosphatidylinositol NN O
( -LRB- O
PI NNP O
) -RRB- O
turnover NN O
. . O

Differences NNS O
in IN O
polyphosphoinositide NN O
metabolism NN O
have VBP O
been VBN O
reported VBN O
for IN O
ras NNS O
- : O
transformed VBD O
cells NNS O
. . O

But CC O
because IN O
these DT O
experiments NNS O
were VBD O
performed VBN O
on IN O
confluent JJ O
cultures NNS O
of IN O
established JJ O
cell NN O
lines NNS O
, , O
the DT O
differences NNS O
are VBP O
difficult JJ O
to TO O
attribute VB O
to TO O
ras JJ O
transformation NN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
exponentially RB O
growing VBG O
NIH NNP B-NP
3T3 CD I-NP
fibroblasts NNS O
recently RB O
transformed VBN O
by IN O
Ha NNP O
- : O
ras NNS O
or CC O
Ki NNP O
- : O
ras NNS O
possess VBP O
elevated VBN O
DG JJ O
concentrations NNS O
without IN O
significant JJ O
alterations NNS O
in IN O
the DT O
levels NNS O
of IN O
other JJ O
polyphosphoinositide NN O
metabolites NNS O
. . O

The DT O
basal JJ O
phosphorylation NN O
of IN O
protein NN O
kinase NN O
C NNP O
substrate NN O
of IN O
relative JJ O
molecular JJ O
mass NN O
( -LRB- O
Mr NNP O
) -RRB- O
80 CD O
, , O
000 CD O
( -LRB- O
80K NN O
) -RRB- O
is VBZ O
significantly RB O
increased VBN O
in IN O
all PDT O
the DT O
ras FW O
- : O
transformed VBD O
cell NN O
lines NNS O
. . O

Surprisingly RB O
, , O
however RB O
, , O
further JJ O
phosphorylation NN O
of IN O
this DT O
protein NN O
on IN O
addition NN O
of IN O
phorbol NN O
ester NN O
was VBD O
greatly RB O
reduced VBN O
. . O

Ha NNP O
- : O
ras NNS O
cells NNS O
also RB O
show VBP O
less JJR O
binding NN O
of IN O
phorbol NN O
ester NN O
than IN O
control NN O
cells NNS O
, , O
suggesting VBG O
that IN O
elevation NN O
of IN O
DG NNP O
causes VBZ O
partial JJ O
down IN O
- : O
regulation NN O
in IN O
addition NN O
to TO O
activation NN O
of IN O
protein NN O
kinase NN O
C NNP O
. . O

-DOCSTART- X X O

Epidermal JJ O
growth NN O
factor NN O
and CC O
its PRP$ O
receptor NN O
. . O

Epidermal JJ O
growth NN O
factor NN O
( -LRB- O
EGF NN O
) -RRB- O
binds NNS O
with IN O
high JJ O
affinity NN O
and CC O
specificity NN O
to TO O
a DT O
single JJ O
site NN O
on IN O
the DT O
external JJ O
domain NN O
of IN O
its PRP$ O
transmembrane NN O
receptor NN O
to TO O
activate VB O
the DT O
tyrosine NN O
protein NN O
kinase NN O
activity NN O
of IN O
its PRP$ O
cytoplasmic JJ O
portion NN O
. . O

The DT O
EGF NN O
receptor NN O
gene NN O
is VBZ O
amplified VBN O
and CC O
over IN O
- : O
expressed VBN O
in IN O
several JJ O
human JJ O
tumors NNS O
, , O
suggesting VBG O
that IN O
increased VBN O
concentrations NNS O
of IN O
the DT O
proto NN O
- : O
oncogene NN O
leads VBZ O
to TO O
constitutive VB O
activity NN O
similar JJ O
to TO O
that DT O
seen VBN O
with IN O
oncogene NN O
erb NN O
B NNP O
. . O

Synthesis NNP O
and CC O
degradation NN O
of IN O
the DT O
EGF NN O
receptor NN O
are VBP O
regulated VBN O
, , O
in IN O
addition NN O
, , O
covalent JJ O
modification NN O
by IN O
phosphorylation NN O
regulates VBZ O
activity NN O
of IN O
the DT O
receptor NN O
protein NN O
. . O

Intramolecular JJ O
self NN O
- : O
phosphorylation NN O
of IN O
Tyr1173 NNP O
removes VBZ O
a DT O
competitive JJ O
inhibitory NN O
constraint NN O
to TO O
enhance VB O
phosphorylation NN O
of IN O
substrates NNS O
. . O

Phosphorylation NNP O
of IN O
Thr654 NNP O
by IN O
protein NN O
kinase NN O
C NNP O
decreases VBZ O
high JJ O
affinity NN O
EGF NN O
binding NN O
and CC O
EGF NNP O
- : O
stimulated VBD O
tyrosine JJ O
protein NN O
kinase NN O
activity NN O
, , O
providing VBG O
a DT O
mechanism NN O
for IN O
heterologous JJ O
regulation NN O
of IN O
the DT O
EGF NN O
receptor NN O
by IN O
tumor NN O
promoters NNS O
and CC O
other JJ O
ligand NN O
X NNP O
receptor NN O
complexes NNS O
. . O

Extensive JJ O
regulation NN O
contributes VBZ O
to TO O
normal JJ O
growth NN O
control NN O
, , O
abrogation IN O
of IN O
regulatory JJ O
controls NNS O
contributes VBZ O
to TO O
uncontrolled JJ O
growth NN O
as IN O
seen VBN O
with IN O
erb NN O
B NNP O
transformation NN O
and CC O
EGF NN O
receptor NN O
gene NN O
amplification NN O
in IN O
human JJ O
tumors NNS O
. . O

-DOCSTART- X X O

Malate JJ O
- : O
citrate JJ O
cycle NN O
during IN O
glycolysis NN O
and CC O
glutaminolysis NN O
in IN O
Ehrlich NNP O
ascites VBZ O
tumor NN O
cells NNS O
. . O

The DT O
malate JJ O
- : O
citrate JJ O
cycle NN O
was VBD O
studied VBN O
during IN O
aerobic JJ O
glycolysis NN O
and CC O
glutaminolysis NN O
in IN O
a DT O
strain NN O
of IN O
Ehrlich NNP O
ascites VBZ O
tumor NN O
cells NNS O
which WDT O
showed VBD O
a DT O
very RB O
low JJ O
malate NN O
- : O
aspartate NN O
shuttle NN O
system NN O
activity NN O
. . O

The DT O
experimental JJ O
approach NN O
includes VBZ O
: : O
estimation NN O
of IN O
mitochondrial JJ O
NAD NNP O
[ NNP O
P NNP O
] SYM O
+ FW O
- : O
dependent JJ O
malic JJ O
enzyme NN O
activity NN O
; : O
respiratory JJ O
activity NN O
of IN O
freshly RB O
harvested VBN O
or CC O
fasted JJ O
cells NNS O
, , O
and CC O
of IN O
isolated VBN O
mitochondria NNS O
; : O
and CC O
determination NN O
of IN O
the DT O
metabolites NNS O
involved VBN O
in IN O
the DT O
glycolytic NN O
and CC O
glutaminolytic JJ O
pathways NNS O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
in IN O
this DT O
strain NN O
, , O
the DT O
malate NN O
- : O
citrate NN O
shuttle NN O
is VBZ O
not RB O
an DT O
effective JJ O
pathway NN O
for IN O
transferring VBG O
glycolytic JJ O
reducing VBG O
equivalents NNS O
from IN O
cytosol JJ O
to TO O
mitochondria NNS O
. . O

Less RBR O
than IN O
15 CD O
% NN O
of IN O
the DT O
glucose NN O
uptake NN O
was VBD O
affected VBN O
by IN O
the DT O
1 CD O
, , O
2 CD O
, , O
3 LS O
- : O
benzenetricarboxylate JJ O
inhibition NN O
of IN O
the DT O
malate NN O
- : O
citrate NN O
shuttle NN O
. . O

Moreover RB O
, , O
in IN O
the DT O
presence NN O
of IN O
glucose NN O
, , O
the DT O
malate JJ O
- : O
citrate JJ O
cycle NN O
did VBD O
not RB O
appear VB O
to TO O
play VB O
an DT O
important JJ O
role NN O
in IN O
the DT O
glutaminolytic JJ O
process NN O
. . O

The DT O
present JJ O
work NN O
supports NNS O
and CC O
extends VBZ O
the DT O
finding NN O
of IN O
previous JJ O
studies NNS O
, , O
since IN O
the DT O
results NNS O
showed VBD O
that IN O
the DT O
glucose NN O
metabolism NN O
depressed VBD O
the DT O
oxidative JJ O
processes NNS O
in IN O
Ehrlich NNP O
ascites NNS O
tumor NN O
mitochondria NN O
, , O
not RB O
only RB O
alone RB O
, , O
but CC O
also RB O
in IN O
the DT O
presence NN O
of IN O
glutamine NN O
. . O

Interestingly RB O
, , O
the DT O
high JJ O
glutamine NN O
uptake NN O
was VBD O
maintained VBN O
in IN O
the DT O
presence NN O
of IN O
glucose NN O
. . O

-DOCSTART- X X O

Differential JJ O
secretion NN O
of IN O
proteins NNS O
and CC O
glycoproteins NNS O
by IN O
livers NNS O
of IN O
immature JJ O
and CC O
adult JJ O
rats NNS O
. . O

Effect NN O
of IN O
antimicrotubule JJ O
drugs NNS O
. . O

This DT O
study NN O
was VBD O
initiated VBN O
to TO O
re VB O
- : O
examine VB O
reported VBN O
differences NNS O
in IN O
the DT O
action NN O
of IN O
antimicrotubule JJ O
agents NNS O
on IN O
plasma NN O
protein NN O
secretion NN O
from IN O
livers NNS O
of IN O
immature JJ O
versus NN O
adult NN O
rats NNS O
. . O

The DT O
aim NN O
was VBD O
( -LRB- O
1 CD O
) -RRB- O
to TO O
determine VB O
the DT O
composition NN O
and CC O
to TO O
monitor VB O
the DT O
secretion NN O
of IN O
various JJ O
plasma NN O
proteins NNS O
and CC O
glycoproteins NNS O
from IN O
liver NN O
slices NNS O
labeled VBN O
in IN O
vitro NN O
with IN O
specific JJ O
amino IN O
acids NNS O
and CC O
sugar NN O
residues NNS O
, , O
and CC O
( -LRB- O
2 CD O
) -RRB- O
to TO O
correlate VB O
observed VBN O
differences NNS O
in IN O
secretion NN O
of IN O
these DT O
proteins NNS O
with IN O
structural JJ O
changes NNS O
in IN O
the DT O
hepatocytes NNS O
of IN O
the DT O
different JJ O
aged VBN O
animals NNS O
. . O

For IN O
the DT O
most JJS O
part NN O
, , O
slices NNS O
of IN O
liver NN O
from IN O
fetal NN O
( -LRB- O
term NN O
) -RRB- O
, , O
neonatal JJ O
( -LRB- O
4 CD O
- : O
to TO O
5 CD O
days NNS O
old JJ O
) -RRB- O
, , O
and CC O
adult NN O
rats NNS O
( -LRB- O
70 CD O
days NNS O
old JJ O
) -RRB- O
were VBD O
incubated VBN O
with IN O
radioactive JJ O
amino IN O
acids NNS O
or CC O
various JJ O
tritiated JJ O
sugars NNS O
specific JJ O
for IN O
N NNP O
- : O
linked VBN O
core NN O
oligosaccharide NN O
and CC O
/ NN O
or CC O
N NNP O
- : O
linked VBD O
terminal JJ O
oligosaccharide JJ O
chains NNS O
. . O

Our PRP$ O
findings NNS O
indicate VBP O
that IN O
liver NN O
slices NNS O
of IN O
fetal NN O
and CC O
neonatal JJ O
rats NNS O
are VBP O
efficient JJ O
in IN O
synthesizing VBG O
plasma NN O
proteins VBZ O
including VBG O
fully RB O
glycosylated VBN O
glycoproteins NNS O
. . O

The DT O
secretion NN O
of IN O
glycosylated JJ O
and CC O
nonglycosylated JJ O
proteins NNS O
believed VBN O
to TO O
be VB O
processed VBN O
through IN O
Golgi NNP O
complexes NNS O
was VBD O
inhibited VBN O
to TO O
the DT O
same JJ O
extent NN O
( -LRB- O
approximately RB O
70 CD O
- : O
80 CD O
% NN O
) -RRB- O
by IN O
antimicrotubule JJ O
agents NNS O
, , O
regardless RB O
of IN O
the DT O
age NN O
of IN O
the DT O
host NN O
animal NN O
. . O

However RB O
, , O
other JJ O
proteins NNS O
and CC O
glycoproteins NNS O
secreted VBN O
by IN O
livers NNS O
of IN O
immature JJ O
rats NNS O
were VBD O
found VBN O
to TO O
be VB O
relatively RB O
insensitive JJ O
( -LRB- O
i FW O
. . O
e NN O
. . O
inhibited VBD O
to TO O
only RB O
30 CD O
- : O
40 CD O
% NN O
) -RRB- O
to TO O
the DT O
action NN O
of IN O
various JJ O
antimicrotubule JJ O
drugs NNS O
. . O

The DT O
glycoproteins NNS O
were VBD O
found VBN O
to TO O
lack VB O
N NNP O
- : O
linked VBD O
terminal JJ O
sugars NNS O
( -LRB- O
although IN O
the DT O
glycoproteins NNS O
did VBD O
contain VB O
N NNP O
- : O
linked VBD O
core JJ O
sugars NNS O
) -RRB- O
, , O
and CC O
it PRP O
is VBZ O
likely JJ O
that IN O
the DT O
drug NN O
- : O
insensitive JJ O
proteins NNS O
bypassed VBN O
critical JJ O
glycosylating NN O
sites NNS O
in IN O
the DT O
Golgi NNP O
compartment NN O
prior RB O
to TO O
release VB O
. . O

Overall RB O
, , O
these DT O
findings NNS O
support VBP O
earlier JJR O
data NNS O
showing VBG O
that IN O
antimicrotubule JJ O
drugs NNS O
have VBP O
a DT O
special JJ O
impact NN O
on IN O
Golgi NNP O
- : O
associated JJ O
events NNS O
in IN O
liver NN O
cells NNS O
. . O

To TO O
what WP O
extent NN O
these DT O
findings NNS O
are VBP O
related VBN O
to TO O
the DT O
action NN O
of IN O
microtubules NNS O
remains VBZ O
to TO O
be VB O
seen VBN O
. . O

-DOCSTART- X X O

Multi VB O
- : O
step VB O
neoplastic JJ O
transformation NN O
of IN O
normal JJ O
human JJ O
fibroblasts NNS O
by IN O
Co NNP O
- : O
60 CD O
gamma NN O
rays NNS O
and CC O
Ha NNP O
- : O
ras VBD O
oncogenes NNS O
. . O

As IN O
reported VBN O
previously RB O
( -LRB- O
Namba NNP O
et NNP O
al NN O
. . O
, , O
1985 CD O
; : O
Namba NNP O
, , O
1985 CD O
) -RRB- O
, , O
normal JJ O
human JJ O
fibroblasts NNS O
were VBD O
transformed VBN O
into IN O
immortal JJ O
cells NNS O
with IN O
abnormal JJ O
karyotypes NNS O
by IN O
Co NNP O
- : O
60 CD O
gamma NN O
- : O
ray NN O
irradiation NN O
. . O

These DT O
immortally PRP O
transformed VBD O
cells NNS O
( -LRB- O
KMST NNP B-NP
- : I-NP
6 CD I-NP
) -RRB- O
showed VBD O
no DT O
clonability NN O
in IN O
soft JJ O
agar NN O
and CC O
were VBD O
not RB O
tumorigenic JJ O
. . O

However RB O
, , O
by IN O
treatment NN O
with IN O
Ha NNP O
- : O
ras VBD O
oncogenes NNS O
derived VBN O
from IN O
a DT O
human JJ O
lung NN O
carcinoma NN O
or CC O
Harvey NNP O
murine NN O
sarcoma NN O
virus NN O
, , O
the DT O
KMST NNP B-NP
- : I-NP
6 CD I-NP
cells NNS O
acquired VBN O
elevated VBD O
clonability NN O
in IN O
soft JJ O
agar NN O
and CC O
transplantability NN O
in IN O
nude JJ O
mice NNS O
. . O

All PDT O
the DT O
tumors NNS O
produced VBD O
grew VBN O
progressively RB O
without IN O
showing VBG O
regression NN O
and CC O
killed VBD O
the DT O
mice NNS O
. . O

The DT O
tumors NNS O
were VBD O
also RB O
serially RB O
transplantable JJ O
into IN O
other JJ O
mice NNS O
. . O

The DT O
Ha NNP O
- : O
ras JJ O
oncogene NN O
alone RB O
did VBD O
not RB O
convert VB O
normal JJ O
human JJ O
fibroblasts NNS O
into IN O
either DT O
immortal JJ O
or CC O
tumorigenic JJ O
cells NNS O
. . O

Our PRP$ O
current JJ O
data NNS O
suggest VBP O
that IN O
gamma NN O
rays NNS O
worked VBD O
as IN O
an DT O
initiator NN O
of IN O
carcinogenesis NN O
in IN O
normal JJ O
human JJ O
cells NNS O
, , O
giving VBG O
rise NN O
to TO O
chromosome NN O
aberrations NNS O
and CC O
immortality NN O
, , O
and CC O
the DT O
Ha NNP O
- : O
ras VBD O
oncogene NNP O
played VBD O
a DT O
role NN O
in IN O
the DT O
progression NN O
of IN O
the DT O
immortally RB O
transformed VBN O
cell NN O
population NN O
to TO O
a DT O
neoplastic JJ O
one CD O
showing NN O
enhanced JJ O
colony NN O
formation NN O
in IN O
soft JJ O
agar NN O
and CC O
tumorigenicity NN O
in IN O
nude JJ O
mice NNS O
. . O

-DOCSTART- X X O

N NNP O
- : O
methyl NN O
- : O
N NNP O
- : O
nitrosourea SYM O
- : O
induced VBN O
transformation NN O
of IN O
rat NN O
urothelial JJ O
cells NNS O
in IN O
vitro NN O
is VBZ O
not RB O
mediated VBN O
by IN O
activation NN O
of IN O
ras NNS O
oncogenes NNS O
. . O

Adult JJ O
rat NN O
urothelial JJ O
cells NNS O
were VBD O
transformed VBN O
in IN O
vitro NN O
following VBG O
treatment NN O
with IN O
a DT O
single JJ O
dose NN O
of IN O
N NNP O
- : O
methyl NN O
- : O
N NNP O
- : O
nitrosourea NN O
( -LRB- O
MNU NNP O
) -RRB- O
or CC O
MNU NNP O
treatment NN O
followed VBN O
by IN O
promotion NN O
with IN O
sodium NN O
saccharin NN O
. . O

This DT O
in IN O
vitro NN O
transformation NN O
process NN O
involves VBZ O
multiple JJ O
steps NNS O
: : O
slow JJ O
- : O
growing VBG O
' '' O
pre NN O
- : O
neoplastic JJ O
' '' O
epithelial NN O
foci NNS O
are VBP O
induced VBN O
70 CD O
- : O
100 CD O
days NNS O
after IN O
MNU NNP O
treatment NN O
and CC O
from IN O
such JJ O
foci NNS O
rapidly RB O
proliferating VBG O
immortal JJ O
cell NN O
lines NNS O
were VBD O
established VBN O
, , O
some DT O
of IN O
which WDT O
became VBD O
tumorigenic JJ O
after IN O
a DT O
further JJ O
latent JJ O
period NN O
. . O

A DT O
series NN O
of IN O
epithelial JJ O
cell NN O
lines NNS O
and CC O
a DT O
single JJ O
fibroblast JJ O
cell NN O
line NN O
established VBN O
in IN O
this DT O
way NN O
were VBD O
analysed VBN O
for IN O
the DT O
presence NN O
of IN O
transforming VBG O
genes NNS O
by IN O
DNA NNP O
transfection NN O
into IN O
NIH3T3 NNP B-NP
cells NNS O
. . O

None NN O
of IN O
the DT O
epithelial NN O
cell NN O
lines NNS O
induced VBN O
foci NNS O
in IN O
a DT O
focus NN O
formation NN O
assay NN O
. . O

The DT O
single JJ O
non FW O
- : O
epithelial JJ O
line NN O
induced VBN O
foci NNS O
and CC O
was VBD O
found VBN O
to TO O
contain VB O
an DT O
activated JJ O
c SYM O
- : O
Ki FW O
- : O
ras NNS O
gene NN O
with IN O
a DT O
G NNP O
- : O
- : O
- : O
- : O
A DT O
transition NN O
in IN O
codon NN O
12 CD O
. . O

To TO O
assay VB O
for IN O
the DT O
possible JJ O
presence NN O
of IN O
transforming VBG O
genes NNS O
which WDT O
were VBD O
not RB O
active JJ O
in IN O
a DT O
focus NN O
formation NN O
assay NN O
, , O
two CD O
of IN O
the DT O
epithelial NN O
lines NNS O
were VBD O
analysed VBN O
further RB O
by IN O
co NN O
- : O
transfection NN O
with IN O
a DT O
dominant JJ O
selectable JJ O
marker NN O
, , O
followed VBN O
by IN O
selection NN O
and CC O
inoculation NN O
into IN O
nude JJ O
mice NNS O
. . O

No DT O
tumours NNS O
were VBD O
induced VBN O
within IN O
the DT O
latent JJ O
period NN O
for IN O
tumour NN O
production NN O
by IN O
control NN O
cells NNS O
transfected VBN O
with IN O
NIH3T3 JJ B-NP
cell NN O
DNA NN O
( -LRB- O
40 CD O
- : O
60 CD O
days NNS O
) -RRB- O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
there EX O
is VBZ O
cell NN O
type NN O
specificity NN O
for IN O
oncogene NNP O
activation NN O
during IN O
in IN O
vitro NN O
rat NN O
bladder NN O
transformation NN O
initiated VBN O
by IN O
a DT O
single JJ O
carcinogen NN O
and CC O
that IN O
ras JJ O
gene NN O
activation NN O
is VBZ O
not RB O
a DT O
necessary JJ O
step NN O
in IN O
urothelial JJ O
transformation NN O
in IN O
vitro NN O
. . O

-DOCSTART- X X O

The DT O
posterior JJ O
tether NN O
in IN O
scoliosis NN O
. . O

The DT O
hypothesis NN O
that IN O
a DT O
localized JJ O
lordosis NN O
, , O
or CC O
tethering NN O
of IN O
the DT O
posterior JJ O
elements NNS O
of IN O
the DT O
spine NN O
, , O
is VBZ O
the DT O
primary JJ O
cause NN O
of IN O
the DT O
vertebral JJ O
rotation NN O
in IN O
idiopathic JJ O
scoliosis NN O
was VBD O
investigated VBN O
in IN O
anatomic JJ O
specimens NNS O
of IN O
human JJ O
and CC O
calf NN O
spinal JJ O
columns NNS O
. . O

The DT O
specimens NNS O
were VBD O
axially RB O
loaded VBN O
with IN O
and CC O
without IN O
a DT O
posterior JJ O
tether JJ O
created VBN O
using VBG O
Zielke NNP O
instrumentation NN O
. . O

Lateral JJ O
deflection NN O
and CC O
axial JJ O
rotation NN O
were VBD O
monitored VBN O
roentgenographically RB O
. . O

The DT O
vertebrae NNS O
of IN O
tethered JJ O
spines NNS O
showed VBD O
increased VBN O
rotation NN O
in IN O
the DT O
direction NN O
associated VBN O
with IN O
idiopathic JJ O
scoliosis NN O
. . O

The DT O
spinous JJ O
processes NNS O
moved VBD O
toward IN O
the DT O
concavity NN O
at IN O
the DT O
apex NN O
of IN O
the DT O
induced JJ O
lateral JJ O
curve NN O
. . O

Conversely RB O
, , O
untethered JJ O
spines NNS O
either CC O
exhibited JJ O
little JJ O
rotation NN O
or CC O
rotated VBD O
in IN O
the DT O
opposite JJ O
direction NN O
; : O
the DT O
spinous JJ O
processes NNS O
moved VBD O
toward IN O
the DT O
convexity NN O
of IN O
the DT O
curve NN O
. . O

Rotations NNS O
toward IN O
the DT O
convexity NN O
occur VBP O
in IN O
rotational JJ O
kyphosis NN O
. . O

Thus RB O
the DT O
hypothesis NN O
that IN O
idiopathic JJ O
scoliosis NN O
is VBZ O
a DT O
rotational JJ O
lordosis NN O
is VBZ O
substantiated VBN O
; : O
the DT O
characteristic JJ O
rotation NN O
can MD O
be VB O
explained VBN O
with IN O
the DT O
aid NN O
of IN O
a DT O
geometric JJ O
model NN O
. . O

-DOCSTART- X X O

Glutamine NN O
and CC O
glucose NN O
as IN O
energy NN O
substrates NNS O
for IN O
Ehrlich NNP O
ascites VBZ O
tumour JJ O
cells NNS O
. . O

Energy NNP O
metabolism NN O
of IN O
freshly RB O
harvested VBN O
Ehrlich NNP O
ascites VBZ O
tumour JJ O
cells NNS O
in IN O
the DT O
presence NN O
of IN O
5 CD O
mM NN O
glucose NN O
and CC O
/ NN O
or CC O
0 CD O
. . O
5 CD O
mM NN O
glutamine NN O
was VBD O
studied VBN O
. . O

The DT O
rate NN O
of IN O
oxygen NN O
utilization NN O
was VBD O
not RB O
altered VBN O
by IN O
the DT O
addition NN O
of IN O
0 CD O
. . O
5 CD O
mM NN O
glutamine NN O
; : O
5 CD O
mM NN O
glucose NN O
induced VBD O
an DT O
inhibition NN O
of IN O
respiration NN O
. . O

In IN O
the DT O
presence NN O
of IN O
both DT O
glucose NN O
and CC O
glutamine NN O
, , O
the DT O
Crabtree NNP O
effect NN O
decreased VBD O
. . O

In IN O
these DT O
conditions NNS O
, , O
the DT O
rates NNS O
of IN O
oxygen NN O
uptake NN O
, , O
the DT O
CO2 NN O
evolution NN O
and CC O
the DT O
changes NNS O
in IN O
the DT O
redox NN O
states NNS O
of IN O
cytochromes NNS O
indicate VBP O
that IN O
glucose NN O
is VBZ O
preferred VBN O
by IN O
Ehrlich NNP O
ascites VBZ O
tumour JJ O
cells NNS O
as IN O
energy NN O
substrate NN O
. . O

Glucose NNP O
decreased VBD O
the DT O
rate NN O
of IN O
glutamine NN O
utilization NN O
by IN O
34 CD O
% NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
glutaminolysis NN O
did VBD O
not RB O
inhibit VB O
glycolysis NN O
. . O

-DOCSTART- X X O

Sensitivity NN O
analysis NN O
of IN O
the DT O
influence NN O
of IN O
source NN O
- : O
term NN O
and CC O
environmental JJ O
parameters NNS O
on IN O
the DT O
radiological JJ O
risk NN O
of IN O
coal NN O
- : O
fired VBN O
plants NNS O
. . O

A DT O
sensitivity NN O
analysis NN O
was VBD O
undertaken VBN O
to TO O
determine VB O
the DT O
influence NN O
of IN O
different JJ O
source NN O
- : O
term NN O
and CC O
environmental JJ O
parameters NNS O
on IN O
the DT O
radiological JJ O
risks NNS O
from IN O
a DT O
coal NN O
- : O
fired VBN O
plant NN O
( -LRB- O
CFP NNP O
) -RRB- O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
release NN O
rate NN O
of IN O
radionuclides NNS O
and CC O
the DT O
effective JJ O
release NN O
height NN O
most RBS O
significantly RB O
influence VBP O
radiological JJ O
risk NN O
. . O

Site NNP O
characteristics NNS O
, , O
such JJ O
as IN O
rain NN O
scavenging VBG O
coefficients NNS O
and CC O
food NN O
acquirement NN O
habits NNS O
, , O
have VBP O
a DT O
lesser JJR O
influence NN O
, , O
and CC O
some DT O
parameters NNS O
, , O
such JJ O
as IN O
time NN O
delay NN O
before IN O
ingestion NN O
of IN O
contaminated JJ O
food NN O
, , O
have VBP O
practically RB O
no DT O
influence NN O
on IN O
the DT O
radiological JJ O
impact NN O
of IN O
a DT O
CFP NNP O
. . O

The DT O
contribution NN O
to TO O
radiation NN O
risks NNS O
of IN O
different JJ O
exposure NN O
modes NNS O
( -LRB- O
i NN O
. . O
e NN O
. . O
inhalation NN O
, , O
ingestion NN O
and CC O
contact NN O
with IN O
ground NN O
surface NN O
) -RRB- O
were VBD O
also RB O
analyzed VBN O
, , O
as RB O
well RB O
as IN O
of IN O
specific JJ O
radionuclides NNS O
and CC O
human JJ O
body NN O
organs NNS O
. . O

Results NNS O
of IN O
the DT O
sensitivity NN O
analysis NN O
were VBD O
interpreted VBN O
in IN O
terms NNS O
of IN O
the DT O
characteristics NNS O
of IN O
the DT O
fuel NN O
, , O
facilities NNS O
and CC O
site NN O
of IN O
a DT O
CFP NNP O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
by IN O
proper JJ O
choice NN O
of IN O
coal NN O
, , O
furnace NN O
, , O
ash NN O
filtration NN O
and CC O
stack NN O
height NN O
, , O
as RB O
well RB O
as IN O
by IN O
proper JJ O
siting NN O
, , O
the DT O
radiological JJ O
impact NN O
of IN O
a DT O
CFP NNP O
can MD O
be VB O
drastically RB O
reduced VBN O
. . O

-DOCSTART- X X O

Cigarette NN O
smoking NN O
and CC O
alveolar NN O
bone NN O
height NN O
in IN O
subjects NNS O
with IN O
a DT O
high JJ O
standard NN O
of IN O
oral JJ O
hygiene NN O
. . O

Smokers NNS O
and CC O
non FW O
- : O
smokers NNS O
were VBD O
compared VBN O
with IN O
respect NN O
to TO O
alveolar JJ O
bone NN O
height NN O
. . O

The DT O
study NN O
covered VBD O
235 CD O
subjects NNS O
aged VBN O
21 CD O
- : O
60 CD O
years NNS O
, , O
72 CD O
of IN O
whom WP O
were VBD O
smokers NNS O
. . O

Oral NNP O
hygiene NN O
status NN O
and CC O
dental JJ O
care NN O
habits NNS O
were VBD O
above RB O
average JJ O
and CC O
of IN O
equal JJ O
standard NN O
in IN O
both DT O
groups NNS O
( -LRB- O
PlI NNS O
= SYM O
0 CD O
. . O
9 CD O
) -RRB- O
. . O

Alveolar NNP O
bone NN O
height NN O
was VBD O
assessed VBN O
on IN O
radiographs NNS O
and CC O
expressed VBD O
as IN O
% NN O
of IN O
the DT O
root NN O
length NN O
. . O

Alveolar NNP O
bone NN O
height NN O
was VBD O
significantly RB O
reduced VBN O
in IN O
smokers NNS O
as IN O
compared VBN O
to TO O
non FW O
- : O
smokers NNS O
, , O
the DT O
mean JJ O
+ NN O
/ NN O
- : O
SEM NNP O
being VBG O
77 CD O
. . O
9 CD O
+ NN O
/ NN O
- : O
1 CD O
. . O
3 CD O
% NN O
and CC O
82 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
6 CD O
% NN O
, , O
respectively RB O
( -LRB- O
P NNP O
less RBR O
than IN O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

Regression NN O
analysis NN O
suggested VBN O
that IN O
periodontal JJ O
breakdown NN O
judged VBN O
from IN O
loss NN O
of IN O
alveolar JJ O
bone NN O
over IN O
time NN O
was VBD O
more JJR O
accelerated VBN O
in IN O
smokers NNS O
than IN O
non FW O
- : O
smokers NNS O
. . O

The DT O
lower JJR O
bone NN O
height NN O
in IN O
smokers NNS O
remained VBD O
when WRB O
age NN O
and CC O
oral JJ O
hygiene NN O
were VBD O
allowed VBN O
for IN O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
smoking NN O
is VBZ O
a DT O
risk NN O
factor NN O
for IN O
periodontal JJ O
health NN O
. . O

-DOCSTART- X X O

Growth NN O
state NN O
- : O
dependent JJ O
regulation NN O
of IN O
protein NN O
kinase NN O
C NNP O
in IN O
normal JJ O
and CC O
transformed VBD O
murine NN O
cells NNS O
. . O

We PRP O
determined VBD O
whether IN O
growth NN O
state NN O
can MD O
influence VB O
the DT O
action NN O
of IN O
protein NN O
kinase NN O
C NNP O
by IN O
measuring VBG O
protein NN O
kinase NN O
C NNP O
activity NN O
in IN O
growing VBG O
and CC O
stationary JJ O
cultures NNS O
of IN O
normal JJ O
and CC O
transformed VBD O
cells NNS O
. . O

Two CD O
approaches NNS O
were VBD O
used VBN O
to TO O
measure VB O
protein NN O
kinase NN O
C NNP O
: : O
assay NN O
of IN O
intact JJ O
cells NNS O
for IN O
inhibition NN O
of IN O
epidermal JJ O
growth NN O
factor NN O
( -LRB- O
EGF NN O
) -RRB- O
binding NN O
in IN O
response NN O
to TO O
phorbol NN O
dibutyrate NN O
( -LRB- O
PDBu NN O
) -RRB- O
; : O
and CC O
assay NN O
of IN O
detergent NN O
extracts NNS O
for IN O
total JJ O
calcium NN O
, , O
phospholipid JJ O
- : O
dependent JJ O
kinase NN O
activity NN O
. . O

In IN O
extracts NNS O
of IN O
growing VBG O
and CC O
stationary JJ O
Swiss JJ B-NP
3T3 JJ I-NP
cells NNS O
, , O
the DT O
total JJ O
amount NN O
of IN O
protein NN O
kinase NN O
C NNP O
activity NN O
was VBD O
similar JJ O
, , O
indicating VBG O
that IN O
growth NN O
state NN O
does VBZ O
not RB O
alter VB O
the DT O
level NN O
of IN O
enzyme NN O
in IN O
the DT O
cell NN O
. . O

The DT O
short JJ O
- : O
term NN O
response NN O
of IN O
Swiss JJ B-NP
3T3 JJ I-NP
cells NNS O
to TO O
an DT O
activator NN O
of IN O
protein NN O
kinase NN O
C NNP O
also RB O
appeared VBD O
to TO O
be VB O
independent JJ O
of IN O
growth NN O
state NN O
, , O
since IN O
the DT O
50 CD O
% NN O
effective JJ O
dose NN O
for IN O
PDBu NNP O
inhibition NN O
of IN O
EGF NNP O
binding NN O
to TO O
its PRP$ O
receptor NN O
was VBD O
approximately RB O
7 CD O
nM NN O
for IN O
both DT O
growth NN O
conditions NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
response NN O
of IN O
cells NNS O
to TO O
long JJ O
- : O
term NN O
treatment NN O
with IN O
PDBu NNP O
was VBD O
significantly RB O
different JJ O
depending VBG O
upon IN O
the DT O
initial JJ O
growth NN O
state NN O
of IN O
the DT O
cells NNS O
. . O

In IN O
both DT O
growth NN O
states NNS O
, , O
PDBu NNP O
caused VBD O
loss NN O
of IN O
protein NN O
kinase NN O
C NNP O
activity NN O
, , O
which WDT O
reflected VBD O
a DT O
loss NN O
in IN O
protein NN O
mass NN O
as IN O
determined VBN O
by IN O
immunoblotting VBG O
with IN O
antiserum NN O
to TO O
protein NN O
kinase NN O
C NNP O
. . O

However RB O
, , O
the DT O
maximum NN O
decrease NN O
approached VBD O
100 CD O
% NN O
in IN O
stationary JJ O
cultures NNS O
versus RB O
approximately RB O
75 CD O
% NN O
in IN O
growing VBG O
cells NNS O
. . O

Protein NNP O
kinase NN O
C NNP O
levels NNS O
in IN O
several JJ O
transformed VBN O
cell NN O
lines NNS O
were VBD O
subject JJ O
to TO O
down RP O
modulation NN O
in IN O
a DT O
similar JJ O
growth NN O
state NN O
- : O
dependent JJ O
manner NN O
. . O

Further RB O
, , O
the DT O
inhibition NN O
of IN O
EGF NNP O
binding NN O
by IN O
tumor NN O
promoters NNS O
following VBG O
long JJ O
- : O
term NN O
treatment NN O
of IN O
Swiss JJ B-NP
3T3 JJ I-NP
cells NNS O
with IN O
PDBu NNP O
also RB O
varied VBD O
with IN O
growth NN O
state NN O
. . O

In IN O
down RB O
modulated JJ O
growing VBG O
cells NNS O
, , O
PDBu NNP O
caused VBD O
almost RB O
complete JJ O
inhibition NN O
of IN O
EGF NNP O
binding NN O
, , O
whereas IN O
in IN O
down IN O
modulated JJ O
stationary JJ O
cells NNS O
, , O
minimal JJ O
inhibition NN O
of IN O
EGF NNP O
binding NN O
by IN O
PDBu NNP O
was VBD O
observed VBN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
prolonged VBN O
treatment NN O
with IN O
tumor NN O
promoters NNS O
alters IN O
the DT O
sensitivity NN O
of IN O
cells NNS O
to TO O
activators NNS O
of IN O
protein NN O
kinase NN O
C NNP O
in IN O
a DT O
growth NN O
state NN O
- : O
dependent JJ O
manner NN O
. . O

-DOCSTART- X X O

Suppression NN O
and CC O
re NN O
- : O
expression NN O
of IN O
transformed VBN O
phenotype NN O
in IN O
hybrids NNS O
of IN O
HA NNP O
- : O
ras FW O
- : O
1 LS O
- : O
transformed VBN O
rat NN B-NP
- : I-NP
1 CD I-NP
cells NNS O
and CC O
early JJ O
- : O
passage NN O
rat NN O
embryonic VBD O
fibroblasts NNS O
. . O

Rat NNP B-NP
- : I-NP
1 CD I-NP
cells NNS O
which WDT O
had VBD O
been VBN O
transformed VBN O
with IN O
the DT O
activated JJ O
Ha NNP O
- : O
ras FW O
- : O
1 CD O
gene NN O
from IN O
human JJ O
EJ NN B-NP
bladder NN O
carcinoma NN O
cells NNS O
were VBD O
fused VBN O
with IN O
diploid JJ O
embryonic JJ O
rat NN O
fibroblasts NNS O
. . O

Four CD O
selected VBN O
cell NN O
hybrids NNS O
expressed VBD O
the DT O
human NN O
transforming NN O
gene NN O
product NN O
p21 VBD O
at IN O
levels NNS O
of IN O
10 CD O
to TO O
30 CD O
% NN O
compared VBN O
to TO O
100 CD O
% NN O
in IN O
the DT O
transformed VBN O
parental JJ O
cells NNS O
. . O

The DT O
hybrid JJ O
cells NNS O
, , O
however RB O
, , O
exhibited VBD O
normal JJ O
morphology NN O
, , O
anchorage NN O
requirement NN O
for IN O
proliferation NN O
, , O
and CC O
largely RB O
extended JJ O
latency NN O
periods NNS O
of IN O
tumorigenicity NN O
in IN O
newborn JJ O
rats NNS O
. . O

Tumorigenic NNP O
hybrid JJ O
derivatives NNS O
contained VBD O
lower JJR O
numbers NNS O
of IN O
chromosomes NNS O
than IN O
the DT O
tetraploid JJ O
parental JJ O
hybrids NNS O
. . O

DNA NN O
of IN O
the DT O
non FW O
- : O
tumorigenic JJ O
cell NN O
hybrids NNS O
transformed VBN O
Rat NNP B-NP
- : I-NP
1 CD I-NP
cells NNS O
to TO O
anchorage VB O
- : O
independent JJ O
proliferation NN O
as IN O
expected VBN O
for IN O
the DT O
transforming JJ O
human JJ O
Ha NNP O
- : O
ras VBD O
gene NN O
present JJ O
in IN O
the DT O
donor NN O
DNA NN O
. . O

We PRP O
conclude VBP O
that IN O
the DT O
transforming VBG O
properties NNS O
of IN O
the DT O
activated JJ O
Ha NNP O
- : O
ras JJ O
gene NN O
in IN O
Rat NNP B-NP
- : I-NP
1 CD I-NP
cells NNS O
can MD O
be VB O
suppressed VBN O
at IN O
the DT O
post NN O
- : O
translational JJ O
level NN O
by IN O
the DT O
presence NN O
of IN O
the DT O
genome NN O
from IN O
diploid JJ O
embryonic JJ O
rat NN O
fibroblasts NNS O
but CC O
additional JJ O
controls NNS O
of IN O
expression NN O
of IN O
the DT O
transforming VBG O
gene NN O
are VBP O
likely JJ O
to TO O
exist VB O
. . O

Normal JJ O
cells NNS O
contain VBP O
suppressor NN O
gene NN O
( -LRB- O
s PRP O
) -RRB- O
which WDT O
safeguard NN O
these DT O
cells NNS O
against IN O
transformation NN O
by IN O
the DT O
product NN O
of IN O
the DT O
transforming NN O
Ha NNP O
- : O
ras FW O
- : O
1 CD O
oncogene NN O
. . O

-DOCSTART- X X O

Antishock JJ O
trousers NNS O
: : O
a DT O
collective JJ O
review NN O
. . O

Antishock JJ O
trousers NNS O
have VBP O
become VBN O
an DT O
integral JJ O
part NN O
of IN O
emergency NN O
medical JJ O
care NN O
for IN O
many JJ O
traumatic JJ O
and CC O
life NN O
- : O
threatening JJ O
emergencies NNS O
. . O

This DT O
article NN O
represents VBZ O
a DT O
summary NN O
of IN O
the DT O
current JJ O
state NN O
of IN O
knowledge NN O
concerning VBG O
the DT O
use NN O
of IN O
this DT O
device NN O
. . O

A DT O
brief JJ O
history NN O
of IN O
the DT O
development NN O
of IN O
antishock NN O
garments NNS O
is VBZ O
discussed VBN O
. . O

This DT O
is VBZ O
followed VBN O
by IN O
a DT O
discussion NN O
of IN O
human JJ O
clinical JJ O
studies NNS O
and CC O
results NNS O
of IN O
clinical JJ O
research NN O
on IN O
hemodynamics NNS O
, , O
respiration NN O
, , O
use NN O
in IN O
head NN O
injury NN O
, , O
and CC O
effects NNS O
on IN O
vascular JJ O
hemostasis NN O
. . O

Indications NNS O
, , O
contraindications NNS O
, , O
complications NNS O
, , O
and CC O
recommended VBD O
procedure NN O
for IN O
use NN O
are VBP O
discussed VBN O
. . O

Based VBN O
on IN O
randomized JJ O
prospective JJ O
studies NNS O
, , O
antishock NN O
garments NNS O
have VBP O
not RB O
, , O
as IN O
yet RB O
, , O
been VBN O
shown VBN O
to TO O
improve VB O
patient NN O
morbidity NN O
or CC O
mortality NN O
. . O

Proper NNP O
use NN O
of IN O
antishock NN O
garments NNS O
requires VBZ O
an DT O
understanding NN O
of IN O
both DT O
their PRP$ O
function NN O
and CC O
their PRP$ O
limitations NNS O
. . O

-DOCSTART- X X O

Measurement NN O
of IN O
serum NN O
glycosylated VBD O
proteins NNS O
and CC O
glycosylated VBD O
low JJ O
density NN O
lipoprotein NN O
fraction NN O
in IN O
diabetes NN O
mellitus NN O
. . O

A DT O
simple JJ O
method NN O
was VBD O
developed VBN O
for IN O
estimating VBG O
serum NN O
glycosylated VBD O
protein NN O
levels NNS O
using VBG O
gel NN O
filtration NN O
with IN O
Bio NNP O
- : O
Gel NNP O
P6 NNP O
by IN O
determining VBG O
the DT O
protein NN O
and CC O
sugar NN O
content NN O
in IN O
the DT O
void NN O
volume NN O
fraction NN O
. . O

The DT O
glycosylated JJ O
protein NN O
levels NNS O
( -LRB- O
GSP NN O
) -RRB- O
correlated VBN O
well RB O
with IN O
fasting VBG O
blood NN O
sugar NN O
levels NNS O
and CC O
glycosylated VBD O
albumin NN O
level NN O
( -LRB- O
G NNP O
- : O
ALB NN O
) -RRB- O
determined VBN O
by IN O
affinity NN O
chromatography NN O
with IN O
Blue NNP O
Sepharose NNP O
CL6B NN O
. . O

The DT O
glycosylation NN O
level NN O
of IN O
heparin NN O
- : O
citrate NN O
precipitable JJ O
fraction NN O
of IN O
serum NN O
which WDT O
predominantly RB O
contained VBD O
low JJ O
density NN O
lipoprotein NN O
( -LRB- O
G NNP O
- : O
LDL NN O
) -RRB- O
also RB O
correlated VBD O
well RB O
with IN O
GSP NNP O
and CC O
LDL NNP O
- : O
cholesterol NN O
levels NNS O
. . O

Significantly RB O
different JJ O
values NNS O
were VBD O
obtained VBN O
for IN O
GSP NNP O
, , O
G NNP O
- : O
ALB NNP O
, , O
and CC O
G NNP O
- : O
LDL NNP O
between IN O
normals NNS O
and CC O
diabetics NNS O
. . O

-DOCSTART- X X O

Combined VBN O
aortic JJ O
, , O
mitral JJ O
and CC O
tricuspid JJ O
surgery NN O
: : O
results NNS O
in IN O
78 CD O
patients NNS O
. . O

Between IN O
1968 CD O
and CC O
1984 CD O
, , O
78 CD O
patients NNS O
( -LRB- O
mean JJ O
age NN O
43 CD O
, , O
range NN O
14 CD O
to TO O
65 CD O
years NNS O
) -RRB- O
underwent IN O
combined VBN O
aortic JJ O
, , O
mitral JJ O
and CC O
tricuspid JJ O
surgery NN O
( -LRB- O
22 CD O
triple JJ O
valve NN O
replacements NNS O
, , O
56 CD O
aortic JJ O
valve NN O
replacements NNS O
with IN O
tricuspid JJ O
conservative JJ O
surgery NN O
and CC O
mitral JJ O
valve NN O
replacement NN O
( -LRB- O
N NNP O
= SYM O
48 CD O
) -RRB- O
, , O
or CC O
commissuroplasty JJ O
( -LRB- O
N NNP O
= SYM O
8 CD O
) -RRB- O
. . O

Pre NNP O
- : O
operative JJ O
consequences NNS O
of IN O
valvular JJ O
disease NN O
( -LRB- O
mainly RB O
mixed VBN O
valve JJ O
disease NN O
) -RRB- O
were VBD O
severe JJ O
as IN O
assessed VBN O
by IN O
functional JJ O
class NN O
( -LRB- O
72 CD O
pts NNS O
in IN O
III NNP O
or CC O
IV NNP O
NYHA NNP O
) -RRB- O
, , O
cardiomegaly JJ O
( -LRB- O
CTR NN O
: : O
62 CD O
+ NN O
/ NN O
- : O
6 CD O
% NN O
) -RRB- O
, , O
increase NN O
of IN O
mean JJ O
pulmonary JJ O
arterial NN O
and CC O
wedge NN O
pressures NNS O
( -LRB- O
respectively RB O
30 CD O
+ NN O
/ NN O
- : O
12 CD O
and CC O
19 CD O
+ NN O
/ NN O
- : O
6 CD O
mmHg NN O
) -RRB- O
decrease NN O
in IN O
cardiac JJ O
index NN O
( -LRB- O
2 CD O
. . O
1 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
5 CD O
l NN O
min NN O
- : O
1 CD O
m NN O
- : O
2 CD O
) -RRB- O
, , O
LV NNP O
dilatation NN O
( -LRB- O
LV JJ O
end NN O
diastolic JJ O
volume NN O
: : O
184 CD O
+ NN O
/ NNS O
- : O
86 CD O
ml NN O
m NN O
- : O
2 CD O
) -RRB- O
and CC O
impairment NN O
of IN O
LV NNP O
systolic JJ O
function NN O
( -LRB- O
LV NNP O
ejection NN O
fraction NN O
: : O
50 CD O
+ NN O
/ NN O
- : O
12 CD O
% NN O
) -RRB- O
. . O

Operative NNP O
mortality NN O
rate NN O
was VBD O
11 CD O
. . O
5 CD O
% NN O
. . O

The DT O
69 CD O
survivors NNS O
were VBD O
all DT O
followed VBN O
up RP O
, , O
for IN O
a DT O
mean NN O
of IN O
56 CD O
months NNS O
( -LRB- O
2 CD O
to TO O
207 CD O
) -RRB- O
. . O

16 CD O
late JJ O
deaths NNS O
occurred VBD O
. . O

Actuarial JJ O
survival NN O
rate NN O
at IN O
10 CD O
years NNS O
was VBD O
58 CD O
. . O
4 CD O
% NN O
, , O
and CC O
greatly RB O
influenced VBN O
by IN O
pre NN O
- : O
operative JJ O
NYHA NNP O
class NN O
. . O

Linearized VBN O
rates NNS O
of IN O
thromboembolic JJ O
events NNS O
, , O
valve NN O
thrombosis NN O
and CC O
haemorrhage NN O
were VBD O
respectively RB O
6 CD O
. . O
4 CD O
, , O
1 CD O
. . O
5 CD O
and CC O
1 CD O
. . O
2 CD O
% NN O
pt NN O
- : O
1 CD O
yr NN O
- : O
1 CD O
. . O

Those DT O
of IN O
infective JJ O
endocarditis NN O
, , O
periprosthetic JJ O
leak NN O
, , O
reoperation NN O
and CC O
valve NN O
failure NN O
were VBD O
0 CD O
. . O
6 CD O
, , O
3 CD O
. . O
3 CD O
and CC O
4 CD O
. . O
9 CD O
% NN O
pt NN O
- : O
1 CD O
yr NN O
- : O
1 CD O
respectively RB O
. . O

At IN O
9 CD O
years NNS O
, , O
42 CD O
% NN O
of IN O
the DT O
patients NNS O
were VBD O
in IN O
NYHA NNP O
class NN O
I PRP O
or CC O
II NNP O
and CC O
free JJ O
from IN O
complications NNS O
. . O

-DOCSTART- X X O

Torsade NNP O
de IN O
pointes NNS O
during IN O
loading NN O
with IN O
amiodarone JJ O
. . O

Torsade NNP O
de IN O
pointes NNS O
represents VBZ O
a DT O
potential JJ O
complication NN O
of IN O
chronic JJ O
amiodarone JJ O
therapy NN O
. . O

Several JJ O
reports NNS O
have VBP O
emphasized VBN O
the DT O
need NN O
for IN O
a DT O
loading NN O
dose NN O
in IN O
order NN O
to TO O
achieve VB O
therapeutic JJ O
blood NN O
levels NNS O
rapidly RB O
. . O

We PRP O
report VBP O
a DT O
case NN O
of IN O
torsade NN O
de IN O
pointes NNS O
following VBG O
a DT O
single JJ O
oral JJ O
dose NN O
of IN O
amiodarone JJ O
( -LRB- O
1400 CD O
mg NN O
or CC O
30 CD O
mg JJ O
kg JJ O
- : O
1 CD O
) -RRB- O
administered VBN O
after IN O
short JJ O
intravenous JJ O
loading NN O
for IN O
prevention NN O
of IN O
paroxysmal JJ O
atrial JJ O
flutter NN O
. . O

Torsades NNP O
de IN O
pointes NNS O
were VBD O
preceded VBN O
and CC O
associated VBN O
with IN O
marked JJ O
QT NNP O
prolongation NN O
and CC O
bradycardia NN O
. . O

This DT O
report NN O
suggests VBZ O
that IN O
careful JJ O
monitoring NN O
of IN O
patients NNS O
undergoing VBG O
oral JJ O
amiodarone JJ O
loading NN O
is VBZ O
necessary JJ O
. . O

-DOCSTART- X X O

Conjunctival NNP O
hypoxia NN O
in IN O
diabetes NN O
mellitus NN O
. . O

A DT O
frequently RB O
cited VBN O
theory NN O
for IN O
the DT O
pathogenesis NN O
of IN O
neovascularization NN O
in IN O
diabetic JJ O
retinopathy NN O
is VBZ O
that IN O
retinal JJ O
hypoxia NN O
and CC O
/ NN O
or CC O
ischemia NN O
release NN O
a DT O
factor NN O
which WDT O
stimulates VBZ O
neovascularization NN O
. . O

To TO O
the DT O
authors NNS O
' POS O
knowledge NN O
, , O
there EX O
is VBZ O
no DT O
direct JJ O
in IN O
vivo JJ O
evidence NN O
in IN O
the DT O
human JJ O
proving NN O
this DT O
theory NN O
. . O

One CD O
hundred CD O
and CC O
twenty CD O
- : O
two CD O
diabetic JJ O
subjects NNS O
were VBD O
studied VBN O
to TO O
see VB O
whether IN O
worsening VBG O
retinopathy NN O
was VBD O
associated VBN O
with IN O
changes NNS O
in IN O
conjunctival JJ O
oxygen NN O
tension NN O
( -LRB- O
pO2 NN O
) -RRB- O
. . O

Diabetics NNS O
without IN O
retinopathy NN O
had VBD O
a DT O
conjunctival NN O
pO2 NN O
which WDT O
was VBD O
similar JJ O
to TO O
an DT O
age NN O
- : O
matched VBN O
normal JJ O
population NN O
. . O

Diabetics NNS O
with IN O
only JJ O
background NN O
retinopathy NN O
had VBD O
a DT O
significantly RB O
lower JJR O
conjunctival NN O
pO2 NN O
than IN O
those DT O
without IN O
retinopathy NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0 CD O
. . O
01 CD O
) -RRB- O
. . O

Diabetics NNS O
with IN O
proliferative JJ O
retinopathy NN O
showed VBD O
a DT O
conjunctival NN O
pO2 NN O
that WDT O
was VBD O
significantly RB O
lower JJR O
than IN O
either DT O
of IN O
the DT O
first JJ O
two CD O
groups NNS O
( -LRB- O
P NNP O
less RBR O
than IN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

The DT O
lowest JJS O
value NN O
of IN O
all DT O
was VBD O
found VBN O
in IN O
patients NNS O
with IN O
rubeosis NNP O
iridis NN O
. . O

Duration IN O
of IN O
diabetes NNS O
alone RB O
did VBD O
not RB O
correlate VB O
significantly RB O
to TO O
conjunctival JJ O
pO2 NN O
. . O

These DT O
findings NNS O
support VBP O
the DT O
hypoxic JJ O
theory NN O
of IN O
diabetic JJ O
neovascular JJ O
retinopathy NN O
. . O

-DOCSTART- X X O

Unsatisfactory NNP O
forehead NN O
scar NN O
following VBG O
face NN O
lift NN O
. . O

The DT O
W NNP O
- : O
plasty JJ O
scar NN O
revision NN O
technique NN O
has VBZ O
been VBN O
found VBN O
to TO O
be VB O
effective JJ O
in IN O
the DT O
repair NN O
of IN O
the DT O
difficult JJ O
and CC O
cosmetically RB O
unsatisfactory JJ O
hairline NN O
scar NN O
following VBG O
the DT O
ill JJ O
- : O
advised VBN O
face NN O
lift NN O
technique NN O
that WDT O
excises VBZ O
forehead NN O
skin NN O
. . O

-DOCSTART- X X O

Clinical NNP O
evaluation NN O
of IN O
radiotherapy NN O
for IN O
Graves NNP O
' POS O
ophthalmopathy NN O
. . O

Seventeen CD O
patients NNS O
with IN O
moderately RB O
severe JJ O
ophthalmopathy NN O
due JJ O
to TO O
Graves NNP O
' POS O
disease NN O
were VBD O
treated VBN O
by IN O
cobalt NN O
or CC O
supervoltage NN O
radiotherapy NN O
. . O

All DT O
patients NNS O
complained VBD O
of IN O
diplopia NN O
. . O

The DT O
mean VBP O
proptosis NN O
value NN O
was VBD O
21 CD O
. . O
4 CD O
mm CD O
. . O

Three CD O
patients NNS O
( -LRB- O
18 CD O
% NN O
) -RRB- O
showed VBD O
good JJ O
response NN O
, , O
7 CD O
( -LRB- O
41 CD O
% NN O
) -RRB- O
moderate JJ O
and CC O
7 CD O
minimal JJ O
or CC O
no DT O
response NN O
. . O

Improvement NN O
was VBD O
noted VBN O
mainly RB O
in IN O
soft JJ O
tissue NN O
changes NNS O
and CC O
diplopia NN O
, , O
while IN O
proptosis NN O
decreased VBD O
in IN O
only JJ O
5 CD O
patients NNS O
. . O

All PDT O
except IN O
one CD O
patient NN O
who WP O
had VBD O
marked VBN O
extraocular JJ O
muscle NN O
involvement NN O
revealed VBN O
by IN O
computed JJ O
tomography NN O
responded VBD O
to TO O
treatment NN O
. . O

These DT O
data NNS O
indicate VBP O
that IN O
radiotherapy NN O
may MD O
be VB O
indicated VBN O
in IN O
patients NNS O
with IN O
progressive JJ O
ophthalmopathy NN O
, , O
especially RB O
in IN O
those DT O
who WP O
are VBP O
associated VBN O
with IN O
extraocular JJ O
muscle NN O
enlargement NN O
. . O

-DOCSTART- X X O

The DT O
origin NN O
of IN O
yolk NN O
- : O
DNA NN O
in IN O
Xenopus NNP O
laevis NN O
. . O

Xenopus NNP O
laevis VBD O
serum NN O
and CC O
plasma NN O
was VBD O
found VBN O
to TO O
contain VB O
an DT O
average NN O
of IN O
25 CD O
microgram NN O
DNA NNP O
/ NNP O
ml NN O
. . O

Isolated NNP O
X NNP O
. . O
laevis '' O
oocytes VBZ O
incubated VBN O
in IN O
medium NN O
containing VBG O
25 CD O
microgram NN O
DNA NN O
/ VBN O
ml JJ O
labeled VBN O
with IN O
either DT O
125I JJ O
, , O
32P JJ O
or CC O
14C JJ O
and CC O
from IN O
three CD O
different JJ O
sources NNS O
( -LRB- O
bovine NN O
, , O
E NNP O
. . O
coli NNS O
and CC O
X NNP O
. . O
laevis NNS O
) -RRB- O
, , O
incorporated JJ O
the DT O
label NN O
at IN O
an DT O
average JJ O
rate NN O
of IN O
0 CD O
. . O
11 CD O
ng NN O
. . O
mm CD O
- : O
2 CD O
. . O
hr FW O
- : O
1 CD O
. . O

Sucrose DT O
gradient JJ O
fractionation NN O
of IN O
oocytes NNS O
revealed VBD O
that IN O
40 CD O
- : O
75 CD O
% NN O
of IN O
the DT O
acid NN O
- : O
precipitable JJ O
label NN O
incorporated VBN O
was VBD O
associated VBN O
with IN O
the DT O
yolk NN O
platelets NNS O
. . O

Additional JJ O
incubations NNS O
of IN O
oocytes NNS O
in IN O
unlabeled JJ O
medium NN O
demonstrated VBD O
that IN O
the DT O
DNA NN O
incorporated VBN O
into IN O
the DT O
yolk NN O
platelets NNS O
was VBD O
undergoing VBG O
turnover NN O
; : O
only RB O
20 CD O
% NN O
of IN O
the DT O
yolk NNP O
- : O
associated JJ O
DNA NN O
was VBD O
still RB O
present JJ O
after IN O
a DT O
one CD O
- : O
week NN O
incubation NN O
. . O

Our PRP$ O
data NNS O
suggest VBP O
that IN O
yolk JJ O
- : O
DNA NN O
arises VBZ O
by IN O
the DT O
adventitious JJ O
uptake NN O
of IN O
DNA NNP O
present NN O
in IN O
the DT O
maternal JJ O
serum NN O
by IN O
vitellogenic JJ O
oocytes NNS O
. . O

-DOCSTART- X X O

New NNP O
functions NNS O
of IN O
epidermal JJ O
growth NN O
factor NN O
: : O
stimulation NN O
of IN O
capillary NN O
endothelial JJ O
cell NN O
migration NN O
and CC O
matrix NN O
dependent JJ O
proliferation NN O
. . O

The DT O
proliferative JJ O
response NN O
of IN O
bovine JJ O
retinal JJ O
capillary NN O
endothelial NN O
cells NNS O
to TO O
EGF NNP O
is VBZ O
dependent JJ O
upon IN O
attaching VBG O
the DT O
cells NNS O
to TO O
a DT O
matrix NN O
of IN O
fibronectin NN O
. . O

Bovine NNP O
capillary NN O
endothelial NN O
cells NNS O
are VBP O
also RB O
stimulated VBN O
to TO O
actively RB O
migrate JJ O
when WRB O
exposed VBN O
to TO O
EGF NNP O
in IN O
vitro NN O
. . O

These DT O
activities NNS O
provide VBP O
an DT O
explanation NN O
for IN O
the DT O
angiogenic JJ O
properties NNS O
of IN O
EGF NNP O
in IN O
vivo RB O
. . O

Capillary NNP O
cell NN O
migration NN O
and CC O
proliferation NN O
are VBP O
proposed VBN O
as IN O
sensitive JJ O
quantifiable JJ O
bioassays NNS O
to TO O
explore VB O
the DT O
functional JJ O
domains NNS O
of IN O
the DT O
EGF NNP O
molecule NN O
. . O

Studies NNS O
on IN O
the DT O
inactivation NN O
of IN O
these DT O
properties NNS O
of IN O
EGF NNP O
by IN O
specific JJ O
cleavage NN O
of IN O
the DT O
molecule NN O
with IN O
CNBr NNP O
or CC O
proteases NNS O
suggest VBP O
that IN O
an DT O
intact JJ O
loop NN O
composed VBN O
in IN O
part NN O
by IN O
amino JJ O
acid NN O
residues NNS O
20 CD O
to TO O
31 CD O
is VBZ O
essential JJ O
for IN O
at IN O
least JJS O
some DT O
functions NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
aflatoxin NN O
B1 NNS O
on IN O
the DT O
utilization NN O
of IN O
serum NN O
calcium NN O
. . O

The DT O
mathematical JJ O
analysis NN O
for IN O
plasma NN O
disappearance NN O
curve NN O
of IN O
aflatoxicosed JJ O
animals NNS O
, , O
subsequently RB O
injected VBN O
with IN O
45Ca DT O
was VBD O
determined VBN O
. . O

The DT O
analysis NN O
showed VBD O
that IN O
the DT O
three CD O
main JJ O
compartments NNS O
of IN O
the DT O
calcium NN O
pool NN O
( -LRB- O
plasma NN O
, , O
bone NN O
and CC O
the DT O
labile NN O
calcium NN O
pool NN O
on IN O
the DT O
surface NN O
of IN O
bone NN O
and CC O
soft JJ O
tissues NNS O
) -RRB- O
had VBD O
been VBN O
affected VBN O
. . O

Specifically RB O
, , O
the DT O
fractional JJ O
rate NN O
constant JJ O
for IN O
migration NN O
of IN O
45Ca CD O
from IN O
plasma NN O
pool NN O
to TO O
the DT O
labile NN O
pool NN O
had VBD O
been VBN O
diminished VBN O
to TO O
its PRP$ O
third JJ O
value NN O
. . O

This DT O
led VBD O
to TO O
a DT O
corresponding JJ O
reduction NN O
in IN O
the DT O
calcium NN O
content NN O
of IN O
the DT O
bone NN O
ash NN O
. . O

The DT O
probable JJ O
mechanism NN O
by IN O
which WDT O
aflatoxin NN O
B1 NNP O
affects VBZ O
calcium NN O
dynamics NNS O
may MD O
be VB O
interpreted VBN O
by IN O
the DT O
inhibitory JJ O
effect NN O
of IN O
aflatoxin NN O
in IN O
the DT O
hydroxylation NN O
mechanism NN O
of IN O
vitamin NN O
D3 . O
into IN O
an DT O
active JJ O
intermediate JJ O
. . O

During IN O
aflatoxicosis NN O
( -LRB- O
induction NN O
of IN O
15 CD O
days NNS O
) -RRB- O
the DT O
animals NNS O
entered VBD O
a DT O
state NN O
of IN O
calcium NN O
deficiency NN O
, , O
secondary JJ O
to TO O
intestinal JJ O
absorption NN O
inhibition NN O
. . O

This DT O
was VBD O
followed VBN O
by IN O
bone NN O
resorption NN O
and CC O
disturbance NN O
of IN O
the DT O
fractional JJ O
removal NN O
rate NN O
constant JJ O
among IN O
different JJ O
calcium NN O
compartments NNS O
. . O

-DOCSTART- X X O

Low NNP O
- : O
level NN O
X NNP O
- : O
radiation NN O
effects NNS O
on IN O
functional JJ O
vascular JJ O
changes NNS O
in IN O
Syrian JJ O
hamster NN O
cheek NN O
pouch NN O
epithelium NN O
during IN O
hydrocarbon NN O
carcinogenesis NN O
. . O

Effects NNS O
of IN O
repeated VBN O
low JJ O
- : O
level NN O
X NNP O
radiation NN O
on IN O
functional JJ O
microvascular JJ O
changes NNS O
in IN O
hamster NN O
cheek NN O
pouch NN O
epithelium NN O
during IN O
and CC O
following VBG O
carcinogenesis NN O
by IN O
7 CD O
, , O
12 CD O
- : O
dimethylbenz NN O
[ IN O
a DT O
] NN O
anthracene NN O
( -LRB- O
DMBA NNP O
) -RRB- O
were VBD O
studied VBN O
. . O

Prior RB O
studies NNS O
showed VBD O
enhancement NN O
of IN O
such JJ O
carcinogenesis NN O
by IN O
repeated VBD O
20 CD O
rad NN O
head NN O
and CC O
neck NN O
X NNP O
- : O
radiation NN O
exposures NNS O
, , O
and CC O
it PRP O
was VBD O
proposed VBN O
that IN O
one CD O
possible JJ O
mechanism NN O
was VBD O
radiogenic JJ O
alteration NN O
of IN O
the DT O
functional JJ O
microvasculature NN O
in IN O
a DT O
manner NN O
which WDT O
favored VBD O
subsequent JJ O
tumor NN O
development NN O
. . O

Hamsters NNS O
were VBD O
treated VBN O
with IN O
either DT O
radiation NN O
, , O
DMBA NNP O
, , O
radiation NN O
+ NN O
DMBA NNP O
, , O
or CC O
no DT O
treatment NN O
. . O

Animals NNS O
were VBD O
sacrificed VBN O
at IN O
3 CD O
- : O
week NN O
intervals NNS O
from IN O
0 CD O
to TO O
39 CD O
weeks NNS O
after IN O
treatments NNS O
began VBD O
. . O

Pouch NNP O
vascular JJ O
volume NN O
and CC O
permeability NN O
changes NNS O
were VBD O
studied VBN O
by IN O
fractional JJ O
distributions NNS O
of IN O
radiotracers NNS O
and CC O
were VBD O
analyzed VBN O
by IN O
a DT O
variety NN O
of IN O
statistical JJ O
methods NNS O
which WDT O
explored VBD O
the DT O
vascular JJ O
parameters NNS O
, , O
treatment NN O
types NNS O
, , O
elapsed VBN O
time NN O
, , O
presence NN O
of IN O
the DT O
carcinogen NN O
, , O
and CC O
histopathologic NN O
changes NNS O
. . O

All DT O
treatments NNS O
resulted VBD O
in IN O
significant JJ O
changes NNS O
in IN O
vascular JJ O
volume NN O
with IN O
time NN O
, , O
while IN O
only RB O
DMBA NNP O
treatments NNS O
alone RB O
resulted VBD O
in IN O
significant JJ O
changes NNS O
in IN O
vascular JJ O
permeability NN O
with IN O
time NN O
. . O

Prior RB O
to TO O
the DT O
appearances NNS O
of IN O
frank JJ O
neoplasms NNS O
, , O
volumetric JJ O
changes NNS O
in IN O
DMBA NNP O
only RB O
and CC O
radiation NN O
only RB O
groups NNS O
were VBD O
similar JJ O
, , O
while IN O
volume NN O
changes NNS O
in IN O
DMBA NNP O
+ NNP O
radiation NN O
groups NNS O
increased VBD O
slowly RB O
to TO O
a DT O
peak NN O
later RB O
than IN O
in IN O
other JJ O
groups NNS O
and CC O
then RB O
declined VBD O
steadily RB O
to TO O
levels NNS O
similar JJ O
to TO O
the DT O
radiation NN O
only RB O
group NN O
. . O

As IN O
in IN O
prior JJ O
studies NNS O
, , O
there EX O
were VBD O
significant JJ O
vascular JJ O
volume NN O
differences NNS O
between IN O
DMBA NNP O
and CC O
DMBA NNP O
+ NNP O
radiation NN O
groups NNS O
of IN O
tumor NN O
- : O
bearing VBG O
cheek NN O
pouches NNS O
. . O

DMBA NNP O
maxima NN O
were VBD O
significantly RB O
higher JJR O
than IN O
those DT O
of IN O
DMBA NNP O
+ NNP O
radiation NN O
. . O

Radiation NN O
significantly RB O
affected VBD O
DMBA NNP O
- : O
associated JJ O
vascular JJ O
volume NN O
and CC O
permeability NN O
changes NNS O
during IN O
carcinogenesis NN O
. . O

Several JJ O
possible JJ O
explanations NNS O
for IN O
the DT O
relationship NN O
of IN O
these DT O
changes NNS O
to TO O
the DT O
enhancement NN O
of IN O
DMBA NNP O
carcinogenesis NN O
include VBP O
: : O
radiation NN O
blocking VBG O
normal JJ O
capillary NN O
proliferative JJ O
and CC O
/ JJ O
or CC O
dilatory JJ O
responses NNS O
to TO O
inflammation NN O
secondary JJ O
to TO O
neoplastic JJ O
changes NNS O
; : O
radiation NN O
- : O
induced VBN O
focal JJ O
increases NNS O
in IN O
the DT O
pericapillary NN O
connective JJ O
tissue NN O
histohematic JJ O
barrier NN O
, , O
stimulating NN O
angiogenesis NN O
but CC O
reducing VBG O
nutrient JJ O
diffusion NN O
; : O
radiation NN O
exposures NNS O
sensitizing VBG O
vascular JJ O
endothelium NN O
to TO O
subsequent JJ O
angiogenic JJ O
stimulation NN O
from IN O
premalignant JJ O
tissues NNS O
; : O
DMBA NNP O
vascular , O
and CC O
epithelial JJ O
effects NNS O
partially RB O
or CC O
completely RB O
blocking VBG O
radiation NN O
effects NNS O
on IN O
epithelial NN O
and CC O
/ NN O
or CC O
endothelial JJ O
cells NNS O
; : O
and CC O
radiation NN O
damage NN O
to TO O
vessel NN O
walls NNS O
partially RB O
or CC O
fully RB O
inhibiting VBG O
normal JJ O
physiologic NN O
mechanisms NNS O
of IN O
repairing VBG O
DMBA NNP O
damage NN O
to TO O
the DT O
vessels NNS O
. . O

-DOCSTART- X X O

Immunoglobulins NNP O
associated VBN O
with IN O
elevated JJ O
riboflavin NN O
binding NN O
by IN O
plasma NN O
from IN O
cancer NN O
patients NNS O
. . O

Plasma NNP O
from IN O
182 CD O
patients NNS O
with IN O
different JJ O
malignant JJ O
diseases NNS O
was VBD O
tested VBN O
for IN O
riboflavin VBG O
binding NN O
by IN O
immunoglobulins NNS O
, , O
which WDT O
have VBP O
been VBN O
recently RB O
identified VBN O
as IN O
major JJ O
carriers NNS O
of IN O
this DT O
micronutrient NN O
. . O

A DT O
wide JJ O
range NN O
of IN O
binding NN O
( -LRB- O
5 CD O
. . O
9 CD O
to TO O
130 CD O
pmole NN O
/ IN O
ml JJ O
plasma NN O
) -RRB- O
was VBD O
observed VBN O
, , O
and CC O
significant JJ O
elevations NNS O
were VBD O
found VBN O
for IN O
patients NNS O
having VBG O
breast NN O
cancer NN O
( -LRB- O
21 CD O
. . O
2 CD O
+ NN O
/ IN O
- : O
1 LS O
. . O
9 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
05 CD O
) -RRB- O
and CC O
melanoma NN O
( -LRB- O
25 CD O
. . O
7 CD O
+ NN O
/ IN O
- : O
1 LS O
. . O
9 CD O
, , O
P NNP O
less JJR O
than IN O
0 CD O
. . O
001 CD O
) -RRB- O
compared VBN O
to TO O
controls NNS O
( -LRB- O
15 CD O
. . O
5 CD O
+ NN O
/ NN O
- : O
1 CD O
. . O
9 CD O
) -RRB- O
. . O

The DT O
proteins VBZ O
responsible JJ O
for IN O
a DT O
majority NN O
of IN O
the DT O
higher JJR O
binding NN O
were VBD O
identified VBN O
as IN O
immunoglobulins NNS O
, , O
based VBN O
on IN O
their PRP$ O
elution NN O
from IN O
gel NNP O
filtration NN O
columns NNS O
and CC O
the DT O
removal NN O
of IN O
57 CD O
- : O
88 CD O
% NN O
of IN O
the DT O
non FW O
- : O
albumin NN O
binding NN O
by IN O
treating VBG O
of IN O
plasma NN O
with IN O
Protein NNP O
A DT O
- : O
agarose NN O
. . O

The DT O
binding NN O
was VBD O
only RB O
weakly RB O
related VBN O
to TO O
the DT O
total JJ O
concentration NN O
of IN O
immunoglobulins NNS O
( -LRB- O
r NN O
= SYM O
0 CD O
. . O
11 CD O
by IN O
linear JJ O
regression NN O
analysis NN O
) -RRB- O
, , O
however RB O
, , O
and CC O
is VBZ O
apparently RB O
due JJ O
to TO O
a DT O
subclass NN O
that WDT O
is VBZ O
elevated VBN O
in IN O
some DT O
types NNS O
of IN O
cancer NN O
. . O

Elevated VBN O
levels NNS O
of IN O
these DT O
immunoglobulins NNS O
may MD O
contribute VB O
to TO O
the DT O
lower JJR O
urinary JJ O
levels NNS O
and CC O
clearance NN O
of IN O
riboflavin VBG O
in IN O
cancer NN O
. . O

-DOCSTART- X X O

Mast NNP O
cells NNS O
and CC O
tumors NNS O
. . O

The DT O
specific JJ O
enhancement NN O
of IN O
tumor NN O
proliferation NN O
in IN O
vitro NN O
. . O

Mast NNP O
cells NNS O
were VBD O
found VBN O
to TO O
be VB O
unique JJ O
among IN O
the DT O
peritoneal JJ O
leukocytes NNS O
by IN O
virtue NN O
of IN O
their PRP$ O
capacity NN O
to TO O
enhance VB O
profoundly RB O
the DT O
proliferation NN O
of IN O
a DT O
variety NN O
of IN O
tumors NNS O
in IN O
vitro NN O
. . O

This DT O
phenomenon NN O
occurs VBZ O
at IN O
mast NN O
cell NN O
/ IN O
tumor NN O
ratios NNS O
which WDT O
reflect VBP O
the DT O
stoichiometry NN O
of IN O
host NN O
cell NN O
/ VBN O
tumor NN O
relationships NNS O
in IN O
vivo NN O
. . O

The DT O
growth NN O
factor NN O
was VBD O
found VBN O
to TO O
reside NN O
in IN O
mast NN O
cell NN O
granules NNS O
and CC O
was VBD O
identified VBN O
as IN O
heparin NN O
by IN O
sequential JJ O
purification NN O
and CC O
enzymatic JJ O
degradation NN O
. . O

This DT O
cellular JJ O
interaction NN O
was VBD O
tumor NN O
- : O
specific JJ O
, , O
although IN O
isolated VBN O
granules NNS O
could MD O
enhance VB O
fibroblast JJ O
proliferation NN O
. . O

The DT O
findings NNS O
are VBP O
discussed VBN O
in IN O
relation NN O
to TO O
previous JJ O
morphologic NN O
studies NNS O
, , O
reports NNS O
of IN O
in IN O
vitro NN O
mast NN O
- : O
cell NN O
- : O
mediated JJ O
tumor NN O
cytotoxicity NN O
, , O
and CC O
the DT O
role NN O
of IN O
mast NN O
cells NNS O
in IN O
angiogenesis NN O
and CC O
connective JJ O
tissue NN O
proliferation NN O
. . O

-DOCSTART- X X O

Management NN O
of IN O
the DT O
tortuous JJ O
internal JJ O
carotid NN O
artery NN O
. . O

The DT O
tortuous JJ O
internal JJ O
carotid NN O
artery NN O
as IN O
the DT O
basis NN O
of IN O
cerebral JJ O
vascular JJ O
insufficiency NN O
is VBZ O
a DT O
controversial JJ O
entity NN O
, , O
as IN O
such JJ O
lesions NNS O
frequently RB O
occur VBP O
without IN O
neurologic NN O
symptoms NNS O
. . O

However RB O
, , O
some DT O
tortuous JJ O
vessels NNS O
are VBP O
associated VBN O
with IN O
significant JJ O
carotid NN O
atherosclerotic JJ O
disease NN O
requiring VBG O
a DT O
specific JJ O
surgical JJ O
approach NN O
. . O

This DT O
formed VBD O
the DT O
basis NN O
of IN O
our PRP$ O
report NN O
. . O

Symptoms NNS O
of IN O
cerebrovascular JJ O
insufficiency NN O
in IN O
association NN O
with IN O
a DT O
tortuous JJ O
internal JJ O
carotid NN O
artery NN O
was VBD O
encountered VBN O
in IN O
27 CD O
of IN O
853 CD O
carotid NN O
endarterectomies NNS O
over IN O
a DT O
22 CD O
year NN O
period NN O
. . O

Stenosis NNP O
of IN O
hemodynamic JJ O
significance NN O
was VBD O
noted VBN O
in IN O
nine CD O
patients NNS O
and CC O
irregularities NNS O
or CC O
ulceration NN O
were VBD O
noted VBN O
in IN O
the DT O
rest NN O
. . O

With IN O
the DT O
standard JJ O
technique NN O
of IN O
carotid NN O
endarterectomy NN O
, , O
removal NN O
of IN O
plaque NN O
from IN O
a DT O
tortuous JJ O
vessel NN O
leads VBZ O
to TO O
loss NN O
of IN O
the DT O
stenting VBG O
effect NN O
provided VBN O
by IN O
the DT O
plaque NN O
such JJ O
that IN O
angulation NN O
occlusion NN O
is VBZ O
likely JJ O
to TO O
occur VB O
. . O

The DT O
optimal JJ O
reconstruction NN O
in IN O
our PRP$ O
experience NN O
is VBZ O
eversion NN O
endarterectomy NN O
by IN O
transection NN O
and CC O
lower JJR O
reimplantation NN O
of IN O
the DT O
internal JJ O
carotid NN O
artery NN O
on IN O
the DT O
common JJ O
carotid NN O
artery NN O
. . O

Our PRP$ O
experience NN O
with IN O
17 CD O
such JJ O
procedures NNS O
in IN O
15 CD O
patients NNS O
has VBZ O
been VBN O
presented VBN O
. . O

-DOCSTART- X X O

Postpartum NNP O
rubella NN O
immunization NN O
: : O
association NN O
with IN O
development NN O
of IN O
prolonged JJ O
arthritis NN O
, , O
neurological JJ O
sequelae NNS O
, , O
and CC O
chronic JJ O
rubella NN O
viremia NN O
. . O

Six CD O
women NNS O
developed VBD O
chronic JJ O
long JJ O
- : O
term NN O
arthropathy NN O
after IN O
postpartum NN O
immunization NN O
against IN O
rubella NN O
. . O

All DT O
individuals NNS O
developed VBD O
acute JJ O
polyarticular JJ O
arthritis NN O
within IN O
12 CD O
days NNS O
to TO O
three CD O
weeks NNS O
postimmunization NN O
and CC O
have VB O
had VBD O
continuing VBG O
chronic JJ O
or CC O
recurrent JJ O
arthralgia NN O
or CC O
arthritis NN O
for IN O
two CD O
to TO O
seven CD O
years NNS O
after IN O
vaccination NN O
. . O

Acute NNP O
neurological JJ O
manifestations NNS O
, , O
consisting VBG O
of IN O
carpal JJ O
tunnel NN O
syndrome NN O
or CC O
multiple JJ O
paresthesiae NNS O
, , O
developed VBN O
postvaccination NN O
in IN O
three CD O
women NNS O
. . O

Two CD O
have VBP O
developed VBN O
continuing VBG O
active JJ O
or CC O
chronic JJ O
recurrent JJ O
episodes NNS O
of IN O
blurred JJ O
vision NN O
, , O
paresthesiae NN O
, , O
and CC O
painful JJ O
limb NN O
syndromes NNS O
together RB O
with IN O
recurrent JJ O
joint JJ O
symptoms NNS O
. . O

Chronic NNP O
rubella NN O
viremia NN O
has VBZ O
been VBN O
detected VBN O
in IN O
peripheral JJ O
blood NN O
mononuclear NN O
cell NN O
( -LRB- O
MNC NNP O
) -RRB- O
populations NNS O
in IN O
five CD O
of IN O
the DT O
six CD O
women NNS O
up RB O
to TO O
six CD O
years NNS O
after IN O
vaccination NN O
. . O

In IN O
addition NN O
rubella NN O
virus NN O
was VBD O
isolated VBN O
from IN O
breast NN O
milk NN O
MNCs NNP O
in IN O
one CD O
individual NN O
at IN O
nine CD O
months NNS O
postvaccination RB O
and CC O
from IN O
peripheral JJ O
blood NN O
MNCs NNS O
in IN O
two CD O
of IN O
four CD O
breast NN O
- : O
fed VBN O
infants NNS O
studied VBN O
at IN O
12 CD O
- : O
18 CD O
months NNS O
of IN O
age NN O
. . O

Immune NNP O
responses NNS O
to TO O
rubella NNP O
virus NN O
studied VBD O
at IN O
sequential NN O
intervals NNS O
after IN O
vaccination NN O
correlated VBN O
with IN O
development NN O
of IN O
rheumatologic NN O
and CC O
neurological JJ O
manifestations NNS O
. . O

-DOCSTART- X X O

Rapid NNP O
enzyme JJ O
analysis NN O
of IN O
amniotic JJ O
fluid NN O
phospholipids NNS O
containing VBG O
choline NN O
: : O
a DT O
comparison NN O
with IN O
the DT O
lecithin JJ O
to TO O
sphingomyelin VB O
ratio NN O
in IN O
prenatal JJ O
assessment NN O
of IN O
fetal NN O
lung NN O
maturity NN O
. . O

The DT O
relation NN O
between IN O
the DT O
choline NN O
containing VBG O
surfactant JJ O
phospholipids NNS O
lecithin JJ O
and CC O
sphingomyelin NN O
in IN O
amniotic JJ O
fluid NN O
and CC O
fetal NN O
lung NN O
maturity NN O
is VBZ O
well RB O
established VBN O
. . O

An DT O
enzymatic JJ O
method NN O
that WDT O
had VBD O
been VBN O
automated VBN O
and CC O
optimised JJ O
for IN O
use NN O
on IN O
a DT O
centrifugal JJ O
analyser NN O
was VBD O
used VBN O
to TO O
measure VB O
the DT O
total NN O
choline NN O
containing VBG O
phospholipids NNS O
in IN O
amniotic JJ O
fluid NN O
. . O

The DT O
total JJ O
time NN O
taken VBN O
for IN O
this DT O
assay NN O
was VBD O
10 CD O
minutes NNS O
. . O

The DT O
results NNS O
obtained VBD O
from IN O
100 CD O
patient NN O
samples NNS O
, , O
using VBG O
this DT O
procedure NN O
, , O
compared VBN O
favourably RB O
with IN O
the DT O
results NNS O
obtained VBN O
by IN O
the DT O
thin JJ O
layer NN O
chromatography NN O
procedure NN O
used VBN O
to TO O
determine VB O
the DT O
lecithin JJ O
to TO O
sphingomyelin NN O
ratio NN O
( -LRB- O
r NN O
= SYM O
0 CD O
. . O
93 CD O
) -RRB- O
. . O

A DT O
clinical JJ O
study NN O
of IN O
60 CD O
patients NNS O
showed VBD O
that IN O
this DT O
assay NN O
predicted VBD O
prenatal NN O
respiratory JJ O
distress NN O
syndrome NN O
as RB O
well RB O
as IN O
the DT O
lecithin JJ O
to TO O
sphingomyelin VB O
ratios NNS O
. . O

The DT O
advantage NN O
of IN O
this DT O
assay NN O
over IN O
existing VBG O
procedures NNS O
is VBZ O
that IN O
it PRP O
requires VBZ O
minimum JJ O
preparation NN O
of IN O
the DT O
specimen NNS O
and CC O
no DT O
extraction NN O
, , O
is VBZ O
quick JJ O
, , O
and CC O
shows VBZ O
a DT O
high JJ O
degree NN O
of IN O
precision NN O
. . O

-DOCSTART- X X O

[ NN O
Histophysiology NN O
and CC O
histopathology NN O
of IN O
the DT O
adrenals NNS O
in IN O
experimental JJ O
hypokinesia NN O
] NN O
. . O

In IN O
experiments NNS O
on IN O
male JJ O
rats NNS O
in IN O
the DT O
course NN O
of IN O
3 CD O
- : O
month NN O
hypokinesia NN O
phasic JJ O
changes NNS O
were VBD O
observed VBN O
in IN O
the DT O
relative JJ O
adrenal JJ O
gland NN O
weight NN O
, , O
in IN O
the DT O
volume NN O
of IN O
the DT O
cell NN O
nuclei NNS O
of IN O
the DT O
glomerular JJ O
, , O
fasicular JJ O
zones NNS O
and CC O
the DT O
medulla NN O
, , O
in IN O
the DT O
activity NN O
of IN O
the DT O
succinic JJ O
dehydrogenase NN O
, , O
alkaline NN O
and CC O
acid NN O
phosphatases NNS O
, , O
in IN O
the DT O
RNA NNP O
and CC O
catecholamine NN O
content NN O
. . O

These DT O
changes NNS O
are VBP O
associated VBN O
with IN O
variations NNS O
in IN O
the DT O
secretion NN O
and CC O
biosynthesis NN O
of IN O
the DT O
hormones NNS O
of IN O
the DT O
cortical JJ O
and CC O
the DT O
medullary NN O
layer NN O
of IN O
the DT O
adrenal JJ O
glands NNS O
during IN O
the DT O
hypokinetic JJ O
stress NN O
development NN O
. . O

-DOCSTART- X X O

Cardiac NNP O
gap NN O
junction NN O
configuration NN O
after IN O
an DT O
uncoupling JJ O
treatment NN O
as IN O
a DT O
function NN O
of IN O
time NN O
. . O

Rabbit NN O
ventricle NN O
either CC O
was VBD O
fixed VBN O
in IN O
glutaraldehyde NN O
without IN O
injury NN O
( -LRB- O
control NN O
) -RRB- O
or CC O
was VBD O
injured VBN O
before IN O
fixation NN O
, , O
presumably RB O
causing VBG O
electrical JJ O
uncoupling NN O
of IN O
the DT O
gap NN O
junctions NNS O
. . O

All DT O
tissue NN O
was VBD O
then RB O
processed VBN O
for IN O
freeze NN O
- : O
fracture NN O
. . O

Replicas NNP O
of IN O
control NN O
gap NN O
junctions NNS O
exhibited VBD O
irregular JJ O
packing NN O
of IN O
the DT O
P NNP O
- : O
face NN O
particles NNS O
and CC O
E NNP O
- : O
face NN O
pits NNS O
. . O

Average JJ O
center NN O
- : O
to TO O
- : O
center NN O
spacing NN O
of IN O
the DT O
particles NNS O
was VBD O
10 CD O
. . O
5 CD O
nm NN O
. . O

Tissue NNP O
fixed VBD O
1 CD O
- : O
5 CD O
min NN O
after IN O
injury NN O
showed VBD O
clumping VBG O
of IN O
gap NN O
junctional JJ O
particles NNS O
and CC O
pits NNS O
. . O

Within IN O
the DT O
clumps NNS O
, , O
the DT O
particles NNS O
and CC O
pits NNS O
were VBD O
hexagonally RB O
packed VBN O
and CC O
the DT O
center NN O
- : O
to TO O
- : O
center NN O
spacing NN O
of IN O
the DT O
particles NNS O
averaged VBD O
9 CD O
. . O
5 CD O
nm NN O
. . O

In IN O
tissue NN O
fixed VBN O
15 CD O
- : O
30 CD O
min NN O
after IN O
injury NN O
, , O
the DT O
clumps NNS O
of IN O
gap NN O
junctional JJ O
particles NNS O
had VBD O
coalesced VBN O
into IN O
a DT O
homogeneous JJ O
structure NN O
in IN O
most JJS O
junctions NNS O
. . O

The DT O
packing NN O
of IN O
the DT O
particles NNS O
and CC O
pits NNS O
was VBD O
hexagonal JJ O
and CC O
the DT O
spacing NN O
of IN O
the DT O
particles NNS O
averaged VBD O
9 CD O
. . O
5 CD O
nm NN O
. . O

A DT O
few JJ O
pieces NNS O
of IN O
rabbit NN O
atrium NN O
were VBD O
frozen VBN O
without IN O
prior JJ O
fixation NN O
or CC O
cryoprotection NN O
to TO O
try VB O
to TO O
assess VB O
the DT O
effect NN O
of IN O
glutarldehyde NN O
fixation NN O
on IN O
gap NN O
junction NN O
structure NN O
. . O

In IN O
this DT O
tissue NN O
the DT O
gap NN O
junctional JJ O
particles NNS O
were VBD O
irregularly RB O
packed VBN O
and CC O
their PRP$ O
spacing NN O
averaged VBD O
10 CD O
. . O
0 CD O
nm NN O
. . O

-DOCSTART- X X O

Absence NN O
of IN O
effect NN O
of IN O
prenatal JJ O
ethanol NN O
on IN O
adult NN O
emotionality NN O
and CC O
ethanol NN O
consumption NN O
in IN O
rats NNS O
. . O

Lower NNP O
peak NN O
blood NN O
ethanol NN O
concentrations NNS O
after IN O
1 CD O
and CC O
2 CD O
g NN O
of IN O
ethanol NN O
per IN O
kg NN O
were VBD O
found VBN O
in IN O
pregnant JJ O
rats NNS O
than IN O
in IN O
virgin NN O
females NNS O
. . O

No DT O
significant JJ O
differences NNS O
in IN O
adult NN O
" `` O
emotionality NN O
" '' O
or CC O
ethanol NN O
consumption NN O
were VBD O
found VBN O
in IN O
rats NNS O
exposed VBN O
to TO O
prenatal JJ O
alcohol NN O
and CC O
in IN O
pair NN O
- : O
fed NN O
and CC O
untreated JJ O
controls NNS O
. . O

-DOCSTART- X X O

Tropical JJ O
splenomegaly JJ O
syndrome NN O
in IN O
Zambia NNP O
: : O
further JJ O
observations NNS O
and CC O
effects NNS O
of IN O
cycloguanil NN O
and CC O
proguanil NN O
. . O

Nineteen CD O
Zambian JJ O
patients NNS O
with IN O
the DT O
tropical JJ O
splenomegaly JJ O
syndrome NN O
and CC O
sinusoidal JJ O
lymphocytosis NN O
on IN O
liver NN O
biopsy NN O
were VBD O
studied VBN O
. . O

The DT O
association NN O
of IN O
macrobulinaemia NN O
with IN O
the DT O
tropical JJ O
splenomegaly JJ O
syndrome NN O
has VBZ O
again RB O
been VBN O
confirmed VBN O
. . O

Sixteen CD O
patients NNS O
were VBD O
treated VBN O
with IN O
antimalarials NNS O
- : O
12 CD O
with IN O
cycloguanil NN O
pamoate NN O
alone RB O
, , O
3 CD O
with IN O
cycloguanil NN O
and CC O
proguanil NN O
, , O
and CC O
1 CD O
with IN O
proguanil NN O
alone RB O
. . O

Twelve CD O
patients NNS O
were VBD O
observed VBN O
for IN O
periods NNS O
of IN O
sufficient JJ O
length NN O
for IN O
the DT O
drug NN O
effect NN O
to TO O
be VB O
assessed VBN O
, , O
and CC O
in IN O
11 CD O
there EX O
was VBD O
a DT O
good JJ O
response NN O
in IN O
terms NNS O
of IN O
decrease NN O
in IN O
spleen JJ O
size NN O
. . O
Cycloguanil NNP O
pamoate NN O
may MD O
be VB O
of IN O
value NN O
both DT O
for IN O
prophylaxis NNS O
and CC O
treatment NN O
in IN O
areas NNS O
where WRB O
tropical JJ O
splenomegaly JJ O
syndrome NN O
is VBZ O
endemic JJ O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
glucosyl NN O
- : O
and CC O
fructosyltransferase NN O
synthesis NN O
by IN O
continuous JJ O
cultures NNS O
of IN O
Streptococcus NNP O
mutans NNS O
. . O

Streptococcus NNP O
mutans NNS O
strains NNS O
Ingbritt NNP O
, , O
and CC O
its PRP$ O
derivative JJ O
B7 NNS O
which WDT O
had VBD O
been VBN O
passaged VBN O
through IN O
monkeys NNS O
, , O
have VBP O
been VBN O
used VBN O
to TO O
investigate VB O
how WRB O
the DT O
synthesis NN O
of IN O
extracellular JJ O
glucosyl NN O
- : O
and CC O
fructosyltransferases NNS O
is VBZ O
regulated VBN O
. . O

The DT O
most RBS O
active JJ O
enzyme NN O
from IN O
carbon NN O
- : O
limited JJ O
continuous JJ O
cultures NNS O
was VBD O
a DT O
fructosyltransferase NN O
; : O
enzymes NNS O
catalysing VBG O
the DT O
formation NN O
of IN O
water NN O
- : O
insoluble JJ O
glucans NNS O
from IN O
sucrose NN O
were VBD O
relatively RB O
inactive JJ O
. . O

Dextransucrase NN O
( -LRB- O
EC NNP O
2 CD O
. . O
4 CD O
. . O
1 CD O
. . O
5 CD O
) -RRB- O
, , O
which WDT O
catalyses VBZ O
soluble JJ O
glucan NN O
synthesis NN O
, , O
was VBD O
most RBS O
active JJ O
in IN O
the DT O
supernatant JJ O
fluid NN O
from IN O
cultures NNS O
grown VBN O
with IN O
excess JJ O
glucose NN O
, , O
fructose NN O
or CC O
sucrose NN O
, , O
but CC O
full JJ O
activity NN O
was VBD O
detected VBN O
only RB O
when WRB O
the DT O
enzyme NN O
was VBD O
incubated VBN O
with IN O
both DT O
sucrose NN O
and CC O
dextran NN O
. . O

Little NNP O
dextransucrase NN O
activity NN O
was VBD O
detected VBN O
in IN O
carbon NN O
- : O
limited JJ O
cultures NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
glucosyl NN O
- : O
and CC O
fructosyltransferases NNS O
are VBP O
constitutive JJ O
enzymes NNS O
in IN O
that IN O
they PRP O
are VBP O
synthesized VBN O
at IN O
similar JJ O
rates NNS O
during IN O
growth NN O
with IN O
an DT O
excess NN O
of IN O
the DT O
substrate JJ O
or CC O
of IN O
the DT O
products NNS O
of IN O
the DT O
reactions NNS O
which WDT O
they PRP O
catalyse VBP O
. . O

Although IN O
the DT O
Ingbritt NNP O
strain NN O
was VBD O
originally RB O
isolated VBN O
from IN O
a DT O
carious JJ O
lesion NN O
, , O
it PRP O
is VBZ O
now RB O
a DT O
poor JJ O
source NN O
of IN O
glucosyltransferase NN O
activity NN O
. . O

Glucosyltransferases NNS O
were VBD O
extremely RB O
active JJ O
in IN O
cultures NNS O
of IN O
a DT O
recent JJ O
clinical JJ O
isolate NN O
, , O
strain NN O
3209 CD O
, , O
and CC O
were VBD O
apparently RB O
induced VBN O
during IN O
growth NN O
with IN O
excess JJ O
glucose NN O
. . O

-DOCSTART- X X O

Differences NNS O
between IN O
the DT O
arterial NN O
and CC O
the DT O
venous JJ O
pathomorphology NN O
in IN O
Buerger NNP O
' POS O
s PRP O
disease NN O
. . O

Morphological NNP O
lesions NNS O
were VBD O
found VBN O
to TO O
be VB O
different JJ O
in IN O
arteries NNS O
and CC O
in IN O
veins NNS O
, , O
in IN O
9 CD O
cases NNS O
of IN O
Buerger NNP O
' POS O
s PRP O
disease NN O
. . O

The DT O
arterial JJ O
lesions NNS O
were VBD O
not RB O
characteristic JJ O
and CC O
consisted VBD O
of IN O
non FW O
- : O
specific JJ O
inflammation NN O
, , O
thrombosis NN O
and CC O
obliteration NN O
which WDT O
also RB O
occur VBP O
in IN O
many JJ O
other JJ O
disease NN O
. . O

In IN O
contrast NN O
, , O
in IN O
addition NN O
to TO O
wall NN O
infiltration NN O
and CC O
thrombosis NN O
, , O
the DT O
veins NNS O
showed VBD O
microabscesses NNS O
and CC O
giant JJ O
cell NN O
granulomas NNS O
, , O
which WDT O
we PRP O
believe VBP O
to TO O
be VB O
absent JJ O
in IN O
all DT O
other JJ O
known JJ O
diseases NNS O
. . O

The DT O
affected JJ O
venous JJ O
segment NN O
exhibited VBD O
a DT O
variety NN O
of IN O
lesions NNS O
. . O

In IN O
the DT O
earliest JJS O
period NN O
, , O
the DT O
morphological JJ O
aspect NN O
of IN O
inflammation NN O
in IN O
arteries NNS O
and CC O
veins NNS O
was VBD O
fairly RB O
similar JJ O
. . O

In IN O
a DT O
late JJ O
periods NNS O
, , O
that WDT O
is VBZ O
those DT O
of IN O
vascular JJ O
obliteration NN O
, , O
the DT O
arteries NNS O
and CC O
veins NNS O
did VBD O
not RB O
show VB O
any DT O
distinguishing NN O
morphological JJ O
differences NNS O
. . O

-DOCSTART- X X O

Scanning VBG O
electron NN O
microscopy NN O
of IN O
vascular JJ O
casts NNS O
in IN O
experimental JJ O
ocular JJ O
vasoproliferation NN O
. . O

Scanning VBG O
electron NN O
microscopy NN O
of IN O
vascular JJ O
casts NNS O
was VBD O
used VBN O
to TO O
investigate VB O
three CD O
experimental JJ O
models NNS O
of IN O
neovascularization NN O
. . O

In IN O
each DT O
experimental JJ O
situation NN O
, , O
the DT O
casts NNS O
provided VBD O
a DT O
valuable JJ O
three CD O
dimensional JJ O
representation NN O
of IN O
the DT O
newly RB O
formed VBN O
blood NN O
vessels NNS O
and CC O
permitted VBD O
subclassification NN O
of IN O
the DT O
vessels NNS O
within IN O
normal JJ O
and CC O
proliferating VBG O
vascular JJ O
networks NNS O
. . O

They PRP O
defined VBD O
also RB O
the DT O
predominant JJ O
origin NN O
of IN O
new JJ O
vessels NNS O
from IN O
venules NNS O
and CC O
capillaries NNS O
, , O
and CC O
enabled VBD O
the DT O
evolution NN O
of IN O
proliferating VBG O
vessels NNS O
into IN O
arterioles NNS O
and CC O
venules NNS O
to TO O
be VB O
documented VBN O
. . O

Although IN O
vascular JJ O
casts NNS O
must MD O
be VB O
interpreted VBN O
with IN O
caution NN O
in IN O
light NN O
of IN O
the DT O
possibility NN O
of IN O
incomplete JJ O
filling NN O
and CC O
other JJ O
artifacts NNS O
, , O
they PRP O
are VBP O
a DT O
valuable JJ O
tool NN O
in IN O
the DT O
study NN O
of IN O
ocular JJ O
vasoproliferation NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
the DT O
putative JJ O
transforming JJ O
protein NN O
of IN O
the DT O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
viruses VBZ O
HTLV NNP O
- : O
I PRP O
and CC O
HTLV NNP O
- : O
II NNP O
. . O

The DT O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
viruses VBZ O
HTLV NNP O
- : O
I PRP O
and CC O
HTLV NNP O
- : O
II NNP O
are VBP O
unique JJ O
among IN O
the DT O
transforming VBG O
retroviruses NNS O
of IN O
vertebrates NNS O
in IN O
their PRP$ O
ability NN O
to TO O
transform VB O
human JJ O
T NNP O
cells NNS O
in IN O
vitro NN O
and CC O
in IN O
their PRP$ O
close JJ O
association NN O
with IN O
human JJ O
malignancies NNS O
( -LRB- O
T NNP O
- : O
cell NN O
lymphomas NNS O
and CC O
leukemia NN O
) -RRB- O
. . O

Their PRP$ O
genomes NNS O
are VBP O
relatively RB O
simple JJ O
, , O
containing VBG O
the DT O
genes NNS O
gag NN O
, , O
pol NN O
, , O
env NN O
, , O
and CC O
a DT O
3 CD O
' POS O
region NN O
termed VBD O
" `` O
X NNP O
. . O
" '' O
This DT O
3 CD O
' POS O
region NN O
may MD O
be VB O
responsible JJ O
for IN O
the DT O
transforming JJ O
potential NN O
of IN O
the DT O
viruses NNS O
. . O

The DT O
existence NN O
of IN O
proteins NNS O
encoded VBN O
by IN O
the DT O
3 CD O
' POS O
region NN O
has VBZ O
been VBN O
postulated VBN O
on IN O
the DT O
basis NN O
of IN O
multiple JJ O
open JJ O
reading NN O
frames NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
this DT O
region NN O
is VBZ O
shown VBN O
to TO O
contain VB O
a DT O
gene NN O
encoding VBG O
a DT O
protein NN O
of IN O
40 CD O
kilodaltons NNS O
in IN O
HTLV NNP O
- : O
I PRP O
and CC O
37 CD O
kilodaltons NNS O
in IN O
HTLV NNP O
- : O
II NNP O
. . O

It PRP O
is VBZ O
proposed VBN O
that IN O
these DT O
proteins NNS O
be VB O
called VBN O
, , O
respectively RB O
, , O
p40xI JJ O
and CC O
p37xII JJ O
. . O

-DOCSTART- X X O

Participation NNP O
of IN O
p53 NN O
cellular JJ O
tumour NN O
antigen NN O
in IN O
transformation NN O
of IN O
normal JJ O
embryonic JJ O
cells NNS O
. . O

The DT O
cellular JJ O
tumour NN O
antigen NN O
p53 NN O
is VBZ O
found VBN O
at IN O
elevated JJ O
levels NNS O
in IN O
a DT O
wide JJ O
variety NN O
of IN O
transformed VBN O
cells NNS O
( -LRB- O
for IN O
reviews NNS O
see VBP O
refs NNS O
1 CD O
, , O
2 CD O
) -RRB- O
. . O

Very RB O
little RB O
is VBZ O
yet RB O
known VBN O
about IN O
the DT O
precise JJ O
relationship NN O
of IN O
p53 NN O
to TO O
malignant JJ O
transformation NN O
. . O

Although IN O
the DT O
increase NN O
in IN O
p53 NN O
levels NNS O
could MD O
be VB O
a DT O
secondary JJ O
by IN O
- : O
product NN O
of IN O
the DT O
transformed VBN O
state NN O
, , O
it PRP O
is VBZ O
equally RB O
possible JJ O
that IN O
p53 NN O
is VBZ O
actively RB O
involved VBN O
in IN O
altering VBG O
cellular JJ O
growth NN O
properties NNS O
, , O
especially RB O
as IN O
it PRP O
has VBZ O
been VBN O
implicated VBN O
in IN O
the DT O
regulation NN O
of IN O
normal JJ O
cell NN O
proliferation NN O
. . O

We PRP O
sought VBD O
to TO O
test VB O
whether IN O
p53 NN O
could MD O
behave VB O
in IN O
a DT O
manner NN O
similar JJ O
to TO O
known JJ O
genes NNS O
in IN O
a DT O
biological JJ O
test NN O
system NN O
, , O
and CC O
we PRP O
demonstrate VBP O
here RB O
that IN O
p53 NN O
can MD O
cooperate VB O
with IN O
the DT O
activated JJ O
Ha NNP O
- : O
ras VBD O
oncogene IN O
to TO O
transform VB O
normal JJ O
embryonic JJ O
cells NNS O
. . O

The DT O
resultant NN O
foci NNS O
contain VBP O
cells NNS O
of IN O
a DT O
markedly NN O
altered VBN O
morphology NN O
which WDT O
produce VBP O
high JJ O
levels NNS O
of IN O
p53 NN O
. . O

Cell NN O
lines NNS O
established VBN O
from IN O
such JJ O
foci NNS O
elicit NN O
tumours NNS O
in IN O
syngeneic JJ O
animals NNS O
. . O

-DOCSTART- X X O

Dynorphin NNP O
is VBZ O
contained VBN O
within IN O
hippocampal NN O
mossy NN O
fibers NNS O
: : O
immunochemical JJ O
alterations NNS O
after IN O
kainic JJ O
acid NN O
administration NN O
and CC O
colchicine NN O
- : O
induced VBN O
neurotoxicity NN O
. . O

Antisera NNP O
raised VBD O
against IN O
synthetic JJ O
dynorphin NN O
or CC O
[ NN O
Leu5 . O
] SYM O
enkephalin RB O
demonstrate VBP O
immunostaining VBG O
in IN O
hippocampal JJ O
mossy NN O
fibers NNS O
and CC O
in IN O
dentate NN O
granule NN O
cells NNS O
. . O

However RB O
, , O
dynorphin NN O
immunoreactivity NN O
( -LRB- O
ir NN O
) -RRB- O
appears VBZ O
to TO O
be VB O
denser VBN O
in IN O
immunocytochemical JJ O
preparations NNS O
and CC O
is VBZ O
quantitatively RB O
greater JJR O
by IN O
radioimmunoassay NN O
than IN O
enkephalin NN O
- : O
ir NN O
. . O

Immunostaining NNP O
with IN O
dynorphin JJ O
antisera NN O
is VBZ O
eliminated VBN O
by IN O
adsorption NN O
with IN O
1 CD O
- : O
100 CD O
microM NN O
dynorphin NN O
- : O
17 CD O
whereas IN O
immunostaining VBG O
with IN O
enkephalin NN O
antisera NN O
is VBZ O
eliminated VBN O
by IN O
adsorption NN O
with IN O
1 CD O
- : O
100 CD O
microM NNS O
[ IN O
Leu5 NNP O
] NNP O
enkephalin NN O
, , O
dynorphin NN O
- : O
17 CD O
, , O
dynorphin NN O
- : O
( -LRB- O
1 LS O
- : O
13 CD O
) -RRB- O
, , O
or CC O
alpha NN O
- : O
neo NN O
- : O
endorphin NN O
. . O

Intrahippocampal NNP O
colchicine NN O
injections NNS O
, , O
which WDT O
selectively RB O
destroy VBP O
dentate NN O
granule NN O
cells NNS O
, , O
significantly RB O
decrease VB O
the DT O
dynorphin NN O
- : O
ir NN O
and CC O
enkephalin VB O
- : O
ir NN O
levels NNS O
in IN O
rat NN O
hippocampus NN O
. . O

Intraventricularly RB O
administered VBN O
kainic NN O
acid NN O
, , O
which WDT O
selectively RB O
destroys VBZ O
CA3 NNP O
- : O
4 CD O
pyramidal JJ O
cells NNS O
, , O
results NNS O
in IN O
an DT O
increase NN O
of IN O
enkephalin NN O
immunostaining NN O
in IN O
mossy JJ O
fibers NNS O
and CC O
a DT O
significant JJ O
increase NN O
in IN O
enkephalin NN O
- : O
ir NN O
by IN O
radioimmunoassay NN O
in IN O
whole JJ O
hippocampus NN O
. . O

The DT O
enkephalin NN O
- : O
ir NN O
cells NNS O
and CC O
fibers NNS O
in IN O
entorhinal JJ O
/ NNS O
perirhinal JJ O
cortex NN O
, , O
which WDT O
innervate JJ O
rat NN O
hippocampus NN O
and CC O
dentate NN O
gyrus NN O
, , O
do VBP O
not RB O
contain VB O
dynorphin JJ O
- : O
ir NN O
. . O

-DOCSTART- X X O

Interaction NNP O
between IN O
cellular JJ O
and CC O
viral JJ O
genes NNS O
in IN O
the DT O
expression NN O
of IN O
the DT O
RSV NNP O
- : O
induced VBN O
transformation NN O
- : O
specific JJ O
cell NN O
- : O
surface NN O
antigen JJ O
VCSA NNP O
. . O

Transformation NN O
of IN O
BHK NNP B-NP
hamster NN O
fibroblasts NNS O
by IN O
an DT O
env NN O
- : O
strain NN O
of IN O
Rous JJ O
sarcoma NN O
virus NN O
( -LRB- O
RSV NNP O
) -RRB- O
leads VBZ O
to TO O
the DT O
appearance NN O
at IN O
the DT O
cell NN O
surface NN O
of IN O
a DT O
virus NN O
- : O
induced VBN O
nonvirion NN O
antigen NN O
( -LRB- O
VCSA NNP O
) -RRB- O
, , O
specific JJ O
for IN O
transformation NN O
, , O
whose WP$ O
expression NN O
is VBZ O
controlled VBN O
by IN O
the DT O
transforming VBG O
src JJ O
gene NN O
. . O

Previous JJ O
work NN O
has VBZ O
shown VBN O
that IN O
a DT O
rabbit NN O
anti NNS O
- : O
VCSA NNP O
serum NN O
lyses NNS O
specifically RB O
, , O
in IN O
the DT O
presence NN O
of IN O
complement NN O
, , O
51Cr JJ O
- : O
labelled JJ O
RSV NN O
- : O
transformed VBN O
cells NNS O
from IN O
different JJ O
animal NN O
species NNS O
. . O

Now RB O
, , O
by IN O
competition NN O
experiments NNS O
with IN O
a DT O
panel NN O
of IN O
different JJ O
unlabelled JJ O
cells NNS O
we PRP O
show VBP O
that IN O
the DT O
VCSA NNP O
expressed VBD O
on IN O
RSV NNP O
- : O
transformed VBN O
hamster NN O
fibroblasts NNS O
is VBZ O
a DT O
complex NN O
of IN O
at IN O
least JJS O
three CD O
distinct JJ O
antigenic JJ O
specificities NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
one CD O
expressed VBN O
on IN O
all DT O
RSV NNP O
- : O
transformed VBN O
fibroblasts NNS O
, , O
regardless RB O
their PRP$ O
species NNS O
and CC O
the DT O
subgroup NN O
or CC O
strain NN O
of IN O
the DT O
transforming NN O
virus NN O
; : O
( -LRB- O
2 CD O
) -RRB- O
one CD O
cross NN O
- : O
reacting VBG O
with IN O
a DT O
cell NN O
- : O
surface NN O
antigen NN O
( -LRB- O
CSA NNP O
) -RRB- O
expressed VBD O
at IN O
various JJ O
degrees NNS O
on IN O
untransformed JJ O
avian JJ O
fibroblasts NNS O
, , O
but CC O
not RB O
on IN O
mammalian JJ O
fibroblasts NNS O
; : O
( -LRB- O
3 CD O
) -RRB- O
one CD O
species NN O
- : O
specific NN O
, , O
present JJ O
only RB O
on IN O
RSV NNP O
- : O
transformed VBN O
hamster NN O
fibroblasts NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
VCSA NNP O
is VBZ O
a DT O
complex NN O
of IN O
several JJ O
antigenic JJ O
determinants NNS O
, , O
and CC O
that IN O
some DT O
of IN O
these DT O
differ VBP O
in IN O
different JJ O
cells NNS O
transformed VBN O
by IN O
RSV NN O
. . O

This DT O
observation NN O
indicates VBZ O
that IN O
VCSA NNP O
expression NN O
at IN O
the DT O
cell NN O
surface NN O
is VBZ O
likely JJ O
to TO O
be VB O
the DT O
result NN O
of IN O
the DT O
interaction NN O
between IN O
the DT O
viral JJ O
src JJ O
gene NN O
product NN O
pp60src VBZ O
with IN O
host NN O
cell NN O
gene NN O
( -LRB- O
s PRP O
) -RRB- O
or CC O
gene NN O
product NN O
( -LRB- O
s PRP O
) -RRB- O
, , O
rather RB O
than IN O
the DT O
simple JJ O
expression NN O
of IN O
this DT O
molecule NN O
at IN O
the DT O
cell NN O
surface NN O
. . O

-DOCSTART- X X O

Angiogenesis NNP O
: : O
initiation NN O
and CC O
control NN O
. . O

From IN O
in IN O
vivo JJ O
experiments NNS O
using VBG O
new JJ O
methods NNS O
such JJ O
as IN O
the DT O
rabbit NN O
cornea NN O
, , O
it PRP O
is VBZ O
now RB O
becoming VBG O
clear JJ O
that IN O
the DT O
growth NN O
of IN O
a DT O
capillary NN O
involves VBZ O
an DT O
ordered JJ O
sequence NN O
of IN O
events NNS O
that WDT O
includes VBZ O
lysis NN O
of IN O
the DT O
basement NN O
membrane NN O
of IN O
a DT O
parent NN O
venule NN O
, , O
directional JJ O
migration NN O
of IN O
capillary NN O
endothelial JJ O
cells NNS O
toward IN O
the DT O
angiogenic JJ O
stimulus NN O
, , O
lumen VBN O
formation NN O
, , O
development NN O
of IN O
branches NNS O
, , O
and CC O
anastomosis NN O
of IN O
the DT O
tip NN O
of IN O
one CD O
tube NN O
with IN O
another DT O
to TO O
form VB O
a DT O
loop NN O
. . O

It PRP O
is VBZ O
also RB O
clear JJ O
that IN O
diffusible JJ O
angiogenic JJ O
stimuli NNS O
can MD O
be VB O
released VBN O
not RB O
only RB O
from IN O
most JJS O
solid JJ O
tumors NNS O
, , O
but CC O
also RB O
from IN O
at IN O
least JJS O
three CD O
non FW O
- : O
neoplastic JJ O
cells NNS O
. . O

These DT O
include VBP O
activated JJ O
macrophages NNS O
, , O
sensitized VBD O
lymphocytes NNS O
, , O
and CC O
adipocytes NNS O
. . O

Other JJ O
normal JJ O
tissues NNS O
can MD O
also RB O
stimulate VB O
angiogenesis NN O
, , O
but CC O
the DT O
type NN O
of IN O
cell NN O
giving VBG O
rise NN O
to TO O
the DT O
angiogenic JJ O
stimulus NN O
is VBZ O
unknown JJ O
, , O
and CC O
the DT O
period NN O
of IN O
angiogenic JJ O
stimulation NN O
is VBZ O
brief JJ O
. . O

With IN O
the DT O
recent JJ O
ability NN O
to TO O
clone VB O
capillary NN O
endothelial JJ O
cells NNS O
and CC O
to TO O
carry VB O
them PRP O
in IN O
long JJ O
- : O
term NN O
culture NN O
, , O
it PRP O
has VBZ O
been VBN O
possible JJ O
to TO O
further JJ O
delineate NN O
the DT O
mechanism NN O
of IN O
capillary NN O
growth NN O
. . O

In IN O
vitro NN O
studies NNS O
have VBP O
shown VBN O
that IN O
the DT O
mast NN O
cell NN O
seems VBZ O
to TO O
behave VB O
as IN O
a DT O
helper NN O
cell NN O
for IN O
capillary NN O
endothelial JJ O
cells NNS O
, , O
in IN O
some DT O
way NN O
speeding VBG O
up RP O
their PRP$ O
rate NN O
of IN O
directional JJ O
migration NN O
. . O

At IN O
this DT O
writing NN O
, , O
heparin NN O
appears VBZ O
to TO O
be VB O
the DT O
principal JJ O
mast NN O
cell NN O
factor NN O
responsible JJ O
for IN O
this DT O
effect NN O
on IN O
capillary NN O
endothelial JJ O
cells NNS O
. . O

One CD O
theoretical JJ O
possibility NN O
is VBZ O
that DT O
mast NN O
cells NNS O
may MD O
prepare VB O
the DT O
matrix NN O
, , O
perhaps RB O
by IN O
slow JJ O
release NN O
of IN O
heparin NN O
, , O
so RB O
that IN O
capillary NN O
sprouts NNS O
can MD O
more RBR O
easily RB O
move VB O
through IN O
it PRP O
toward IN O
their PRP$ O
angiogenic JJ O
target NN O
. . O

While IN O
the DT O
study NN O
of IN O
angiogenesis NN O
as IN O
a DT O
phenomenon NN O
is VBZ O
still RB O
in IN O
an DT O
early JJ O
phase NN O
, , O
it PRP O
has VBZ O
become VBN O
possible JJ O
, , O
by IN O
using VBG O
a DT O
combination NN O
of IN O
in IN O
vitro NN O
and CC O
in IN O
vivo VBG O
techniques NNS O
, , O
to TO O
more RBR O
thoroughly RB O
understand VB O
the DT O
initiation NN O
and CC O
control NN O
of IN O
capillary NN O
growth NN O
. . O

-DOCSTART- X X O

Role NNP O
of IN O
interleukin NN O
1 CD O
in IN O
antigen NN O
- : O
specific JJ O
T NNP O
cell NN O
proliferation NN O
. . O

The DT O
role NN O
of IN O
interleukin NN O
1 CD O
( -LRB- O
IL NN O
1 CD O
) -RRB- O
in IN O
human JJ O
antigen NN O
- : O
specific JJ O
T NNP O
cell NN O
proliferation NN O
was VBD O
examined VBN O
. . O

Nylon NNP O
wool NN O
- : O
purified VBN O
T NNP O
cells NNS O
proliferated VBN O
in IN O
the DT O
presence NN O
of IN O
autologous JJ O
monocytes NNS O
( -LRB- O
Mo NNP O
. . O
) -RRB- O
pulsed VBD O
for IN O
18 CD O
h NN O
with IN O
tetanus NN O
toxoid NN O
( -LRB- O
TT NNP O
) -RRB- O
antigen NN O
( -LRB- O
Mo NNP O
. . O
TT NNP O
) -RRB- O
. . O

Irradiation NNP O
of IN O
Mo NNP O
. . O
TT NNP O
with IN O
ultraviolet NN O
( -LRB- O
UV NN O
) -RRB- O
light NN O
( -LRB- O
72 CD O
J NN O
/ JJ O
m2 JJ O
) -RRB- O
abolished VBD O
their PRP$ O
capacity NN O
to TO O
support VB O
T NNP O
cell NN O
proliferation NN O
and CC O
drastically RB O
reduced VBD O
their PRP$ O
capacity NN O
to TO O
secrete VB O
IL NNP O
1 CD O
after IN O
stimulation NN O
with IN O
Staphylococcus NNP O
albus NN O
. . O

The DT O
defect NN O
in IN O
antigen JJ O
presentation NN O
induced VBN O
by IN O
UV NN O
irradiation NN O
of IN O
Mo NNP O
. . O
TT NNP O
was VBD O
reversed VBN O
in IN O
a DT O
dose NN O
- : O
dependent JJ O
manner NN O
by IN O
the DT O
addition NN O
of IN O
two CD O
different JJ O
preparations NNS O
containing VBG O
human JJ O
interleukin NN O
1 CD O
( -LRB- O
IL NN O
1 CD O
) -RRB- O
. . O

The DT O
first JJ O
preparation NN O
consisted VBD O
of IN O
supernatants NNS O
of IN O
Mo NNP O
. . O
stimulated VBD O
with IN O
Con NNP O
A NNP O
for IN O
18 CD O
hr NN O
and CC O
in IN O
which WDT O
Con NNP O
A DT O
activity NN O
was VBD O
blocked VBN O
by IN O
alpha NN O
- : O
D LS O
- : O
methyl NN O
- : O
mannoside NN O
( -LRB- O
Mo NNP O
. . O
- : O
Con NNP O
A NNP O
- : O
Sup NN O
) -RRB- O
. . O

The DT O
second JJ O
preparation NN O
consisted VBD O
of IN O
human JJ O
IL NNP O
1 CD O
partially RB O
purified VBN O
from IN O
supernatants NNS O
of IN O
human JJ O
peripheral NN O
blood NN O
mononuclear NN O
cells NNS O
stimulated VBN O
with IN O
S NNP O
. . O
albus NN O
. . O

This DT O
IL NNP O
1 CD O
copurified VBN O
with IN O
human JJ O
leukocyte NN O
pyrogen NN O
( -LRB- O
LP NNP O
) -RRB- O
and CC O
was VBD O
termed VBN O
IL NNP O
1 CD O
/ NN O
LP NNP O
. . O

Both DT O
IL NNP O
1 CD O
- : O
containing VBG O
preparations NNS O
enhanced VBD O
the DT O
response NN O
of IN O
C57BL JJ O
/ NNP O
6 CD O
mouse NN O
thymocytes NNS O
to TO O
phytohemagglutinin NN O
. . O

A DT O
rabbit NN O
antibody NN O
to TO O
human JJ O
IL NNP O
1 CD O
/ , O
LP NNP O
inhibited VBD O
the DT O
capacity NN O
of IN O
T NNP O
cells NNS O
to TO O
proliferate VB O
in IN O
response NN O
to TO O
Mo NNP O
. . O
TT NNP O
and CC O
inhibited VBD O
the DT O
capacity NN O
of IN O
Mo NNP O
. . O
- : O
Con NNP O
A NNP O
- : O
Sup NN O
to TO O
reconstitute VB O
the DT O
T NNP O
cell NN O
response NN O
to TO O
UV NNP O
- : O
irradiated JJ O
Mo NNP O
. . O
TT NNP O
. . O

IL NNP O
1 CD O
/ , O
LP NNP O
was VBD O
not RB O
necessary JJ O
for IN O
T NNP O
cells NNS O
to TO O
recognize VB O
the DT O
immunogenic JJ O
moiety NN O
presented VBN O
by IN O
Mo NNP O
. . O
, , O
because IN O
monolayers NNS O
of IN O
UV NN O
- : O
irradiated JJ O
Mo NNP O
. . O
TT NNP O
were VBD O
equivalent JJ O
to TO O
monolayers NNS O
of IN O
unirradiated JJ O
MO VBZ O
. . O
TT NNP O
in IN O
their PRP$ O
capacity NN O
to TO O
adsorb VB O
TT NNP O
- : O
reactive JJ O
T NNP O
cells NNS O
specifically RB O
. . O

Furthermore RB O
, , O
the DT O
addition NN O
of IN O
rabbit NN O
antibody NN O
to TO O
IL NNP O
1 CD O
/ , O
LP NNP O
did VBD O
not RB O
interfere VB O
with IN O
the DT O
capacity NN O
of IN O
UV NN O
- : O
irradiated JJ O
Mo NNP O
. . O
TT NNP O
to TO O
adsorb VB O
TT NNP O
- : O
reactive JJ O
T NNP O
cells NNS O
. . O

The DT O
results NNS O
obtained VBD O
in IN O
this DT O
study NN O
indicate VBP O
that IN O
IL NNP O
1 CD O
is VBZ O
involved VBN O
in IN O
optimal JJ O
antigen JJ O
- : O
driven JJ O
proliferation NN O
of IN O
human JJ O
T NNP O
lymphocytes NNS O
. . O

-DOCSTART- X X O

Ca MD O
+ VB O
+ JJ O
distribution NN O
after IN O
Na NNP O
+ NNP O
pump NN O
inhibition NN O
in IN O
cultured JJ O
neonatal JJ O
rat NN O
myocardial JJ O
cells NNS O
. . O

The DT O
influence NN O
of IN O
inhibition NN O
of IN O
the DT O
Na NNP O
+ NNP O
pump NN O
, , O
with IN O
secondary JJ O
stimulation NN O
of IN O
Na NNP O
+ NNP O
- : O
Ca MD O
+ RB O
+ VB O
exchange NN O
, , O
on IN O
cellular JJ O
Ca JJ O
+ NN O
+ NN O
distribution NN O
is VBZ O
examined VBN O
using VBG O
the DT O
on IN O
- : O
line NN O
scintillation NN O
disk NN O
technique NN O
and CC O
cultured VBD O
neonatal JJ O
rat NN O
myocardial JJ O
cells NNS O
. . O

Under IN O
control NN O
conditions NNS O
, , O
La NNP O
+ NNP O
+ IN O
+ RB O
displaced VBN O
78 CD O
. . O
1 CD O
+ NN O
/ IN O
- : O
1 LS O
. . O
13 CD O
% NN O
( -LRB- O
SEM NNP O
) -RRB- O
of IN O
the DT O
total JJ O
cell NN O
associated VBN O
45Ca CD O
. . O

Application NNP O
of IN O
1 CD O
mm CD O
ouabain JJ O
or CC O
reduction NN O
of IN O
[ JJ O
K NNP O
+ NNP O
] VBD O
o IN O
to TO O
0 CD O
. . O
5 CD O
mM NN O
resulted VBD O
in IN O
a DT O
net JJ O
increase NN O
of IN O
10 CD O
. . O
6 CD O
+ NN O
/ IN O
- : O
1 LS O
. . O
3 CD O
% NN O
and CC O
13 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
2 CD O
% NN O
, , O
respectively RB O
, , O
in IN O
total JJ O
cell NN O
- : O
associated VBN O
Ca MD O
+ VB O
+ NN O
. . O

Of IN O
this DT O
added VBN O
45Ca CD O
, , O
75 CD O
. . O
9 CD O
+ NN O
/ IN O
- : O
2 LS O
. . O
7 CD O
% NN O
and CC O
78 CD O
. . O
4 CD O
+ NN O
/ IN O
- : O
2 LS O
. . O
1 CD O
% NN O
, , O
respectively RB O
remained VBD O
La NNP O
+ NNP O
+ NNP O
+ NNP O
- : O
displaceable JJ O
. . O

The DT O
45Ca JJ O
- : O
binding JJ O
characteristics NNS O
of IN O
isolated VBN O
sarcolemma NN O
, , O
prepared VBN O
from IN O
the DT O
cultured JJ O
neonatal JJ O
rat NN O
myocardial JJ O
cells NNS O
using VBG O
the DT O
gas NN O
dissection NN O
technique NN O
, , O
were VBD O
examined VBN O
. . O

When WRB O
treated VBN O
with IN O
either DT O
ouabain JJ O
or CC O
low JJ O
[ NN O
K NNP O
+ NNP O
] SYM O
o IN O
solutions NNS O
, , O
sarcolemmal JJ O
45Ca JJ O
binding NN O
did VBD O
not RB O
change NN O
. . O

This DT O
result NN O
indicates VBZ O
that IN O
functional JJ O
, , O
intact JJ O
tissue NN O
is VBZ O
necessary JJ O
to TO O
observe VB O
the DT O
Ca JJ O
+ NN O
+ NN O
increase NN O
. . O

Treatment NNP O
of IN O
the DT O
cells NNS O
with IN O
verapamil JJ O
before IN O
and CC O
during IN O
ouabain JJ O
exposure NN O
failed VBD O
to TO O
inhibit VB O
the DT O
ouabain JJ O
- : O
induced JJ O
increase NN O
in IN O
cell NN O
- : O
associated VBN O
45Ca CD O
. . O

The DT O
evidence NN O
indicates VBZ O
that IN O
inhibition NN O
of IN O
the DT O
Na NNP O
+ NNP O
- : O
pump NN O
, , O
and CC O
secondary JJ O
stimulation NN O
of IN O
Na NNP O
+ NNP O
- : O
Ca MD O
+ RB O
+ VB O
exchange NN O
, , O
result NN O
in IN O
a DT O
net JJ O
increase NN O
of IN O
11 CD O
- : O
15 CD O
% NN O
in IN O
cell NN O
- : O
associated VBN O
Ca MD O
+ VB O
+ NN O
, , O
78 CD O
% NN O
of IN O
which WDT O
remains VBZ O
La NNP O
+ NNP O
+ NNP O
+ NNP O
- : O
displaceable JJ O
and CC O
is VBZ O
, , O
therefore RB O
, , O
localized VBN O
to TO O
the DT O
sarcolemma FW O
- : O
glycocalyx NN O
complex NN O
. . O

-DOCSTART- X X O

Phosphorylation NNP O
- : O
induced VBD O
mobility JJ O
shift NN O
in IN O
phospholamban NN O
in IN O
sodium NN O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gels NNS O
. . O

Evidence NN O
for IN O
a DT O
protein NN O
structure NN O
consisting VBG O
of IN O
multiple JJ O
identical JJ O
phosphorylatable JJ O
subunits NNS O
. . O

Phosphorylation NNP O
of IN O
purified VBN O
phospholamban JJ O
isolated VBN O
from IN O
canine CD O
cardiac JJ O
sarcoplasmic JJ O
reticulum NN O
vesicles NNS O
decreased VBD O
the DT O
electrophoretic JJ O
mobility NN O
of IN O
the DT O
protein NN O
in IN O
sodium NN O
dodecyl NN O
sulfate NN O
( -LRB- O
SDS NNP O
) -RRB- O
- : O
polyacrylamide NN O
gels NNS O
. . O

Different JJ O
mobility NN O
forms NNS O
of IN O
phospholamban NN O
in IN O
SDS NNP O
gels NNS O
were VBD O
visualized VBN O
both DT O
by IN O
direct JJ O
protein NN O
staining NN O
and CC O
by IN O
autoradiography NN O
. . O

Unphosphorylated JJ O
phospholamban NN O
migrated VBN O
with IN O
an DT O
apparent JJ O
Mr NNP O
= SYM O
25 CD O
, , O
000 CD O
in IN O
SDS NNP O
gels NNS O
; : O
maximal JJ O
phosphorylation NN O
of IN O
phospholamban NN O
by IN O
cAMP JJ O
- : O
or CC O
Ca2 NNP O
+ NNP O
- : O
calmodulin NN O
- : O
dependent JJ O
protein NN O
kinase NN O
increased VBD O
the DT O
apparent JJ O
Mr NNP O
to TO O
27 CD O
, , O
000 CD O
. . O

Partial JJ O
phosphorylation NN O
of IN O
phospholamban NN O
by IN O
either DT O
protein NN O
kinase NN O
gave VBD O
intermediate JJ O
mobility NN O
forms NNS O
of IN O
molecular JJ O
weights NNS O
between IN O
25 CD O
, , O
000 CD O
and CC O
27 CD O
, , O
000 CD O
, , O
suggesting VBG O
that IN O
more JJR O
than IN O
one CD O
phosphorylation NN O
site NN O
was VBD O
present JJ O
on IN O
the DT O
holoprotein NN O
for IN O
each DT O
activity NN O
. . O

Boiling NNP O
of IN O
phospholamban NN O
in IN O
SDS NNP O
dissociated VBD O
the DT O
holoprotein NN O
into IN O
an DT O
apparently RB O
homogeneous JJ O
class NN O
of IN O
low JJ O
molecular JJ O
weight NN O
" '' O
monomers NNS O
. . O
" '' O
Only RB O
two CD O
mobility JJ O
forms NNS O
of IN O
monomeric JJ O
phospholamban NN O
were VBD O
observed VBN O
in IN O
SDS NNP O
gels NNS O
after IN O
phosphorylation NN O
by IN O
cAMP NNS O
- : O
dependent JJ O
protein NN O
kinase NN O
, , O
corresponding JJ O
to TO O
9 CD O
- : O
kDa NN O
dephospho NN O
- : O
and CC O
11 CD O
- : O
kDa NN O
phosphoproteins NNS O
. . O

All DT O
of IN O
the DT O
9 CD O
- : O
kDa JJ O
protein NN O
could MD O
be VB O
phosphorylated VBN O
and CC O
converted VBN O
into IN O
the DT O
11 CD O
- : O
kDa NN O
mobility NN O
form NN O
, , O
suggesting VBG O
the DT O
presence NN O
of IN O
only RB O
one CD O
site NN O
of IN O
phosphorylation NN O
on IN O
a DT O
single JJ O
type NN O
of IN O
monomer NN O
for IN O
cAMP NNS O
- : O
dependent JJ O
protein NN O
kinase NN O
. . O

Simultaneous JJ O
phosphorylation NN O
of IN O
monomeric JJ O
phospholamban NN O
by IN O
cAMP NNS O
- : O
dependent JJ O
protein NN O
kinase NN O
and CC O
Ca2 VB O
+ JJ O
- : O
calmodulin NN O
- : O
dependent JJ O
protein NN O
kinase NN O
gave VBD O
an DT O
additional JJ O
mobility NN O
form NN O
of IN O
the DT O
protein NN O
, , O
suggesting VBG O
that IN O
different JJ O
sites NNS O
of IN O
phosphorylation NN O
were VBD O
present JJ O
for IN O
each DT O
activity NN O
on IN O
each DT O
monomer NN O
. . O

Incomplete JJ O
dissociation NN O
of IN O
the DT O
holoprotein NN O
by IN O
boiling VBG O
it PRP O
in IN O
a DT O
relatively RB O
low JJ O
concentration NN O
of IN O
SDS NNP O
facilitated VBD O
the DT O
detection NN O
of IN O
five CD O
major JJ O
mobility NN O
forms NNS O
of IN O
the DT O
protein NN O
in IN O
SDS NNP O
gels NNS O
, , O
and CC O
the DT O
mobilities NNS O
of IN O
all DT O
of IN O
these DT O
forms NNS O
were VBD O
decreased VBN O
by IN O
phosphorylation NN O
. . O

We PRP O
propose VBP O
that IN O
the DT O
high JJ O
molecular JJ O
weight NN O
form NN O
of IN O
phospholamban NN O
is VBZ O
a DT O
multimer NN O
of IN O
electrophoretically RB O
indistinguishable JJ O
monomers NNS O
, , O
each DT O
of IN O
which WDT O
contains VBZ O
a DT O
different JJ O
phosphorylation NN O
site NN O
for IN O
cAMP JJ O
- : O
dependent JJ O
protein NN O
kinase NN O
activity NN O
and CC O
Ca2 NNP O
+ NNP O
- : O
calmodulin NN O
- : O
dependent JJ O
protein NN O
kinase NN O
activity NN O
. . O

Phosphorylation NNP O
of IN O
phospholamban NN O
at IN O
multiple JJ O
sites NNS O
is VBZ O
responsible JJ O
for IN O
the DT O
various JJ O
mobility NN O
forms NNS O
of IN O
the DT O
holoprotein NN O
detected VBD O
in IN O
SDS NNP O
- : O
polyacrylamide NN O
gels NNS O
. . O

-DOCSTART- X X O

Protection NNP O
from IN O
experimental JJ O
ocular JJ O
herpetic JJ O
keratitis NN O
by IN O
a DT O
heat NN O
- : O
killed VBN O
virus NN O
vaccine NN O
. . O

New NNP O
Zealand NNP O
white JJ O
rabbits NNS O
were VBD O
given VBN O
limbal JJ O
inoculations NNS O
of IN O
a DT O
heat NN O
- : O
killed VBN O
suspension NN O
of IN O
herpes PRP$ O
simplex JJ O
virus NN O
( -LRB- O
HSV NNP O
) -RRB- O
in IN O
a DT O
lysate NN O
of IN O
human JJ O
embryonic JJ O
kidney NN O
cells NNS O
. . O

At IN O
intervals NNS O
of IN O
four CD O
to TO O
14 CD O
days NNS O
, , O
the DT O
animals NNS O
were VBD O
challenged VBN O
by IN O
intrastromal JJ O
inoculation NN O
with IN O
10 CD O
, , O
000 CD O
plaque NN O
- : O
forming VBG O
units NNS O
of IN O
viable JJ O
HSV NNP O
. . O

Epithelial NNP O
keratitis NN O
, , O
disciform NN O
edema NN O
, , O
and CC O
necrotizing JJ O
keratitis NN O
with IN O
neovascularization NN O
of IN O
the DT O
cornea NN O
developed VBN O
in IN O
control NN O
animals NNS O
. . O

Epithelial NNP O
keratitis NN O
and CC O
corneal NN O
edema NN O
also RB O
developed VBN O
in IN O
the DT O
immunized JJ O
animals NNS O
during IN O
the DT O
first JJ O
week NN O
after IN O
virus NN O
challenge NN O
, , O
but CC O
these DT O
symptoms NNS O
rapidly RB O
resolved VBD O
during IN O
the DT O
following JJ O
weeks NNS O
. . O

The DT O
absence NN O
of IN O
iritis NN O
, , O
neovascularization NN O
, , O
and CC O
necrotizing JJ O
keratitis NN O
in IN O
the DT O
corneas NNS O
of IN O
the DT O
immunized JJ O
animals NNS O
was VBD O
particularly RB O
striking JJ O
. . O

-DOCSTART- X X O

Cells NNP O
transformed VBN O
by IN O
Rous JJ O
sarcoma NN O
virus NN O
release NN O
transforming VBG O
growth NN O
factors NNS O
. . O

Chicken NN O
embryo NN O
fibroblasts NNS O
and CC O
hamster NN O
BHK NN B-NP
cells NNS O
transformed VBN O
by IN O
Rous JJ O
sarcoma NN O
virus NN O
( -LRB- O
RSV NN O
) -RRB- O
release NN O
in IN O
their PRP$ O
culture NN O
media NNS O
growth NN O
factors NNS O
which WDT O
enhance VB O
markedly VB O
anchorage NN O
- : O
independent JJ O
colony NN O
formation NN O
in IN O
gelified JJ O
medium NN O
, , O
at IN O
the DT O
restrictive JJ O
temperature NN O
( -LRB- O
41 CD O
degrees NNS O
5 CD O
C NN O
) -RRB- O
, , O
of IN O
chicken NN O
embryo NN O
fibroblasts NNS O
( -LRB- O
CEF NN O
) -RRB- O
infected VBN O
by IN O
RSV NNP O
mutants NNS O
with IN O
a DT O
ts NNS O
mutation NN O
of IN O
the DT O
src JJ O
gene NN O
. . O

This DT O
action NN O
is VBZ O
not RB O
observed VBN O
with IN O
uninfected JJ O
CEF NNP O
, , O
and CC O
, , O
therefore RB O
, , O
appears VBZ O
to TO O
require VB O
some DT O
expression NN O
of IN O
the DT O
viral JJ O
src JJ O
gene NN O
in IN O
the DT O
target NN O
cells NNS O
. . O

The DT O
enhancing NN O
factors NNS O
are VBP O
proteins NNS O
related VBN O
to TO O
the DT O
family NN O
of IN O
the DT O
transforming VBG O
growth NN O
factors NNS O
( -LRB- O
TGFs NNS O
) -RRB- O
by IN O
their PRP$ O
molecular JJ O
weight NN O
( -LRB- O
about IN O
20 CD O
kd NN O
) -RRB- O
, , O
their PRP$ O
heat NN O
and CC O
acid NN O
resistance NN O
, , O
and CC O
their PRP$ O
sensitivity NN O
to TO O
dithiothreitol NN O
. . O

They PRP O
do VBP O
not RB O
compete VB O
with IN O
125I JJ O
EGF NNP O
for IN O
binding NN O
on IN O
the DT O
EGF NNP O
receptors NNS O
of IN O
the DT O
membrane NN O
of IN O
A431 NNP B-NP
cells NNS O
. . O

As IN O
chicken NN O
embryo NN O
fibroblasts NNS O
are VBP O
devoid JJ O
of IN O
EGF NNP O
receptors NNS O
, , O
their PRP$ O
activity NN O
is VBZ O
not RB O
potentiated VBN O
by IN O
EGF NNP O
. . O

-DOCSTART- X X O

The DT O
genetics NNS O
of IN O
transformation NN O
by IN O
SV NNP O
40 CD O
. . O

Experiments NNS O
using VBG O
the DT O
tsA NN O
58 CD O
allele NN O
of IN O
the DT O
SV NNP O
40 CD O
- : O
A DT O
gene NN O
have VBP O
demonstrated VBN O
that IN O
the DT O
SV NNP O
40 CD O
large JJ O
T NNP O
- : O
antigen NN O
is VBZ O
strictly RB O
required VBN O
both DT O
for IN O
immortalization NN O
and CC O
induction NN O
anchorage NN O
independence NN O
of IN O
cells NNS O
. . O

It PRP O
has VBZ O
been VBN O
suggested VBN O
that IN O
the DT O
immortalized JJ O
phenotype NN O
is VBZ O
mediated VBN O
by IN O
an DT O
extra JJ O
cellular JJ O
factor NN O
. . O

The DT O
synthesis NN O
and CC O
/ NN O
or CC O
the DT O
excretion NN O
of IN O
this DT O
factor NN O
in IN O
a DT O
medium NN O
is VBZ O
controlled VBN O
by IN O
the DT O
A NNP O
gene NN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
growth NN O
temperature NN O
, , O
47 CD O
- : O
megadalton NN O
plasmid NN O
, , O
and CC O
calcium NN O
deficiency NN O
on IN O
the DT O
outer JJ O
membrane NN O
protein NN O
porin NN O
and CC O
lipopolysaccharide NN O
composition NN O
of IN O
Yersinia NNP O
pestis NN O
EV76 NNP O
. . O

The DT O
expression NN O
of IN O
several JJ O
virulence NN O
determinants NNS O
of IN O
Yersinia NNP O
pestis NN O
is VBZ O
known VBN O
to TO O
be VB O
dependent JJ O
on IN O
the DT O
in IN O
vitro NN O
growth NN O
temperature NN O
. . O

One CD O
of IN O
these DT O
, , O
calcium NN O
dependence NN O
, , O
is VBZ O
associated VBN O
with IN O
the DT O
presence NN O
of IN O
a DT O
47 CD O
- : O
megadalton NN O
plasmid NN O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
effects NNS O
of IN O
incubation NN O
temperature NN O
, , O
calcium NN O
in IN O
the DT O
growth NN O
medium NN O
, , O
the DT O
presence NN O
of IN O
the DT O
47 CD O
- : O
megadalton NN O
plasmid NN O
on IN O
the DT O
outer JJ O
membrane NN O
protein NN O
, , O
and CC O
the DT O
lipopolysaccharide NN O
composition NN O
of IN O
Y NNP O
. . O
pestis NNS O
EV76 NNP O
. . O

When WRB O
cells NNS O
were VBD O
grown VBN O
at IN O
37 CD O
degrees NNS O
C NN O
as IN O
opposed VBN O
to TO O
26 CD O
degrees NNS O
C NN O
, , O
a DT O
change NN O
in IN O
lipopolysaccharide NN O
composition NN O
and CC O
a DT O
decrease NN O
in IN O
the DT O
amount NN O
of IN O
an DT O
outer JJ O
membrane NN O
protein NN O
( -LRB- O
protein NN O
E NN O
) -RRB- O
were VBD O
observed VBN O
. . O

The DT O
lipopolysaccharide NN O
obtained VBD O
from IN O
cells NNS O
incubated VBN O
at IN O
37 CD O
degrees NNS O
C NN O
had VBD O
a DT O
lower JJR O
proportion NN O
of IN O
2 CD O
keto NN O
- : O
3 LS O
- : O
deoxyoctanate NN O
, , O
a DT O
lower JJR O
phosphate NN O
to TO O
2 CD O
- : O
keto FW O
- : O
3 LS O
- : O
deoxyoctanate JJ O
ratio NN O
, , O
and CC O
an DT O
increased VBN O
gel NN O
mobility NN O
upon IN O
sodium NN O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
when WRB O
compared VBN O
with IN O
lipopolysaccharide NN O
obtained VBN O
from IN O
cells NNS O
grown VBN O
at IN O
26 CD O
degrees NNS O
C NN O
. . O

Because IN O
of IN O
its PRP$ O
growth NN O
temperature NN O
- : O
related JJ O
abundance NN O
, , O
we PRP O
investigated VBD O
the DT O
nature NN O
of IN O
protein NN O
E NNP O
. . O

This DT O
protein NN O
had VBD O
physical JJ O
properties NNS O
similar JJ O
to TO O
those DT O
of IN O
other JJ O
enterobacterial JJ O
porins NNS O
, , O
including VBG O
apparent JJ O
formation NN O
of IN O
an DT O
oligomer NN O
on IN O
sodium NN O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gels NNS O
when WRB O
solubilized VBN O
at IN O
low JJ O
temperature NN O
, , O
acidic JJ O
isoelectric JJ O
point NN O
, , O
and CC O
strong JJ O
noncovalent JJ O
association NN O
with IN O
the DT O
peptidoglycan NN O
. . O

Protein NNP O
E NNP O
was VBD O
purified VBN O
and CC O
shown VBN O
to TO O
form VB O
an DT O
aqueous JJ O
channel NN O
in IN O
planar JJ O
lipid JJ O
membranes NNS O
with IN O
a DT O
conductance NN O
of IN O
1 CD O
. . O
1 CD O
nS . O
in IN O
1 CD O
M NNP O
KCl NNP O
. . O

In IN O
addition NN O
to TO O
growth NN O
temperature NN O
- : O
related VBN O
alterations NNS O
in IN O
the DT O
lipopolysaccharide NN O
and CC O
porin JJ O
components NNS O
of IN O
the DT O
outer JJ O
membrane NN O
, , O
the DT O
amount NN O
of IN O
three CD O
spots NNS O
in IN O
two CD O
- : O
dimensional JJ O
polyacrylamide NN O
gels NNS O
was VBD O
shown VBN O
to TO O
be VB O
related VBN O
to TO O
the DT O
temperature NN O
or CC O
the DT O
presence NN O
of IN O
calcium NN O
during IN O
growth NN O
. . O

One CD O
of IN O
these DT O
spots NNS O
was VBD O
shown VBN O
to TO O
contain VB O
residual JJ O
unmodified JJ O
portions NNS O
of IN O
two CD O
major JJ O
heat NN O
- : O
modifiable JJ O
proteins NNS O
which WDT O
failed VBD O
to TO O
shift VB O
to TO O
their PRP$ O
heat NN O
- : O
modified VBN O
positions NNS O
on IN O
gels NNS O
, , O
despite IN O
solubilization NN O
at IN O
100 CD O
degrees NNS O
C NN O
for IN O
10 CD O
min NN O
before IN O
electrophoresis NN O
. . O

The DT O
other JJ O
two CD O
spots NNS O
were VBD O
the DT O
heat NN O
- : O
modified VBN O
and CC O
unmodified JJ O
forms NNS O
of IN O
another DT O
outer JJ O
membrane NN O
protein NN O
( -LRB- O
J NN O
) -RRB- O
which WDT O
did VBD O
not RB O
appear VB O
in IN O
the DT O
isoelectric JJ O
focusing VBG O
gel NN O
of IN O
cells NNS O
grown VBN O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

It PRP O
is VBZ O
proposed VBN O
that IN O
the DT O
appearance NN O
of IN O
these DT O
spots NNS O
in IN O
two CD O
- : O
dimensional JJ O
analyses NNS O
is VBZ O
related VBN O
to TO O
the DT O
lipopolysaccharide NN O
composition NN O
of IN O
the DT O
cells NNS O
from IN O
which WDT O
the DT O
outer JJ O
membrane NN O
is VBZ O
derived VBN O
and CC O
reflects VBZ O
lipopolysaccharide NN O
- : O
protein NN O
interactions NNS O
or CC O
calcium NN O
- : O
protein NN O
interactions NNS O
. . O

-DOCSTART- X X O

Protein NNP O
kinase NN O
activities NNS O
in IN O
immune JJ O
complexes NNS O
of IN O
simian JJ O
virus NN O
40 CD O
large JJ O
T NNP O
- : O
antigen NN O
and CC O
transformation NN O
- : O
associated VBN O
cellular JJ O
p53 NN O
protein NN O
. . O

Immune NNP O
complex JJ O
kinase NN O
assays VBZ O
in IN O
the DT O
simian JJ O
virus NN O
40 CD O
system NN O
were VBD O
performed VBN O
by IN O
incubation NN O
of IN O
immunoprecipitates NNS O
containing VBG O
tumor NN O
antigens NNS O
with IN O
[ NN O
gamma NN O
- : O
32P JJ O
] NN O
ATP NNP O
, , O
followed VBN O
by IN O
analysis NN O
of IN O
any DT O
phosphoacceptor JJ O
proteins NNS O
. . O

These DT O
assays VBZ O
yielded VBD O
mainly RB O
the DT O
viral JJ O
large JJ O
T NNP O
- : O
antigen JJ O
and CC O
, , O
in IN O
particular JJ O
, , O
the DT O
associated VBN O
cellular JJ O
p53 NN O
as IN O
endogenous JJ O
substrates NNS O
. . O

The DT O
nature NN O
of IN O
these DT O
substrates NNS O
was VBD O
confirmed VBN O
by IN O
proteolysis NN O
techniques NNS O
. . O

Under IN O
specific JJ O
conditions NNS O
, , O
casein NN O
could MD O
be VB O
used VBN O
as IN O
an DT O
exogenous JJ O
substrate NN O
as RB O
well RB O
. . O

The DT O
kinase NN O
reactions NNS O
showed VBD O
preference NN O
for IN O
ATP NNP O
and CC O
MgCl2 NNP O
instead RB O
of IN O
GTP NNP O
or CC O
MnCl2 NNP O
. . O

Both DT O
phosphoserine NN O
and CC O
phosphothreonine NN O
, , O
but CC O
in IN O
no DT O
case NN O
phosphotyrosine NN O
, , O
were VBD O
detected VBN O
after IN O
an DT O
immune JJ O
complex NN O
kinase NN O
reaction NN O
. . O

Apparently RB O
, , O
several JJ O
in IN O
vivo JJ O
phosphorylation NN O
sites NNS O
were VBD O
recognized VBN O
in IN O
vitro NN O
in IN O
both DT O
large JJ O
T NNP O
- : O
antigen NN O
and CC O
p53 NN O
, , O
but CC O
the DT O
presence NN O
of IN O
some DT O
artifactual JJ O
sites NNS O
could MD O
not RB O
be VB O
completely RB O
excluded VBN O
. . O

Although IN O
contaminating VBG O
kinases NNS O
were VBD O
detectable JJ O
in IN O
the DT O
immune JJ O
complexes NNS O
, , O
at IN O
least JJS O
the DT O
p53 NN O
molecules NNS O
were VBD O
phosphorylated VBN O
in IN O
vitro NN O
in IN O
a DT O
more RBR O
specific JJ O
way NN O
. . O

This DT O
followed VBD O
from IN O
several JJ O
characteristics NNS O
of IN O
the DT O
immune JJ O
complex JJ O
kinase NN O
reactions NNS O
and CC O
especially RB O
from IN O
the DT O
strong JJ O
inhibition NN O
of IN O
p53 NN O
phosphorylation NN O
by IN O
two CD O
anti NNS O
- : O
large JJ O
- : O
T NN O
monoclonal JJ O
antibodies NNS O
. . O

It PRP O
was VBD O
shown VBN O
that IN O
large JJ O
T NNP O
- : O
antigen NN O
showed VBD O
associated VBN O
kinase NN O
activity NN O
, , O
although IN O
none NN O
of IN O
our PRP$ O
results NNS O
could MD O
unambiguously RB O
demonstrate VB O
an DT O
intrinsic JJ O
kinase NN O
activity NN O
of IN O
this DT O
protein NN O
. . O

Finally RB O
, , O
anti JJ O
- : O
p53 NN O
monoclonal JJ O
antibodies NNS O
only RB O
slightly RB O
affected VBN O
in IN O
vitro NN O
phosphorylation NN O
reactions NNS O
, , O
whereas IN O
a DT O
p53 NN O
molecule NN O
from IN O
a DT O
simian JJ O
virus NN O
40 CD O
- : O
free JJ O
, , O
chemically RB O
transformed VBN O
human JJ O
cell NN O
line NN O
was VBD O
not RB O
phosphorylated VBN O
in IN O
vitro NN O
under IN O
any DT O
condition NN O
tested VBN O
. . O

Thus RB O
, , O
it PRP O
is VBZ O
highly RB O
unlikely JJ O
that IN O
the DT O
p53 NN O
molecule NN O
per IN O
se NN O
carries VBZ O
intrinsic JJ O
or CC O
even RB O
associated VBN O
kinase NN O
activities NNS O
. . O

-DOCSTART- X X O

Molecular JJ O
events NNS O
leading VBG O
to TO O
enhanced JJ O
glucose NN O
transport NN O
in IN O
Rous JJ O
sarcoma NN O
virus NN O
- : O
transformed VBN O
cells NNS O
. . O

Transformation NN O
by IN O
Rous NNP O
sarcoma NN O
virus NN O
results NNS O
in IN O
a DT O
dramatic JJ O
increase NN O
in IN O
the DT O
rate NN O
at IN O
which WDT O
the DT O
transformed VBN O
cells NNS O
transport NN O
glucose NN O
across IN O
the DT O
cell NN O
membrane NN O
. . O

The DT O
increased VBN O
transport NN O
rate NN O
is VBZ O
a DT O
consequence NN O
of IN O
an DT O
increased JJ O
number NN O
of IN O
transporters NNS O
in IN O
the DT O
transformed VBN O
cells NNS O
. . O

Utilizing VBG O
antibody NN O
raised VBD O
against IN O
the DT O
purified VBN O
human JJ O
erythrocyte NN O
glucose NN O
transporter NN O
, , O
we PRP O
have VBP O
identified VBN O
the DT O
glucose NN O
transporter NN O
as IN O
a DT O
membrane NN O
glycoprotein NN O
with IN O
a DT O
monomer NN O
Mr NNP O
of IN O
approximately RB O
41 CD O
, , O
000 CD O
. . O

The DT O
increased VBN O
rate NN O
of IN O
glucose NN O
transport NN O
is VBZ O
dependent JJ O
on IN O
the DT O
activity NN O
of IN O
pp60src NN O
, , O
the DT O
transforming JJ O
protein NN O
of IN O
Rous JJ O
sarcoma NN O
virus NN O
. . O

This DT O
protein NN O
has VBZ O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
protein NN O
kinase NN O
that IN O
phosphorylates NNS O
on IN O
tyrosine NN O
residues NNS O
. . O

We PRP O
have VBP O
examined VBN O
the DT O
tyrosine NN O
phosphorylation NN O
of IN O
a DT O
major JJ O
cellular JJ O
protein NN O
of IN O
Mr NNP O
36 CD O
, , O
000 CD O
in IN O
cells NNS O
infected VBN O
with IN O
a DT O
panel NN O
of IN O
partially RB O
transforming VBG O
mutants NNS O
of IN O
Rous JJ O
sarcoma NN O
virus NN O
. . O

One CD O
of IN O
these DT O
mutants NNS O
( -LRB- O
CU2 NN O
) -RRB- O
increases VBZ O
the DT O
rate NN O
of IN O
glucose NN O
transport NN O
only RB O
slightly RB O
and CC O
does VBZ O
not RB O
render VB O
the DT O
infected JJ O
cells NNS O
fully RB O
anchorage VB O
independent JJ O
or CC O
tumorigenic JJ O
( -LRB- O
although IN O
other JJ O
transformation NN O
parameters NNS O
are VBP O
fully RB O
induced VBN O
) -RRB- O
. . O

Cells NNP O
infected VBD O
with IN O
this DT O
mutant JJ O
display NN O
a DT O
36 CD O
, , O
000 CD O
- : O
dalton NN O
protein NN O
that WDT O
is VBZ O
phosphorylated VBN O
to TO O
a DT O
considerably RB O
lesser JJR O
extent NN O
than IN O
cells NNS O
infected VBN O
with IN O
wild JJ O
- : O
type NN O
virus NN O
. . O

Analyses NNS O
of IN O
this DT O
sort NN O
may MD O
help VB O
to TO O
identify VB O
the DT O
cellular JJ O
targets NNS O
of IN O
pp60src NN O
whose WP$ O
phosphorylation NN O
is VBZ O
necessary JJ O
for IN O
the DT O
increased VBN O
glucose NN O
transport NN O
rate NN O
. . O

-DOCSTART- X X O

Preliminary JJ O
evidence NN O
for IN O
a DT O
pyridine JJ O
nucleotide JJ O
cycle NN O
in IN O
Bordetella NNP O
pertussis NN O
. . O

Preliminary JJ O
evidence NN O
that IN O
Bordetella NNP O
pertussis NN O
has VBZ O
a DT O
functional JJ O
pyridine JJ O
nucleotide JJ O
cycle NN O
was VBD O
the DT O
observation NN O
that IN O
[ JJ O
14C JJ O
] SYM O
- : O
nicotinic JJ O
acid NN O
was VBD O
rapidly RB O
metabolized VBN O
during IN O
its PRP$ O
uptake NN O
by IN O
the DT O
bacteria NNS O
to TO O
pyridine VB O
nucleotides NNS O
and CC O
nicotinamide NN O
. . O

Nicotinamide NNP O
deamidase NN O
activity NN O
, , O
necessary JJ O
for IN O
the DT O
completion NN O
of IN O
the DT O
cycle NN O
by IN O
conversion NN O
of IN O
nicotinamide JJ O
to TO O
nicotinic JJ O
acid NN O
, , O
was VBD O
found VBN O
in IN O
a DT O
soluble NN O
extract VB O
( -LRB- O
20 CD O
000 CD O
X NNP O
g NN O
supernatant NN O
) -RRB- O
of IN O
B NNP O
. . O
pertussis NN O
cell NN O
lysates NNS O
. . O

-DOCSTART- X X O

Use NN O
of IN O
monoclonal JJ O
antibodies NNS O
to TO O
investigate VB O
a DT O
possible JJ O
role NN O
of IN O
thyroglobulin NN O
in IN O
the DT O
pathogenesis NN O
of IN O
Graves NNP O
' POS O
ophthalmopathy NN O
. . O

One CD O
possible JJ O
mechanism NN O
for IN O
Graves NNP O
' POS O
ophthalmopathy NN O
is VBZ O
that IN O
the DT O
progressive JJ O
orbital NN O
inflammation NN O
is VBZ O
initiated VBN O
by IN O
formation NN O
of IN O
thyroglobulin NN O
( -LRB- O
Tg NN O
) -RRB- O
- : O
anti JJ O
- : O
Tg JJ O
immune JJ O
complexes NNS O
at IN O
sites NNS O
of IN O
Tg NNP O
binding NN O
to TO O
extraocular JJ O
muscle NN O
membranes NNS O
. . O

In IN O
this DT O
study NN O
monoclonal JJ O
antibodies NNS O
( -LRB- O
MCAB NNP O
) -RRB- O
against IN O
human JJ O
Tg NN O
were VBD O
used VBN O
as IN O
probes NNS O
( -LRB- O
1 CD O
) -RRB- O
to TO O
identify VB O
Tg JJ O
in IN O
eye NN O
muscle NN O
membranes NNS O
prepared VBD O
from IN O
normal JJ O
subjects NNS O
and CC O
( -LRB- O
2 CD O
) -RRB- O
to TO O
measure VB O
binding NN O
of IN O
human JJ O
Tg NN O
and CC O
Tg NNP O
- : O
anti NNS O
- : O
Tg JJ O
immune JJ O
complexes NNS O
to TO O
eye NN O
muscle NN O
membranes NNS O
. . O

Reactivity NN O
of IN O
anti NNS O
- : O
Tg JJ O
MCAB NNP O
with IN O
Tg NNP O
, , O
thyroid VBD O
, , O
and CC O
eye NN O
muscle NN O
membranes NNS O
was VBD O
determined VBN O
by IN O
binding NN O
of IN O
[ JJ O
125I JJ O
] SYM O
anti FW O
- : O
Tg NN O
monoclonal JJ O
antibody NN O
, , O
an DT O
enzyme JJ O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
( -LRB- O
ELISA NNP O
) -RRB- O
, , O
and CC O
the DT O
indirect JJ O
immunofluorescence NN O
technique NN O
. . O

Seven CD O
membrane NN O
fractions NNS O
, , O
prepared VBN O
by IN O
differential JJ O
sucrose NN O
gradient NN O
centrifugation NN O
, , O
were VBD O
used VBN O
. . O

Whereas IN O
[ JJ O
125I JJ O
] SYM O
anti FW O
- : O
Tg RB O
MCAB NNP O
bound VBD O
to TO O
all DT O
thyroid JJ O
membrane NN O
fractions NNS O
tested VBN O
, , O
no DT O
[ NN O
125I IN O
] NN O
anti NNS O
- : O
Tg NN O
bound VBN O
to TO O
eye NN O
muscle NN O
membranes NNS O
. . O

Similarly RB O
, , O
reactivity NN O
of IN O
anti NNS O
- : O
Tg JJ O
MCAB NNP O
with IN O
eye NN O
muscle NN O
membranes NNS O
was VBD O
not RB O
demonstrated VBN O
in IN O
ELISA NNP O
or CC O
immunofluorescence NN O
tests NNS O
. . O

Although IN O
Tg NNP O
- : O
anti NNS O
- : O
Tg JJ O
immune JJ O
complexes NNS O
bound VBN O
to TO O
thyroid VB O
membranes NNS O
, , O
such JJ O
complexes NNS O
did VBD O
not RB O
bind NN O
to TO O
eye NN O
muscle NN O
membranes NNS O
. . O

Significant JJ O
binding NN O
of IN O
[ NN O
125I JJ O
] SYM O
human JJ O
Tg NN O
to TO O
eye NN O
muscle NN O
or CC O
thyroid JJ O
membranes NNS O
was VBD O
not RB O
demonstrated VBN O
for IN O
any DT O
membrane NN O
preparation NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
moderate JJ O
, , O
but CC O
significant JJ O
, , O
binding JJ O
to TO O
skeletal JJ O
muscle NN O
was VBD O
shown VBN O
. . O

Similar JJ O
results NNS O
were VBD O
found VBN O
using VBG O
an DT O
ELISA NNP O
. . O

Binding NNP O
of IN O
[ NNP O
125I CD O
] NN O
anti NNS O
- : O
Tg SYM O
- : O
Tg JJ O
complexes NNS O
of IN O
[ JJ O
125I JJ O
] SYM O
Tg NNP O
to TO O
thyroid VB O
and CC O
eye NN O
muscle NN O
membranes NNS O
was VBD O
not RB O
affected VBN O
by IN O
the DT O
presence NN O
of IN O
normal JJ O
human JJ O
serum NN O
, , O
phosphate NN O
ions NNS O
, , O
pH NNS O
, , O
or CC O
incubation NN O
temperature NN O
, , O
conditions NNS O
claimed VBN O
by IN O
others NNS O
to TO O
be VB O
critical JJ O
for IN O
Tg NNP O
and CC O
Tg NNP O
- : O
anti NNS O
- : O
Tg JJ O
immune JJ O
complex JJ O
binding NN O
. . O

Since IN O
Tg NNP O
is VBZ O
not RB O
present JJ O
in IN O
normal JJ O
human JJ O
eye NN O
muscle NN O
a DT O
major JJ O
role NN O
of IN O
Tg NNP O
, , O
or CC O
Tg NNP O
- : O
anti NNS O
- : O
Tg JJ O
immune JJ O
complexes NNS O
, , O
in IN O
the DT O
pathogenesis NN O
of IN O
Graves NNP O
' POS O
ophthalmopathy NN O
appears VBZ O
to TO O
have VB O
been VBN O
excluded VBN O
by IN O
these DT O
findings NNS O
. . O

-DOCSTART- X X O

DNA NNP O
methylation NN O
and CC O
expression NN O
of IN O
HLA NNP O
- : O
DR NN O
alpha NN O
. . O

B LS O
- : O
cell NN O
lines NNS O
established VBN O
from IN O
two CD O
individuals NNS O
with IN O
T NNP O
- : O
cell NN O
acute JJ O
lymphocytic JJ O
leukemia NN O
( -LRB- O
T NNP O
- : O
ALL NNP O
) -RRB- O
express VB O
HLA NNP O
- : O
DR NN O
antigens NNS O
, , O
whereas IN O
the DT O
isogenic JJ O
T NNP O
- : O
cells NNS O
do VBP O
not RB O
. . O

The DT O
lack NN O
of IN O
expression NN O
correlates NNS O
with IN O
a DT O
lack NN O
of IN O
detectable JJ O
HLA NNP O
- : O
DR NN O
mRNA NN O
. . O

All DT O
of IN O
the DT O
DR NN O
alpha NN O
DNA NN O
sequences NNS O
detected VBN O
by IN O
a DT O
cloned JJ O
DR NN O
alpha NN O
cDNA NN O
probe NN O
are VBP O
contained VBN O
in IN O
a DT O
BglII JJ O
fragment NN O
which WDT O
varies VBZ O
slightly RB O
in IN O
size NN O
( -LRB- O
4 CD O
. . O
0 CD O
to TO O
4 CD O
. . O
8 CD O
kilobases NNS O
) -RRB- O
from IN O
one CD O
individual NN O
to TO O
another DT O
. . O

In IN O
DNA NNP O
from IN O
the DT O
T NNP O
- : O
cells NNS O
not RB O
expressing VBG O
DR NN O
alpha NN O
mRNA NN O
, , O
all DT O
of IN O
the DT O
potential JJ O
HpaII NNP O
sites NNS O
within IN O
the DT O
BglII JJ O
fragment NN O
appeared VBD O
to TO O
be VB O
methylated VBN O
. . O

In IN O
contrast NN O
, , O
at IN O
least JJS O
some DT O
of IN O
these DT O
sites NNS O
were VBD O
not RB O
methylated VBN O
in IN O
DNA NNP O
from IN O
the DT O
B NNP O
- : O
cells NNS O
expressing VBG O
high JJ O
levels NNS O
of IN O
DR NN O
alpha NN O
mRNA NN O
. . O

Treatment NNP O
of IN O
these DT O
T NNP O
- : O
cells NNS O
with IN O
5 CD O
- : O
azacytidine NN O
resulted VBD O
in IN O
the DT O
induction NN O
of IN O
DR NN O
surface NN O
antigen JJ O
expression NN O
, , O
the DT O
appearance NN O
of IN O
DR NN O
alpha NN O
mRNA NN O
, , O
and CC O
the DT O
partial JJ O
demethylation NN O
of IN O
the DT O
DR NN O
alpha NN O
DNA NNP O
sequences NNS O
. . O

T NNP O
- : O
cell NN O
lines NNS O
established VBN O
from IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
- : O
lymphoma NN O
virus NN O
associated VBN O
T NNP O
- : O
cell NN O
neoplasias NNS O
, , O
in IN O
contrast NN O
to TO O
the DT O
T NNP O
- : O
cell NN O
acute JJ O
lymphocytic JJ O
leukemia NN O
cell NN O
lines NNS O
, , O
expressed VBD O
both DT O
DR NN O
antigens NNS O
and CC O
DR NN O
alpha NN O
mRNA NN O
; : O
the DT O
HpaII NNP O
sites NNS O
within IN O
the DT O
BglII JJ O
fragment NN O
of IN O
DR NN O
alpha NN O
DNA NN O
of IN O
these DT O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
- : O
lymphoma NN O
virus NN O
- : O
positive JJ O
T NNP O
- : O
cell NN O
lines NNS O
were VBD O
in IN O
all DT O
cases NNS O
at IN O
least JJS O
partially RB O
unmethylated JJ O
. . O

Uncultured JJ O
peripheral JJ O
blood NN O
T NNP O
- : O
cells NNS O
from IN O
human JJ O
T NNP O
- : O
cell NN O
leukemia NN O
- : O
lymphoma NN O
virus NN O
- : O
infected VBN O
individuals NNS O
expressed VBD O
DR NN O
antigens NNS O
at IN O
a DT O
low JJ O
level NN O
, , O
and CC O
the DT O
DR NN O
alpha NN O
locus NN O
was VBD O
partially RB O
unmethylated JJ O
. . O

After IN O
48 CD O
h NN O
in IN O
culture NN O
, , O
DR NN O
antigen NN O
expression NN O
was VBD O
substantially RB O
increased VBN O
, , O
but CC O
no DT O
significant JJ O
changes NNS O
were VBD O
observed VBN O
in IN O
methylation NN O
of IN O
the DT O
DR NN O
alpha NN O
locus NN O
or CC O
in IN O
the DT O
amount NN O
of IN O
DR NN O
mRNA NN O
which WDT O
was VBD O
present JJ O
. . O

This DT O
suggests VBZ O
that WDT O
expression NN O
of IN O
DR NN O
antigens NNS O
also RB O
can MD O
be VB O
modulated VBN O
post NN O
- : O
transcriptionally NN O
. . O

-DOCSTART- X X O

Oesophageal JJ O
candidiasis NN O
and CC O
croup NN O
in IN O
a DT O
child NN O
with IN O
defective JJ O
neutrophil JJ O
motility NN O
. . O

Severe JJ O
oesophageal JJ O
candidiasis NN O
and CC O
croup NN O
due JJ O
to TO O
involvement NN O
of IN O
the DT O
larynx NN O
developed VBD O
insidiously RB O
in IN O
a DT O
girl NN O
aged VBN O
20 CD O
months NNS O
. . O

There EX O
had VBD O
been VBN O
delayed VBN O
separation NN O
of IN O
the DT O
umbilical JJ O
cord NN O
and CC O
repeated VBD O
infections NNS O
associated VBN O
with IN O
a DT O
defect NN O
of IN O
neutrophil JJ O
motility NN O
. . O

The DT O
significance NN O
of IN O
the DT O
early JJ O
clinical JJ O
features NNS O
was VBD O
not RB O
fully RB O
appreciated VBN O
and CC O
the DT O
diagnosis NN O
considered VBN O
only RB O
when WRB O
stricture NN O
of IN O
the DT O
oesophagus NN O
became VBD O
evident JJ O
. . O

She PRP O
was VBD O
treated VBN O
with IN O
oral JJ O
ketoconazole NN O
100 CD O
mg JJ O
daily JJ O
. . O

After IN O
one CD O
month NN O
' '' O
s PRP O
treatment NN O
there EX O
was VBD O
striking JJ O
radiological JJ O
improvement NN O
apart RB O
from IN O
the DT O
persistence NN O
of IN O
the DT O
oesophageal JJ O
stricture NN O
. . O

The DT O
croup NN O
resolved VBD O
completely RB O
but CC O
there EX O
was VBD O
only RB O
partial JJ O
relief NN O
of IN O
dysphagia NN O
because IN O
of IN O
the DT O
residual JJ O
stricture NN O
. . O

We PRP O
would MD O
emphasis NN O
that IN O
candidiasis NN O
should MD O
be VB O
anticipated VBN O
and CC O
treated VBN O
vigorously RB O
in IN O
children NNS O
with IN O
such JJ O
a DT O
defect NN O
of IN O
neutrophil JJ O
motility NN O
. . O

-DOCSTART- X X O

Rapid NNP O
micromeasurement NN O
of IN O
lactate NN O
in IN O
whole JJ O
blood NN O
. . O

A DT O
new JJ O
lactate NN O
sensor NN O
makes VBZ O
it PRP O
possible JJ O
to TO O
measure VB O
the DT O
lactate NN O
content NN O
of IN O
whole JJ O
blood NN O
directly RB O
in IN O
less JJR O
than IN O
1 CD O
min NN O
, , O
using VBG O
only RB O
a DT O
10 CD O
- : O
microL JJ O
blood NN O
sample NN O
. . O

The DT O
procedure NN O
works VBZ O
equally RB O
well RB O
with IN O
plasma NN O
, , O
serum NN O
, , O
spinal JJ O
fluid NN O
, , O
other JJ O
body NN O
fluids NNS O
, , O
or CC O
tissue NN O
homogenates NNS O
. . O

The DT O
instrument NN O
is VBZ O
calibrated VBN O
with IN O
lactate NN O
standards NNS O
between IN O
0 CD O
and CC O
15 CD O
mMol JJ O
/ NN O
L NNP O
. . O

The DT O
sensor NN O
, , O
a DT O
polarographic JJ O
enzyme NN O
electrode NN O
, , O
gives VBZ O
a DT O
current NN O
which WDT O
is VBZ O
a DT O
linear JJ O
function NN O
of IN O
the DT O
lactate NN O
concentration NN O
. . O

There EX O
is VBZ O
no DT O
interference NN O
from IN O
glucose NN O
, , O
pyruvate JJ O
, , O
alcohol NN O
, , O
ascorbate NN O
, , O
anticoagulants NNS O
, , O
lidocaine NN O
, , O
acetaminophen RB O
, , O
or CC O
other JJ O
drugs NNS O
and CC O
metabolites NNS O
commonly RB O
encountered VBN O
in IN O
critically RB O
ill JJ O
patients NNS O
. . O

The DT O
lactate NN O
sensor NN O
is VBZ O
composed VBN O
of IN O
a DT O
peroxide NN O
sensor NN O
and CC O
an DT O
enzyme NN O
transducer NN O
membrane NN O
. . O

The DT O
lactate NN O
is VBZ O
stoichiometrically RB O
converted VBN O
to TO O
pyruvate VB O
and CC O
hydrogen NN O
peroxide NN O
by IN O
lactate NN O
oxygen NN O
oxidoreductase NN O
derived VBN O
from IN O
Pediococcus NNP O
species NNS O
. . O

The DT O
oxygen NN O
required VBD O
for IN O
the DT O
enzymatic JJ O
oxidation NN O
is VBZ O
supplied VBN O
via IN O
an DT O
air NN O
- : O
permeable JJ O
silicone NN O
elastomeric JJ O
membrane NN O
used VBN O
for IN O
stirring VBG O
. . O

Comparison NN O
of IN O
our PRP$ O
new JJ O
electroenzymatic JJ O
method NN O
with IN O
the DT O
Boehringer NNP O
- : O
Mannheim NN O
photoenzymatic JJ O
method NN O
gives VBZ O
correlations NNS O
of IN O
0 CD O
. . O
997 CD O
for IN O
both DT O
whole JJ O
blood NN O
and CC O
plasma NN O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
translocations NNS O
on IN O
the DT O
cellular JJ O
myc JJ O
gene NN O
in IN O
Burkitt NNP O
lymphomas NNS O
. . O

Chromosomal JJ O
translocations NNS O
are VBP O
found VBN O
to TO O
be VB O
a DT O
characteristic JJ O
feature NN O
of IN O
Burkitt NNP O
lymphomas NNS O
. . O

Similar JJ O
translocations NNS O
are VBP O
found VBN O
in IN O
mouse NN O
plasmacytomas NNS O
and CC O
both DT O
diseases NNS O
involve VBP O
interchanges NNS O
between IN O
one CD O
of IN O
the DT O
immunoglobulin NN O
loci NNS O
and CC O
DNA NN O
in IN O
the DT O
vicinity NN O
of IN O
the DT O
myc JJ O
gene NN O
. . O

The DT O
structure NN O
of IN O
the DT O
myc JJ O
gene NN O
has VBZ O
been VBN O
elucidated VBN O
from IN O
studies NNS O
on IN O
translocated JJ O
versions NNS O
of IN O
the DT O
gene NN O
. . O

Activation NN O
of IN O
the DT O
myc JJ O
gene NN O
may MD O
play VB O
a DT O
role NN O
in IN O
transformation NN O
by IN O
promoting VBG O
growth NN O
of IN O
the DT O
cells NNS O
bearing VBG O
the DT O
rearranged JJ O
chromosomes NNS O
. . O

-DOCSTART- X X O

Preparation NNP O
and CC O
physicochemical JJ O
and CC O
immunological JJ O
characterization NN O
of IN O
polysaccharide NN O
- : O
outer JJ O
membrane NN O
protein NN O
complexes NNS O
of IN O
Neisseria NNP O
meningitidis NNS O
. . O

A DT O
crude NN O
complex NN O
containing VBG O
group NN O
C NNP O
polysaccharide NN O
, , O
outer JJ O
membrane NN O
proteins NNS O
, , O
and CC O
lipopolysaccharide NN O
( -LRB- O
LPS NNP O
) -RRB- O
was VBD O
isolated VBN O
from IN O
the DT O
cell NN O
- : O
free JJ O
culture NN O
liquid NN O
of IN O
Neisseria NNP O
meningitidis POS O
serogroup NN O
C NNP O
, , O
serotype NN O
2a CD O
. . O

Group NNP O
C NNP O
polysaccharide NN O
and CC O
LPS NNP O
were VBD O
removed VBN O
from IN O
this DT O
complex NN O
, , O
resulting VBG O
in IN O
an DT O
outer JJ O
membrane NN O
complex NN O
and CC O
a DT O
purified VBN O
complex NN O
, , O
respectively RB O
. . O

Analysis NN O
by IN O
electron NN O
microscopy NN O
showed VBD O
the DT O
outer JJ O
membrane NN O
origin NN O
of IN O
the DT O
crude NN O
complex NN O
and CC O
the DT O
outer JJ O
membrane NN O
complex NN O
, , O
whereas IN O
such JJ O
a DT O
structure NN O
was VBD O
absent JJ O
in IN O
the DT O
purified VBN O
complex NN O
. . O

Sodium NNP O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
patterns NNS O
of IN O
the DT O
three CD O
complexes NNS O
were VBD O
identical JJ O
. . O

Pyrolysis NNP O
- : O
mass NN O
spectrometry NN O
data NNS O
correlated VBN O
well RB O
with IN O
those DT O
obtained VBN O
by IN O
the DT O
biochemical JJ O
assays NNS O
and CC O
suggested VBD O
a DT O
low JJ O
LPS NNP O
content NN O
in IN O
the DT O
purified VBN O
complex NN O
and CC O
a DT O
low JJ O
polysaccharide NN O
content NN O
in IN O
the DT O
outer JJ O
membrane NN O
complex NN O
. . O

The DT O
purified VBN O
complex NN O
was VBD O
shown VBN O
to TO O
be VB O
nonpyrogenic JJ O
and CC O
could MD O
be VB O
prepared VBN O
with IN O
the DT O
same JJ O
yield NN O
as IN O
that DT O
of IN O
purified VBN O
polysaccharide NN O
. . O

The DT O
immunogenic JJ O
activities NNS O
of IN O
the DT O
complexes NNS O
were VBD O
studied VBN O
in IN O
mice NNS O
. . O

The DT O
antibodies NNS O
were VBD O
measured VBN O
by IN O
the DT O
enzyme JJ O
- : O
linked VBN O
immunosorbent JJ O
assay NN O
; : O
and CC O
the DT O
bactericidal JJ O
antibody NN O
assay NN O
. . O

All DT O
complexes NNS O
induced VBN O
immunoglobulin IN O
G NNP O
antibodies NNS O
to TO O
group NN O
C NNP O
polysaccharide NN O
as RB O
well RB O
as IN O
to TO O
the DT O
serotype NN O
antigen NN O
, , O
although IN O
the DT O
removal NN O
of IN O
polysaccharide NN O
and CC O
LPS NNP O
resulted VBD O
in IN O
a DT O
reduction NN O
of IN O
the DT O
immunogenic JJ O
activities NNS O
of IN O
outer JJ O
membrane NN O
complex NN O
and CC O
purified VBN O
complex JJ O
, , O
respectively RB O
. . O

A DT O
second JJ O
dose NN O
of IN O
all DT O
complexes NNS O
produced VBD O
a DT O
clear JJ O
booster NN O
effect NN O
of IN O
both DT O
antibody NN O
responses NNS O
. . O

The DT O
antibodies NNS O
were VBD O
bactericidal JJ O
. . O

-DOCSTART- X X O

[ NN O
Suppurated NNP O
acute JJ O
obstructive JJ O
cholangitis NN O
. . O
Anatomoclinical NNP O
and CC O
therapeutic JJ O
aspects NNS O
] VBP O
. . O

A DT O
total NN O
of IN O
134 CD O
cases NNS O
are VBP O
discussed VBN O
, , O
with IN O
suppurated VBN O
acute JJ O
obstructive JJ O
angiocholitis NN O
, , O
that IN O
underwent JJ O
surgical JJ O
treatment NN O
over IN O
a DT O
period NN O
of IN O
10 CD O
years NNS O
, , O
representing VBG O
12 CD O
, , O
8 CD O
% NN O
of IN O
the DT O
total JJ O
number NN O
of IN O
organic JJ O
obstructions NNS O
of IN O
the DT O
hepato FW O
- : O
choledocus NN O
. . O

From IN O
the DT O
standpoint NN O
of IN O
the DT O
etiopathogenic JJ O
mechanisms NNS O
the DT O
angiocholitis NN O
was VBD O
determined VBN O
by IN O
biliary JJ O
lithiasis NN O
in IN O
59 CD O
cases NNS O
, , O
by IN O
sclerosis NN O
of IN O
the DT O
Oddi NNP O
sphincter NN O
in IN O
5 CD O
cases NNS O
, , O
by IN O
postoperative JJ O
cicatriceal JJ O
stenosis NN O
of IN O
the DT O
main JJ O
biliary NN O
pathway NN O
in IN O
2 CD O
cases NNS O
, , O
by IN O
hepatic JJ O
hydatitosis NN O
in IN O
16 CD O
cases NNS O
, , O
by IN O
Vater NNP O
ampuloma NN O
in IN O
10 CD O
cases NNS O
by IN O
cancers NNS O
of IN O
the DT O
main JJ O
biliary NN O
pathway NN O
in IN O
40 CD O
cases NNS O
and CC O
by IN O
the DT O
congenital JJ O
cyst NN O
of IN O
the DT O
choledocus NN O
in IN O
one CD O
case NN O
. . O

The DT O
high JJ O
frequency NN O
was VBD O
noted VBN O
, , O
of IN O
the DT O
severe JJ O
forms NNS O
of IN O
ictero NN O
- : O
uremigenic JJ O
angiocholitis NN O
( -LRB- O
representing VBG O
68 CD O
cases NNS O
, , O
or CC O
50 CD O
, , O
7 CD O
% NN O
of IN O
the DT O
total NN O
, , O
with IN O
a DT O
death NN O
rate NN O
of IN O
34 CD O
% NN O
) -RRB- O
. . O

Medico NNP O
- : O
surgical JJ O
treatment NN O
should MD O
be VB O
performed VBN O
as RB O
early RB O
as IN O
possible JJ O
, , O
and CC O
it PRP O
must MD O
be VB O
intensive JJ O
, , O
complex JJ O
, , O
and CC O
adapted VBD O
to TO O
the DT O
anatomo NN O
- : O
clinical JJ O
forms NNS O
. . O

The DT O
authors NNS O
performed VBN O
evacuation NN O
choledocotomy NN O
with IN O
external JJ O
draining NN O
in IN O
22 CD O
cases NNS O
( -LRB- O
3 CD O
deaths NNS O
) -RRB- O
, , O
and CC O
choledoco NN O
- : O
duodenal JJ O
anastomosis NN O
in IN O
46 CD O
cases NNS O
( -LRB- O
10 CD O
deaths NNS O
) -RRB- O
, , O
choledoco FW O
- : O
jejunostomia NN O
in IN O
3 CD O
cases NNS O
, , O
Oddi NNP O
sphincterotomia NN O
in IN O
12 CD O
cases NNS O
( -LRB- O
2 CD O
deaths NNS O
) -RRB- O
ampulectomia NN O
in IN O
5 CD O
cases NNS O
( -LRB- O
2 CD O
deaths NNS O
) -RRB- O
. . O

Peripheral JJ O
bilio NN O
- : O
hepatodigestive JJ O
anastomoses NNS O
were VBD O
performed VBN O
in IN O
40 CD O
cases NNS O
with IN O
5 CD O
deaths NNS O
. . O

-DOCSTART- X X O

[ NN O
Reactive JJ O
states NNS O
among IN O
psychopathic JJ O
personalities NNS O
of IN O
different JJ O
clinical JJ O
groups NNS O
] VBP O
. . O

On IN O
the DT O
basis NN O
of IN O
a DT O
clinical JJ O
follow VB O
- : O
up IN O
of IN O
71 CD O
psychopaths NNS O
with IN O
manifestations NNS O
of IN O
reactive NN O
psychosis NN O
, , O
the DT O
authors NNS O
established VBN O
the DT O
clinico NN O
- : O
typological JJ O
characteristics NNS O
of IN O
both DT O
groups NNS O
of IN O
pathology NN O
and CC O
the DT O
system NN O
of IN O
correlations NNS O
between IN O
them PRP O
. . O

They PRP O
also RB O
described VBD O
the DT O
structure NN O
of IN O
the DT O
psychopathic JJ O
and CC O
psychogenic JJ O
syndromes NNS O
, , O
the DT O
type NN O
of IN O
psychopathic JJ O
personality NN O
reaction NN O
and CC O
the DT O
form NN O
of IN O
psychogenic JJ O
responses NNS O
and CC O
proved VBD O
statistically RB O
their PRP$ O
close JJ O
interrelationship NN O
. . O

Data NNP O
were VBD O
obtained VBN O
on IN O
some DT O
general JJ O
regularities NNS O
of IN O
interrelations NNS O
of IN O
reactive NN O
psychoses NNS O
with IN O
a DT O
psychopathic JJ O
background NN O
which WDT O
are VBP O
important JJ O
for IN O
the DT O
prognosis NN O
, , O
prophylaxis NNS O
and CC O
therapy NN O
of IN O
reactive NN O
states NNS O
. . O

-DOCSTART- X X O

Hemostasis NNP O
and CC O
mechanism NN O
of IN O
action NN O
of IN O
selective JJ O
antimetastatic JJ O
drugs NNS O
in IN O
mice NNS O
bearing VBG O
Lewis NNP O
lung NN O
carcinoma NN O
. . O

The DT O
selective JJ O
antimetastatic JJ O
agents NNS O
p NN O
- : O
( -LRB- O
3 CD O
, , O
3 CD O
- : O
dimethyl NN O
- : O
1 LS O
- : O
triazeno NN O
) -RRB- O
benzoic JJ O
acid NN O
potassium NN O
salt NN O
( -LRB- O
DM FW O
- : O
COOK NN O
) -RRB- O
, , O
5 CD O
- : O
( -LRB- O
3 CD O
, , O
3 CD O
- : O
dimethyl NN O
- : O
1 LS O
- : O
triazeno NN O
) -RRB- O
imidazole VBP O
- : O
4 CD O
- : O
carboxamide NN O
( -LRB- O
DTIC NN O
) -RRB- O
and CC O
( -LRB- O
+ NN O
/ JJ O
- : O
) -RRB- O
1 CD O
, , O
2 CD O
- : O
di FW O
( -LRB- O
3 CD O
, , O
5 CD O
- : O
dioxopiperazin NN O
- : O
1 LS O
- : O
yl NN O
) -RRB- O
propane NN O
( -LRB- O
ICRF NNP O
- : O
159 CD O
) -RRB- O
have VBP O
been VBN O
shown VBN O
to TO O
markedly RB O
depress VB O
the DT O
formation NN O
of IN O
spontaneous JJ O
hematogenous JJ O
metastases NNS O
in IN O
mice NNS O
bearing VBG O
s PRP O
. . O
c NN O
. . O

Lewis NNP O
lung NN O
carcinoma NN O
, , O
with IN O
a DT O
mechanism NN O
unrelated JJ O
to TO O
cytotoxicity NN O
for IN O
tumor NN O
cells NNS O
. . O

The DT O
effects NNS O
on IN O
hemostasis NN O
of IN O
DM NNP O
- : O
COOK NN O
, , O
DTIC NNP O
and CC O
ICRF NNP O
- : O
159 CD O
have VBP O
thus RB O
been VBN O
examined VBN O
in IN O
comparison NN O
with IN O
those DT O
of IN O
a DT O
purely RB O
cytotoxic JJ O
agent NN O
, , O
cyclophosphamide NN O
, , O
in IN O
mice NNS O
bearing VBG O
i FW O
. . O
m NN O
. . O

Lewis NNP O
lung NN O
carcinoma NN O
. . O

The DT O
parameters NNS O
considered VBN O
are VBP O
the DT O
number NN O
of IN O
platelets NNS O
and CC O
their PRP$ O
aggregability NN O
, , O
prothrombin NN O
and CC O
partial JJ O
thromboplastin IN O
times NNS O
, , O
plasma NN O
fibrinogen NN O
concentration NN O
and CC O
tumor NN O
cell NN O
procoagulant NN O
activity NN O
. . O

Slight JJ O
variations NNS O
are VBP O
caused VBN O
by IN O
drug NN O
treatment NN O
in IN O
tumor NN O
- : O
bearing NN O
mice NNS O
as IN O
compared VBN O
with IN O
untreated JJ O
tumor NN O
- : O
bearing NN O
controls NNS O
; : O
the DT O
pattern NN O
of IN O
effects NNS O
of IN O
the DT O
selective JJ O
antimetastatic JJ O
agents NNS O
does VBZ O
not RB O
differ VB O
from IN O
that DT O
of IN O
the DT O
reference NN O
cytotoxic JJ O
compound NN O
used VBN O
, , O
cyclophosphamide NN O
. . O

These DT O
data NNS O
thus RB O
indicate VBP O
that IN O
the DT O
effects NNS O
on IN O
hemostasis NN O
of IN O
the DT O
drugs NNS O
examined VBD O
can MD O
contribute VB O
only RB O
marginally RB O
to TO O
their PRP$ O
antimetastatic JJ O
action NN O
, , O
since IN O
more RBR O
pronounced JJ O
effects NNS O
on IN O
hemostasis NN O
have VBP O
been VBN O
shown VBN O
to TO O
be VB O
required VBN O
to TO O
significantly RB O
affect VB O
metastasis NN O
formation NN O
. . O

-DOCSTART- X X O

Purification NNP O
and CC O
characterization NN O
of IN O
various JJ O
esterases NNS O
from IN O
rat NN O
liver NN O
. . O

The DT O
major JJ O
rat NN O
liver NN O
microsomal NN O
esterases NNS O
acting VBG O
on IN O
o IN O
- : O
nitrophenylacetate NN O
with IN O
isoelectric JJ O
points NNS O
5 CD O
. . O
0 CD O
, , O
5 CD O
. . O
5 CD O
, , O
6 CD O
. . O
1 CD O
and CC O
6 CD O
. . O
4 CD O
were VBD O
resolved VBN O
by IN O
isoelectric JJ O
focusing VBG O
. . O

Molecular JJ O
weights NNS O
were VBD O
determined VBN O
by IN O
sedimentation NN O
analysis NN O
in IN O
isokinetic JJ O
gradients NNS O
of IN O
sucrose NN O
and CC O
, , O
after IN O
purification NN O
, , O
in IN O
sodium NN O
dodecyl NN O
sulphate NN O
/ IN O
polyacrylamide NN O
gel NN O
electrophoresis NN O
. . O

Their PRP$ O
subunit NN O
molecular JJ O
weights NNS O
were VBD O
between IN O
57 CD O
000 CD O
and CC O
60 CD O
000 CD O
. . O

They PRP O
behaved VBD O
as IN O
monomers NNS O
except IN O
the DT O
pI JJ O
- : O
6 CD O
. . O
1 CD O
enzyme NN O
which WDT O
behaved VBD O
as IN O
a DT O
trimer NN O
. . O

Esterases NNS O
of IN O
pI JJ O
5 CD O
. . O
0 CD O
, , O
pI RB O
6 CD O
. . O
1 CD O
and CC O
pI RB O
6 CD O
. . O
4 CD O
behaved VBD O
like IN O
glycoproteins NNS O
of IN O
the DT O
polymannose NN O
type NN O
in IN O
the DT O
presence NN O
of IN O
125I CD O
- : O
labelled VBN O
concanavalin NN O
A DT O
. . O

Preparations NNS O
of IN O
the DT O
pI NN O
- : O
5 CD O
. . O
0 CD O
enzyme NN O
contained VBD O
two CD O
esterases NNS O
of IN O
highly RB O
homologous JJ O
structure NN O
. . O

Antibodies NNS O
directed VBD O
against IN O
this DT O
preparation NN O
did VBD O
not RB O
inhibit VB O
but CC O
precipitated VBD O
pI DT O
- : O
5 CD O
. . O
0 CD O
esterase NN O
activity NN O
quantitatively RB O
. . O

They PRP O
did VBD O
not RB O
react VB O
with IN O
the DT O
pI JJ O
- : O
6 CD O
. . O
1 CD O
and CC O
pI VB O
- : O
6 CD O
. . O
4 CD O
esterases NNS O
but CC O
precipitated VBD O
several JJ O
nonimmunologically RB O
related VBN O
esterases NNS O
. . O

Two CD O
of IN O
these DT O
enzymes NNS O
were VBD O
inducible JJ O
by IN O
phenobarbital NN O
. . O

Total JJ O
activity NN O
was VBD O
very RB O
low JJ O
in IN O
3 CD O
- : O
day NN O
- : O
old JJ O
animals NNS O
. . O

Individual JJ O
esterase NN O
activities NNS O
rose VBD O
at IN O
different JJ O
rates NNS O
during IN O
development NN O
; : O
the DT O
enzyme NN O
focusing VBG O
near IN O
pI NN O
5 CD O
. . O
0 CD O
was VBD O
about IN O
three CD O
times NNS O
more RBR O
active JJ O
in IN O
adult NN O
females NNS O
than IN O
in IN O
males NNS O
. . O

All DT O
microsomal JJ O
esterases NNS O
are VBP O
located VBN O
on IN O
the DT O
luminal JJ O
side NN O
of IN O
the DT O
endoplasmic JJ O
reticulum NN O
. . O

-DOCSTART- X X O

Hippocampal NNP O
afterdischarge NN O
interferes VBZ O
with IN O
storage NN O
of IN O
spatial JJ O
information NN O
in IN O
a DT O
working VBG O
memory NN O
test NN O
. . O

In IN O
an DT O
attempt NN O
to TO O
impair VB O
spatial JJ O
working VBG O
memory NN O
by IN O
reversible JJ O
functional JJ O
blockade NN O
rather RB O
than IN O
by IN O
irreversible JJ O
lesion NN O
of IN O
the DT O
hippocampus NN O
, , O
eight CD O
male JJ O
hooded JJ O
rats NNS O
were VBD O
trained VBN O
to TO O
asymptotic JJ O
performance NN O
of IN O
1 CD O
. . O
2 CD O
to TO O
1 CD O
. . O
4 CD O
errors NNS O
per IN O
trial NN O
in IN O
the DT O
spatial JJ O
12 CD O
- : O
choice NN O
apparatus NN O
( -LRB- O
Bure NNP O
s VBZ O
et NNP O
al NN O
. . O
1982 CD O
) -RRB- O
, , O
formally RB O
similar JJ O
to TO O
the DT O
radial JJ O
maze NN O
. . O

The DT O
rats NNS O
were VBD O
implanted VBN O
with IN O
hippocampal JJ O
stimulating NN O
and CC O
recording NN O
electrodes NNS O
, , O
which WDT O
were VBD O
used VBN O
for IN O
eliciting VBG O
and CC O
monitoring VBG O
hippocampal JJ O
afterdischarge NN O
( -LRB- O
HAD NN O
) -RRB- O
lasting VBG O
for IN O
at IN O
least JJS O
20 CD O
s VBZ O
. . O

In IN O
Experiment NNP O
1 CD O
, , O
HAD NNP O
elicited VBD O
1 CD O
or CC O
10 CD O
min NN O
before IN O
testing VBG O
increased VBD O
the DT O
incidence NN O
of IN O
errors NNS O
to TO O
2 CD O
. . O
75 CD O
or CC O
2 CD O
. . O
50 CD O
per IN O
trial NN O
, , O
respectively RB O
, , O
but CC O
the DT O
performance NN O
still RB O
remained VBD O
above IN O
chance NN O
level NN O
( -LRB- O
4 CD O
. . O
18 CD O
) -RRB- O
. . O

In IN O
Experiment NN O
2 CD O
, , O
interruption NN O
of IN O
the DT O
trial NN O
by IN O
1 CD O
, , O
10 CD O
, , O
20 CD O
and CC O
30 CD O
min NN O
intervals NNS O
inserted VBN O
between IN O
choices NNS O
6 CD O
and CC O
7 CD O
increased VBD O
the DT O
incidence NN O
of IN O
errors NNS O
in IN O
choices NNS O
7 CD O
to TO O
12 CD O
to TO O
1 CD O
. . O
0 CD O
, , O
1 CD O
. . O
5 CD O
, , O
2 CD O
. . O
1 CD O
and CC O
2 CD O
. . O
5 CD O
, , O
respectively RB O
. . O

HAD NNP O
elicited VBD O
immediately RB O
after IN O
choice NN O
6 CD O
increased VBN O
error NN O
incidence NN O
in IN O
the DT O
subsequent JJ O
6 CD O
choices NNS O
performed VBN O
after IN O
1 CD O
- : O
min NN O
or CC O
10 CD O
- : O
min NN O
intervals NNS O
to TO O
3 CD O
. . O
1 CD O
or CC O
2 CD O
. . O
75 CD O
, , O
respectively RB O
, , O
i FW O
. . O
e NN O
. . O
to TO O
the DT O
chance NN O
level NN O
of IN O
3 CD O
errors NNS O
in IN O
6 CD O
choices NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
HAD NNP O
elicits NNS O
transient JJ O
shortening NN O
of IN O
the DT O
memory NN O
span NN O
for IN O
newly RB O
acquired VBN O
spatial JJ O
information NN O
( -LRB- O
anterograde JJ O
effect NN O
) -RRB- O
and CC O
erases VBZ O
the DT O
current JJ O
spatial JJ O
working JJ O
memory NN O
record NN O
( -LRB- O
retrograde NN O
effect NN O
) -RRB- O
. . O

-DOCSTART- X X O

Inhibition NN O
by IN O
N NNP O
- : O
( -LRB- O
phosphonacetyl NN O
) -RRB- O
- : O
L JJ O
- : O
aspartate NN O
of IN O
Ehrlich NNP O
ascites VBZ O
tumour JJ O
growth NN O
and CC O
glucose NN O
transport NN O
. . O

N NNP O
- : O
( -LRB- O
Phosphonacetyl NN O
) -RRB- O
- : O
L JJ O
- : O
aspartate NN O
( -LRB- O
PALA NNP O
) -RRB- O
suppressed VBD O
the DT O
growth NN O
of IN O
Ehrlich NNP O
ascites VBZ O
tumour JJ O
cells NNS O
in IN O
vivo RB O
in IN O
a DT O
dose NN O
- : O
dependent JJ O
manner NN O
. . O

Simultaneously RB O
as IN O
the DT O
growth NN O
rate NN O
decreased VBN O
, , O
the DT O
cellular JJ O
uptake NN O
of IN O
glucose NN O
and CC O
the DT O
density NN O
of IN O
a DT O
class NN O
of IN O
glucose NN O
- : O
reversible JJ O
binding NN O
sites NNS O
for IN O
cytochalasin VBG O
B NNP O
on IN O
the DT O
cell NN O
surface NN O
were VBD O
also RB O
found VBN O
to TO O
be VB O
reduced VBN O
. . O

There EX O
is VBZ O
a DT O
highly RB O
significant JJ O
correlation NN O
between IN O
the DT O
magnitude NN O
of IN O
changes NNS O
in IN O
the DT O
number NN O
of IN O
cytochalasin NN O
B NNP O
binding NN O
sites NNS O
and CC O
the DT O
magnitude NN O
of IN O
changes NNS O
in IN O
glucose NN O
uptake NN O
. . O

The DT O
physiological JJ O
significance NN O
of IN O
these DT O
observations NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

[ NN O
In IN O
vitro NN O
studies NNS O
of IN O
the DT O
thyroid NN O
gland NN O
regulation NN O
principles NNS O
and CC O
their PRP$ O
evaluation NN O
] NN O
. . O

The DT O
free JJ O
fractions NNS O
of IN O
the DT O
thyroid NN O
hormone NN O
further RB O
the DT O
metabolism NN O
of IN O
the DT O
body NN O
cells NNS O
and CC O
regulate VB O
the DT O
synthesis NN O
of IN O
the DT O
thyroid NN O
hormone NN O
. . O

Once RB O
the DT O
level NN O
of IN O
FT3 NNP O
and CC O
FT4 NNP O
decreases VBZ O
. . O

With IN O
the DT O
help NN O
of IN O
a DT O
liberation NN O
of IN O
the DT O
hormone NN O
stimulating VBG O
the DT O
thyroid JJ O
gland NN O
from IN O
the DT O
anterior JJ O
lobe NN O
of IN O
the DT O
pituitary NN O
gland CC O
the DT O
lack NN O
of IN O
thyroid NN O
hormone NN O
is VBZ O
corrected VBN O
. . O

The DT O
synthesis NN O
and CC O
secretion NN O
of IN O
the DT O
thyroid JJ O
gland NN O
stimulating NN O
hormone NN O
is VBZ O
induced VBN O
by IN O
the DT O
thyreotropin NN O
releasing NN O
hormone NN O
which WDT O
is VBZ O
given VBN O
by IN O
the DT O
hypothalamus NN O
. . O

Moreover RB O
, , O
the DT O
organism NN O
is VBZ O
able JJ O
as IN O
needed VBN O
to TO O
carry VB O
out RP O
the DT O
monodiodation NN O
of IN O
LT4 NNP O
to TO O
biologically RB O
active JJ O
LT3 NNP O
or CC O
biologically RB O
inactive JJ O
so IN O
- : O
called VBN O
revers NNS O
T3 . O
( -LRB- O
RT3 JJ O
) -RRB- O
. . O

The DT O
estimation NN O
of IN O
thyroid DT O
gland NN O
stimulating NN O
hormone NN O
before RB O
and CC O
30 CD O
minutes NNS O
after IN O
intravenous JJ O
application NN O
of IN O
thyreotropin DT O
releasing NN O
hormone NN O
has VBZ O
its PRP$ O
main JJ O
importance NN O
for IN O
the DT O
early JJ O
recognition NN O
of IN O
a DT O
disturbance NN O
of IN O
the DT O
regulating JJ O
circle NN O
hypophysis NN O
- : O
thyroid NN O
gland NN O
, , O
above IN O
all DT O
in IN O
the DT O
diagnosis NN O
of IN O
clinically RB O
not RB O
yet RB O
manifest JJ O
clinical JJ O
pictures NNS O
, , O
such JJ O
as IN O
the DT O
latent JJ O
hypothyreosis NN O
and CC O
the DT O
latent JJ O
hyperthyreosis NN O
, , O
respectively RB O
( -LRB- O
Basedow NNP O
hyperthyreosis NN O
and CC O
thyroidal JJ O
autonomy NN O
) -RRB- O
. . O

According VBG O
to TO O
the DT O
questioning VBG O
the DT O
estimations NNS O
of IN O
the DT O
levels NNS O
of IN O
the DT O
thyroid NN O
hormones NNS O
and CC O
of IN O
the DT O
thyroid JJ O
gland NN O
stimulating NN O
hormone NN O
should MD O
be VB O
used VBN O
stepwise RB O
. . O

-DOCSTART- X X O

Relationship NN O
of IN O
self NN O
- : O
concept NN O
during IN O
late JJ O
pregnancy NN O
to TO O
neonatal JJ O
perception NN O
and CC O
parenting NN O
profile NN O
. . O

Thirty CD O
- : O
one CD O
gravidas NN O
were VBD O
studied VBN O
to TO O
examine VB O
the DT O
relationship NN O
between IN O
a DT O
woman NN O
' POS O
s VBZ O
feelings NNS O
about IN O
herself PRP O
during IN O
late JJ O
pregnancy NN O
, , O
her PRP$ O
perception NN O
of IN O
her PRP$ O
newborn JJ O
, , O
and CC O
her PRP$ O
profile NN O
of IN O
parenting NN O
. . O

The DT O
Tennessee NNP O
Self NNP O
- : O
Concept IN O
Scale NNP O
was VBD O
completed VBN O
during IN O
the DT O
third JJ O
trimester NN O
of IN O
pregnancy NN O
, , O
the DT O
Neonatal NNP O
Perception NNP O
Inventory NNP O
I PRP O
at IN O
one CD O
- : O
to TO O
- : O
two CD O
days NNS O
postpartum NN O
, , O
and CC O
the DT O
Neonatal JJ O
Perception NNP O
Inventory NNP O
II NNP O
and CC O
the DT O
Michigan NNP O
Screening NNP O
Profile NNP O
of IN O
Parenting NNP O
at IN O
four CD O
- : O
to TO O
- : O
six CD O
weeks NNS O
postpartum NN O
. . O

When WRB O
considered VBN O
separately RB O
, , O
no DT O
positive JJ O
significant JJ O
relationships NNS O
were VBD O
found VBN O
between IN O
scores NNS O
on IN O
these DT O
variables NNS O
. . O

However RB O
, , O
all DT O
subjects NNS O
with IN O
negative JJ O
scores NNS O
on IN O
both DT O
self NN O
- : O
concept NN O
and CC O
neonatal NN O
perception NN O
had VBD O
negative JJ O
scores NNS O
on IN O
at IN O
least JJS O
two CD O
subscales NNS O
of IN O
the DT O
parenting NN O
profile NN O
. . O

-DOCSTART- X X O

Differential JJ O
reactivity NN O
of IN O
the DT O
functional JJ O
sulfhydryl NN O
groups NNS O
of IN O
cysteine JJ O
- : O
32 CD O
and CC O
cysteine NN O
- : O
35 CD O
present NN O
in IN O
the DT O
reduced JJ O
form NN O
of IN O
thioredoxin NN O
from IN O
Escherichia NNP O
coli NNS O
. . O

Only RB O
one CD O
of IN O
the DT O
sulfhydryl NN O
groups NNS O
from IN O
Cys NNS O
- : O
32 CD O
and CC O
Cys NNP O
- : O
35 CD O
in IN O
the DT O
active JJ O
center NN O
of IN O
native JJ O
Escherichia NNP O
coli NNS O
thioredoxin NN O
- : O
( -LRB- O
SH NNS O
) -RRB- O
2 CD O
was VBD O
alkylated VBN O
by IN O
excess JJ O
iodoacetic JJ O
acid NN O
at IN O
pH NN O
values NNS O
below IN O
8 CD O
. . O
0 CD O
. . O

Both DT O
groups NNS O
reacted VBD O
in IN O
the DT O
protein NN O
denatured VBD O
with IN O
4 CD O
. . O
5 CD O
M NNP O
guanidine NNP O
hydrochloride NN O
. . O

The DT O
second JJ O
order NN O
rate NN O
of IN O
alkylation NN O
of IN O
thioredoxin NN O
- : O
( -LRB- O
SH NNS O
) -RRB- O
2 CD O
with IN O
1 CD O
eq NN O
of IN O
iodoacetic JJ O
acid NN O
was VBD O
pH DT O
- : O
dependent JJ O
and CC O
showed VBD O
independent JJ O
initial JJ O
reactions NNS O
of IN O
one CD O
thiolate JJ O
ion NN O
with IN O
a DT O
pK JJ O
value NN O
of IN O
6 CD O
. . O
7 CD O
and CC O
a DT O
second JJ O
with IN O
a DT O
pK NN O
value NN O
close RB O
to TO O
9 CD O
. . O
0 CD O
. . O

The DT O
same JJ O
pH NN O
dependence NN O
was VBD O
observed VBN O
for IN O
alkylation NN O
with IN O
iodoacetamide NN O
but CC O
the DT O
apparent JJ O
rate NN O
constant JJ O
, , O
107 CD O
M NNP O
- : O
1 CD O
S NNP O
- : O
1 CD O
at IN O
pH NN O
7 CD O
. . O
2 CD O
, , O
was VBD O
about IN O
20 CD O
- : O
fold NN O
higher JJR O
than IN O
the DT O
corresponding JJ O
rate NN O
with IN O
iodoacetate NN O
. . O

The DT O
sulfhydryl NN O
group NN O
with IN O
a DT O
pK JJ O
value NN O
of IN O
6 CD O
. . O
7 CD O
was VBD O
shown VBN O
to TO O
belong VB O
to TO O
Cys NNP O
- : O
32 CD O
by IN O
labeling VBG O
thioredoxin NN O
with IN O
[ JJ O
14C JJ O
] SYM O
iodoacetic JJ O
acid NN O
followed VBN O
by IN O
complete JJ O
alkylation NN O
with IN O
[ NNP O
3H NNP O
] SYM O
iodoacetate NN O
and CC O
amino DT O
acid NN O
sequence NN O
analysis NN O
of IN O
peptides NNS O
from IN O
the DT O
active JJ O
center NN O
. . O

The DT O
abnormally RB O
low JJ O
pK NN O
value NN O
of IN O
Cys NNS O
- : O
32 CD O
is VBZ O
suggested VBN O
to TO O
arise VB O
by IN O
electrostatic JJ O
influence NN O
from IN O
a DT O
positive JJ O
charge NN O
on IN O
the DT O
amino JJ O
group NN O
of IN O
Lys NNP O
- : O
36 CD O
. . O

A DT O
mechanism NN O
of IN O
action NN O
for IN O
thioredoxin NN O
- : O
( -LRB- O
SH NNS O
) -RRB- O
2 CD O
as IN O
a DT O
protein NN O
disulfide NN O
reductase NN O
has VBZ O
been VBN O
formulated VBN O
. . O

This DT O
is VBZ O
based VBN O
on IN O
an DT O
initial JJ O
nucleophilic JJ O
attack NN O
by IN O
the DT O
thiolate NN O
of IN O
Cys NNS O
- : O
32 CD O
with IN O
the DT O
formation NN O
of IN O
an DT O
unstable JJ O
transient NN O
mixed JJ O
disulfide NN O
involving VBG O
Cys NNS O
- : O
32 CD O
and CC O
one CD O
of IN O
the DT O
sulfurs NNS O
in IN O
the DT O
substrate NN O
. . O

This DT O
is VBZ O
followed VBN O
by IN O
a DT O
conformational JJ O
change NN O
and CC O
a DT O
nucleophilic JJ O
attack NN O
of IN O
Cys NNS O
- : O
35 CD O
to TO O
give VB O
the DT O
14 CD O
- : O
membered VBN O
disulfide JJ O
ring NN O
in IN O
thioredoxin NN O
- : O
S2 NN O
and CC O
the DT O
dithiol NN O
of IN O
the DT O
substrate NN O
. . O

-DOCSTART- X X O

Subretinal JJ O
neovascularization NN O
following VBG O
rubella NN O
retinopathy NN O
. . O

A DT O
17 CD O
- : O
year NN O
- : O
old JJ O
girl NN O
and CC O
an DT O
11 CD O
- : O
year NN O
- : O
old JJ O
girl NN O
with IN O
rubella NN O
retinopathy NN O
had VBD O
decreased VBN O
vision NN O
in IN O
one CD O
eye NN O
secondary JJ O
to TO O
subretinal JJ O
neovascularization NN O
and CC O
hemorrhage NN O
. . O

In IN O
both DT O
cases NNS O
a DT O
disciform NN O
scar NN O
with IN O
permanent JJ O
decrease NN O
in IN O
central JJ O
vision NN O
resulted VBD O
. . O

-DOCSTART- X X O

Verrucous JJ O
carcinoma NN O
of IN O
the DT O
endometrium NN O
- : O
- : O
a DT O
unique JJ O
neoplasm NN O
with IN O
long JJ O
survival NN O
. . O

A DT O
case NN O
of IN O
verrucous JJ O
carcinoma NN O
of IN O
the DT O
endometrium NN O
with IN O
long JJ O
survival NN O
is VBZ O
described VBN O
. . O

It PRP O
represents VBZ O
the DT O
first JJ O
of IN O
its PRP$ O
type NN O
to TO O
be VB O
recorded VBN O
in IN O
this DT O
site NN O
. . O

The DT O
literature NN O
on IN O
verrucous JJ O
carcinoma NN O
and CC O
on IN O
other JJ O
cases NNS O
of IN O
squamous JJ O
carcinoma NN O
of IN O
the DT O
endometrium NN O
is VBZ O
briefly RB O
reviewed VBN O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
3 CD O
- : O
chloromethylthiochromone NN O
- : O
1 CD O
, , O
1 CD O
- : O
dioxide NN O
on IN O
nucleic JJ O
acid NN O
, , O
protein NN O
, , O
and CC O
aerobic JJ O
and CC O
anaerobic JJ O
metabolism NN O
of IN O
Ehrlich NNP O
ascites VBZ O
tumor NN O
cells NNS O
. . O

3 LS O
- : O
Chloromethylthiochromone NN O
- : O
1 CD O
, , O
1 CD O
- : O
dioxide NN O
was VBD O
observed VBN O
to TO O
be VB O
a DT O
potent JJ O
inhibitor NN O
of IN O
Ehrlich NNP O
ascites VBZ O
carcinoma NN O
growth NN O
and CC O
a DT O
moderate JJ O
inhibitor NN O
of IN O
P NNP B-NP
- : I-NP
388 CD I-NP
lymphocytic JJ O
leukemia NN O
growth NN O
at IN O
10 CD O
mg JJ O
/ NNS O
kg IN O
/ JJ O
day NN O
. . O

Preliminary NNP O
in IN O
vitro NN O
studies NNS O
showed VBD O
that IN O
the DT O
agents NNS O
significantly RB O
inhibited VBD O
RNA NNP O
and CC O
DNA NNP O
synthesis NN O
in IN O
Ehrlich NNP O
ascites VBZ O
cells NNS O
. . O

In IN O
vivo JJ O
studies NNS O
after IN O
dosing VBG O
on IN O
Days NNS O
6 CD O
, , O
7 CD O
, , O
and CC O
8 CD O
demonstrated VBD O
the DT O
same JJ O
reductions NNS O
in IN O
nucleic JJ O
acid NN O
synthesis NN O
and CC O
a DT O
moderate JJ O
reduction NN O
in IN O
protein NN O
synthesis NN O
. . O

The DT O
primary JJ O
site NN O
of IN O
nucleic JJ O
acid NN O
synthesis NN O
, , O
which WDT O
was VBD O
blocked VBN O
by IN O
3 CD O
- : O
chloromethylthiochromone NN O
, , O
was VBD O
at IN O
orotidine NNP O
monophosphate NN O
decarboxylase NN O
in IN O
the DT O
primidine JJ O
pathway NN O
. . O

Other JJ O
enzymes NNS O
, , O
in IN O
anaerobic JJ O
and CC O
aerobic JJ O
glycolysis NN O
, , O
which WDT O
were VBD O
blocked VBN O
include VBP O
hexokinase NN O
, , O
phosphofructokinase NN O
, , O
succinic NN O
and CC O
alpha NN O
- : O
ketoglutarate NN O
dehydrogenases NNS O
, , O
as RB O
well RB O
as IN O
States NNP O
3 CD O
and CC O
4 CD O
of IN O
oxidative JJ O
phosphorylation NN O
. . O

-DOCSTART- X X O

Metabolic NNP O
alterations NNS O
in IN O
a DT O
noncachectic JJ O
animal NN O
tumor NN O
system NN O
. . O

The DT O
increased VBD O
energy NN O
expended VBN O
by IN O
the DT O
host NN O
to TO O
synthesize VB O
substrate NN O
, , O
which WDT O
is VBZ O
utilized VBN O
by IN O
the DT O
tumor NN O
, , O
is VBZ O
a DT O
potential JJ O
cause NN O
of IN O
cancer NN O
cachexia NN O
. . O

In IN O
vivo JJ O
glucose NN O
and CC O
alanine JJR O
kinetics NNS O
were VBD O
examined VBN O
by IN O
tracer NN O
methodology NN O
in IN O
a DT O
sarcoma NN O
- : O
bearing NN O
rat NN O
model NN O
. . O

The DT O
effects NNS O
of IN O
3 CD O
- : O
mercaptopicolinic NN O
acid NN O
, , O
a DT O
potent JJ O
inhibitor NN O
of IN O
gluconeogenesis NN O
, , O
was VBD O
also RB O
examined VBN O
on IN O
this DT O
model NN O
. . O

Both DT O
tumor NN O
- : O
bearing NN O
( -LRB- O
TB NN O
) -RRB- O
and CC O
nontumor JJ O
bearing NN O
( -LRB- O
NTB NN O
) -RRB- O
animals NNS O
were VBD O
gaining VBG O
weight NN O
prior JJ O
to TO O
study VB O
and CC O
the DT O
tumors NNS O
were VBD O
relatively RB O
small JJ O
. . O

The DT O
TB NNP O
animals NNS O
had VBD O
significantly RB O
lower JJR O
plasma NN O
glucose NN O
and CC O
higher JJR O
blood NN O
lactic JJ O
acid NN O
levels NNS O
compared VBN O
with IN O
NTB NNP O
animals NNS O
. . O

After IN O
inhibition NN O
of IN O
gluconeogenesis NN O
, , O
the DT O
plasma NN O
glucose NN O
decreased VBD O
and CC O
the DT O
blood NN O
lactate VBP O
increased VBN O
significantly RB O
more RBR O
in IN O
TB NNP O
than IN O
NTB NNP O
animals NNS O
. . O

The DT O
glucose JJ O
turnover NN O
rate NN O
was VBD O
significantly RB O
greater JJR O
in IN O
TB NN O
compared VBN O
with IN O
NTB NNP O
animals NNS O
, , O
as RB O
was VBD O
the DT O
rate NN O
of IN O
glucose NN O
recycling NN O
and CC O
the DT O
rate NN O
of IN O
gluconeogenesis NN O
( -LRB- O
alanine DT O
leads VBZ O
to TO O
glucose VB O
) -RRB- O
, , O
both DT O
energy NN O
demanding VBG O
processes NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
tumor NN O
- : O
bearing NN O
animal NN O
, , O
even RB O
prior RB O
to TO O
significant JJ O
cachexia NN O
, , O
has VBZ O
an DT O
excess JJ O
demand NN O
for IN O
energy NN O
, , O
the DT O
provision NN O
of IN O
which WDT O
may MD O
be VB O
a DT O
significant JJ O
factor NN O
in IN O
malignant JJ O
cachexia NN O
. . O

-DOCSTART- X X O

[ JJ O
Organization NNP O
of IN O
pectoral JJ O
muscle NN O
motor NN O
neurons NNS O
in IN O
the DT O
rat NN O
. . O
Contribution NN O
to TO O
the DT O
study NN O
of IN O
the DT O
axillary NN O
arch NN O
( -LRB- O
Achselbogen NN O
) -RRB- O
] SYM O
. . O

In IN O
spite NN O
of IN O
their PRP$ O
role NN O
of IN O
the DT O
forelimb NN O
activity NN O
, , O
the DT O
organization NN O
of IN O
the DT O
mammalian JJ O
pectoral JJ O
muscles NNS O
remains VBZ O
unclear JJ O
. . O

In IN O
order NN O
to TO O
get VB O
more JJR O
information NN O
, , O
we PRP O
have VBP O
studied VBN O
, , O
qualitatively RB O
and CC O
quantitatively RB O
, , O
the DT O
motor NN O
pools NNS O
of IN O
the DT O
various JJ O
pectoral JJ O
muscles NNS O
in IN O
the DT O
rat NN O
( -LRB- O
musculus NN O
pectoralis NNS O
major JJ O
, , O
musculus JJ O
pectoralis NNS O
minor JJ O
and CC O
musculus JJ O
panniculus NN O
carnosus NN O
) -RRB- O
. . O

The DT O
method NN O
applied VBD O
was VBD O
the DT O
retrograde NN O
transport NN O
of IN O
horseradish NN O
peroxidase NN O
by IN O
the DT O
peripheral JJ O
nerves NNS O
supplying VBG O
the DT O
various JJ O
muscles NNS O
. . O

The DT O
results NNS O
provided VBD O
the DT O
precise JJ O
localization NN O
within IN O
the DT O
ventral JJ O
horn NN O
of IN O
the DT O
motor NN O
neurons NNS O
from IN O
the DT O
pectoral JJ O
muscles NNS O
which WDT O
were VBD O
all DT O
in IN O
the DT O
most RBS O
ventral JJ O
part NN O
of IN O
the DT O
gray JJ O
matter NN O
. . O

Three CD O
distinct JJ O
motor NN O
pools NNS O
were VBD O
observed VBN O
, , O
which WDT O
confirms VBZ O
the DT O
functional JJ O
identity NN O
of IN O
each DT O
muscle NN O
. . O

The DT O
motor NN O
neurons NNS O
of IN O
m NN O
. . O
panniculus NN O
carnosus NN O
exhibited VBD O
some DT O
particularities NNS O
. . O

They PRP O
were VBD O
4 CD O
times NNS O
more RBR O
numerous JJ O
than IN O
those DT O
from IN O
m NN O
. . O
pectoralis NNPS O
major JJ O
, , O
they PRP O
occupied VBD O
the DT O
whole NN O
ventral JJ O
edge NN O
of IN O
the DT O
ventral JJ O
horn NN O
, , O
from IN O
its PRP$ O
medial JJ O
part NN O
to TO O
its PRP$ O
lateral JJ O
tip NN O
. . O

The DT O
cell NN O
size NN O
was VBD O
different JJ O
from IN O
that DT O
of IN O
the DT O
other JJ O
muscles NNS O
. . O

These DT O
results NNS O
were VBD O
discussed VBN O
, , O
according VBG O
to TO O
the DT O
role NN O
of IN O
this DT O
muscle NN O
, , O
which WDT O
links VBZ O
the DT O
forelimb NN O
to TO O
the DT O
whole JJ O
trunk NN O
. . O

In IN O
mammals NNS O
, , O
m NN O
. . O
panniculus NN O
carnosus NN O
constitutes VBZ O
, , O
with IN O
musculus NN O
latissimus NN O
dorsi NN O
, , O
the DT O
axillary NN O
arch NN O
( -LRB- O
Achselbogen NN O
) -RRB- O
. . O

A DT O
small JJ O
area NN O
of IN O
overlapping VBG O
between IN O
the DT O
motor NN O
pools NNS O
of IN O
these DT O
two CD O
muscles NNS O
was VBD O
observed VBN O
. . O

It PRP O
was VBD O
suggested VBN O
that IN O
the DT O
muscular JJ O
fibers NNS O
from IN O
the DT O
axillary NN O
arch NN O
were VBD O
innervated VBN O
by IN O
the DT O
same JJ O
, , O
well RB O
- : O
defined VBN O
spinal JJ O
area NN O
, , O
independent JJ O
of IN O
the DT O
muscle NN O
from IN O
which WDT O
they PRP O
originate VBP O
. . O

-DOCSTART- X X O

An DT O
unusual JJ O
case NN O
of IN O
benign JJ O
mucous JJ O
membrane NN O
pemphigoid NN O
. . O

This DT O
case NN O
of IN O
benign JJ O
mucous JJ O
membrane NN O
pemphigoid NN O
( -LRB- O
BMMP NNP O
) -RRB- O
is VBZ O
unusual JJ O
in IN O
that DT O
blistering NN O
, , O
scarring VBG O
lesions NNS O
were VBD O
confined VBN O
to TO O
the DT O
skin NN O
for IN O
15 CD O
years NNS O
before IN O
mucous JJ O
membranes NNS O
were VBD O
involved VBN O
. . O

The DT O
onset NN O
of IN O
this DT O
disorder NN O
at IN O
the DT O
age NN O
of IN O
38 CD O
is VBZ O
also RB O
unusual JJ O
. . O

Detailed VBN O
immunological JJ O
investigation NN O
was VBD O
performed VBN O
on IN O
this DT O
patient NN O
but CC O
the DT O
results NNS O
in IN O
no DT O
way NN O
clarify VB O
the DT O
present JJ O
confusion NN O
regarding VBG O
the DT O
immunopathological JJ O
processes NNS O
in IN O
BMMP NNP O
related VBN O
to TO O
those DT O
operative JJ O
in IN O
bullous JJ O
pemphigoid NN O
. . O

-DOCSTART- X X O

Mast NNP O
cell NN O
heparin NN O
stimulates VBZ O
migration NN O
of IN O
capillary NN O
endothelial JJ O
cells NNS O
in IN O
vitro NN O
. . O

Migration NNP O
of IN O
capillary NN O
endothelial JJ O
cells NNS O
is VBZ O
an DT O
important JJ O
component NN O
of IN O
angiogenesis NN O
in IN O
vivo NN O
. . O

Increased VBN O
numbers NNS O
of IN O
mast NN O
cells NNS O
have VBP O
been VBN O
associated VBN O
with IN O
several JJ O
types NNS O
of IN O
angiogenesis NN O
. . O

We PRP O
have VBP O
used VBN O
a DT O
quantitative JJ O
assay NN O
in IN O
vitro NN O
to TO O
demonstrate VB O
that IN O
mast NN O
cells NNS O
release VBP O
a DT O
factor NN O
that WDT O
significantly RB O
increases VBZ O
bovine NN O
capillary NN O
endothelial JJ O
cell NN O
migration NN O
. . O

The DT O
factor NN O
is VBZ O
present JJ O
in IN O
medium NN O
conditioned VBN O
by IN O
mast NN O
cells NNS O
as RB O
well RB O
as IN O
lysates NNS O
of IN O
mast NN O
cells NNS O
. . O

The DT O
stimulatory JJ O
effect NN O
of IN O
mast NN O
cells NNS O
on IN O
migration NN O
is VBZ O
specific JJ O
for IN O
capillary NN O
endothelial JJ O
cells NNS O
. . O

Furthermore RB O
, , O
mast NN O
cells NNS O
have VBP O
no DT O
mitogenic JJ O
activity NN O
for IN O
capillary NN O
endothelial JJ O
cells NNS O
. . O

Of IN O
all PDT O
the DT O
secretory NN O
products NNS O
of IN O
mast NN O
cells NNS O
tested VBN O
, , O
only RB O
heparin IN O
stimulated VBN O
capillary NN O
endothelial NN O
cell NN O
migration NN O
in IN O
vitro NN O
. . O

Heparin NNP O
preparations NNS O
from IN O
a DT O
variety NN O
of IN O
sources NNS O
stimulated VBD O
capillary NN O
endothelial JJ O
cell NN O
migration NN O
to TO O
the DT O
same JJ O
degree NN O
but CC O
did VBD O
not RB O
stimulate VB O
migration NN O
of IN O
several JJ O
other JJ O
cell NN O
types NNS O
. . O

The DT O
migration NN O
activity NN O
of IN O
heparin NN O
and CC O
mast NN O
cell NN O
conditioned VBN O
medium NN O
was VBD O
blocked VBN O
by IN O
specific JJ O
antagonists NNS O
of IN O
heparin NN O
( -LRB- O
protamine NN O
and CC O
heparinase NN O
) -RRB- O
, , O
but CC O
not RB O
by IN O
chondroitinase NN O
ABC NNP O
. . O

The DT O
migration NN O
activity NN O
of IN O
mast NN O
cell NN O
conditioned VBN O
medium NN O
was VBD O
resistant JJ O
to TO O
heat NN O
( -LRB- O
100 CD O
degrees NNS O
C NN O
) -RRB- O
and CC O
incubation NN O
with IN O
proteolytic JJ O
enzymes NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
role NN O
of IN O
mast NN O
cells NNS O
in IN O
angiogenesis NN O
may MD O
be VB O
to TO O
enhance VB O
migration NN O
of IN O
the DT O
endothelial JJ O
cells NNS O
of IN O
growing VBG O
capillaries NNS O
. . O

-DOCSTART- X X O

The DT O
inhibition NN O
of IN O
cultured JJ O
myoblast JJ O
differentiation NN O
by IN O
the DT O
simian JJ O
virus NN O
40 CD O
large JJ O
T NNP O
antigen NN O
occurs VBZ O
after IN O
myogenin JJ O
expression NN O
and CC O
Rb VB O
up RP O
- : O
regulation NN O
and CC O
is VBZ O
not RB O
exerted VBN O
by IN O
transformation NN O
- : O
competent JJ O
cytoplasmic JJ O
mutants NNS O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
mechanism NN O
by IN O
which WDT O
the DT O
simian JJ O
virus NN O
40 CD O
large JJ O
T NNP O
antigen NN O
( -LRB- O
SVLT NNP O
) -RRB- O
interferes VBZ O
with IN O
the DT O
differentiation NN O
of IN O
C2 NNP B-NP
myoblasts NNS O
. . O

SVLT NNP O
mutants NNS O
, , O
defective JJ O
either CC O
in IN O
the DT O
Rb NNP O
binding NN O
site NN O
, , O
near IN O
the DT O
N NNP O
- : O
terminal JJ O
end NN O
, , O
in IN O
a DT O
region NN O
that WDT O
affects VBZ O
binding NN O
to TO O
p53 NN O
, , O
or CC O
in IN O
the DT O
nuclear JJ O
transport NN O
signal NN O
, , O
were VBD O
also RB O
employed VBN O
to TO O
determine VB O
whether IN O
the DT O
interference NN O
was VBD O
especially RB O
dependent JJ O
on IN O
these DT O
functional JJ O
domains NNS O
. . O

It PRP O
was VBD O
found VBN O
that IN O
wild JJ O
- : O
type NN O
( -LRB- O
wt NN O
) -RRB- O
SVLT NNP O
strongly RB O
inhibited VBD O
the DT O
terminal NN O
differentiation NN O
of IN O
mouse NN O
C2 IN B-NP
myoblasts NNS O
, , O
but CC O
this DT O
arrest NN O
occurred VBD O
only RB O
after IN O
the DT O
synthesis NN O
of IN O
myogenin NN O
, , O
an DT O
initial JJ O
step NN O
in IN O
biochemical JJ O
differentiation NN O
. . O

Neither CC O
the DT O
synthesis NN O
nor CC O
some DT O
basic JJ O
activities NNS O
of IN O
MyoD NNP O
appeared VBD O
to TO O
be VB O
affected VBN O
by IN O
wt JJ O
SVLT NNP O
. . O

In IN O
these DT O
transformants NNS O
, , O
mitogen NN O
depletion NN O
elicited VBD O
an DT O
increase NN O
in IN O
the DT O
Rb NN O
level NN O
comparable JJ O
to TO O
that DT O
in IN O
normal JJ O
C2 NN B-NP
cells NNS O
; : O
wt JJ O
SVLT NNP O
, , O
however RB O
, , O
promoted VBD O
the DT O
phosphorylation NN O
of IN O
a DT O
large JJ O
part NN O
of IN O
the DT O
induced JJ O
Rb NN O
. . O

Mutations NNS O
affecting VBG O
nuclear JJ O
transport NN O
were VBD O
far RB O
more RBR O
critical JJ O
for IN O
the DT O
ability NN O
to TO O
interfere VB O
with IN O
myogenic JJ O
differentiation NN O
than IN O
were VBD O
those DT O
affecting VBG O
the DT O
transforming JJ O
potential JJ O
; : O
cytoplasmic JJ O
SVLT JJ O
expression NN O
was VBD O
fully RB O
compatible JJ O
with IN O
the DT O
terminal NN O
differentiation NN O
of IN O
C2 NNP B-NP
cells NNS O
, , O
despite IN O
enabling VBG O
them PRP O
to TO O
grow VB O
in IN O
semisolid JJ O
medium NN O
, , O
thus RB O
showing VBG O
that IN O
the DT O
myogenesis NN O
- : O
inhibiting JJ O
property NN O
can MD O
be VB O
dissociated VBN O
from IN O
transforming VBG O
competence NN O
. . O

The DT O
remaining VBG O
SVLT NNP O
mutants NNS O
presented VBD O
different JJ O
degrees NNS O
of IN O
ability NN O
to TO O
inhibit VB O
differentiation NN O
( -LRB- O
as IN O
shown VBN O
by IN O
the DT O
expression NN O
of IN O
tissue NN O
- : O
specific JJ O
markers NNS O
in IN O
transformants NNS O
) -RRB- O
. . O

The DT O
inhibiting JJ O
mutants NNS O
, , O
including VBG O
the DT O
Rb NNP O
binding NN O
site NN O
mutant JJ O
, , O
were VBD O
able JJ O
to TO O
promote VB O
a DT O
higher JJR O
state NN O
of IN O
Rb NNP O
phosphorylation NN O
than IN O
that DT O
observed VBN O
in IN O
either DT O
normal JJ O
cells NNS O
or CC O
cytoplasmic JJ O
- : O
SVLT JJ O
transformants NNS O
. . O

-DOCSTART- X X O

A DT O
transcript NN O
from IN O
the DT O
long JJ O
terminal NN O
repeats NNS O
of IN O
a DT O
murine NN O
retrovirus NN O
associated VBN O
with IN O
trans NNS O
activation NN O
of IN O
cellular JJ O
genes NNS O
. . O

Infection NN O
of IN O
human JJ O
or CC O
murine JJ O
cells NNS O
with IN O
murine NN O
leukemia NN O
viruses NNS O
rapidly RB O
increases VBZ O
the DT O
expression NN O
of IN O
a DT O
number NN O
of IN O
genes NNS O
that WDT O
belong VBP O
to TO O
the DT O
immunoglobulin NN O
superfamily NN O
and CC O
are VBP O
involved VBN O
in IN O
T NNP O
- : O
lymphocyte NN O
activation NN O
, , O
including VBG O
the DT O
class NN O
I PRP O
major VBP O
histocompatibility NN O
complex JJ O
antigens NNS O
. . O

We PRP O
have VBP O
reported VBN O
recently RB O
that IN O
the DT O
long JJ O
terminal NN O
repeat NN O
( -LRB- O
LTR NNP O
) -RRB- O
of IN O
Moloney NNP O
murine NN O
leukemia NN O
virus NN O
encodes VBZ O
a DT O
trans NNS O
activator NN O
which WDT O
induces VBZ O
transcription NN O
and CC O
expression NN O
of IN O
class NN O
I PRP O
major VBP O
histocompatibility NN O
complex JJ O
genes NNS O
and CC O
certain JJ O
cytokine NN O
genes NNS O
. . O

The DT O
portion NN O
of IN O
the DT O
LTR NNP O
responsible JJ O
for IN O
trans NNS O
activation NN O
was VBD O
mapped VBN O
by IN O
deletions NNS O
to TO O
lie VB O
within IN O
the DT O
U3 JJ O
region NN O
. . O

We PRP O
demonstrate VBP O
here RB O
that IN O
a DT O
transcript NN O
is VBZ O
initiated VBN O
within IN O
the DT O
U3 JJ O
region NN O
and CC O
that DT O
its PRP$ O
presence NN O
correlates NNS O
with IN O
the DT O
trans NNS O
- : O
activating NN O
activity NN O
. . O

Analysis NN O
of IN O
the DT O
LTR NNP O
region NN O
reveals VBZ O
a DT O
potential JJ O
internal JJ O
promoter NN O
element NN O
for IN O
RNA NNP O
polymerase NN O
III NNP O
transcription NN O
within IN O
the DT O
U3 JJ O
region NN O
. . O

Studies NNS O
with IN O
polymerase NN O
inhibitors NNS O
suggest VBP O
that IN O
this DT O
LTR NNP O
transcript NN O
, , O
designated VBN O
let VB O
( -LRB- O
LTR VB O
- : O
encoded VBN O
trans NNS O
activator NN O
) -RRB- O
, , O
is VBZ O
a DT O
product NN O
of IN O
RNA NNP O
polymerase NN O
III NNP O
. . O

The DT O
mechanisms NNS O
whereby WRB O
RNA NNP O
leukemia NN O
viruses NNS O
cause VBP O
lymphoid JJ O
neoplasia NN O
after IN O
a DT O
long JJ O
latent JJ O
period NN O
have VBP O
been VBN O
extensively RB O
studied VBN O
but CC O
are VBP O
only RB O
partially RB O
understood VBN O
. . O

The DT O
region NN O
of IN O
the DT O
LTR NNP O
identified VBD O
here RB O
as IN O
being VBG O
important JJ O
in IN O
trans NNS O
activation NN O
has VBZ O
recently RB O
been VBN O
shown VBN O
to TO O
be VB O
a DT O
critical JJ O
determinant NN O
of IN O
the DT O
leukemogenicity NN O
and CC O
latency RB O
of IN O
Moloney NNP O
murine NN O
leukemia NN O
virus NN O
. . O

These DT O
findings NNS O
suggest VBP O
a DT O
novel NN O
mechanism NN O
of IN O
retrovirus NN O
- : O
induced JJ O
activation NN O
of IN O
cellular JJ O
gene NN O
expression NN O
, , O
potentially RB O
contributing VBG O
to TO O
leukemogenesis NN O
. . O

-DOCSTART- X X O

Cancer NNP O
progression NN O
and CC O
p53 NN O
. . O

In IN O
a DT O
complex JJ O
organism NN O
, , O
somatic JJ O
cells NNS O
are VBP O
under IN O
intermittent NN O
selection NN O
pressure NN O
for IN O
the DT O
emergence NN O
of IN O
mutants NNS O
that WDT O
can MD O
survive VB O
environmental JJ O
insults NNS O
and CC O
that DT O
can MD O
grow VB O
autonomously RB O
despite IN O
adverse JJ O
conditions NNS O
. . O

Repeated VBN O
rounds NNS O
of IN O
mutation NN O
, , O
selection NN O
, , O
and CC O
proliferation NN O
may MD O
lead VB O
to TO O
cancer NN O
. . O

The DT O
organism NN O
prevents VBZ O
malignant JJ O
transformation NN O
by IN O
assuring VBG O
accurate JJ O
DNA NN O
repair NN O
before IN O
cell NN O
division NN O
, , O
by IN O
forcing VBG O
the DT O
death NN O
of IN O
cells NNS O
with IN O
excessive JJ O
DNA NN O
damage NN O
, , O
and CC O
by IN O
placing VBG O
limits NNS O
on IN O
the DT O
replicative JJ O
lifespans NNS O
of IN O
most JJS O
somatic JJ O
cells NNS O
. . O

The DT O
p53 NN O
gene NN O
is VBZ O
a DT O
" `` O
guardian NN O
of IN O
the DT O
genome NN O
" `` O
- : O
- : O
it PRP O
regulates VBZ O
multiple JJ O
components NNS O
of IN O
the DT O
DNA NNP O
damage NN O
control NN O
response NN O
and CC O
promotes NNS O
cellular JJ O
senescence NN O
. . O

Disabling JJ O
mutations NNS O
and CC O
deletions NNS O
of IN O
p53 NN O
occur VBP O
in IN O
50 CD O
% NN O
of IN O
human JJ O
tumours NNS O
. . O

p53 NN O
- : O
deficient NN O
cancers NNS O
are VBP O
often RB O
unstable JJ O
, , O
aggressive JJ O
, , O
and CC O
resistant JJ O
to TO O
therapy NN O
. . O

-DOCSTART- X X O

Anti NNP O
- : O
transforming JJ O
growth NN O
factor NN O
( -LRB- O
TGF NN O
) -RRB- O
- : O
beta JJ O
antibodies NNS O
inhibit VBP O
breast NN O
cancer NN O
cell NN O
tumorigenicity NN O
and CC O
increase NN O
mouse NN O
spleen JJ O
natural JJ O
killer NN O
cell NN O
activity NN O
. . O

Implications NNS O
for IN O
a DT O
possible JJ O
role NN O
of IN O
tumor NN O
cell NN O
/ IN O
host NN O
TGF NN O
- : O
beta JJ O
interactions NNS O
in IN O
human JJ O
breast NN O
cancer NN O
progression NN O
. . O

TGF NN O
- : O
beta JJ O
effects NNS O
on IN O
angiogenesis NN O
, , O
stroma VBD O
formation NN O
, , O
and CC O
immune JJ O
function NN O
suggest VBP O
its PRP$ O
possible JJ O
involvement NN O
in IN O
tumor NN O
progression NN O
. . O

This DT O
hypothesis NN O
was VBD O
tested VBN O
using VBG O
the DT O
2G7 CD O
IgG2b NNP O
, , O
which WDT O
neutralizes VBZ O
TGF NNP O
- : O
beta NN O
1 CD O
, , O
- : O
beta NN O
2 CD O
, , O
and CC O
- : O
beta NN O
3 CD O
, , O
and CC O
the DT O
MDA NNP B-NP
- : I-NP
231 CD I-NP
human JJ O
breast NN O
cancer NN O
cell NN O
line NN O
. . O

Inoculation NN O
of IN O
these DT O
cells NNS O
in IN O
athymic JJ O
mice NNS O
decreases VBZ O
mouse NN O
spleen JJ O
natural JJ O
killer NN O
( -LRB- O
NK NNP O
) -RRB- O
cell NN O
activity NN O
. . O

Intraperitoneal NNP O
injections NNS O
of IN O
2G7 DT O
starting VBG O
1 CD O
d NN O
after IN O
intraperitoneal JJ O
inoculation NN O
of IN O
tumor NN O
cells NNS O
suppressed VBN O
intraabdominal JJ O
tumor NN O
and CC O
lung NN O
metastases NNS O
, , O
whereas IN O
the DT O
nonneutralizing JJ O
anti NNS O
- : O
TGF SYM O
- : O
beta JJ O
12H5 IN O
IgG2a NNP O
had VBD O
no DT O
effect NN O
. . O

2G7 DT O
transiently RB O
inhibited JJ O
growth NN O
of IN O
established VBN O
MDA NNP B-NP
- : I-NP
231 CD I-NP
subcutaneous JJ O
tumors NNS O
. . O

Histologically RB O
, , O
both DT O
2G7 FW O
- : O
treated VBN O
and CC O
control NN O
tumors NNS O
were VBD O
identical JJ O
. . O

Intraperitoneal NNP O
administration NN O
of IN O
2G7 CD O
resulted VBD O
in IN O
a DT O
marked JJ O
increase NN O
in IN O
mouse NN O
spleen NN O
NK NNP O
cell NN O
activity NN O
. . O

2G7 PRP O
did VBD O
not RB O
inhibit VB O
MDA NNP B-NP
- : I-NP
231 CD I-NP
primary JJ O
tumor NN O
or CC O
metastases NNS O
formation NN O
, , O
nor CC O
did VBD O
it PRP O
stimulate VB O
NK NNP O
cell NN O
- : O
mediated JJ O
cytotoxicity NN O
in IN O
beige JJ O
NK NNP O
- : O
deficient JJ O
nude JJ O
mice NNS O
. . O

Finally RB O
, , O
serum NN O
- : O
free JJ O
conditioned JJ O
medium NN O
from IN O
MDA NNP B-NP
- : I-NP
231 CD I-NP
cells NNS O
inhibited VBN O
the DT O
NK NNP O
cell NN O
activity NN O
of IN O
human JJ O
blood NN O
lymphocytes NNS O
. . O

This DT O
inhibition NN O
was VBD O
blocked VBN O
by IN O
the DT O
neutralizing JJ O
anti NNS O
- : O
TGF SYM O
- : O
beta JJ O
2G7 IN O
antibody NN O
but CC O
not RB O
by IN O
a DT O
nonspecific JJ O
IgG2 NN O
. . O

These DT O
data NNS O
support VBP O
a DT O
possible JJ O
role NN O
for IN O
tumor NN O
cell NN O
TGF NN O
- : O
beta NN O
in IN O
the DT O
progression NN O
of IN O
mammary JJ O
carcinomas NNS O
by IN O
suppressing VBG O
host NN O
immune JJ O
surveillance NN O
. . O

-DOCSTART- X X O

The DT O
Met NNP O
proto NN O
- : O
oncogene NN O
mesenchymal NN O
to TO O
epithelial JJ O
cell NN O
conversion NN O
. . O

Coexpression NN O
of IN O
the DT O
human JJ O
Met NNP O
receptor NN O
and CC O
its PRP$ O
ligand NN O
, , O
hepatocyte NN O
growth NN O
factor NN O
/ VBD O
scatter JJ O
factor NN O
( -LRB- O
HGF NNP O
/ NN O
SF NNP O
) -RRB- O
, , O
in IN O
NIH NNP B-NP
3T3 CD I-NP
fibroblasts NNS O
causes VBZ O
the DT O
cells NNS O
to TO O
become VB O
tumorigenic JJ O
in IN O
nude JJ O
mice NNS O
. . O

The DT O
resultant NN O
tumors NNS O
display VBP O
lumen VBN O
- : O
like IN O
morphology NN O
, , O
contain VB O
carcinoma NN O
- : O
like IN O
focal JJ O
areas NNS O
with IN O
intercellular JJ O
junctions NNS O
resembling VBG O
desmosomes NNS O
, , O
and CC O
coexpress NN O
epithelial NN O
( -LRB- O
cytokeratin NN O
) -RRB- O
and CC O
mesenchymal JJ O
( -LRB- O
vimentin NN O
) -RRB- O
cytoskeletal NN O
markers NNS O
. . O

The DT O
tumor NN O
cells NNS O
also RB O
display VBP O
enhanced JJ O
expression NN O
of IN O
desmosomal JJ O
and CC O
tight JJ O
- : O
junction NN O
proteins NNS O
. . O

The DT O
apparent JJ O
mesenchymal NN O
to TO O
epithelial JJ O
conversion NN O
of IN O
the DT O
tumor NN O
cells NNS O
mimics NNS O
the DT O
conversion NN O
that WDT O
occurs VBZ O
during IN O
embryonic JJ O
kidney NN O
development NN O
, , O
suggesting VBG O
that IN O
Met NNP O
- : O
HGF NNP O
/ NNP O
SF NNP O
signaling VBG O
plays VBZ O
a DT O
role NN O
in IN O
this DT O
process NN O
as RB O
well RB O
as IN O
in IN O
tumors NNS O
that WDT O
express VBP O
both DT O
epithelial NN O
and CC O
mesenchymal NN O
markers NNS O
. . O

-DOCSTART- X X O

Additional JJ O
tests NNS O
of IN O
interest NN O
to TO O
the DT O
dermatologist NN O
. . O

The DT O
carcinoid JJ O
syndrome NN O
and CC O
its PRP$ O
clinical JJ O
manifestations NNS O
have VBP O
been VBN O
discussed VBN O
. . O

The DT O
standard JJ O
laboratory NN O
test NN O
for IN O
making VBG O
that DT O
diagnosis NN O
is VBZ O
urinary JJ O
5 CD O
- : O
HIAA NN O
levels NNS O
but CC O
newer JJR O
, , O
more RBR O
sensitive JJ O
tests NNS O
may MD O
also RB O
be VB O
available JJ O
. . O

-DOCSTART- X X O

Molecular JJ O
mediators NNS O
of IN O
interactions NNS O
with IN O
extracellular JJ O
matrix NN O
components NNS O
in IN O
metastasis NN O
and CC O
angiogenesis NN O
. . O

Metastasis NNP O
and CC O
tumor NN O
angiogenesis NN O
are VBP O
invasive JJ O
phenomena NNS O
and CC O
share NN O
many JJ O
common JJ O
properties NNS O
at IN O
the DT O
physiological JJ O
level NN O
and CC O
some DT O
similarities NNS O
at IN O
the DT O
molecular JJ O
level NN O
. . O

Each DT O
consists VBZ O
of IN O
repetitive JJ O
cycles NNS O
of IN O
interaction NN O
with IN O
adjacent JJ O
extracellular JJ O
matrix NN O
components NNS O
by IN O
mediating JJ O
cellular JJ O
adhesion NN O
, , O
matrix NN O
dissolution NN O
, , O
and CC O
cellular JJ O
motility NN O
to TO O
achieve VB O
metastasis NN O
of IN O
cancer NN O
cells NNS O
or CC O
neovascularization NN O
of IN O
tumors NNS O
. . O

Molecular JJ O
factors NNS O
which WDT O
implement VB O
this DT O
triad NN O
of IN O
events NNS O
are VBP O
reviewed VBN O
, , O
as RB O
are VBP O
several JJ O
signal NN O
transduction NN O
components NNS O
which WDT O
may MD O
regulate VB O
them PRP O
. . O

Some DT O
potentially RB O
promising JJ O
prognostic NN O
, , O
diagnostic JJ O
, , O
and CC O
therapeutic JJ O
modalities NNS O
for IN O
tumor NN O
angiogenesis NN O
and CC O
metastatic JJ O
disease NN O
are VBP O
also RB O
discussed VBN O
. . O

-DOCSTART- X X O

Enhanced JJ O
DNA NNP O
- : O
binding JJ O
activity NN O
of IN O
a DT O
Stat3 JJ O
- : O
related JJ O
protein NN O
in IN O
cells NNS O
transformed VBN O
by IN O
the DT O
Src NNP O
oncoprotein NNP O
. . O

Cytokines NNS O
and CC O
growth NN O
factors NNS O
induce VB O
tyrosine NN O
phosphorylation NN O
of IN O
signal NN O
transducers NNS O
and CC O
activators NNS O
of IN O
transcription NN O
( -LRB- O
STATs NNP O
) -RRB- O
that WDT O
directly RB O
activate VBP O
gene NN O
expression NN O
. . O

Cells NNP O
stably NN O
transformed VBN O
by IN O
the DT O
Src NNP O
oncogene NNP O
tyrosine FW O
kinase NN O
were VBD O
examined VBN O
for IN O
STAT NNP O
protein NN O
activation NN O
. . O

Assays NNP O
of IN O
electrophoretic JJ O
mobility NN O
, , O
DNA NNP O
- : O
binding JJ O
specificity NN O
, , O
and CC O
antigenicity NN O
indicated VBD O
that IN O
Stat3 NNP O
or CC O
a DT O
closely RB O
related VBN O
STAT NNP O
family NN O
member NN O
was VBD O
constitutively RB O
activated VBN O
by IN O
the DT O
Src NNP O
oncoprotein NNP O
. . O

Induction NN O
of IN O
this DT O
DNA NN O
- : O
binding JJ O
activity NN O
was VBD O
accompanied VBN O
by IN O
tyrosine NN O
phosphorylation NN O
of IN O
Stat3 NNP O
and CC O
correlated VBN O
with IN O
Src NNP O
transformation NN O
. . O

These DT O
findings NNS O
demonstrate VBP O
that IN O
Src NNP O
can MD O
activate VB O
STAT NNP O
signaling VBG O
pathways NNS O
and CC O
raise VB O
the DT O
possibility NN O
that IN O
Stat3 NNP O
contributes VBZ O
to TO O
oncogenesis VB O
by IN O
Src NNP O
. . O

-DOCSTART- X X O

Ultraviolet NNP O
B NNP O
irradiation NN O
promotes NNS O
tumorigenic JJ O
and CC O
metastatic JJ O
properties NNS O
in IN O
primary JJ O
cutaneous JJ O
melanoma NN O
via IN O
induction NN O
of IN O
interleukin JJ O
8 CD O
. . O

UV NN O
radiation NN O
has VBZ O
been VBN O
shown VBN O
to TO O
play VB O
a DT O
role NN O
in IN O
the DT O
initiation NN O
of IN O
human JJ O
cutaneous JJ O
melanoma NN O
, , O
but CC O
its PRP$ O
role NN O
in IN O
the DT O
development NN O
of IN O
malignant JJ O
melanoma NN O
to TO O
the DT O
metastatic JJ O
state NN O
is VBZ O
not RB O
very RB O
well RB O
defined VBN O
. . O

Although IN O
previous JJ O
studies NNS O
have VBP O
concentrated VBN O
on IN O
the DT O
effect NN O
of IN O
UV NN O
- : O
B NN O
on IN O
the DT O
host NN O
immune JJ O
response NN O
, , O
the DT O
effect NN O
of IN O
UV NN O
- : O
B NN O
on IN O
the DT O
tumor NN O
cells NNS O
was VBD O
not RB O
elucidated VBN O
. . O

Here RB O
we PRP O
show VBP O
that IN O
UV NN O
- : O
B NNP O
can MD O
induce VB O
interleukin JJ O
8 CD O
( -LRB- O
IL NN O
- : O
8 CD O
) -RRB- O
mRNA NN O
and CC O
protein NN O
secretion NN O
in IN O
human JJ O
cutaneous JJ O
melanoma NN O
with IN O
negligible JJ O
expression NN O
of IN O
IL NNP O
- : O
8 CD O
. . O

UV NN O
- : O
B LS O
- : O
induced JJ O
IL NN O
- : O
8 CD O
was VBD O
constitutively RB O
expressed VBN O
60 CD O
days NNS O
after IN O
irradiation NN O
in IN O
tumors NNS O
implanted VBN O
in IN O
mice NNS O
. . O

Induction NN O
of IN O
IL NNP O
- : O
8 CD O
was VBD O
UV NN O
- : O
B NNP O
dose NN O
dependent JJ O
and CC O
blocked VBN O
by IN O
cyclohexamide NN O
, , O
indicating VBG O
that IN O
de FW O
novo FW O
protein NN O
synthesis NN O
is VBZ O
required VBN O
for IN O
its PRP$ O
expression NN O
. . O

The DT O
UV NN O
- : O
irradiated JJ O
cells NNS O
demonstrated VBN O
enhanced JJ O
tumorigenicity NN O
and CC O
metastatic JJ O
potential NN O
in IN O
nude JJ O
mice NNS O
. . O

The DT O
increase NN O
in IN O
tumorigenicity NN O
and CC O
metastatic JJ O
ability NN O
could MD O
be VB O
explained VBN O
by IN O
the DT O
increase NN O
in IN O
Mr NNP O
72 CD O
, , O
000 CD O
type NN O
IV NNP O
collagenase NN O
activity NN O
and CC O
angiogenesis NN O
attributed VBD O
to TO O
the DT O
induction NN O
of IN O
IL NNP O
- : O
8 CD O
after IN O
irradiation NN O
. . O

The DT O
acquisition NN O
of IN O
the DT O
metastatic JJ O
phenotype NN O
induced VBN O
by IN O
UV NN O
- : O
B NNP O
could MD O
not RB O
be VB O
attributed VBN O
to TO O
abnormalities NNS O
in IN O
the DT O
p53 NN O
or CC O
MTS NNS O
- : O
1 CD O
( -LRB- O
p16INK4 NN O
) -RRB- O
genes NNS O
. . O

To TO O
the DT O
best JJS O
of IN O
our PRP$ O
knowledge NN O
, , O
this DT O
is VBZ O
the DT O
first JJ O
report NN O
to TO O
show VB O
that IN O
UV NN O
- : O
B NN O
can MD O
increase VB O
the DT O
aggressiveness NN O
of IN O
human JJ O
cutaneous JJ O
melanoma NN O
for IN O
growth NN O
and CC O
metastasis NN O
. . O

-DOCSTART- X X O

Suppressed VBN O
transformation NN O
and CC O
induced JJ O
differentiation NN O
of IN O
HER NNP O
- : O
2 CD O
/ NN O
neu FW O
- : O
overexpressing JJ O
breast NN O
cancer NN O
cells NNS O
by IN O
emodin NN O
. . O

The DT O
amplification NN O
and CC O
overexpression NN O
of IN O
the DT O
HER NNP O
- : O
2 CD O
/ NN O
neu NN O
proto NN O
- : O
oncogene NN O
, , O
which WDT O
encodes VBZ O
the DT O
tyrosine NN O
kinase NN O
receptor NN O
p185neu NN O
, , O
have VBP O
been VBN O
observed VBN O
frequently RB O
in IN O
tumors NNS O
from IN O
human JJ O
breast NN O
cancer NN O
patients NNS O
and CC O
are VBP O
correlated VBN O
with IN O
poor JJ O
prognosis NN O
. . O

To TO O
explore VB O
the DT O
potential NN O
of IN O
chemotherapy NN O
directed VBN O
at IN O
the DT O
tyrosine NN O
kinase NN O
of IN O
p185neu NN O
, , O
we PRP O
have VBP O
found VBN O
that IN O
emodin NN O
( -LRB- O
3 LS O
- : O
methyl NN O
- : O
1 CD O
, , O
6 CD O
, , O
8 CD O
- : O
trihydroxyanthraquinone NN O
) -RRB- O
, , O
a DT O
tyrosine NN O
kinase NN O
inhibitor NN O
, , O
suppresses NNS O
autophosphorylation NN O
and CC O
transphosphorylation NN O
activities NNS O
of IN O
HER NNP O
- : O
2 CD O
/ NN O
neu NN O
tyrosine NN O
kinase NN O
, , O
resulting VBG O
in IN O
tyrosine NN O
hypophosphorylation NN O
of IN O
p185neu NN O
in IN O
HER NNP O
- : O
2 CD O
/ NN O
neu FW O
- : O
overexpressing JJ O
breast NN O
cancer NN O
cells NNS O
. . O

Emodin NNP O
, , O
at IN O
a DT O
40 CD O
- : O
microM JJ O
concentration NN O
, , O
which WDT O
repressed VBD O
tyrosine NN O
kinase NN O
of IN O
p185neu NN O
, , O
efficiently RB O
inhibited VBD O
both DT O
anchorage NN O
- : O
dependent JJ O
and CC O
anchorage JJ O
- : O
independent JJ O
growth NN O
of IN O
HER NNP O
- : O
2 CD O
/ NN O
neu FW O
- : O
overexpressing JJ O
breast NN O
cancer NN O
cells NNS O
. . O

However RB O
, , O
the DT O
inhibition NN O
was VBD O
much RB O
less RBR O
effective JJ O
for IN O
those DT O
cells NNS O
expressing VBG O
basal JJ O
levels NNS O
of IN O
p185neu NN O
under IN O
the DT O
same JJ O
conditions NNS O
. . O

Emodin NNP O
also RB O
induced VBD O
differentiation NN O
of IN O
HER NNP O
- : O
2 CD O
/ NN O
neu FW O
- : O
overexpressing JJ O
breast NN O
cancer NN O
cells NNS O
by IN O
exhibiting VBG O
a DT O
morphological JJ O
maturation NN O
property NN O
of IN O
large JJ O
lacy NN O
nuclei NNS O
surrounded VBN O
by IN O
sizable JJ O
flat JJ O
cytoplasm NN O
and CC O
by IN O
showing VBG O
a DT O
measurable JJ O
production NN O
of IN O
large JJ O
lipid JJ O
droplets NNS O
, , O
which WDT O
is VBZ O
a DT O
marker NN O
of IN O
mature JJ O
breast NN O
cells NNS O
. . O

Therefore RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
emodin NN O
inhibits VBZ O
HER NNP O
- : O
2 CD O
/ NN O
neu NN O
tyrosine NN O
kinase NN O
activity NN O
and CC O
preferentially RB O
suppresses NNS O
growth NN O
and CC O
induces VBZ O
differentiation NN O
of IN O
HER NNP O
- : O
2 CD O
/ NN O
neu NN O
- : O
overexpressing JJ O
cancer NN O
cells NNS O
. . O

These DT O
results NNS O
may MD O
have VB O
chemotherapeutic JJ O
implications NNS O
for IN O
using VBG O
emodin NN O
to TO O
target VB O
HER NNP O
- : O
2 CD O
/ NN O
neu NN O
- : O
overexpressing JJ O
cancer NN O
cells NNS O
. . O

-DOCSTART- X X O

The DT O
LHRH NNP O
pulse NN O
generator NN O
: : O
a DT O
mediobasal JJ O
hypothalamic JJ O
location NN O
. . O

The DT O
location NN O
and CC O
mechanism NN O
of IN O
LHRH NNP O
pulse NN O
generator NN O
are VBP O
discussed VBN O
based VBN O
on IN O
our PRP$ O
series NN O
of IN O
experiments NNS O
. . O

Suckling JJ O
stimulus NN O
is VBZ O
a DT O
novel JJ O
stimulus NN O
that IN O
inhibits VBZ O
LH NNP O
pulses NNS O
without IN O
any DT O
cooperation NN O
from IN O
ovarian JJ O
steroids NNS O
, , O
unlike IN O
other JJ O
stimuli NNS O
such JJ O
as IN O
stress NN O
, , O
photoperiod NN O
etc NN O
. . O

It PRP O
is VBZ O
directly RB O
involved VBN O
in IN O
suppressing VBG O
the DT O
activity NN O
of IN O
the DT O
LHRH NNP O
pulse NN O
generator NN O
. . O

The DT O
information NN O
from IN O
teats NNS O
suckled VBN O
by IN O
pups NNS O
or CC O
babies NNS O
is VBZ O
conveyed VBN O
dorsally RB O
to TO O
the DT O
mediobasal JJ O
hypothalamus NN O
( -LRB- O
MBH NNP O
) -RRB- O
, , O
where WRB O
the DT O
LHRH NNP O
pulse NN O
generator NN O
may MD O
be VB O
located VBN O
. . O

Experiments NNS O
using VBG O
various JJ O
types NNS O
of IN O
deafferentation NN O
and CC O
fetal JJ O
brain NN O
tissue NN O
transplantation NN O
confirmed VBD O
that IN O
the DT O
LHRH NNP O
pulse NN O
generator NN O
is VBZ O
located VBN O
in IN O
the DT O
MBH NNP O
and CC O
suggested VBD O
that IN O
LHRH NNP O
pulse NN O
generator NN O
consists VBZ O
of IN O
nonLHRH JJ O
neurons NNS O
. . O

Endogenous JJ O
excitatory NN O
amino IN O
acid NN O
is VBZ O
one CD O
of IN O
the DT O
possible JJ O
neurotransmitters NNS O
that IN O
regulate VB O
LHRH NNP O
release NN O
at IN O
the DT O
nerve NN O
terminal NN O
in IN O
ME NNP O
. . O

-DOCSTART- X X O

Bicistronic NNP O
retroviral NN O
vector NN O
reveals VBZ O
capacity NN O
of IN O
v FW O
- : O
erbA NN O
to TO O
induce VB O
erythroleukemia NN O
and CC O
to TO O
co VB O
- : O
operate VB O
with IN O
v FW O
- : O
myb NN O
. . O

Previous JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
v FW O
- : O
erbA NN O
and CC O
v NN O
- : O
myb NN O
can MD O
induce VB O
the DT O
proliferation NN O
of IN O
avian JJ O
erythroid JJ O
cells NNS O
in IN O
culture NN O
. . O

To TO O
study VB O
the DT O
combined VBN O
effects NNS O
of IN O
v NN O
- : O
erbA NN O
and CC O
v NN O
- : O
myb NN O
, , O
the DT O
two CD O
oncogenes NNS O
were VBD O
engineered VBN O
into IN O
a DT O
retrovirus NN O
bicistronic NN O
vector NN O
with IN O
an DT O
internal JJ O
ribosomal JJ O
entry NN O
site NN O
( -LRB- O
IRES NNP O
) -RRB- O
or CC O
into IN O
a DT O
vector NN O
with IN O
a DT O
splice NN O
acceptor NN O
( -LRB- O
SPL NNP O
) -RRB- O
. . O

This DT O
allowed VBD O
coexpression NN O
of IN O
the DT O
two CD O
proteins NNS O
and CC O
a DT O
comparison NN O
with IN O
the DT O
same JJ O
vector NN O
containing VBG O
either CC O
v FW O
- : O
erbA NN O
or CC O
v FW O
- : O
myb NN O
only RB O
. . O

Both DT O
the DT O
erbA NN O
IRES NNP O
and CC O
the DT O
erbA NN O
/ NN O
myb VBD O
IRES NNP O
virus NN O
constructs NNS O
transformed VBN O
erythroid JJ O
cells NNS O
after IN O
infection NN O
of IN O
bone NN O
marrow NN O
or CC O
blastoderm NN O
cultures NNS O
. . O

The DT O
erbA JJ O
/ NN O
myb VBD O
IRES NNP O
virus NN O
exhibited VBD O
a DT O
5 CD O
- : O
10 CD O
- : O
fold NN O
higher JJR O
transformed VBN O
colony NN O
forming VBG O
efficiency NN O
than IN O
the DT O
erbA NN O
IRES NNP O
virus NN O
in IN O
the DT O
blastoderm NN O
assay NN O
. . O

Surprisingly RB O
, , O
when WRB O
injected VBN O
into IN O
chicken NN O
embryos NNS O
in IN O
the DT O
presence NN O
of IN O
helper NN O
virus NN O
, , O
both DT O
viruses NNS O
induced VBD O
an DT O
erythroleukemia NN O
in IN O
about IN O
half NN O
of IN O
the DT O
animals NNS O
. . O

In IN O
contrast NN O
, , O
no DT O
leukemia NN O
was VBD O
observed VBN O
with IN O
a DT O
myb JJ O
IRES NNP O
virus NN O
, , O
with IN O
spliced VBN O
vectors NNS O
containing VBG O
v FW O
- : O
erbA NNS O
alone RB O
or CC O
v FW O
- : O
erbA NN O
in IN O
combination NN O
with IN O
v FW O
- : O
myb NN O
, , O
nor CC O
with IN O
erbA DT O
IRES NNP O
and CC O
erbA DT O
/ NN O
myb NN O
IRES NNP O
viruses VBZ O
produced VBN O
in IN O
the DT O
absence NN O
of IN O
helper NN O
virus NN O
. . O

The DT O
average JJ O
latency NN O
of IN O
leukemia NN O
induction NN O
was VBD O
shorter JJR O
for IN O
the DT O
erbA NN O
/ NN O
myb VBD O
IRES NNP O
virus NN O
( -LRB- O
3 CD O
. . O
5 CD O
weeks NNS O
) -RRB- O
than IN O
for IN O
the DT O
erbA NN O
IRES NNP O
virus NN O
( -LRB- O
5 CD O
weeks NNS O
) -RRB- O
. . O

Nevertheless RB O
, , O
for IN O
both DT O
viruses NNS O
the DT O
leukemic JJ O
blasts NNS O
retained VBD O
full JJ O
factor NN O
dependence NN O
for IN O
growth NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
v FW O
- : O
erbA NN O
is VBZ O
capable JJ O
of IN O
inducing VBG O
an DT O
erythroleukemia NN O
when WRB O
expressed VBN O
by IN O
a DT O
high JJ O
titer NN O
bicistronic NN O
retrovirus NN O
under IN O
conditions NNS O
of IN O
virus NN O
spreading VBG O
and CC O
that IN O
its PRP$ O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
transforming NN O
potential NN O
can MD O
be VB O
enhanced VBN O
by IN O
v FW O
- : O
myb NN O
. . O

-DOCSTART- X X O

Cancer NNP O
metastasis NN O
: : O
negative JJ O
regulation NN O
by IN O
an DT O
invasion NN O
- : O
suppressor NN O
complex NN O
. . O

Invasion NN O
is VBZ O
the DT O
hallmark NN O
of IN O
tumor NN O
malignancy NN O
. . O

We PRP O
situate VBP O
invasion NN O
within IN O
microecosystems NNS O
comprising VBG O
neoplastic JJ O
cells NNS O
as RB O
well RB O
as IN O
host NN O
cells NNS O
. . O

Modulation NNP O
of IN O
invasion NN O
within IN O
such JJ O
systems NNS O
is VBZ O
ascribed VBN O
to TO O
balances NNS O
between IN O
promoter NN O
and CC O
suppressor NN O
pathways NNS O
. . O

The DT O
E NNP O
- : O
cadherin NN O
/ NN O
alpha NN O
- : O
, , O
beta JJ O
- : O
, , O
gamma NNP O
- : O
catenin NN O
complex NN O
has VBZ O
an DT O
invasion NN O
- : O
suppressor NN O
function NN O
as IN O
evidenced VBN O
by IN O
transfections NNS O
either CC O
with IN O
sense NN O
cDNA NNS O
encoding VBG O
these DT O
molecules NNS O
or CC O
with IN O
antisense JJ O
cDNA NN O
inhibiting VBG O
their PRP$ O
expression NN O
. . O

Loss NN O
of IN O
heterozygosity NN O
at IN O
the DT O
E NNP O
- : O
Cadherin NNP O
( -LRB- O
uvo NN O
) -RRB- O
locus NN O
has VBZ O
been VBN O
reported VBN O
, , O
but CC O
mutations NNS O
in IN O
the DT O
E NNP O
- : O
cadherin NN O
gene NN O
seem VBP O
to TO O
be VB O
rare JJ O
. . O

Downregulation NN O
of IN O
E NNP O
- : O
cadherin NN O
occurred VBD O
at IN O
the DT O
level NN O
of IN O
transcription NN O
or CC O
of IN O
mRNA JJ O
stability NN O
. . O

Ex NNP O
vivo JJ O
cultures NNS O
from IN O
invasive JJ O
tumors NNS O
or CC O
metastases NNS O
produced VBD O
cells NNS O
that WDT O
were VBD O
homogeneously RB O
E NNP O
- : O
cadherin NN O
- : O
positive JJ O
and CC O
noninvasive JJ O
in IN O
vitro NN O
. . O

These DT O
observations NNS O
have VBP O
led VBN O
to TO O
the DT O
idea NN O
that IN O
factors NNS O
in IN O
the DT O
host NN O
downmodulate IN O
the DT O
E NNP O
- : O
cadherin NN O
complex NN O
and CC O
promote VB O
invasion NN O
most RBS O
probably RB O
in IN O
a DT O
transient JJ O
way NN O
. . O

-DOCSTART- X X O

VEGF165 CD O
expressed VBN O
by IN O
a DT O
replication NN O
- : O
deficient JJ O
recombinant JJ O
adenovirus NN O
vector NN O
induces VBZ O
angiogenesis NN O
in IN O
vivo NN O
. . O

To TO O
evaluate VB O
the DT O
concept NN O
that IN O
localized JJ O
delivery NN O
of IN O
angiogenic JJ O
factors NNS O
via IN O
virus NN O
- : O
mediated VBN O
gene NN O
transfer NN O
may MD O
be VB O
useful JJ O
in IN O
the DT O
treatment NN O
of IN O
ischemic JJ O
disorders NNS O
, , O
the DT O
replication NN O
- : O
deficient NN O
adenovirus NN O
( -LRB- O
Ad NN O
) -RRB- O
vector NN O
AdCMV NNP O
. . O
VEGF165 CD O
( -LRB- O
where WRB O
CMV NNP O
is VBZ O
cytomegalovirus JJ O
and CC O
VEGF NNP O
is VBZ O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
) -RRB- O
containing VBG O
the DT O
cDNA NN O
for IN O
human JJ O
VEGF165 CD O
, , O
a DT O
secreted VBN O
endothelial NN O
cell NN O
- : O
specific JJ O
angiogenic JJ O
growth NN O
factor NN O
, , O
was VBD O
constructed VBN O
. . O

Human JJ O
umbilical JJ O
vein NN O
endothelial NN O
cells NNS O
( -LRB- O
HUVECs NNS O
) -RRB- O
and CC O
rat VB O
aorta DT O
smooth JJ O
muscle NN O
cells NNS O
( -LRB- O
RASMCs NNS O
) -RRB- O
infected VBN O
with IN O
AdCMV NNP O
. . O
VEGF165 CD O
( -LRB- O
5 CD O
and CC O
20 CD O
plaque NN O
- : O
forming VBG O
units NNS O
[ IN O
pfu NN O
] SYM O
per FW O
cell NN O
) -RRB- O
demonstrated VBN O
VEGF IN O
mRNA JJ O
expression NN O
and CC O
protein NN O
secretion NN O
into IN O
the DT O
supernatant NN O
. . O

Furthermore RB O
, , O
the DT O
conditioned JJ O
medium NN O
from IN O
these DT O
cells NNS O
enhanced VBN O
vascular JJ O
permeability NN O
in IN O
vivo NN O
. . O

In IN O
contrast NN O
, , O
neither DT O
VEGF NNP O
mRNA NN O
nor CC O
secreted JJ O
protein NN O
was VBD O
found VBN O
in IN O
uninfected JJ O
HUVECs NNP O
or CC O
RASMCs NNP O
or CC O
in IN O
cells NNS O
infected VBN O
with IN O
the DT O
control NN O
vector NN O
AdCMV NNP O
. . O
beta NN O
gal NN O
( -LRB- O
where WRB O
beta JJ O
gal NN O
is VBZ O
beta JJ O
- : O
galactosidase NN O
) -RRB- O
. . O

Assessment NNP O
of IN O
starved JJ O
HUVECs NNS O
at IN O
14 CD O
days NNS O
demonstrated VBD O
sixfold RB O
more JJR O
cells NNS O
for IN O
AdCMV NNP O
. . O
VEGF165 CD O
- : O
infected JJ O
HUVECs NNS O
( -LRB- O
20 CD O
pfu NN O
per IN O
cell NN O
) -RRB- O
than IN O
for IN O
either DT O
infected JJ O
or CC O
uninfected JJ O
control NN O
cells NNS O
. . O

RASMC NNP O
proliferation NN O
was VBD O
unaffected JJ O
by IN O
infection NN O
with IN O
AdCMV NNP O
. . O
VEGF165 '' O
. . O

When WRB O
plated VBN O
in IN O
2 CD O
% NN O
serum NN O
on IN O
dishes NNS O
precoated VBN O
with IN O
reconstituted JJ O
basement NN O
membrane NN O
( -LRB- O
Matrigel NNP O
) -RRB- O
, , O
HUVECs NNP O
infected VBD O
with IN O
AdCMV NNP O
. . O
VEGF165 CD O
( -LRB- O
20 CD O
pfu NN O
per IN O
cell NN O
) -RRB- O
differentiated VBZ O
into IN O
capillary NN O
- : O
like IN O
structures NNS O
. . O

Under IN O
similar JJ O
conditions NNS O
, , O
both DT O
uninfected JJ O
HUVECs NNP O
and CC O
HUVECs NNP O
infected VBD O
with IN O
AdCMV NNP O
. . O
beta NN O
gal NN O
did VBD O
not RB O
differentiate JJ O
. . O

To TO O
evaluate VB O
the DT O
ability NN O
of IN O
AdCMV NNP O
. . O
VEGF165 '' O
to TO O
function VB O
in IN O
vivo NN O
, , O
either CC O
AdCMV NNP O
. . O

VEGF165 CD O
or CC O
AdCMV NNP O
. . O
beta NN O
gal NN O
( -LRB- O
2 CD O
x NN O
10 CD O
( -LRB- O
10 CD O
) -RRB- O
pfu NN O
) -RRB- O
was VBD O
resuspended VBN O
in IN O
0 CD O
. . O
5 CD O
mL NN O
Matrigel NNP O
and CC O
injected VBD O
subcutaneously RB O
into IN O
mice NNS O
. . O

Immunohistochemical NNP O
staining NN O
demonstrated VBD O
VEGF NNP O
in IN O
the DT O
tissues NNS O
surrounding VBG O
the DT O
Matrigel NNP O
plugs NNS O
containing VBG O
AdCMV NNP O
. . O
VEGF165 PRP O
up RP O
to TO O
3 CD O
weeks NNS O
after IN O
injection NN O
, , O
whereas IN O
no DT O
VEGF NN O
was VBD O
found VBN O
in IN O
the DT O
control NN O
plugs NNS O
with IN O
AdCMV NNP O
. . O
beta NN O
gal NN O
. . O

Two CD O
weeks NNS O
after IN O
injection NN O
, , O
there EX O
was VBD O
histological JJ O
evidence NN O
of IN O
neovascularization NN O
in IN O
the DT O
tissues NNS O
surrounding VBG O
the DT O
Matrigel NNP O
containing VBG O
AdCMV NNP O
. . O
VEGF165 CD O
, , O
whereas IN O
no DT O
significant JJ O
angiogenesis NN O
was VBD O
observed VBN O
in IN O
response NN O
to TO O
AdCMV NNP O
. . O
beta NN O
gal NN O
. . O

Furthermore RB O
, , O
the DT O
Matrigel NNP O
plugs NNS O
with IN O
AdCMV NNP O
. . O
VEGF165 CD O
demonstrated VBD O
hemoglobin NN O
content NN O
fourfold RB O
higher JJR O
than IN O
the DT O
plugs NNS O
with IN O
AdCMV NNP O
. . O
beta NN O
gal NN O
. . O

Together RB O
, , O
these DT O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
studies NNS O
are VBP O
consistent JJ O
with IN O
the DT O
concept NN O
that IN O
Ad NN O
vectors NNS O
may MD O
provide VB O
a DT O
useful JJ O
strategy NN O
for IN O
efficient JJ O
local JJ O
delivery NN O
of IN O
VEGF165 CD O
in IN O
the DT O
treatment NN O
of IN O
ischemic JJ O
diseases NNS O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
NAB1 NNP O
, , O
a DT O
repressor NN O
of IN O
NGFI NNP O
- : O
A DT O
- : O
and CC O
Krox20 NNP O
- : O
mediated JJ O
transcription NN O
. . O

NGFI NNP O
- : O
A DT O
( -LRB- O
also RB O
called VBN O
Egr1 NNP O
, , O
Zif268 CD O
, , O
or CC O
Krox24 NNP O
) -RRB- O
and CC O
the DT O
closely RB O
related JJ O
proteins NNS O
Krox20 NNP O
, , O
NGFI NNP O
- : O
C NNP O
, , O
and CC O
Egr3 NNP O
are VBP O
zinc FW O
- : O
finger NN O
transcription NN O
factors NNS O
encoded VBN O
by IN O
immediate JJ O
- : O
early JJ O
genes NNS O
which WDT O
are VBP O
induced VBN O
by IN O
a DT O
wide JJ O
variety NN O
of IN O
extracellular JJ O
stimuli NNS O
. . O

NGFI NNP O
- : O
A DT O
has VBZ O
been VBN O
implicated VBN O
in IN O
cell NN O
proliferation NN O
, , O
macrophage NN O
differentiation NN O
, , O
synaptic JJ O
activation NN O
, , O
and CC O
long JJ O
- : O
term NN O
potentiation NN O
, , O
whereas IN O
Krox20 NNP O
is VBZ O
critical JJ O
for IN O
proper JJ O
hindbrain NN O
segmentation NN O
and CC O
peripheral JJ O
nerve NN O
myelination NN O
. . O

In IN O
previous JJ O
work NN O
, , O
a DT O
structure NN O
/ IN O
function NN O
analysis NN O
of IN O
NGFI NNP O
- : O
A DT O
revealed VBN O
a DT O
34 CD O
- : O
aa JJ O
inhibitory JJ O
domain NN O
that WDT O
was VBD O
hypothesized VBN O
to TO O
be VB O
the DT O
target NN O
of IN O
a DT O
cellular JJ O
factor NN O
that WDT O
represses VBZ O
NGFI NNP O
- : O
A DT O
transcriptional JJ O
activity NN O
. . O

Using VBG O
the DT O
yeast NN O
two CD O
- : O
hybrid JJ O
system NN O
, , O
we PRP O
have VBP O
isolated VBN O
a DT O
cDNA NN O
clone NN O
which WDT O
encodes VBZ O
a DT O
protein NN O
that IN O
interacts NNS O
with IN O
this DT O
inhibitory JJ O
domain NN O
and CC O
inhibits VBZ O
the DT O
ability NN O
of IN O
NGFI NNP O
- : O
A DT O
to TO O
activate VB O
transcription NN O
. . O

This DT O
NGFI NN O
- : O
A DT O
- : O
binding JJ O
protein NN O
, , O
NAB1 NNP O
, , O
is VBZ O
a DT O
570 CD O
- : O
aa JJ O
nuclear JJ O
protein NN O
that WDT O
bears VBZ O
no DT O
obvious JJ O
sequence NN O
homology NN O
to TO O
known JJ O
proteins NNS O
. . O

NAB1 NNP O
also RB O
represses VBZ O
Krox20 NNP O
activity NN O
, , O
but CC O
it PRP O
does VBZ O
not RB O
influence VB O
Egr3 NNP O
or CC O
NGFI NNP O
- : O
G NNP O
, , O
thus RB O
providing VBG O
a DT O
mechanism NN O
for IN O
the DT O
differential JJ O
regulation NN O
of IN O
this DT O
family NN O
of IN O
immediate JJ O
- : O
early JJ O
transcription NN O
factors NNS O
. . O

-DOCSTART- X X O

Metastatic JJ O
NIH NNP B-NP
3T3 CD I-NP
x NN O
LTA NNP B-NP
cell NN O
hybrids NNS O
express VBP O
72 CD O
kDa DT O
type NN O
IV NNP O
collagenase NN O
. . O

We PRP O
previously RB O
reported VBD O
that IN O
the DT O
murine NN O
fibroblast JJ O
cell NN O
line NN O
LTA NNP B-NP
is VBZ O
tumorigenic JJ O
but CC O
non FW O
- : O
metastatic JJ O
, , O
and CC O
is VBZ O
non JJ O
- : O
responsive JJ O
to TO O
a DT O
transfected VBN O
H NNP O
- : O
ras JJ O
oncogene NN O
. . O

In IN O
contrast NN O
, , O
NIH NNP B-NP
3T3 CD I-NP
cells NNS O
are VBP O
non FW O
- : O
tumorigenic JJ O
but CC O
are VBP O
ras JJ O
- : O
responsive JJ O
and CC O
become VBN O
metastatic JJ O
when WRB O
transfected VBN O
with IN O
ras NNS O
. . O

Somatic JJ O
cell NN O
hybrids NNS O
between IN O
LTA NNP B-NP
and CC O
NIH NNP B-NP
3T3 VBP I-NP
cells NNS O
are VBP O
tumorigenic JJ O
, , O
metastatic JJ O
and CC O
ras JJ O
- : O
responsive JJ O
. . O

Here RB O
we PRP O
examined VBD O
expression NN O
of IN O
type NN O
IV NNP O
collagenases NNS O
in IN O
parental JJ O
LTA NNP B-NP
and CC O
NIH NNP B-NP
3T3 CD I-NP
cells NNS O
( -LRB- O
with IN O
and CC O
without IN O
ras NNS O
) -RRB- O
and CC O
four CD O
metastatic JJ O
LTA NNP B-NP
x NN O
NIH NNP B-NP
3T3 CD I-NP
hybrids NNS O
( -LRB- O
also RB O
with IN O
and CC O
without IN O
ras NNS O
) -RRB- O
. . O

Parental JJ O
NIH NNP B-NP
3T3 CD I-NP
- : O
derived VBN O
cells NNS O
had VBD O
both DT O
72 CD O
kDa NN O
and CC O
92 CD O
kDa NN O
gelatinase NN O
activities NNS O
, , O
and CC O
LTA NNP B-NP
- : O
derived VBD O
cells NNS O
had VBD O
either RB O
aberrantly RB O
sized VBD O
approximately RB O
90 CD O
kDa NN O
activity NN O
alone RB O
or CC O
neither DT O
enzyme JJ O
activity NN O
. . O

All DT O
four CD O
metastatic JJ O
hybrids NNS O
expressed VBN O
60 CD O
- : O
72 CD O
kDa NN O
gelatinase NN O
activity NN O
, , O
while IN O
three CD O
of IN O
them PRP O
also RB O
had VBD O
92 CD O
kDa NN O
activity NN O
and CC O
one NN O
had VBD O
only RB O
minimal JJ O
92 CD O
kDa NN O
activity NN O
. . O

Thus RB O
the DT O
metastatic JJ O
phenotype NN O
of IN O
the DT O
hybrids NNS O
was VBD O
associated VBN O
with IN O
expression NN O
of IN O
72 CD O
kDa NN O
gelatinase NN O
. . O

Levels NNP O
of IN O
RNA NNP O
for IN O
tissue NN O
inhibitors NNS O
of IN O
metalloproteinases NNS O
( -LRB- O
TIMP NNP O
- : O
1 CD O
, , O
TIMP NNP O
- : O
2 CD O
) -RRB- O
were VBD O
relatively RB O
constant JJ O
, , O
suggesting VBG O
independent JJ O
regulation NN O
of IN O
type NN O
IV NNP O
collagenases NNS O
and CC O
their PRP$ O
inhibitors NNS O
. . O

Southern JJ O
blotting NN O
and CC O
probing NN O
with IN O
PCR NNP O
- : O
synthesized JJ O
cDNA NN O
fragments NNS O
of IN O
the DT O
mouse NN O
72 CD O
kDa NN O
type NN O
IV NNP O
collagenase NN O
gene NN O
showed VBD O
that IN O
this DT O
gene NN O
was VBD O
present JJ O
in IN O
all DT O
cells NNS O
although IN O
the DT O
structure NN O
of IN O
this DT O
gene NN O
in IN O
one CD O
of IN O
the DT O
three CD O
LTA NNP B-NP
cell NN O
lines NNS O
differed VBD O
from IN O
that DT O
of IN O
the DT O
other JJ O
cells NNS O
. . O

Our PRP$ O
results NNS O
suggest VBP O
that IN O
a DT O
key JJ O
change NN O
in IN O
the DT O
metastatic JJ O
hybrids NNS O
, , O
relative JJ O
to TO O
non FW O
- : O
metastatic JJ O
parental JJ O
LTA NNP B-NP
cells NNS O
, , O
is VBZ O
induction NN O
of IN O
expression NN O
of IN O
72 CD O
kDa NN O
type NN O
IV NNP O
collagenase NN O
. . O

-DOCSTART- X X O

Central NNP O
nervous JJ O
system NN O
infection NN O
with IN O
Eikenella NNP O
corrodens VBZ O
: : O
report NN O
of IN O
two CD O
cases NNS O
. . O

Two CD O
cases NNS O
of IN O
central JJ O
nervous JJ O
system NN O
infections NNS O
from IN O
which WDT O
E NNP O
. . O
corrodens NNS O
has VBZ O
been VBN O
isolated VBN O
are VBP O
reported VBN O
. . O

The DT O
portals NNS O
of IN O
entry NN O
, , O
clinical JJ O
course NN O
, , O
and CC O
antimicrobial JJ O
responses NNS O
conform VBP O
to TO O
other JJ O
reports NNS O
in IN O
the DT O
literature NN O
. . O

The DT O
importance NN O
of IN O
obtaining VBG O
careful JJ O
anaerobic JJ O
cultures NNS O
is VBZ O
emphasized VBN O
. . O

-DOCSTART- X X O

Neoplastic JJ O
progression NN O
of IN O
human JJ O
colorectal NN O
cancer NN O
is VBZ O
associated VBN O
with IN O
overexpression NN O
of IN O
the DT O
stromelysin NN O
- : O
3 CD O
and CC O
BM NNP O
- : O
40 CD O
/ NN O
SPARC NNP O
genes NNS O
. . O

The DT O
interaction NN O
of IN O
neoplastic JJ O
cells NNS O
with IN O
the DT O
extracellular JJ O
matrix NN O
is VBZ O
a DT O
critical JJ O
event NN O
for IN O
the DT O
initiation NN O
of IN O
cancer NN O
invasion NN O
and CC O
metastasis NN O
. . O

This DT O
study NN O
was VBD O
designed VBN O
to TO O
evaluate VB O
the DT O
potential JJ O
implication NN O
of IN O
stromelysin JJ O
- : O
3 CD O
( -LRB- O
ST3 NN O
) -RRB- O
, , O
a DT O
newly RB O
identified VBN O
member NN O
of IN O
the DT O
matrix NN O
- : O
degrading NN O
metalloproteinase NN O
family NN O
, , O
and CC O
of IN O
BM NNP O
- : O
40 CD O
/ NN O
SPARC NNP O
, , O
a DT O
glycoprotein NN O
associated VBN O
with IN O
the DT O
extracellular JJ O
matrix NN O
, , O
during IN O
the DT O
progression NN O
of IN O
human JJ O
colorectal NN O
cancers NNS O
. . O

We PRP O
analyzed VBD O
the DT O
relative JJ O
abundance NN O
of IN O
ST3 NNP O
and CC O
BM NNP O
- : O
40 CD O
/ NN O
SPARC NNP O
transcripts NNS O
by IN O
Northern NNP O
blot NN O
, , O
and CC O
their PRP$ O
distribution NN O
by IN O
in IN O
situ FW O
hybridization NN O
, , O
in IN O
normal JJ O
mucosa NN O
, , O
benign JJ O
adenomas NNS O
, , O
and CC O
primary JJ O
colorectal JJ O
adenocarcinomas NNS O
and CC O
their PRP$ O
liver NN O
metastases NNS O
. . O

The DT O
ST3 NNP O
and CC O
BM NNP O
- : O
40 CD O
/ NN O
SPARC NNP O
transcripts NNS O
were VBD O
overexpressed VBN O
in IN O
primary JJ O
colorectal NN O
cancers NNS O
and CC O
their PRP$ O
liver NN O
metastases NNS O
compared VBN O
to TO O
non FW O
- : O
neoplastic JJ O
mucosa NN O
. . O

These DT O
transcripts NNS O
were VBD O
localized VBN O
in IN O
stromal JJ O
fibroblasts NNS O
adjacent JJ O
to TO O
the DT O
neoplastic JJ O
foci NNS O
. . O

Overexpression NNP O
of IN O
ST3 NNP O
correlated VBD O
with IN O
the DT O
progression NN O
of IN O
human JJ O
colorectal NN O
tumors NNS O
toward IN O
local JJ O
invasion NN O
and CC O
liver NN O
metastasis NN O
. . O

Induction NN O
of IN O
these DT O
genes NNS O
also RB O
occurred VBD O
in IN O
diverticulitis NN O
and CC O
digestive JJ O
neoplasms NNS O
such JJ O
as IN O
gastric JJ O
and CC O
esophageal JJ O
carcinomas NNS O
. . O

-DOCSTART- X X O

Comparative JJ O
immunohistochemical JJ O
study NN O
of IN O
primary JJ O
and CC O
metastatic JJ O
carcinomas NNS O
of IN O
the DT O
liver NN O
. . O

Distinguishing VBG O
primary JJ O
hepatocellular JJ O
carcinoma NN O
( -LRB- O
HCC NNP O
) -RRB- O
from IN O
metastatic JJ O
carcinomas NNS O
to TO O
the DT O
liver NN O
is VBZ O
often RB O
difficult JJ O
, , O
if IN O
not RB O
impossible JJ O
, , O
particularly RB O
in IN O
needle NN O
biopsy NN O
and CC O
fine JJ O
- : O
needle NN O
aspiration NN O
specimens NNS O
. . O

In IN O
an DT O
attempt NN O
to TO O
identify VB O
a DT O
specific JJ O
immunohistochemical JJ O
profile NN O
that WDT O
would MD O
distinguish VB O
HCC NNP O
from IN O
metastatic JJ O
carcinomas NNS O
, , O
we PRP O
studied VBD O
56 CD O
HCCs NNS O
, , O
8 CD O
cholangiocarcinomas NN O
, , O
and CC O
24 CD O
metastatic JJ O
adenocarcinomas NNS O
with IN O
monoclonal JJ O
antibodies NNS O
to TO O
alpha DT O
- : O
fetoprotein NN O
( -LRB- O
AFP NNP O
) -RRB- O
, , O
keratin FW O
( -LRB- O
AE1 NN O
, , O
AE3 NNP O
, , O
and CC O
CAM5 NNP O
. . O
2 CD O
) -RRB- O
, , O
Leu FW O
- : O
M1 NNS O
, , O
human JJ O
milk NN O
fat JJ O
globule NN O
( -LRB- O
HMFG NNP O
- : O
2 CD O
) -RRB- O
, , O
tumor NN O
- : O
associated VBN O
glycoprotein NN O
- : O
72 CD O
( -LRB- O
B72 NN O
. . O
3 CD O
) -RRB- O
, , O
epithelial JJ O
specific JJ O
membrane NN O
antigen NN O
( -LRB- O
Ber NNP O
- : O
EP4 NN O
) -RRB- O
, , O
and CC O
BCA NNP O
- : O
225 CD O
( -LRB- O
CU NNP O
- : O
18 CD O
) -RRB- O
. . O

Both DT O
monoclonal JJ O
and CC O
polyclonal JJ O
( -LRB- O
mCEA NN O
and CC O
pCEA NN O
) -RRB- O
antibodies NNS O
to TO O
carcinoembryonic JJ O
antigen NN O
also RB O
were VBD O
used VBN O
. . O

Metastatic NNP O
adenocarcinomas NNS O
were VBD O
often RB O
positive JJ O
for IN O
CU NNP O
- : O
18 CD O
( -LRB- O
71 CD O
% NN O
) -RRB- O
, , O
Leu FW O
- : O
M1 NNS O
( -LRB- O
75 CD O
% NN O
) -RRB- O
, , O
B72 NNP O
. . O
3 CD O
( -LRB- O
50 CD O
% NN O
) -RRB- O
, , O
HMFG NNP O
- : O
2 CD O
( -LRB- O
67 CD O
% NN O
) -RRB- O
, , O
Ber NNP O
- : O
EP4 FW O
( -LRB- O
83 CD O
% NN O
) -RRB- O
and CC O
mCEA NN O
( -LRB- O
71 CD O
% NN O
) -RRB- O
. . O

Using VBG O
these DT O
antibodies NNS O
, , O
the DT O
frequency NN O
of IN O
positivity NN O
for IN O
HCC NNP O
was VBD O
9 CD O
% NN O
, , O
16 CD O
% NN O
, , O
11 CD O
% NN O
, , O
20 CD O
% NN O
, , O
36 CD O
% NN O
, , O
and CC O
11 CD O
% NN O
, , O
respectively RB O
. . O

CU NNP O
- : O
18 CD O
was VBD O
the DT O
only JJ O
monoclonal JJ O
antibody NN O
in IN O
which WDT O
there EX O
was VBD O
a DT O
significant JJ O
difference NN O
in IN O
positive JJ O
rates NNS O
between IN O
HCC NNP O
and CC O
metastatic JJ O
adenocarcinomas NNS O
. . O

Most JJS O
HCCs NNS O
( -LRB- O
71 CD O
% NN O
) -RRB- O
revealed VBD O
a DT O
bile NN O
canalicular JJ O
staining NN O
pattern NN O
with IN O
pCEA NN O
. . O

Because IN O
this DT O
staining NN O
pattern NN O
was VBD O
absent JJ O
in IN O
metastatic JJ O
carcinomas NNS O
, , O
pCEA NN O
appears VBZ O
to TO O
be VB O
useful JJ O
in IN O
confirming VBG O
a DT O
diagnosis NN O
of IN O
HCC NNP O
. . O

AE1 NNP O
, , O
AE3 NNP O
and CC O
CAM5 NNP O
. . O
2 CD O
antibodies NNS O
were VBD O
not RB O
useful JJ O
in IN O
distinguishing VBG O
HCC NNP O
from IN O
metastatic JJ O
carcinomas NNS O
. . O

Each DT O
cholangiocarcinoma NN O
shared VBD O
a DT O
staining NN O
profile NN O
similar JJ O
to TO O
that DT O
of IN O
metastatic JJ O
carcinomas NNS O
. . O

-DOCSTART- X X O

Heparin NNP O
- : O
steroid JJ O
conjugates NNS O
: : O
new JJ O
angiogenesis NN O
inhibitors NNS O
with IN O
antitumor JJ O
activity NN O
in IN O
mice NNS O
. . O

Inhibitors NNS O
of IN O
angiogenesis NN O
hold VBP O
potential JJ O
in IN O
the DT O
treatment NN O
of IN O
cancer NN O
and CC O
other JJ O
diseases NNS O
where WRB O
the DT O
disease NN O
is VBZ O
caused VBN O
or CC O
maintained VBN O
by IN O
the DT O
inappropriate JJ O
growth NN O
of IN O
blood NN O
vessels NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
a DT O
novel JJ O
inhibitor NN O
of IN O
angiogenesis NN O
was VBD O
synthesized VBN O
by IN O
covalently RB O
linking VBG O
a DT O
nonanticoagulating JJ O
derivative NN O
of IN O
heparin NN O
, , O
heparin NN O
adipic NN O
hydrazide NN O
( -LRB- O
HAH NNP O
) -RRB- O
, , O
by IN O
an DT O
acid NN O
- : O
labile NN O
bond NN O
to TO O
the DT O
antiangiogenic JJ O
steroid NN O
, , O
cortisol NN O
. . O

The DT O
rationale NN O
was VBD O
that IN O
the DT O
heparin NN O
derivative NN O
, , O
which WDT O
binds VBZ O
to TO O
sulfated JJ O
polyanion NN O
receptors NNS O
on IN O
endothelial JJ O
cells NNS O
, , O
should MD O
concentrate VB O
the DT O
steroid JJ O
on IN O
the DT O
surface NN O
of IN O
vascular JJ O
endothelial JJ O
cells NNS O
. . O

Endocytosis NN O
of IN O
the DT O
conjugate NN O
and CC O
decomposition NN O
of IN O
the DT O
acid NN O
- : O
labile NN O
linkage NN O
inside IN O
lysosomes NNS O
and CC O
other JJ O
acidic JJ O
intracellular JJ O
compartments NNS O
should MD O
then RB O
lead VB O
to TO O
release NN O
of IN O
the DT O
cortisol NN O
and CC O
expression NN O
of IN O
its PRP$ O
antiproliferative JJ O
activity NN O
. . O

Analysis NN O
of IN O
the DT O
stability NN O
of IN O
HAH NNP O
- : O
cortisol NN O
showed VBD O
that IN O
it PRP O
was VBD O
stable JJ O
at IN O
pH NN O
7 CD O
. . O
4 CD O
and CC O
broke VBD O
down RP O
rapidly RB O
( -LRB- O
t1 IN O
/ NN O
2 CD O
15 CD O
min NN O
) -RRB- O
at IN O
pH DT O
4 CD O
. . O
8 CD O
at IN O
37 CD O
degrees NNS O
C NN O
. . O

Treatment NNP O
of IN O
murine NN O
pulmonary NN O
capillary NN O
endothelial JJ O
cells NNS O
with IN O
HAH NNP O
- : O
cortisol NN O
at IN O
10 CD O
( -LRB- O
- : O
5 CD O
) -RRB- O
M NNP O
( -LRB- O
with IN O
respect NN O
to TO O
cortisol NN O
) -RRB- O
suppressed VBN O
their PRP$ O
DNA NN O
synthesis NN O
by IN O
50 CD O
% NN O
and CC O
inhibited VBD O
their PRP$ O
migration NN O
into IN O
wounded JJ O
areas NNS O
of IN O
confluent JJ O
monolayers NNS O
. . O

HAH NNP O
- : O
cortisol NN O
at IN O
10 CD O
( -LRB- O
- : O
4 CD O
) -RRB- O
M NNP O
( -LRB- O
with IN O
respect NN O
to TO O
cortisol NN O
) -RRB- O
did VBD O
not RB O
suppress VB O
the DT O
DNA NNP O
synthesis NN O
of IN O
Lewis NNP O
lung NN O
carcinoma NN O
cells NNS O
. . O

Daily NNP O
i NN O
. . O
p NN O
. . O
injections NNS O
of IN O
HAH NNP O
- : O
cortisol NN O
into IN O
mice NNS O
bearing VBG O
s PRP O
. . O
c NN O
. . O
sponge NN O
implants VBZ O
retarded VBN O
vascularization NN O
of IN O
the DT O
sponge NN O
, , O
and CC O
injections NNS O
directly RB O
into IN O
the DT O
sponge NN O
abolished VBD O
vascularization NN O
for IN O
as RB O
long JJ O
as IN O
the DT O
injections NNS O
were VBD O
continued VBN O
. . O

Daily NNP O
i NN O
. . O
v NN O
. . O
injections NNS O
of IN O
HAH NNP O
- : O
cortisol NN O
at IN O
doses NNS O
causing VBG O
no DT O
apparent JJ O
toxicity NN O
retarded VBD O
the DT O
growth NN O
of IN O
solid JJ O
s PRP O
. . O
c NN O
. . O

Lewis NNP O
lung NN O
carcinomas NNS O
in IN O
mice NNS O
by IN O
up RB O
to TO O
65 CD O
% NN O
. . O

In IN O
all DT O
of IN O
these DT O
assays NNS O
, , O
equivalent JJ O
treatments NNS O
with IN O
a DT O
mixture NN O
of IN O
the DT O
HAH NNP O
plus CC O
cortisol NN O
was VBD O
significantly RB O
less RBR O
effective JJ O
. . O

The DT O
antiproliferative JJ O
effect NN O
of IN O
HAH NNP O
- : O
cortisol NN O
on IN O
endothelial JJ O
cells NNS O
appeared VBD O
independent JJ O
of IN O
the DT O
glucocorticoid JJ O
activity NN O
of IN O
the DT O
steroid NN O
since IN O
HAH NNP O
conjugated VBD O
to TO O
5 CD O
beta NN O
- : O
pregnane NN O
- : O
3 CD O
alpha NN O
, , O
17 CD O
alpha NN O
, , O
21 CD O
- : O
triol NN O
- : O
20 CD O
- : O
one CD O
, , O
a DT O
steroid NN O
lacking VBG O
glucocorticoid JJ O
or CC O
mineralocorticoid JJ O
activity NN O
, , O
was VBD O
even RB O
more RBR O
effective JJ O
at IN O
inhibiting VBG O
DNA NNP O
synthesis NN O
by IN O
murine NN O
pulmonary NN O
capillary NN O
endothelial NN O
cells NNS O
than IN O
was VBD O
HAH NNP O
- : O
cortisol NN O
. . O

In IN O
conclusion NN O
, , O
HAH NNP O
- : O
cortisol NN O
represents VBZ O
the DT O
prototype NN O
of IN O
a DT O
new JJ O
class NN O
of IN O
angiogenesis NN O
inhibitors NNS O
for IN O
the DT O
treatment NN O
of IN O
cancer NN O
and CC O
other JJ O
angiogenic JJ O
diseases NNS O
. . O

-DOCSTART- X X O

Colorimetrical JJ O
rate NN O
assay NN O
for IN O
urinary JJ O
dipeptidyl NN O
peptidase NN O
IV NNP O
( -LRB- O
DPPIV NNP O
) -RRB- O
activity NN O
using VBG O
a DT O
new JJ O
substrate NN O
. . O

We PRP O
synthesized VBD O
a DT O
new JJ O
substrate NN O
glycyl NN O
- : O
L NNP O
- : O
proline NN O
3 CD O
, , O
5 CD O
- : O
dibromo NN O
- : O
4 LS O
- : O
hydroxyanilide NN O
( -LRB- O
Gly NNP O
- : O
Pro FW O
- : O
DBAP NNP O
) -RRB- O
, , O
for IN O
dipeptidyl NN O
peptidase NN O
IV NNP O
( -LRB- O
DPPIV NNP O
) -RRB- O
. . O

Its PRP$ O
hydrolysis NN O
by IN O
DPPIV NNP O
resulted VBD O
in IN O
the DT O
formation NN O
of IN O
a DT O
chromophore NN O
, , O
2 CD O
, , O
6 CD O
- : O
dibromophenol NN O
- : O
indo SYM O
- : O
p NN O
- : O
xylenol NN O
, , O
and CC O
its PRP$ O
maximal JJ O
absorption NN O
wavelength NN O
( -LRB- O
600 CD O
nm NN O
) -RRB- O
was VBD O
longer JJR O
than IN O
that DT O
of IN O
p NN O
- : O
nitroaniline NN O
( -LRB- O
415 CD O
nm NN O
) -RRB- O
released VBN O
from IN O
conventional JJ O
substrate NN O
, , O
glycyl NN O
- : O
L NNP O
- : O
proline VB O
p NN O
- : O
nitroanilide NN O
( -LRB- O
Gly NNP O
- : O
Pro FW O
- : O
pNA NN O
) -RRB- O
. . O

We PRP O
also RB O
established VBD O
the DT O
rate NN O
assay NN O
for IN O
urinary JJ O
DPPIV NNP O
activity NN O
using VBG O
Gly NNP O
- : O
Pro FW O
- : O
DBAP NNP O
. . O

The DT O
optimum JJ O
pH NN O
was VBD O
between IN O
8 CD O
. . O
5 CD O
and CC O
9 CD O
. . O
0 CD O
. . O

The DT O
apparent JJ O
Km NNP O
was VBD O
1 CD O
. . O
1 CD O
mmol NN O
/ NN O
1 CD O
. . O

The DT O
detectable JJ O
range NN O
was VBD O
2 CD O
. . O
5 CD O
- : O
350 CD O
U NNP O
/ NNP O
l NN O
. . O

No DT O
changes NNS O
in IN O
blank JJ O
values NNS O
occurred VBD O
throughout IN O
the DT O
enzyme NN O
reaction NN O
in IN O
the DT O
optimum JJ O
pH NN O
. . O

Its PRP$ O
value NN O
was VBD O
also RB O
much RB O
lower JJR O
than IN O
Gly NNP O
- : O
Pro FW O
- : O
pNA NN O
. . O

CVs NNS O
for IN O
within IN O
- : O
run NN O
and CC O
between IN O
- : O
run NN O
were VBD O
1 LS O
. . O
1 CD O
% NN O
( -LRB- O
n NN O
= SYM O
10 CD O
) -RRB- O
and CC O
3 CD O
. . O
0 CD O
% NN O
( -LRB- O
n NN O
= SYM O
10 CD O
) -RRB- O
, , O
respectively RB O
. . O

Among IN O
tested VBN O
peptidases NNS O
, , O
only RB O
DPPIV NNP O
could MD O
hydrolyze VB O
Gly NNP O
- : O
Pro FW O
- : O
DBAP NNP O
. . O

Among IN O
the DT O
protease NN O
inhibitors NNS O
, , O
only RB O
two CD O
, , O
diprotin NN O
- : O
A DT O
and CC O
phenylmethylsulfonyl NN O
fluoride NN O
( -LRB- O
PMSA NNP O
) -RRB- O
, , O
could MD O
inhibit VB O
DPPIV NNP O
activity NN O
. . O

The DT O
present JJ O
method NN O
did VBD O
not RB O
interfere VB O
with IN O
urinary JJ O
ingredients NNS O
such JJ O
as IN O
hemoglobin NN O
. . O

The DT O
correlation NN O
between IN O
the DT O
present NN O
( -LRB- O
y NN O
) -RRB- O
and CC O
conventional JJ O
( -LRB- O
x NN O
) -RRB- O
methods NNS O
is VBZ O
presented VBN O
by IN O
the DT O
equation NN O
y NN O
= SYM O
1 CD O
. . O
121x CD O
+ NNP O
0 CD O
. . O
096 CD O
( -LRB- O
r NN O
= SYM O
0 CD O
. . O
993 CD O
) -RRB- O
. . O

Thus RB O
the DT O
present JJ O
method NN O
provides VBZ O
practical JJ O
advantages NNS O
over IN O
the DT O
conventional JJ O
method NN O
for IN O
routine JJ O
laboratory NN O
use NN O
. . O

-DOCSTART- X X O

Primary JJ O
hyperparathyroidism NN O
and CC O
the DT O
heart NN O
: : O
cardiac JJ O
abnormalities NNS O
correlated VBN O
to TO O
clinical JJ O
and CC O
biochemical JJ O
data NNS O
. . O

Comparing VBG O
patients NNS O
with IN O
primary JJ O
hyperparathyroidism NN O
( -LRB- O
PHP NNP O
) -RRB- O
to TO O
a DT O
normocalcemic JJ O
control NN O
population NN O
, , O
those DT O
with IN O
PHP NNP O
have VBP O
a DT O
higher JJR O
incidence NN O
of IN O
cardiovascular JJ O
disease NN O
and CC O
cardiac JJ O
abnormalities NNS O
. . O

This DT O
study NN O
aimed VBD O
at IN O
correlating VBG O
cardiac JJ O
findings NNS O
( -LRB- O
valvular JJ O
and CC O
myocardial JJ O
calcification NN O
, , O
myocardial JJ O
hypertrophy NN O
) -RRB- O
with IN O
clinical JJ O
data NNS O
( -LRB- O
age NN O
, , O
sex NN O
, , O
clinical JJ O
manifestation NN O
, , O
nephrolithiasis NN O
, , O
nephrocalcinosis NN O
, , O
hypertension NN O
, , O
skeletal NN O
abnormalities NNS O
, , O
hypercalcemic JJ O
syndrome NN O
) -RRB- O
and CC O
biochemical JJ O
data NNS O
( -LRB- O
serum NN O
calcium NN O
, , O
serum NN O
phosphate NN O
, , O
serum NN O
iPTH IN O
level NN O
, , O
serum JJ O
creatinine NN O
) -RRB- O
. . O

A DT O
group NN O
of IN O
132 CD O
consecutive JJ O
patients NNS O
with IN O
surgically RB O
verified VBN O
PHP NNP O
( -LRB- O
94 CD O
women NNS O
, , O
38 CD O
men NNS O
; : O
ages NNS O
15 CD O
- : O
86 CD O
, , O
mean JJ O
age NN O
57 CD O
+ NN O
/ NN O
- : O
16 CD O
years NNS O
) -RRB- O
were VBD O
included VBN O
in IN O
this DT O
study NN O
. . O

Blood NN O
chemistry NN O
, , O
clinical JJ O
presentation NN O
, , O
radiography NN O
, , O
and CC O
echocardiography NN O
were VBD O
carried VBN O
out RP O
in IN O
all DT O
patients NNS O
for IN O
univariate JJ O
and CC O
multivariate JJ O
analyses NNS O
of IN O
all DT O
parameters NNS O
. . O

There EX O
was VBD O
no DT O
statistical JJ O
correlation NN O
between IN O
clinical JJ O
symptoms NNS O
, , O
biochemical JJ O
data NNS O
, , O
and CC O
cardiac JJ O
calcific JJ O
alterations NNS O
. . O

Typical JJ O
skeletal NN O
manifestations NNS O
( -LRB- O
osteolysis NN O
/ NN O
subperiostal JJ O
resorption NN O
) -RRB- O
and CC O
valvular JJ O
calcifications NNS O
were VBD O
significantly RB O
correlated VBN O
to TO O
left JJ O
ventricular JJ O
hypertrophy NN O
( -LRB- O
p NN O
= SYM O
0 CD O
. . O
005 CD O
) -RRB- O
. . O

Cardiac NNP O
abnormalities NNS O
such JJ O
as IN O
calcific JJ O
myocardial JJ O
deposits NNS O
or CC O
mitral JJ O
and CC O
aortic JJ O
valvular JJ O
calcifications NNS O
do VBP O
not RB O
correlate VB O
with IN O
laboratory NN O
findings NNS O
and CC O
clinical JJ O
presentation NN O
at IN O
the DT O
time NN O
of IN O
diagnosis NN O
. . O

There EX O
was VBD O
no DT O
biochemical JJ O
or CC O
clinical JJ O
variable JJ O
that DT O
could MD O
predict VB O
the DT O
frequency NN O
or CC O
severity NN O
of IN O
valvular JJ O
sclerosis NN O
or CC O
calcific JJ O
deposits NNS O
in IN O
the DT O
myocardium NN O
. . O

However RB O
, , O
PHP NNP O
- : O
related VBN O
skeletal NN O
abnormalities NNS O
and CC O
valvular JJ O
calcification NN O
were VBD O
predicting VBG O
factors NNS O
for IN O
left JJ O
ventricular JJ O
hypertrophy NN O
, , O
a DT O
reversible JJ O
cardiac JJ O
manifestation NN O
of IN O
PHP NNP O
. . O

Myocardial JJ O
hypertrophy NN O
is VBZ O
more RBR O
often RB O
found VBN O
with IN O
classic JJ O
symptomatic JJ O
PHP NNP O
with IN O
osseous JJ O
abnormalities NNS O
. . O

-DOCSTART- X X O

Childhood NNP O
conscientiousness NN O
and CC O
longevity NN O
: : O
health NN O
behaviors NNS O
and CC O
cause NN O
of IN O
death NN O
. . O

Previous JJ O
research NN O
showed VBD O
that IN O
conscientiousness NN O
( -LRB- O
social JJ O
dependability NN O
) -RRB- O
in IN O
childhood NN O
predicted VBD O
longevity NN O
in IN O
an DT O
archival NN O
prospective JJ O
cohort JJ O
study NN O
of IN O
bright JJ O
children NNS O
first RB O
studied VBN O
by IN O
Terman NNP O
in IN O
the DT O
1920s CD O
( -LRB- O
H NNP O
. . O
S NNP O
. . O
Friedman NNP O
et NNP O
al NN O
. . O
, , O
1993 CD O
) -RRB- O
. . O

Possible JJ O
behavioral JJ O
mechanisms NNS O
for IN O
this DT O
robust JJ O
association NN O
are VBP O
now RB O
examined VBN O
by IN O
gathering VBG O
cause NN O
of IN O
death NN O
information NN O
and CC O
by IN O
considering VBG O
the DT O
possible JJ O
mediating JJ O
influences NNS O
of IN O
drinking NN O
alcohol NN O
, , O
smoking NN O
, , O
and CC O
overeating VBG O
. . O

Survival JJ O
analyses NNS O
( -LRB- O
N NNP O
= SYM O
1 CD O
, , O
215 CD O
) -RRB- O
suggest VBP O
that IN O
the DT O
protective JJ O
effect NN O
of IN O
conscientiousness NN O
is VBZ O
not RB O
primarily RB O
due JJ O
to TO O
accident NN O
avoidance NN O
and CC O
cannot MD O
be VB O
mostly RB O
explained VBN O
by IN O
abstinence NN O
from IN O
unhealthy JJ O
substance NN O
intake NN O
. . O

Conscientiousness NNP O
may MD O
have VB O
more JJR O
wide JJ O
- : O
ranging VBG O
effects NNS O
on IN O
health NN O
- : O
relevant JJ O
activities NNS O
. . O

-DOCSTART- X X O

Selenoperoxidase NNP O
- : O
dependent JJ O
glutathione NN O
cycle NN O
activity NN O
in IN O
peroxide NN O
- : O
challenged VBN O
leukemia NN O
cells NNS O
. . O

Murine NNP O
leukemia NN O
L1210 CD B-NP
cells NNS O
rendered VBN O
deficient JJ O
in IN O
glutathione NN O
peroxidase NN O
( -LRB- O
GPX NNP O
) -RRB- O
and CC O
phospholipid JJ O
hydroperoxide NN O
glutathione NN O
peroxidase NN O
( -LRB- O
PHGPX NNP O
) -RRB- O
by IN O
Se NNP O
deprivation NN O
( -LRB- O
L NNP O
. . O
Se NNP O
( -LRB- O
- : O
) -RRB- O
cells NNS O
) -RRB- O
were VBD O
found VBN O
to TO O
be VB O
more RBR O
sensitive JJ O
to TO O
tert VB O
- : O
butyl NN O
hydroperoxide NN O
( -LRB- O
t NN O
- : O
BuOOH CC O
) -RRB- O
cytotoxicity NN O
than IN O
Se NNP O
- : O
replete JJ O
controls NNS O
( -LRB- O
L NNP O
. . O
Se NNP O
( -LRB- O
+ NN O
) -RRB- O
cells NNS O
) -RRB- O
. . O

Human JJ O
K562 NNP B-NP
cells NNS O
, , O
which WDT O
express VBP O
PHGPX NNP O
, , O
but CC O
not RB O
GPX NNP O
, , O
were VBD O
also RB O
more RBR O
sensitive JJ O
to TO O
t VB O
- : O
BuOOH NNP O
in IN O
the DT O
Se NNP O
- : O
deficient NN O
( -LRB- O
K NNP O
. . O
Se NNP O
( -LRB- O
- : O
) -RRB- O
) -RRB- O
than IN O
Se NNP O
- : O
satisfied JJ O
( -LRB- O
K NNP O
. . O
Se NNP O
( -LRB- O
+ NN O
) -RRB- O
) -RRB- O
condition NN O
. . O

In IN O
examining VBG O
the DT O
metabolic JJ O
basis NN O
for IN O
selenoperoxidase JJ O
- : O
dependent JJ O
resistance NN O
, , O
we PRP O
found VBD O
that IN O
glucose NN O
- : O
replete JJ O
Se NNP O
( -LRB- O
- : O
) -RRB- O
cells NNS O
reduce VB O
t IN O
- : O
BuOOH NNP O
to TO O
t VB O
- : O
butanol NN O
far RB O
more RBR O
slowly RB O
than IN O
Se NNP O
( -LRB- O
+ NN O
) -RRB- O
cells NNS O
, , O
the DT O
ratio NN O
of IN O
the DT O
first JJ O
- : O
order NN O
rate NN O
constants NNS O
approximating VBG O
that IN O
of IN O
the DT O
GPX NNP O
activities NNS O
( -LRB- O
L1210 JJ B-NP
cells NNS O
) -RRB- O
or CC O
PHGPX JJ O
activities NNS O
( -LRB- O
K562 NN B-NP
cells NNS O
) -RRB- O
. . O

Monitoring NN O
peroxide NN O
- : O
induced VBN O
changes NNS O
in IN O
GSH NNP O
and CC O
GSSG NNP O
gave VBD O
consistent JJ O
results NNS O
; : O
e LS O
. . O
g NN O
. . O
, , O
glucose NN O
- : O
depleted VBN O
L NNP O
. . O
Se NNP O
( -LRB- O
+ NN O
) -RRB- O
cells NNS O
exhibited VBN O
a DT O
first JJ O
order NN O
loss NN O
of IN O
GSH NNP O
that WDT O
was VBD O
substantially RB O
faster JJR O
than IN O
that DT O
of IN O
glucose NN O
- : O
depleted VBN O
L NNP O
. . O
Se NNP O
( -LRB- O
- : O
) -RRB- O
cells NNS O
. . O

Under IN O
the DT O
conditions NNS O
used VBN O
, , O
peroxide VB O
- : O
induced VBN O
conversion NN O
of IN O
GSH NNP O
to TO O
GSSG NNP O
could MD O
be VB O
stoichiometrically RB O
reversed VBN O
by IN O
resupplying NN O
D LS O
- : O
glucose NN O
, , O
indicating VBG O
that IN O
no DT O
significant JJ O
lysis NN O
or CC O
GSSG NNP O
efflux NN O
and CC O
/ NN O
or CC O
interchange NN O
had VBD O
taken VBN O
place NN O
. . O

The DT O
apparent JJ O
first JJ O
- : O
order NN O
rate NN O
constant JJ O
for IN O
GSH NNP O
decay NN O
increased VBD O
progressively RB O
for IN O
L1210 NNP B-NP
cells NNS O
expressing VBG O
a DT O
range NN O
of IN O
GPX NNP O
activities NNS O
from IN O
approximately RB O
5 CD O
% NN O
to TO O
100 CD O
% NN O
, , O
demonstrating VBG O
that IN O
peroxide NN O
detoxification NN O
is VBZ O
strictly RB O
dependent JJ O
on IN O
enzyme JJ O
content NN O
. . O

The DT O
initial JJ O
rate NN O
of IN O
14CO2 CD O
release NN O
from IN O
D NNP O
- : O
[ NN O
1 CD O
- : O
14C JJ O
] SYM O
glucose NN O
supplied VBN O
in IN O
the DT O
medium NN O
was VBD O
much JJ O
greater JJR O
for IN O
L NNP O
. . O
Se NNP O
( -LRB- O
+ NN O
) -RRB- O
or CC O
K NNP O
. . O
Se NNP O
( -LRB- O
+ NN O
) -RRB- O
cells NNS O
than IN O
for IN O
their PRP$ O
respective JJ O
Se NNP O
( -LRB- O
- : O
) -RRB- O
counterparts NNS O
, , O
consistent JJ O
with IN O
greater JJR O
hexose NN O
monophosphate NN O
shunt NN O
activity NN O
in IN O
the DT O
former JJ O
. . O

These DT O
results NNS O
highlight NN O
the DT O
importance NN O
of IN O
selenoperoxidase JJ O
action NN O
in IN O
the DT O
glutathione NN O
cycle NN O
as IN O
a DT O
means NN O
by IN O
which WDT O
tumor NN O
cells NNS O
cope VB O
with IN O
hydroperoxide JJ O
stress NN O
. . O

-DOCSTART- X X O

Differential JJ O
expression NN O
and CC O
mutation NN O
of IN O
NME NNP O
genes NNS O
in IN O
autologous JJ O
cultured JJ O
human JJ O
melanoma NN O
cells NNS O
with IN O
different JJ O
metastatic JJ O
potentials NNS O
. . O

The DT O
putative JJ O
metastasis NN O
suppressor NN O
genes NNS O
, , O
NME1 NNP O
( -LRB- O
nm23 FW O
- : O
1 CD O
) -RRB- O
and CC O
NME2 NNP O
( -LRB- O
nm23 FW O
- : O
2 CD O
) -RRB- O
, , O
were VBD O
examined VBN O
in IN O
a DT O
model NN O
system NN O
we PRP O
developed VBD O
to TO O
approximate JJ O
the DT O
dissemination NN O
of IN O
melanoma NN O
from IN O
a DT O
primary JJ O
skin NN O
tumor NN O
. . O

We PRP O
utilized VBD O
two CD O
autologous JJ O
human JJ O
melanoma NN O
cell NN O
lines NNS O
, , O
IV NNP B-NP
Cl NNP I-NP
1 CD I-NP
and CC O
IV NNP B-NP
Cl NNP I-NP
3 CD I-NP
, , O
which WDT O
displayed VBD O
qualitatively RB O
different JJ O
metastatic JJ O
phenotypes NNS O
following VBG O
subdermal JJ O
inoculation NN O
into IN O
nude JJ O
mice NNS O
. . O

Highly NNP O
metastatic JJ O
IV NNP B-NP
Cl NNP I-NP
1 CD I-NP
cells NNS O
expressed VBD O
approximately RB O
5 CD O
fold NN O
lower JJR O
levels NNS O
of IN O
protein NN O
encoded VBN O
by IN O
NME NNP O
genes NNS O
than IN O
non FW O
- : O
metastatic JJ O
IV NNP B-NP
Cl NNP I-NP
3 CD I-NP
cells NNS O
. . O

Similar JJ O
differences NNS O
in IN O
NME JJ O
protein NN O
levels NNS O
were VBD O
observed VBN O
in IN O
tumors NNS O
induced VBN O
by IN O
the DT O
two CD O
cell NN O
lines NNS O
in IN O
nude JJ O
mice NNS O
. . O

There EX O
were VBD O
no DT O
differences NNS O
in IN O
NME JJ O
mRNA NN O
levels NNS O
between IN O
these DT O
two CD O
cell NN O
lines NNS O
, , O
suggesting VBG O
that IN O
expression NN O
of IN O
these DT O
proteins NNS O
is VBZ O
regulated VBN O
at IN O
a DT O
post NN O
- : O
transcriptional JJ O
level NN O
. . O

We PRP O
found VBD O
a DT O
ser122 NN O
- : O
pro JJ O
mutation NN O
in IN O
the DT O
NME2 NNP O
gene NN O
of IN O
metastatic JJ O
IV NNP B-NP
Cl NNP I-NP
1 CD I-NP
cells NNS O
. . O

A DT O
similar JJ O
ser120 NN O
- : O
gly RB O
mutation NN O
in IN O
NME1 NNP O
has VBZ O
been VBN O
found VBN O
in IN O
human JJ O
neuroblastoma NN O
, , O
suggesting VBG O
that IN O
mutation NN O
in IN O
this DT O
region NN O
may MD O
be VB O
a DT O
general JJ O
phenomenon NN O
related VBN O
to TO O
tumor NN O
progression NN O
. . O

These DT O
mutations NNS O
may MD O
have VB O
functional JJ O
consequences NNS O
since IN O
they PRP O
eliminate VBP O
potential JJ O
phosphorylation NN O
sites NNS O
and CC O
may MD O
affect VB O
the DT O
tertiary JJ O
structure NN O
of IN O
mature JJ O
protein NN O
complexes NNS O
. . O

-DOCSTART- X X O

Image VB O
- : O
directed VBN O
and CC O
color JJ O
Doppler NNP O
studies NNS O
of IN O
gallbladder NN O
tumors NNS O
. . O

Thirteen CD O
cases NNS O
of IN O
primary JJ O
adenocarcinoma NN O
of IN O
the DT O
gallbladder NN O
( -LRB- O
GB NNP O
) -RRB- O
, , O
1 CD O
of IN O
malignant JJ O
fibrous JJ O
histocytoma NN O
, , O
3 CD O
of IN O
metastatic JJ O
adenocarcinoma NN O
, , O
5 CD O
of IN O
adenoma NN O
, , O
5 CD O
of IN O
polypus NN O
, , O
2 CD O
of IN O
xanthogranuloma NN O
, , O
6 CD O
of IN O
chronic NN O
cholecystitis NN O
, , O
4 CD O
of IN O
acute JJ O
cholecystitis NN O
, , O
and CC O
8 CD O
of IN O
subacute JJ O
cholecystitis NN O
were VBD O
studied VBN O
by IN O
image NN O
- : O
directed VBN O
and CC O
color JJ O
Doppler NNP O
ultrasonography NN O
( -LRB- O
CDUS NNP O
) -RRB- O
. . O

All DT O
of IN O
the DT O
14 CD O
cases NNS O
of IN O
primary JJ O
GB NN O
cancer NN O
( -LRB- O
10 CD O
masses NNS O
, , O
4 CD O
thickening JJ O
wall NN O
) -RRB- O
were VBD O
found VBN O
to TO O
have VB O
a DT O
high JJ O
velocity NN O
arterial NN O
blood NN O
flow NN O
signal NN O
in IN O
the DT O
wall NN O
of IN O
the DT O
GB NNP O
. . O

In IN O
contrast NN O
, , O
the DT O
3 CD O
cases NNS O
of IN O
metastatic JJ O
cancer NN O
of IN O
the DT O
GB NNP O
had VBD O
no DT O
blood NN O
flow NN O
signal NN O
in IN O
the DT O
wall NN O
of IN O
the DT O
GB NNP O
. . O

For IN O
the DT O
30 CD O
cases NNS O
of IN O
benign JJ O
lesions NNS O
of IN O
the DT O
GB NNP O
, , O
only RB O
in IN O
12 CD O
cases NNS O
was VBD O
a DT O
low JJ O
velocity NN O
blood NN O
flow NN O
signal NN O
found VBD O
. . O

Nine CD O
of IN O
10 CD O
cases NNS O
of IN O
primary JJ O
GB NNP O
malignancy NN O
were VBD O
found VBN O
to TO O
have VB O
high JJ O
velocity NN O
arterial NN O
blood NN O
flow NN O
signals NNS O
in IN O
the DT O
tumor NN O
masses NNS O
. . O

No DT O
blood NN O
flow NN O
signal NN O
was VBD O
observed VBN O
in IN O
the DT O
masses NNS O
of IN O
13 CD O
cases NNS O
( -LRB- O
3 CD O
of IN O
metastatic JJ O
adenocarcinoma NN O
, , O
5 CD O
of IN O
adenoma NN O
, , O
5 CD O
of IN O
polypus NN O
) -RRB- O
. . O

An DT O
abnormal JJ O
high JJ O
velocity NN O
arterial NN O
blood NN O
flow NN O
signal NN O
observed VBD O
within IN O
masses NNS O
in IN O
the DT O
GB NNP O
or CC O
in IN O
the DT O
GB NNP O
wall NN O
is VBZ O
a DT O
significant JJ O
feature NN O
of IN O
primary JJ O
GB NNP O
cancer NN O
and CC O
thus RB O
helps VBZ O
to TO O
differentiate JJ O
primary JJ O
GB NNP O
cancer NN O
from IN O
metastatic JJ O
and CC O
benign JJ O
lesions NNS O
of IN O
the DT O
GB NNP O
. . O

-DOCSTART- X X O

Differential JJ O
effects NNS O
of IN O
carbachol NN O
on IN O
calcium NN O
entry NN O
and CC O
release NN O
in IN O
CHO NNP B-NP
cells NNS O
expressing VBG O
the DT O
m3 JJ O
muscarinic NN O
receptor NN O
. . O

Calcium NNP O
signalling NN O
was VBD O
examined VBN O
in IN O
CHO NNP B-NP
- : I-NP
k1 JJ I-NP
cells NNS O
that WDT O
stably RB O
express VBP O
the DT O
m3 CD O
subtype NN O
of IN O
the DT O
muscarinic NN O
receptor NN O
. . O

The DT O
calcium NN O
indicator NN O
Fura NNP O
- : O
2 CD O
was VBD O
retained VBN O
in IN O
these DT O
cells NNS O
only RB O
in IN O
the DT O
presence NN O
of IN O
probenecid JJ O
( -LRB- O
1 CD O
mM NN O
) -RRB- O
, , O
suggesting VBG O
that IN O
Fura NNP O
- : O
2 CD O
efflux NN O
was VBD O
mediated VBN O
by IN O
an DT O
organic JJ O
anion NN O
transporter NN O
. . O

The DT O
addition NN O
of IN O
carbachol NN O
( -LRB- O
CCh NN O
) -RRB- O
to TO O
Fura NNP O
- : O
2 CD O
loaded JJ O
cells NNS O
in IN O
suspension NN O
caused VBD O
a DT O
rapid JJ O
transient NN O
increase NN O
in IN O
intracellular JJ O
calcium NN O
[ NN O
Ca MD O
] SYM O
i NN O
followed VBN O
by IN O
a DT O
smaller JJR O
sustained JJ O
plateau NN O
phase NN O
. . O

The DT O
transient JJ O
rise NN O
in IN O
[ NN O
Ca MD O
] SYM O
i NN O
was VBD O
dose NN O
- : O
dependent JJ O
with IN O
a DT O
threshold NN O
response NN O
of IN O
89 CD O
+ JJ O
/ NNS O
- : O
18 CD O
nM NNS O
above IN O
baseline NN O
with IN O
10 CD O
nM JJ O
CCh NNP O
and CC O
a DT O
maximum JJ O
stimulation NN O
of IN O
734 CD O
+ NN O
/ NN O
- : O
46 CD O
nM NN O
with IN O
10 CD O
microM NNS O
CCh NNP O
. . O

This DT O
phase NN O
was VBD O
accompanied VBN O
by IN O
a DT O
similar JJ O
dose NN O
- : O
dependent JJ O
stimulation NN O
of IN O
total JJ O
inositol NN O
phosphate NN O
production NN O
and CC O
was VBD O
assumed VBN O
to TO O
be VB O
generated VBN O
by IN O
release NN O
from IN O
intracellular JJ O
stores NNS O
of IN O
the DT O
endoplasmic JJ O
reticulum NN O
( -LRB- O
ER NNP O
) -RRB- O
. . O

The DT O
sustained VBD O
increase NN O
in IN O
[ NN O
Ca MD O
] SYM O
i NN O
was VBD O
generated VBN O
by IN O
entry NN O
from IN O
the DT O
extracellular JJ O
bath NN O
since IN O
it PRP O
was VBD O
blocked VBN O
by IN O
pretreatment NN O
with IN O
La3 JJ O
+ NN O
( -LRB- O
1 CD O
microM NN O
) -RRB- O
and CC O
was VBD O
absent JJ O
when WRB O
bath NN O
calcium NN O
was VBD O
chelated VBN O
with IN O
EGTA NNP O
. . O

This DT O
phase NN O
was VBD O
not RB O
dependent JJ O
on IN O
CCh JJ O
dose NN O
, , O
and CC O
a DT O
stimulation NN O
of IN O
[ NN O
Ca MD O
] SYM O
i NN O
of IN O
approximately RB O
90 CD O
nM NNS O
above IN O
baseline NN O
was VBD O
observed VBN O
with IN O
CCh JJ O
concentrations NNS O
between IN O
50 CD O
nM NNS O
and CC O
10 CD O
microM NNS O
. . O

With IN O
this DT O
dose NN O
range NN O
, , O
the DT O
rate NN O
of IN O
Mn2 NNP O
+ NNP O
quenching NN O
of IN O
Fura NNP O
- : O
2 CD O
at IN O
the DT O
Ca JJ O
- : O
insensitive JJ O
excitation NN O
wavelength NN O
of IN O
360 CD O
nm NN O
was VBD O
likewise RB O
maximally RB O
stimulated VBN O
. . O

At IN O
lower JJR O
CCh NN O
concentrations NNS O
( -LRB- O
10 CD O
- : O
50 CD O
nM NN O
) -RRB- O
, , O
it PRP O
was VBD O
clear JJ O
that IN O
the DT O
activation NN O
of IN O
Ca JJ O
entry NN O
could MD O
not RB O
be VB O
dissociated VBN O
from IN O
a DT O
threshold NN O
release NN O
of IN O
Ca JJ O
from IN O
intracellular JJ O
stores NNS O
. . O

The DT O
phorbol NN O
ester NN O
PMA NNP O
, , O
which WDT O
uncouples VBZ O
the DT O
muscarinic NN O
receptor NN O
from IN O
phospholipase NN O
C NNP O
, , O
reduced VBD O
the DT O
transient JJ O
rise NN O
in IN O
[ NN O
Ca MD O
] SYM O
i NN O
by IN O
approximately RB O
50 CD O
% NN O
with IN O
little JJ O
or CC O
no DT O
effect NN O
on IN O
Ca JJ O
entry NN O
at IN O
higher JJR O
CCh NN O
levels NNS O
( -LRB- O
> NN O
or CC O
= SYM O
1 CD O
microM NN O
) -RRB- O
. . O

At IN O
lower JJR O
CCh NN O
concentrations NNS O
( -LRB- O
< NN O
or CC O
= SYM O
100 CD O
nM NNS O
) -RRB- O
however RB O
, , O
pretreatment NN O
with IN O
PMA NNP O
completely RB O
blocked VBD O
all DT O
Ca JJ O
mobilization NN O
and CC O
supports VBZ O
the DT O
contention NN O
that IN O
Ca JJ O
entry NN O
is VBZ O
coupled VBN O
to TO O
Ca MD O
release VB O
from IN O
stores NNS O
or CC O
to TO O
store VB O
depletion NN O
. . O

The DT O
emptying JJ O
of IN O
inositol NN O
trisphosphate NN O
- : O
sensitive JJ O
stores NNS O
with IN O
thapsigargin DT O
( -LRB- O
10 CD O
nM NN O
) -RRB- O
stimulated VBN O
Ca JJ O
entry NN O
and CC O
also RB O
the DT O
rate NN O
of IN O
Mn2 NNP O
+ NNP O
quenching NN O
. . O

Store NNP O
depletion NN O
by IN O
incubation NN O
in IN O
Ca JJ O
- : O
free JJ O
media NNS O
likewise RB O
stimulated VBN O
Mn2 IN O
+ NN O
uptake NN O
without IN O
a DT O
rise NN O
in IN O
[ NN O
Ca MD O
] VB O
i NN O
. . O

Our PRP$ O
data NNS O
are VBP O
therefore RB O
consistent JJ O
with IN O
a DT O
' '' O
capacitative JJ O
' '' O
coupling NN O
model NN O
, , O
whereby WRB O
the DT O
activation NN O
of IN O
the DT O
plasma NN O
membrane NN O
receptor NN O
leads VBZ O
to TO O
an DT O
InsP3 NNP O
- : O
induced JJ O
change NN O
in IN O
the DT O
degree NN O
of IN O
filling NN O
of IN O
the DT O
ER NNP O
Ca MD O
pool NN O
. . O
( -LRB- O
ABSTRACT NNP O
TRUNCATED NNP O
AT WDT O
400 CD O
WORDS NNS O
) -RRB- O

-DOCSTART- X X O

Down IN O
- : O
regulation NN O
of IN O
collagen NN O
XII NNS O
in IN O
transformed VBN O
mesenchymal JJ O
cells NNS O
. . O

Collagen NNP O
XII NNP O
is VBZ O
a DT O
complex JJ O
multidomain JJ O
protein NN O
associated VBN O
with IN O
the DT O
surface NN O
of IN O
interstitial JJ O
collagen NN O
fibrils NNS O
. . O

This DT O
protein NN O
is VBZ O
produced VBN O
in IN O
large JJ O
amounts NNS O
by IN O
fibroblasts NNS O
cultivated VBN O
in IN O
vitro NN O
. . O

However RB O
, , O
it PRP O
is VBZ O
completely RB O
absent JJ O
from IN O
cells NNS O
transformed VBN O
by IN O
the DT O
oncogene NN O
v FW O
- : O
myc JJ O
or CC O
v FW O
- : O
src NN O
and CC O
from IN O
cells NNS O
derived VBN O
from IN O
a DT O
methylcholanthrene NN O
- : O
induced VBN O
fibrosarcoma NN O
. . O

Since IN O
all PDT O
these DT O
cells NNS O
lack VBP O
any DT O
mRNA NN O
for IN O
collagen NN O
, , O
XII NNP O
, , O
it PRP O
seems VBZ O
likely JJ O
that IN O
the DT O
synthesis NN O
is VBZ O
blocked VBN O
at IN O
the DT O
transcriptional JJ O
level NN O
. . O

Experiments NNS O
with IN O
a DT O
temperature NN O
- : O
sensitive JJ O
mutant NN O
of IN O
Rous JJ O
sarcoma NN O
virus NN O
demonstrated VBD O
that IN O
a DT O
single JJ O
oncogene NN O
product NN O
is VBZ O
sufficient JJ O
to TO O
inhibit VB O
the DT O
synthesis NN O
. . O

A DT O
reduction NN O
in IN O
the DT O
expression NN O
of IN O
collagen NN O
XII NNP O
might MD O
have VB O
profound JJ O
effects NNS O
on IN O
the DT O
stability NN O
of IN O
the DT O
extracellular JJ O
matrix NN O
of IN O
transformed VBN O
cells NNS O
. . O

-DOCSTART- X X O

Comparative JJ O
NMR NNP O
study NN O
of IN O
a DT O
differentiated JJ O
rat NN O
hepatoma NN O
and CC O
its PRP$ O
dedifferentiated JJ O
subclone NN O
cultured VBD O
as IN O
spheroids NNS O
and CC O
as IN O
implanted JJ O
tumors NNS O
. . O

H4IIEC3 PRP B-NP
( -LRB- O
H4 IN B-NP
) -RRB- O
, , O
a DT O
differentiated JJ O
rat NN O
hepatoma NN O
line NN O
and CC O
H5 CD B-NP
, , O
its PRP$ O
dedifferentiated JJ O
subclone NN O
, , O
were VBD O
investigated VBN O
as IN O
proliferating VBG O
spheroids NNS O
and CC O
as IN O
implanted JJ O
subcutaneous JJ O
tumors NNS O
in IN O
juvenile JJ O
rats NNS O
. . O

H4 IN B-NP
cells NNS O
formed VBN O
tight JJ O
, , O
round JJ O
spheroids NNS O
whereas IN O
H5 CD B-NP
cells NNS O
formed VBN O
loose RB O
, , O
grape VB O
- : O
like IN O
structures NNS O
. . O

31P JJ O
MR NNP O
spectra NN O
showed VBD O
that IN O
phosphocreatine NN O
was VBD O
present JJ O
in IN O
H5 CD B-NP
spheroids NNS O
but CC O
not RB O
in IN O
H4 NNP B-NP
spheroids NNS O
or CC O
tumors NNS O
. . O

[ JJ O
13C JJ O
] SYM O
Lactate JJ O
production NN O
from IN O
[ NNP O
13C CD O
] NN O
glucose NN O
, , O
with IN O
no DT O
detectable JJ O
uptake NN O
of IN O
[ JJ O
13C JJ O
] SYM O
alanine JJR O
, , O
indicated VBD O
that IN O
energy NN O
production NN O
in IN O
H5 CD B-NP
spheroids NNS O
was VBD O
primarily RB O
via IN O
glycolysis NN O
. . O

No DT O
[ JJ O
13C JJ O
] SYM O
glucose DT O
utilization NN O
was VBD O
detected VBN O
in IN O
H4 NNP B-NP
spheroids NNS O
, , O
but CC O
uptake NN O
of IN O
alanine NN O
and CC O
accumulation NN O
of IN O
labeled VBN O
lactate NN O
, , O
glutamate NN O
and CC O
glutamine NN O
indicated VBD O
oxidation NN O
via IN O
the DT O
tricarboxylic JJ O
acid NN O
( -LRB- O
TCA NNP O
) -RRB- O
cycle NN O
. . O

Tumors NNS O
of IN O
H4 NNP B-NP
cells NNS O
were VBD O
well RB O
perfused VBN O
, , O
unlike IN O
tumors NNS O
of IN O
H5 CD B-NP
cells NNS O
which WDT O
were VBD O
highly RB O
necrotic JJ O
. . O

Following VBG O
i FW O
. . O
v FW O
. . O
infusion NN O
with IN O
[ JJ O
13C JJ O
] SYM O
alanine JJR O
, , O
[ JJ O
13C JJ O
] SYM O
lactate NN O
and CC O
glutamate NN O
, , O
evidence NN O
of IN O
oxidation NN O
via IN O
the DT O
TCA NNP O
cycle NN O
, , O
were VBD O
observed VBN O
in IN O
H4 NNP B-NP
tumors NNS O
. . O

Thus RB O
the DT O
results NNS O
obtained VBN O
by IN O
31P JJ O
and CC O
13C JJ O
MRS NNS O
correlated VBN O
with IN O
the DT O
differentiation NN O
state NN O
of IN O
H4 NNP B-NP
and CC O
H5 NNP B-NP
spheroids NNS O
and CC O
tumors NNS O
. . O

-DOCSTART- X X O

Modulation NNP O
of IN O
apoptosis NN O
in IN O
human JJ O
myeloid JJ O
leukemic JJ O
cells NNS O
by IN O
GM NNP O
- : O
CSF NNP O
. . O

Apoptosis NNP O
( -LRB- O
programmed VBD O
cell NN O
death NN O
) -RRB- O
regulates VBZ O
cell NN O
population NN O
size NN O
. . O

To TO O
determine VB O
the DT O
mechanisms NNS O
whereby WRB O
hematopoietic JJ O
growth NN O
factors NNS O
( -LRB- O
HGFs NNS O
) -RRB- O
modulate VBP O
apoptosis NN O
in IN O
human JJ O
myeloid JJ O
leukemic JJ O
cells NNS O
, , O
we PRP O
evaluated VBD O
the DT O
roles NNS O
of IN O
protein NN O
and CC O
mRNA NN O
synthesis NN O
for IN O
altering VBG O
apoptosis NN O
in IN O
growth NN O
factor NN O
- : O
stimulated VBN O
vs JJ O
. . O
quiescent JJ O
leukemic JJ O
TF1 JJ B-NP
cells NNS O
. . O

Lysates NNS O
of IN O
cells NNS O
from IN O
the DT O
granulocyte NN O
- : O
macrophage NN O
colony NN O
- : O
stimulating NN O
factor NN O
( -LRB- O
GM NNP O
- : O
CSF NNP O
) -RRB- O
- : O
dependent JJ O
myeloid JJ O
leukemic JJ O
cell NN O
line NN O
TF1 . B-NP
were VBD O
separated VBN O
into IN O
high JJ O
molecular JJ O
weight NN O
( -LRB- O
HMW NNP O
) -RRB- O
pellets NNS O
of IN O
intact JJ O
DNA NN O
and CC O
supernatants NNS O
of IN O
fragmented JJ O
low JJ O
MW NNP O
( -LRB- O
LMW NNP O
) -RRB- O
DNA NNP O
, , O
and CC O
the DT O
DNA NNP O
purified VBN O
from IN O
these DT O
fractions NNS O
was VBD O
quantified VBN O
. . O

In IN O
the DT O
absence NN O
of IN O
both DT O
GM NNP O
- : O
CSF NNP O
and CC O
fetal NN O
bovine NN O
serum NN O
( -LRB- O
FBS NNP O
) -RRB- O
, , O
70 CD O
% NN O
of IN O
the DT O
DNA NNP O
was VBD O
fragmented JJ O
after IN O
3 CD O
days NNS O
in IN O
culture NN O
, , O
with IN O
a DT O
characteristic JJ O
apoptotic JJ O
ladder NN O
- : O
like IN O
pattern NN O
on IN O
agarose DT O
gel NNP O
electrophoresis NN O
, , O
whereas IN O
this DT O
proportion NN O
had VBD O
initially RB O
been VBN O
< IN O
5 CD O
% NN O
. . O

In IN O
contrast NN O
, , O
less JJR O
than IN O
5 CD O
% NN O
of IN O
the DT O
DNA NNP O
was VBD O
fragmented JJ O
in IN O
cells NNS O
incubated VBN O
with IN O
GM NNP O
- : O
CSF NNP O
plus CC O
FBS NNP O
or CC O
GM NNP O
- : O
CSF NNP O
alone RB O
. . O

Delayed JJ O
addition NN O
of IN O
GM NNP O
- : O
CSF NNP O
, , O
but CC O
not RB O
FBS NNP O
, , O
permitted VBN O
partial JJ O
rescue NN O
of IN O
the DT O
cells NNS O
, , O
inhibiting VBG O
increasing VBG O
rates NNS O
of IN O
accumulation NN O
of IN O
fragmented JJ O
DNA NN O
. . O

When WRB O
the DT O
macro FW O
- : O
molecular JJ O
synthesis NN O
inhibitor NN O
cycloheximide NN O
( -LRB- O
CHX NNP O
) -RRB- O
or CC O
actinomycin NN O
D NNP O
( -LRB- O
Act NNP O
D NNP O
) -RRB- O
was VBD O
present JJ O
for IN O
26 CD O
hours NNS O
in IN O
the DT O
absence NN O
of IN O
GM NNP O
- : O
CSF NNP O
and CC O
FBS NNP O
, , O
apoptosis NN O
was VBD O
inhibited VBN O
. . O

In IN O
contrast NN O
, , O
in IN O
the DT O
presence NN O
of IN O
GM NNP O
- : O
CSF NNP O
or CC O
FBS NNP O
, , O
apoptosis NN O
was VBD O
enhanced VBN O
upon IN O
addition NN O
of IN O
CHX NNP O
or CC O
Act NNP O
D NNP O
. . O

The DT O
latter JJ O
effect NN O
persisted VBD O
even RB O
with IN O
the DT O
late JJ O
addition NN O
of IN O
CHX NNP O
. . O

These DT O
findings NNS O
indicate VBP O
that IN O
disparate JJ O
mechanisms NNS O
of IN O
enhancing VBG O
or CC O
inhibiting VBG O
apoptosis NN O
exist VBP O
in IN O
myeloid JJ O
leukemic JJ O
cells NNS O
related VBN O
to TO O
environmental JJ O
conditions NNS O
, , O
including VBG O
HGF NNP O
- : O
regulated VBN O
cellular JJ O
synthesis NN O
of IN O
distinct JJ O
proteins NNS O
and CC O
mRNA NNS O
. . O

-DOCSTART- X X O

Effects NNS O
of IN O
doxycycline NN O
on IN O
in IN O
vitro NN O
growth NN O
, , O
migration NN O
, , O
and CC O
gelatinase JJ O
activity NN O
of IN O
breast NN O
carcinoma NN O
cells NNS O
. . O

Metastatic NNP O
disease NN O
is VBZ O
one CD O
of IN O
the DT O
major JJ O
causes NNS O
of IN O
death NN O
from IN O
cancer NN O
in IN O
human JJ O
beings NNS O
. . O

Several JJ O
enzyme NN O
systems NNS O
have VBP O
been VBN O
implicated VBN O
in IN O
the DT O
metastatic JJ O
process NN O
, , O
but CC O
the DT O
metalloproteinases NNS O
( -LRB- O
MPs NNS O
) -RRB- O
appear VBP O
to TO O
be VB O
the DT O
major JJ O
group NN O
involved VBN O
in IN O
most JJS O
instances NNS O
of IN O
neoplastic JJ O
invasion NN O
. . O

Increased VBN O
MP NNP O
activity NN O
has VBZ O
been VBN O
correlated VBN O
with IN O
the DT O
metastatic JJ O
potential NN O
of IN O
many JJ O
cancers NNS O
, , O
including VBG O
breast NN O
cancer NN O
. . O

MPs NNS O
also RB O
play VBP O
a DT O
role NN O
in IN O
tumor NN O
angiogenesis NN O
. . O

Tetracyclines NNS O
are VBP O
antimicrobial JJ O
agents NNS O
that WDT O
can MD O
suppress VB O
MP NNP O
activity NN O
in IN O
a DT O
variety NN O
of IN O
tissues NNS O
, , O
including VBG O
gingiva NN O
, , O
bone NN O
, , O
and CC O
cartilage NN O
. . O

Several JJ O
reports NNS O
have VBP O
indicated VBN O
that IN O
tetracyclines NNS O
can MD O
suppress VB O
tumor NN O
MPs NNS O
as RB O
well RB O
. . O

A DT O
synthetic JJ O
tetracycline NN O
, , O
doxycycline NN O
, , O
inhibits VBZ O
migration NN O
of IN O
human JJ O
MDA NNS B-NP
- : I-NP
MB SYM I-NP
- : I-NP
435 CD I-NP
breast NN O
adenocarcinoma NN O
cells NNS O
through IN O
a DT O
reconstituted JJ O
basement NN O
membrane NN O
( -LRB- O
Matrigel NNP O
) -RRB- O
, , O
an DT O
assay NN O
used VBN O
as IN O
an DT O
in IN O
vitro NN O
surrogate NN O
for IN O
the DT O
in IN O
vivo JJ O
process NN O
of IN O
tumor NN O
invasion NN O
through IN O
basement NN O
membranes NNS O
. . O

Additionally RB O
, , O
doxycycline NN O
diminishes VBZ O
the DT O
proliferation NN O
of IN O
this DT O
breast NN O
cancer NN O
cell NN O
line NN O
and CC O
also RB O
decreases VBZ O
its PRP$ O
gelatinolytic JJ O
activity NN O
, , O
as IN O
determined VBN O
by IN O
gel NNP O
zymography NN O
. . O

-DOCSTART- X X O

[ NNS O
The DT O
erbB NN O
gene NN O
family NN O
: : O
significance NN O
for IN O
tumor NN O
development NN O
, , O
prognosis NN O
and CC O
new JJ O
therapeutic JJ O
modalities NNS O
] VBP O
. . O

RNA NNP O
and CC O
DNA NNP O
viruses NNS O
can MD O
be VB O
transforming JJ O
and CC O
tumourigenic JJ O
agents NNS O
. . O

The DT O
transformation NN O
is VBZ O
a DT O
consequence NN O
of IN O
the DT O
ability NN O
of IN O
viruses NNS O
to TO O
integrate VB O
into IN O
the DT O
host NN O
cell NN O
' '' O
s VBZ O
DNA NNP O
and CC O
to TO O
produce VB O
transforming JJ O
proteins NNS O
. . O

These DT O
proteins NNS O
are VBP O
mainly RB O
produced VBN O
by IN O
specific JJ O
integral JJ O
parts NNS O
of IN O
the DT O
viral JJ O
genome NN O
, , O
the DT O
oncogenes NNS O
. . O

Comparison NNP O
between IN O
RNA NNP O
/ CC O
DNA NNP O
sequence NN O
of IN O
viral JJ O
oncogenes NNS O
and CC O
normal JJ O
human JJ O
genome NN O
of IN O
non FW O
- : O
transformed VBN O
cells NNS O
revealed VBD O
high JJ O
sequence NN O
similarities NNS O
in IN O
specific JJ O
genomic JJ O
areas NNS O
, , O
which WDT O
were VBD O
named VBN O
cellular JJ O
proto NN O
- : O
oncogens NNS O
. . O

They PRP O
are VBP O
important JJ O
components NNS O
of IN O
the DT O
growth NN O
regulatory JJ O
pathways NNS O
in IN O
normal JJ O
cells NNS O
. . O

The DT O
accumulation NN O
of IN O
genetic JJ O
alterations NNS O
of IN O
some DT O
proto NN O
- : O
oncogens NNS O
, , O
like IN O
the DT O
erbB NN O
- : O
family NN O
, , O
may MD O
be VB O
part NN O
of IN O
the DT O
mechanism NN O
, , O
by IN O
which WDT O
malignant JJ O
cells NNS O
can MD O
acquire VB O
a DT O
selective JJ O
growth NN O
advantage NN O
. . O

The DT O
epidermal JJ O
growth NN O
factor NN O
receptor NN O
( -LRB- O
EGF NN O
- : O
R NN O
, , O
c SYM O
- : O
erbB1 NN O
) -RRB- O
, , O
Her PRP$ O
- : O
2 CD O
/ NN O
neu NN O
( -LRB- O
c SYM O
- : O
erbB2 NN O
) -RRB- O
, , O
and CC O
c SYM O
- : O
erbB3 NNS O
are VBP O
members NNS O
of IN O
the DT O
erbB NN O
- : O
family NN O
. . O

The DT O
detection NN O
of IN O
increased JJ O
abundance NN O
of IN O
EGF NN O
- : O
R NN O
or CC O
Her PRP$ O
- : O
2 CD O
/ NN O
neu NNS O
proteins VBZ O
in IN O
human JJ O
tumours NNS O
can MD O
provide VB O
additional JJ O
information NN O
on IN O
the DT O
disease NN O
- : O
free JJ O
survival NN O
and CC O
overall JJ O
survival NN O
for IN O
patients NNS O
with IN O
breast NN O
, , O
ovarian JJ O
, , O
endometrial JJ O
or CC O
cervical JJ O
cancer NN O
. . O

Molecular JJ O
and CC O
cell NN O
- : O
physiological JJ O
analyses NNS O
have VBP O
improved VBN O
the DT O
understanding NN O
of IN O
tumour JJ O
biology NN O
and CC O
provide VB O
the DT O
opportunity NN O
for IN O
new JJ O
therapeutic JJ O
approaches NNS O
. . O

Monoclonal NNP O
antibody NN O
targeted VBN O
therapy NN O
directed VBN O
against IN O
EGF NNP O
- : O
R NN O
or CC O
Her PRP$ O
- : O
2 CD O
/ NN O
neu NN O
, , O
the DT O
use NN O
of IN O
anti NNS O
- : O
sense NN O
oligonucleotides NNS O
and CC O
oligodeoxynucleotides NNS O
, , O
and CC O
the DT O
application NN O
of IN O
tyrosine NN O
kinase NN O
and CC O
protein NN O
C NNP O
- : O
kinase NN O
inhibitors NNS O
are VBP O
currently RB O
being VBG O
investigated VBN O
. . O

-DOCSTART- X X O

Transforming VBG O
growth NN O
factor NN O
beta NN O
1 CD O
promotes VBZ O
spontaneous JJ O
transformation NN O
of IN O
cultured JJ O
rat NN O
liver NN O
epithelial NN O
cells NNS O
. . O

The DT O
neoplastic JJ O
transformation NN O
of IN O
cultured JJ O
rat NN O
liver NN O
epithelial NN O
cells NNS O
by IN O
various JJ O
means NNS O
has VBZ O
consistently RB O
been VBN O
associated VBN O
with IN O
the DT O
development NN O
of IN O
resistance NN O
to TO O
the DT O
mito NN O
- : O
inhibitory JJ O
effect NN O
of IN O
transforming VBG O
growth NN O
factor NN O
beta NN O
( -LRB- O
TGF FW O
- : O
beta NN O
) -RRB- O
, , O
suggesting VBG O
that IN O
such JJ O
phenotype NN O
plays VBZ O
a DT O
mechanistic JJ O
role NN O
during IN O
the DT O
transformation NN O
of IN O
these DT O
cells NNS O
. . O

We PRP O
have VBP O
studied VBN O
the DT O
induction NN O
of IN O
the DT O
" `` O
TGF NNP O
- : O
beta JJ O
- : O
resistant JJ O
" `` O
phenotype NN O
in IN O
a DT O
clonal JJ O
strain NN O
of IN O
early JJ O
passage NN O
WB IN B-NP
- : I-NP
F344 IN I-NP
normal JJ O
cultured JJ O
rat NN O
liver NN O
epithelial NN O
cells NNS O
, , O
the DT O
proliferation NN O
of IN O
which WDT O
was VBD O
markedly RB O
inhibited VBN O
by IN O
TGF NNP O
- : O
beta NN O
. . O

The DT O
control NN O
WB IN O
cells NNS O
in IN O
continuous JJ O
culture NN O
slowly RB O
developed VBD O
TGF NNP O
- : O
beta JJ O
resistance NN O
. . O

However RB O
, , O
when WRB O
the DT O
same JJ O
cells NNS O
were VBD O
exposed VBN O
to TO O
step VB O
- : O
wise JJ O
increases NNS O
of IN O
TGF NNP O
- : O
beta JJ O
concentration NN O
in IN O
their PRP$ O
culture NN O
medium NN O
, , O
the DT O
development NN O
of IN O
TGF NNP O
- : O
beta JJ O
resistance NN O
was VBD O
accelerated VBN O
. . O

Cells NNP O
which WDT O
had VBD O
been VBN O
grown VBN O
in IN O
medium NN O
containing VBG O
1 CD O
ng JJ O
/ JJ O
ml NN O
TGF NN O
- : O
beta JJ O
developed JJ O
colony NN O
- : O
forming VBG O
capacity NN O
in IN O
soft JJ O
agar NN O
containing VBG O
epidermal JJ O
growth NN O
factor NN O
. . O

Cells NNP O
which WDT O
were VBD O
grown VBN O
in IN O
media NNS O
containing VBG O
5 CD O
and CC O
10 CD O
ng JJ O
/ JJ O
ml NN O
TGF NN O
- : O
beta NN O
demonstrated VBD O
a DT O
low JJ O
level NN O
of IN O
colony NN O
- : O
forming VBG O
efficiency NN O
in IN O
soft JJ O
agar NN O
medium NN O
without IN O
added VBD O
epidermal JJ O
growth NN O
factor NN O
and CC O
tumorigenicity NN O
in IN O
isogeneic JJ O
rats NNS O
. . O

These DT O
TGF NNP O
- : O
beta JJ O
- : O
resistant JJ O
cells NNS O
also RB O
exhibited VBD O
progressively RB O
increasing VBG O
levels NNS O
of IN O
expression NN O
of IN O
the DT O
c NN O
- : O
fos NNS O
and CC O
and CC O
myc JJ O
mRNA NN O
, , O
and CC O
increased VBD O
resistance NN O
to TO O
the DT O
cytotoxicity NN O
of IN O
Adriamycin NNP O
and CC O
melphalan NN O
. . O

The DT O
latter JJ O
phenomenon NN O
was VBD O
accompanied VBN O
by IN O
an DT O
increase NN O
in IN O
the DT O
mdr NN O
- : O
1 CD O
mRNA NN O
expression NN O
, , O
cellular JJ O
glutathione NN O
level NN O
, , O
and CC O
glutathione NN O
S NNP O
- : O
transferase NN O
activity NN O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
chronic JJ O
exposure NN O
to TO O
high JJ O
concentration NN O
of IN O
TGF JJ O
- : O
beta NN O
promotes VBZ O
the DT O
spontaneous JJ O
neoplastic JJ O
transformation NN O
of IN O
cultured JJ O
rat NN O
liver NN O
epithelial NN O
cells NNS O
, , O
and CC O
that IN O
this DT O
process NN O
may MD O
represent VB O
one CD O
of IN O
the DT O
mechanisms NNS O
of IN O
cellular JJ O
adaptation NN O
for IN O
induction NN O
of IN O
the DT O
multidrug NN O
- : O
resistant JJ O
phenotype NN O
during IN O
the DT O
carcinogenesis NN O
of IN O
epithelial JJ O
cells NNS O
. . O

-DOCSTART- X X O

Human JJ O
cytomegalovirus NN O
elevates NNS O
levels NNS O
of IN O
the DT O
cellular JJ O
protein NN O
p53 NN O
in IN O
infected JJ O
fibroblasts NNS O
. . O

Human JJ O
cytomegalovirus NN O
( -LRB- O
HCMV NNP O
) -RRB- O
, , O
like IN O
other JJ O
DNA NNP O
tumor NN O
viruses NNS O
, , O
induces VBZ O
morphological JJ O
transformation NN O
of IN O
cells NNS O
in IN O
vitro NN O
and CC O
stimulates NNS O
host NN O
cell NN O
macromolecular JJ O
synthesis NN O
in IN O
infected JJ O
cells NNS O
. . O

Since IN O
other JJ O
DNA NNP O
tumor NN O
viruses NNS O
, , O
such JJ O
as IN O
simian JJ O
virus NN O
40 CD O
and CC O
adenovirus NN O
, , O
have VBP O
previously RB O
been VBN O
shown VBN O
to TO O
interact VB O
with IN O
cellular JJ O
protein NN O
p53 NN O
, , O
we PRP O
investigated VBD O
whether IN O
infection NN O
of IN O
cells NNS O
by IN O
HCMV NNP O
would MD O
modulate VB O
cellular JJ O
p53 NN O
levels NNS O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
HCMV NNP O
elevates NNS O
cellular JJ O
p53 NN O
levels NNS O
on IN O
the DT O
order NN O
of IN O
10 CD O
- : O
to TO O
20 CD O
- : O
fold NN O
in IN O
infected JJ O
fibroblasts NNS O
. . O

The DT O
induction NN O
of IN O
elevated VBN O
p53 NN O
levels NNS O
was VBD O
dependent JJ O
upon IN O
the DT O
presence NN O
of IN O
active JJ O
virus NN O
and CC O
was VBD O
prevented VBN O
by IN O
neutralizing VBG O
antibody NN O
. . O

The DT O
induction NN O
of IN O
elevated VBN O
p53 NN O
levels NNS O
was VBD O
determined VBN O
not RB O
to TO O
be VB O
due JJ O
to TO O
virus NN O
- : O
receptor NN O
interactions NNS O
or CC O
HCMV VB O
late JJ O
events NNS O
. . O

The DT O
induction NN O
of IN O
elevated VBN O
p53 NN O
levels NNS O
commenced VBD O
at IN O
immediate JJ O
- : O
early JJ O
times NNS O
of IN O
the DT O
HCMV NNP O
multiplication NN O
cycle NN O
( -LRB- O
6 CD O
h NN O
postinfection NN O
) -RRB- O
and CC O
reached VBD O
maximal JJ O
levels NNS O
by IN O
24 CD O
h NN O
postinfection NN O
, , O
before IN O
most JJS O
of IN O
the DT O
HCMV NNP O
DNA NNP O
synthesis NN O
was VBD O
initiated VBN O
. . O

HCMV VB O
immediate JJ O
- : O
early JJ O
proteins NNS O
were VBD O
clearly RB O
shown VBN O
to TO O
be VB O
responsible JJ O
for IN O
elevating VBG O
p53 NN O
levels NNS O
in IN O
infected JJ O
fibroblasts NNS O
; : O
expression NN O
of IN O
HCMV NNP O
immediate JJ O
- : O
early JJ O
region NN O
1 CD O
and CC O
2 CD O
proteins VBZ O
resulted VBN O
in IN O
elevation NN O
of IN O
p53 NN O
levels NNS O
in IN O
transfected VBN O
human JJ O
fibroblasts NNS O
. . O

This DT O
is VBZ O
the DT O
first JJ O
report NN O
of IN O
increased VBN O
p53 NN O
levels NNS O
caused VBN O
by IN O
HCMV NNP O
in IN O
infected JJ O
fibroblasts NNS O
. . O

-DOCSTART- X X O

Appetite NNP O
regulation NN O
by IN O
serotoninergic JJ O
mechanisms NNS O
and CC O
effects NNS O
of IN O
d JJ O
- : O
fenfluramine NN O
. . O

In IN O
this DT O
literature NN O
review NN O
, , O
evidence NN O
is VBZ O
presented VBN O
for IN O
the DT O
theory NN O
that IN O
the DT O
neurotransmitter NN O
, , O
serotonin FW O
( -LRB- O
5 CD O
- : O
hydroxytryptamine NN O
, , O
5HT JJ O
) -RRB- O
, , O
in IN O
medial JJ O
hypothalamic JJ O
centres NNS O
is VBZ O
an DT O
important JJ O
regulator NN O
for IN O
appetite NN O
and CC O
for IN O
the DT O
selection NN O
of IN O
major JJ O
food NN O
constituents NNS O
. . O

High JJ O
local JJ O
levels NNS O
of IN O
5HT JJ O
cause NN O
a DT O
reduction NN O
of IN O
appetite NN O
and CC O
a DT O
preference NN O
for IN O
protein NN O
, , O
low JJ O
levels NNS O
the DT O
opposite NN O
. . O

The DT O
main JJ O
antagonistic NN O
system NN O
is VBZ O
noradrenergic JJ O
. . O

The DT O
drug NN O
d NN O
- : O
fenfluramine NN O
mimics NNS O
the DT O
effects NNS O
of IN O
5HT JJ O
by IN O
releasing VBG O
5HT JJ O
from IN O
serotoninergic JJ O
nerve NN O
endings NNS O
and CC O
inhibiting VBG O
its PRP$ O
neuronal JJ O
re NN O
- : O
uptake NN O
. . O

Further JJ O
experimental JJ O
data NNS O
prove VBP O
that IN O
a DT O
high JJ O
- : O
carbohydrate NN O
, , O
low JJ O
- : O
protein NN O
diet NN O
promotes NNS O
uptake NN O
of IN O
serum NN O
tryptophan VBN O
in IN O
the DT O
brain NN O
and CC O
its PRP$ O
conversion NN O
into IN O
5HT JJ O
. . O

Hence RB O
, , O
this DT O
serotoninergic JJ O
system NN O
may MD O
function VB O
as IN O
a DT O
self NN O
- : O
regulatory JJ O
mechanism NN O
. . O

In IN O
patients NNS O
with IN O
decreased VBN O
peripheral JJ O
insulin NN O
sensitivity NN O
, , O
the DT O
system NN O
may MD O
be VB O
disturbed VBN O
, , O
causing VBG O
overconsumption IN O
of IN O
carbohydrates NNS O
. . O

This DT O
is VBZ O
sometimes RB O
compulsive JJ O
( -LRB- O
" `` O
carbohydrate VB O
craving JJ O
" '' O
) -RRB- O
. . O

It PRP O
may MD O
be VB O
presumed VBN O
that IN O
in IN O
the DT O
treatment NN O
of IN O
obesity NN O
, , O
in IN O
addition NN O
to TO O
the DT O
use NN O
of IN O
serotoninergic JJ O
drugs NNS O
, , O
successes NNS O
with IN O
reducing VBG O
diets NNS O
may MD O
be VB O
enhanced VBN O
by IN O
including VBG O
periods NNS O
of IN O
high JJ O
- : O
carbohydrate NN O
, , O
low JJ O
- : O
protein NN O
intake NN O
. . O

It PRP O
would MD O
be VB O
worthwhile JJ O
to TO O
explore VB O
whether IN O
similar JJ O
alimentary JJ O
self NN O
- : O
regulatory JJ O
mechanisms NNS O
of IN O
neurotransmitter NN O
function NN O
exist VBP O
in IN O
other JJ O
regulatory JJ O
systems NNS O
. . O

-DOCSTART- X X O

Comparison NN O
of IN O
image NN O
( -LRB- O
CAS NNP O
200 CD O
) -RRB- O
and CC O
flow NN O
cytometry NN O
determined VBN O
DNA NNP O
content NN O
of IN O
paraffin NN O
- : O
embedded VBN O
Hodgkin NNP O
' POS O
s PRP O
disease NN O
tissue NN O
. . O

To TO O
assess VB O
the DT O
reliability NN O
of IN O
DNA NNP O
estimation NN O
using VBG O
image NN O
cytometry NN O
, , O
deparaffinized VBD O
lymph NN O
nodes NNS O
from IN O
70 CD O
patients NNS O
with IN O
Hodgkin NNP O
' POS O
s PRP O
disease NN O
were VBD O
examined VBN O
and CC O
the DT O
results NNS O
obtained VBN O
were VBD O
compared VBN O
with IN O
those DT O
from IN O
flow NN O
cytometry NN O
. . O

Image NNP O
analysis NN O
without IN O
discriminating VBG O
between IN O
the DT O
various JJ O
cell NN O
types NNS O
, , O
as IN O
found VBN O
in IN O
Hodgkin NNP O
' POS O
s PRP O
disease NN O
, , O
revealed VBD O
no DT O
separate JJ O
aneuploid JJ O
peak NN O
. . O

Selecting VBG O
on IN O
morphologically RB O
defined VBN O
nuclear JJ O
types NNS O
DNA NN O
aneuploidy NN O
was VBD O
detected VBN O
in IN O
20 CD O
% NN O
of IN O
the DT O
cases NNS O
( -LRB- O
14 CD O
/ NN O
70 CD O
) -RRB- O
. . O

The DT O
aneuploid JJ O
populations NNS O
were VBD O
limited VBN O
to TO O
the DT O
population NN O
of IN O
nuclei JJ O
defined VBN O
as IN O
Reed NNP O
- : O
Sternberg NNP O
( -LRB- O
RS NNS O
) -RRB- O
- : O
like IN O
or CC O
medium JJ O
- : O
sized JJ O
lymphocytes NNS O
. . O

Benign NNP O
lymph NN O
nodes VBZ O
DNA NNP O
aneuploidy NN O
was VBD O
not RB O
found VBN O
in IN O
any DT O
of IN O
the DT O
controls NNS O
. . O

Comparison NNP O
of IN O
DNA NNP O
histograms NNS O
obtained VBN O
by IN O
image NN O
and CC O
flow NN O
cytometry NN O
showed VBD O
aneuploid JJ O
peaks NNS O
using VBG O
image NN O
cytometry NN O
in IN O
4 CD O
of IN O
30 CD O
diploid JJ O
and CC O
10 CD O
of IN O
40 CD O
aneuploid JJ O
flow NN O
histograms NNS O
. . O

In IN O
conclusion NN O
, , O
image NN O
analysis NN O
using VBG O
the DT O
CAS NNP O
200 CD O
system NN O
as IN O
compared VBN O
to TO O
flow VB O
cytometry NN O
is VBZ O
more JJR O
time NN O
- : O
consuming NN O
and CC O
less JJR O
sensitive JJ O
to TO O
assess VB O
ploidy JJ O
status NN O
, , O
although IN O
it PRP O
may MD O
provide VB O
extra JJ O
information NN O
in IN O
some DT O
selected JJ O
cases NNS O
. . O

Evidence NN O
is VBZ O
obtained VBN O
that IN O
DNA NNP O
aneuploidy RB O
in IN O
Hodgkin NNP O
' POS O
s PRP O
disease NN O
is VBZ O
preferentially RB O
expressed VBN O
by IN O
cells NNS O
with IN O
the DT O
RS NNP O
/ NNP O
H NNP O
- : O
like JJ O
and CC O
medium JJ O
- : O
sized JJ O
lymphocyte NN O
morphology NN O
. . O

-DOCSTART- X X O

Inhibition NN O
of IN O
calmodulin NN O
- : O
dependent JJ O
myosin RP O
light JJ O
- : O
chain NN O
kinase NN O
by IN O
growth NN O
- : O
hormone NN O
- : O
releasing VBG O
factor NN O
and CC O
vasoactive JJ O
intestinal JJ O
peptide NN O
. . O

In IN O
view NN O
of IN O
the DT O
ability NN O
of IN O
calmodulin NN O
to TO O
bind NN O
vasoactive JJ O
intestinal JJ O
peptide NN O
( -LRB- O
VIP NN O
) -RRB- O
and CC O
growth NN O
- : O
hormone NN O
- : O
releasing NN O
factor NN O
( -LRB- O
GRF NN O
) -RRB- O
with IN O
high JJ O
affinity NN O
[ NN O
Stallwood NNP O
, , O
Brugger NNP O
, , O
Baggenstoss NNP O
, , O
Stemmer NNP O
, , O
Shiraga NNP O
, , O
Landers NNP O
and CC O
Paul NNP O
( -LRB- O
1992 CD O
) -RRB- O
J NNP O
. . O
Biol NNP O
. . O
Chem NNP O
. . O
267 CD O
, , O
19617 CD O
- : O
19621 CD O
] NN O
, , O
the DT O
effects NNS O
of IN O
these DT O
neuropeptides NNS O
on IN O
a DT O
model NN O
calmodulin NN O
- : O
dependent JJ O
enzyme NN O
, , O
myosin VB O
light JJ O
- : O
chain NN O
kinase NN O
( -LRB- O
MLCK NNP O
) -RRB- O
, , O
were VBD O
studied VBN O
. . O

Both DT O
peptides NNS O
were VBD O
potent JJ O
inhibitors NNS O
of IN O
MLCK NNP O
activity NN O
. . O

The DT O
inhibition NN O
of IN O
enzyme NN O
activity NN O
by IN O
VIP NNP O
and CC O
GRF NNP O
was VBD O
progressively RB O
overcome VBN O
with IN O
increasing VBG O
calmodulin NN O
concentrations NNS O
, , O
with IN O
no DT O
inhibition NN O
observed VBD O
at IN O
a DT O
saturating NN O
calmodulin NN O
concentration NN O
. . O

Nanomolar NNP O
concentrations NNS O
of IN O
MLCK NNP O
blocked VBD O
the DT O
formation NN O
of IN O
calmodulin NN O
- : O
[ NN O
125I CD O
- : O
Tyr10 CD O
] NN O
VIP NNP O
complexes NNS O
. . O

These DT O
data NNS O
provide VBP O
support NN O
for IN O
a DT O
functional JJ O
role NN O
of IN O
VIP NNP O
and CC O
GRF NNP O
binding NN O
by IN O
calmodulin NN O
. . O

-DOCSTART- X X O

Cyclin NNP O
D1 NNP O
/ , O
bcl JJ O
- : O
1 CD O
cooperates NNS O
with IN O
myc JJ O
genes NNS O
in IN O
the DT O
generation NN O
of IN O
B NNP O
- : O
cell NN O
lymphoma NN O
in IN O
transgenic JJ O
mice NNS O
. . O

The DT O
chromosomal NN O
translocation NN O
t NN O
( -LRB- O
11 CD O
: : O
14 CD O
) -RRB- O
is VBZ O
associated VBN O
with IN O
human JJ O
lymphoid NN O
neoplasia NN O
affecting VBG O
centrocytic JJ O
B NNP O
- : O
cells NNS O
of IN O
intermediate JJ O
differentiation NN O
. . O

As IN O
a DT O
consequence NN O
the DT O
cyclin NN O
D1 IN O
( -LRB- O
bcl NN O
- : O
1 CD O
) -RRB- O
gene NN O
is VBZ O
juxtaposed VBN O
to TO O
the DT O
immunoglobulin NN O
heavy JJ O
chain NN O
enhancer NN O
E NNP O
mu NN O
. . O

To TO O
show VB O
that DT O
transcriptional JJ O
activation NN O
of IN O
cyclin NN O
D1 NNP O
is VBZ O
causally RB O
involved VBN O
in IN O
the DT O
generation NN O
of IN O
B NNP O
- : O
cell NN O
neoplasia NN O
we PRP O
have VBP O
generated VBN O
transgenic JJ O
mice NNS O
that WDT O
carry VBP O
a DT O
cyclin NN O
D1 NNP O
gene NN O
under IN O
the DT O
transcriptional JJ O
control NN O
of IN O
the DT O
E NNP O
mu NN O
element NN O
. . O

E NNP O
mu NN O
cyclin NN O
D1 IN O
transgenic JJ O
mice NNS O
show VBP O
only RB O
very RB O
subtle JJ O
alterations NNS O
in IN O
the DT O
cycling NN O
behaviour NN O
of IN O
B NNP O
- : O
cell NN O
populations NNS O
in IN O
the DT O
bone NN O
marrow NN O
compared VBN O
with IN O
normal JJ O
mice NNS O
and CC O
do VBP O
not RB O
develop VB O
lymphoid JJ O
tumours NNS O
. . O

However RB O
, , O
E NNP O
mu MD O
- : O
directed VBN O
coexpression NN O
of IN O
cyclin NN O
D1 NNP O
and CC O
N NNP O
- : O
MYC NNP O
or CC O
L NNP O
- : O
MYC RB O
in IN O
double JJ O
transgenic NN O
mice NNS O
reveals VBZ O
a DT O
strong JJ O
cooperative JJ O
effect NN O
between IN O
MYC NNP O
and CC O
cyclin NN O
D1 IN O
provoking VBG O
the DT O
rapid JJ O
development NN O
of IN O
clonal JJ O
pre NN O
- : O
B NN O
and CC O
B NNP O
- : O
cell NN O
lymphomas NNS O
. . O

Interestingly RB O
, , O
crossing VBG O
of IN O
cyclin NN O
D1 IN O
transgenic JJ O
mice NNS O
with IN O
E NNP O
mu NN O
L NNP O
- : O
myc JJ O
transgenics NNS O
that WDT O
express VBP O
their PRP$ O
transgene NN O
in IN O
both DT O
B NNP O
- : O
and CC O
T NNP O
- : O
cells NNS O
but CC O
predominantly RB O
develop VB O
T NNP O
- : O
cell NN O
tumours NNS O
leads VBZ O
in IN O
double JJ O
transgenics NNS O
exclusively RB O
to TO O
B NNP O
- : O
cell NN O
neoplasia NN O
. . O

The DT O
data NNS O
presented VBN O
here RB O
demonstrate VBP O
that IN O
transcriptional JJ O
activation NN O
of IN O
cyclin NN O
D1 NNP O
can MD O
oncogenically RB O
transform VB O
B NNP O
- : O
cells NNS O
in IN O
concert NN O
with IN O
a DT O
myc JJ O
gene NN O
. . O

They PRP O
establish VBP O
cyclin NN O
D1 NNS O
as IN O
a DT O
proto NN O
- : O
oncogene NN O
whose WP$ O
activity NN O
appears VBZ O
to TO O
depend VB O
on IN O
a DT O
specific JJ O
cell NN O
type NN O
as RB O
well RB O
as IN O
on IN O
a DT O
specific JJ O
cooperating VBG O
partner NN O
and CC O
link NN O
disturbances NNS O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
cycle NN O
progression NN O
to TO O
the DT O
development NN O
of IN O
human JJ O
malignancies NNS O
. . O

-DOCSTART- X X O

Imaging VBG O
techniques NNS O
for IN O
the DT O
assessment NN O
of IN O
body NN O
composition NN O
. . O

Three CD O
imaging VBG O
methods NNS O
, , O
ultrasound JJ O
imaging NN O
( -LRB- O
UI NNP O
) -RRB- O
, , O
computer NN O
- : O
assisted VBN O
axial NN O
tomography NN O
( -LRB- O
CAT NN O
) -RRB- O
and CC O
magnetic JJ O
resonance NN O
imaging NN O
( -LRB- O
MRI NNP O
) -RRB- O
, , O
are VBP O
widely RB O
used VBN O
in IN O
medicine NN O
. . O

Their PRP$ O
application NN O
to TO O
the DT O
assessment NN O
of IN O
body NN O
composition NN O
in IN O
nutrition NN O
research NN O
is VBZ O
still RB O
being VBG O
explored VBN O
and CC O
developed VBN O
. . O

Ultrasound NNP O
imaging VBG O
yields NNS O
poor JJ O
image NN O
quality NN O
but CC O
, , O
because IN O
it PRP O
is VBZ O
cheap JJ O
and CC O
safe JJ O
, , O
deserves VBZ O
further JJ O
exploration NN O
. . O

Both DT O
CAT NNP O
and CC O
MRI NNP O
can MD O
produce VB O
images NNS O
with IN O
good JJ O
discrimination NN O
among IN O
bone NN O
, , O
muscle NN O
and CC O
adipose VB O
tissue NN O
. . O

Movement VB O
artifacts NNS O
tend VB O
to TO O
be VB O
more RBR O
serious JJ O
in IN O
MRI NNP O
than IN O
in IN O
CAT NN O
due JJ O
to TO O
the DT O
longer JJR O
imaging NN O
time NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
the DT O
X NNP O
- : O
ray NN O
exposure NN O
in IN O
CAT NN O
is VBZ O
likely JJ O
to TO O
limit VB O
its PRP$ O
use NN O
in IN O
human JJ O
nutrition NN O
research NN O
. . O

Repeated VBN O
measurements NNS O
of IN O
tissue NN O
volumes NNS O
by IN O
CAT NNP O
and CC O
MRI NNP O
give VBP O
similar JJ O
CV NN O
. . O

In IN O
both DT O
CAT NNP O
and CC O
MRI NNP O
, , O
intra NN O
- : O
abdominal JJ O
adipose JJ O
tissue NN O
presents VBZ O
greater JJR O
problems NNS O
of IN O
measurement NN O
than IN O
subcutaneous JJ O
adipose JJ O
tissue NN O
. . O

Validation NNP O
studies NNS O
with IN O
77 CD O
- : O
kg NN O
pigs NNS O
of IN O
MRI NNP O
, , O
using VBG O
13 CD O
slices NNS O
, , O
predicted VBD O
total JJ O
body NN O
lipid VBD O
with IN O
residual JJ O
standard JJ O
deviation NN O
of IN O
1 CD O
. . O
9 CD O
% NN O
. . O

In IN O
validating VBG O
any DT O
of IN O
these DT O
methods NNS O
, , O
account VBP O
should MD O
be VB O
take VB O
of IN O
the DT O
extent NN O
to TO O
which WDT O
the DT O
information NN O
they PRP O
give VBP O
can MD O
augment VB O
that DT O
given VBN O
by IN O
more JJR O
simple JJ O
measures NNS O
like IN O
age NN O
and CC O
weight NN O
. . O

-DOCSTART- X X O

[ NN O
Preliminary JJ O
results NNS O
of IN O
observing VBG O
18 CD O
cases NNS O
of IN O
retinoblastoma NN O
carried VBD O
within IN O
the DT O
international JJ O
research NN O
program NN O
RICS NNP O
] NNP O
. . O

In IN O
the DT O
years NNS O
1988 CD O
- : O
1989 CD O
, , O
the DT O
Ophthalmological NNP O
Clinic NNP O
in IN O
Cracow NNP O
took VBD O
part NN O
in IN O
the DT O
International NNP O
Research NNP O
Programme NNP O
on IN O
Retinoblastoma NNP O
as IN O
one CD O
of IN O
28 CD O
clinical JJ O
centres NNS O
in IN O
14 CD O
countries NNS O
. . O

The DT O
study NN O
included VBD O
18 CD O
children NNS O
with IN O
retinoblastoma NN O
, , O
in IN O
most JJS O
cases NNS O
in IN O
the DT O
advanced JJ O
stadium NN O
of IN O
the DT O
disease NN O
. . O

As IN O
a DT O
rule NN O
, , O
the DT O
eyes NNS O
filled VBN O
with IN O
tumours NNS O
were VBD O
enucleated VBN O
, , O
and CC O
the DT O
less RBR O
advanced JJ O
cases NNS O
were VBD O
treated VBN O
with IN O
combined VBN O
methods NNS O
applying VBG O
radiation NN O
with IN O
60Co CD O
plaques NNS O
with IN O
xenon NN O
arc NN O
photocoagulation NN O
, , O
cryopexy NN O
, , O
and CC O
chemotherapy NN O
. . O

In IN O
18 CD O
treated VBN O
children NNS O
23 CD O
eyes NNS O
were VBD O
enucleated VBN O
( -LRB- O
in IN O
5 CD O
children NNS O
both DT O
eyes NNS O
, , O
in IN O
6 CD O
children NNS O
with IN O
bilateral JJ O
retinoblastoma NN O
1 CD O
eye NN O
, , O
and CC O
7 CD O
eyes NNS O
in IN O
all DT O
unilateral JJ O
cases NNS O
) -RRB- O
. . O

Six CD O
eyes NNS O
with IN O
less JJR O
advanced JJ O
lesions NNS O
were VBD O
treated VBN O
with IN O
combined VBN O
methods NNS O
. . O

One CD O
child NN O
died VBD O
because IN O
of IN O
metastases NNS O
to TO O
the DT O
brain NN O
. . O

The DT O
obtained VBN O
data NNS O
reveal VBP O
that IN O
retinoblastoma NN O
is VBZ O
diagnosed VBN O
too RB O
late JJ O
, , O
which WDT O
decreases VBZ O
the DT O
chance NN O
of IN O
cure NN O
and CC O
causes VBZ O
great JJ O
danger NN O
for IN O
the DT O
life NN O
of IN O
the DT O
child NN O
. . O

-DOCSTART- X X O

Identification NN O
of IN O
latency RB O
- : O
associated VBN O
transcripts NNS O
that IN O
map NN O
antisense NN O
to TO O
the DT O
ICP4 NNP O
homolog NN O
gene NN O
of IN O
Marek NNP O
' POS O
s PRP O
disease NN O
virus NN O
. . O

Two CD O
small JJ O
RNAs NNP O
( -LRB- O
0 CD O
. . O
9 CD O
and CC O
0 CD O
. . O
75 CD O
kb NN O
) -RRB- O
, , O
named VBN O
Marek NNP O
' POS O
s PRP O
disease NN O
virus NN O
( -LRB- O
MDV NN O
) -RRB- O
small JJ O
RNAs NNS O
( -LRB- O
MSRs NNS O
) -RRB- O
and CC O
a DT O
10 CD O
- : O
kb NN O
RNA NN O
, , O
all DT O
of IN O
which WDT O
map NN O
antisense NN O
to TO O
the DT O
MDV NNP O
ICP4 NNP O
homolog NN O
gene NN O
, , O
have VBP O
been VBN O
readily RB O
detected VBN O
in IN O
MDCC NNP B-NP
- : I-NP
MSB1 CD I-NP
MDV NN O
- : O
transformed VBN O
T NNP O
- : O
lymphoblastoid JJ O
cells NNS O
. . O

These DT O
RNAs NNP O
were VBD O
not RB O
detectable JJ O
in IN O
reticuloendotheliosis NN O
virus NN O
- : O
transformed VBN O
T NNP O
cells NNS O
. . O

When WRB O
MDV NNP O
was VBD O
reactivated VBN O
by IN O
treatment NN O
of IN O
lymphoblastoid JJ O
cells NNS O
with IN O
25 CD O
micrograms NNS O
of IN O
iododeoxyuridine NN O
per IN O
ml NN O
, , O
the DT O
relative JJ O
levels NNS O
of IN O
the DT O
transcripts NNS O
decreased VBD O
. . O

These DT O
RNAs NNP O
were VBD O
not RB O
detected VBN O
by IN O
Northern NNP O
( -LRB- O
RNA NN O
) -RRB- O
hybridization NN O
in IN O
productively NN O
infected JJ O
chicken NN O
embryo NN O
fibroblasts NNS O
48 CD O
h NN O
postinfection NN O
; : O
however RB O
, , O
they PRP O
were VBD O
apparent JJ O
140 CD O
h JJ O
postinfection NN O
. . O

By IN O
using VBG O
Northern JJ O
hybridization NN O
, , O
RNase NNP O
protection NN O
assays VBZ O
, , O
and CC O
primer JJ O
extension NN O
analysis NN O
, , O
the DT O
MSRs NNS O
were VBD O
determined VBN O
to TO O
map NN O
antisense NN O
to TO O
the DT O
predicted VBN O
translational JJ O
start NN O
site NN O
of IN O
the DT O
ICP4 NNP O
homolog NN O
gene NN O
. . O

The DT O
conclusion NN O
most RBS O
consistent JJ O
with IN O
the DT O
data NNS O
is VBZ O
that IN O
the DT O
two CD O
MSRs NNS O
are VBP O
overlapping VBG O
, , O
spliced VBD O
RNAs NNP O
. . O

Both DT O
small JJ O
RNAs NNS O
contain VBP O
a DT O
latency RB O
promoter NN O
binding JJ O
factor NN O
consensus NN O
recognition NN O
sequence NN O
located VBN O
toward IN O
their PRP$ O
5 CD O
' POS O
ends NNS O
as RB O
well RB O
as IN O
two CD O
potential JJ O
ICP4 NNP O
recognition NN O
consensus NN O
sequences NNS O
, , O
one CD O
in IN O
each DT O
orientation NN O
. . O

The DT O
region NN O
contains VBZ O
a DT O
number NN O
of IN O
small JJ O
open JJ O
reading NN O
frames NNS O
on IN O
each DT O
side NN O
and CC O
within IN O
the DT O
MSRs NNS O
. . O

Although IN O
the DT O
exact JJ O
endpoints NNS O
are VBP O
unknown JJ O
, , O
the DT O
large JJ O
10 CD O
- : O
kb NN O
species NNS O
spans VBZ O
the DT O
entire JJ O
ICP4 NNP O
homolog NN O
region NN O
. . O

We PRP O
believe VBP O
that IN O
this DT O
group NN O
of IN O
RNAs NNP O
, , O
which WDT O
map VBP O
antisense NN O
to TO O
the DT O
ICP4 NNP O
homolog NN O
gene NN O
, , O
are VBP O
latency RB O
- : O
associated VBN O
transcripts NNS O
of IN O
MDV NNP O
. . O

-DOCSTART- X X O

Elevated JJ O
expression NN O
of IN O
the DT O
junB NN O
proto NN O
- : O
oncogene NN O
is VBZ O
essential JJ O
for IN O
v FW O
- : O
fos NNS O
induced VBN O
transformation NN O
of IN O
Rat NNP B-NP
- : I-NP
1 CD I-NP
cells NNS O
. . O

We PRP O
previously RB O
described VBD O
the DT O
isolation NN O
of IN O
non FW O
- : O
tumorigenic JJ O
revertants NNS O
from IN O
mutagenized JJ O
populations NNS O
of IN O
v FW O
- : O
fos NNS O
- : O
transformed VBN O
Rat NNP B-NP
- : I-NP
1 CD I-NP
cells NNS O
( -LRB- O
Zarbl NNP O
et NNP O
al NN O
. . O
, , O
1987 CD O
) -RRB- O
. . O

In IN O
the DT O
present JJ O
study NN O
we PRP O
examined VBD O
the DT O
possibility NN O
that IN O
the DT O
revertant NN O
phenotype NN O
resulted VBD O
from IN O
mutations NNS O
that WDT O
altered VBD O
the DT O
expression NN O
or CC O
activities NNS O
of IN O
the DT O
c NN O
- : O
jun NN O
or CC O
junB NN O
proto NN O
- : O
oncogenes NNS O
. . O

The DT O
results NNS O
demonstrated VBD O
that IN O
levels NNS O
of IN O
the DT O
c NN O
- : O
jun NN O
mRNA NN O
and CC O
protein NN O
were VBD O
unchanged JJ O
in IN O
the DT O
revertants NNS O
when WRB O
compared VBN O
to TO O
the DT O
transformed VBN O
parental JJ O
cells NNS O
, , O
and CC O
ectopic JJ O
overexpression IN O
of IN O
c SYM O
- : O
jun NN O
failed VBD O
to TO O
retransform VB O
the DT O
revertants NNS O
. . O

Although IN O
one CD O
mutant JJ O
allele NN O
was VBD O
detected VBN O
in IN O
revertant NN O
EMS NNP B-NP
- : I-NP
1 LS I-NP
- : I-NP
19 CD I-NP
, , O
overexpression IN O
of IN O
this DT O
mutant JJ O
allele NN O
failed VBD O
to TO O
inhibit VB O
v FW O
- : O
fos NNS O
induced VBN O
cell NN O
transformation NN O
. . O

Together RB O
these DT O
results NNS O
indicated VBD O
that IN O
the DT O
revertant NN O
phenotype NN O
did VBD O
not RB O
result VB O
from IN O
altered JJ O
expression NN O
or CC O
mutations NNS O
in IN O
the DT O
c SYM O
- : O
jun NN O
gene NN O
. . O

In IN O
contrast NN O
to TO O
the DT O
results NNS O
obtained VBN O
with IN O
c SYM O
- : O
jun NN O
, , O
the DT O
levels NNS O
of IN O
junB NN O
mRNA NN O
and CC O
protein NN O
were VBD O
found VBN O
to TO O
be VB O
reduced VBN O
two CD O
- : O
or CC O
threefold JJ O
in IN O
revertant NN O
EMS NNP B-NP
- : I-NP
1 LS I-NP
- : I-NP
19 CD I-NP
. . O

Ectopic NNP O
overexpression IN O
of IN O
junB NN O
induced VBN O
transformation NN O
of IN O
revertant NN O
EMS NNP B-NP
- : I-NP
1 LS I-NP
- : I-NP
19 CD I-NP
, , O
but CC O
failed VBD O
to TO O
transform VB O
Rat NNP B-NP
- : I-NP
1 CD I-NP
cells NNS O
. . O

Moreover RB O
, , O
about IN O
10 CD O
% NN O
of IN O
v FW O
- : O
fos NNS O
transformed VBN O
cells NNS O
transfected VBN O
with IN O
vectors NNS O
that WDT O
express VBP O
antisense JJ O
junB NN O
mRNA NNS O
acquired VBD O
a DT O
non FW O
- : O
transformed VBN O
phenotype NN O
. . O

Together RB O
these DT O
results NNS O
indicate VBP O
that IN O
expression NN O
of IN O
junB NN O
above IN O
a DT O
threshold NN O
level NN O
is VBZ O
essential JJ O
for IN O
v FW O
- : O
fos NNS O
- : O
induced VBN O
transformation NN O
of IN O
Rat NNP B-NP
- : I-NP
1 CD I-NP
fibroblasts NNS O
. . O

-DOCSTART- X X O

Increased VBN O
expression NN O
of IN O
specific JJ O
protein NN O
tyrosine NN O
phosphatases NNS O
in IN O
human JJ O
breast NN O
epithelial NN O
cells NNS O
neoplastically RB O
transformed VBN O
by IN O
the DT O
neu NN O
oncogene NN O
. . O

Protein NNP O
tyrosine FW O
phosphorylation NN O
/ NN O
dephosphorylation NN O
is VBZ O
a DT O
fundamental JJ O
mechanism NN O
in IN O
the DT O
regulation NN O
of IN O
cell NN O
proliferation NN O
and CC O
neoplastic JJ O
transformation NN O
; : O
this DT O
metabolic JJ O
process NN O
is VBZ O
modulated VBN O
by IN O
the DT O
opposing VBG O
activities NNS O
of IN O
protein NN O
tyrosine NN O
kinases NNS O
and CC O
protein NN O
tyrosine NN O
phosphatases NNS O
( -LRB- O
PTPases NNS O
) -RRB- O
. . O

While IN O
the DT O
role NN O
of IN O
protein NN O
tyrosine NN O
kinases NNS O
has VBZ O
been VBN O
examined VBN O
extensively RB O
in IN O
human JJ O
breast NN O
tumorigenesis NN O
, , O
the DT O
role NN O
of IN O
PTPases NNS O
in IN O
this DT O
process NN O
is VBZ O
virtually RB O
unknown JJ O
. . O

To TO O
address VB O
this DT O
issue NN O
, , O
an DT O
activated JJ O
neu NN O
oncogene NN O
was VBD O
introduced VBN O
into IN O
an DT O
immortalized JJ O
nontumorigenic JJ O
human JJ O
breast NN O
epithelial NN O
cell NN O
line NN O
( -LRB- O
184B5 CD B-NP
) -RRB- O
. . O

This DT O
resulted VBD O
in IN O
a DT O
substantial JJ O
increase NN O
in IN O
P185neu NNP O
expression NN O
, , O
which WDT O
led VBD O
to TO O
the DT O
formation NN O
of IN O
progressively RB O
growing VBG O
carcinomas NNS O
after IN O
such JJ O
cells NNS O
were VBD O
inoculated VBN O
into IN O
athymic JJ O
nude JJ O
mice NNS O
. . O

Importantly RB O
, , O
a DT O
striking JJ O
increase NN O
in IN O
the DT O
expression NN O
of IN O
specific JJ O
PTPases NNS O
, , O
LAR NNP O
and CC O
PTP1B NNP O
, , O
was VBD O
observed VBN O
in IN O
3 CD O
independently RB O
neu NN O
transformed VBD O
cell NN O
lines NNS O
and CC O
their PRP$ O
derived VBN O
tumors NNS O
. . O

This DT O
elevation NN O
was VBD O
verified VBN O
at IN O
both DT O
the DT O
mRNA NN O
and CC O
protein NN O
levels NNS O
. . O

TC NNP O
- : O
PTP NNP O
PTPase NNP O
expression NN O
was VBD O
only RB O
slightly RB O
increased VBN O
in IN O
these DT O
neu NN O
transformed VBD O
cells NNS O
, , O
and CC O
no DT O
expression NN O
of IN O
CD45 NNP O
PTPase NNP O
was VBD O
observed VBN O
. . O

The DT O
level NN O
of IN O
neu JJ O
expression NN O
, , O
as RB O
well RB O
as IN O
the DT O
differential JJ O
expression NN O
between IN O
P185neu NNP O
and CC O
LAR NNP O
/ NNP O
PTP1B NNP O
, , O
directly RB O
correlated VBN O
with IN O
tumorigenicity NN O
. . O

Furthermore RB O
, , O
rat NN O
mammary NN O
carcinomas NNS O
with IN O
elevated JJ O
neu NN O
expression NN O
( -LRB- O
neu FW O
- : O
induced VBN O
) -RRB- O
also RB O
had VBD O
sharply RB O
elevated VBN O
LAR NN O
- : O
PTPase JJ O
expression NN O
when WRB O
compared VBN O
to TO O
rat VB O
mammary JJ O
carcinomas NNS O
with IN O
little JJ O
or CC O
no DT O
neu NN O
expression NN O
( -LRB- O
7 CD O
, , O
12 CD O
- : O
dimethylbenzanthracene NN O
induced VBN O
) -RRB- O
; : O
the DT O
level NN O
of IN O
expression NN O
of IN O
LAR NNP O
PTPase NNP O
was VBD O
directly RB O
correlated VBN O
with IN O
the DT O
level NN O
of IN O
neu JJ O
expression NN O
. . O

Thus RB O
, , O
our PRP$ O
results NNS O
provide VBP O
the DT O
first JJ O
evidence NN O
that IN O
, , O
in IN O
human JJ O
breast NN O
carcinoma NN O
cells NNS O
and CC O
in IN O
rat NN O
mammary NN O
carcinomas NNS O
that WDT O
have VBP O
an DT O
induced JJ O
increase NN O
in IN O
neu JJ O
expression NN O
, , O
a DT O
consistent JJ O
and CC O
substantial JJ O
increase NN O
in IN O
the DT O
expression NN O
of IN O
specific JJ O
PTPases NNS O
occurs VBZ O
. . O

The DT O
relationship NN O
between IN O
P185neu NNP O
- : O
protein NN O
tyrosine NN O
kinase NN O
expression NN O
and CC O
specific JJ O
PTPase JJ O
expression NN O
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
human JJ O
breast NN O
tumorigenesis NN O
. . O

-DOCSTART- X X O

Epilepsy NNP O
in IN O
Down NNP O
syndrome NN O
: : O
clinical JJ O
aspects NNS O
and CC O
possible JJ O
mechanisms NNS O
. . O

Although IN O
epilepsy NN O
is VBZ O
more RBR O
common JJ O
in IN O
persons NNS O
with IN O
trisomy NN O
21 CD O
( -LRB- O
Down IN O
syndrome NN O
) -RRB- O
than IN O
in IN O
the DT O
general JJ O
population NN O
, , O
the DT O
mechanisms NNS O
by IN O
which WDT O
seizures NNS O
are VBP O
generated VBN O
in IN O
this DT O
population NN O
have VBP O
received VBN O
little JJ O
attention NN O
. . O

It PRP O
is VBZ O
likely JJ O
that IN O
this DT O
increased VBN O
seizure NN O
susceptibility NN O
is VBZ O
due JJ O
to TO O
a DT O
combination NN O
of IN O
medical JJ O
risk NN O
factors NNS O
and CC O
inherent JJ O
neurologic JJ O
abnormalities NNS O
characteristic JJ O
of IN O
Down NNP O
syndrome NN O
. . O

In IN O
this DT O
review NN O
clinical JJ O
aspects NNS O
of IN O
seizures NNS O
among IN O
individuals NNS O
with IN O
Down NNP O
syndrome NN O
were VBD O
described VBN O
and CC O
possible JJ O
mechanisms NNS O
by IN O
which WDT O
the DT O
trisomy NN O
21 CD O
brain NN O
may MD O
generate VB O
seizures NNS O
were VBD O
explored VBN O
. . O

-DOCSTART- X X O

In IN O
vivo JJ O
effects NNS O
of IN O
insulin NN O
on IN O
tumor NN O
and CC O
skeletal JJ O
muscle NN O
glucose NN O
metabolism NN O
in IN O
patients NNS O
with IN O
lymphoma NN O
. . O

BACKGROUND NNP O
: : O
The DT O
anabolic JJ O
properties NNS O
of IN O
insulin NN O
have VBP O
been VBN O
suggested VBN O
for IN O
use NN O
to TO O
reverse VB O
malnutrition NN O
associated VBN O
with IN O
cancer NN O
. . O

The DT O
host NN O
and CC O
tumor NN O
sensitivities NNS O
to TO O
insulin NN O
are VBP O
critical JJ O
for IN O
such JJ O
treatments NNS O
, , O
which WDT O
aim VBP O
to TO O
improve VB O
patient NN O
nutrition NN O
. . O

The DT O
authors NNS O
studied VBD O
insulin NN O
effects NNS O
on IN O
tumor NN O
and CC O
skeletal JJ O
muscle NN O
metabolism NN O
with IN O
2 CD O
- : O
[ NN O
18F CD O
] SYM O
- : O
fluoro NN O
- : O
2 LS O
- : O
deoxy NN O
- : O
D LS O
- : O
glucose NN O
( -LRB- O
[ NN O
18F IN O
] JJ O
FDG NNP O
) -RRB- O
and CC O
positron NN O
emission NN O
tomography NN O
( -LRB- O
PET NN O
) -RRB- O
. . O

METHODS NNS O
: : O
Six CD O
patients NNS O
with IN O
lymphoma NN O
twice RB O
underwent JJ O
[ NN O
18F . O
] SYM O
FDG FW O
- : O
PET NN O
imaging NN O
: : O
once RB O
after IN O
fasting VBG O
overnight JJ O
and CC O
once RB O
during IN O
euglycemic JJ O
hyperinsulinemic JJ O
clamp NN O
. . O

The DT O
dynamic JJ O
uptake NN O
of IN O
the DT O
glucose NN O
analogue NN O
[ IN O
18F PRP O
] SYM O
FDG NNP O
was VBD O
measured VBN O
in IN O
diseased JJ O
nodes NNS O
and CC O
upper JJ O
arm NN O
skeletal JJ O
muscle NN O
in IN O
both DT O
metabolic JJ O
states NNS O
. . O

The DT O
[ NN O
18F IN O
] NNP O
FDG NNP O
uptake NN O
in IN O
muscle NN O
and CC O
the DT O
whole JJ O
body NN O
glucose NN O
use NN O
during IN O
euglycemic JJ O
hyperinsulinemic JJ O
clamp NN O
were VBD O
compared VBN O
with IN O
those DT O
of IN O
weight NN O
- : O
matched VBN O
healthy JJ O
subjects NNS O
studied VBN O
under IN O
similar JJ O
circumstances NNS O
. . O

RESULTS NNS O
: : O
In IN O
lymphomatous JJ O
tissue NN O
, , O
[ VBD O
18F PRP O
] SYM O
FDG NNP O
uptake NN O
rates NNS O
were VBD O
similar JJ O
in IN O
overnight JJ O
fasting NN O
and CC O
euglycemic JJ O
hyperinsulinemic JJ O
clamp NN O
( -LRB- O
38 CD O
+ NN O
/ NNS O
- : O
10 CD O
versus NN O
41 CD O
+ NN O
/ NN O
- : O
9 CD O
mumol NN O
/ VBD O
100 CD O
g NN O
/ IN O
minute NN O
, , O
not RB O
significant JJ O
) -RRB- O
, , O
whereas IN O
glucose NN O
uptake NN O
in IN O
skeletal JJ O
muscle NN O
was VBD O
increased VBN O
by IN O
insulin NN O
( -LRB- O
1 CD O
. . O
7 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
2 CD O
versus NN O
3 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
5 CD O
mumol NN O
/ IN O
100 CD O
g NN O
/ NN O
minute NN O
, , O
P NNP O
= SYM O
0 CD O
. . O
012 CD O
) -RRB- O
. . O

Both DT O
basal NN O
( -LRB- O
2 CD O
. . O
3 CD O
+ NN O
/ NNS O
- : O
0 CD O
. . O
2 CD O
mumol NN O
/ IN O
100 CD O
g NN O
/ NN O
minute NN O
, , O
P NNP O
= SYM O
0 CD O
. . O
061 CD O
) -RRB- O
and CC O
insulin NN O
- : O
stimulated VBN O
( -LRB- O
8 CD O
. . O
5 CD O
+ NN O
/ NN O
- : O
1 CD O
. . O
9 CD O
mumol NN O
/ VBD O
100 CD O
g NN O
/ NN O
minute NN O
, , O
P NNP O
= SYM O
0 CD O
. . O
055 CD O
) -RRB- O
skeletal NN O
arm NN O
muscle NN O
glucose NN O
uptake NN O
rates NNS O
were VBD O
higher JJR O
in IN O
control NN O
subjects NNS O
than IN O
in IN O
patients NNS O
. . O

Whole JJ O
body NN O
glucose NN O
use NN O
was VBD O
55 CD O
% NN O
lower JJR O
in IN O
patients NNS O
than IN O
in IN O
control NN O
subjects NNS O
( -LRB- O
17 CD O
+ NN O
/ CD O
- : O
3 CD O
mumol NN O
/ NN O
kg VBZ O
/ JJ O
minute NN O
versus NN O
38 CD O
+ NN O
/ NN O
- : O
3 CD O
mumol NN O
/ NN O
kg VBZ O
/ JJ O
minute NN O
, , O
P NNP O
= SYM O
0 CD O
. . O
002 CD O
) -RRB- O
, , O
consistent JJ O
with IN O
insulin NN O
resistance NN O
in IN O
cancer NN O
. . O

CONCLUSIONS NNS O
: : O
We PRP O
found VBD O
that IN O
insulin NN O
does VBZ O
not RB O
induce VB O
major JJ O
changes NNS O
in IN O
glucose NN O
uptake NN O
of IN O
lymphomatous JJ O
tissue NN O
. . O

Although IN O
insulin NN O
sensitivity NN O
of IN O
skeletal JJ O
muscle NN O
was VBD O
also RB O
reduced VBN O
in IN O
patients NNS O
with IN O
lymphoma NN O
, , O
the DT O
net JJ O
insulin NN O
effect NN O
may MD O
counteract VB O
imbalance NN O
between IN O
glucose NN O
uptake NN O
of IN O
tumor NN O
and CC O
muscle NN O
, , O
offering VBG O
a DT O
potential JJ O
means NN O
to TO O
circumvent VB O
at IN O
least JJS O
some DT O
metabolic JJ O
abnormalities NNS O
found VBD O
in IN O
cancer NN O
. . O

-DOCSTART- X X O

Kinins NNP O
contribute VBP O
to TO O
the DT O
improvement NN O
of IN O
insulin NN O
sensitivity NN O
during IN O
treatment NN O
with IN O
angiotensin NN O
converting VBG O
enzyme JJ O
inhibitor NN O
. . O

Although IN O
angiotensin IN O
converting VBG O
enzyme JJ O
inhibitors NNS O
and CC O
alpha NN O
1 LS O
- : O
blockers NNS O
have VBP O
been VBN O
reported VBN O
to TO O
improve VB O
insulin NN O
sensitivity NN O
, , O
their PRP$ O
mechanisms NNS O
of IN O
action NN O
have VBP O
not RB O
been VBN O
elucidated VBN O
. . O

To TO O
investigate VB O
the DT O
role NN O
of IN O
kinins NNS O
in IN O
insulin NN O
sensitivity NN O
, , O
we PRP O
treated VBD O
4 LS O
- : O
week NN O
- : O
old JJ O
spontaneously NN O
hypertensive JJ O
rats NNS O
with IN O
either DT O
an DT O
angiotensin NN O
converting VBG O
enzyme JJ O
inhibitor NN O
( -LRB- O
enalapril NN O
) -RRB- O
, , O
an DT O
alpha NN O
1 LS O
- : O
blocker NN O
( -LRB- O
doxazosin NN O
) -RRB- O
, , O
or CC O
an DT O
angiotensin NN O
II NNP O
antagonist NN O
( -LRB- O
losartan NN O
) -RRB- O
for IN O
3 CD O
weeks NNS O
. . O

A DT O
control NN O
group NN O
received VBD O
no DT O
drugs NNS O
. . O

In IN O
addition NN O
, , O
18 CD O
rats NNS O
treated VBN O
with IN O
enalapril NN O
or CC O
doxazosin NN O
received VBD O
a DT O
simultaneous JJ O
administration NN O
of IN O
a DT O
kinin NN O
antagonist NN O
( -LRB- O
Hoe NNP O
140 CD O
) -RRB- O
. . O

Glucose DT O
clamp NN O
testing NN O
was VBD O
performed VBN O
in IN O
each DT O
group NN O
. . O

Enalapril NNP O
( -LRB- O
128 CD O
+ NN O
/ NN O
- : O
1 CD O
mmHg NN O
) -RRB- O
and CC O
doxazosin NN O
( -LRB- O
132 CD O
+ NN O
/ NN O
- : O
2 CD O
mmHg NN O
) -RRB- O
decreased VBN O
mean JJ O
blood NN O
pressure NN O
compared VBN O
with IN O
control NN O
levels NNS O
( -LRB- O
148 CD O
+ NN O
/ NN O
- : O
1 CD O
mmHg NN O
) -RRB- O
( -LRB- O
P NNP O
< NNP O
. . O
01 CD O
) -RRB- O
. . O

The DT O
glucose NN O
requirement NN O
for IN O
the DT O
clamp NN O
test NN O
during IN O
the DT O
administration NN O
of IN O
enalapril NN O
( -LRB- O
25 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
5 CD O
mg NN O
/ IN O
kg NN O
per IN O
minute NN O
) -RRB- O
or CC O
doxazosin NN O
( -LRB- O
28 CD O
. . O
6 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
7 CD O
mg NN O
/ NN O
kg NN O
per IN O
minute NN O
) -RRB- O
was VBD O
higher JJR O
than IN O
that DT O
of IN O
the DT O
control NN O
group NN O
( -LRB- O
19 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
5 CD O
mg NN O
/ IN O
kg NN O
per IN O
minute NN O
) -RRB- O
( -LRB- O
P NNP O
< NNP O
. . O
05 CD O
) -RRB- O
. . O

Although IN O
Hoe NNP O
140 CD O
did VBD O
not RB O
alter VB O
the DT O
glucose NN O
requirement NN O
of IN O
doxazosin NN O
( -LRB- O
27 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
5 CD O
mg NN O
/ IN O
kg NN O
per IN O
minute NN O
) -RRB- O
, , O
it PRP O
decreased VBD O
that IN O
of IN O
enalapril NN O
( -LRB- O
22 CD O
. . O
6 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
9 CD O
mg NN O
/ NN O
kg NN O
per IN O
minute NN O
) -RRB- O
( -LRB- O
P NNP O
< NNP O
. . O
05 CD O
) -RRB- O
without IN O
affecting VBG O
the DT O
changes NNS O
in IN O
mean JJ O
blood NN O
pressure NN O
induced VBN O
by IN O
enalapril NN O
. . O

In IN O
addition NN O
, , O
losartan NN O
decreased VBD O
mean JJ O
blood NN O
pressure NN O
but CC O
did VBD O
not RB O
affect VB O
the DT O
glucose NN O
requirement NN O
. . O

Thus RB O
, , O
the DT O
improvement NN O
in IN O
insulin NN O
sensitivity NN O
produced VBN O
by IN O
an DT O
angiotensin NN O
converting VBG O
enzyme JJ O
inhibitor NN O
is VBZ O
mostly RB O
dependent JJ O
on IN O
kinins NNS O
but CC O
not RB O
on IN O
angiotensin DT O
II NNP O
antagonism NN O
, , O
and CC O
an DT O
alpha NN O
1 LS O
- : O
blocker NN O
improves VBZ O
insulin NN O
sensitivity NN O
irrespective NN O
of IN O
kinins NNS O
. . O

-DOCSTART- X X O

H NNP O
- : O
ras VBD O
mutations NNS O
in IN O
human JJ O
pituitary NN O
carcinoma NN O
metastases NNS O
. . O

Molecular JJ O
mechanisms NNS O
of IN O
pituitary JJ O
tumorigenesis NN O
were VBD O
studied VBN O
using VBG O
Polymerase NN O
chain NN O
reaction NN O
- : O
single JJ O
stranded VBN O
conformational JJ O
polymorphism NN O
with IN O
DNA NNP O
sequencing NN O
to TO O
identify VB O
potential JJ O
mutations NNS O
in IN O
the DT O
ras NNS O
protooncogenes NNS O
and CC O
the DT O
tumor NN O
suppressor NN O
gene NN O
p53 NN O
in IN O
invasive JJ O
pituitary JJ O
adenomas NNS O
and CC O
carcinomas NNS O
. . O

Sequencing NN O
of IN O
exons NNS O
5 CD O
through IN O
8 CD O
of IN O
the DT O
p53 NN O
gene NN O
revealed VBD O
no DT O
mutations NNS O
, , O
nor CC O
were VBD O
mutations NNS O
detected VBN O
in IN O
the DT O
N NNP O
- : O
or CC O
K NNP O
- : O
ras VBD O
protooncogenes NNS O
in IN O
four CD O
of IN O
the DT O
carcinomas NNS O
and CC O
their PRP$ O
respective JJ O
metastatic JJ O
deposits NNS O
. . O

Point NNP O
mutations NNS O
of IN O
H NNP O
- : O
ras VBD O
however RB O
, , O
were VBD O
identified VBN O
in IN O
three CD O
distant JJ O
metastatic JJ O
pituitary JJ O
tumor NN O
secondaries NNS O
, , O
but CC O
not RB O
in IN O
their PRP$ O
respective JJ O
primary JJ O
pituitary JJ O
carcinomas NNS O
, , O
or CC O
in IN O
six CD O
invasive JJ O
adenomas NNS O
. . O

Two CD O
of IN O
the DT O
mutations NNS O
included VBD O
a DT O
G NNP O
to TO O
C NNP O
substitution NN O
at IN O
codon NN O
12 CD O
, , O
and CC O
a DT O
G NNP O
to TO O
A DT O
substitution NN O
at IN O
codon NN O
18 CD O
, , O
resulting VBG O
in IN O
a DT O
glycine NN O
to TO O
arginine VB O
, , O
and CC O
an DT O
alanine JJR O
to TO O
threonine CD O
change NN O
at IN O
these DT O
amino IN O
acids NNS O
, , O
respectively RB O
. . O

A DT O
third JJ O
mutation NN O
involved VBD O
a DT O
single JJ O
base NN O
pair NN O
( -LRB- O
adenine NN O
) -RRB- O
deletion NN O
in IN O
codon NN O
3 CD O
of IN O
H NNP O
- : O
ras NNS O
which WDT O
causes VBZ O
a DT O
frame NN O
shift NN O
, , O
resulting VBG O
in IN O
a DT O
termination NN O
signal NN O
at IN O
codon NN O
19 CD O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
point NN O
mutations NNS O
in IN O
p53 NN O
and CC O
ras NNS O
are VBP O
not RB O
associated VBN O
with IN O
pituitary JJ O
tumorigenesis NN O
, , O
however RB O
, , O
point NN O
mutations NNS O
of IN O
the DT O
H NNP O
- : O
ras JJ O
gene NN O
may MD O
be VB O
important JJ O
in IN O
the DT O
formation NN O
and CC O
or CC O
growth NN O
of IN O
pituitary JJ O
metastases NNS O
. . O

This DT O
observed VBD O
genomic JJ O
instability NN O
will MD O
be VB O
of IN O
value NN O
in IN O
predicting VBG O
the DT O
potential JJ O
metastatic JJ O
behavior NN O
of IN O
these DT O
aggressive JJ O
pituitary JJ O
tumors NNS O
. . O

-DOCSTART- X X O

Distribution NN O
and CC O
predictors NNS O
of IN O
depressive JJ O
symptoms NNS O
in IN O
osteoarthritis NNP O
. . O

OBJECTIVE CD O
: : O

To TO O
determine VB O
the DT O
prevalence NN O
and CC O
correlates NNS O
of IN O
depressive JJ O
symptoms NNS O
in IN O
a DT O
sample NN O
of IN O
elderly JJ O
persons NNS O
with IN O
osteoarthritis NN O
( -LRB- O
OA NN O
) -RRB- O
. . O

METHODS NNS O
: : O

Secondary JJ O
analysis NN O
of IN O
cross NN O
sectional JJ O
interview NN O
data NNS O
from IN O
108 CD O
community NN O
living VBG O
persons NNS O
age NN O
50 CD O
or CC O
over IN O
who WP O
met VBD O
American NNP O
College NNP O
of IN O
Rheumatology NNP O
clinical JJ O
criteria NNS O
for IN O
OA NNP O
of IN O
the DT O
hip NN O
and CC O
/ NN O
or CC O
knee NN O
. . O

RESULTS NNS O
: : O

The DT O
prevalence NN O
of IN O
substantial JJ O
depressive JJ O
symptomatology NN O
appeared VBD O
to TO O
be VB O
no RB O
greater JJR O
than IN O
would MD O
be VB O
expected VBN O
in IN O
the DT O
general JJ O
population NN O
for IN O
this DT O
age NN O
group NN O
. . O

However RB O
, , O
persons NNS O
currently RB O
under IN O
a DT O
physician NN O
' '' O
s PRP O
care VBP O
for IN O
OA NN O
were VBD O
significantly RB O
more RBR O
depressed JJ O
than IN O
those DT O
not RB O
under IN O
care NN O
, , O
and CC O
, , O
with IN O
the DT O
exception NN O
of IN O
those DT O
who WP O
had VBD O
post NN O
- : O
high JJ O
school NN O
education NN O
, , O
depression NN O
was VBD O
a DT O
better JJR O
predictor NN O
of IN O
being VBG O
under IN O
care NN O
than IN O
OA NN O
symptoms NNS O
. . O

The DT O
direct JJ O
and CC O
interactive JJ O
effects NNS O
of IN O
3 CD O
variables NNS O
- : O
- : O
education NN O
, , O
age NN O
and CC O
self NN O
- : O
perceived VBN O
impact NN O
of IN O
the DT O
OA NN O
problem NN O
- : O
- : O
were VBD O
found VBN O
to TO O
explain VB O
40 CD O
% NN O
of IN O
variance NN O
in IN O
depression NN O
scores NNS O
in IN O
the DT O
total JJ O
sample NN O
and CC O
50 CD O
% NN O
among IN O
those DT O
currently RB O
receiving VBG O
care NN O
. . O

Younger NNP O
and CC O
less RBR O
educated VBN O
subjects NNS O
had VBD O
relatively RB O
more JJR O
depressive JJ O
symptoms NNS O
and CC O
, , O
furthermore RB O
, , O
in IN O
this DT O
subgroup NN O
the DT O
correlation NN O
between IN O
OA NNP O
impact NN O
and CC O
depression NN O
was VBD O
high JJ O
. . O

CONCLUSIONS NNS O
: : O

The DT O
importance NN O
of IN O
assessing VBG O
depression NN O
in IN O
persons NNS O
who WP O
seek VBP O
care NN O
for IN O
OA NNP O
is VBZ O
supported VBN O
. . O

Furthermore RB O
, , O
our PRP$ O
results NNS O
suggest VBP O
that IN O
the DT O
observed JJ O
relationship NN O
between IN O
education NN O
and CC O
arthritis NN O
outcomes NNS O
could MD O
be VB O
mediated VBN O
, , O
at IN O
least JJS O
in IN O
part NN O
, , O
by IN O
depression NN O
. . O

-DOCSTART- X X O

Methotrexate NNP O
osteopathy NN O
in IN O
rheumatic JJ O
disease NN O
. . O

OBJECTIVE CD O
: : O

To TO O
determine VB O
whether IN O
two CD O
adults NNS O
with IN O
stress NN O
fractures NNS O
receiving VBG O
low JJ O
weekly JJ O
doses NNS O
of IN O
methotrexate NN O
had VBD O
methotrexate NN O
osteopathy NN O
. . O

CASE NNP O
REPORTS NNS O
: : O

Two CD O
adult JJ O
patients NNS O
developed VBD O
features NNS O
consistent JJ O
with IN O
methotrexate NN O
osteopathy NN O
while IN O
receiving VBG O
low JJ O
weekly JJ O
doses NNS O
of IN O
methotrexate NN O
. . O

METHODS NNS O
: : O

Iliac NNP O
crest NN O
biopsy NN O
samples NNS O
were VBD O
taken VBN O
and CC O
bone NN O
histomorphometry NN O
carried VBD O
out RP O
. . O

RESULTS NNS O
: : O

Symptoms NNP O
resolved VBD O
when WRB O
the DT O
methotrexate NN O
was VBD O
discontinued VBN O
. . O

Bone NN O
histology NN O
showed VBD O
changes NNS O
consistent JJ O
with IN O
osteoblast JJ O
inhibition NN O
by IN O
methotrexate NN O
. . O

CONCLUSIONS NNS O
: : O

When WRB O
given VBN O
in IN O
low JJ O
doses NNS O
for IN O
prolonged VBN O
periods NNS O
, , O
methotrexate NN O
may MD O
have VB O
adverse JJ O
effects NNS O
on IN O
bone NN O
, , O
particularly RB O
in IN O
post NN O
- : O
menopausal JJ O
women NNS O
. . O

-DOCSTART- X X O

Overexpression IN O
of IN O
Glut NNP O
- : O
1 CD O
glucose NN O
transporter NN O
in IN O
human JJ O
breast NN O
cancer NN O
. . O

An DT O
immunohistochemical JJ O
study NN O
. . O

BACKGROUND NNP O
: : O
Breast NN O
cancers NNS O
have VBP O
higher JJR O
than IN O
normal JJ O
glucose NN O
metabolism NN O
, , O
but CC O
the DT O
mechanism NN O
of IN O
glucose JJ O
entry NN O
into IN O
these DT O
tumors NNS O
is VBZ O
not RB O
well RB O
understood VBN O
. . O

METHODS NNP O
: : O
The DT O
expression NN O
of IN O
five CD O
facilitative JJ O
glucose NN O
transporters NNS O
, , O
Glut NNP O
- : O
1 CD O
( -LRB- O
erythrocyte NN O
type NN O
) -RRB- O
, , O
Glut NNP O
- : O
2 CD O
( -LRB- O
liver NN O
type NN O
) -RRB- O
, , O
Glut NNP O
- : O
3 CD O
( -LRB- O
brain NN O
type NN O
) -RRB- O
, , O
Glut NNP O
- : O
4 CD O
( -LRB- O
muscle NN O
/ , O
fat JJ O
type NN O
) -RRB- O
, , O
and CC O
Glut NNP O
- : O
5 CD O
( -LRB- O
small JJ O
intestine JJ O
type NN O
) -RRB- O
, , O
was VBD O
studied VBN O
by IN O
immunohistochemistry NN O
of IN O
paraffin NN O
sections NNS O
from IN O
12 CD O
primary JJ O
human JJ O
breast NN O
cancers NNS O
and CC O
8 CD O
lymph NN O
node NN O
metastases NNS O
from IN O
2 CD O
patients NNS O
. . O

Rat NNP O
tissues NNS O
known VBN O
to TO O
express VB O
these DT O
glucose NN O
transporters NNS O
were VBD O
used VBN O
as IN O
controls NNS O
. . O

RESULTS NNS O
: : O
All PDT O
the DT O
primary JJ O
breast NN O
cancers NNS O
and CC O
the DT O
lymph NN O
node NN O
metastases NNS O
were VBD O
positive JJ O
for IN O
Glut NNP O
- : O
1 CD O
. . O

This DT O
transporter NN O
was VBD O
expressed VBN O
on IN O
the DT O
cell NN O
membrane NN O
and CC O
in IN O
the DT O
cytoplasm NN O
of IN O
the DT O
tumor NN O
cells NNS O
, , O
but CC O
exhibited VBD O
marked VBN O
intratumoral JJ O
and CC O
intertumoral JJ O
variability NN O
in IN O
the DT O
proportions NNS O
of IN O
positive JJ O
cells NNS O
and CC O
the DT O
intensity NN O
of IN O
staining NN O
. . O

Staining NN O
of IN O
the DT O
normal JJ O
mammary NN O
epithelium NN O
, , O
if IN O
present JJ O
, , O
was VBD O
much RB O
lower JJR O
than IN O
observed VBN O
in IN O
tumor NN O
cells NNS O
from IN O
the DT O
same JJ O
patient NN O
. . O

Glut NNP O
- : O
2 CD O
was VBD O
expressed VBN O
in IN O
all DT O
of IN O
the DT O
tumors NNS O
, , O
but CC O
the DT O
intensity NN O
of IN O
staining NN O
was VBD O
not RB O
consistently RB O
stronger JJR O
than IN O
that DT O
seen VBN O
in IN O
healthy JJ O
breast NN O
. . O

Clusters NNS O
of IN O
Glut NNP O
- : O
4 LS O
- : O
positive JJ O
granule NN O
were VBD O
observed VBN O
in IN O
cells NNS O
in IN O
six CD O
of IN O
the DT O
tumors NNS O
. . O

None NN O
of IN O
the DT O
tumors NNS O
or CC O
the DT O
healthy JJ O
breast NN O
in IN O
the DT O
tissues NNS O
studied VBD O
expressed VBN O
Glut NNP O
- : O
3 CD O
or CC O
Glut NNP O
- : O
5 CD O
. . O

CONCLUSIONS NNS O
: : O
Higher JJR O
expression NN O
of IN O
the DT O
glucose NN O
transporter NN O
Glut NNP O
- : O
1 CD O
by IN O
breast NN O
cancer NN O
cells NNS O
compared VBN O
with IN O
the DT O
healthy JJ O
breast NN O
tissue NN O
is VBZ O
common JJ O
. . O

Increased VBN O
glucose NN O
transporter NN O
protein NN O
expression NN O
may MD O
contribute VB O
to TO O
the DT O
increased VBN O
uptake NN O
of IN O
2 CD O
- : O
[ NN O
18F CD O
] SYM O
- : O
fluoro NN O
- : O
2 LS O
- : O
deoxy NN O
- : O
D LS O
- : O
glucose NN O
( -LRB- O
FDG NNP O
) -RRB- O
by IN O
these DT O
tumors NNS O
observed VBN O
by IN O
positron NN O
emission NN O
tomography NN O
( -LRB- O
PET NN O
) -RRB- O
imaging NN O
. . O

-DOCSTART- X X O

Methodologies NNS O
for IN O
measuring VBG O
carcinogen NN O
adducts NNS O
in IN O
humans NNS O
. . O

In IN O
summary NN O
, , O
although IN O
some DT O
of IN O
the DT O
more RBR O
optimistic JJ O
aspirations NNS O
for IN O
human JJ O
biomonitoring NN O
studies NNS O
envisaged VBD O
a DT O
decade NN O
ago RB O
have VBP O
not RB O
been VBN O
realized VBN O
thus RB O
far RB O
, , O
some DT O
considerable JJ O
advances NNS O
have VBP O
been VBN O
made VBN O
. . O

The DT O
examples NNS O
cited VBD O
above JJ O
indicate VBP O
that IN O
the DT O
feasibility NN O
of IN O
biomonitoring NN O
has VBZ O
been VBN O
clearly RB O
established VBN O
. . O

In IN O
addition NN O
, , O
they PRP O
demonstrate VBP O
the DT O
need NN O
for IN O
preliminary JJ O
biomarker NN O
testing NN O
and CC O
validation NN O
through IN O
transitional JJ O
studies NNS O
prior RB O
to TO O
their PRP$ O
field NN O
application NN O
. . O

In IN O
the DT O
next JJ O
decade NN O
of IN O
research NN O
into IN O
carcinogen NN O
adducts NNS O
in IN O
humans NNS O
, , O
continued VBD O
improvements NNS O
in IN O
the DT O
reproducibility NN O
and CC O
specificity NN O
of IN O
assays VBG O
for IN O
DNA NNP O
adducts NNS O
will MD O
be VB O
needed VBN O
. . O

Perhaps RB O
the DT O
increasing VBG O
use NN O
of IN O
hybrid JJ O
methodologies NNS O
to TO O
concentrate VB O
adducts NNS O
followed VBN O
by IN O
specific JJ O
chemical NN O
analyses NNS O
will MD O
allow VB O
such JJ O
adducts NNS O
to TO O
be VB O
monitored VBN O
more RBR O
precisely RB O
. . O

Of IN O
course NN O
, , O
further JJ O
basic JJ O
research NN O
into IN O
the DT O
mechanisms NNS O
of IN O
carcinogenesis NN O
will MD O
allow VB O
the DT O
measurement NN O
of IN O
specific JJ O
novel NN O
markers NNS O
which WDT O
are VBP O
more RBR O
closely RB O
tied VBN O
to TO O
the DT O
disease NN O
endpoint NN O
than IN O
adducts NNS O
. . O

The DT O
development NN O
of IN O
new JJ O
assays NNS O
for IN O
determining VBG O
metabolic JJ O
phenotypes NNS O
and CC O
genotypes NNS O
relevant JJ O
to TO O
carcinogenesis NN O
should MD O
improve VB O
our PRP$ O
estimates NNS O
of IN O
susceptibility NN O
( -LRB- O
46 CD O
- : O
48 CD O
) -RRB- O
. . O

Such JJ O
new JJ O
approaches NNS O
along IN O
with IN O
the DT O
sustained JJ O
improvement NN O
of IN O
current JJ O
assays NNS O
will MD O
allow VB O
molecular JJ O
approaches NNS O
to TO O
continue VB O
to TO O
enrich VB O
cancer NN O
epidemiology NN O
in IN O
the DT O
future NN O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
1 CD O
- : O
alkylpyrrolidine NN O
N NNP O
- : O
oxides NNS O
on IN O
energy NN O
metabolism NN O
of IN O
cancer NN O
cells NNS O
. . O

The DT O
main JJ O
purpose NN O
of IN O
the DT O
present JJ O
investigation NN O
was VBD O
to TO O
study VB O
the DT O
effect NN O
of IN O
a DT O
homologous JJ O
series NN O
of IN O
1 CD O
- : O
alkylpyrrolidine NN O
N NNP O
- : O
oxides NNS O
on IN O
ATP NNP O
- : O
producing VBG O
processes NNS O
in IN O
Ehrlich NNP O
ascites NNS O
and CC O
L1210 JJ B-NP
murine NN O
leukemia NN O
cells NNS O
. . O

The DT O
effect NN O
on IN O
aerobic JJ O
glucose NN O
consumption NN O
, , O
lactic JJ O
acid NN O
formation NN O
, , O
content NN O
of IN O
total NN O
( -LRB- O
T NNP O
- : O
SH NNS O
) -RRB- O
and CC O
non FW O
- : O
protein NN O
thiol NN O
groups NNS O
( -LRB- O
NP NNP O
- : O
SH NNS O
) -RRB- O
, , O
endogenous JJ O
respiration NN O
and CC O
the DT O
level NN O
of IN O
ATP NNP O
in IN O
tumor NN O
cells NNS O
incubated VBN O
in IN O
vitro NN O
was VBD O
investigated VBN O
. . O

1 LS O
- : O
Tetradecylpyrrolidine NN O
N NNP O
- : O
oxide NN O
( -LRB- O
TPNO NNP O
) -RRB- O
, , O
one CD O
of IN O
the DT O
most RBS O
active JJ O
compounds NNS O
, , O
immediately RB O
after IN O
addition NN O
to TO O
the DT O
suspension NN O
of IN O
Ehrlich NNP O
cells NNS O
in IN O
an DT O
ice NN O
bath NN O
, , O
decreased VBD O
the DT O
level NN O
of IN O
ATP NNP O
to TO O
the DT O
same JJ O
extent NN O
over IN O
the DT O
whole JJ O
concentration NN O
range NN O
. . O

After IN O
2 CD O
h NN O
incubation NN O
at IN O
37 CD O
degrees NNS O
C NN O
the DT O
drop NN O
in IN O
the DT O
ATP NNP O
level NN O
was VBD O
lower JJR O
. . O

The DT O
decrease NN O
in IN O
ATP NNP O
level NN O
might MD O
be VB O
explained VBN O
through IN O
the DT O
interaction NN O
of IN O
the DT O
amine JJ O
oxide NN O
with IN O
the DT O
cell NN O
membrane NN O
integrity NN O
. . O

-DOCSTART- X X O

High NNP O
density NN O
of IN O
somatostatin NN O
receptors NNS O
in IN O
veins NNS O
surrounding VBG O
human JJ O
cancer NN O
tissue NN O
: : O
role NN O
in IN O
tumor NN O
- : O
host NN O
interaction NN O
? . O

Somatostatin NN O
receptors NNS O
were VBD O
detected VBN O
in IN O
peritumoral JJ O
veins NNS O
of IN O
various JJ O
human JJ O
cancer NN O
tissue NN O
specimens NNS O
. . O

Vascular NNP O
and CC O
neoplastic JJ O
tissue NN O
from IN O
14 CD O
colonic JJ O
adenocarcinomas NNS O
, , O
13 CD O
carcinoids NNS O
, , O
6 CD O
renal JJ O
- : O
cell NN O
carcinomas NNS O
and CC O
7 CD O
malignant JJ O
lymphomas NNS O
were VBD O
analyzed VBN O
for IN O
somatostatin NN O
receptors NNS O
by IN O
use NN O
of IN O
quantitative NN O
receptor NN O
autoradiography NN O
. . O

In IN O
colonic JJ O
carcinoma NN O
specimens NNS O
, , O
the DT O
peritumoral JJ O
vessels NNS O
expressed VBD O
a DT O
high JJ O
density NN O
of IN O
somatostatin NN O
receptors NNS O
, , O
whereas IN O
the DT O
neoplastic JJ O
tissue NN O
itself PRP O
was VBD O
receptor NN O
- : O
negative JJ O
in IN O
many JJ O
cases NNS O
. . O

In IN O
contrast NN O
, , O
the DT O
incidence NN O
and CC O
density NN O
of IN O
somatostatin NN O
receptors NNS O
in IN O
peritumoral JJ O
vessels NNS O
was VBD O
low JJ O
in IN O
well RB O
- : O
differentiated JJ O
gastrointestinal JJ O
and CC O
bronchial JJ O
carcinoids NNS O
, , O
in IN O
contrast NN O
to TO O
the DT O
high JJ O
density NN O
of IN O
such JJ O
receptors NNS O
in IN O
the DT O
carcinoid JJ O
tumor NN O
tissue NN O
. . O

Autochthonous NNP O
vessels NNS O
surrounding VBG O
other JJ O
tumors NNS O
such JJ O
as IN O
renal JJ O
- : O
cell NN O
carcinomas NNS O
or CC O
malignant JJ O
lymphomas NNS O
also RB O
frequently RB O
expressed VBN O
somatostatin NN O
receptors NNS O
. . O

In IN O
all DT O
cases NNS O
, , O
the DT O
somatostatin NN O
receptors NNS O
were VBD O
localized VBN O
in IN O
veins NNS O
, , O
particularly RB O
in IN O
the DT O
smooth JJ O
- : O
muscle NN O
cell NN O
layer NN O
. . O

They PRP O
exhibited VBD O
specific JJ O
and CC O
high JJ O
- : O
affinity NN O
binding NN O
of IN O
somatostatin NN O
- : O
14 CD O
, , O
somatostatin RB O
- : O
28 CD O
and CC O
octreotide RB O
, , O
suggesting VBG O
a DT O
preferential JJ O
expression NN O
of IN O
the DT O
SSTR2 NN O
receptor NN O
subtype NN O
. . O

Since IN O
the DT O
vessels NNS O
of IN O
normal JJ O
non FW O
- : O
neoplastic JJ O
human JJ O
tissues NNS O
, , O
e NN O
. . O
g NN O
. . O
of IN O
intestine JJ O
or CC O
lymphatic JJ O
organs NNS O
, , O
have VBP O
few JJ O
somatostatin NN O
receptors NNS O
, , O
the DT O
increased VBN O
somatostatin NN O
receptor NN O
expression NN O
in IN O
peritumoral JJ O
vessels NNS O
observed VBD O
in IN O
this DT O
study NN O
may MD O
be VB O
linked VBN O
to TO O
the DT O
neoplastic JJ O
process NN O
itself PRP O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
somatostatin NN O
and CC O
somatostatin NN O
receptors NNS O
may MD O
play VB O
a DT O
regulatory JJ O
role NN O
for IN O
hemodynamic JJ O
tumor NN O
- : O
host NN O
interactions NNS O
, , O
possibly RB O
involving VBG O
tumor NN O
stroma NN O
generation NN O
, , O
tumor NN O
environment NN O
, , O
angiogenesis NN O
and CC O
, , O
particularly RB O
, , O
vascular JJ O
drainage NN O
of IN O
poorly RB O
differentiated JJ O
neoplasms NNS O
. . O

-DOCSTART- X X O

[ JJ O
Treatment NNP O
of IN O
the DT O
diabetic JJ O
foot NN O
by IN O
hyperbaric JJ O
oxygen NN O
] NNS O

Diabetic JJ O
foot NN O
wounds NNS O
are VBP O
consequences NNS O
of IN O
the DT O
neuropathy NN O
and CC O
the DT O
small JJ O
and CC O
large JJ O
vessel NN O
disease NN O
that WDT O
complicate VB O
diabetes NN O
. . O

At IN O
the DT O
cellular JJ O
level NN O
, , O
the DT O
result NN O
is VBZ O
hypoxia NN O
which WDT O
impairs VBZ O
wound VBN O
healing NN O
. . O

Hyperbaric NNP O
oxygenation NN O
( -LRB- O
HBO NNP O
) -RRB- O
may MD O
be VB O
a DT O
useful JJ O
adjuvant NN O
to TO O
wound VB O
care NN O
. . O

It PRP O
leads VBZ O
to TO O
enhanced JJ O
oxygenation NN O
of IN O
the DT O
affected JJ O
tissues NNS O
, , O
has VBZ O
an DT O
antiseptic JJ O
effect NN O
, , O
reduces VBZ O
edema NN O
, , O
and CC O
accelerates NNS O
collagen NN O
production NN O
and CC O
angiogenesis NN O
, , O
thus RB O
enhancing VBG O
tissue NN O
repair NN O
. . O

14 CD O
diabetics NNS O
with IN O
chronic JJ O
nonhealing NN O
wounds NNS O
which WDT O
did VBD O
not RB O
respond VB O
to TO O
treatment NN O
for IN O
at IN O
least JJS O
3 CD O
months NNS O
were VBD O
treated VBN O
by IN O
HBO NNP O
. . O

All DT O
had VBD O
palpable JJ O
pedal NN O
pulses NNS O
. . O

Transcutaneous JJ O
measurements NNS O
of IN O
tissue NN O
pO2 NNS O
showed VBD O
elevation NN O
from IN O
20 CD O
+ NN O
/ IN O
- : O
10 CD O
mm CD O
Hg NN O
during IN O
air NN O
breathing NN O
to TO O
643 CD O
+ NN O
/ NNS O
- : O
242 CD O
mm CD O
Hg NN O
while IN O
breathing NN O
pure JJ O
oxygen NN O
at IN O
2 CD O
. . O
5 CD O
ATA NNP O
. . O

They PRP O
were VBD O
treated VBN O
with IN O
HBO NNP O
in IN O
56 CD O
+ NN O
/ IN O
- : O
10 CD O
consecutive JJ O
HBO NNP O
sessions NNS O
. . O

In IN O
11 CD O
there EX O
was VBD O
complete JJ O
wound NN O
healing NN O
, , O
while IN O
in IN O
1 CD O
there EX O
was VBD O
partial JJ O
response NN O
, , O
in IN O
1 CD O
minimal JJ O
response NN O
, , O
and CC O
in IN O
1 CD O
a DT O
transient JJ O
response NN O
. . O

HBO NNP O
is VBZ O
useful JJ O
in IN O
chronic JJ O
nonhealing NN O
wounds NNS O
of IN O
the DT O
diabetic JJ O
foot NN O
and CC O
of IN O
the DT O
diabetic JJ O
foot NN O
with IN O
impending JJ O
amputation NN O
. . O

It PRP O
is VBZ O
a DT O
safe JJ O
mode NN O
of IN O
therapy NN O
, , O
but CC O
further JJ O
studies NNS O
are VBP O
required VBN O
to TO O
establish VB O
its PRP$ O
efficacy NN O
and CC O
to TO O
ascertain VB O
which WDT O
diabetic NN O
patients NNS O
and CC O
wounds NNS O
will MD O
benefit VB O
the DT O
most RBS O
from IN O
it PRP O
. . O

-DOCSTART- X X O

Chelation NNP O
treatment NN O
of IN O
neurological JJ O
Wilson NNP O
' POS O
s PRP O
disease NN O
. . O

The DT O
results NNS O
of IN O
chelation NN O
treatment NN O
of IN O
137 CD O
patients NNS O
presenting VBG O
with IN O
neurological JJ O
Wilson NNP O
' POS O
s PRP O
disease NN O
are VBP O
described VBN O
, , O
together RB O
with IN O
the DT O
more RBR O
commonly RB O
observed VBN O
toxic JJ O
reactions NNS O
to TO O
the DT O
various JJ O
drugs NNS O
employed VBN O
. . O

Fifty CD O
- : O
seven CD O
patients NNS O
made VBD O
an DT O
excellent JJ O
response NN O
to TO O
treatment NN O
and CC O
became VBD O
symptom JJ O
free JJ O
. . O

Thirty CD O
- : O
six CD O
patients NNS O
made VBD O
a DT O
good JJ O
recovery NN O
, , O
but CC O
were VBD O
left VBN O
with IN O
some DT O
minor JJ O
neurological JJ O
deficit NN O
. . O

Twenty CD O
- : O
four CD O
patients NNS O
had VBD O
a DT O
poor JJ O
response NN O
: : O
although IN O
the DT O
disease NN O
process NN O
was VBD O
arrested VBN O
they PRP O
were VBD O
left VBN O
more RBR O
or CC O
less RBR O
disabled JJ O
. . O

Twenty CD O
patients NNS O
died VBD O
: : O
nine CD O
had VBD O
little RB O
or CC O
no DT O
treatment NN O
, , O
but CC O
11 CD O
died VBD O
despite IN O
apparently RB O
adequate JJ O
chelation NN O
therapy NN O
. . O

There EX O
was VBD O
no DT O
obvious JJ O
reason NN O
for IN O
this DT O
failure NN O
. . O

The DT O
liver NN O
copper NN O
level NN O
was VBD O
estimated VBN O
in IN O
six CD O
of IN O
these DT O
patients NNS O
: : O
it PRP O
was VBD O
still RB O
significantly RB O
elevated VBD O
in IN O
only RB O
one CD O
, , O
but CC O
in IN O
all DT O
four CD O
in IN O
whom WP O
it PRP O
was VBD O
possible JJ O
to TO O
make VB O
the DT O
determination NN O
, , O
the DT O
concentration NN O
of IN O
copper NN O
in IN O
the DT O
basal NN O
ganglia NN O
was VBD O
in IN O
excess NN O
of IN O
45 CD O
micrograms NNS O
/ RB O
g JJ O
wet JJ O
weight NN O
. . O

It PRP O
was VBD O
not RB O
apparent JJ O
why WRB O
adequate JJ O
therapy NN O
failed VBD O
to TO O
remove VB O
copper NN O
from IN O
the DT O
brains NNS O
of IN O
these DT O
patients NNS O
. . O

There EX O
was VBD O
no DT O
obvious JJ O
clinical JJ O
, , O
histological JJ O
or CC O
biochemical JJ O
indicator NN O
of IN O
failure NN O
to TO O
respond VB O
to TO O
treatment NN O
. . O

Initial JJ O
deterioration NN O
before IN O
improvement NN O
was VBD O
seen VBN O
in IN O
30 CD O
patients NNS O
: : O
the DT O
prognosis NN O
for IN O
a DT O
useful JJ O
recovery NN O
was VBD O
not RB O
necessarily RB O
worse JJR O
than IN O
that IN O
in IN O
patients NNS O
who WP O
did VBD O
not RB O
show VB O
this DT O
phenomenon NN O
. . O

-DOCSTART- X X O

Transformation NNP O
- : O
associated VBN O
cytokine NN O
9E3 IN O
/ NNP O
CEF4 NNP O
is VBZ O
chemotactic NN O
for IN O
chicken NN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
. . O

9E3 DT O
/ NNP O
CEF4 NNP O
, , O
which WDT O
is VBZ O
released VBN O
from IN O
transformed VBN O
chicken NN O
embryo NN O
fibroblasts NNS O
( -LRB- O
CEF NN O
) -RRB- O
, , O
is VBZ O
a DT O
member NN O
of IN O
the DT O
platelet NN O
factor NN O
4 CD O
family NN O
of IN O
inflammatory JJ O
proteins NNS O
and CC O
may MD O
be VB O
the DT O
avian JJ O
homolog NN O
of IN O
interleukin JJ O
- : O
8 CD O
. . O

Since IN O
the DT O
function NN O
of IN O
9E3 DT O
/ NNP O
CEF4 NNP O
is VBZ O
unknown JJ O
, , O
we PRP O
examined VBD O
the DT O
effect NN O
of IN O
the DT O
protein NN O
on IN O
mitogenicity NN O
and CC O
chemotaxis NN O
, , O
as RB O
well RB O
as IN O
its PRP$ O
expression NN O
, , O
in IN O
fibroblasts NNS O
and CC O
peripheral JJ O
blood NN O
cells NNS O
. . O

9E3 DT O
/ NNP O
CEF4 NNP O
mRNA NN O
was VBD O
expressed VBN O
in IN O
chicken NN O
peripheral JJ O
blood NN O
monocytes NNS O
, , O
and CC O
its PRP$ O
expression NN O
was VBD O
stimulated VBN O
by IN O
incubation NN O
of IN O
the DT O
monocytes NNS O
with IN O
lipopolysaccharide NN O
or CC O
phorbol NN O
myristic JJ O
acetate NN O
. . O

Boyden NNP O
double JJ O
- : O
membrane NN O
analysis NN O
of IN O
chemotaxis NN O
showed VBD O
that IN O
9E3 DT O
/ JJ O
CEF4 NNP O
was VBD O
chemotactic NN O
for IN O
chicken NN O
peripheral JJ O
blood NN O
mononuclear NN O
cells NNS O
, , O
as RB O
well RB O
as IN O
for IN O
heterophils NNS O
. . O

Untransformed JJ O
CEF NNP O
and CC O
CEF NNP O
transformed VBD O
with IN O
Rous JJ O
sarcoma NN O
virus NN O
also RB O
migrated VBN O
to TO O
9E3 VB O
/ DT O
CEF4 NNP O
protein NN O
, , O
as IN O
measured VBN O
by IN O
Boyden NNP O
single JJ O
- : O
membrane NN O
analysis NN O
. . O

9E3 DT O
/ NNP O
CEF4 NNP O
was VBD O
slightly RB O
mitogenic JJ O
for IN O
CEF NNP O
, , O
causing VBG O
a DT O
doubling NN O
of IN O
[ NN O
3H . O
] SYM O
thymidine JJ O
uptake NN O
when WRB O
added VBN O
to TO O
serum VB O
- : O
starved VBD O
CEF NNP O
. . O
9E3 CD O
/ NNP O
CEF4 NNP O
was VBD O
found VBN O
associated VBN O
not RB O
only RB O
with IN O
the DT O
cell NN O
and CC O
in IN O
the DT O
culture NN O
medium NN O
of IN O
Rous JJ O
sarcoma NN O
virus NN O
- : O
transformed VBN O
CEF NN O
but CC O
also RB O
with IN O
the DT O
extracellular JJ O
matrix NN O
. . O

The DT O
in IN O
vivo JJ O
role NN O
of IN O
9E3 DT O
/ NNP O
CEF4 NNP O
may MD O
be VB O
involved VBN O
with IN O
chemotaxis NNS O
and CC O
metastasis NN O
, , O
rather RB O
than IN O
with IN O
direct JJ O
stimulation NN O
of IN O
mitogenicity NN O
. . O

-DOCSTART- X X O

Lactotransferrin VBG O
binding NN O
to TO O
its PRP$ O
platelet NN O
receptor NN O
inhibits VBZ O
platelet VBN O
aggregation NN O
. . O

A DT O
fluorescent JJ O
lactotransferrin NN O
probe NN O
was VBD O
prepared VBN O
by IN O
coupling VBG O
5 CD O
- : O
( -LRB- O
( -LRB- O
[ NN O
2 CD O
- : O
( -LRB- O
carbhydrazino NN O
) -RRB- O
methyl NN O
] SYM O
- : O
thio NN O
) -RRB- O
acetyl NN O
) -RRB- O
amino IN O
fluorescein NN O
to TO O
aldehyde VB O
groups NNS O
that WDT O
were VBD O
produced VBN O
by IN O
a DT O
mild JJ O
periodic JJ O
- : O
acid NN O
oxidation NN O
of IN O
the DT O
glycan NN O
moieties NNS O
of IN O
lactotransferrin NN O
. . O

In IN O
this DT O
manner NN O
, , O
the DT O
receptor NN O
- : O
binding JJ O
site NN O
of IN O
the DT O
lactotransferrin NN O
remains VBZ O
active JJ O
in IN O
contrast NN O
to TO O
the DT O
binding JJ O
site NN O
of IN O
the DT O
lactotransferrin VBG O
derivatized VBN O
with IN O
fluorescein NN O
isothiocyanate NN O
. . O

The DT O
fluorescent NN O
probe NN O
allowed VBD O
us PRP O
to TO O
characterize VB O
, , O
by IN O
flow NN O
cytometry NN O
, , O
the DT O
binding NN O
of IN O
lactotransferrin VBG O
to TO O
non FW O
- : O
activated VBN O
human JJ O
platelets NNS O
. . O

The DT O
putative JJ O
lactotransferrin NN O
platelet NN O
receptor NN O
was VBD O
purified VBN O
and CC O
its PRP$ O
immunological JJ O
and CC O
physico JJ O
- : O
chemical NN O
properties NNS O
were VBD O
found VBN O
to TO O
be VB O
very RB O
similar JJ O
to TO O
those DT O
of IN O
the DT O
receptor NN O
previously RB O
isolated VBN O
from IN O
activated JJ O
human JJ O
lymphocytes NNS O
. . O

Lactotransferrin NNP O
inhibits VBZ O
ADP NNP O
- : O
induced JJ O
platelet NN O
aggregation NN O
at IN O
concentrations NNS O
down IN O
to TO O
5 CD O
nM NN O
, , O
which WDT O
can MD O
be VB O
reached VBN O
in IN O
the DT O
plasma NN O
after IN O
leukocyte NN O
degranulation NN O
. . O

Inhibition NN O
of IN O
platelet NN O
aggregation NN O
was VBD O
also RB O
observed VBN O
with IN O
the DT O
N NNP O
- : O
terminal JJ O
fragment NN O
of IN O
lactotransferrin VBG O
( -LRB- O
residues NNS O
3 CD O
- : O
281 CD O
; : O
50 CD O
% NN O
inhibition IN O
= SYM O
2 CD O
microM NN O
) -RRB- O
and CC O
with IN O
CFQWQRNMRKVRGPPVSC NNP O
synthetic NN O
octodecapeptide NN O
( -LRB- O
residues NNS O
20 CD O
- : O
37 CD O
; : O
50 CD O
% NN O
inhibition NN O
= SYM O
20 CD O
microM NNS O
) -RRB- O
corresponding JJ O
to TO O
one CD O
of IN O
the DT O
two CD O
external JJ O
loops NNS O
( -LRB- O
residues NNS O
28 CD O
- : O
34 CD O
and CC O
39 CD O
- : O
42 CD O
) -RRB- O
where WRB O
we PRP O
recently RB O
located VBD O
the DT O
receptor NN O
- : O
binding JJ O
site NN O
. . O

The DT O
activity NN O
( -LRB- O
50 CD O
% NN O
inhibition IN O
= SYM O
500 CD O
microM NNS O
) -RRB- O
of IN O
the DT O
tetrapeptide NN O
KRDS NNP O
( -LRB- O
residues NNS O
39 CD O
- : O
42 CD O
) -RRB- O
, , O
which WDT O
has VBZ O
already RB O
been VBN O
described VBN O
, , O
was VBD O
at IN O
least JJS O
25 CD O
- : O
times NNS O
and CC O
16000 CD O
- : O
times NNS O
lower JJR O
than IN O
the DT O
activity NN O
of IN O
the DT O
octodecapeptide NN O
and CC O
of IN O
the DT O
lactotransferrin NN O
molecules NNS O
, , O
respectively RB O
. . O

Finally RB O
, , O
the DT O
inhibition NN O
was VBD O
demonstrated VBN O
to TO O
be VB O
mediated VBN O
by IN O
a DT O
mechanism NN O
which WDT O
requires VBZ O
the DT O
binding NN O
of IN O
lactotransferrin VBG O
to TO O
its PRP$ O
putative JJ O
receptor NN O
and CC O
not RB O
to TO O
platelet VB O
glycoprotein NN O
IIb NNP O
- : O
IIIa NNP O
. . O

-DOCSTART- X X O

Vitamins NNP O
regulate VB O
gene NN O
expression NN O
and CC O
induce VB O
differentiation NN O
and CC O
growth NN O
inhibition NN O
in IN O
cancer NN O
cells NNS O
. . O

Their PRP$ O
relevance NN O
in IN O
cancer NN O
prevention NN O
. . O

Although IN O
several JJ O
hypotheses NNS O
for IN O
human JJ O
carcinogenesis NN O
have VBP O
been VBN O
proposed VBN O
, , O
the DT O
specific JJ O
genetic JJ O
changes NNS O
that WDT O
cause VBP O
normal JJ O
cells NNS O
to TO O
become VB O
cancer NN O
cells NNS O
have VBP O
not RB O
been VBN O
identified VBN O
. . O

In IN O
spite NN O
of IN O
uncertainties NNS O
regarding VBG O
the DT O
mechanisms NNS O
of IN O
carcinogenesis NN O
, , O
several JJ O
vitamins NNS O
such JJ O
as IN O
beta JJ O
- : O
carotene NN O
and CC O
vitamins NNS O
A DT O
, , O
C NNP O
, , O
and CC O
E NNP O
, , O
which WDT O
can MD O
reduce VB O
the DT O
risk NN O
of IN O
cancer NN O
, , O
have VBP O
been VBN O
identified VBN O
, , O
using VBG O
animal NN O
and CC O
in IN O
vitro NN O
models NNS O
of IN O
carcinogenesis NN O
. . O

These DT O
studies NNS O
have VBP O
led VBN O
to TO O
a DT O
hypothesis NN O
that IN O
the DT O
supplemental JJ O
intake NN O
of IN O
these DT O
vitamins NNS O
may MD O
reduce VB O
the DT O
risk NN O
of IN O
cancer NN O
. . O

This DT O
hypothesis NN O
in IN O
humans NNS O
can MD O
be VB O
tested VBN O
only RB O
by IN O
intervention NN O
trials NNS O
that WDT O
are VBP O
in IN O
progress NN O
. . O

Prospective JJ O
and CC O
retrospective JJ O
case NN O
- : O
controlled JJ O
experimental JJ O
designs NNS O
are VBP O
not RB O
suitable JJ O
for IN O
testing VBG O
the DT O
above JJ O
hypothesis NN O
. . O

The DT O
fact NN O
that IN O
some DT O
vitamins NNS O
induce VB O
cell NN O
differentiation NN O
and CC O
/ NN O
or CC O
growth NN O
inhibition NN O
in IN O
tumor NN O
cells NNS O
in IN O
culture NN O
suggests VBZ O
that IN O
the DT O
use NN O
of IN O
these DT O
vitamins NNS O
in IN O
cancer NN O
prevention NN O
has VBZ O
a DT O
cellular JJ O
basis NN O
. . O

In IN O
addition NN O
to TO O
having VBG O
a DT O
direct JJ O
effect NN O
on IN O
tumor NN O
cells NNS O
, , O
vitamins NNS O
such JJ O
as IN O
alpha NN O
- : O
tocopheryl NN O
succinate JJ O
and CC O
beta JJ O
- : O
carotene NN O
enhance VB O
the DT O
effect NN O
of IN O
other JJ O
agents NNS O
that WDT O
induce VB O
differentiation NN O
in IN O
tumor NN O
cells NNS O
. . O

Some DT O
vitamins NNS O
like IN O
beta JJ O
- : O
carotene NN O
, , O
retinoic JJ O
acid NN O
, , O
alpha NN O
- : O
tocopheryl NN O
succinate NN O
, , O
and CC O
vitamin NN O
D NNP O
also RB O
regulate VB O
the DT O
expressions NNS O
of IN O
certain JJ O
oncogenes NNS O
and CC O
cellular JJ O
genes NNS O
. . O

These DT O
are VBP O
exciting JJ O
new JJ O
functions NNS O
of IN O
vitamins NNS O
that IN O
nobody NN O
could MD O
have VB O
predicted VBN O
only RB O
a DT O
few JJ O
years NNS O
ago RB O
. . O

-DOCSTART- X X O

Increased VBN O
nm23 CD O
- : O
H1 CD O
and CC O
nm23 CD O
- : O
H2 CD O
messenger NN O
RNA NNP O
expression NN O
and CC O
absence NN O
of IN O
mutations NNS O
in IN O
colon NN O
carcinomas NNS O
of IN O
low JJ O
and CC O
high JJ O
metastatic JJ O
potential NN O
. . O

BACKGROUND NNP O
: : O
The DT O
murine NN O
nm23 VBD O
gene NN O
suppresses NNS O
the DT O
metastatic JJ O
behavior NN O
of IN O
malignant JJ O
rodent NN O
tumor NN O
lines NNS O
, , O
and CC O
reduced VBD O
nm23 CD O
expression NN O
correlates NNS O
with IN O
increased JJ O
likelihood NN O
of IN O
lymph NN O
node NN O
metastases NNS O
in IN O
human JJ O
breast NN O
cancers NNS O
. . O

More JJR O
recent JJ O
data NNS O
have VBP O
demonstrated VBN O
the DT O
existence NN O
of IN O
two CD O
human JJ O
nm23 CD O
gene NN O
homologues NNS O
, , O
nm23 CD O
- : O
H1 CD O
and CC O
nm23 CD O
- : O
H2 NN O
, , O
and CC O
have VBP O
shown VBN O
that IN O
deletion NN O
of IN O
nm23 CD O
- : O
H1 CD O
alleles NNS O
occurs VBZ O
in IN O
some DT O
colon NN O
carcinomas NNS O
associated VBN O
with IN O
poor JJ O
prognosis NN O
. . O

These DT O
findings NNS O
suggest VBP O
that IN O
nm23 CD O
- : O
H1 CD O
encodes NNS O
for IN O
suppression NN O
of IN O
colon NN O
carcinoma NN O
metastasis NN O
. . O

In IN O
contrast NN O
, , O
we PRP O
have VBP O
previously RB O
reported VBN O
that IN O
total JJ O
nm23 NN O
messenger NN O
RNA NNP O
( -LRB- O
mRNA NN O
) -RRB- O
expression NN O
is VBZ O
increased VBN O
to TO O
similar JJ O
levels NNS O
in IN O
colon NN O
tumors NNS O
of IN O
both DT O
high JJ O
and CC O
low JJ O
metastatic JJ O
potential NN O
. . O

PURPOSE NNP O
: : O
This DT O
study NN O
was VBD O
designed VBN O
to TO O
reconcile VB O
our PRP$ O
previous JJ O
findings NNS O
with IN O
the DT O
recent JJ O
report NN O
of IN O
nm23 CD O
- : O
H1 CC O
allelic JJ O
deletion NN O
in IN O
human JJ O
colon NN O
cancers NNS O
associated VBN O
with IN O
poor JJ O
prognosis NN O
. . O

Our PRP$ O
purpose NN O
was VBD O
to TO O
examine VB O
human JJ O
colon NN O
cancers NNS O
for IN O
inactivation NN O
of IN O
two CD O
candidate NN O
metastasis NN O
suppressor NN O
genes NNS O
, , O
nm23 VB O
- : O
H1 NNP O
and CC O
nm23 CD O
- : O
H2 NN O
, , O
either CC O
by IN O
mutation NN O
or CC O
by IN O
loss NN O
of IN O
gene NN O
transcription NN O
. . O

METHODS NNS O
: : O
We PRP O
used VBD O
ribonuclease NN O
protection NN O
assays IN O
to TO O
analyze VB O
human JJ O
colon NN O
tumors NNS O
for IN O
the DT O
level NN O
of IN O
nm23 CD O
- : O
H1 CD O
( -LRB- O
43 CD O
samples NNS O
) -RRB- O
and CC O
nm23 CD O
- : O
H2 NN O
( -LRB- O
41 CD O
samples NNS O
) -RRB- O
transcript NN O
( -LRB- O
mRNA NN O
) -RRB- O
expression NN O
and CC O
the DT O
presence NN O
of IN O
mutations NNS O
that WDT O
could MD O
inactivate VB O
potential JJ O
suppressor NN O
function NN O
. . O

RESULTS NNS O
: : O
We PRP O
detected VBD O
only RB O
wild JJ O
- : O
type NN O
nm23 CD O
- : O
H1 CD O
and CC O
nm23 CD O
- : O
H2 CD O
mRNA NN O
. . O

Expression NN O
of IN O
nm23 CD O
- : O
H1 JJ O
mRNA NN O
increased VBN O
in IN O
33 CD O
of IN O
41 CD O
colon NN O
tumors NNS O
, , O
and CC O
expression NN O
of IN O
nm23 CD O
- : O
H2 CD O
mRNA NN O
was VBD O
elevated VBN O
in IN O
28 CD O
of IN O
41 CD O
colon NN O
tumors NNS O
relative JJ O
to TO O
that DT O
in IN O
matched VBN O
normal JJ O
mucosa NN O
. . O

Increases NNS O
in IN O
these DT O
mRNA JJ O
levels NNS O
were VBD O
similar JJ O
in IN O
tumors NNS O
of IN O
both DT O
low JJ O
and CC O
high JJ O
metastatic JJ O
potential NN O
. . O

CONCLUSIONS NNS O
: : O
These DT O
results NNS O
suggest VBP O
that IN O
, , O
despite IN O
correlation NN O
of IN O
nm23 CD O
- : O
H1 CC O
allelic JJ O
deletions NNS O
with IN O
colon NN O
cancers NNS O
associated VBN O
with IN O
poor JJ O
prognosis NN O
, , O
nm23 CD O
- : O
H1 CD O
and CC O
nm23 CD O
- : O
H2 NN O
alleles NNS O
do VBP O
not RB O
directly RB O
mediate JJ O
metastasis NN O
suppression NN O
in IN O
colon NN O
carcinoma NN O
. . O

Our PRP$ O
results NNS O
leave VBP O
unexplained JJ O
the DT O
observation NN O
that IN O
nm23 CD O
- : O
H1 CD O
allelic NN O
deletion NN O
correlates VBZ O
with IN O
metastatic JJ O
potential JJ O
of IN O
colon NN O
carcinomas NNS O
. . O

IMPLICATIONS NNS O
: : O
These DT O
findings NNS O
also RB O
contrast NN O
with IN O
the DT O
demonstration NN O
of IN O
nm23 DT O
metastasis NN O
suppressor NN O
activity NN O
in IN O
murine NN O
melanoma NN O
and CC O
with IN O
the DT O
correlation NN O
of IN O
loss NN O
of IN O
nm23 CD O
expression NN O
in IN O
breast NN O
cancer NN O
with IN O
poor JJ O
prognosis NN O
. . O

It PRP O
may MD O
be VB O
that DT O
metastasis NN O
suppression NN O
by IN O
the DT O
nm23 CD O
gene NN O
is VBZ O
a DT O
tissue NN O
- : O
specific JJ O
phenomenon NN O
. . O

-DOCSTART- X X O

E NNP O
mu NNS O
- : O
bcl SYM O
- : O
2 CD O
transgene NN O
facilitates NNS O
spontaneous JJ O
transformation NN O
of IN O
early JJ O
pre NN O
- : O
B NN O
and CC O
immunoglobulin NN O
- : O
secreting NN O
cells NNS O
but CC O
not RB O
T NNP O
cells NNS O
. . O

To TO O
assess VB O
the DT O
lymphoid NN O
tumorigenic JJ O
potential NN O
of IN O
bcl JJ O
- : O
2 CD O
, , O
mice NNS O
of IN O
five CD O
independent JJ O
strains NNS O
expressing VBG O
a DT O
bcl JJ O
- : O
2 CD O
transgene NN O
in IN O
B NNP O
and CC O
/ RB O
or CC O
T NNP O
cells NNS O
were VBD O
monitored VBN O
for IN O
disease NN O
up IN O
to TO O
12 CD O
months NNS O
of IN O
age NN O
. . O

Lymphoma NNP O
prevalence NN O
was VBD O
minimal JJ O
in IN O
the DT O
T NNP O
lineage NN O
but CC O
significant JJ O
, , O
although IN O
low JJ O
( -LRB- O
3 CD O
- : O
15 CD O
% NN O
) -RRB- O
, , O
in IN O
the DT O
B NNP O
lineage NN O
. . O

The DT O
principal JJ O
types NNS O
of IN O
tumors NNS O
were VBD O
plasmacytomas NNS O
secreting VBG O
immunoglobulin NN O
and CC O
novel NN O
lymphomas NNS O
that IN O
expressed VBN O
markers NNS O
such JJ O
as IN O
Sca NNP O
- : O
1 CD O
, , O
CD4 NNP O
, , O
Thy NNPS O
- : O
1 CD O
, , O
CD34 NNP O
and CC O
CD45 NNP O
( -LRB- O
B220 NN O
) -RRB- O
, , O
consistent JJ O
with IN O
an DT O
origin NN O
very RB O
early RB O
in IN O
B NNP O
- : O
lymphoid NN O
development NN O
. . O

Rearrangement NN O
of IN O
the DT O
c NN O
- : O
myc JJ O
gene NN O
was VBD O
common JJ O
in IN O
the DT O
plasmacytomas NNS O
, , O
implying VBG O
a DT O
synergistic JJ O
role NN O
for IN O
myc JJ O
and CC O
bcl JJ O
- : O
2 CD O
in IN O
their PRP$ O
etiology NN O
, , O
but CC O
was VBD O
not RB O
detected VBN O
in IN O
the DT O
lymphomas NNS O
. . O

-DOCSTART- X X O

Appearance NNP O
of IN O
tumorous JJ O
phenotypes NNS O
in IN O
goldfish NN O
erythrophores NNS O
transfected VBN O
with IN O
ras NNS O
, , O
src NN O
, , O
and CC O
myc JJ O
oncogenes NNS O
and CC O
spontaneous JJ O
differentiation NN O
of IN O
the DT O
transformants NNS O
in IN O
vitro NN O
. . O

When WRB O
goldfish JJ O
erythrophores NNS O
isolated VBN O
from IN O
the DT O
skin NN O
by IN O
tissue NN O
digestion NN O
and CC O
centrifugation NN O
in IN O
a DT O
Percoll NNP O
density NN O
gradient NN O
were VBD O
transfected VBN O
in IN O
a DT O
monolayer NN O
- : O
culture NN O
with IN O
v FW O
- : O
Ha SYM O
- : O
ras NNS O
or CC O
v FW O
- : O
src NN O
oncogene NN O
either CC O
singly RB O
or CC O
in IN O
combination NN O
with IN O
v FW O
- : O
myc NN O
by IN O
means NNS O
of IN O
calcium NN O
phosphate NN O
- : O
DNA NN O
co NN O
- : O
precipitation NN O
, , O
there EX O
appeared VBD O
a DT O
certain JJ O
number NN O
of IN O
transformants NNS O
manifesting VBG O
a DT O
chromatoblast NN O
- : O
like IN O
profile NN O
and CC O
tumorous JJ O
phenotypes NNS O
as IN O
seen VBN O
in IN O
the DT O
capability NN O
for IN O
unlimited JJ O
growth NN O
, , O
and CC O
piling VBG O
- : O
up RB O
in IN O
a DT O
monolayer NN O
- : O
culture NN O
or CC O
colony NN O
formation NN O
in IN O
semi FW O
- : O
solid JJ O
soft JJ O
agar NN O
. . O

After IN O
successive JJ O
growth NN O
in IN O
vitro NN O
for IN O
longer JJR O
than IN O
one CD O
month NN O
which WDT O
was VBD O
scarcely RB O
observed VBN O
with IN O
the DT O
erythrophores NNS O
, , O
the DT O
vast JJ O
majority NN O
of IN O
such JJ O
transformants NNS O
began VBD O
to TO O
differentiate VB O
into IN O
erythrophores NNS O
and CC O
ceased VBD O
proliferation NN O
spontaneously RB O
. . O

The DT O
onset NN O
of IN O
their PRP$ O
differentiation NN O
was VBD O
ascertained VBN O
by IN O
the DT O
deposition NN O
of IN O
marker NN O
pteridine NN O
pigments NNS O
. . O

None NN O
of IN O
the DT O
transformants NNS O
differentiated VBD O
into IN O
melanophores NNS O
or CC O
iridophores NNS O
or CC O
other JJ O
neural JJ O
crest NN O
derivatives VBZ O
as RB O
seen VBN O
in IN O
goldfish JJ O
erythrophoroma NN O
cells NNS O
. . O

Little NNP O
difference NN O
was VBD O
observed VBN O
in IN O
their PRP$ O
transforming JJ O
efficiency NN O
( -LRB- O
0 CD O
. . O
2 LS O
- : O
0 CD O
. . O
3 CD O
transformants NNS O
/ JJ O
micrograms NNS O
DNA NN O
) -RRB- O
between IN O
the DT O
combinations NNS O
of IN O
oncogenes NNS O
applied VBN O
but CC O
a DT O
tendency NN O
was VBD O
noted VBN O
that IN O
cells NNS O
transfected VBN O
with IN O
ras NNS O
or CC O
src NN O
in IN O
combination NN O
with IN O
myc JJ O
developed VBN O
the DT O
capacity NN O
to TO O
grow VB O
for IN O
a DT O
longer JJR O
period NN O
and CC O
differentiated VBD O
at IN O
a DT O
later RB O
stage NN O
than IN O
those DT O
transfected VBN O
solely RB O
with IN O
ras NNS O
or CC O
src NN O
. . O

One CD O
cell NN O
line NN O
( -LRB- O
ESM FW B-NP
- : I-NP
1 CD I-NP
) -RRB- O
derived VBN O
from IN O
the DT O
erythrophores NNS O
transfected VBN O
with IN O
src JJ O
/ NN O
myc NN O
grew VBD O
successively RB O
over IN O
nine CD O
months NNS O
, , O
indicating VBG O
its PRP$ O
acquisition NN O
of IN O
immortality NN O
. . O

The DT O
expression NN O
of IN O
the DT O
transfected JJ O
oncogenes NNS O
in IN O
this DT O
cell NN O
line NN O
was VBD O
examined VBN O
in IN O
comparison NN O
with IN O
the DT O
erythrophoroma NN O
cells NNS O
by IN O
Western JJ O
and CC O
Northern JJ O
blot NN O
analyses NNS O
. . O

-DOCSTART- X X O

[ NN O
Prehospital NNP O
service NN O
in IN O
Denmark NNP O
] NNP O
. . O

In IN O
Denmark NNP O
, , O
emergency NN O
ambulances NNS O
are VBP O
dispatched VBN O
by IN O
41 CD O
centres NNS O
manned VBD O
either RB O
by IN O
trained JJ O
firemen NNS O
( -LRB- O
in IN O
Copenhagen NNP O
) -RRB- O
or CC O
policemen NNS O
( -LRB- O
outside JJ O
Copenhagen NN O
) -RRB- O
. . O

In IN O
1990 CD O
, , O
emergency NN O
ambulance NN O
calls VBZ O
totalled VBN O
284 CD O
, , O
000 CD O
. . O

Utilisation NN O
of IN O
emergency NN O
ambulance NN O
services NNS O
increases VBZ O
with IN O
urbanisation NN O
. . O

A DT O
doctor NN O
- : O
manned JJ O
ambulance NN O
is VBZ O
in IN O
operation NN O
in IN O
Copenhagen NNP O
, , O
and CC O
in IN O
some DT O
other JJ O
large JJ O
towns NNS O
anaesthesiology NN O
and CC O
intensive JJ O
care NN O
teams NNS O
can MD O
be VB O
dispatched VBN O
from IN O
hospital NN O
to TO O
give VB O
on RP O
- : O
the DT O
- : O
spot NN O
care NN O
. . O

In IN O
less RBR O
populated JJ O
areas NNS O
, , O
some DT O
general JJ O
practitioners NNS O
give VBP O
advanced VBN O
life NN O
- : O
support NN O
. . O

Although IN O
many JJ O
areas NNS O
are VBP O
serviced VBN O
by IN O
ambulances NNS O
equipped VBN O
with IN O
defibrillators NNS O
, , O
the DT O
majority NN O
of IN O
patients NNS O
receive VBP O
only JJ O
basic JJ O
life NN O
- : O
support NN O
from IN O
ambulance NN O
personnel NNS O
. . O

New NNP O
initiatives NNS O
resulting VBG O
from IN O
a DT O
recent JJ O
report NN O
by IN O
a DT O
commission NN O
appointed VBN O
by IN O
central JJ O
authorities NNS O
, , O
and CC O
focused VBD O
on IN O
prehospital NN O
treatment NN O
, , O
are VBP O
expected VBN O
to TO O
improve VB O
the DT O
service NN O
by IN O
raising VBG O
the DT O
level NN O
of IN O
training NN O
given VBN O
to TO O
ambulance NN O
personnel NNS O
. . O

-DOCSTART- X X O

Tumorigenic JJ O
activity NN O
of IN O
rho NNP O
genes NNS O
from IN O
Aplysia NNP O
californica NN O
. . O

rho VBN O
genes NNS O
have VBP O
been VBN O
found VBN O
in IN O
both DT O
lower JJR O
and CC O
higher JJR O
eucaryotes NNS O
. . O

They PRP O
code NN O
for IN O
proteins NNS O
of IN O
21 CD O
kDa NN O
, , O
highly RB O
conserved VBN O
in IN O
evolution NN O
, , O
which WDT O
belong VBP O
to TO O
the DT O
superfamily NN O
of IN O
ras NNS O
GTPases NNS O
. . O

Among IN O
the DT O
members NNS O
of IN O
this DT O
superfamily NN O
there EX O
are VBP O
proteins NNS O
with IN O
a DT O
regulatory JJ O
function NN O
, , O
such JJ O
as IN O
ras NNS O
, , O
and CC O
proteins VBZ O
involved VBN O
in IN O
vesicular JJ O
trafficking NN O
, , O
such JJ O
as IN O
the DT O
family NN O
of IN O
rab JJ O
proteins NNS O
. . O

We PRP O
have VBP O
investigated VBN O
the DT O
putative JJ O
role NN O
of IN O
rho NNP O
proteins VBZ O
from IN O
Aplysia NNP O
californica NN O
as IN O
transforming VBG O
GTPases NNS O
utilizing VBG O
the DT O
wild JJ O
- : O
type NN O
and CC O
a DT O
Val NNP O
- : O
14 CD O
mutant NN O
, , O
equivalent JJ O
to TO O
the DT O
oncogenic JJ O
Val NNP O
- : O
12 CD O
mutation NN O
of IN O
ras NNS O
genes NNS O
found VBD O
in IN O
animal NN O
and CC O
human JJ O
tumors NNS O
. . O

Over IN O
- : O
expression NN O
of IN O
either DT O
rho NNP O
gene NN O
was VBD O
sufficient JJ O
to TO O
confer VB O
anchorage NN O
- : O
and CC O
serum NN O
- : O
independent JJ O
growth NN O
. . O

Moreover RB O
, , O
when WRB O
introduced VBN O
into IN O
nude JJ O
mice NNS O
, , O
selected VBN O
clones NNS O
generated VBD O
from IN O
either DT O
gene NN O
were VBD O
able JJ O
to TO O
induce VB O
tumors NNS O
, , O
although IN O
those DT O
carrying VBG O
the DT O
mutated JJ O
version NN O
were VBD O
more RBR O
efficient JJ O
. . O

Pathological NNP O
analysis NN O
indicated VBD O
that IN O
generated VBD O
tumors NNS O
corresponded VBD O
to TO O
well VB O
- : O
differentiated JJ O
fibrosarcomas NNS O
with IN O
distinct JJ O
and CC O
intersecting JJ O
bundles NNS O
and CC O
spindle NN O
cells NNS O
. . O

By IN O
contrast NN O
, , O
ras FW O
- : O
induced VBN O
tumors NNS O
were VBD O
poorly RB O
differentiated JJ O
fibrosarcomas NNS O
. . O

Thus RB O
, , O
our PRP$ O
results NNS O
indicate VBP O
that IN O
under IN O
appropriate JJ O
conditions NNS O
rho VBD O
genes NNS O
function VBP O
as IN O
oncogenes NNS O
and CC O
may MD O
have VB O
a DT O
role NN O
in IN O
the DT O
regulation NN O
of IN O
proliferation NN O
in IN O
fibroblast JJ O
cells NNS O
. . O

-DOCSTART- X X O

Immune NNP O
consequences NNS O
of IN O
burn NN O
injury NN O
. . O

The DT O
purpose NN O
of IN O
the DT O
immune JJ O
system NN O
is VBZ O
to TO O
protect VB O
cells NNS O
from IN O
invasion NN O
by IN O
microorganisms NNS O
. . O

The DT O
body NN O
has VBZ O
three CD O
equally RB O
important JJ O
interactive JJ O
immune JJ O
defense NN O
systems NNS O
, , O
all DT O
of IN O
which WDT O
are VBP O
profoundly RB O
disrupted VBN O
with IN O
major JJ O
burn NN O
injury NN O
. . O

The DT O
immune JJ O
response NN O
to TO O
burn VB O
injury NN O
is VBZ O
immediate JJ O
, , O
prolonged VBN O
, , O
and CC O
severe JJ O
. . O

The DT O
end NN O
result NN O
in IN O
individuals NNS O
surviving VBG O
burn NN O
shock NN O
is VBZ O
immunosuppression NN O
, , O
with IN O
increased VBN O
susceptibility NN O
to TO O
potentially RB O
fatal JJ O
systemic JJ O
burn NN O
wound NN O
or CC O
pulmonary NN O
sepsis NN O
. . O

Nursing VBG O
actions NNS O
to TO O
support VB O
the DT O
humoral JJ O
and CC O
cell NN O
- : O
mediated VBN O
immune JJ O
system NN O
of IN O
the DT O
burned JJ O
patient NN O
include VBP O
providing VBG O
nutritional JJ O
support NN O
to TO O
maintain VB O
serum JJ O
protein NN O
levels NNS O
at IN O
optimal JJ O
levels NNS O
; : O
measures NNS O
to TO O
decrease VB O
edema NN O
and CC O
promote VB O
angiogenesis NN O
in IN O
areas NNS O
of IN O
partial JJ O
- : O
thickness NN O
injury NN O
; : O
meticulous JJ O
treatment NN O
of IN O
the DT O
wound NN O
to TO O
prevent VB O
infection NN O
and CC O
promote VB O
healing NN O
; : O
monitoring NN O
of IN O
antibiotic JJ O
use NN O
; : O
conservative JJ O
use NN O
of IN O
invasive JJ O
techniques NNS O
, , O
including VBG O
intubation NN O
and CC O
vascular JJ O
access NN O
devices NNS O
; : O
maintenance NN O
of IN O
fluid NN O
and CC O
electrolyte JJ O
balance NN O
and CC O
body NN O
temperature NN O
; : O
and CC O
energy NN O
conservation NN O
measures NNS O
. . O

-DOCSTART- X X O

Autocrine NNP O
angiogenic JJ O
vascular JJ O
prosthesis NN O
with IN O
bone NN O
marrow NN O
transplantation NN O
. . O

Synthetic JJ O
vascular JJ O
prostheses NNS O
are VBP O
foreign JJ O
bodies NNS O
, , O
so RB O
that IN O
blood NN O
coagulation NN O
can MD O
occur VB O
on IN O
their PRP$ O
luminal JJ O
surfaces NNS O
, , O
causing VBG O
graft NN O
occlusion NN O
very RB O
frequently RB O
in IN O
prostheses NNS O
of IN O
small JJ O
diameter NN O
. . O

A DT O
vascular JJ O
prosthesis NN O
needs VBZ O
angiogenesis NN O
for IN O
endothelialization NN O
of IN O
the DT O
luminal JJ O
surface NN O
, , O
as IN O
endothelial JJ O
cells NNS O
have VBP O
natural JJ O
and CC O
permanent JJ O
antithrombogenic JJ O
properties NNS O
. . O

To TO O
induce VB O
capillary NN O
growth NN O
into IN O
the DT O
graft NN O
, , O
we PRP O
developed VBD O
a DT O
method NN O
of IN O
transplanting VBG O
bone NN O
marrow NN O
cells NNS O
, , O
which WDT O
are VBP O
primitive JJ O
, , O
strong JJ O
enough RB O
to TO O
survive VB O
, , O
and CC O
create VB O
blood NN O
cells NNS O
, , O
resulting VBG O
in IN O
the DT O
inducement NN O
of IN O
capillary NN O
growth NN O
. . O

In IN O
an DT O
animal NN O
experiment NN O
, , O
marrow JJ O
cells NNS O
were VBD O
infiltrated VBN O
into IN O
the DT O
walls NNS O
of IN O
long JJ O
- : O
fibril NN O
expanded VBN O
polytetrafluoroethylene NN O
( -LRB- O
ePTFE NN O
) -RRB- O
vascular JJ O
grafts NNS O
. . O

The DT O
grafts NNS O
were VBD O
implanted VBN O
in IN O
the DT O
abdominal JJ O
aortic JJ O
position NN O
of IN O
24 CD O
dogs NNS O
autologously RB O
. . O

Marrow JJ O
cells NNS O
survived VBN O
and CC O
continued VBN O
exogenous JJ O
hemopoiesis NN O
for IN O
up RB O
to TO O
six CD O
months NNS O
and CC O
were VBD O
immunohistochemically RB O
reactive JJ O
to TO O
basic JJ O
fibroblast NN O
growth NN O
factor NN O
( -LRB- O
bFGF NN O
) -RRB- O
. . O

All PDT O
the DT O
grafts NNS O
older JJR O
than IN O
three CD O
weeks NNS O
had VBD O
complete JJ O
endothelialization NN O
and CC O
maintained VBD O
their PRP$ O
patency NN O
. . O

Twenty CD O
grafts NNS O
without IN O
bone NN O
marrow NN O
were VBD O
implanted VBN O
as IN O
controls NNS O
. . O

Endothelialization NNP O
was VBD O
present JJ O
at IN O
anastomotic JJ O
sites NNS O
, , O
but CC O
other JJ O
areas NNS O
were VBD O
covered VBN O
with IN O
fresh JJ O
thrombi NN O
. . O

Four CD O
out IN O
of IN O
seven CD O
control NN O
grafts NNS O
were VBD O
patent NN O
with IN O
endothelial JJ O
cell NN O
lining NN O
at IN O
six CD O
months NNS O
, , O
but CC O
three CD O
were VBD O
occluded VBN O
and CC O
one CD O
of IN O
the DT O
four CD O
grafts NNS O
was VBD O
still RB O
covered VBN O
with IN O
a DT O
thrombus NN O
layer NN O
. . O

Bone NNP O
marrow NN O
with IN O
its PRP$ O
unique JJ O
native JJ O
properties NNS O
produced VBN O
autocrine JJ O
angiogenicity NN O
in IN O
the DT O
graft NN O
. . O

-DOCSTART- X X O

Toward IN O
a DT O
theory NN O
regarding VBG O
the DT O
pathogenesis NN O
of IN O
the DT O
systemic JJ O
inflammatory JJ O
response NN O
syndrome NN O
: : O
what WP O
we PRP O
do VBP O
and CC O
do VBP O
not RB O
know VB O
about IN O
cytokine NN O
regulation NN O
. . O

OBJECTIVES NNS O
: : O

The DT O
systemic JJ O
inflammatory JJ O
response NN O
syndrome NN O
( -LRB- O
SIRS NNP O
) -RRB- O
is VBZ O
the DT O
massive JJ O
inflammatory NN O
reaction NN O
resulting VBG O
from IN O
systemic JJ O
mediator NN O
release NN O
that WDT O
may MD O
lead VB O
to TO O
multiple JJ O
organ NN O
dysfunction NN O
. . O

The DT O
objective NN O
of IN O
this DT O
review NN O
article NN O
is VBZ O
to TO O
analyze VB O
the DT O
roles NNS O
of IN O
cytokines NNS O
, , O
cytokine NN O
production NN O
, , O
and CC O
the DT O
relationship NN O
of IN O
cytokine JJ O
production NN O
to TO O
the DT O
development NN O
of IN O
SIRS NNP O
. . O

DATA NNP O
SOURCES NNP O
: : O

Previous JJ O
research NN O
and CC O
clinical JJ O
studies NNS O
related VBN O
to TO O
cytokines NNS O
and CC O
their PRP$ O
relationship NN O
to TO O
SIRS NNP O
. . O

STUDY NNP O
SELECTION NNP O
: : O

From IN O
the DT O
studies NNS O
reviewed VBN O
, , O
three CD O
critical JJ O
questions NNS O
are VBP O
addressed VBN O
. . O

First RB O
, , O
what WP O
is VBZ O
the DT O
definition NN O
of IN O
increased VBN O
cytokine NN O
concentrations NNS O
? . O

Second JJ O
, , O
what WP O
other JJ O
systemic JJ O
illnesses NNS O
besides IN O
sepsis NN O
can MD O
alter VB O
cytokine NN O
concentrations NNS O
? . O

Third JJ O
, , O
what WP O
are VBP O
the DT O
right JJ O
cytokines NNS O
to TO O
measure VB O
? . O

DATA NNP O
SYNTHESIS NNP O
: : O

This DT O
article NN O
postulates VBZ O
a DT O
three CD O
- : O
stage NN O
development NN O
of IN O
SIRS NNP O
, , O
in IN O
which WDT O
stage NN O
1 CD O
is VBZ O
a DT O
local JJ O
production NN O
of IN O
cytokines NNS O
in IN O
response NN O
to TO O
an DT O
injury NN O
or CC O
infection NN O
. . O

Stage NN O
2 CD O
is VBZ O
the DT O
protective JJ O
release NN O
of IN O
a DT O
small JJ O
amount NN O
of IN O
cytokines NNS O
into IN O
the DT O
body NN O
' POS O
s VBZ O
circulation NN O
. . O

Stage NN O
3 CD O
is VBZ O
the DT O
massive JJ O
systemic JJ O
reaction NN O
where WRB O
cytokines NNS O
turn VBP O
destructive JJ O
by IN O
compromising VBG O
the DT O
integrity NN O
of IN O
the DT O
capillary NN O
walls NNS O
and CC O
flooding VBG O
end NN O
organs NNS O
. . O

CONCLUSIONS NNS O
: : O

While IN O
cytokines NNS O
are VBP O
generally RB O
viewed VBN O
as IN O
a DT O
destructive JJ O
development NN O
in IN O
the DT O
patient NN O
that WDT O
generally RB O
leads VBZ O
to TO O
multiple JJ O
organ NN O
dysfunction NN O
, , O
cytokines NNS O
also RB O
protect VBP O
the DT O
body NN O
when WRB O
localized VBN O
. . O

It PRP O
will MD O
be VB O
necessary JJ O
to TO O
study VB O
the DT O
positive JJ O
effects NNS O
of IN O
cytokines NNS O
while IN O
also RB O
studying VBG O
their PRP$ O
role NN O
in IN O
causing VBG O
SIRS NNP O
. . O

It PRP O
will MD O
also RB O
be VB O
important JJ O
to TO O
investigate VB O
the DT O
relationship NN O
between IN O
cytokines NNS O
and CC O
their PRP$ O
blockers NNS O
in IN O
SIRS NNP O
. . O

-DOCSTART- X X O

Application NNP O
of IN O
clonal JJ O
analysis NN O
. . O

Differential JJ O
diagnosis NN O
for IN O
synchronous JJ O
primary JJ O
ovarian JJ O
and CC O
endometrial JJ O
cancers NNS O
and CC O
metastatic JJ O
cancer NN O
. . O

Simultaneous JJ O
involvement NN O
of IN O
the DT O
endometrium NN O
and CC O
the DT O
ovary NN O
by IN O
carcinoma NN O
is VBZ O
a DT O
familiar JJ O
problem NN O
in IN O
the DT O
routine JJ O
practice NN O
of IN O
surgical JJ O
pathology NN O
. . O

Such JJ O
cases NNS O
may MD O
be VB O
considered VBN O
either DT O
examples NNS O
of IN O
a DT O
single JJ O
primary JJ O
carcinoma NN O
with IN O
metastasis NN O
or CC O
as IN O
synchronous JJ O
primary JJ O
neoplasms NNS O
. . O

The DT O
distinction NN O
between IN O
these DT O
two CD O
possibilities NNS O
is VBZ O
made VBN O
based VBN O
on IN O
clinicopathologic NN O
observations NNS O
, , O
and CC O
therefore RB O
may MD O
not RB O
be VB O
definitive JJ O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
the DT O
authors NNS O
used VBD O
molecular JJ O
techniques NNS O
to TO O
analyze VB O
the DT O
clonal JJ O
composition NN O
of IN O
five CD O
cases NNS O
of IN O
concurrent JJ O
adenocarcinomas NNS O
of IN O
the DT O
endometrium NN O
and CC O
ovary NN O
that WDT O
were VBD O
clinicopathologically RB O
diagnosed VBN O
as IN O
synchronous JJ O
primary JJ O
tumors NNS O
. . O

Patterns NNP O
of IN O
X NNP O
- : O
chromosome NN O
inactivation NN O
, , O
mutations NNS O
in IN O
the DT O
K NNP O
- : O
ras JJ O
gene NN O
, , O
mutations NNS O
or CC O
allelic JJ O
loss NN O
of IN O
the DT O
p53 NN O
gene NN O
, , O
or CC O
human JJ O
papillomavirus NN O
detection NN O
were VBD O
identical JJ O
in IN O
both DT O
endometrial JJ O
and CC O
ovarian JJ O
lesions NNS O
in IN O
three CD O
of IN O
the DT O
cases NNS O
suggesting VBG O
that IN O
those DT O
three CD O
cases NNS O
represented VBD O
single JJ O
primary JJ O
tumors NNS O
with IN O
metastases NNS O
. . O

In IN O
both DT O
of IN O
the DT O
other JJ O
two CD O
cases NNS O
, , O
the DT O
patterns NNS O
of IN O
X NNP O
- : O
chromosome NN O
inactivation NN O
clearly RB O
demonstrated VBD O
the DT O
presence NN O
of IN O
independent JJ O
primary JJ O
tumors NNS O
. . O

The DT O
application NN O
of IN O
molecular JJ O
technology NN O
may MD O
play VB O
an DT O
important JJ O
role NN O
for IN O
the DT O
differential JJ O
diagnosis NN O
between IN O
synchronous JJ O
primary JJ O
carcinomas NNS O
and CC O
a DT O
single JJ O
carcinoma NN O
with IN O
metastasis NN O
. . O

-DOCSTART- X X O

Pancreatic JJ O
somatostatin NN O
- : O
secreting NN O
gangliocytic NN O
paraganglioma NN O
with IN O
lymph NN O
node NN O
metastases NNS O
. . O

Gangliocytic JJ O
paraganglioma NN O
( -LRB- O
GPG NNP O
) -RRB- O
with IN O
local JJ O
lymph NN O
node NN O
metastasis NN O
was VBD O
found VBN O
in IN O
the DT O
pancreas NNS O
of IN O
a DT O
74 CD O
- : O
yr NN O
- : O
old JJ O
female NN O
who WP O
presented VBD O
with IN O
diarrhea NN O
, , O
steatorrhea NN O
, , O
vomiting VBG O
, , O
nausea NN O
, , O
and CC O
abdominal JJ O
pain NN O
. . O

A DT O
Whipple NNP O
procedure NN O
led VBN O
to TO O
a DT O
complete JJ O
resolution NN O
of IN O
these DT O
symptoms NNS O
and CC O
a DT O
return NN O
of IN O
an DT O
elevated JJ O
stomatostatin NN O
level NN O
to TO O
normal JJ O
. . O

This DT O
is VBZ O
the DT O
first JJ O
description NN O
of IN O
GPG NNP O
in IN O
this DT O
location NN O
and CC O
the DT O
first JJ O
endocrinologically RB O
active JJ O
GPG NNP O
. . O

-DOCSTART- X X O

Molecular JJ O
biology NN O
of IN O
cervical JJ O
cancer NN O
and CC O
its PRP$ O
precursors NNS O
. . O

Cervical JJ O
cancer NN O
develops VBZ O
from IN O
well RB O
- : O
defined VBN O
precursor NN O
lesions NNS O
referred VBD O
to TO O
as IN O
either DT O
cervical JJ O
intraepithelial JJ O
neoplasia NN O
or CC O
squamous JJ O
intraepithelial JJ O
lesions NNS O
. . O

It PRP O
is VBZ O
now RB O
known VBN O
that IN O
specific JJ O
types NNS O
of IN O
human JJ O
papillomaviruses NNS O
( -LRB- O
HPV NN O
) -RRB- O
are VBP O
the DT O
principal JJ O
etiologic NN O
agents NNS O
for IN O
both DT O
cervical JJ O
cancer NN O
and CC O
its PRP$ O
precursors NNS O
. . O

The DT O
high JJ O
- : O
oncogenic JJ O
- : O
risk NN O
HPV NN O
types NNS O
associated VBN O
with IN O
invasive JJ O
cervical JJ O
cancer NN O
produce VBP O
two CD O
oncoproteins NNS O
, , O
designated VBN O
E6 NNP O
and CC O
E7 NNP O
, , O
which WDT O
interact NN O
with IN O
endogenous JJ O
cell NN O
cycle NN O
regulatory JJ O
proteins NNS O
, , O
including VBG O
p53 NN O
and CC O
Rb NN O
. . O

The DT O
interaction NN O
of IN O
virally RB O
derived VBN O
and CC O
endogenous JJ O
cellular JJ O
proteins NNS O
converges NNS O
in IN O
deregulation NN O
of IN O
cell NN O
cycle NN O
progression NN O
and CC O
appears VBZ O
to TO O
be VB O
critical JJ O
for IN O
the DT O
development NN O
of IN O
cervical JJ O
cancers NNS O
. . O

However RB O
, , O
the DT O
development NN O
of IN O
cervical JJ O
cancer NN O
is VBZ O
a DT O
multistep JJ O
process NN O
that WDT O
cannot MD O
be VB O
explained VBN O
simply RB O
by IN O
infection NN O
with IN O
specific JJ O
types NNS O
of IN O
HPV NNP O
. . O

One CD O
additional JJ O
event NN O
that WDT O
appears VBZ O
to TO O
play VB O
a DT O
role NN O
in IN O
tumor NN O
progression NN O
is VBZ O
integration NN O
of IN O
HPV NNP O
DNA NNP O
into IN O
the DT O
host NN O
genome NN O
. . O

Integration NNP O
of IN O
HPV NNP O
DNA NNP O
frequently RB O
disrupts VBZ O
the DT O
E2 NN O
open JJ O
reading NN O
frames NNS O
, , O
resulting VBG O
in IN O
overexpression NN O
of IN O
the DT O
E6 NNP O
and CC O
E7 NNP O
oncoproteins NNS O
and CC O
possibly RB O
causing VBG O
genomic JJ O
instability NN O
. . O

Additional JJ O
cofactors NNS O
and CC O
mutational JJ O
events NNS O
may MD O
be VB O
important JJ O
in IN O
the DT O
pathogenesis NN O
of IN O
invasive JJ O
cervical JJ O
cancers NNS O
and CC O
may MD O
include VB O
chromosomal NN O
rearrangements NNS O
, , O
loss NN O
of IN O
constitutional JJ O
heterozygosity NN O
, , O
and CC O
proto NN O
- : O
oncogene NN O
activation NN O
. . O

-DOCSTART- X X O

Cell NNP O
surface NN O
binding NN O
characteristics NNS O
correlate VBP O
with IN O
consensus NN O
type NN O
I PRP O
interferon RB O
enhanced JJ O
activity NN O
. . O

The DT O
binding JJ O
characteristics NNS O
of IN O
a DT O
genetically RB O
engineered VBN O
consensus NN O
interferon NN O
with IN O
unusually RB O
high JJ O
biologic NN O
activity NN O
were VBD O
compared VBN O
to TO O
the DT O
characteristics NNS O
of IN O
recombinant JJ O
interferon NN O
- : O
alpha NN O
2 CD O
. . O

Both DT O
interferon NN O
- : O
alpha NN O
2 CD O
and CC O
the DT O
consensus NN O
interferon NN O
produced VBD O
typical JJ O
biphasic JJ O
Scatchard NNP O
plots NNS O
, , O
indicating VBG O
multiple JJ O
independent JJ O
binding NN O
sites NNS O
. . O

The DT O
consensus NN O
interferon NN O
, , O
which WDT O
exhibited VBD O
a DT O
biologic NN O
potency NN O
more JJR O
than IN O
10 CD O
- : O
fold NN O
greater JJR O
than IN O
all DT O
other JJ O
type NN O
I PRP O
interferons VBD O
, , O
also RB O
exhibited VBD O
binding JJ O
site NN O
affinities NNS O
greater JJR O
than IN O
those DT O
for IN O
IFN NNP O
- : O
alpha NN O
2b CD O
. . O

In IN O
addition NN O
, , O
a DT O
larger JJR O
number NN O
of IN O
high JJ O
, , O
and CC O
low JJ O
- : O
affinity NN O
cell NN O
surface NN O
sites NNS O
were VBD O
recognized VBN O
by IN O
the DT O
consensus NN O
interferon NN O
, , O
resulting VBG O
in IN O
equivalent JJ O
numbers NNS O
of IN O
sites NNS O
at IN O
reduced JJ O
molar NN O
concentrations NNS O
compared VBN O
to TO O
IFN NNP O
- : O
a2b NN O
. . O

Thus RB O
, , O
at IN O
any DT O
given VBN O
biologic NN O
activity NN O
, , O
similar JJ O
numbers NNS O
of IN O
sites NNS O
were VBD O
bound VBN O
by IN O
the DT O
consensus NN O
interferon NN O
and CC O
IFN NNP O
- : O
alpha NN O
2 CD O
, , O
despite IN O
differences NNS O
in IN O
their PRP$ O
molar JJ O
concentrations NNS O
. . O

No DT O
differences NNS O
in IN O
internalization NN O
kinetics NNS O
were VBD O
identified VBN O
between IN O
the DT O
two CD O
interferons NNS O
, , O
indicating VBG O
that IN O
the DT O
differences NNS O
in IN O
cell NN O
surface NN O
binding NN O
may MD O
be VB O
sufficient JJ O
to TO O
produce VB O
the DT O
differences NNS O
in IN O
biologic JJ O
activity NN O
. . O

-DOCSTART- X X O

Human JJ O
immunodeficiency NN O
virus NN O
type NN O
1 CD O
viral JJ O
background NN O
plays VBZ O
a DT O
major JJ O
role NN O
in IN O
development NN O
of IN O
resistance NN O
to TO O
protease VB O
inhibitors NNS O
. . O

The DT O
observed VBD O
in IN O
vitro NN O
and CC O
in IN O
vivo JJ O
benefit NN O
of IN O
combination NN O
treatment NN O
with IN O
anti NNS O
- : O
human JJ O
immunodeficiency NN O
virus NN O
( -LRB- O
HIV NN O
) -RRB- O
agents NNS O
prompted VBD O
us PRP O
to TO O
examine VB O
the DT O
potential NN O
of IN O
resistance NN O
development NN O
when WRB O
two CD O
protease NN O
inhibitors NNS O
are VBP O
used VBN O
concurrently RB O
. . O

Recombinant VB O
HIV NNP O
- : O
1 CD O
( -LRB- O
NL4 FW O
- : O
3 CD O
) -RRB- O
proteases NNS O
containing VBG O
combined VBN O
resistance NN O
mutations NNS O
associated VBN O
with IN O
BMS NNP O
- : O
186318 CD O
and CC O
A DT O
- : O
77003 CD O
( -LRB- O
or CC O
saquinavir NN O
) -RRB- O
were VBD O
either DT O
inactive JJ O
or CC O
had VBD O
impaired VBN O
enzyme NN O
activity NN O
. . O

Subsequent JJ O
construction NN O
of IN O
HIV NNP O
- : O
1 CD O
( -LRB- O
NL4 FW O
- : O
3 CD O
) -RRB- O
proviral NN O
clones NNS O
containing VBG O
the DT O
same JJ O
mutations NNS O
yielded VBD O
viruses NNS O
that WDT O
were VBD O
severely RB O
impaired VBN O
in IN O
growth NN O
or CC O
nonviable JJ O
, , O
confirming VBG O
that IN O
combination NN O
therapy NN O
may MD O
be VB O
advantageous JJ O
. . O

However RB O
, , O
passage NN O
of IN O
BMS NNP O
- : O
186318 CD O
- : O
resistant JJ O
HIV NNP O
- : O
1 CD O
( -LRB- O
RF NN O
) -RRB- O
in IN O
the DT O
presence NN O
of IN O
either DT O
saquinavir NN O
or CC O
SC52151 NNP O
, , O
which WDT O
represented VBD O
sequential JJ O
drug NN O
treatment NN O
, , O
produced VBD O
viable JJ O
viruses NNS O
resistant JJ O
to TO O
both DT O
BMS NNP O
- : O
186318 CD O
and CC O
the DT O
second JJ O
compound NN O
. . O

The DT O
predominant JJ O
breakthrough NN O
virus NN O
contained VBD O
the DT O
G48V NNP O
/ NNP O
A71T NNP O
/ NNP O
V82A NNP O
protease NN O
mutations NNS O
. . O

The DT O
clone NN O
- : O
purified VBN O
RF NN O
( -LRB- O
G48V NNP O
/ NNP O
A71T NNP O
/ JJ O
V82A NN O
) -RRB- O
virus NN O
, , O
unlike IN O
the DT O
corresponding JJ O
defective JJ O
NL4 NNP O
- : O
3 CD O
triple JJ O
mutant NN O
, , O
grew VBD O
well RB O
and CC O
displayed VBN O
cross NN O
- : O
resistance NN O
to TO O
four CD O
distinct JJ O
protease NN O
inhibitors NNS O
. . O

Chimeric NNP O
virus NN O
and CC O
in IN O
vitro NN O
mutagenesis NN O
studies NNS O
indicated VBD O
that IN O
the DT O
RF NN O
- : O
specific JJ O
protease NN O
sequence NN O
, , O
specifically RB O
the DT O
Ile NNP O
at IN O
residue JJ O
10 CD O
, , O
enabled VBD O
the DT O
NL4 NNP O
- : O
3 CD O
strain NN O
with IN O
the DT O
triple JJ O
mutant NN O
to TO O
grow VB O
. . O

Our PRP$ O
results NNS O
clearly RB O
indicate VBP O
that IN O
viral JJ O
genetic JJ O
background NN O
will MD O
play VB O
a DT O
key JJ O
role NN O
in IN O
determining VBG O
whether IN O
cross NN O
- : O
resistance NN O
variants NNS O
will MD O
arise VB O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
radiation NN O
on IN O
neovascularization NN O
in IN O
a DT O
rat NN O
model NN O
. . O

It PRP O
is VBZ O
thought VBN O
that IN O
radiation NN O
treatment NN O
inhibits VBZ O
neovascularization NN O
of IN O
recipient NN O
and CC O
/ NN O
or CC O
graft NN O
tissues NNS O
, , O
and CC O
this DT O
may MD O
account VB O
in IN O
part NN O
for IN O
abnormalities NNS O
in IN O
wound NN O
healing NN O
associated VBN O
with IN O
radiation NN O
therapy NN O
. . O

We PRP O
have VBP O
examined VBN O
this DT O
hypothesis NN O
using VBG O
a DT O
model NN O
that WDT O
measures VBZ O
the DT O
neovascularization NN O
of IN O
an DT O
implanted JJ O
foreign JJ O
material NN O
. . O

Expanded VBN O
polytetrafluoroethylene NN O
( -LRB- O
PTFE NNP O
) -RRB- O
sheets NNS O
were VBD O
implanted VBN O
adjacent JJ O
to TO O
both DT O
superficial JJ O
epigastric JJ O
vascular JJ O
pedicles NNS O
of IN O
63 CD O
rats NNS O
distributed VBN O
into IN O
7 CD O
groups NNS O
( -LRB- O
n NN O
= SYM O
7 CD O
) -RRB- O
that WDT O
differed VBD O
with IN O
respect NN O
to TO O
dose NN O
and CC O
timing NN O
of IN O
irradiation NN O
. . O

Zero NNP O
to TO O
10 CD O
daily JJ O
fractions NNS O
of IN O
electron JJ O
- : O
beam NN O
radiation NN O
( -LRB- O
300 CD O
cGy NN O
each DT O
) -RRB- O
were VBD O
delivered VBN O
to TO O
the DT O
implant NN O
in IN O
the DT O
right JJ O
groin NN O
, , O
while IN O
the DT O
implant NN O
in IN O
the DT O
left JJ O
groin NN O
served VBD O
as IN O
a DT O
nonirradiated JJ O
internal JJ O
control NN O
. . O

Unirradiated NNP O
animals NNS O
showed VBD O
equal JJ O
neovascularization NN O
of IN O
both DT O
implants NNS O
. . O

Rats NNS O
that WDT O
were VBD O
irradiated VBN O
twice RB O
( -LRB- O
single JJ O
fractions NNS O
at IN O
0 CD O
and CC O
24 CD O
hours NNS O
after IN O
implantation NN O
) -RRB- O
did VBD O
not RB O
show VB O
a DT O
significant JJ O
decrease NN O
in IN O
the DT O
neovascularization NN O
of IN O
the DT O
irradiated JJ O
implant NN O
compared VBN O
with IN O
the DT O
contralateral JJ O
control NN O
implant NN O
. . O

In IN O
contrast NN O
, , O
the DT O
implants NNS O
that WDT O
were VBD O
irradiated VBN O
three CD O
times NNS O
( -LRB- O
single JJ O
fractions NNS O
at IN O
0 CD O
, , O
24 CD O
, , O
and CC O
48 CD O
hours NNS O
after IN O
implantation NN O
) -RRB- O
demonstrated VBD O
significantly RB O
diminished VBN O
( -LRB- O
greater JJR O
than IN O
25 CD O
percent NN O
, , O
p NN O
less RBR O
than IN O
0 CD O
. . O
05 CD O
) -RRB- O
neovascularization NN O
beyond IN O
day NN O
7 CD O
, , O
whereas IN O
implants NNS O
irradiated VBD O
only RB O
at IN O
48 CD O
hours NNS O
after IN O
implantation NN O
did VBD O
not RB O
. . O

Interestingly RB O
, , O
neovascularization NN O
of IN O
the DT O
implants NNS O
irradiated VBN O
with IN O
10 CD O
fractions NNS O
( -LRB- O
3000 CD O
cGy NN O
) -RRB- O
was VBD O
not RB O
significantly RB O
decreased VBD O
compared VBN O
with IN O
irradiation NN O
with IN O
three CD O
fractions NNS O
( -LRB- O
900 CD O
cGy NN O
) -RRB- O
. . O

Irradiation NNP O
delivered VBD O
before IN O
implantation NN O
( -LRB- O
900 CD O
cGy NN O
) -RRB- O
inhibited VBN O
neovascularization NN O
significantly RB O
less JJR O
than IN O
the DT O
same JJ O
dose NN O
administered VBN O
after IN O
implantation NN O
. . O

The DT O
results NNS O
of IN O
this DT O
study NN O
suggest VBP O
that IN O
a DT O
subclinical JJ O
cumulative JJ O
dose NN O
of IN O
900 CD O
cGy NN O
is VBZ O
the DT O
threshold NN O
for IN O
impaired VBN O
tissue NN O
revascularization NN O
provided VBD O
that DT O
treatment NN O
is VBZ O
delivered VBN O
immediately RB O
after IN O
implantation NN O
over IN O
a DT O
48 CD O
- : O
hour NN O
interval NN O
. . O

-DOCSTART- X X O

Stimulation NN O
of IN O
endothelial JJ O
cell NN O
migration NN O
by IN O
vascular JJ O
permeability NN O
factor NN O
/ IN O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
through IN O
cooperative JJ O
mechanisms NNS O
involving VBG O
the DT O
alphavbeta3 NN O
integrin NN O
, , O
osteopontin NN O
, , O
and CC O
thrombin NN O
. . O

We PRP O
have VBP O
identified VBN O
several JJ O
mechanisms NNS O
by IN O
which WDT O
the DT O
angiogenic JJ O
cytokine NN O
vascular JJ O
permeability NN O
factor NN O
/ IN O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
VPF NN O
/ JJ O
VEGF NN O
) -RRB- O
likely JJ O
regulates VBZ O
endothelial JJ O
cells NNS O
( -LRB- O
EC NNP O
) -RRB- O
migration NN O
. . O

VPF NNP O
/ NNP O
VEGF NNP O
induced VBD O
dermal JJ O
microvascular JJ O
EC NNP O
expression NN O
of IN O
mRNAs NNS O
encoding VBG O
the DT O
alphav NN O
and CC O
beta3 CD O
integrin NN O
subunits NNS O
resulting VBG O
in IN O
increased VBN O
levels NNS O
of IN O
the DT O
alphavbeta3 NN O
heterodimer NN O
at IN O
the DT O
cell NN O
surface NN O
, , O
and CC O
VPF NNP O
/ NNP O
VEGF NNP O
also RB O
induced VBD O
mRNA NNS O
encoding VBG O
osteopontin NN O
( -LRB- O
OPN NNP O
) -RRB- O
, , O
an DT O
alphavbeta3 NN O
ligand NN O
. . O

OPN NNP O
promoted VBD O
EC NNP O
migration NN O
in IN O
vitro NN O
; : O
and CC O
VPF NNP O
/ NNP O
VEGF NNP O
induction NN O
of IN O
alphavbeta3 NN O
was VBD O
accompanied VBN O
by IN O
increased VBN O
EC NNP O
migration NN O
toward IN O
OPN NNP O
. . O

Because IN O
thrombin IN O
cleavage NN O
of IN O
OPN NNP O
results NNS O
in IN O
substantial JJ O
enhancement NN O
of IN O
OPN NNP O
' POS O
s PRP O
adhesive JJ O
properties NNS O
, , O
and CC O
because IN O
VPF NNP O
/ NNP O
VEGF NNP O
promotes VBZ O
increased VBN O
microvascular JJ O
permeability NN O
leading VBG O
to TO O
activation NN O
of IN O
the DT O
extrinsic JJ O
coagulation NN O
pathway NN O
, , O
we PRP O
also RB O
investigated VBD O
whether IN O
VPF NNP O
/ NNP O
VEGF NNP O
facilitates VBZ O
thrombin IN O
cleavage NN O
of IN O
OPN NNP O
in IN O
vivo RB O
. . O

Consistent NN O
with IN O
this DT O
hypothesis NN O
, , O
co NN O
- : O
injection NN O
of IN O
VPF NNP O
/ NNP O
VEGF NNP O
together RB O
with IN O
OPN NNP O
resulted VBD O
in IN O
rapid JJ O
cleavage NN O
of IN O
OPN NNP O
by IN O
endogenous JJ O
thrombin NN O
. . O

Furthermore RB O
, , O
in IN O
comparison NN O
with IN O
native JJ O
OPN NNP O
, , O
thrombin IN O
- : O
cleaved VBD O
OPN NNP O
stimulated VBD O
a DT O
greater JJR O
rate NN O
of IN O
EC NNP O
migration NN O
in IN O
vitro NN O
, , O
which WDT O
was VBD O
additive JJ O
to TO O
the DT O
increased VBN O
migration NN O
associated VBN O
with IN O
induction NN O
of IN O
alpha NN O
v NN O
beta NN O
3 CD O
. . O

Thus RB O
, , O
these DT O
data NNS O
demonstrate VBP O
cooperative JJ O
mechanisms NNS O
for IN O
VPF NNP O
/ NNP O
VEGF NNP O
regulation NN O
of IN O
EC NNP O
migration NN O
involving VBG O
the DT O
alphavbeta3 NN O
integrin NN O
, , O
the DT O
alphavbeta3 NN O
ligand NN O
OPN NNP O
, , O
and CC O
thrombin IN O
cleavage NN O
of IN O
OPN NNP O
. . O

These DT O
findings NNS O
also RB O
illustrate VBP O
an DT O
operational JJ O
link NN O
between IN O
VPF NNP O
/ NNP O
VEGF NNP O
induction NN O
of IN O
EC NNP O
gene NN O
expression NN O
and CC O
VPF NNP O
/ NNP O
VEGF NNP O
enhancement NN O
of IN O
microvascular JJ O
permeability NN O
, , O
suggesting VBG O
that IN O
these DT O
distinct JJ O
biological JJ O
activities NNS O
may MD O
act VB O
accordingly RB O
to TO O
stimulate VB O
EC NNP O
migration NN O
during IN O
angiogenesis NN O
. . O

-DOCSTART- X X O

Referral NNP O
bias NN O
among IN O
health NN O
workers NNS O
in IN O
studies NNS O
using VBG O
hospitalization NN O
as IN O
a DT O
proxy JJ O
measure NN O
of IN O
the DT O
underlying VBG O
incidence NN O
rate NN O
. . O

Contacts NNS O
with IN O
health NN O
services NNS O
like IN O
hospitals NNS O
or CC O
general JJ O
practitioners NNS O
are VBP O
usually RB O
the DT O
only RB O
available JJ O
proxy JJ O
measure NN O
of IN O
incidence NN O
of IN O
disease NN O
in IN O
studies NNS O
based VBN O
on IN O
secondary JJ O
data NNS O
and CC O
differential JJ O
referrals NNS O
or CC O
care VB O
- : O
seeking VBG O
behavior NN O
often RB O
bias NN O
such JJ O
proxy JJ O
measures NNS O
. . O

In IN O
former JJ O
analyses NNS O
based VBN O
on IN O
the DT O
Occupational NNP O
Hospitalization NNP O
Register NNP O
in IN O
Denmark NNP O
assisting VBG O
nurses NNS O
had VBD O
high JJ O
Standardized JJ O
Hospitalization NN O
Ratios NNS O
for IN O
many JJ O
diseases NNS O
. . O

It PRP O
was VBD O
, , O
however RB O
, , O
suspected VBD O
that IN O
it PRP O
fully RB O
or CC O
partly RB O
was VBD O
due JJ O
to TO O
a DT O
referral JJ O
bias NN O
or CC O
self NN O
- : O
selection NN O
to TO O
hospital NN O
treatment NN O
rather RB O
than IN O
exposures NNS O
to TO O
occupational JJ O
hazards NNS O
. . O

The DT O
aim NN O
of IN O
the DT O
present JJ O
study NN O
is VBZ O
to TO O
evaluate VB O
the DT O
referral NN O
bias NN O
hypothesis NN O
by IN O
comparing VBG O
hospitalization NN O
and CC O
mortality NN O
data NNS O
for IN O
health NN O
workers NNS O
for IN O
a DT O
disease NN O
category NN O
with IN O
a DT O
high JJ O
mortality NN O
. . O

Cohorts NNS O
of IN O
all DT O
gainfully RB O
employed VBN O
20 CD O
- : O
to TO O
59 CD O
- : O
year NN O
- : O
old JJ O
Danes NNPS O
were VBD O
formed VBN O
in IN O
order NN O
to TO O
compare VB O
Standardized VBN O
Mortality NNP O
Ratios NNP O
and CC O
Standardized NNP O
Hospitalization NNP O
Ratios NNP O
of IN O
ischemic JJ O
heart NN O
disease NN O
( -LRB- O
IHD NN O
) -RRB- O
in IN O
occupational JJ O
groups NNS O
. . O

The DT O
follow VBP O
- : O
up RP O
period NN O
was VBD O
10 CD O
years NNS O
. . O

For IN O
most JJS O
of IN O
the DT O
investigated VBN O
occupational RP O
groups NNS O
a DT O
similar JJ O
disease NN O
pattern NN O
was VBD O
found VBN O
whether IN O
hospitalization NN O
or CC O
death NN O
was VBD O
used VBN O
as IN O
the DT O
outcome NN O
measure NN O
. . O

In IN O
" `` O
nurse NN O
assistants NNS O
" `` O
a DT O
statistically RB O
significant JJ O
higher JJR O
risk NN O
was VBD O
, , O
however RB O
, , O
found VBD O
using VBG O
hospitalization NN O
due JJ O
to TO O
IHD NNP O
as IN O
the DT O
end NN O
point NN O
rather RB O
than IN O
mortality NN O
. . O

Additional JJ O
analysis NN O
did VBD O
not RB O
support VB O
the DT O
hypothesis NN O
that IN O
the DT O
finding NN O
could MD O
be VB O
explained VBN O
by IN O
differentiated JJ O
hospitalization NN O
due JJ O
to TO O
social JJ O
factors NNS O
. . O

The DT O
true JJ O
incidence NN O
rates NNS O
of IN O
the DT O
disease NN O
need MD O
not RB O
be VB O
equally RB O
well RB O
described VBN O
by IN O
proxy JJ O
measures NNS O
such JJ O
as IN O
hospitalization NN O
diagnosis NN O
or CC O
death NN O
diagnosis NN O
in IN O
all DT O
occupational JJ O
groups NNS O
. . O

Differential JJ O
access NN O
to TO O
medical JJ O
treatment NN O
in IN O
some DT O
groups NNS O
may MD O
lead VB O
to TO O
bias NN O
when WRB O
hospital NN O
data NNS O
are VBP O
used VBN O
as IN O
proxy JJ O
measures NNS O
for IN O
the DT O
underlying JJ O
incidence NN O
rates NNS O
. . O

-DOCSTART- X X O

Prognostic JJ O
value NN O
of IN O
angiogenesis NN O
in IN O
operable JJ O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

Tumour NNP O
angiogenesis NN O
is VBZ O
an DT O
important JJ O
factor NN O
for IN O
tumour NN O
growth NN O
and CC O
metastasis NN O
. . O

Although IN O
some DT O
recent JJ O
reports NNS O
suggest VBP O
that IN O
microvessel NN O
counts NNS O
in IN O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
are VBP O
related VBN O
to TO O
a DT O
poor JJ O
disease NN O
outcome NN O
, , O
the DT O
results NNS O
were VBD O
not RB O
conclusive JJ O
and CC O
were VBD O
not RB O
compared VBN O
with IN O
other JJ O
molecular JJ O
prognostic JJ O
markers NNS O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
the DT O
vascular JJ O
grade NN O
was VBD O
assessed VBN O
in IN O
107 CD O
( -LRB- O
T1 NNP O
, , O
2 CD O
- : O
N0 NN O
, , O
1 CD O
) -RRB- O
operable NN O
non FW O
- : O
small JJ O
cell NN O
lung NN O
carcinomas NNS O
, , O
using VBG O
the DT O
JC70 CD O
monoclonal JJ O
antibody NN O
to TO O
CD31 NNP O
. . O

Three CD O
vascular JJ O
grades NNS O
were VBD O
defined VBN O
with IN O
appraisal NN O
by IN O
eye NN O
and CC O
by IN O
Chalkley NNP O
counting NN O
: : O
high JJ O
( -LRB- O
Chalkley NNP O
score NN O
7 CD O
- : O
12 CD O
) -RRB- O
, , O
medium NN O
( -LRB- O
5 CD O
- : O
6 CD O
) -RRB- O
, , O
and CC O
low JJ O
( -LRB- O
2 CD O
- : O
4 CD O
) -RRB- O
. . O

There EX O
was VBD O
a DT O
significant JJ O
correlation NN O
between IN O
eye NN O
appraisal NN O
and CC O
Chalkley NNP O
counting VBG O
( -LRB- O
P NNP O
less RBR O
than IN O
0 CD O
. . O
0001 CD O
) -RRB- O
. . O

Vascular JJ O
grade NN O
was VBD O
not RB O
related VBN O
to TO O
histology NN O
, , O
grade NN O
, , O
proliferation NN O
index NN O
( -LRB- O
Ki67 NNP O
) -RRB- O
, , O
or CC O
EGFR NNP O
or CC O
p53 NN O
expression NN O
. . O

Tumours NNS O
from IN O
younger JJR O
patients NNS O
had VBD O
a DT O
higher JJR O
grade NN O
of IN O
angiogenesis NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

Apart RB O
from IN O
the DT O
vascular JJ O
grade NN O
, , O
none NN O
of IN O
the DT O
other JJ O
factors NNS O
examined VBN O
was VBD O
statistically RB O
related VBN O
to TO O
lymph VB O
node NN O
metastasis NN O
( -LRB- O
P NNP O
less RBR O
than IN O
0 CD O
. . O
0001 CD O
) -RRB- O
. . O

A DT O
univariate JJ O
analysis NN O
of IN O
survival NN O
showed VBD O
that IN O
vascular JJ O
grade NN O
was VBD O
the DT O
most RBS O
significant JJ O
prognostic JJ O
factor NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
0004 CD O
) -RRB- O
, , O
followed VBN O
by IN O
N NNP O
- : O
stage NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

In IN O
a DT O
multivariate JJ O
analysis NN O
, , O
N NNP O
- : O
stage NN O
and CC O
vascular JJ O
grade NN O
were VBD O
not RB O
found VBN O
to TO O
be VB O
independent JJ O
prognostic JJ O
factors NNS O
, , O
since IN O
they PRP O
were VBD O
strongly RB O
related VBN O
to TO O
each DT O
other JJ O
. . O

Excluding VBG O
N NNP O
- : O
stage NN O
, , O
vascular JJ O
grade NN O
was VBD O
the DT O
only JJ O
independent JJ O
prognostic JJ O
factor NN O
( -LRB- O
P NNP O
= SYM O
0 CD O
. . O
007 CD O
) -RRB- O
. . O

Kaplan NNP O
- : O
Meier NN O
survival NN O
curves NNS O
showed VBD O
a DT O
statistically NN O
significant JJ O
worse JJR O
prognosis NN O
for IN O
patients NNS O
with IN O
high JJ O
vascular JJ O
grade NN O
, , O
but CC O
no DT O
difference NN O
was VBD O
observed VBN O
between IN O
low JJ O
and CC O
medium JJ O
vascular JJ O
grade NN O
. . O

These DT O
data NNS O
suggest VBP O
that IN O
angiogenesis NN O
in IN O
operable JJ O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
is VBZ O
a DT O
major JJ O
prognostic JJ O
factor NN O
for IN O
survival NN O
and CC O
, , O
among IN O
the DT O
parameters NNS O
tested VBN O
, , O
is VBZ O
the DT O
only JJ O
factor NN O
related VBN O
to TO O
cancer NN O
cell NN O
migration NN O
to TO O
lymph VB O
nodes NNS O
. . O

The DT O
integration NN O
of IN O
vascular JJ O
grading NN O
in IN O
clinical JJ O
trials NNS O
on IN O
adjuvant JJ O
chemotherapy NN O
and CC O
/ NN O
or CC O
radiotherapy NN O
could MD O
substantially RB O
contribute VB O
in IN O
defining VBG O
groups NNS O
of IN O
operable JJ O
patients NNS O
who WP O
might MD O
benefit VB O
from IN O
cytotoxic JJ O
treatment NN O
. . O

-DOCSTART- X X O

The DT O
impact NN O
of IN O
multiskilling VBG O
on IN O
quality NN O
of IN O
care NN O
. . O

Hospital NN O
finances NNS O
in IN O
the DT O
USA NNP O
are VBP O
in IN O
a DT O
crisis NN O
. . O

While IN O
profits NNS O
earned VBN O
from IN O
the DT O
healthcare NN O
industry NN O
appear VBP O
to TO O
be VB O
at IN O
an DT O
all DT O
- : O
time NN O
high JJ O
, , O
individual JJ O
hospitals NNS O
are VBP O
going VBG O
bankrupt JJ O
. . O

Hospitals NNS O
are VBP O
not RB O
generating VBG O
sufficient JJ O
income NN O
to TO O
pay VB O
their PRP$ O
expenses NNS O
given VBN O
how WRB O
they PRP O
have VBP O
traditionally RB O
operated VBN O
. . O

Hence RB O
, , O
we PRP O
are VBP O
witnessing VBG O
the DT O
merger NN O
and CC O
consolidation NN O
of IN O
competitors NNS O
, , O
resulting VBG O
in IN O
significantly RB O
fewer JJR O
hospital NN O
beds NNS O
in IN O
certain JJ O
geographical JJ O
areas NNS O
. . O

In IN O
addition NN O
to TO O
the DT O
strategy NN O
of IN O
closing VBG O
hospital NN O
beds NNS O
, , O
severe JJ O
budget NN O
restrictions NNS O
are VBP O
impacting VBG O
upon IN O
all DT O
remaining VBG O
services NNS O
within IN O
the DT O
hospitals NNS O
. . O

-DOCSTART- X X O

Vitamin NNP O
E NNP O
inhibits VBZ O
experimental JJ O
carcinogenesis NN O
and CC O
tumour NN O
angiogenesis NN O
. . O

In IN O
an DT O
experiment NN O
in IN O
which WDT O
vitamin NN O
E NNP O
inhibited VBD O
carcinogenesis NN O
, , O
it PRP O
was VBD O
found VBN O
that IN O
tumour NN O
angiogenesis NN O
and CC O
tumour NN O
growth NN O
- : O
factor NN O
alpha NN O
( -LRB- O
TGF NN O
alpha NN O
) -RRB- O
expression NN O
were VBD O
also RB O
inhibited VBN O
. . O

Forty VBG O
male JJ O
golden JJ O
hamsters NNS O
were VBD O
divided VBN O
into IN O
four CD O
equal JJ O
groups NNS O
. . O

Group NNP O
1 CD O
animals NNS O
had VBD O
the DT O
left JJ O
buccal JJ O
pouches NNS O
painted VBD O
three CD O
times NNS O
weekly RB O
with IN O
7 CD O
, , O
12 CD O
- : O
dimethylbenz NN O
( -LRB- O
a DT O
) -RRB- O
anthracene NN O
( -LRB- O
DMBA NNP O
) -RRB- O
for IN O
14 CD O
weeks NNS O
. . O

Group NNP O
2 CD O
animals NNS O
had VBD O
the DT O
same JJ O
procedure NN O
of IN O
DMBA NNP O
applications NNS O
but CC O
also RB O
received VBD O
alpha NN O
tocopherol NN O
. . O

Groups NNP O
3 CD O
and CC O
4 CD O
were VBD O
vitamin JJ O
E NNP O
and CC O
untreated JJ O
controls NNS O
. . O

Angiogenesis NNP O
was VBD O
studied VBN O
with IN O
factor NN O
8 CD O
- : O
related JJ O
antigen NN O
( -LRB- O
F8 FW O
- : O
RA NNP O
) -RRB- O
which WDT O
identifies VBZ O
endothelial JJ O
cells NNS O
. . O

TGF NN O
alpha NN O
was VBD O
studied VBN O
with IN O
the DT O
appropriate JJ O
antibody NN O
. . O

Staining NNP O
was VBD O
effected VBN O
by IN O
the DT O
standard JJ O
avidin NN O
- : O
biotin NN O
horseradish NN O
peroxidase NN O
system NN O
. . O

Mean JJ O
tumour NN O
volume NN O
was VBD O
significantly RB O
lower JJR O
in IN O
the DT O
DMBA NNP O
- : O
vitamin NN O
E NNP O
group NN O
compared VBN O
to TO O
the DT O
tumour NN O
control NN O
group NN O
. . O

Angiogenesis NNP O
was VBD O
significantly RB O
inhibited VBN O
in IN O
the DT O
DMBA NNP O
- : O
vitamin NN O
E NNP O
group NN O
and CC O
TGF NN O
alpha NN O
expression NN O
was VBD O
also RB O
inhibited VBN O
. . O

It PRP O
is VBZ O
suggested VBN O
that IN O
inhibition NN O
of IN O
tumour NN O
angiogenesis NN O
by IN O
vitamin NN O
E NNP O
may MD O
be VB O
an DT O
additional JJ O
mechanism NN O
for IN O
the DT O
anticancer NN O
action NN O
of IN O
vitamin NN O
E NNP O
. . O

-DOCSTART- X X O

Acetaminophen NNP O
and CC O
hepatic JJ O
dysfunction NN O
in IN O
infectious JJ O
mononucleosis NN O
. . O

Two CD O
family NN O
members NNS O
developed VBD O
severe JJ O
hepatitic NN O
dysfunction NN O
in IN O
association NN O
with IN O
infectious JJ O
mononucleosis NN O
and CC O
acetaminophen RB O
administration NN O
. . O

Since IN O
severe JJ O
hepatitis NN O
is VBZ O
an DT O
extremely RB O
rare JJ O
complication NN O
of IN O
infectious JJ O
mononucleosis NN O
, , O
we PRP O
postulate VBP O
that IN O
the DT O
hepatic JJ O
dysfunction NN O
was VBD O
induced VBN O
by IN O
acetaminophen NNS O
. . O

-DOCSTART- X X O

Syndecan NNP O
- : O
1 CD O
expression NN O
in IN O
mammary JJ O
epithelial JJ O
tumor NN O
cells NNS O
is VBZ O
E NNP O
- : O
cadherin NN O
- : O
dependent JJ O
. . O

E NNP O
- : O
cadherin NN O
is VBZ O
a DT O
Ca JJ O
( -LRB- O
2 CD O
+ NN O
) -RRB- O
- : O
dependent JJ O
cell NN O
- : O
cell NN O
adhesion NN O
molecule NN O
, , O
which WDT O
is VBZ O
mainly RB O
expressed VBN O
in IN O
epithelial NN O
cells NNS O
. . O

Recent JJ O
studies NNS O
have VBP O
shown VBN O
that IN O
E NNP O
- : O
cadherin NN O
has VBZ O
an DT O
important JJ O
role NN O
as IN O
an DT O
invasion NN O
suppressor NN O
molecule NN O
in IN O
epithelial JJ O
tumor NN O
cells NNS O
. . O

Syndecan NNP O
- : O
1 CD O
is VBZ O
a DT O
cell NN O
surface NN O
proteoglycan NN O
that WDT O
has VBZ O
been VBN O
implicated VBN O
in IN O
a DT O
number NN O
of IN O
cellular JJ O
functions NNS O
including VBG O
cell NN O
- : O
cell NN O
adhesion NN O
, , O
cell NN O
- : O
matrix NN O
anchorage NN O
and CC O
growth NN O
factor NN O
presentation NN O
for IN O
signalling VBG O
receptors NNS O
. . O

Its PRP$ O
suppression NN O
has VBZ O
also RB O
been VBN O
shown VBN O
to TO O
be VB O
associated VBN O
with IN O
malignant JJ O
transformation NN O
of IN O
epithelial JJ O
cells NNS O
. . O

In IN O
order NN O
to TO O
better RB O
understand VB O
the DT O
coordinated JJ O
regulation NN O
of IN O
cell NN O
- : O
cell NN O
and CC O
cell NN O
- : O
matrix NN O
interactions NNS O
during IN O
malignant JJ O
transformation NN O
, , O
we PRP O
have VBP O
studied VBN O
the DT O
expression NN O
of IN O
syndecan NN O
- : O
1 CD O
in IN O
malignant JJ O
mammary JJ O
tumor NN O
cells NNS O
genetically RB O
manipulated VBN O
for IN O
E NNP O
- : O
cadherin NN O
expression NN O
. . O

In IN O
invasive JJ O
NM NNP B-NP
- : I-NP
e SYM I-NP
- : O
ras FW O
- : O
MAC1 NNP O
cells NNS O
, , O
where WRB O
E NNP O
- : O
cadherin NN O
was VBD O
partially RB O
downregulated VBN O
by IN O
specific JJ O
antisense NN O
RNA NNP O
, , O
syndecan NN O
- : O
1 CD O
expression NN O
was VBD O
suppressed VBN O
. . O

Furthermore RB O
, , O
transfection NN O
of IN O
E NNP O
- : O
cadherin NN O
cDNA NN O
into IN O
invasive JJ O
NM NNP B-NP
- : I-NP
f SYM I-NP
- : O
ras FW O
- : O
TD NN O
cells NNS O
resulted VBN O
in IN O
the DT O
upregulation NN O
of IN O
syndecan NN O
- : O
1 CD O
expression NN O
in IN O
association NN O
with IN O
decreased VBN O
invasiveness NN O
. . O

In IN O
both DT O
cases NNS O
, , O
regulation NN O
of IN O
syndecan NN O
- : O
1 CD O
occurred VBN O
post NN O
- : O
transcriptionally RB O
, , O
since IN O
syndecan NN O
- : O
1 CD O
mRNA NN O
levels NNS O
remained VBD O
unchanged JJ O
. . O

Instead RB O
, , O
a DT O
translational JJ O
regulation NN O
is VBZ O
suggested VBN O
, , O
since IN O
syndecan NN O
- : O
1 CD O
core NN O
protein NN O
synthesis NN O
was VBD O
E NNP O
- : O
cadherin NN O
dependent JJ O
. . O

Another DT O
cell NN O
adhesion NN O
protein NN O
, , O
beta NN O
1 CD O
- : O
integrin NN O
was VBD O
not RB O
affected VBN O
by IN O
E NNP O
- : O
cadherin NN O
expression NN O
. . O

The DT O
data NNS O
provide VBP O
an DT O
example NN O
of IN O
coordinated JJ O
changes NNS O
in IN O
the DT O
expression NN O
of IN O
two CD O
cell NN O
adhesion NN O
molecules NNS O
, , O
syndecan NN O
- : O
1 CD O
and CC O
E NNP O
- : O
cadherin NN O
during IN O
epithelial JJ O
cell NN O
transformation NN O
. . O

-DOCSTART- X X O

Curcumin NNP O
induces VBZ O
apoptosis NN O
in IN O
immortalized JJ O
NIH NNP B-NP
3T3 CD I-NP
and CC O
malignant JJ O
cancer NN O
cell NN O
lines NNS O
. . O

Curcumin NNP O
, , O
which WDT O
is VBZ O
a DT O
widely RB O
used VBN O
dietary NN O
pigment NN O
and CC O
spice NN O
, , O
has VBZ O
been VBN O
demonstrated VBN O
to TO O
be VB O
an DT O
effective JJ O
inhibitor NN O
of IN O
tumor NN O
promotion NN O
in IN O
mouse NN O
skin NN O
carcinogenesis NN O
. . O

We PRP O
report VBP O
that IN O
curcumin NN O
induces VBZ O
cell NN O
shrinkage NN O
, , O
chromatin NN O
condensation NN O
, , O
and CC O
DNA NNP O
fragmentation NN O
, , O
characteristics NNS O
of IN O
apoptosis NN O
, , O
in IN O
immortalized JJ O
mouse NN O
embryo NN O
fibroblast NN O
NIH NNP B-NP
3T3 CD I-NP
erb NN O
B2 NN O
oncogene NN O
- : O
transformed VBN O
NIH NNP B-NP
3T3 CD I-NP
, , O
mouse NN O
sarcoma NN O
S180 NN B-NP
, , O
human JJ O
colon NN O
cancer NN O
cell NN O
HT NN B-NP
- : I-NP
29 CD I-NP
, , O
human JJ O
kidney NN O
cancer NN O
cell NN O
293 CD B-NP
, , O
and CC O
human JJ O
hepatocellular NN O
carcinoma NN O
Hep IN B-NP
G2 NNP I-NP
cells NNS O
, , O
but CC O
not RB O
in IN O
primary JJ O
culture NN O
of IN O
mouse NN O
embryonic JJ O
fibroblast JJ O
C3H NNP B-NP
10T1 CD I-NP
/ NN I-NP
2 CD I-NP
, , O
rat NN O
embryonic JJ O
fibroblast NN O
, , O
and CC O
human JJ O
foreskin IN O
fibroblast JJ O
cells NNS O
in IN O
a DT O
concentration NN O
- : O
and CC O
time NN O
- : O
dependent JJ O
manner NN O
. . O

Many JJ O
cellular JJ O
and CC O
biochemical JJ O
effects NNS O
of IN O
curcumin NN O
in IN O
mouse NN O
fibroblast NN O
cells NNS O
have VBP O
been VBN O
reported VBN O
, , O
such JJ O
as IN O
inhibition NN O
of IN O
protein NN O
kinase NN O
C NNP O
( -LRB- O
PKC NNP O
) -RRB- O
activity NN O
induced VBN O
by IN O
phorbol NN O
12 CD O
- : O
myristate NN O
13 CD O
- : O
acetate NN O
treatment NN O
, , O
inhibition NN O
of IN O
tyrosine NN O
protein NN O
kinase NN O
activity NN O
, , O
and CC O
inhibition NN O
of IN O
arachidonic JJ O
acid NN O
( -LRB- O
AA NNP O
) -RRB- O
metabolism NN O
. . O

Treatment NNP O
of IN O
NIH NNP B-NP
3T3 CD I-NP
cells NNS O
with IN O
the DT O
PKC NNP O
inhibitor NN O
staurosporine NN O
, , O
the DT O
tyrosine NN O
kinase NN O
inhibitor NN O
herbimycin IN O
A DT O
, , O
and CC O
the DT O
AA NNP O
metabolism NN O
inhibitor NN O
quinacrine NN O
induces VBZ O
apoptotic JJ O
cell NN O
death NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
, , O
in IN O
some DT O
immortalized JJ O
and CC O
transformed VBD O
cells NNS O
, , O
blocking VBG O
the DT O
cellular JJ O
signal NN O
transduction NN O
might MD O
trigger VB O
the DT O
induction NN O
of IN O
apoptosis NN O
. . O

-DOCSTART- X X O

c SYM O
- : O
erb NN O
B2 NN O
overexpression IN O
decreases VBZ O
the DT O
benefit NN O
of IN O
adjuvant JJ O
tamoxifen NNS O
in IN O
early JJ O
- : O
stage NN O
breast NN O
cancer NN O
without IN O
axillary NN O
lymph NN O
node NN O
metastases NNS O
. . O

PURPOSE NNP O
: : O
We PRP O
studied VBD O
retrospectively RB O
the DT O
interaction NN O
between IN O
c NNS O
- : O
erbB2 JJ O
overexpression NN O
and CC O
adjuvant JJ O
tomoxifen NN O
in IN O
node NN O
- : O
negative JJ O
breast NN O
cancer NN O
patients NNS O
enrolled VBN O
in IN O
the DT O
Gruppo NNP O
Universitario NNP O
Napoletano NNP O
1 CD O
( -LRB- O
GUN NNP O
- : O
1 CD O
) -RRB- O
trial NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
c SYM O
- : O
erbB2 NN O
, , O
evaluated VBN O
by IN O
immunohistochemistry NN O
in IN O
145 CD O
of IN O
173 CD O
patients NNS O
randomly RB O
assigned VBN O
to TO O
2 CD O
- : O
year NN O
adjuvant NN O
tamoxifen NN O
or CC O
no DT O
further JJ O
therapy NN O
, , O
was VBD O
considered VBN O
overexpressed IN O
if IN O
greater JJR O
than IN O
10 CD O
% NN O
of IN O
the DT O
cells NNS O
showed VBN O
specific JJ O
membrane NN O
staining NN O
. . O

The DT O
role NN O
of IN O
each DT O
prognostic JJ O
variable JJ O
and CC O
their PRP$ O
independent JJ O
effect NN O
were VBD O
studied VBN O
using VBG O
the DT O
Cox NNP O
model NN O
. . O

Disease VB O
- : O
free JJ O
( -LRB- O
DFS NNS O
) -RRB- O
and CC O
overall JJ O
( -LRB- O
OAS NNP O
) -RRB- O
survival NN O
curves NNS O
were VBD O
estimated VBN O
by IN O
the DT O
Kaplan NNP O
- : O
Meier NN O
method NN O
. . O

RESULTS NNS O
: : O
As IN O
of IN O
November NNP O
30 CD O
, , O
1994 CD O
, , O
the DT O
median NN O
follow VB O
- : O
up RP O
period NN O
was VBD O
12 CD O
years NNS O
. . O

c SYM O
- : O
erbB2 NN O
was VBD O
overexpressed VBN O
in IN O
43 CD O
of IN O
145 CD O
patients NNS O
( -LRB- O
29 CD O
. . O
7 CD O
% NN O
) -RRB- O
, , O
which WDT O
directly RB O
correlated VBN O
with IN O
tumor NN O
size NN O
and CC O
inversely NN O
with IN O
estrogen NN O
receptor NN O
( -LRB- O
ER NN O
) -RRB- O
level NN O
. . O

At IN O
univariate JJ O
analysis NN O
, , O
overexpression IN O
of IN O
c SYM O
- : O
erbB2 NN O
did VBD O
not RB O
affect VB O
either DT O
DFS NNS O
or CC O
OAS NNP O
; : O
tamoxifen NNS O
had VBD O
a DT O
greater JJR O
effect NN O
on IN O
reducing VBG O
the DT O
risk NN O
of IN O
recurrence NN O
than IN O
of IN O
death NN O
. . O

Addition NNP O
of IN O
c SYM O
- : O
erbB2 NN O
to TO O
a DT O
multivariate JJ O
Cox NNP O
model NN O
that WDT O
contained VBD O
menopausal JJ O
status NN O
, , O
tumor NN O
size NN O
, , O
nuclear JJ O
grade NN O
, , O
and CC O
treatment NN O
as IN O
covariates NNS O
did VBD O
not RB O
affect VB O
the DT O
significance NN O
of IN O
the DT O
model NN O
for IN O
DSF NNP O
or CC O
OAS NNP O
, , O
whereas IN O
addition NN O
of IN O
the DT O
first JJ O
- : O
order NN O
interaction NN O
between IN O
c NNS O
- : O
erbB2 NN O
and CC O
tamoxifen NN O
was VBD O
statistically RB O
significant JJ O
both DT O
for IN O
DFS NNP O
and CC O
OAS NNP O
. . O

The DT O
same JJ O
result NN O
was VBD O
obtained VBN O
when WRB O
the DT O
model NN O
contained VBD O
ER NN O
status NN O
and CC O
ER NNP O
- : O
tamoxifen JJ O
interaction NN O
. . O

Indeed RB O
, , O
adjuvant VBP O
tamoxifen VBN O
significantly RB O
prolonged VBN O
DFS NNP O
and CC O
OAS NNP O
in IN O
c SYM O
- : O
erbB2 JJ O
- : O
negative JJ O
cases NNS O
, , O
whereas IN O
it PRP O
had VBD O
no DT O
effect NN O
on IN O
DFS NNP O
and CC O
OAS NNP O
in IN O
c SYM O
- : O
erbB2 NN O
- : O
positive JJ O
patients NNS O
. . O

CONCLUSION NN O
: : O
In IN O
early JJ O
- : O
stage NN O
breast NN O
cancer NN O
patients NNS O
, , O
overexpression NNP O
of IN O
c SYM O
- : O
erbB2 NN O
is VBZ O
a DT O
marker NN O
of IN O
lack NN O
of IN O
efficacy NN O
of IN O
adjuvant NN O
tamoxifen NNS O
. . O

-DOCSTART- X X O

Gene NNP O
transfer NN O
of IN O
naked JJ O
DNA NN O
encoding VBG O
for IN O
three CD O
isoforms NNS O
of IN O
vascular JJ O
endothelial JJ O
growth NN O
factor NN O
stimulates NNS O
collateral NN O
development NN O
in IN O
vivo NN O
. . O

Vascular JJ O
endothelial JJ O
growth NN O
factor NN O
( -LRB- O
VEGF NN O
) -RRB- O
is VBZ O
a DT O
naturally RB O
secreted VBN O
endothelial JJ O
cell NN O
- : O
specific JJ O
mitogen NN O
. . O

We PRP O
investigated VBD O
the DT O
hypothesis NN O
that IN O
naked JJ O
DNA NN O
encoding VBG O
for IN O
VEGF NNP O
could MD O
be VB O
used VBN O
in IN O
a DT O
strategy NN O
of IN O
arterial JJ O
gene NN O
therapy NN O
to TO O
stimulate VB O
collateral NN O
artery NN O
development NN O
. . O

Plasmid NNP O
DNA NNP O
encoding VBG O
each DT O
of IN O
the DT O
three CD O
principal JJ O
human JJ O
VEGF NN O
isoforms VBZ O
( -LRB- O
phVEGF121 NN O
, , O
phVEGF165 PRP O
, , O
or CC O
phVEGF189 DT O
) -RRB- O
was VBD O
applied VBN O
to TO O
the DT O
hydrogel NN O
polymer NN O
coating NN O
of IN O
an DT O
angioplasty JJ O
balloon NN O
and CC O
delivered VBD O
percutaneously RB O
to TO O
one CD O
iliac JJ O
artery NN O
of IN O
rabbits NNS O
with IN O
operatively RB O
induced VBN O
hindlimb JJ O
ischemia NN O
. . O

Compared VBN O
with IN O
control NN O
animals NNS O
transfected VBN O
with IN O
LacZ NNP O
, , O
site NN O
- : O
specific JJ O
transfection NN O
of IN O
phVEGF NN O
resulted VBD O
in IN O
augmented JJ O
collateral NN O
vessel NN O
development NN O
documented VBN O
by IN O
serial JJ O
angiography NN O
, , O
and CC O
improvement NN O
in IN O
calf NN O
blood NN O
pressure NN O
ratio NN O
( -LRB- O
ischemic JJ O
to TO O
normal JJ O
limb NN O
) -RRB- O
, , O
resting VBG O
and CC O
maximum JJ O
blood NN O
flow NN O
, , O
and CC O
capillary NN O
to TO O
myocyte VB O
ratio NN O
. . O

Similar JJ O
results NNS O
were VBD O
obtained VBN O
with IN O
phVEGF121 JJ O
, , O
phVEGF165 PRP O
, , O
and CC O
phVEGF189 PRP O
, , O
which WDT O
suggests VBZ O
that IN O
these DT O
isoforms NNS O
are VBP O
biologically RB O
equivalent JJ O
with IN O
respect NN O
to TO O
in IN O
vivo JJ O
angiogenesis NN O
. . O

The DT O
fact NN O
that IN O
viral JJ O
or CC O
other JJ O
adjunctive JJ O
vectors NNS O
were VBD O
not RB O
required VBN O
further RB O
suggests VBZ O
that IN O
secreted VBN O
gene NN O
products NNS O
may MD O
have VB O
potential JJ O
therapeutic JJ O
utility NN O
even RB O
when WRB O
the DT O
number NN O
of IN O
successfully RB O
transfected VBN O
cells NNS O
remains VBZ O
low JJ O
. . O

Arterial NNP O
gene NN O
transfer NN O
of IN O
naked JJ O
DNA NN O
encoding VBG O
for IN O
a DT O
secreted JJ O
angiogenic JJ O
cytokine NN O
, , O
thus RB O
, , O
represents VBZ O
a DT O
potential JJ O
alternative NN O
to TO O
recombinant JJ O
protein NN O
administration NN O
for IN O
stimulating VBG O
collateral NN O
vessel NN O
development NN O
. . O

-DOCSTART- X X O

Metastasis NNP O
- : O
associated VBN O
5T4 IN O
antigen JJ O
disrupts NNS O
cell NN O
- : O
cell NN O
contacts NNS O
and CC O
induces VBZ O
cellular JJ O
motility NN O
in IN O
epithelial JJ O
cells NNS O
. . O

The DT O
5T4 CD O
antigen NN O
is VBZ O
defined VBN O
by IN O
a DT O
monoclonal JJ O
antibody NN O
( -LRB- O
MAb NN O
) -RRB- O
specific NN O
for IN O
human JJ O
trophoblast NN O
. . O

It PRP O
is VBZ O
also RB O
expressed VBN O
by IN O
many JJ O
types NNS O
of IN O
tumour NN O
cell NN O
and CC O
has VBZ O
been VBN O
associated VBN O
with IN O
metastasis NN O
and CC O
poor JJ O
clinical JJ O
outcome NN O
in IN O
a DT O
number NN O
of IN O
cancers NNS O
. . O

This DT O
pattern NN O
of IN O
expression NN O
is VBZ O
consistent JJ O
with IN O
a DT O
mechanistic JJ O
involvement NN O
of IN O
5T4 DT O
molecules NNS O
in IN O
the DT O
spread NN O
of IN O
cancer NN O
cells NNS O
. . O

The DT O
5T4 CD O
antigen NN O
is VBZ O
a DT O
transmembrane NN O
glycoprotein NN O
with IN O
a DT O
310 CD O
amino IN O
acid NN O
extracellular JJ O
domain NN O
and CC O
a DT O
44 CD O
amino IN O
acid NN O
cytoplasmic JJ O
domain NN O
. . O

Transfection NN O
of IN O
full JJ O
- : O
length NN O
5T4 VBZ O
cDNA RB O
into IN O
epithelial NN O
cells NNS O
alters IN O
cell NN O
- : O
cell NN O
contacts NNS O
and CC O
cellular JJ O
motility NN O
. . O

Thus RB O
, , O
in IN O
5T4 CD O
- : O
transfected VBN O
CL NN B-NP
- : I-NP
S1 JJ I-NP
murine NN O
mammary NN O
cells NNS O
, , O
5T4 DT O
expression NN O
is VBZ O
associated VBN O
with IN O
dendritic NN O
morphology NN O
, , O
accompanied VBN O
by IN O
abrogation RB O
of IN O
actin NN O
/ NN O
cadherin NN O
- : O
containing VBG O
contacts NNS O
and CC O
increased VBD O
motility NN O
. . O

In IN O
transfected VBN O
MDCK NNP O
canine CD O
kidney NN O
epithelial NN O
cells NNS O
, , O
5T4 VBG O
over IN O
- : O
expression NN O
also RB O
results VBZ O
in IN O
increased VBN O
motility NN O
, , O
but CC O
disruption NN O
of IN O
cell NN O
- : O
cell NN O
contacts NNS O
, , O
either CC O
by IN O
culturing VBG O
cells NNS O
in IN O
low JJ O
calcium NN O
medium NN O
or CC O
by IN O
addition NN O
of IN O
HGF NNP O
/ NNP O
SF NNP O
, , O
is VBZ O
needed VBN O
. . O

The DT O
effects NNS O
of IN O
5T4 DT O
expression NN O
on IN O
morphology NN O
and CC O
motility NN O
are VBP O
separable JJ O
since IN O
cells NNS O
transfected VBN O
with IN O
a DT O
truncated JJ O
form NN O
of IN O
5T4 DT O
cDNA NN O
in IN O
which WDT O
the DT O
cytoplasmic JJ O
domain NN O
is VBZ O
deleted VBN O
reveal VB O
that IN O
the DT O
latter NN O
is VBZ O
necessary JJ O
to TO O
abrogate VB O
actin NN O
/ NN O
cadherin NN O
- : O
containing VBG O
contacts NNS O
but CC O
does VBZ O
not RB O
influence VB O
the DT O
effects NNS O
on IN O
motility NN O
. . O

Thus RB O
, , O
5T4 IN O
molecules NNS O
can MD O
deliver VB O
signals NNS O
through IN O
both DT O
the DT O
extracellular JJ O
and CC O
intracellular JJ O
domains NNS O
, , O
and CC O
the DT O
resultant JJ O
effects NNS O
are VBP O
consistent JJ O
with IN O
a DT O
role NN O
for IN O
5T4 DT O
molecules NNS O
in IN O
invasion NN O
processes NNS O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
p18INK4c JJ O
and CC O
its PRP$ O
predominant JJ O
association NN O
with IN O
CDK4 NNP O
and CC O
CDK6 NNP O
during IN O
myogenic JJ O
differentiation NN O
. . O

Terminal JJ O
cell NN O
differentiation NN O
involves VBZ O
permanent JJ O
withdrawal NN O
from IN O
the DT O
cell NN O
division NN O
cycle NN O
. . O

The DT O
inhibitors NNS O
of IN O
cyclin NN O
- : O
dependent JJ O
kinases NNS O
( -LRB- O
CDKs NNS O
) -RRB- O
are VBP O
potential JJ O
molecules NNS O
functioning VBG O
to TO O
couple NN O
cell NN O
cycle NN O
arrest NN O
and CC O
cell NN O
differentiation NN O
. . O

In IN O
murine NN O
C2C12 IN B-NP
myoblast JJ O
cells NNS O
, , O
G1 NNP O
CDK NNP O
enzymes VBZ O
( -LRB- O
CDK2 NNP O
, , O
CDK4 NNP O
, , O
and CC O
CDK6 NNP O
) -RRB- O
associate NN O
with IN O
four CD O
CDK NNP O
inhibitors NNS O
: : O
p18INK4c JJ O
, , O
p19INK4d JJ O
, , O
p21 JJ O
, , O
and CC O
p27Kip1 NNS O
. . O

During IN O
induced VBN O
myogenesis NN O
, , O
p21 NN O
and CC O
its PRP$ O
associated JJ O
CDK NNP O
proteins VBZ O
underwent IN O
an DT O
initial JJ O
increase NN O
followed VBD O
by IN O
a DT O
decrease NN O
as IN O
cells NNS O
became VBD O
terminally RB O
differentiated JJ O
. . O

The DT O
level NN O
of IN O
p27 JJ O
protein NN O
gradually RB O
increased VBD O
, , O
but CC O
the DT O
amount NN O
of IN O
total NN O
associated VBN O
CDK NNP O
proteins NNS O
remained VBD O
unchanged JJ O
. . O

p19 JJ O
protein NN O
decreased VBD O
gradually RB O
during IN O
differentiation NN O
, , O
as IN O
did VBD O
its PRP$ O
associated JJ O
CDK4 NNP O
protein NN O
. . O

In IN O
contrast NN O
, , O
p18 VBP O
protein NN O
increased VBN O
50 CD O
- : O
fold NN O
, , O
from IN O
negligible JJ O
levels NNS O
in IN O
proliferating VBG O
myoblasts NNS O
to TO O
clearly RB O
detectable JJ O
levels NNS O
within IN O
8 CD O
- : O
12 CD O
h NN O
of IN O
myogenic JJ O
induction NN O
. . O

This DT O
initial JJ O
rise NN O
was VBD O
followed VBN O
by IN O
a DT O
precipitous JJ O
increase NN O
between IN O
12 CD O
and CC O
24 CD O
h NN O
postinduction NN O
, , O
with IN O
p18 DT O
protein NN O
finally RB O
accumulating VBG O
to TO O
its PRP$ O
highest JJS O
level NN O
in IN O
terminally RB O
differentiated JJ O
cells NNS O
. . O

Induction NN O
of IN O
p18 DT O
correlated JJ O
with IN O
increased VBN O
and CC O
sequential JJ O
complex JJ O
formation NN O
- : O
- : O
first JJ O
increasing JJ O
association NN O
with IN O
CDK6 NNP O
and CC O
then RB O
with IN O
CDK4 NNP O
over IN O
the DT O
course NN O
of IN O
myogenic JJ O
differentiation NN O
. . O

All DT O
of IN O
the DT O
CDK6 NNP O
and CC O
half NN O
of IN O
the DT O
CDK4 NNP O
were VBD O
complexed VBN O
with IN O
p18 NNS O
in IN O
terminally RB O
differentiated JJ O
C2C12 NN B-NP
cells NNS O
as RB O
well RB O
as IN O
in IN O
adult NN O
mouse NN O
muscle NN O
tissue NN O
. . O

Finally RB O
, , O
kinase NN O
activity NN O
of IN O
CDK2 NNP O
and CC O
CDK4 NNP O
decreases VBZ O
as IN O
C2C12 NNP B-NP
cells NNS O
differentiate JJ O
, , O
whereas IN O
the DT O
CDK6 NN O
kinase NN O
activity NN O
is VBZ O
low JJ O
in IN O
both DT O
proliferating VBG O
myoblasts NNS O
and CC O
differentiated JJ O
myotubes NNS O
. . O

Our PRP$ O
results NNS O
indicate VBP O
that IN O
p18 PRP O
may MD O
play VB O
a DT O
critical JJ O
role NN O
in IN O
causing VBG O
and CC O
/ VBG O
or CC O
maintaining VBG O
permanent JJ O
cell NN O
cycle NN O
arrest NN O
associated VBN O
with IN O
mature JJ O
muscle NN O
formation NN O
. . O

-DOCSTART- X X O

Defective NNP O
biliary NN O
copper NN O
excretion NN O
in IN O
Wilson NNP O
' POS O
s PRP O
disease NN O
: : O
the DT O
role NN O
of IN O
caeruloplasmin NN O
. . O

Previous JJ O
studies NNS O
have VBP O
failed VBN O
to TO O
explain VB O
the DT O
link NN O
between IN O
copper NN O
accumulation NN O
and CC O
abnormal JJ O
caeruloplasmin NN O
expression NN O
in IN O
Wilson NNP O
' POS O
s PRP O
disease NN O
. . O

Furthermore RB O
, , O
despite IN O
the DT O
isolation NN O
of IN O
a DT O
candidate NN O
gene NN O
for IN O
Wilson NNP O
' POS O
s PRP O
disease NN O
, , O
which WDT O
predicts VBZ O
a DT O
defective JJ O
copper NN O
transport NN O
protein NN O
, , O
the DT O
localization NN O
of IN O
this DT O
putative JJ O
protein NN O
and CC O
its PRP$ O
relationship NN O
to TO O
the DT O
pathway NN O
involved VBN O
in IN O
copper NN O
excretion NN O
and CC O
to TO O
caeruloplasmin VB O
remain VB O
unknown JJ O
. . O

We PRP O
now RB O
present JJ O
evidence NN O
that IN O
caeruloplasmin NN O
, , O
the DT O
major JJ O
plasma NN O
copper NN O
- : O
carrying VBG O
protein NN O
, , O
is VBZ O
present JJ O
in IN O
the DT O
liver NN O
in IN O
Wilson NNP O
' POS O
s PRP O
disease NN O
, , O
and CC O
thus RB O
that IN O
reduced VBN O
circulating VBG O
levels NNS O
of IN O
the DT O
protein NN O
result NN O
from IN O
a DT O
post NN O
- : O
translational JJ O
defect NN O
in IN O
the DT O
secretory NN O
pathway NN O
. . O

We PRP O
have VBP O
also RB O
identified VBN O
a DT O
novel JJ O
form NN O
of IN O
caeruloplasmin NN O
, , O
molecular JJ O
weight NN O
125 CD O
kD NN O
, , O
which WDT O
we PRP O
propose VBP O
may MD O
act VB O
as IN O
the DT O
carrier NN O
for IN O
excretory NN O
copper NN O
into IN O
bile NN O
, , O
since IN O
it PRP O
is VBZ O
normally RB O
present JJ O
in IN O
both DT O
liver NN O
and CC O
bile NN O
, , O
although IN O
largely RB O
absent JJ O
from IN O
serum NN O
, , O
and CC O
undetectable JJ O
in IN O
bile NN O
from IN O
Wilson NNP O
' POS O
s PRP O
disease NN O
patients NNS O
. . O

The DT O
presence NN O
of IN O
this DT O
form NN O
of IN O
caeruloplasmin NN O
in IN O
Wilson NNP O
' POS O
s PRP O
disease NN O
liver NN O
suggests VBZ O
that IN O
a DT O
related VBN O
post NN O
- : O
translational JJ O
defect NN O
may MD O
also RB O
be VB O
responsible JJ O
for IN O
its PRP$ O
absence NN O
from IN O
bile NN O
in IN O
Wilson NNP O
' POS O
s PRP O
disease NN O
. . O

This DT O
study NN O
thus RB O
provides VBZ O
the DT O
first JJ O
plausible JJ O
explanation NN O
of IN O
a DT O
link NN O
between IN O
the DT O
defective JJ O
copper NN O
excretion NN O
and CC O
the DT O
reduced VBN O
plasma NN O
caeruloplasmin NN O
, , O
which WDT O
characterize VBP O
Wilson NNP O
' POS O
s PRP O
disease NN O
. . O

-DOCSTART- X X O

Functional JJ O
model NN O
of IN O
benign JJ O
paroxysmal JJ O
positional JJ O
vertigo NN O
using VBG O
an DT O
isolated VBN O
frog IN O
semicircular JJ O
canal NN O
. . O

Bull NNP O
frogs NNS O
posterior JJ O
semicircular JJ O
canals NNS O
( -LRB- O
psc NN O
) -RRB- O
wee NN O
used VBD O
to TO O
simulate VB O
the DT O
condition NN O
of IN O
benign JJ O
paroxysmal JJ O
positional JJ O
vertigo NN O
( -LRB- O
BPPV NNP O
) -RRB- O
. . O

The DT O
psc NN O
was VBD O
isolated VBN O
in IN O
frog JJ O
Ringer NNP O
' POS O
s PRP O
solution NN O
, , O
and CC O
the DT O
saccular JJ O
otoconia NN O
were VBD O
used VBN O
as IN O
a DT O
responsible JJ O
material NN O
to TO O
stimulate VB O
the DT O
cupula NN O
. . O

When WRB O
the DT O
otoconia NN O
were VBD O
placed VBN O
on IN O
the DT O
cupular JJ O
surface NN O
to TO O
mimic VB O
the DT O
condition NN O
of IN O
cupulolithiasis NN O
, , O
the DT O
psc NN O
ampullary NN O
nerve NN O
action NN O
potentials VBD O
instantaneously RB O
changed VBN O
according VBG O
to TO O
the DT O
direction NN O
of IN O
the DT O
gravity NN O
produced VBN O
by IN O
otoconia NNP O
. . O

When WRB O
the DT O
otoconia NNP O
were VBD O
dropped VBN O
into IN O
the DT O
canal NN O
to TO O
mimic VB O
the DT O
condition NN O
of IN O
moving VBG O
otoconia NNP O
in IN O
the DT O
canal NN O
, , O
the DT O
action NN O
potentials RB O
changed VBD O
together RB O
with IN O
the DT O
otoconial JJ O
flow NN O
after IN O
a DT O
latent JJ O
period NN O
. . O

Both DT O
cupulolithiasis NN O
and CC O
moving VBG O
otoconia NNP O
are VBP O
possibly RB O
valid JJ O
mechanisms NNS O
of IN O
BPPV NNP O
, , O
since IN O
they PRP O
effectively RB O
stimulate VB O
the DT O
cupula NN O
. . O

However RB O
, , O
moving VBG O
otoconia NNP O
with IN O
a DT O
latent JJ O
period NN O
would MD O
better RB O
explain VB O
clinical JJ O
features NNS O
of IN O
BPPV NNP O
. . O

-DOCSTART- X X O

Do VBP O
we PRP O
know VB O
how WRB O
much JJ O
people NNS O
like IN O
one CD O
another DT O
? . O

Metaperception NNP O
is VBZ O
a DT O
person NN O
' POS O
s VBZ O
perception NN O
about IN O
a DT O
second JJ O
person NN O
' POS O
s VBZ O
perception NN O
of IN O
a DT O
third JJ O
person NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
article NN O
is VBZ O
to TO O
examine VB O
the DT O
accuracy NN O
of IN O
metaperceptions NNS O
of IN O
liking NN O
. . O

A DT O
related JJ O
question NN O
concerns VBZ O
whether IN O
the DT O
heuristics NNS O
of IN O
balance NN O
, , O
reciprocity NN O
, , O
and CC O
agreement NN O
are VBP O
used VBN O
by IN O
perceivers NNS O
when WRB O
forming VBG O
such JJ O
judgments NNS O
. . O

The DT O
authors NNS O
present VBP O
analyses NNS O
from IN O
5 CD O
diverse JJ O
research NN O
studies NNS O
that WDT O
used VBD O
an DT O
adaptation NN O
of IN O
the DT O
social JJ O
relations NNS O
model NN O
for IN O
triads NNS O
( -LRB- O
C NNP O
. . O
F NNP O
. . O
Bond NNP O
, , O
E NNP O
. . O
M NNP O
. . O
Horn NNP O
, , O
& CC O
D NNP O
. . O
A NNP O
. . O
Kenny NNP O
, , O
in IN O
press NN O
) -RRB- O
. . O

The DT O
results NNS O
indicate VBP O
that IN O
people NNS O
know VBP O
how WRB O
much JJ O
people NNS O
like IN O
one CD O
another DT O
, , O
even RB O
with IN O
small JJ O
amounts NNS O
of IN O
information NN O
. . O

Although IN O
there EX O
is VBZ O
evidence NN O
for IN O
the DT O
use NN O
of IN O
heuristics NNS O
, , O
particularly RB O
reciprocity NN O
and CC O
agreement NN O
, , O
accuracy NN O
is VBZ O
sometimes RB O
enhanced VBN O
by IN O
using VBG O
these DT O
heuristics NNS O
. . O

-DOCSTART- X X O

Genetic JJ O
heterogeneity NN O
evidenced VBN O
by IN O
low JJ O
incidence NN O
of IN O
KAL NNP O
- : O
1 CD O
gene NN O
mutations NNS O
in IN O
sporadic JJ O
cases NNS O
of IN O
gonadotropin NN O
- : O
releasing NN O
hormone NN O
deficiency NN O
. . O

Isolated NNP O
GnRH NNP O
deficiency NN O
is VBZ O
a DT O
heritable JJ O
condition NN O
characterized VBN O
by IN O
a DT O
functional JJ O
deficit NN O
in IN O
GnRH NNP O
secretion NN O
. . O

Familial JJ O
cases NNS O
with IN O
different JJ O
modes NNS O
of IN O
inheritance NN O
have VBP O
been VBN O
described VBN O
, , O
and CC O
the DT O
gene NN O
responsible JJ O
for IN O
the DT O
X NNP O
- : O
linked VBN O
form NN O
( -LRB- O
KAL FW O
- : O
1 CD O
) -RRB- O
has VBZ O
been VBN O
identified VBN O
. . O

However RB O
, , O
sporadic JJ O
cases NNS O
with IN O
no DT O
documented VBN O
family NN O
history NN O
of IN O
GnRH NNP O
deficiency NN O
account NN O
for IN O
the DT O
majority NN O
of IN O
the DT O
affected JJ O
patients NNS O
. . O

For IN O
this DT O
reason NN O
, , O
we PRP O
sought VBD O
to TO O
determine VB O
the DT O
frequency NN O
with IN O
which WDT O
KAL NNP O
- : O
1 CD O
gene NN O
mutations NNS O
occur VBP O
in IN O
patients NNS O
with IN O
sporadic JJ O
GnRH NNP O
deficiency NN O
. . O

Only RB O
1 CD O
of IN O
21 CD O
patients NNS O
with IN O
sporadic JJ O
GnRH NNP O
deficiency NN O
was VBD O
found VBN O
to TO O
bear VB O
a DT O
defect NN O
in IN O
the DT O
KAL NNP O
- : O
1 CD O
gene NN O
( -LRB- O
a DT O
deletion NN O
of IN O
14 CD O
bases NNS O
starting VBG O
at IN O
codon NN O
464 CD O
) -RRB- O
. . O

Three CD O
types NNS O
of IN O
polymorphic JJ O
single JJ O
base NN O
substitutions NNS O
with IN O
no DT O
apparent JJ O
correlation NN O
with IN O
GnRH NNP O
deficiency NN O
were VBD O
also RB O
detected VBN O
in IN O
several JJ O
patients NNS O
. . O

In IN O
each DT O
of IN O
3 CD O
different JJ O
patients NNS O
with IN O
an DT O
X NNP O
- : O
linked VBN O
mode NN O
of IN O
inheritance NN O
, , O
3 CD O
genetic JJ O
defects NNS O
, , O
2 CD O
point NN O
mutations NNS O
and CC O
a DT O
small JJ O
intragenic JJ O
deletion NN O
, , O
were VBD O
detected VBN O
. . O

These DT O
defects NNS O
consist VBP O
of IN O
a DT O
single JJ O
base NN O
mutation NN O
introducing VBG O
a DT O
stop NN O
codon NN O
at IN O
position NN O
328 CD O
, , O
a DT O
single JJ O
base NN O
mutation NN O
resulting VBG O
in IN O
a DT O
phenylalanine NN O
to TO O
leucine VB O
substitution NN O
at IN O
position NN O
517 CD O
, , O
and CC O
a DT O
9 CD O
- : O
base NN O
deletion NN O
at IN O
the DT O
3 CD O
' POS O
- : O
exon SYM O
- : O
intron NN O
splice NN O
site NN O
of IN O
exon JJ O
8 CD O
, , O
respectively RB O
. . O

All DT O
identified VBN O
genetic JJ O
defects NNS O
occur VBP O
within IN O
the DT O
fibronectin NN O
type NN O
III NNP O
repeats NNS O
of IN O
the DT O
predicted VBN O
protein NN O
encoded VBN O
by IN O
the DT O
KAL NNP O
- : O
1 CD O
gene NN O
. . O

In IN O
conclusion NN O
, , O
our PRP$ O
study NN O
indicates VBZ O
that IN O
the DT O
incidence NN O
of IN O
genetic JJ O
defects NNS O
within IN O
the DT O
coding NN O
region NN O
of IN O
the DT O
KAL NNP O
- : O
1 CD O
gene NN O
in IN O
patients NNS O
with IN O
sporadic JJ O
GnRH NNP O
deficiency NN O
is VBZ O
low JJ O
( -LRB- O
5 CD O
- : O
8 CD O
% NN O
) -RRB- O
, , O
thus RB O
supporting VBG O
the DT O
idea NN O
that IN O
the DT O
X NNP O
- : O
linked VBN O
form NN O
of IN O
inheritance NN O
represents VBZ O
the DT O
least RBS O
common JJ O
form NN O
of IN O
the DT O
disease NN O
. . O

-DOCSTART- X X O

[ NN O
Considerations NNS O
regarding VBG O
two CD O
cases NNS O
of IN O
macromastia NN O
( -LRB- O
author NN O
' POS O
s VBZ O
transl NN O
) -RRB- O
] SYM O
. . O

Two CD O
cases NNS O
of IN O
macromastia NN O
have VBP O
been VBN O
shown VBN O
; : O
one CD O
which WDT O
appeared VBD O
during IN O
puberty NN O
, , O
the DT O
other JJ O
during IN O
menopause NN O
. . O

Histopathological JJ O
examination NN O
has VBZ O
demonstrated VBN O
for IN O
the DT O
both DT O
cases NNS O
a DT O
cystic JJ O
degeneracy NN O
of IN O
the DT O
glandular JJ O
tissue NN O
with IN O
a DT O
hyperplazia NN O
and CC O
hypertrophy NN O
of IN O
the DT O
conjunctive JJ O
tissue NN O
. . O

The DT O
pathogeny NN O
of IN O
macromastia NN O
is VBZ O
being VBG O
discussed VBN O
and CC O
it PRP O
is VBZ O
demonstrated VBN O
both DT O
the DT O
role NN O
of IN O
hypophysis NN O
hormones NNS O
( -LRB- O
prolactine NN O
and CC O
growth NN O
hormone NN O
) -RRB- O
and CC O
of IN O
ovarian JJ O
hormones NNS O
( -LRB- O
estrogens NNS O
) -RRB- O
. . O

The DT O
treatment NN O
was VBD O
surgical JJ O
for IN O
the DT O
both DT O
cases NNS O
. . O

-DOCSTART- X X O

The DT O
effect NN O
of IN O
early JJ O
diagnosis NN O
and CC O
treatment NN O
in IN O
cystic JJ O
fibrosis NN O
: : O
a DT O
seven CD O
- : O
year NN O
study NN O
of IN O
16 CD O
sibling NN O
pairs NNS O
. . O

Data NNS O
on IN O
16 CD O
sibling NN O
pairs NNS O
with IN O
cystic JJ O
fibrosis NN O
were VBD O
analyzed VBN O
to TO O
test VB O
the DT O
hypothesis NN O
that IN O
early JJ O
treatment NN O
of IN O
this DT O
condition NN O
improves VBZ O
prognosis NN O
. . O

Younger NNP O
siblings NNS O
' POS O
conditions NNS O
were VBD O
diagnosed VBN O
before IN O
1 CD O
year NN O
of IN O
age NN O
, , O
usually RB O
before IN O
the DT O
onset NN O
of IN O
pulmonary JJ O
disease NN O
. . O

Older JJR O
siblings NNS O
' POS O
conditions NNS O
were VBD O
diagnosed VBN O
after IN O
1 CD O
year NN O
of IN O
age NN O
and CC O
after IN O
the DT O
onset NN O
of IN O
pulmonary JJ O
disease NN O
. . O

Although IN O
the DT O
sibling NN O
pairs NNS O
received VBD O
similar JJ O
treatment NN O
, , O
comparison NN O
at IN O
7 CD O
years NNS O
of IN O
age NN O
showed VBD O
that IN O
the DT O
younger JJR O
siblings NNS O
had VBD O
significantly RB O
better JJR O
chest NN O
roentgenogram NN O
scores NNS O
, , O
total JJ O
clinical JJ O
scores NNS O
, , O
residual JJ O
lung NN O
volumes NNS O
, , O
and CC O
ratios NNS O
of IN O
residual JJ O
volume NN O
to TO O
total JJ O
lung NN O
volume NN O
. . O

Younger NNP O
siblings NNS O
also RB O
required VBD O
fewer JJR O
hospital NN O
admissions NNS O
to TO O
control VB O
their PRP$ O
lung NN O
disease NN O
. . O

The DT O
results NNS O
suggest VBP O
that IN O
, , O
in IN O
general JJ O
, , O
early JJ O
initiation NN O
of IN O
therapy NN O
is VBZ O
beneficial JJ O
for IN O
patients NNS O
with IN O
cystic JJ O
fibrosis NN O
. . O

-DOCSTART- X X O

Comparison NNP O
of IN O
transformation NN O
by IN O
manganese JJ O
sulfate NN O
and CC O
5 CD O
- : O
azacytidine NN O
in IN O
Rat NNP B-NP
6 CD I-NP
cells NNS O
overexpressing VBG O
the DT O
c SYM O
- : O
myc JJ O
oncogene NN O
. . O

Rat NNP B-NP
6 CD I-NP
cells NNS O
are VBP O
not RB O
transformed VBN O
by IN O
treatment NN O
with IN O
the DT O
well NN O
- : O
known VBN O
carcinogens NNS O
benzo IN O
[ VBG O
a DT O
] NN O
pyrene NN O
( -LRB- O
BP NNP O
) -RRB- O
or CC O
N NNP O
- : O
methyl NN O
- : O
N NNP O
- : O
nitro NN O
- : O
N NNP O
' POS O
- : O
nitrosoguanidine NN O
( -LRB- O
MNNG NNP O
) -RRB- O
. . O

Upon IN O
retroviral JJ O
transduction NN O
of IN O
the DT O
mouse NN O
c SYM O
- : O
myc JJ O
gene NN O
, , O
Rat NNP B-NP
6 CD I-NP
cells NNS O
showed VBD O
mildly RB O
altered VBN O
morphology NN O
and CC O
formed VBD O
microcolonies NNS O
in IN O
soft JJ O
agar NN O
; : O
furthermore RB O
, , O
they PRP O
could MD O
be VB O
transformed VBN O
by IN O
BP NNP O
and CC O
MNNG NNP O
to TO O
form VB O
large JJ O
colonies NNS O
in IN O
agar NN O
( -LRB- O
Hsiao FW O
et FW O
al NN O
. . O
( -LRB- O
1992 CD O
) -RRB- O
Mol JJ O
. . O
Carcinogenesis NNP O
, , O
5 CD O
, , O
140 CD O
- : O
154 CD O
) -RRB- O
. . O

In IN O
the DT O
current JJ O
report NN O
, , O
we PRP O
tested VBD O
the DT O
sensitivity NN O
of IN O
the DT O
c NNS O
- : O
myc SYM O
- : O
overexpressing JJ O
cells NNS O
( -LRB- O
Rat RB B-NP
6 CD I-NP
/ NN O
c SYM O
- : O
myc NN O
) -RRB- O
to TO O
two CD O
additional JJ O
chemicals NNS O
: : O
5 CD O
- : O
azacytidine NN O
and CC O
MnSO4 NNP O
. . O

These DT O
chemicals NNS O
differ VBP O
from IN O
the DT O
direct JJ O
- : O
acting JJ O
mutagens NNS O
tested VBN O
previously RB O
. . O

5 CD O
- : O
Azacytidine NNP O
, , O
a DT O
potent JJ O
DNA NNP O
methylation NN O
inhibitor NN O
, , O
induced JJ O
growth NN O
of IN O
large JJ O
colonies NNS O
in IN O
soft JJ O
agar NN O
cultures NNS O
of IN O
Rat NNP B-NP
6 CD I-NP
or CC O
Rat NNP B-NP
6 CD I-NP
/ NN O
c SYM O
- : O
myc JJ O
cells NNS O
. . O

On IN O
the DT O
other JJ O
hand NN O
, , O
MnSO4 NNP O
only RB O
induced VBD O
transformation NN O
in IN O
Rat NNP B-NP
6 CD I-NP
/ NN O
c SYM O
- : O
myc JJ O
cells NNS O
, , O
but CC O
not RB O
the DT O
parental JJ O
Rat NNP B-NP
6 CD I-NP
cells NNS O
. . O

Transformants NNS O
induced VBN O
by IN O
5 CD O
- : O
azacytidine NN O
lost VBN O
c SYM O
- : O
myc SYM O
- : O
induced VBN O
apoptotic JJ O
cell NN O
death NN O
, , O
whereas IN O
MnSO4 NNP O
- : O
induced JJ O
transformants NNS O
showed VBD O
a DT O
higher JJR O
degree NN O
of IN O
apoptosis NN O
than IN O
the DT O
parental JJ O
Rat NNP B-NP
6 CD I-NP
/ NN O
c SYM O
- : O
myc JJ O
cells NNS O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
MnSO4 NNP O
co NN O
- : O
operates VBZ O
with IN O
overexpressed JJ O
c SYM O
- : O
myc NN O
in IN O
inducing NN O
transformation NN O
, , O
while IN O
5 CD O
- : O
azacytidine NN O
transformation NN O
is VBZ O
independent JJ O
of IN O
c SYM O
- : O
myc JJ O
overexpression NN O
and CC O
may MD O
involve VB O
alterations NNS O
in IN O
the DT O
regulation NN O
of IN O
apoptosis NN O
. . O

-DOCSTART- X X O

Fas NNP O
- : O
signaling VBG O
and CC O
effects NNS O
on IN O
receptor NN O
tyrosine NN O
kinase NN O
signal NN O
transduction NN O
in IN O
human JJ O
breast NN O
epithelial NN O
cells NNS O
. . O

Fas NNP O
- : O
mediated JJ O
cell NN O
death NN O
was VBD O
examined VBN O
in IN O
MCF NNP B-NP
- : I-NP
10AT JJ I-NP
preneoplastic JJ O
human JJ O
breast NN O
epithelial NN O
cells NNS O
. . O

Treatment NNP O
with IN O
anti NNS O
- : O
Fas NN O
for IN O
48 CD O
h NN O
induced VBD O
apoptosis NN O
with IN O
cells NNS O
exhibiting VBG O
typical JJ O
apoptotic JJ O
features NNS O
including VBG O
loss NN O
of IN O
cell NN O
contact NN O
, , O
condensation NN O
of IN O
chromatin NN O
, , O
and CC O
increased VBD O
staining NN O
of IN O
the DT O
nuclear JJ O
membrane NN O
. . O

DNA NN O
fragmentation NN O
occurred VBD O
in IN O
response NN O
to TO O
anti NNS O
- : O
Fas NN O
treatment NN O
. . O

Anti NNP O
- : O
Fas NN O
treatment NN O
resulted VBD O
in IN O
decreased VBN O
p53 NN O
protein NN O
levels NNS O
, , O
while IN O
bcl JJ O
- : O
2 CD O
and CC O
bax JJ O
protein NN O
levels NNS O
remained VBD O
unaffected JJ O
. . O

Cells NNP O
treated VBD O
with IN O
anti NNS O
- : O
Fas NN O
also RB O
exhibited VBD O
increased VBN O
tyrosine NN O
phosphorylation NN O
of IN O
the DT O
c NN O
- : O
met VBN O
growth NN O
factor NN O
receptor NN O
tyrosine NN O
kinase NN O
. . O

Immunoprecipitation NN O
experiments NNS O
demonstrated VBD O
that IN O
Fas NNP O
associated VBN O
with IN O
c SYM O
- : O
erbB2 NN O
and CC O
c SYM O
- : O
met VBN O
in IN O
untreated JJ O
cells NNS O
. . O

Treatment NNP O
with IN O
anti NNS O
- : O
Fas NN O
, , O
however RB O
, , O
significantly RB O
decreased VBD O
Fas NNP O
- : O
c SYM O
- : O
erbB2 NN O
and CC O
Fas NNP O
- : O
c SYM O
- : O
met VBN O
association NN O
. . O

Anti NNP O
- : O
Fas NN O
treatment NN O
of IN O
these DT O
cells NNS O
caused VBD O
a DT O
significant JJ O
decrease NN O
in IN O
p120 DT O
- : O
GAP NNP O
levels NNS O
, , O
ERK NNP O
- : O
1 CD O
levels NNS O
, , O
and CC O
phosphorylation NN O
, , O
as RB O
well RB O
as IN O
Grb2 NNP O
- : O
Sosl JJ O
and CC O
MEK NNP O
- : O
1 LS O
- : O
ERK JJ O
- : O
1 CD O
association NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
Fas NNP O
- : O
signaling VBG O
exerted VBN O
a DT O
suppressive JJ O
effect NN O
on IN O
p53 NN O
levels NNS O
and CC O
on IN O
downstream NN O
effectors NNS O
of IN O
receptor NN O
tyrosine NN O
kinase NN O
signal NN O
transduction NN O
, , O
thereby RB O
ensuring VBG O
cell NN O
death NN O
. . O

-DOCSTART- X X O

Prevention NNP O
of IN O
hepatic JJ O
tumor NN O
metastases NNS O
in IN O
rats NNS O
with IN O
herpes PRP$ O
viral JJ O
vaccines NNS O
and CC O
gamma NN O
- : O
interferon NN O
. . O

Previous JJ O
studies NNS O
showed VBD O
that IN O
gammaIFN NN O
decreases VBZ O
metastatic JJ O
hepatic JJ O
tumor NN O
growth NN O
by IN O
stimulating JJ O
Kupffer NN O
cells NNS O
( -LRB- O
KC NN O
) -RRB- O
. . O

The DT O
present JJ O
studies NNS O
examine VBP O
whether IN O
lymphocyte NN O
stimulation NN O
via IN O
cells NNS O
engineered VBN O
to TO O
secrete VB O
GM NNP O
- : O
CSF NNP O
or CC O
IL NNP O
- : O
2 CD O
decreases VBZ O
hepatic JJ O
tumor NN O
growth NN O
, , O
and CC O
whether IN O
stimulation NN O
of IN O
both DT O
macrophages NNS O
and CC O
lymphocytes NNS O
is VBZ O
more RBR O
effective JJ O
than IN O
either DT O
individually RB O
. . O

Rats NNS O
were VBD O
immunized VBN O
with IN O
irradiated JJ O
hepatoma NN O
cells NNS O
transduced VBN O
by IN O
herpes PRP$ O
viral JJ O
amplicon NN O
vectors NNS O
containing VBG O
the DT O
genes NNS O
for IN O
GM NNP O
- : O
CSF NNP O
, , O
IL NNP O
- : O
2 CD O
or CC O
LacZ NNP O
. . O

On IN O
day NN O
18 CD O
, , O
half NN O
of IN O
each DT O
group NN O
was VBD O
treated VBN O
with IN O
5 CD O
x NN O
10 CD O
( -LRB- O
4 CD O
) -RRB- O
U NNP O
gammaIFN NNP O
, , O
or CC O
saline NN O
intraperitoneally RB O
for IN O
3 CD O
d NN O
. . O

On IN O
day NN O
21 CD O
, , O
all DT O
rats NNS O
received VBD O
5 CD O
x NN O
10 CD O
( -LRB- O
5 CD O
) -RRB- O
hepatoma NN O
cells NNS O
intrasplenically RB O
. . O

On IN O
day NN O
41 CD O
, , O
rats NNS O
were VBD O
killed VBN O
and CC O
tumor NN O
nodules NNS O
were VBD O
counted VBN O
. . O

Separate JJ O
rats NNS O
underwent IN O
splenocyte NN O
and CC O
KC NN O
harvest NN O
for IN O
assessment NN O
of IN O
lymphocyte NN O
- : O
and CC O
macrophage NN O
- : O
mediated JJ O
tumor NN O
cell NN O
kill NN O
in IN O
vitro NN O
. . O

GM NNP O
- : O
CSF NNP O
or CC O
IL NNP O
- : O
2 CD O
vaccines NNS O
or CC O
gammaIFN NN O
decreased VBD O
tumor NN O
nodules NNS O
significantly RB O
( -LRB- O
GM NNP O
- : O
CSF NNP O
13 CD O
+ NN O
/ NN O
- : O
4 CD O
, , O
IL NNP O
- : O
2 CD O
14 CD O
+ NN O
/ NNS O
- : O
6 CD O
vs NN O
. . O
control VB O
75 CD O
+ NN O
/ JJ O
- : O
24 CD O
, , O
P NNP O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

Combination NNP O
therapy NN O
was VBD O
more RBR O
effective JJ O
, , O
and CC O
completely RB O
eliminated VBN O
tumor NN O
in IN O
4 CD O
of IN O
12 CD O
IFN NNP O
- : O
GM NNP O
- : O
CSF NNP O
and CC O
8 CD O
of IN O
11 CD O
IFN IN O
- : O
IL LS O
- : O
2 CD O
animals NNS O
. . O

Additional JJ O
rats NNS O
underwent IN O
partial JJ O
hepatectomy NN O
, , O
an DT O
immunosuppressive JJ O
procedure NN O
known VBN O
to TO O
accelerate VB O
the DT O
growth NN O
of IN O
hepatic JJ O
tumor NN O
, , O
following VBG O
tumor NN O
challenge NN O
. . O

Therapy NNP O
was VBD O
equally RB O
effective JJ O
in IN O
this DT O
immunosuppressive JJ O
setting NN O
. . O

Vaccination NNP O
is VBZ O
associated VBN O
with IN O
enhancement NN O
of IN O
splenocyte JJ O
- : O
mediated JJ O
tumoricidal JJ O
activity NN O
, , O
whereas IN O
the DT O
effect NN O
of IN O
gammaIFN NN O
is VBZ O
mediated VBN O
by IN O
KC NNS O
. . O

GM NNP O
- : O
CSF NNP O
and CC O
IL NNP O
- : O
2 CD O
vaccine NN O
therapy NN O
and CC O
pretreatment NN O
with IN O
gammaIFN NNP O
represent VBP O
effective JJ O
strategies NNS O
in IN O
reducing VBG O
hepatic JJ O
tumor NN O
. . O

Combination NNP O
therapy NN O
targets VBZ O
both DT O
lymphocytes NNS O
and CC O
macrophages NNS O
, , O
and CC O
is VBZ O
more RBR O
effective JJ O
in IN O
reducing VBG O
tumor NN O
than IN O
either DT O
therapy NN O
alone RB O
. . O

-DOCSTART- X X O

[ JJ O
Effects NNS O
of IN O
carcinostatic JJ O
agents NNS O
in IN O
the DT O
hematogenous JJ O
metastasis NN O
of IN O
cancer NN O
] NN O
. . O

The DT O
experimental JJ O
studies NNS O
in IN O
vitro NN O
and CC O
in IN O
vivo NN O
were VBD O
performed VBN O
to TO O
investigate VB O
the DT O
effects NNS O
of IN O
carcinostatic JJ O
agents NNS O
in IN O
the DT O
adhesion NN O
of IN O
cancer NN O
cells NNS O
to TO O
endothelial JJ O
cells NNS O
. . O

Certain JJ O
carcinostatic JJ O
agents NNS O
induce VB O
the DT O
expression NN O
of IN O
E NNP O
- : O
selectin NN O
on IN O
endothelial JJ O
cells NNS O
and CC O
enhance VB O
the DT O
expression NN O
of IN O
carbohydrate NN O
ligands NNS O
on IN O
cancer NN O
cells NNS O
. . O

Consequently RB O
, , O
increased VBD O
adhesion NN O
of IN O
cancer NN O
cells NNS O
to TO O
endothelial JJ O
cells NNS O
was VBD O
observed VBN O
by IN O
the DT O
treatment NN O
of IN O
carcinostatic JJ O
agents NNS O
. . O

In IN O
the DT O
trans NNS O
- : O
splenic JJ O
hepatic JJ O
metastasis NN O
model NN O
using VBG O
nude JJ O
mice NNS O
, , O
the DT O
augmentation NN O
of IN O
cancer NN O
metastasis NN O
was VBD O
observed VBN O
by IN O
the DT O
treatment NN O
of IN O
carcinostatic JJ O
agents NNS O
. . O

From IN O
the DT O
above JJ O
, , O
we PRP O
concluded VBD O
that IN O
carcinostatic JJ O
agents NNS O
may MD O
increase VB O
the DT O
metastatic JJ O
ability NN O
of IN O
cancer NN O
cells NNS O
in IN O
patients NNS O
with IN O
cancer NN O
. . O

-DOCSTART- X X O

Procedural JJ O
memory NN O
stimulation NN O
in IN O
Alzheimer NNP O
' POS O
s PRP O
disease NN O
: : O
impact NN O
of IN O
a DT O
training NN O
programme NN O
. . O

The DT O
study NN O
evaluates VBZ O
the DT O
efficacy NN O
of IN O
a DT O
procedural JJ O
memory NN O
stimulation NN O
programme NN O
in IN O
mild JJ O
and CC O
mild JJ O
- : O
moderate JJ O
Alzheimer NNP O
' POS O
s PRP O
disease NN O
( -LRB- O
AD NN O
) -RRB- O
. . O

Twenty CD O
basic NN O
and CC O
instrumental JJ O
activities NNS O
of IN O
daily JJ O
living NN O
have VBP O
been VBN O
selected VBN O
, , O
and CC O
divided VBN O
into IN O
two CD O
groups NNS O
, , O
comparable JJ O
for IN O
difficulty NN O
. . O

Ten CD O
normal JJ O
elderly JJ O
subjects NNS O
( -LRB- O
age NN O
68 CD O
. . O
0 CD O
+ NN O
/ NNS O
- : O
4 CD O
. . O
8 CD O
years NNS O
; : O
MMSE NNP O
score NN O
: : O
28 CD O
. . O
7 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
9 CD O
; : O
education NN O
: : O
7 CD O
. . O
6 CD O
+ NN O
/ NN O
- : O
3 CD O
. . O
5 CD O
years NNS O
) -RRB- O
were VBD O
asked VBN O
to TO O
perform VB O
the DT O
two CD O
groups NNS O
of IN O
daily JJ O
activities NNS O
and CC O
the DT O
time NN O
required VBD O
to TO O
perform VB O
the DT O
tasks NNS O
of IN O
each DT O
group NN O
was VBD O
recorded VBN O
and CC O
used VBN O
as IN O
a DT O
reference NN O
. . O

Ten CD O
mild JJ O
and CC O
mild JJ O
- : O
moderate JJ O
AD NN O
patients NNS O
( -LRB- O
age NN O
77 CD O
. . O
2 CD O
+ NN O
/ NN O
- : O
5 CD O
. . O
3 CD O
years NNS O
; : O
MMSE NNP O
score NN O
: : O
19 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
3 CD O
. . O
5 CD O
; : O
education NN O
: : O
7 CD O
. . O
3 CD O
+ NN O
/ NNS O
- : O
4 CD O
. . O
7 CD O
years NNS O
) -RRB- O
without IN O
major JJ O
behavioural NN O
disturbances NNS O
constituted VBD O
the DT O
experimental JJ O
group NN O
. . O

Patients NNS O
were VBD O
evaluated VBN O
in IN O
all DT O
20 CD O
daily JJ O
activities NNS O
and CC O
the DT O
time NN O
employed VBN O
was VBD O
recorded VBN O
at IN O
baseline NN O
and CC O
after IN O
a DT O
3 LS O
- : O
week NN O
training NN O
( -LRB- O
1 CD O
h NN O
/ NN O
d VBD O
, , O
5 CD O
d VBD O
/ JJ O
week NN O
) -RRB- O
period NN O
. . O

Five CD O
patients NNS O
were VBD O
trained VBN O
during IN O
the DT O
3 CD O
weeks NNS O
on IN O
half NN O
of IN O
the DT O
20 CD O
daily JJ O
activities NNS O
and CC O
the DT O
other JJ O
five CD O
patients NNS O
were VBD O
trained VBN O
on IN O
the DT O
remainder NN O
. . O

This DT O
procedure NN O
was VBD O
adopted VBN O
in IN O
order NN O
to TO O
detect VB O
separately RB O
the DT O
improvement NN O
in IN O
" `` O
trained JJ O
" '' O
and CC O
" `` O
not RB O
trained JJ O
" '' O
activities NNS O
, , O
allowing VBG O
to TO O
control VB O
better RB O
the DT O
effects NNS O
of IN O
the DT O
intervention NN O
. . O

The DT O
assessment NN O
of IN O
the DT O
functional JJ O
impact NN O
of IN O
the DT O
training NN O
was VBD O
directly RB O
measured VBN O
, , O
through IN O
the DT O
variation NN O
of IN O
time NN O
employed VBN O
to TO O
perform VB O
tasks NNS O
before IN O
and CC O
after IN O
training NN O
. . O

After IN O
3 CD O
weeks NNS O
of IN O
training VBG O
a DT O
significant JJ O
improvement NN O
was VBD O
observed VBN O
for IN O
the DT O
trained JJ O
activities NNS O
, , O
from IN O
3 CD O
. . O
6 CD O
to TO O
1 CD O
. . O
9 CD O
standard NN O
deviations NNS O
below IN O
the DT O
performance NN O
of IN O
the DT O
normal JJ O
elderly JJ O
controls NNS O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

AD NN O
patients NNS O
improved VBD O
also RB O
in IN O
not RB O
- : O
trained VBN O
activities NNS O
from IN O
3 CD O
. . O
5 CD O
to TO O
2 CD O
. . O
7 CD O
standard NN O
deviations NNS O
below IN O
the DT O
controls NNS O
' POS O
performance NN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

The DT O
rehabilitation NN O
of IN O
activities NNS O
of IN O
daily JJ O
living NN O
through IN O
developing VBG O
procedural JJ O
memory NN O
strategies NNS O
may MD O
be VB O
effective JJ O
in IN O
mild JJ O
and CC O
mild JJ O
- : O
moderate JJ O
AD NN O
patients NNS O
. . O

-DOCSTART- X X O

Regulation NN O
of IN O
p53 NN O
- : O
dependent JJ O
apoptosis NN O
, , O
transcriptional JJ O
repression NN O
, , O
and CC O
cell NN O
transformation NN O
by IN O
phosphorylation NN O
of IN O
the DT O
55 CD O
- : O
kilodalton NN O
E1B JJ O
protein NN O
of IN O
human JJ O
adenovirus NN O
type NN O
5 CD O
. . O

The DT O
adenovirus NN O
type NN O
5 CD O
55 CD O
- : O
kDa NN O
E1B NN O
protein NN O
( -LRB- O
E1B FW O
- : O
55kDa CD O
) -RRB- O
cooperates VBZ O
with IN O
E1A NNP O
gene NN O
products NNS O
to TO O
induce VB O
cell NN O
transformation NN O
. . O

E1A DT O
proteins VBZ O
stimulate VB O
DNA NN O
synthesis NN O
and CC O
cell NN O
proliferation NN O
; : O
however RB O
, , O
they PRP O
also RB O
cause VBP O
rapid JJ O
cell NN O
death NN O
by IN O
p53 NN O
- : O
dependent JJ O
and CC O
p53 NN O
- : O
independent JJ O
apoptosis NN O
. . O

It PRP O
is VBZ O
believed VBN O
that IN O
the DT O
role NN O
of IN O
the DT O
E1B NNP O
- : O
55kDa JJ O
protein NN O
in IN O
transformation NN O
is VBZ O
to TO O
protect VB O
against IN O
p53 NN O
- : O
dependent JJ O
apoptosis NN O
by IN O
binding NN O
to TO O
and CC O
inactivating VBG O
p53 NN O
. . O

It PRP O
has VBZ O
been VBN O
shown VBN O
previously RB O
that IN O
the DT O
55 CD O
- : O
kDa NN O
polypeptide NN O
abrogates NNS O
p53 NN O
- : O
mediated JJ O
transactivation NN O
and CC O
that IN O
mutants NNS O
defective JJ O
in IN O
p53 NN O
binding NN O
are VBP O
unable JJ O
to TO O
cooperate VB O
with IN O
E1A NNP O
in IN O
transformation NN O
. . O

We PRP O
have VBP O
previously RB O
mapped VBN O
phosphorylation NN O
sites NNS O
near IN O
the DT O
carboxy NN O
terminus NN O
of IN O
the DT O
E1B NNP O
- : O
55kDa JJ O
protein NN O
at IN O
Ser NN O
- : O
490 CD O
and CC O
Ser NNP O
- : O
491 CD O
, , O
which WDT O
lie VBP O
within IN O
casein NN O
kinase NN O
II NNP O
consensus NN O
sequences NNS O
. . O

Conversion NN O
of IN O
these DT O
sites NNS O
to TO O
alanine VB O
residues NNS O
greatly RB O
reduced VBN O
transforming NN O
activity NN O
, , O
and CC O
although IN O
the DT O
mutant JJ O
55 CD O
- : O
kDa JJ O
protein NN O
was VBD O
found VBN O
to TO O
interact VB O
with IN O
p53 NN O
at IN O
normal JJ O
levels NNS O
, , O
it PRP O
was VBD O
somewhat RB O
defective JJ O
for IN O
suppression NN O
of IN O
p53 NN O
transactivation NN O
activity NN O
. . O

We PRP O
now RB O
report VBP O
that IN O
a DT O
nearby JJ O
residue NN O
, , O
Thr NNP O
- : O
495 CD O
, , O
also RB O
appears VBZ O
to TO O
be VB O
phosphorylated VBN O
. . O

We PRP O
demonstrate VBP O
directly RB O
that IN O
the DT O
wild JJ O
- : O
type NN O
55 CD O
- : O
kDa JJ O
protein NN O
is VBZ O
able JJ O
to TO O
block VB O
E1A DT O
- : O
induced VBN O
p53 NN O
- : O
dependent JJ O
apoptosis NN O
, , O
whereas IN O
cells NNS O
infected VBN O
by IN O
mutant JJ O
pm490 JJ O
/ NN O
1 CD O
/ NN O
5A CD O
, , O
which WDT O
contains VBZ O
alanine DT O
residues NNS O
at IN O
all DT O
three CD O
phosphorylation NN O
sites NNS O
, , O
exhibited JJ O
extensive JJ O
DNA NN O
fragmentation NN O
and CC O
classic JJ O
apoptotic JJ O
cell NN O
death NN O
. . O

The DT O
E1B NNP O
- : O
55kDa JJ O
product NN O
has VBZ O
been VBN O
shown VBN O
to TO O
exhibit VB O
intrinsic JJ O
transcriptional JJ O
repression NN O
activity NN O
when WRB O
localized VBN O
to TO O
promoters NNS O
, , O
such JJ O
as IN O
by IN O
fusion NN O
with IN O
the DT O
GAL4 NNP O
DNA NNP O
- : O
binding JJ O
domain NN O
, , O
even RB O
in IN O
the DT O
absence NN O
of IN O
p53 NN O
. . O

Such JJ O
repression NN O
activity NN O
was VBD O
totally RB O
absent JJ O
with IN O
mutant JJ O
pm490 JJ O
/ NN O
1 CD O
/ NN O
5A CD O
. . O

These DT O
data NNS O
suggested VBD O
that IN O
inhibition NN O
of IN O
p53 NN O
- : O
dependent JJ O
apoptosis NN O
may MD O
depend VB O
on IN O
the DT O
transcriptional JJ O
repression NN O
function NN O
of IN O
the DT O
55 CD O
- : O
kDa JJ O
protein NN O
, , O
which WDT O
appears VBZ O
to TO O
be VB O
regulated VBN O
be VB O
phosphorylation NN O
at IN O
the DT O
carboxy NN O
terminus NN O
. . O

-DOCSTART- X X O

Non FW O
- : O
invasive JJ O
grading NN O
of IN O
primary JJ O
brain NN O
tumours NNS O
: : O
results NNS O
of IN O
a DT O
comparative JJ O
study NN O
between IN O
SPET NNP O
with IN O
123I CD O
- : O
alpha NN O
- : O
methyl NN O
tyrosine NN O
and CC O
PET NN O
with IN O
18F CD O
- : O
deoxyglucose NN O
. . O

Use NNP O
of IN O
iodine DT O
- : O
123 CD O
- : O
alpha NN O
- : O
methyl NN O
tyrosine FW O
( -LRB- O
123I CD O
- : O
IMT NN O
) -RRB- O
allows VBZ O
investigation NN O
of IN O
the DT O
amino NN O
acid NN O
transport NN O
rate NN O
in IN O
gliomas NNP O
. . O

It PRP O
was VBD O
the DT O
aim NN O
of IN O
this DT O
study NN O
to TO O
compare VB O
the DT O
value NN O
of IN O
measurement NN O
of IN O
glucose NN O
metabolism NN O
with IN O
that DT O
of IN O
measurement NN O
of IN O
123I CD O
- : O
IMT NN O
uptake NN O
for IN O
the DT O
non JJ O
- : O
invasive JJ O
grading NN O
of IN O
brain NN O
tumours NNS O
. . O

The DT O
study NN O
population NN O
comprised VBD O
23 CD O
patients NNS O
with IN O
histopathologically PRP$ O
proven VBN O
primary JJ O
brain NN O
tumours NNS O
; : O
14 CD O
had VBD O
high JJ O
- : O
grade NN O
gliomas NNS O
, , O
and CC O
nine CD O
low JJ O
- : O
grade NN O
brain NN O
neoplasms NNS O
. . O

Glucose DT O
metabolism NN O
was VBD O
studied VBN O
using VBG O
an DT O
ECAT NNP O
EXACT NNPS O
47 CD O
positron NN O
emission NN O
tomography NN O
( -LRB- O
PET NN O
) -RRB- O
camera NN O
and CC O
fluorine VB O
- : O
18 CD O
fluorodeoxyglucose NN O
( -LRB- O
18F FW O
- : O
FDG NN O
) -RRB- O
; : O
123I CD O
- : O
IMT NN O
uptake NN O
was VBD O
measured VBN O
with IN O
the DT O
triple JJ O
- : O
headed VBN O
single JJ O
- : O
photon NN O
emission NN O
tomography NN O
( -LRB- O
SPET NNP O
) -RRB- O
camera NN O
, , O
MULTISPECT NNP O
3 CD O
. . O

18F CD O
- : O
FDG NN O
and CC O
123I CD O
- : O
IMT NN O
uptake NN O
was VBD O
quantified VBN O
as IN O
ratios NNS O
between IN O
the DT O
uptake NN O
by IN O
the DT O
tumour NN O
and CC O
contralateral JJ O
regions NNS O
of IN O
reference NN O
. . O

Glucose NNP O
metabolism NN O
and CC O
amino IN O
acid NN O
uptake NN O
of IN O
the DT O
brain NN O
tumours VBZ O
correlated JJ O
significantly RB O
( -LRB- O
r NN O
= SYM O
0 CD O
. . O
71 CD O
, , O
P NNP O
< NNP O
0 CD O
. . O
001 CD O
) -RRB- O
. . O

Assuming VBG O
discrimination NN O
thresholds NNS O
between IN O
high JJ O
- : O
grade NN O
and CC O
low JJ O
- : O
grade NN O
tumours NNS O
of IN O
0 CD O
. . O
8 CD O
for IN O
18F CD O
- : O
FDG NN O
uptake NN O
and CC O
1 CD O
. . O
8 CD O
for IN O
123I CD O
- : O
IMT NN O
uptake NN O
, , O
the DT O
accuracy NN O
values NNS O
of IN O
18F CD O
- : O
FDG NNP O
PET NNP O
and CC O
123I CD O
- : O
IMT NNP O
SPET NNP O
for IN O
differentiating VBG O
between IN O
high JJ O
- : O
grade NN O
and CC O
low JJ O
- : O
grade NN O
tumours NNS O
were VBD O
21 CD O
/ NN O
23 CD O
( -LRB- O
91 CD O
% NN O
) -RRB- O
and CC O
19 CD O
/ NN O
23 CD O
( -LRB- O
83 CD O
% NN O
) -RRB- O
, , O
respectively RB O
. . O

The DT O
difference NN O
in IN O
diagnostic JJ O
performance NN O
was VBD O
not RB O
significant JJ O
on IN O
receiver NN O
operating NN O
characteristic NN O
analysis NN O
( -LRB- O
P NNP O
> NNP O
0 CD O
. . O
4 CD O
) -RRB- O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
there EX O
is VBZ O
no DT O
major JJ O
difference NN O
between IN O
the DT O
PET NNP O
investigation NN O
of IN O
glucose NN O
metabolism NN O
and CC O
the DT O
less RBR O
expensive JJ O
SPET NNP O
measurement NN O
of IN O
amino JJ O
acid NN O
uptake NN O
in IN O
terms NNS O
of IN O
their PRP$ O
accuracy NN O
in IN O
evaluating VBG O
the DT O
malignancy NN O
grade NN O
of IN O
primary JJ O
brain NN O
tumours NNS O
. . O

This DT O
encourages VBZ O
the DT O
performance NN O
of IN O
further JJ O
studies NNS O
to TO O
analyse VB O
the DT O
potential JJ O
impact NN O
of IN O
123I CD O
- : O
IMT NNP O
SPET NNP O
on IN O
the DT O
therapeutic JJ O
management NN O
of IN O
patients NNS O
with IN O
brain NN O
tumours NNS O
. . O

-DOCSTART- X X O

Some DT O
findings NNS O
concerning VBG O
beliefs NNS O
about IN O
alcoholism NN O
. . O

The DT O
beliefs NNS O
that IN O
alcoholics NNS O
hold VBP O
about IN O
alcoholism NN O
and CC O
themselves PRP O
, , O
and CC O
the DT O
beliefs NNS O
that IN O
hospital NN O
staff NN O
and CC O
other JJ O
personnel NNS O
hold VBP O
about IN O
alcoholism NN O
, , O
were VBD O
investigated VBN O
using VBG O
methods NNS O
derived VBN O
from IN O
the DT O
repertory NN O
grid NN O
, , O
with IN O
anonymous JJ O
facial JJ O
photographs NNS O
as IN O
elements NNS O
. . O

Data NNP O
are VBP O
presented VBN O
as IN O
to TO O
the DT O
degree NN O
of IN O
association NN O
of IN O
various JJ O
characteristics NNS O
with IN O
alcoholism NN O
for IN O
the DT O
various JJ O
groups NNS O
. . O

Differences NNS O
between IN O
groups NNS O
, , O
and CC O
overall JJ O
changes NNS O
during IN O
group NN O
psychotherapy NN O
for IN O
patients NNS O
were VBD O
small JJ O
. . O

The DT O
relative JJ O
contribution NN O
of IN O
personal JJ O
and CC O
shared VBN O
aspects NNS O
of IN O
belief NN O
was VBD O
measured VBN O
. . O

It PRP O
was VBD O
found VBN O
that IN O
the DT O
agreement NN O
between IN O
groups NNS O
was VBD O
high JJ O
and CC O
closely RB O
similar JJ O
to TO O
that DT O
predictable JJ O
from IN O
consistencies NNS O
within IN O
groups NNS O
. . O

It PRP O
is VBZ O
concluded VBN O
that IN O
there EX O
may MD O
be VB O
a DT O
very RB O
general JJ O
stereotype NN O
of IN O
alcoholism NN O
, , O
consistent JJ O
with IN O
a DT O
personality NN O
disorder NN O
concept NN O
which WDT O
is VBZ O
implicitly RB O
held VBN O
even RB O
in IN O
the DT O
face NN O
of IN O
nominal JJ O
acceptance NN O
of IN O
other JJ O
concepts NNS O
. . O

The DT O
self NN O
constructs NNS O
of IN O
alcoholics NNS O
were VBD O
found VBN O
to TO O
be VB O
complex JJ O
. . O

In IN O
a DT O
small JJ O
follow VBP O
- : O
up RP O
study NN O
of IN O
patients NNS O
, , O
there EX O
was VBD O
found VBN O
to TO O
be VB O
a DT O
relationship NN O
of IN O
poor JJ O
outcome NN O
with IN O
tightness NN O
of IN O
construing VBG O
for IN O
key JJ O
constructs NNS O
after IN O
psychotherapy NN O
. . O

The DT O
implications NNS O
of IN O
the DT O
findings NNS O
are VBP O
discussed VBN O
briefly RB O
. . O

-DOCSTART- X X O

The DT O
effects NNS O
of IN O
oxidative JJ O
stress NN O
on IN O
in IN O
vivo JJ O
brain NN O
GSH NNP O
turnover NN O
in IN O
young JJ O
and CC O
mature JJ O
mice NNS O
. . O

Glutathione NN O
( -LRB- O
GSH NNP O
) -RRB- O
synthetase NN O
activities NNS O
and CC O
GSH NNP O
turnover NN O
rates NNS O
were VBD O
examined VBN O
during IN O
severe JJ O
oxidative JJ O
stress NN O
in IN O
the DT O
mouse NN O
brain NN O
as IN O
induced VBN O
by IN O
t NN O
- : O
butylhydroperoxide NN O
( -LRB- O
t NN O
- : O
BuOOH NNP O
) -RRB- O
. . O

Brain NN O
GSH NNP O
synthetase NN O
activities NNS O
in IN O
8 CD O
- : O
mo NN O
- : O
old JJ O
mice NNS O
in IN O
the DT O
cortex NN O
, , O
striatum NN O
, , O
thalamus NN O
, , O
hippocampus NN O
, , O
midbrain NN O
, , O
and CC O
cerebellum NN O
were VBD O
found VBN O
to TO O
increase VB O
following VBG O
t JJ O
- : O
BuOOH CC O
treatment NN O
. . O

The DT O
effect NN O
of IN O
GSH NNP O
synthesis NN O
on IN O
brain NN O
GSH NNP O
turnover NN O
rates NNS O
for IN O
2 CD O
- : O
and CC O
8 CD O
- : O
mo NN O
- : O
old JJ O
mice NNS O
were VBD O
determined VBN O
after IN O
intracerebroventricular JJ O
( -LRB- O
icv NN O
) -RRB- O
injection NN O
of IN O
[ NNP O
35S NNP O
] NNP O
cysteine NN O
. . O

Rate NN O
constants NNS O
for IN O
GSH NNP O
turnover NN O
were VBD O
determined VBN O
by IN O
least JJS O
- : O
squares NNS O
iterative VBP O
minimization NN O
from IN O
the DT O
specific JJ O
activity NN O
data NNS O
from IN O
20 CD O
min NN O
to TO O
108 CD O
h NN O
after IN O
[ NNP O
35S NNP O
] SYM O
cysteine JJ O
administration NN O
. . O

GSH NNP O
and CC O
glutathione NN O
disulfide NN O
( -LRB- O
GSSG NN O
) -RRB- O
specific JJ O
activities NNS O
were VBD O
determined VBN O
after IN O
separation NN O
by IN O
high JJ O
- : O
pressure NN O
liquid NN O
chromatography NN O
( -LRB- O
HPLC NNP O
) -RRB- O
. . O

The DT O
half NN O
- : O
life NN O
of IN O
GSH NNP O
in IN O
the DT O
2 LS O
- : O
mo NN O
- : O
old JJ O
mouse NN O
was VBD O
59 CD O
. . O
5 CD O
h NN O
and CC O
in IN O
the DT O
8 CD O
- : O
mo NN O
- : O
old JJ O
mouse NN O
was VBD O
79 CD O
. . O
1 CD O
h NN O
. . O

In IN O
summary NN O
, , O
defense NN O
mechanisms NNS O
against IN O
oxidative JJ O
stress NN O
in IN O
the DT O
brain NN O
differ VBP O
with IN O
age NN O
. . O

Young JJ O
mice NNS O
can MD O
increase VB O
the DT O
cellular JJ O
availability NN O
of IN O
GSH NNP O
, , O
whereas IN O
mature JJ O
mice NNS O
can MD O
increase VB O
GSH NNP O
synthetase NN O
activity NN O
during IN O
oxidative JJ O
stress NN O
. . O

These DT O
differences NNS O
make VBP O
mature JJ O
mice NNS O
more RBR O
susceptible JJ O
to TO O
brain NN O
oxidative JJ O
damage NN O
. . O

-DOCSTART- X X O

Changes NNS O
in IN O
plasminogen NN O
activator NN O
inhibitor VBZ O
- : O
1 CD O
levels NNS O
in IN O
non FW O
- : O
small JJ O
cell NN O
lung NN O
cancer NN O
. . O

Increased VBN O
urokinase NN O
plasminogen NN O
activator NN O
( -LRB- O
uPA NN O
) -RRB- O
levels NNS O
are VBP O
increased VBN O
in IN O
a DT O
number NN O
of IN O
malignancies NNS O
and CC O
have VBP O
been VBN O
correlated VBN O
with IN O
decreased VBN O
disease NN O
- : O
free JJ O
interval NN O
and CC O
decreased VBN O
overall JJ O
survival NN O
. . O

We PRP O
have VBP O
, , O
therefore RB O
, , O
examined VBD O
components NNS O
of IN O
this DT O
plasminogen NN O
activating VBG O
system NN O
in IN O
patients NNS O
with IN O
Non FW O
- : O
Small JJ O
Cell NNP O
Lung NNP O
Cancer NNP O
( -LRB- O
NSCLC NNP O
) -RRB- O
. . O

Levels NNP O
of IN O
uPA NNP O
, , O
urokinase NN O
- : O
plasminogen NN O
activator NN O
receptor NN O
( -LRB- O
uPAR NN O
) -RRB- O
and CC O
plasminogen NN O
activator NN O
inhibitor VBZ O
- : O
1 CD O
( -LRB- O
PAI NNP O
- : O
1 CD O
) -RRB- O
were VBD O
measured VBN O
semiquantitatively RB O
in IN O
paraffin NN O
sections NNS O
of IN O
tumours NNS O
from IN O
147 CD O
patients NNS O
with IN O
NSCLC NNP O
. . O

Immunohistochemically RB O
stained JJ O
sections NNS O
of IN O
tumour JJ O
were VBD O
allocated VBN O
a DT O
score NN O
for IN O
stain JJ O
intensity NN O
and CC O
results NNS O
correlated VBD O
to TO O
: : O
survival NN O
; : O
tumour NN O
stage NN O
( -LRB- O
T NNP O
) -RRB- O
; : O
nodal JJ O
stage NN O
( -LRB- O
N NN O
) -RRB- O
; : O
stage NN O
grouping NN O
( -LRB- O
I PRP O
to TO O
IIIb NNP O
) -RRB- O
, , O
survival NN O
status NN O
and CC O
sex NN O
. . O

Increased VBN O
levels NNS O
of IN O
PAI NNP O
- : O
1 CD O
were VBD O
associated VBN O
with IN O
a DT O
decreased VBN O
survival NN O
in IN O
squamous JJ O
cell NN O
carcinoma NN O
( -LRB- O
SCC NNP O
) -RRB- O
X2 NNP O
= SYM O
5 CD O
. . O
72 CD O
, , O
p NN O
= SYM O
0 CD O
. . O
017 CD O
( -LRB- O
n NN O
= SYM O
74 CD O
) -RRB- O
. . O

There EX O
was VBD O
a DT O
significant JJ O
positive JJ O
relationship NN O
between IN O
PAI NNP O
- : O
1 CD O
levels NNS O
and CC O
N NNP O
- : O
stage NN O
( -LRB- O
p NN O
= SYM O
< FW O
0 CD O
. . O
05 CD O
) -RRB- O
, , O
presence NN O
of IN O
nodal JJ O
metastases NNS O
( -LRB- O
p NN O
= SYM O
< FW O
0 CD O
. . O
05 CD O
) -RRB- O
, , O
stage NN O
grouping NN O
( -LRB- O
p NN O
= SYM O
< FW O
0 CD O
. . O
01 CD O
) -RRB- O
and CC O
extent NN O
of IN O
disease NN O
( -LRB- O
p NN O
= SYM O
< FW O
0 CD O
. . O
05 CD O
) -RRB- O
in IN O
the DT O
total JJ O
group NN O
and CC O
the DT O
SCC NNP O
subgroup NN O
, , O
but CC O
not RB O
adenocarcinoma NN O
. . O

There EX O
was VBD O
a DT O
significant JJ O
positive JJ O
relationship NN O
between IN O
PAI NNP O
- : O
1 CD O
levels NNS O
and CC O
T NNP O
- : O
stage NN O
( -LRB- O
p NN O
= SYM O
< FW O
0 CD O
. . O
05 CD O
) -RRB- O
in IN O
the DT O
total JJ O
group NN O
, , O
and CC O
survival NN O
status NN O
( -LRB- O
p NN O
= SYM O
< FW O
0 CD O
. . O
05 CD O
) -RRB- O
in IN O
the DT O
SCC NNP O
subgroup NN O
alone RB O
. . O

uPA NN O
and CC O
uPAR NN O
levels NNS O
were VBD O
not RB O
significantly RB O
associated VBN O
with IN O
tumour NN O
staging NN O
or CC O
survival NN O
. . O

We PRP O
conclude VBP O
that IN O
increased VBN O
PAI NNS O
- : O
1 CD O
antigen NN O
levels NNS O
may MD O
be VB O
associated VBN O
with IN O
a DT O
decreased VBN O
survival NN O
in IN O
patients NNS O
with IN O
SCC NNP O
. . O

-DOCSTART- X X O

Insulin NNP O
- : O
like IN O
growth NN O
factor NN O
I PRP O
induces VBZ O
tumor NN O
hexokinase NN O
RNA NNP O
expression NN O
in IN O
cancer NN O
cells NNS O
. . O

Increased VBN O
glycolysis NN O
is VBZ O
a DT O
characteristic JJ O
of IN O
cancer NN O
cells NNS O
. . O

Though IN O
less RBR O
efficient JJ O
in IN O
energy NN O
production NN O
, , O
it PRP O
ensures VBZ O
continuous JJ O
supply NN O
of IN O
energy NN O
and CC O
phosphometabolites NNS O
for IN O
biosynthesis NN O
enabling VBG O
metastatic JJ O
and CC O
less RBR O
vascularized JJ O
cancer NN O
cells NNS O
to TO O
proliferate VB O
even RB O
under IN O
hypoxic JJ O
conditions NNS O
. . O

Since IN O
hexokinase NN O
is VBZ O
the DT O
first JJ O
rate NN O
limiting VBG O
enzyme NN O
in IN O
the DT O
glycolytic JJ O
pathway NN O
, , O
elevated VBD O
levels NNS O
of IN O
Type NNP O
II NNP O
like IN O
hexokinase NN O
in IN O
tumors NNS O
are VBP O
of IN O
great JJ O
significance NN O
in IN O
this DT O
context NN O
. . O

Under IN O
normal JJ O
conditions NNS O
insulin NN O
regulates VBZ O
expression NN O
of IN O
hexokinase JJ O
Type NNP O
II NNP O
isoenzyme NN O
, , O
which WDT O
is VBZ O
predominantly RB O
expressed VBN O
in IN O
muscle NN O
. . O

On IN O
the DT O
other JJ O
hand NN O
cancer NN O
cells NNS O
overexpress IN O
insulin NN O
- : O
like IN O
growth NN O
factors NNS O
and CC O
their PRP$ O
receptors NNS O
which WDT O
mimic VBP O
many JJ O
activities NNS O
of IN O
insulin NN O
. . O

This DT O
prompted VBD O
us PRP O
to TO O
examine VB O
a DT O
hypothesis NN O
that IN O
insulin NN O
- : O
like IN O
growth NN O
factors NNS O
may MD O
be VB O
responsible JJ O
for IN O
overexpression NN O
of IN O
tumor NN O
hexokinase NN O
. . O

Our PRP$ O
experiments NNS O
demonstrate VBP O
that IN O
insulin NN O
- : O
like IN O
growth NN O
factor NN O
I PRP O
indeed RB O
induces VBZ O
hexokinase NN O
gene NN O
expression NN O
in IN O
a DT O
concentration NN O
and CC O
time NN O
dependent JJ O
manner NN O
in IN O
two CD O
cancer NN O
cell NN O
lines NNS O
we PRP O
studied VBD O
. . O

-DOCSTART- X X O

The DT O
Wilms NNP O
tumor NN O
suppressor NN O
gene NN O
WT1 JJ O
induces NNS O
G1 IN O
arrest NN O
and CC O
apoptosis NN O
in IN O
myeloblastic JJ O
leukemia NN O
M1 IN B-NP
cells NNS O
. . O

WT1 PRP O
was VBD O
isolated VBN O
as IN O
a DT O
tumor NN O
suppressor NN O
gene NN O
of IN O
Wilms NNP O
tumor NN O
. . O

However RB O
, , O
high JJ O
expression NN O
of IN O
WT1 NNP O
correlates NNS O
with IN O
poor JJ O
prognosis NN O
in IN O
acute JJ O
leukemia NN O
. . O

In IN O
addition NN O
suppression NN O
of IN O
WT1 JJ O
expression NN O
by IN O
WT1 NNP O
anti NNS O
- : O
sense NN O
oligonucleotide JJ O
inhibits VBZ O
proliferation NN O
of IN O
leukemia NN O
cells NNS O
, , O
suggesting VBG O
that IN O
WT1 PRP O
is VBZ O
important JJ O
for IN O
their PRP$ O
proliferation NN O
. . O

To TO O
further RBR O
elucidate VB O
the DT O
biological JJ O
significance NN O
of IN O
WT1 NNP O
in IN O
leukemic JJ O
cell NN O
growth NN O
, , O
we PRP O
overexpressed VBD O
exogenous JJ O
WT1 NNP O
in IN O
murine NN O
M1 IN B-NP
myeloblastic JJ O
leukemia NN O
cells NNS O
using VBG O
the DT O
isopropyl NN O
- : O
beta NN O
- : O
D LS O
- : O
thiogalactoside NN O
( -LRB- O
IPTG NN O
) -RRB- O
- : O
controlled JJ O
expression NN O
system NN O
. . O

We PRP O
found VBD O
that IN O
induction NN O
of IN O
one CD O
splicing NN O
variant NN O
of IN O
WT1 NNP O
[ NNP O
WT1 NNP O
- : O
17AA FW O
( -LRB- O
+ NN O
) -RRB- O
- : O
KTS NNS O
( -LRB- O
- : O
) -RRB- O
] SYM O
in IN O
M1 NNP B-NP
cells NNS O
induces VBZ O
cell NN O
cycle NN O
arrest NN O
and CC O
apoptotic JJ O
cell NN O
death NN O
. . O

These DT O
results NNS O
suggest VBP O
that IN O
the DT O
role NN O
of IN O
WT1 NNP O
is VBZ O
different JJ O
depending VBG O
on IN O
the DT O
type NN O
of IN O
leukemia NN O
cell NN O
in IN O
which WDT O
it PRP O
is VBZ O
expressed VBN O
. . O

-DOCSTART- X X O

[ JJ O
Expression NNP O
of IN O
metastasis NN O
suppressor NN O
gene NN O
nm23 NNS O
in IN O
human JJ O
hepatocellular NN O
carcinoma NN O
] NN O
. . O

For IN O
the DT O
purpose NN O
of IN O
investigating VBG O
the DT O
relationship NN O
between IN O
the DT O
metastatic JJ O
potential NN O
of IN O
the DT O
tumor NN O
as RB O
well RB O
as IN O
the DT O
expression NN O
of IN O
nm23 CD O
- : O
H1 CD O
mRNA NN O
, , O
and CC O
for IN O
determing VBG O
the DT O
location NN O
of IN O
the DT O
positive JJ O
sites NNS O
in IN O
the DT O
cells NNS O
, , O
tumor NN O
metastasis NN O
suppressor NN O
gene NN O
nm23 CD O
- : O
H1 NN O
in IN O
human JJ O
hepatocellular NN O
carcinoma NN O
( -LRB- O
and CC O
the DT O
nonneoplastic JJ O
area NN O
surrounding VBG O
the DT O
tumor NN O
) -RRB- O
was VBD O
detected VBN O
by IN O
in IN O
situ FW O
hybridization NN O
using VBG O
digoxiginin FW O
- : O
labeled VBN O
nm23 CD O
- : O
H1 CD O
antisense NN O
complementary NN O
RNA NNP O
probe NN O
. . O

The DT O
primary JJ O
results NNS O
indicated VBD O
( -LRB- O
i NN O
) -RRB- O
positive JJ O
results NNS O
of IN O
in IN O
situ FW O
hybridization NN O
are VBP O
presence NN O
of IN O
granules NNS O
or CC O
masses NNS O
in IN O
the DT O
cytoplasm NN O
; : O
( -LRB- O
ii NNS O
) -RRB- O
the DT O
less JJR O
expression NN O
of IN O
nm23 CD O
- : O
H1 CD O
mRNA NN O
, , O
the DT O
higher JJR O
metastatic JJ O
rate NN O
of IN O
the DT O
human JJ O
hepatocellular NN O
carcinoma NN O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
; : O
( -LRB- O
iii NN O
) -RRB- O
expression NN O
of IN O
nm23 CD O
- : O
H1 CD O
mRNA NN O
dose NN O
not RB O
correlate JJ O
with IN O
some DT O
other JJ O
factors NNS O
such JJ O
as IN O
tumor NN O
size NN O
and CC O
the DT O
background NN O
of IN O
other JJ O
liver NN O
diseases NNS O
. . O

-DOCSTART- X X O

Monitoring VBG O
the DT O
efficiency NN O
of IN O
interferon NN O
- : O
alpha NN O
therapy NN O
in IN O
chronic NN O
myelogenous JJ O
leukemia NN O
( -LRB- O
CML NNP O
) -RRB- O
patients NNS O
by IN O
competitive JJ O
polymerase NN O
chain NN O
reaction NN O
. . O

Interferon NNP O
alpha NN O
( -LRB- O
IFN NNP O
- : O
alpha NN O
) -RRB- O
induces VBZ O
cytogenetic JJ O
responses NNS O
of IN O
variable JJ O
degree NN O
in IN O
patients NNS O
with IN O
CML NNP O
. . O

We PRP O
sought VBD O
to TO O
establish VB O
the DT O
relationship NN O
between IN O
BCR NNP O
- : O
ABL NNP O
transcript NN O
numbers NNS O
measured VBN O
by IN O
competitive JJ O
two CD O
- : O
step NN O
reverse NN O
transcription NN O
polymerase NN O
chain NN O
reaction NN O
( -LRB- O
RT NNP O
- : O
PCR NN O
) -RRB- O
and CC O
cytogenetic JJ O
status NN O
in IN O
CML NNP O
patients NNS O
treated VBD O
with IN O
IFN NNP O
- : O
alpha NN O
. . O

All DT O
398 CD O
samples NNS O
from IN O
163 CD O
patients NNS O
investigated VBN O
by IN O
RT NNP O
- : O
PCR NN O
were VBD O
positive JJ O
for IN O
BCR NNP O
- : O
ABL JJ O
transcripts NNS O
. . O

In IN O
order NN O
to TO O
standardize VB O
results NNS O
for IN O
variability NN O
in IN O
RNA NNP O
and CC O
cDNA DT O
quality NN O
, , O
we PRP O
quantified VBD O
total JJ O
ABL NNP O
transcripts NNS O
in IN O
each DT O
sample NN O
as IN O
internal JJ O
control NN O
. . O

The DT O
BCR NNP O
- : O
ABL JJ O
/ JJ O
ABL JJ O
ratios NNS O
correlated VBN O
with IN O
the DT O
cytogenetic JJ O
results NNS O
. . O

Quantitative JJ O
nested VBN O
PCR NN O
allowed VBD O
the DT O
detection NN O
of IN O
residual JJ O
BCR NNP O
- : O
ABL JJ O
transcripts NNS O
in IN O
all DT O
complete JJ O
cytogenetic JJ O
responders NNS O
on IN O
IFN NNP O
- : O
alpha NN O
. . O

We PRP O
conclude VBP O
that IN O
competitive JJ O
PCR NN O
with IN O
internal JJ O
controls NNS O
is VBZ O
a DT O
reliable JJ O
method NN O
for IN O
monitoring VBG O
patients NNS O
on IN O
IFN NNP O
- : O
alpha NN O
and CC O
reduces VBZ O
the DT O
need NN O
for IN O
repeated VBN O
marrow NN O
investigations NNS O
. . O

-DOCSTART- X X O

Suppression NN O
of IN O
tumor NN O
growth NN O
by IN O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
of IN O
mel NN O
- : O
18 CD O
in IN O
3Y1 CD B-NP
cells NNS O
transformed VBN O
by IN O
the DT O
E6 NNP O
and CC O
E7 DT O
genes NNS O
of IN O
human JJ O
papillomavirus NN O
type NN O
18 CD O
. . O

By IN O
introducing VBG O
a DT O
cDNA NN O
library NN O
derived VBD O
from IN O
rat NN O
embryonic JJ O
fibroblast JJ O
cells NNS O
, , O
we PRP O
isolated VBD O
several JJ O
morphologically RB O
flat JJ O
revertants NNS O
of IN O
rat NN O
3Y1 IN B-NP
cells NNS O
transformed VBN O
by IN O
the DT O
E6 NNP O
and CC O
E7 DT O
genes NNS O
of IN O
human JJ O
papillomavirus NN O
type NN O
18 CD O
( -LRB- O
HPV18 IN O
) -RRB- O
. . O

From IN O
one CD O
of IN O
the DT O
revertants NNS O
, , O
we PRP O
recovered VBD O
a DT O
0 CD O
. . O
2 LS O
- : O
kb NN O
cDNA NN O
, , O
N56 NNP O
, , O
that WDT O
suppresses VBZ O
the DT O
tumor NN O
growth NN O
of IN O
the DT O
transformed VBN O
3Y1 IN B-NP
cells NNS O
irrespective JJ O
of IN O
the DT O
expression NN O
of IN O
the DT O
E6 NNP O
and CC O
E7 NNP O
genes NNS O
. . O

The DT O
nucleotide JJ O
sequence NN O
of IN O
the DT O
cDNA NN O
was VBD O
shown VBN O
to TO O
be VB O
identical JJ O
to TO O
that DT O
of IN O
the DT O
3 CD O
' POS O
untranslated JJ O
region NN O
of IN O
a DT O
putative JJ O
mammalian JJ O
polycomb NN O
group NN O
gene NN O
, , O
mel VB O
- : O
18 CD O
. . O

-DOCSTART- X X O

[ JJ O
Treatment NNP O
of IN O
acute JJ O
liver NN O
failure NN O
in IN O
children NNS O
] NNS O
. . O

Among IN O
the DT O
main JJ O
causes NNS O
of IN O
acute JJ O
liver NN O
failure NN O
( -LRB- O
ALF NN O
) -RRB- O
in IN O
children NNS O
, , O
metabolic JJ O
diseases NNS O
( -LRB- O
especially RB O
in IN O
infants NNS O
) -RRB- O
, , O
viral JJ O
and CC O
toxin NN O
or CC O
drug NN O
induced VBN O
hepatitis NN O
are VBP O
the DT O
most RBS O
frequent JJ O
. . O

The DT O
cause NN O
remains VBZ O
, , O
however RB O
, , O
undetermined VBD O
in IN O
about IN O
30 CD O
% NN O
of IN O
the DT O
cases NNS O
. . O

Management NN O
must MD O
be VB O
conducted VBN O
in IN O
a DT O
pediatric JJ O
hepatology NN O
unit NN O
or CC O
intensive JJ O
care NN O
unit NN O
in IN O
relation NN O
with IN O
a DT O
pediatric JJ O
transplant NN O
team NN O
in IN O
order NN O
: : O
1 CD O
) -RRB- O
to TO O
perform VB O
urgent JJ O
etiological JJ O
diagnosis NN O
; : O
2 CD O
) -RRB- O
to TO O
initiate VB O
specific JJ O
therapy NN O
and CC O
symptomatic JJ O
treatment NN O
; : O
3 CD O
) -RRB- O
to TO O
evaluate VB O
the DT O
severity NN O
and CC O
prognosis NN O
of IN O
liver NN O
disease NN O
for IN O
selection NN O
of IN O
children NNS O
for IN O
emergency NN O
liver NN O
transplantation NN O
; : O
4 CD O
) -RRB- O
to TO O
evaluate VB O
contraindications NNS O
to TO O
liver NN O
transplantation NN O
. . O

The DT O
overall JJ O
survival NN O
of IN O
post NN O
- : O
emergency NN O
liver NN O
transplantation NN O
for IN O
ALF NNP O
in IN O
children NNS O
averages NNS O
65 CD O
% NN O
. . O

-DOCSTART- X X O

Blind JJ O
separation NN O
of IN O
auditory JJ O
event NN O
- : O
related VBN O
brain NN O
responses NNS O
into IN O
independent JJ O
components NNS O
. . O

Averaged JJ O
event NN O
- : O
related JJ O
potential NN O
( -LRB- O
ERP NNP O
) -RRB- O
data NNS O
recorded VBN O
from IN O
the DT O
human JJ O
scalp NN O
reveal VBP O
electroencephalographic JJ O
( -LRB- O
EEG NN O
) -RRB- O
activity NN O
that WDT O
is VBZ O
reliably RB O
time NN O
- : O
locked VBN O
and CC O
phase NN O
- : O
locked VBN O
to TO O
experimental JJ O
events NNS O
. . O

We PRP O
report VBP O
here RB O
the DT O
application NN O
of IN O
a DT O
method NN O
based VBN O
on IN O
information NN O
theory NN O
that WDT O
decomposes VBZ O
one CD O
or CC O
more JJR O
ERPs NNS O
recorded VBN O
at IN O
multiple JJ O
scalp NN O
sensors NNS O
into IN O
a DT O
sum NN O
of IN O
components NNS O
with IN O
fixed JJ O
scalp NN O
distributions NNS O
and CC O
sparsely RB O
activated VBN O
, , O
maximally RB O
independent JJ O
time NN O
courses NNS O
. . O

Independent JJ O
component NN O
analysis NN O
( -LRB- O
ICA NNP O
) -RRB- O
decomposes VBZ O
ERP JJ O
data NNS O
into IN O
a DT O
number NN O
of IN O
components NNS O
equal JJ O
to TO O
the DT O
number NN O
of IN O
sensors NNS O
. . O

The DT O
derived VBN O
components NNS O
have VBP O
distinct JJ O
but CC O
not RB O
necessarily RB O
orthogonal JJ O
scalp NN O
projections NNS O
. . O

Unlike IN O
dipole NN O
- : O
fitting JJ O
methods NNS O
, , O
the DT O
algorithm NN O
does VBZ O
not RB O
model VB O
the DT O
locations NNS O
of IN O
their PRP$ O
generators NNS O
in IN O
the DT O
head NN O
. . O

Unlike IN O
methods NNS O
that WDT O
remove VBP O
second JJ O
- : O
order NN O
correlations NNS O
, , O
such JJ O
as IN O
principal JJ O
component NN O
analysis NN O
( -LRB- O
PCA NNP O
) -RRB- O
, , O
ICA NNP O
also RB O
minimizes VBZ O
higher JJR O
- : O
order NN O
dependencies NNS O
. . O

Applied NNP O
to TO O
detected VBN O
- : O
and CC O
undetected JJ O
- : O
target NN O
ERPs NNS O
from IN O
an DT O
auditory JJ O
vigilance NN O
experiment NN O
, , O
the DT O
algorithm NN O
derived VBD O
ten CD O
components NNS O
that WDT O
decomposed VBD O
each DT O
of IN O
the DT O
major JJ O
response NN O
peaks NNS O
into IN O
one CD O
or CC O
more JJR O
ICA IN O
components NNS O
with IN O
relatively RB O
simple JJ O
scalp NN O
distributions NNS O
. . O

Three CD O
of IN O
these DT O
components NNS O
were VBD O
active JJ O
only RB O
when WRB O
the DT O
subject NN O
detected VBD O
the DT O
targets NNS O
, , O
three CD O
other JJ O
components NNS O
only RB O
when WRB O
the DT O
target NN O
went VBD O
undetected VBN O
, , O
and CC O
one CD O
in IN O
both DT O
cases NNS O
. . O

Three CD O
additional JJ O
components NNS O
accounted VBD O
for IN O
the DT O
steady JJ O
- : O
state NN O
brain NN O
response NN O
to TO O
a DT O
39 CD O
- : O
Hz NN O
background NN O
click NN O
train NN O
. . O

Major JJ O
features NNS O
of IN O
the DT O
decomposition NN O
proved VBD O
robust JJ O
across IN O
sessions NNS O
and CC O
changes NNS O
in IN O
sensor NN O
number NN O
and CC O
placement NN O
. . O

This DT O
method NN O
of IN O
ERP JJ O
analysis NN O
can MD O
be VB O
used VBN O
to TO O
compare VB O
responses NNS O
from IN O
multiple JJ O
stimuli NNS O
, , O
task NN O
conditions NNS O
, , O
and CC O
subject JJ O
states NNS O
. . O

-DOCSTART- X X O

CD56 DT O
+ NN O
putative JJ O
natural JJ O
killer NN O
cell NN O
lymphomas VBZ O
: : O
production NN O
of IN O
cytolytic JJ O
effectors NNS O
and CC O
related JJ O
proteins NNS O
mediating VBG O
tumor NN O
cell NN O
apoptosis NN O
? . O

Apoptosis NNP O
is VBZ O
a DT O
regulated JJ O
form NN O
of IN O
cell NN O
death NN O
that WDT O
may MD O
be VB O
triggered VBN O
by IN O
natural JJ O
killer NN O
( -LRB- O
NK NNP O
) -RRB- O
or CC O
cytotoxic JJ O
T NNP O
cells NNS O
, , O
which WDT O
effect NN O
target NN O
cell NN O
lysis NN O
by IN O
cytolytic JJ O
effector NN O
and CC O
related JJ O
proteins NNS O
through IN O
complex JJ O
intracellular JJ O
signals NNS O
. . O

This DT O
study NN O
was VBD O
aimed VBN O
to TO O
investigate VB O
whether IN O
there EX O
is VBZ O
selective JJ O
expression NN O
of IN O
these DT O
cytolytic JJ O
markers NNS O
in IN O
the DT O
putative JJ O
NK NNP O
- : O
cell NN O
lymphomas NNS O
and CC O
whether IN O
there EX O
is VBZ O
correlation NN O
with IN O
zonal JJ O
tumor NN O
cell NN O
death NN O
in IN O
these DT O
tumors NNS O
. . O

Expression NN O
of IN O
the DT O
cytolytic JJ O
effectors NNS O
perforin RB O
, , O
granzyme JJ O
B9 NNP O
, , O
and CC O
the DT O
granule NN O
membrane NN O
protein NN O
TIA1 NN O
were VBD O
examined VBN O
in IN O
24 CD O
putative NN O
NK NNP O
- : O
cell NN O
lymphomas NNS O
, , O
18 CD O
postthymic JJ O
T NNP O
- : O
cell NN O
lymphomas NNS O
( -LRB- O
one CD O
case NN O
CD8 IN O
+ NNP O
CD56 NNP O
+ NNP O
and CC O
three CD O
anaplastic JJ O
large JJ O
cell NN O
lymphomas NNS O
( -LRB- O
ALCL NNP O
) -RRB- O
, , O
three CD O
T NNP O
- : O
lymphoblastic JJ O
lymphomas NNS O
, , O
and CC O
20 CD O
B NNP O
- : O
cell NN O
lymphomas NNS O
. . O

Nineteen CD O
( -LRB- O
79 CD O
% NN O
) -RRB- O
putative JJ O
NK NNP O
- : O
cell NN O
lymphomas NNS O
expressed VBD O
perforin NN O
, , O
and CC O
all DT O
24 CD O
cases NNS O
expressed VBN O
granzyme NN O
B9 . O
and CC O
TIA1 NNP O
. . O

The DT O
only JJ O
CD8 NNS O
+ IN O
CD56 NNP O
+ , O
postthymic JJ O
T NNP O
- : O
cell NN O
lymphoma NN O
also RB O
expressed VBD O
all DT O
three CD O
cytolytic JJ O
markers NNS O
, , O
two CD O
CD8 NNS O
- : O
ALCL NNP O
expressed VBD O
TIA1 NNP O
; : O
other JJ O
postthymic JJ O
T NNP O
- : O
cell NN O
, , O
T NNP O
- : O
lymphoblastic JJ O
, , O
and CC O
B NNP O
- : O
cell NN O
lymphomas NNS O
were VBD O
consistently RB O
negative JJ O
. . O

There EX O
was VBD O
strong JJ O
correlation NN O
between IN O
percentage NN O
perforin NN O
- : O
positive JJ O
cells NNS O
and CC O
zonal JJ O
tumor NN O
cell NN O
death NN O
. . O

Angioinvasion NNP O
, , O
in IN O
contrast NN O
, , O
was VBD O
present JJ O
only RB O
in IN O
a DT O
proportion NN O
( -LRB- O
37 CD O
% NN O
) -RRB- O
of IN O
these DT O
lymphomas NNS O
despite IN O
the DT O
frequent JJ O
presence NN O
of IN O
zonal JJ O
tumor NN O
cell NN O
death NN O
( -LRB- O
71 CD O
% NN O
) -RRB- O
. . O

We PRP O
propose VBP O
that IN O
cytolytic JJ O
effector NN O
and CC O
related JJ O
proteins NNS O
produced VBN O
by IN O
putative JJ O
NK NNP O
and CC O
some DT O
CD8 NNS O
+ VBP O
CD56 IN O
+ JJ O
postthymic JJ O
T NNP O
- : O
cell NN O
lymphomas NNS O
, , O
probably RB O
in IN O
conjunction NN O
with IN O
other JJ O
mechanisms NNS O
, , O
may MD O
effect VB O
massive JJ O
tumor NN O
cell NN O
apoptosis NN O
. . O

The DT O
frequent JJ O
expression NN O
of IN O
cytolytic JJ O
effector NN O
markers NNS O
in IN O
the DT O
CD2 NNP O
+ NNP O
surface NN O
CD3 IN O
- : O
CD56 `` O
+ VBN O
putative JJ O
NK NNP O
- : O
cell NN O
lymphomas NNS O
lends VBZ O
further JJ O
support NN O
to TO O
their PRP$ O
probable JJ O
NK NNP O
cell NN O
origin NN O
. . O

-DOCSTART- X X O

Calretinin NNP O
. . O

A DT O
selective JJ O
marker NN O
of IN O
normal JJ O
and CC O
neoplastic JJ O
mesothelial NN O
cells NNS O
in IN O
serous JJ O
effusions NNS O
. . O

OBJECTIVE CD O
: : O
To TO O
document VB O
that IN O
a DT O
polyclonal JJ O
antiserum NN O
to TO O
calretinin VB O
, , O
a DT O
29 CD O
- : O
kd NN O
calcium NN O
- : O
binding JJ O
protein NN O
, , O
consistently RB O
decorates VBZ O
normal JJ O
and CC O
tumor NN O
mesothelial NN O
cells NNS O
in IN O
cytologic JJ O
preparations NNS O
. . O

STUDY NNP O
DESIGN NNP O
: : O
Thirty CD O
- : O
three CD O
archival NN O
cytologic NN O
specimens NNS O
from IN O
eight CD O
patients NNS O
with IN O
histologically RB O
confirmed VBN O
malignant JJ O
mesothelioma NN O
and CC O
13 CD O
from IN O
patients NNS O
with IN O
metastatic JJ O
serous JJ O
effusions NNS O
were VBD O
destained VBN O
and CC O
then RB O
immunostained VBD O
with IN O
anticalretinin JJ O
antiserum NN O
. . O

For IN O
investigation NN O
of IN O
cell NN O
suspensions NNS O
, , O
four CD O
pleural JJ O
fluids NNS O
were VBD O
incubated VBN O
with IN O
anticalretinin JJ O
antiserum NN O
. . O

After IN O
cytocentrifugation NN O
the DT O
specimens NNS O
were VBD O
stained VBN O
in IN O
accordance NN O
with IN O
the DT O
alkaline NN O
phosphatase NN O
anti NNS O
- : O
alkaline NN O
phosphatase NN O
( -LRB- O
APAAP NNP O
) -RRB- O
method NN O
. . O

For IN O
electron NN O
microscopic NN O
examination NN O
the DT O
cell NN O
suspensions NNS O
were VBD O
then RB O
incubated VBN O
with IN O
gold JJ O
- : O
labeled VBD O
antirabbit JJ O
antibody NN O
. . O

RESULTS NNS O
: : O
The DT O
diagnostic JJ O
sensitivity NN O
of IN O
this DT O
new JJ O
immunocytochemical JJ O
approach NN O
reached VBD O
100 CD O
% NN O
for IN O
the DT O
eight CD O
malignant JJ O
mesotheliomas NNS O
investigated VBN O
. . O

Only RB O
3 CD O
of IN O
the DT O
13 CD O
adenocarcinomas NNS O
metastatic JJ O
to TO O
the DT O
serous JJ O
membranes NNS O
included VBD O
in IN O
this DT O
study NN O
were VBD O
weakly RB O
reactive VB O
, , O
accounting VBG O
for IN O
81 CD O
% NN O
specificity NN O
. . O

Binding NNP O
of IN O
anticalretinin DT O
antiserum NN O
to TO O
living VBG O
mesothelial JJ O
cells NNS O
was VBD O
consistently RB O
documented VBN O
in IN O
all DT O
four CD O
cases NNS O
investigated VBN O
. . O

CONCLUSION NN O
: : O
Calretinin NNP O
is VBZ O
a DT O
very RB O
useful JJ O
marker NN O
for IN O
positive JJ O
identification NN O
of IN O
normal JJ O
and CC O
tumor NN O
mesothelial NN O
cells NNS O
in IN O
serous JJ O
effusions NNS O
. . O

-DOCSTART- X X O

[ VB O
Extra NNP O
- : O
anatomic JJ O
bypass NN O
from IN O
the DT O
ascending VBG O
aorta NN O
to TO O
the DT O
supraceliac JJ O
abdominal NN O
aorta NN O
- : O
- : O
surgical JJ O
option NN O
applied VBD O
to TO O
reoperation VB O
for IN O
aortic JJ O
coarctation NN O
or CC O
interruption NN O
] NN O
. . O

The DT O
optimal JJ O
approach NN O
for IN O
reoperation NN O
following VBG O
repair NN O
of IN O
aortic JJ O
coarctation NN O
( -LRB- O
CoA NNP O
) -RRB- O
or CC O
interruption NN O
( -LRB- O
IAA NNP O
) -RRB- O
remains VBZ O
controversial JJ O
. . O

Four CD O
patients NNS O
underwent JJ O
extra JJ O
- : O
anatomic JJ O
bypass NN O
for IN O
restenosis NN O
after IN O
repair NN O
of IN O
CoA NNP O
or CC O
IAA NNP O
. . O

The DT O
age NN O
ranged VBD O
from IN O
4 CD O
to TO O
12 CD O
years NNS O
. . O

The DT O
initial JJ O
repairs NNS O
for IN O
two CD O
CoA NNP O
, , O
one CD O
type NN O
A DT O
- : O
IAA NNP O
, , O
and CC O
one CD O
type NN O
B NNP O
- : O
IAA NNP O
consisted VBD O
of IN O
two CD O
grafting NN O
, , O
one CD O
subclavian NN O
arterial NN O
turning VBG O
- : O
down RP O
aortoplasty NN O
, , O
and CC O
one CD O
subclavian NN O
flap NN O
aortoplasty NN O
. . O

All DT O
of IN O
them PRP O
underwent JJ O
during IN O
infancy NN O
. . O

Preoperative JJ O
right JJ O
arm NN O
systolic JJ O
pressure NN O
ranged VBD O
from IN O
140 CD O
to TO O
190 CD O
mmHg NN O
ar NN O
rest NN O
. . O

Through IN O
a DT O
midline NN O
sternotomy NN O
and CC O
an DT O
upper JJ O
laparotmy NN O
incision NN O
, , O
an DT O
extra JJ O
- : O
anatomic JJ O
bypass NN O
from IN O
the DT O
ascending VBG O
aorta NN O
to TO O
the DT O
supraceliac NN O
abdominal NN O
aorta NN O
was VBD O
employed VBN O
using VBG O
a DT O
12 CD O
to TO O
18 CD O
mm CD O
tube NN O
graft NN O
. . O

All DT O
patients NNS O
survived VBD O
surgeries NNS O
, , O
and CC O
their PRP$ O
hypertension NN O
markedly RB O
improved VBD O
. . O

Our PRP$ O
experience NN O
confirms VBZ O
safety NN O
and CC O
effectiveness NN O
of IN O
this DT O
option NN O
in IN O
selected JJ O
young JJ O
patients NNS O
with IN O
re NNP O
- : O
stenosis NN O
of IN O
following VBG O
repair NN O
of IN O
CoA NNP O
or CC O
IAA NNP O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
a DT O
mutation NN O
in IN O
the DT O
anticodon NN O
of IN O
human JJ O
mitochondrial NN O
tRNAPro NN O
on IN O
its PRP$ O
post NN O
- : O
transcriptional JJ O
modification NN O
pattern NN O
. . O

Although IN O
the DT O
gene NN O
sequences NNS O
of IN O
all DT O
22 CD O
tRNAs NNS O
encoded VBN O
in IN O
the DT O
human JJ O
mitochondrial NN O
genome NN O
are VBP O
known VBN O
, , O
little JJ O
information NN O
exists VBZ O
about IN O
their PRP$ O
sequences NNS O
at IN O
the DT O
RNA NNP O
level NN O
. . O

This DT O
becomes VBZ O
a DT O
crucial JJ O
limitation NN O
when WRB O
searching VBG O
for IN O
a DT O
molecular JJ O
understanding NN O
of IN O
the DT O
growing VBG O
number NN O
of IN O
maternally RB O
inherited VBN O
human JJ O
diseases NNS O
correlated VBN O
with IN O
point NN O
mutations NNS O
in IN O
tRNA DT O
genes NNS O
. . O

Here RB O
we PRP O
describe VBP O
the DT O
sequence NN O
of IN O
human JJ O
mt NN O
- : O
tRNAPropurified VBN O
from IN O
placenta NN O
. . O

It PRP O
shows VBZ O
absence NN O
of IN O
editing VBG O
events NNS O
in IN O
this DT O
tRNA NN O
and CC O
highlights NNS O
the DT O
presence NN O
of IN O
eight CD O
post NN O
- : O
transcriptional JJ O
modifications NNS O
. . O

These DT O
include VBP O
T54 NNP O
, , O
never RB O
found VBD O
so RB O
far RB O
in IN O
an DT O
animal NN O
mt NN O
- : O
tRNA NN O
, , O
and CC O
m1G37 CD O
, , O
a DT O
modification NN O
known VBN O
to TO O
have VB O
fundamental JJ O
functional JJ O
properties NNS O
in IN O
a DT O
number NN O
of IN O
canonical JJ O
tRNAs NNS O
. . O

Occurrence NNP O
of IN O
m1G37 CD O
was VBD O
further RB O
investigated VBN O
in IN O
an DT O
analysis NN O
of IN O
the DT O
substrate JJ O
properties NNS O
of IN O
in IN O
vitro NN O
transcripts NNS O
of IN O
human JJ O
mt NN O
- : O
tRNAProtowards NNS O
pure JJ O
Escherichia NNP O
coli NNS O
methylguanosine NN O
transferase NN O
. . O

This DT O
enzyme NN O
properly RB O
methylates VBZ O
G37 JJ O
in IN O
mt JJ O
- : O
tRNA NN O
and CC O
is VBZ O
sensitive JJ O
to TO O
the DT O
presence NN O
of IN O
a DT O
second JJ O
G NNP O
at IN O
position NN O
36 CD O
, , O
neighboring VBG O
the DT O
target NN O
nucleotide NN O
for IN O
methylation NN O
. . O

Since IN O
mutation NN O
of IN O
nt JJ O
36 CD O
was VBD O
shown VBN O
to TO O
be VB O
correlated VBN O
with IN O
myopathy NN O
, , O
the DT O
potential JJ O
consequences NNS O
of IN O
non FW O
- : O
modification NN O
or CC O
under IN O
- : O
modification NN O
of IN O
mt JJ O
- : O
tRNA NN O
nucleotides NNS O
in IN O
expression NN O
of IN O
the DT O
particular JJ O
myopathy NN O
and CC O
of IN O
mitochondrial JJ O
diseases NNS O
in IN O
general JJ O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

Prognostic JJ O
value NN O
of IN O
HLA NNP O
- : O
DR NN O
expression NN O
and CC O
dendritic NN O
cell NN O
infiltration NN O
in IN O
gastric JJ O
cancer NN O
. . O

We PRP O
attempted VBD O
to TO O
correlate VB O
the DT O
expression NN O
of IN O
human JJ O
leukocyte NN O
antigen NN O
DR NN O
( -LRB- O
HLA NNP O
- : O
DR NN O
) -RRB- O
and CC O
tumor NN O
infiltration NN O
by IN O
S NNP O
- : O
100 CD O
- : O
protein NN O
- : O
positive JJ O
dendritic NN O
cells NNS O
with IN O
clinicopathologic NN O
features NNS O
in IN O
165 CD O
patients NNS O
with IN O
gastric JJ O
cancer NN O
. . O

The DT O
expression NN O
of IN O
HLA NNP O
- : O
DR NN O
was VBD O
correlated VBN O
with IN O
the DT O
histologic NN O
type NN O
. . O

Infiltration NN O
of IN O
dendritic NN O
cells NNS O
correlated VBN O
negatively RB O
with IN O
distant JJ O
lymph NN O
node NN O
metastases NNS O
, , O
clinical JJ O
stage NN O
, , O
and CC O
peritoneal NN O
invasion NN O
. . O

There EX O
was VBD O
no DT O
correlation NN O
between IN O
the DT O
expression NN O
of IN O
HLA NNP O
- : O
DR NN O
and CC O
infiltration NN O
by IN O
dendritic JJ O
cells NNS O
. . O

In IN O
patients NNS O
with IN O
resectable JJ O
gastric JJ O
cancer NN O
, , O
the DT O
grade NN O
of IN O
infiltrating VBG O
dendritic JJ O
cells NNS O
may MD O
be VB O
a DT O
suitable JJ O
predictor NN O
of IN O
prognosis NN O
. . O

-DOCSTART- X X O

Integrin NNP O
alphavbeta3 NN O
requirement NN O
for IN O
sustained JJ O
mitogen NN O
- : O
activated JJ O
protein NN O
kinase NN O
activity NN O
during IN O
angiogenesis NN O
. . O

Angiogenesis NNP O
depends VBZ O
on IN O
growth NN O
factors NNS O
and CC O
vascular JJ O
cell NN O
adhesion NN O
events NNS O
. . O

Integrins NNS O
and CC O
growth NN O
factors NNS O
are VBP O
capable JJ O
of IN O
activating VBG O
the DT O
ras NNS O
/ IN O
MAP NNP O
kinase NN O
pathway NN O
in IN O
vitro NN O
, , O
yet RB O
how WRB O
these DT O
signals NNS O
influence VBP O
endothelial JJ O
cells NNS O
during IN O
angiogenesis DT O
is VBZ O
unknown JJ O
. . O

Upon IN O
initiation NN O
of IN O
angiogenesis NN O
with IN O
basic JJ O
fibroblast JJ O
growth NN O
factor NN O
( -LRB- O
bFGF NN O
) -RRB- O
on IN O
the DT O
chick NN O
chorioallantoic NN O
membrane NN O
( -LRB- O
CAM NNP O
) -RRB- O
, , O
endothelial JJ O
cell NN O
mitogen NN O
- : O
activated JJ O
protein NN O
( -LRB- O
MAP NNP O
) -RRB- O
kinase FW O
( -LRB- O
ERK NN O
) -RRB- O
activity NN O
was VBD O
detected VBN O
as RB O
early RB O
as IN O
5 CD O
min NN O
yet RB O
was VBD O
sustained VBN O
for IN O
at IN O
least JJS O
20 CD O
h NN O
. . O

The DT O
initial JJ O
wave NN O
of IN O
ERK NN O
activity NN O
( -LRB- O
5 CD O
- : O
120 CD O
min NN O
) -RRB- O
was VBD O
refractory JJ O
to TO O
integrin VB O
antagonists NNS O
, , O
whereas IN O
the DT O
sustained JJ O
activity NN O
( -LRB- O
4 CD O
- : O
20 CD O
h NN O
) -RRB- O
depended VBD O
on IN O
integrin NN O
alphavbeta3 NNS O
, , O
but CC O
not RB O
beta1 IN O
integrins NNS O
. . O

Inhibition NN O
of IN O
MAP NNP O
kinase NN O
kinase NN O
( -LRB- O
MEK NNP O
) -RRB- O
during IN O
this DT O
sustained VBN O
alphavbeta3 NN O
- : O
dependent JJ O
ERK JJ O
signal NN O
blocked VBD O
the DT O
formation NN O
of IN O
new JJ O
blood NN O
vessels NNS O
while IN O
not RB O
influencing VBG O
preexisting VBG O
blood NN O
vessels NNS O
on IN O
the DT O
CAM NNP O
. . O

Inhibition NN O
of IN O
MEK NNP O
also RB O
blocked VBD O
growth NN O
factor NN O
induced VBN O
migration NN O
but CC O
not RB O
adhesion NN O
of IN O
endothelial JJ O
cells NNS O
in IN O
vitro NN O
. . O

Therefore RB O
, , O
angiogenesis NN O
depends VBZ O
on IN O
sustained JJ O
ERK JJ O
activity NN O
regulated VBN O
by IN O
the DT O
ligation NN O
state NN O
of IN O
both DT O
a DT O
growth NN O
factor NN O
receptor NN O
and CC O
integrin NN O
alphavbeta3 NNS O
. . O

-DOCSTART- X X O

Conservative JJ O
treatment NN O
of IN O
endometriosis NN O
: : O
the DT O
effects NNS O
of IN O
limited JJ O
surgery NN O
and CC O
hormonal JJ O
pseudopregnancy NN O
. . O

This DT O
study NN O
compares VBZ O
the DT O
effects NNS O
of IN O
limited JJ O
surgery NN O
or CC O
hormonal JJ O
pseudopregnancy NN O
, , O
or CC O
a DT O
combination NN O
of IN O
these DT O
two CD O
, , O
upon IN O
fertility NN O
and CC O
the DT O
need NN O
for IN O
subsequent JJ O
surgery NN O
with IN O
respect NN O
to TO O
the DT O
extent NN O
of IN O
the DT O
disease NN O
at IN O
the DT O
time NN O
of IN O
initial JJ O
diagnosis NN O
in IN O
patients NNS O
with IN O
endometriosis NN O
externa NN O
. . O

Of IN O
the DT O
61 CD O
patients NNS O
who WP O
desired VBD O
to TO O
enhance VB O
or CC O
preserve VB O
reproductive JJ O
capacity NN O
, , O
20 CD O
patients NNS O
became VBD O
pregnant JJ O
, , O
for IN O
a DT O
pregnancy NN O
rate NN O
of IN O
33 CD O
% NN O
. . O

The DT O
pregnancy NN O
rate NN O
in IN O
all DT O
categories NNS O
, , O
that DT O
is VBZ O
, , O
those DT O
patients NNS O
treated VBD O
with IN O
pseudopregnancy NN O
, , O
conservative JJ O
surgery NN O
, , O
and CC O
combined VBN O
pseudopregnancy NN O
and CC O
surgery NN O
, , O
was VBD O
found VBN O
to TO O
be VB O
in IN O
direct JJ O
relationship NN O
to TO O
the DT O
initial JJ O
extent NN O
of IN O
disease NN O
. . O

In IN O
such JJ O
patients NNS O
, , O
conservative JJ O
surgery NN O
alone RB O
seemed VBD O
to TO O
give VB O
the DT O
best JJS O
results NNS O
in IN O
the DT O
achievement NN O
of IN O
pregnancy NN O
. . O

There EX O
seemed VBD O
to TO O
be VB O
little JJ O
difference NN O
between IN O
pseudopregnancy NN O
alone RB O
and CC O
conservative JJ O
surgery NN O
in IN O
regard NN O
to TO O
the DT O
need NN O
for IN O
subsequent JJ O
surgery NN O
after IN O
initial JJ O
therapy NN O
, , O
although IN O
there EX O
seemed VBD O
to TO O
be VB O
a DT O
significantly RB O
greater JJR O
chance NN O
for IN O
the DT O
need NN O
for IN O
subsequent JJ O
surgery NN O
in IN O
patients NNS O
receiving VBG O
a DT O
combination NN O
of IN O
the DT O
two CD O
forms NNS O
of IN O
therapy NN O
. . O

The DT O
need NN O
for IN O
subsequent JJ O
surgery NN O
after IN O
initial JJ O
therapy NN O
in IN O
80 CD O
patients NNS O
increased VBD O
in IN O
direct JJ O
relationship NN O
to TO O
the DT O
initial JJ O
extent NN O
of IN O
disease NN O
present JJ O
, , O
despite IN O
the DT O
form NN O
of IN O
therapy NN O
used VBN O
. . O

Fifty CD O
- : O
nine CD O
other JJ O
patients NNS O
with IN O
endometriosis NN O
, , O
who WP O
did VBD O
not RB O
desire NN O
to TO O
preserve VB O
fertility NN O
and CC O
presented VBD O
for IN O
relief NN O
of IN O
other JJ O
symptoms NNS O
, , O
underwent JJ O
initial JJ O
" `` O
radical JJ O
" '' O
therapy NN O
. . O

Forty CD O
- : O
six CD O
patients NNS O
underwent JJ O
complete JJ O
operation NN O
, , O
including VBG O
removal NN O
of IN O
uterus NN O
, , O
tubes NNS O
and CC O
ovaries NNS O
, , O
and CC O
none NN O
required VBN O
subsequent JJ O
reoperation NN O
. . O

Of IN O
the DT O
13 CD O
remaining VBG O
patients NNS O
, , O
who WP O
underwent VBP O
incomplete JJ O
surgical JJ O
removal NN O
, , O
leaving VBG O
one CD O
or CC O
both DT O
ovaries NNS O
in IN O
situ FW O
, , O
11 CD O
required VBN O
subsequent JJ O
reoperation NN O
for IN O
recurrent JJ O
pelvic JJ O
endometriosis NN O
. . O

-DOCSTART- X X O

Clozapine NNP O
- : O
induced JJ O
agranulocytosis NN O
and CC O
thrombopenia NN O
in IN O
a DT O
patient NN O
with IN O
dopaminergic JJ O
psychosis NN O
. . O

In IN O
patients NNS O
with IN O
Parkinson NNP O
' POS O
disease NN O
and CC O
dopaminergic JJ O
psychosis NN O
, , O
clozapine NN O
treatment NN O
is VBZ O
recommended VBN O
as IN O
the DT O
drug NN O
is VBZ O
free JJ O
from IN O
extrapyramidal JJ O
side NN O
effects NNS O
and CC O
does VBZ O
not RB O
worsen VB O
motor NN O
symptoms NNS O
of IN O
the DT O
underlying JJ O
disease NN O
. . O

The DT O
use NN O
of IN O
clozapine NN O
, , O
however RB O
, , O
is VBZ O
limited VBN O
due JJ O
to TO O
its PRP$ O
hematotoxic JJ O
side NN O
effects NNS O
. . O

For IN O
treatment NN O
of IN O
clozapine JJ O
- : O
induced JJ O
agranulocytosis NN O
, , O
granulocyte JJ O
colony NN O
- : O
stimulating NN O
factors NNS O
( -LRB- O
G NNP O
- : O
CSF NNP O
) -RRB- O
are VBP O
recommended VBN O
. . O

We PRP O
report VBP O
the DT O
case NN O
of IN O
a DT O
72 CD O
- : O
years NNS O
- : O
old JJ O
male JJ O
patient NN O
with IN O
clozapine JJ O
- : O
induced JJ O
agranulocytosis NN O
and CC O
thrombopenia NN O
. . O

Neutropenia NNP O
was VBD O
successfully RB O
treated VBN O
with IN O
G NNP O
- : O
CSF NNP O
, , O
but CC O
thrombopenia DT O
persisted VBD O
and CC O
resolved VBD O
spontaneously RB O
after IN O
14 CD O
days NNS O
. . O

Bone NNP O
marrow NN O
toxicity NN O
of IN O
clozapine NN O
is VBZ O
not RB O
restricted VBN O
to TO O
white JJ O
cell NN O
maturation NN O
, , O
but CC O
may MD O
also RB O
impair VB O
thrombocytopoesis NN O
. . O

-DOCSTART- X X O

Basic NNP O
fibroblast JJ O
growth NN O
factor NN O
: : O
a DT O
missing VBG O
link NN O
between IN O
collagen NN O
VII NNP O
, , O
increased VBD O
collagenase NN O
, , O
and CC O
squamous JJ O
cell NN O
carcinoma NN O
in IN O
recessive JJ O
dystrophic JJ O
epidermolysis NN O
bullosa NN O
. . O

BACKGROUND NNP O
: : O
Patients NNS O
with IN O
recessive JJ O
dystrophic JJ O
epidermolysis NN O
bullosa NN O
( -LRB- O
RDEB NN O
) -RRB- O
have VBP O
deficiencies NNS O
of IN O
collagen NN O
type NN O
VII NNP O
and CC O
have VBP O
elevated VBN O
levels NNS O
of IN O
fibroblast JJ O
collagenase NN O
, , O
and CC O
a DT O
greatly RB O
increased VBN O
risk NN O
of IN O
cutaneous JJ O
squamous JJ O
cell NN O
carcinoma NN O
. . O

Patients NNS O
with IN O
other JJ O
genetic JJ O
blistering NN O
disorders NNS O
do VBP O
not RB O
have VB O
elevated VBN O
collagenase NN O
or CC O
an DT O
increased VBN O
risk NN O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
, , O
despite IN O
chronic JJ O
wounding NN O
. . O

The DT O
connection NN O
between IN O
collagen NN O
type NN O
VII NNP O
deficiency NN O
, , O
increased VBN O
collagenase NN O
, , O
and CC O
squamous JJ O
cell NN O
carcinoma NN O
is VBZ O
not RB O
understood VBN O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O
: : O
Urine NNP O
from IN O
81 CD O
patients NNS O
with IN O
RDEB NNP O
( -LRB- O
39 CD O
patients NNS O
) -RRB- O
, , O
junctional JJ O
epidermolysis NN O
bullosa NN O
( -LRB- O
JEB NNP O
; : O
12 CD O
patients NNS O
) -RRB- O
, , O
and CC O
epidermolysis NN O
bullosa NN O
simplex FW O
( -LRB- O
EBS NNP O
; : O
30 CD O
patients NNS O
) -RRB- O
, , O
as RB O
well RB O
as IN O
unaffected JJ O
family NN O
members NNS O
of IN O
RDEB NN O
patients NNS O
( -LRB- O
33 CD O
patients NNS O
) -RRB- O
, , O
was VBD O
tested VBN O
for IN O
the DT O
presence NN O
of IN O
basic JJ O
fibroblast JJ O
growth NN O
factor NN O
( -LRB- O
bFGF NN O
) -RRB- O
using VBG O
a DT O
sensitive JJ O
radioimmunoassay NN O
. . O

These DT O
patients NNS O
included VBD O
many JJ O
who WP O
were VBD O
enrolled VBN O
in IN O
the DT O
Epidermolysis NNP O
Bullosa NNP O
Registry NNP O
and CC O
others NNS O
who WP O
were VBD O
referred VBN O
by IN O
their PRP$ O
physicians NNS O
. . O

RESULTS NNS O
: : O
Fifty CD O
- : O
one CD O
percent NN O
of IN O
patients NNS O
with IN O
RDEB NNP O
had VBD O
elevated VBN O
levels NNS O
( -LRB- O
greater JJR O
than IN O
5000 CD O
pg NN O
/ JJ O
g NN O
) -RRB- O
of IN O
urinary JJ O
bFGF NN O
. . O

In IN O
contrast NN O
, , O
none NN O
of IN O
the DT O
patients NNS O
with IN O
JEB NNP O
had VBD O
elevated VBN O
levels NNS O
of IN O
bFGF NN O
. . O

Twenty CD O
- : O
one CD O
percent NN O
of IN O
clinically RB O
unaffected JJ O
family NN O
members NNS O
had VBD O
elevated VBN O
levels NNS O
of IN O
bFGF NN O
, , O
and CC O
13 CD O
% NN O
of IN O
patients NNS O
with IN O
EBS NNP O
had VBD O
elevated VBN O
levels NNS O
of IN O
bFGF NN O
. . O

The DT O
frequency NN O
of IN O
elevated JJ O
bFGF NN O
values NNS O
among IN O
all DT O
groups NNS O
was VBD O
statistically RB O
significant JJ O
( -LRB- O
p NN O
= SYM O
0 CD O
. . O
002 CD O
) -RRB- O
, , O
and CC O
the DT O
levels NNS O
of IN O
bFGF NN O
in IN O
RDEB NNP O
patients NNS O
were VBD O
significantly RB O
elevated VBN O
compared VBN O
with IN O
those DT O
of IN O
other JJ O
groups NNS O
( -LRB- O
p NN O
less JJR O
than IN O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

CONCLUSIONS NNS O
: : O
We PRP O
have VBP O
found VBN O
that IN O
patients NNS O
with IN O
RDEB NNP O
have VBP O
elevated VBN O
levels NNS O
of IN O
bFGF NN O
, , O
which WDT O
may MD O
contribute VB O
to TO O
increased VBN O
fibroblast JJ O
collagenase NN O
and CC O
the DT O
development NN O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
. . O

These DT O
results NNS O
suggest VBP O
a DT O
novel NN O
treatment NN O
for IN O
RDEB NNP O
, , O
namely RB O
, , O
angiogenesis DT O
inhibitors NNS O
, , O
which WDT O
may MD O
antagonize VB O
the DT O
effects NNS O
of IN O
bFGF NN O
in IN O
this DT O
disorder NN O
. . O

There EX O
are VBP O
currently RB O
no DT O
other JJ O
means NNS O
of IN O
treatment NN O
for IN O
this DT O
disorder NN O
, , O
which WDT O
has VBZ O
a DT O
high JJ O
morbidity NN O
and CC O
mortality NN O
rate NN O
. . O

-DOCSTART- X X O

Multiple JJ O
phosphotyrosine NN O
phosphatase NN O
mRNAs NNS O
are VBP O
expressed VBN O
in IN O
the DT O
human JJ O
lung NN O
fibroblast JJ O
cell NN O
line NN O
WI IN B-NP
- : I-NP
38 CD I-NP
. . O

Protein NNP O
tyrosine NN O
phosphatases NNS O
are VBP O
important JJ O
components NNS O
of IN O
signal NN O
transduction NN O
pathways NNS O
. . O

The DT O
authors NNS O
have VBP O
used VBN O
reverse JJ O
transcription NN O
/ NN O
polymerase NN O
chain NN O
reactions NNS O
to TO O
accomplish VB O
a DT O
comprehensive JJ O
examination NN O
of IN O
the DT O
RNA NNP O
expression NN O
for IN O
58 CD O
distinct JJ O
mammalian JJ O
protein NN O
tyrosine NN O
and CC O
dual JJ O
specificity NN O
phosphatase NN O
( -LRB- O
PTPase NN O
) -RRB- O
and CC O
PTPase VB O
- : O
like IN O
genes NNS O
in IN O
the DT O
normal JJ O
human JJ O
diploid NN O
fibroblast JJ O
cell NN O
line NN O
WI IN B-NP
- : I-NP
38 CD I-NP
. . O

Thirty CD O
- : O
seven CD O
of IN O
these DT O
PTPase JJ O
genes NNS O
express VBP O
easily RB O
measurable JJ O
RNA NNP O
, , O
and CC O
four CD O
simultaneously RB O
express VB O
the DT O
RNA NNP O
for IN O
two CD O
or CC O
more JJR O
isoforms NNS O
. . O

Messages NNS O
for IN O
an DT O
additional JJ O
eight CD O
PTPase NNP O
genes NNS O
are VBP O
detectable JJ O
at IN O
low JJ O
levels NNS O
. . O

Only RB O
14 CD O
known VBN O
PTPase NN O
genes NNS O
do VBP O
not RB O
express VB O
measurable JJ O
RNA NNS O
under IN O
our PRP$ O
conditions NNS O
. . O

For IN O
purposes NNS O
of IN O
comparison NN O
, , O
the DT O
authors NNS O
also RB O
assessed VBN O
the DT O
PTPases NNS O
expressed VBN O
in IN O
the DT O
WI NN B-NP
- : I-NP
38 CD I-NP
cell NN O
line NN O
using VBG O
highly RB O
degenerate JJ O
primers NNS O
to TO O
conserved VB O
motifs NNS O
found VBN O
in IN O
the DT O
classical JJ O
tyrosine NN O
- : O
specific JJ O
PTPases NNS O
. . O

Only RB O
eight CD O
of IN O
the DT O
22 CD O
classic NN O
tyrosine FW O
- : O
specific JJ O
PTPases NNS O
detected VBN O
using VBG O
the DT O
specific JJ O
primers NNS O
were VBD O
detected VBN O
using VBG O
these DT O
degenerate JJ O
primers NNS O
. . O

Our PRP$ O
panel NN O
of IN O
specific JJ O
PTPase NN O
primers NNS O
should MD O
be VB O
very RB O
useful JJ O
for IN O
semiquantitatively RB O
assessing VBG O
the DT O
repertoire NN O
of IN O
PTPases NNS O
expressed VBN O
by IN O
cells NNS O
. . O

-DOCSTART- X X O

Epstein NNP O
- : O
Barr NNP O
virus NN O
- : O
associated VBN O
nonsmall JJ O
cell NN O
lung NN O
carcinoma NN O
: : O
undifferentiated JJ O
" `` O
lymphoepithelioma FW O
- : O
like IN O
" `` O
carcinoma NN O
as IN O
a DT O
distinct JJ O
entity NN O
with IN O
better JJR O
prognosis NN O
. . O

BACKGROUND NNP O
: : O

Epstein NNP O
- : O
Barr NNP O
virus NN O
( -LRB- O
EBV NN O
) -RRB- O
infection NN O
in IN O
nonsmall JJ O
cell NN O
lung NN O
carcinoma NN O
( -LRB- O
NSCLC NNP O
) -RRB- O
has VBZ O
been VBN O
demonstrated VBN O
in IN O
some DT O
ethnic JJ O
groups NNS O
. . O

The DT O
pathobiology NN O
and CC O
the DT O
role NN O
of IN O
EBV NNP O
and CC O
oncoprotein NNP O
expression NN O
in IN O
these DT O
tumors NNS O
have VBP O
not RB O
been VBN O
studied VBN O
extensively RB O
. . O

In IN O
this DT O
study NN O
, , O
the DT O
authors NNS O
investigated VBN O
EBV NNP O
- : O
encoded VBD O
RNA NNP O
- : O
1 CD O
( -LRB- O
EBER1 NN O
) -RRB- O
transcripts NNS O
by IN O
in IN O
situ FW O
hybridization NN O
and CC O
the DT O
expression NN O
of IN O
latent JJ O
membrane NN O
protein NN O
- : O
1 CD O
( -LRB- O
LMP NNP O
- : O
1 CD O
) -RRB- O
and CC O
bcl VB O
- : O
2 CD O
protein NN O
by IN O
immunohistochemistry NN O
in IN O
NSCLC NNP O
patients NNS O
from IN O
Taiwan NNP O
, , O
where WRB O
nasopharyngeal JJ O
carcinoma NN O
is VBZ O
endemic JJ O
. . O

METHODS NNS O
: : O

A DT O
total NN O
of IN O
127 CD O
cases NNS O
of IN O
NSCLC NNP O
( -LRB- O
43 CD O
cases NNS O
of IN O
squamous JJ O
cell NN O
carcinoma NN O
[ VBZ O
SCC NNP O
] NNP O
, , O
67 CD O
cases NNS O
of IN O
adenocarcinoma NN O
[ NN O
AD NN O
] NN O
, , O
12 CD O
cases NNS O
of IN O
large JJ O
cell NN O
carcinoma NN O
[ VBZ O
LCC NNP O
] NNP O
, , O
and CC O
5 CD O
cases NNS O
of IN O
lymphoepithelioma NN O
- : O
like IN O
carcinoma NN O
[ NN O
LE JJ O
] SYM O
) -RRB- O
were VBD O
included VBN O
. . O

A DT O
sensitive JJ O
polymerase NN O
chain NN O
reaction NN O
- : O
derived VBN O
, , O
digoxigenin FW O
- : O
labeled VBN O
DNA NN O
probe NN O
for IN O
in IN O
situ NN O
detection NN O
of IN O
EBER1 NNP O
transcripts NNS O
was VBD O
performed VBN O
for IN O
the DT O
detection NN O
of IN O
EBV NNP O
. . O

Immunohistochemistry NNP O
using VBG O
the DT O
avidin NN O
- : O
biotin NN O
- : O
immunoperoxidase JJ O
method NN O
was VBD O
also RB O
performed VBN O
to TO O
evaluate VB O
the DT O
expression NN O
of IN O
bcl JJ O
- : O
2 CD O
and CC O
LMP NNP O
- : O
1 CD O
. . O

RESULTS NNS O
: : O

EBER1 PRP O
was VBD O
detected VBN O
in IN O
11 CD O
of IN O
the DT O
127 CD O
NSCLC NNP O
cases NNS O
( -LRB- O
8 CD O
. . O
7 CD O
% NN O
; : O
6 CD O
SCC NNP O
cases NNS O
and CC O
5 CD O
LE JJ O
cases NNS O
) -RRB- O
. . O

All DT O
5 CD O
LE JJ O
cases NNS O
were VBD O
EBV NNP O
- : O
positive JJ O
, , O
whereas IN O
only RB O
6 CD O
of IN O
the DT O
43 CD O
SCC NNP O
cases NNS O
( -LRB- O
14 CD O
% NN O
) -RRB- O
, , O
0 CD O
of IN O
67 CD O
AD NN O
cases NNS O
, , O
and CC O
12 CD O
LCC JJ O
cases NNS O
were VBD O
EBV NNP O
- : O
positive JJ O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

All DT O
five CD O
LE JJ O
cases NNS O
showed VBD O
diffuse JJ O
, , O
strong JJ O
, , O
positive JJ O
staining NN O
of IN O
tumor NN O
cells NNS O
; : O
five CD O
of IN O
the DT O
six CD O
SCC NNP O
cases NNS O
showed VBD O
diffuse JJ O
but CC O
weak JJ O
staining NN O
. . O

Among IN O
the DT O
nontumor NN O
epithelial NN O
cells NNS O
, , O
there EX O
was VBD O
no DT O
EBER1 JJ O
staining NN O
of IN O
any DT O
of IN O
the DT O
11 CD O
EBER1 NNS O
- : O
positive JJ O
cases NNS O
. . O

The DT O
mean JJ O
age NN O
of IN O
the DT O
LE JJ O
patients NNS O
was VBD O
10 CD O
years NNS O
younger JJR O
than IN O
that DT O
of IN O
the DT O
patients NNS O
with IN O
other JJ O
histological JJ O
types NNS O
. . O

All DT O
5 CD O
LE JJ O
patients NNS O
were VBD O
nonsmokers NNS O
, , O
whereas IN O
3 CD O
of IN O
the DT O
6 CD O
patients NNS O
with IN O
EBER1 NNP O
- : O
positive JJ O
SCC NNP O
( -LRB- O
50 CD O
% NN O
) -RRB- O
were VBD O
smokers NNS O
. . O

EBER1 JJ O
expression NN O
did VBD O
not RB O
correlate VB O
with IN O
the DT O
2 LS O
- : O
year NN O
survival NN O
rate NN O
of IN O
overall JJ O
cases NNS O
, , O
but CC O
all DT O
5 CD O
LE JJ O
patients NNS O
were VBD O
alive JJ O
without IN O
clinical JJ O
evidence NN O
of IN O
disease NN O
at IN O
last JJ O
follow VB O
- : O
up RB O
. . O

Gender NNP O
, , O
lymph NN O
node NN O
or CC O
distant JJ O
metastasis NN O
, , O
and CC O
clinical JJ O
stage NN O
were VBD O
not RB O
found VBN O
to TO O
have VB O
any DT O
correlation NN O
with IN O
EBER1 JJ O
expression NN O
( -LRB- O
P NNP O
> NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

All DT O
LE JJ O
cases NNS O
had VBD O
bcl NN O
- : O
2 CD O
oncoprotein NN O
expression NN O
( -LRB- O
100 CD O
% NN O
) -RRB- O
. . O

This DT O
frequency NN O
was VBD O
significantly RB O
different JJ O
from IN O
other JJ O
histologic NN O
types NNS O
( -LRB- O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

The DT O
LMP NNP O
- : O
1 CD O
detection NN O
rate NN O
was VBD O
low JJ O
and CC O
demonstrated VBD O
no DT O
correlation NN O
with IN O
bcl JJ O
- : O
2 CD O
expression NN O
. . O

CONCLUSIONS NNS O
: : O

In IN O
this DT O
study NN O
, , O
the DT O
authors NNS O
found VBD O
that IN O
the DT O
primary JJ O
LE JJ O
of IN O
the DT O
lung NN O
is VBZ O
associated VBN O
with IN O
young JJ O
age NN O
, , O
a DT O
history NN O
of IN O
not RB O
smoking VBG O
, , O
high JJ O
bcl NN O
- : O
2 CD O
immunoreactivity NN O
, , O
and CC O
better JJR O
survival NN O
rate NN O
. . O

These DT O
characteristics NNS O
demonstrate VBP O
that IN O
EBV NNP O
- : O
associated JJ O
LE NN O
of IN O
the DT O
lung NN O
is VBZ O
a DT O
unique JJ O
entity NN O
. . O

The DT O
findings NNS O
of IN O
the DT O
current JJ O
study NN O
suggest VBP O
that IN O
EBV NNP O
infection NN O
may MD O
play VB O
a DT O
different JJ O
role NN O
in IN O
the DT O
tumorigenesis NN O
of IN O
primary JJ O
LE JJ O
of IN O
the DT O
lung NN O
than IN O
it PRP O
does VBZ O
in IN O
other JJ O
EBER1 NNS O
- : O
positive JJ O
NSCLCs NNP O
. . O

-DOCSTART- X X O

Prophylactic NNP O
thyroidectomy NN O
in IN O
MEN NNP O
IIA NNP O
: : O
does VBZ O
the DT O
calcitonin NN O
level NN O
correlate NN O
with IN O
tumor NN O
spread NN O
? . O

BACKGROUND NNP O
: : O
The DT O
fate NN O
of IN O
patients NNS O
with IN O
multiple JJ O
endocrine NN O
neoplasia NN O
of IN O
type NN O
II NNP O
A NNP O
( -LRB- O
MEN NNP O
II NNP O
A DT O
) -RRB- O
is VBZ O
determined VBN O
by IN O
medullary NN O
thyroid NN O
carcinoma NN O
, , O
which WDT O
occurs VBZ O
in IN O
all DT O
cases NNS O
. . O

This DT O
has VBZ O
led VBN O
to TO O
the DT O
therapeutic JJ O
concept NN O
of IN O
prophylactic JJ O
thyroidectomy NN O
in IN O
affected JJ O
family NN O
members NNS O
with IN O
the DT O
goal NN O
of IN O
removing VBG O
the DT O
thyroid NN O
before IN O
the DT O
manifestation NN O
of IN O
carcinoma NN O
. . O

We PRP O
investigated VBD O
a DT O
prophylactically RB O
thyroidectomized JJ O
MEN NNP O
II NNP O
A DT O
population NN O
to TO O
determine VB O
whether IN O
the DT O
highly RB O
specific JJ O
and CC O
sensitive JJ O
tumor NN O
marker NN O
calcitonin NN O
correlates VBZ O
with IN O
tumor NN O
spread NN O
. . O

PATIENTS NNS O
AND CC O
METHODS NNS O
: : O
Fifteen CD O
patients NNS O
with IN O
MEN NNP O
II NNP O
A DT O
( -LRB- O
aged VBN O
4 CD O
- : O
24 CD O
years NNS O
) -RRB- O
who WP O
had VBD O
undergone VBN O
prophylactic JJ O
thyroidectomy NN O
since IN O
1990 CD O
were VBD O
included VBN O
in IN O
the DT O
study NN O
. . O

Baseline NNP O
and CC O
pentagastrin VB O
- : O
stimulated VBN O
calcitonin NN O
levels NNS O
were VBD O
preoperatively RB O
determined VBN O
in IN O
all DT O
cases NNS O
. . O

The DT O
indication NN O
for IN O
surgery NN O
was VBD O
established VBN O
on IN O
the DT O
basis NN O
of IN O
pathologic NN O
calcitonin NN O
levels NNS O
in IN O
the DT O
first JJ O
seven CD O
patients NNS O
and CC O
on IN O
the DT O
basis NN O
of IN O
detected VBN O
RET NNP O
proto FW O
- : O
oncogene NN O
mutation NN O
in IN O
the DT O
other JJ O
eight CD O
patients NNS O
. . O

Bilateral JJ O
central JJ O
lymphadenectomy NN O
was VBD O
performed VBN O
in IN O
all DT O
patients NNS O
in IN O
addition NN O
to TO O
thyroidectomy NN O
. . O

RESULTS NNS O
: : O
Histology NNP O
demonstrated VBD O
C LS O
- : O
cell NN O
hyperplasia NN O
in IN O
five CD O
patients NNS O
( -LRB- O
aged VBN O
4 CD O
- : O
13 CD O
years NNS O
) -RRB- O
, , O
unilateral JJ O
medullary NN O
microcarcinoma NN O
in IN O
six CD O
( -LRB- O
aged VBN O
9 CD O
- : O
17 CD O
years NNS O
) -RRB- O
and CC O
a DT O
bilateral JJ O
medullary NN O
microcarcinoma NN O
in IN O
three CD O
cases NNS O
( -LRB- O
aged VBN O
17 CD O
- : O
24 CD O
years NNS O
) -RRB- O
. . O

One CD O
9 CD O
- : O
year NN O
- : O
old JJ O
boy NN O
with IN O
bilateral JJ O
microcarcinoma NN O
already RB O
had VBD O
a DT O
lymph NN O
node NN O
metastasis NN O
. . O

The DT O
mean JJ O
baseline NN O
calcitonin NN O
level NN O
correlated VBN O
with IN O
the DT O
histologic NN O
findings NNS O
( -LRB- O
r SYM O
= SYM O
0 CD O
. . O
71 CD O
, , O
P NNP O
= SYM O
0 CD O
. . O
003 CD O
) -RRB- O
but CC O
there EX O
was VBD O
no DT O
correlation NN O
between IN O
pentagastrin NN O
- : O
stimulated VBN O
calcitonin NN O
levels NNS O
and CC O
histology NN O
( -LRB- O
r NN O
= SYM O
0 CD O
. . O
21 CD O
, , O
P NNP O
= SYM O
0 CD O
. . O
47 CD O
) -RRB- O
. . O

CONCLUSION NN O
: : O
In IN O
MEN NNP O
II NNP O
A DT O
patients NNS O
undergoing VBG O
prophylactic JJ O
thyroidectomy NN O
, , O
baseline NN O
but CC O
not RB O
stimulated VBN O
calcitonin NN O
levels NNS O
already RB O
correlate VBP O
with IN O
the DT O
histologic NN O
tumor NN O
stage NN O
at IN O
the DT O
stage NN O
of IN O
clinically RB O
occult JJ O
C LS O
- : O
cell NN O
hyperplasia NN O
or CC O
medullary NN O
microcarcinoma NN O
. . O

However RB O
, , O
biochemical JJ O
screening NN O
cannot IN O
reliably RB O
discriminate VB O
the DT O
transition NN O
from IN O
C NNP O
- : O
cell NN O
hyperplasia NN O
to TO O
invasive VB O
microcarcinoma NN O
. . O

Individuals NNS O
with IN O
MEN NNP O
IIA NNP O
should MD O
therefore RB O
undergo VB O
early JJ O
prophylactic JJ O
thyroidectomy NN O
once IN O
the DT O
diagnosis NN O
is VBZ O
confirmed VBN O
by IN O
molecular JJ O
genetic JJ O
testing NN O
. . O

-DOCSTART- X X O

Induction NN O
of IN O
Ets NNP O
- : O
1 CD O
in IN O
endothelial JJ O
cells NNS O
during IN O
reendothelialization NN O
after IN O
denuding VBG O
injury NN O
. . O

Ets NNS O
- : O
1 CD O
, , O
a DT O
transcription NN O
factor NN O
, , O
is VBZ O
induced VBN O
in IN O
endothelial JJ O
cells NNS O
( -LRB- O
ECs NNS O
) -RRB- O
during IN O
angiogenesis NN O
. . O

Here RB O
, , O
we PRP O
investigated VBD O
the DT O
expression NN O
of IN O
Ets NNP O
- : O
1 CD O
during IN O
reendothelialization NN O
. . O

When WRB O
a DT O
confluent JJ O
monolayer NN O
of IN O
human JJ O
umbilical JJ O
vein NN O
endothelial JJ O
cell NN O
line NN O
, , O
ECV304 NNP B-NP
, , O
was VBD O
denuded VBN O
, , O
ECV304 NNP B-NP
at IN O
the DT O
wound NN O
edge NN O
expressed VBN O
Ets NNP O
- : O
1 CD O
. . O

An DT O
immunohistochemical JJ O
analysis NN O
revealed VBN O
that IN O
Ets NNP O
- : O
1 CD O
accumulated VBN O
in IN O
migrating VBG O
cells NNS O
at IN O
the DT O
wound NN O
edge NN O
and CC O
returned VBD O
to TO O
basal VB O
level NN O
when WRB O
reendothelialization NN O
was VBD O
accomplished VBN O
. . O

This DT O
induction NN O
of IN O
Ets NNP O
- : O
1 CD O
could MD O
be VB O
reproduced VBN O
in IN O
in IN O
vivo JJ O
denudation NN O
of IN O
rat NN O
aortic JJ O
endothelium NN O
by IN O
a DT O
balloon NN O
catheter NN O
. . O

The DT O
induction NN O
of IN O
Ets NNP O
- : O
1 CD O
in IN O
ECs NNP O
after IN O
denudation NN O
was VBD O
regulated VBN O
transcriptionally RB O
, , O
and CC O
humeral JJ O
factors NNS O
released VBN O
from IN O
injured JJ O
ECs NNS O
might MD O
not RB O
be VB O
responsible JJ O
. . O

Mitogen FW O
- : O
activated JJ O
protein NN O
kinase NN O
( -LRB- O
MAPK NN O
) -RRB- O
activities NNS O
were VBD O
investigated VBN O
to TO O
explore VB O
the DT O
mechanism NN O
of IN O
this DT O
induction NN O
. . O

Although IN O
extracellular JJ O
signal NN O
- : O
regulated JJ O
protein NN O
kinase NN O
1 CD O
/ NN O
2 CD O
( -LRB- O
ERK1 NN O
/ JJ O
2 CD O
) -RRB- O
, , O
c SYM O
- : O
Jun NNP O
N NNP O
- : O
terminal NN O
kinase NN O
1 CD O
( -LRB- O
JNK1 NN O
) -RRB- O
, , O
and CC O
p38 NNS O
were VBD O
activated VBN O
after IN O
denudation NN O
, , O
the DT O
activation NN O
of IN O
ERK1 NNP O
and CC O
p38 VBD O
was VBD O
more RBR O
rapid JJ O
and CC O
prominent JJ O
. . O

PD98059 CD O
, , O
a DT O
specific JJ O
MAPK NNP O
/ NNP O
ERK NNP O
kinase NN O
( -LRB- O
MEK NNP O
) -RRB- O
1 CD O
inhibitor NN O
, , O
did VBD O
not RB O
affect VB O
the DT O
induction NN O
of IN O
ets NNS O
- : O
1 CD O
mRNA NN O
, , O
whereas IN O
SB203580 NNP O
, , O
a DT O
specific JJ O
p38 VBG O
inhibitor NN O
, , O
almost RB O
completely RB O
abrogated VBN O
its PRP$ O
induction NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
Ets NNP O
- : O
1 CD O
is VBZ O
induced VBN O
in IN O
ECs NNP O
after IN O
denudation NN O
through IN O
activation NN O
of IN O
p38 NNS O
. . O

This DT O
induction NN O
of IN O
Ets NNP O
- : O
1 CD O
may MD O
be VB O
relevant JJ O
for IN O
reendothelialization NN O
by IN O
regulating VBG O
the DT O
expression NN O
of IN O
certain JJ O
genes NNS O
. . O

-DOCSTART- X X O

SV40 DT O
Tag NNP O
transformation NN O
of IN O
the DT O
normal JJ O
invasive JJ O
trophoblast NN O
results NNS O
in IN O
a DT O
premalignant JJ O
phenotype NN O
. . O

I PRP O
. . O

Mechanisms NNS O
responsible JJ O
for IN O
hyperinvasiveness NN O
and CC O
resistance NN O
to TO O
anti NNS O
- : O
invasive JJ O
action NN O
of IN O
TGFbeta NNP O
. . O

Invasion NN O
of IN O
the DT O
uterus NN O
by IN O
first JJ O
trimester NN O
human JJ O
placental NN O
extravillous JJ O
trophoblast FW O
( -LRB- O
EVT NN O
) -RRB- O
cells NNS O
depends VBZ O
on IN O
mechanisms NNS O
shared VBN O
by IN O
malignant JJ O
cells NNS O
. . O

However RB O
, , O
unlike IN O
tumor NN O
invasion NN O
, , O
trophoblast NN O
invasion NN O
of IN O
the DT O
uterus NN O
is VBZ O
stringently RB O
controlled VBN O
in IN O
situ NN O
by IN O
local JJ O
molecules NNS O
such JJ O
as IN O
transforming VBG O
growth NN O
factor NN O
( -LRB- O
TGF NN O
) -RRB- O
beta NN O
. . O

Since IN O
EVT NNP O
cells NNS O
possess VBP O
active JJ O
invasion NN O
- : O
associated VBN O
genes NNS O
but CC O
are VBP O
nontumorigenic JJ O
, , O
our PRP$ O
objective NN O
was VBD O
to TO O
induce VB O
premalignant JJ O
and CC O
then RB O
malignant JJ O
phenotype NN O
into IN O
a DT O
normal JJ O
EVT NNP B-NP
cell NN O
line NN O
in IN O
order NN O
to TO O
identify VB O
the DT O
molecular JJ O
basis NN O
of IN O
tumor NN O
progression NN O
. . O

Simian NNP O
virus NN O
40 CD O
large JJ O
T NNP O
antigen NN O
( -LRB- O
SV40 JJ O
Tag NN O
) -RRB- O
was VBD O
introduced VBN O
into IN O
a DT O
normal JJ O
human JJ O
first JJ O
trimester NN O
invasive JJ O
EVT NNP B-NP
cell NN O
line NN O
, , O
HTR8 PRP B-NP
, , O
established VBN O
in IN O
our PRP$ O
laboratory NN O
. . O

Since IN O
the DT O
HTR8 CD B-NP
line NN O
has VBZ O
a DT O
limited JJ O
in IN O
vitro NN O
lifespan NN O
of IN O
12 CD O
- : O
15 CD O
passages NNS O
, , O
SV40 VB O
Tag NNP O
- : O
transformed VBD O
cells NNS O
were VBD O
selected VBN O
on IN O
the DT O
basis NN O
of IN O
extended JJ O
lifespan NN O
. . O

A DT O
long JJ O
- : O
lived VBD O
line NN O
, , O
RSVT NNP B-NP
- : I-NP
2 CD I-NP
, , O
was VBD O
produced VBN O
and CC O
an DT O
immortalized JJ O
subclone NN O
, , O
RSVT2 NNP B-NP
/ NNP I-NP
C NNP I-NP
, , O
was VBD O
further RB O
derived VBN O
under IN O
a DT O
forced VBN O
crisis NN O
regimen NNS O
. . O

We PRP O
examined VBN O
transformation NN O
- : O
induced VBN O
alterations NNS O
in IN O
proliferative JJ O
and CC O
invasive JJ O
abilities NNS O
, , O
responses NNS O
to TO O
the DT O
invasion NN O
and CC O
proliferation NN O
- : O
regulating JJ O
growth NN O
factor NN O
TGFbeta NN O
and CC O
changes NNS O
in IN O
gene NN O
expression NN O
for IN O
invasion NN O
- : O
associated VBN O
enzymes NNS O
or CC O
enzyme JJ O
inhibitors NNS O
. . O

RSVT NNP B-NP
- : I-NP
2 CD I-NP
and CC O
RSVT2 NNP B-NP
/ NNP I-NP
C NNP I-NP
cell NN O
lines NNS O
were VBD O
hyperproliferative JJ O
and CC O
hyperinvasive JJ O
when WRB O
compared VBN O
with IN O
the DT O
parental JJ O
HTR8 IN B-NP
cell NN O
line NN O
. . O

They PRP O
were VBD O
also RB O
variably RB O
resistant JJ O
to TO O
the DT O
anti NNS O
- : O
proliferative JJ O
and CC O
anti JJ O
- : O
invasive JJ O
signals NNS O
from IN O
TGFbeta NNP O
. . O

Since IN O
both DT O
cell NN O
lines NNS O
remained VBD O
non JJ O
- : O
tumorigenic JJ O
in IN O
nude JJ O
mice NNS O
, , O
these DT O
properties NNS O
indicate VBP O
that IN O
they PRP O
attained VBD O
a DT O
premalignant JJ O
phenotype NN O
. . O

Both DT O
cell NN O
lines NNS O
showed VBD O
reduced JJ O
expression NN O
of IN O
tissue NN O
inhibitor NN O
of IN O
metalloproteases NNS O
( -LRB- O
TIMP NN O
) -RRB- O
- : O
1 CD O
, , O
while IN O
TIMP NNP O
- : O
2 CD O
and CC O
plasminogen NN O
activator NN O
inhibitor NN O
( -LRB- O
PAI NN O
) -RRB- O
- : O
I PRP O
expression NN O
was VBD O
was VBD O
also RB O
reduced VBN O
in IN O
RSVT2 NNP B-NP
/ NNP I-NP
C NNP I-NP
cells NNS O
, , O
thus RB O
contributing VBG O
to TO O
their PRP$ O
hyperinvasiveness NN O
. . O

Their PRP$ O
resistance NN O
to TO O
the DT O
anti NNS O
- : O
invasive JJ O
action NN O
of IN O
TGFbeta NN O
was VBD O
explained VBN O
by IN O
the DT O
failure NN O
of IN O
TGFbeta NNP O
to TO O
upregulate VB O
TIMPs NNP O
and CC O
PAI NNP O
- : O
I PRP O
, , O
in IN O
contrast NN O
to TO O
the DT O
TGFbeta NNP O
- : O
induced JJ O
upregulation NN O
noted VBD O
in IN O
parental JJ O
HTR8 CD B-NP
cells NNS O
. . O

-DOCSTART- X X O

Antisocial JJ O
patients NNS O
: : O
a DT O
comparison NN O
of IN O
those DT O
with IN O
and CC O
those DT O
without IN O
childhood NN O
conduct NN O
disorder NN O
. . O

The DT O
purpose NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
compare VB O
persons NNS O
with IN O
antisocial JJ O
personality NN O
disorder NN O
( -LRB- O
ASP NNP O
) -RRB- O
with IN O
those DT O
who WP O
meet VBP O
the DT O
adult NN O
criteria NNS O
for IN O
ASP NNP O
but CC O
fail VB O
to TO O
meet VB O
the DT O
criteria NNS O
for IN O
childhood NN O
conduct NN O
disorder NN O
. . O

Sociodemographic NNP O
data NNS O
, , O
medical JJ O
history NN O
, , O
and CC O
psychiatric JJ O
symptoms NNS O
exhibited VBN O
during IN O
a DT O
recent JJ O
hospital NN O
admission NN O
were VBD O
compared VBN O
in IN O
the DT O
two CD O
groups NNS O
by IN O
chart NN O
review NN O
. . O

The DT O
two CD O
groups NNS O
were VBD O
virtually RB O
indistinguishable JJ O
, , O
except IN O
that IN O
patients NNS O
without IN O
childhood NN O
conduct NN O
disorder NN O
were VBD O
less RBR O
likely JJ O
to TO O
smoke VB O
or CC O
consume VB O
alcohol NN O
, , O
were VBD O
less RBR O
likely JJ O
to TO O
have VB O
spent VBN O
time NN O
in IN O
a DT O
training NN O
school NN O
/ NN O
boot NN O
camp NN O
as IN O
a DT O
child NN O
or CC O
adolescent NN O
, , O
were VBD O
less RBR O
likely JJ O
to TO O
have VB O
been VBN O
admitted VBN O
for IN O
a DT O
recent JJ O
suicide NN O
attempt NN O
, , O
and CC O
were VBD O
less RBR O
likely JJ O
to TO O
have VB O
conned VBN O
others NNS O
. . O

We PRP O
conclude VBP O
that IN O
persons NNS O
meeting VBG O
the DT O
adult NN O
criteria NNS O
for IN O
ASP NNP O
but CC O
not RB O
the DT O
childhood NN O
conduct NN O
disorder NN O
criteria NNS O
essentially RB O
suffer VBP O
the DT O
same JJ O
disorder NN O
as IN O
those DT O
who WP O
meet VBP O
full JJ O
ASP IN O
criteria NNS O
but CC O
are VBP O
less JJR O
severely RB O
affected VBN O
. . O

-DOCSTART- X X O

Acylase NN O
I PRP O
- : O
catalyzed JJ O
deacetylation NN O
of IN O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
and CC O
S NNP O
- : O
alkyl NN O
- : O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteines NNS O
. . O

The DT O
aminoacylase JJ O
that IN O
catalyzes NNS O
the DT O
hydrolysis NN O
of IN O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
( -LRB- O
NAC NNP O
) -RRB- O
was VBD O
identified VBN O
as IN O
acylase NN O
I PRP O
after IN O
purification NN O
by IN O
column NN O
chromatography NN O
and CC O
electrophoretic JJ O
analysis NN O
. . O

Rat NNP O
kidney NN O
cytosol NN O
was VBD O
fractionated VBN O
by IN O
ammonium NN O
sulfate NN O
precipitation NN O
, , O
and CC O
the DT O
proteins NNS O
were VBD O
separated VBN O
by IN O
ion NN O
- : O
exchange NN O
column NN O
chromatography NN O
, , O
gel NNP O
- : O
filtration NN O
column NN O
chromatography NN O
, , O
and CC O
hydrophobic JJ O
interaction NN O
column NN O
chromatography NN O
. . O

Acylase NNP O
activity NN O
with IN O
NAC NNP O
and CC O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
methionine CD O
( -LRB- O
NAM NNP O
) -RRB- O
, , O
a DT O
known VBN O
substrate NN O
for IN O
acylase NN O
I PRP O
, , O
as IN O
substrates NNS O
coeluted VBN O
during IN O
all DT O
chromatographic JJ O
steps NNS O
. . O

Sodium NNP O
dodecyl NN O
sulfate NN O
- : O
polyacrylamide NN O
gel NN O
electrophoresis NN O
showed VBD O
that IN O
the DT O
protein NN O
was VBD O
purified VBN O
to TO O
near VB O
homogeneity NN O
and CC O
had VBD O
a DT O
subunit NN O
Mr NNP O
of IN O
43 CD O
000 CD O
, , O
which WDT O
is VBZ O
identical JJ O
with IN O
the DT O
Mr NNP O
of IN O
acylase NN O
I PRP O
from IN O
porcine NN O
kidney NN O
and CC O
bovine NN O
liver NN O
. . O

n NN O
- : O
Butylmalonic CC O
acid NN O
was VBD O
a DT O
slow JJ O
- : O
binding JJ O
inhibitor NN O
of IN O
acylase NN O
I PRP O
and CC O
inhibited VBD O
the DT O
deacetylation NN O
of IN O
NAC NNP O
with IN O
a DT O
Ki NNP O
of IN O
192 CD O
+ NN O
/ NNS O
- : O
27 CD O
microM NN O
. . O

These DT O
results NNS O
show VBP O
that IN O
acylase NN O
I PRP O
catalyzes VBP O
the DT O
deacetylation NN O
of IN O
NAC NNP O
. . O

The DT O
acylase NN O
I PRP O
- : O
catalyzed JJ O
deacetylation NN O
of IN O
a DT O
range NN O
of IN O
S NNP O
- : O
alkyl NN O
- : O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteines NNS O
, , O
their PRP$ O
carbon NN O
and CC O
oxygen NN O
analogues NNS O
, , O
and CC O
the DT O
selenium NN O
analogue NN O
of IN O
NAM NNP O
was VBD O
also RB O
studied VBN O
with IN O
porcine NN O
kidney NN O
acylase NN O
I PRP O
. . O

The DT O
specific JJ O
activity NN O
of IN O
the DT O
acylase NN O
I PRP O
- : O
catalyzed JJ O
deacetylation NN O
of IN O
these DT O
substrates NNS O
was VBD O
related VBN O
to TO O
their PRP$ O
calculated VBN O
molar JJ O
volumes NNS O
and CC O
log VBP O
P NNP O
values NNS O
. . O

The DT O
S NNP O
- : O
alkyl NN O
- : O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteines NNS O
with IN O
short JJ O
( -LRB- O
C0 VB O
- : O
C3 NN O
) -RRB- O
and CC O
unbranched JJ O
S NNP O
- : O
alkyl NN O
substituents NNS O
were VBD O
good JJ O
acylase NN O
I PRP O
substrates NNS O
, , O
whereas IN O
the DT O
S NNP O
- : O
alkyl NN O
- : O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteines NNS O
with IN O
long JJ O
( -LRB- O
> JJ O
C3 NN O
) -RRB- O
and CC O
branched VBD O
S NNP O
- : O
alkyl NN O
substituents NNS O
were VBD O
poLr JJ O
acylase NN O
I PRP O
substrates NNS O
. . O

The DT O
carbon NN O
and CC O
oxygen NN O
analogues NNS O
of IN O
S NNP O
- : O
methyl NN O
- : O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
and CC O
the DT O
carbon NN O
analogue NN O
of IN O
S NNP O
- : O
ethyl NN O
- : O
N NNP O
- : O
acetyl NN O
- : O
L NNP O
- : O
cysteine NN O
were VBD O
poor JJ O
acylase NN O
I PRP O
substrates NNS O
, , O
whereas IN O
the DT O
selenium NN O
analogue NN O
of IN O
NAM NNP O
was VBD O
a DT O
good JJ O
acylase NN O
I PRP O
substrate VBP O
. . O

-DOCSTART- X X O

Expression NN O
of IN O
two CD O
type NN O
II NNP O
- : O
like IN O
tumor NN O
hexokinase NN O
RNA NNP O
transcripts NNS O
in IN O
cancer NN O
cell NN O
lines NNS O
. . O

To TO O
maintain VB O
an DT O
elevated JJ O
glycolytic NN O
rate NN O
, , O
cancerous JJ O
or CC O
proliferating JJ O
cells NNS O
alter VBP O
the DT O
expression NN O
pattern NN O
of IN O
rate NN O
limiting VBG O
glycolytic JJ O
enzymes NNS O
. . O

Since IN O
glucose NN O
phosphorylation NN O
is VBZ O
the DT O
first JJ O
step NN O
in IN O
glycolysis NN O
, , O
hexokinase NN O
( -LRB- O
HK NN O
) -RRB- O
, , O
the DT O
first JJ O
rate NN O
limiting VBG O
glycolytic JJ O
enzyme NN O
, , O
can MD O
play VB O
a DT O
key JJ O
regulatory JJ O
role NN O
in IN O
this DT O
process NN O
. . O

A DT O
low JJ O
- : O
Km NN O
, , O
mitochondrial JJ O
type NN O
II NNP O
- : O
like IN O
tumor NN O
HK NNP O
is VBZ O
described VBN O
as IN O
the DT O
predominant JJ O
form NN O
in IN O
hepatomas NN O
. . O

However RB O
, , O
recent JJ O
identification NN O
of IN O
a DT O
high JJ O
- : O
Km IN O
glucose NN O
phosphorylating NN O
activity NN O
in IN O
a DT O
range NN O
of IN O
cancer NN O
cells NNS O
prompted VBN O
us PRP O
to TO O
characterize VB O
glucose NN O
phosphorylating NN O
enzymes NNS O
of IN O
cancer NN O
cells NNS O
at IN O
the DT O
molecular JJ O
level NN O
. . O

Highly NNP O
sensitive JJ O
reverse NN O
- : O
transcription NN O
polymerase NN O
chain NN O
reaction NN O
identifies VBZ O
an DT O
induction NN O
and CC O
overexpression NN O
of IN O
a DT O
type NN O
II NNP O
- : O
like IN O
tumor NN O
HK NNP O
RNA NNP O
in IN O
a DT O
range NN O
of IN O
cancer NN O
cell NN O
lines NNS O
irrespective JJ O
of IN O
tissue NN O
origin NN O
. . O

In IN O
addition NN O
, , O
we PRP O
report VBP O
here RB O
the DT O
identification NN O
of IN O
two CD O
RNA NNP O
transcripts NNS O
of IN O
type NN O
II NNP O
- : O
like IN O
tumor NN O
HK NN O
of IN O
approximately RB O
5 CD O
. . O
5 CD O
and CC O
approximately RB O
4 CD O
. . O
0 CD O
kb NN O
in IN O
these DT O
cancer NN O
cells NNS O
lines NNS O
, , O
including VBG O
muscle NN O
- : O
derived VBN O
L6 CD B-NP
myoblast JJ O
cells NNS O
. . O

Interestingly RB O
, , O
under IN O
normal JJ O
conditions NNS O
muscle NN O
cells NNS O
express VBP O
only RB O
a DT O
approximately RB O
5 CD O
. . O
5 CD O
- : O
kb NN O
type NN O
II NNP O
HK NNP O
RNA NNP O
transcript NN O
. . O

A DT O
significant JJ O
amount NN O
of IN O
type NN O
I PRP O
HK VBP O
RNA NNP O
was VBD O
also RB O
found VBN O
expressed VBN O
in IN O
cancer NN O
cell NN O
lines NNS O
. . O

RNA NNP O
encoding NN O
glucokinase NN O
( -LRB- O
GK NNP O
) -RRB- O
, , O
the DT O
high JJ O
- : O
Km IN O
HK NNP O
isozyme NN O
, , O
was VBD O
found VBN O
only RB O
in IN O
cancer NN O
cells NNS O
originating VBG O
from IN O
liver NN O
and CC O
pancreas NNS O
, , O
which WDT O
express VBP O
GK NNP O
under IN O
normal JJ O
conditions NNS O
. . O

-DOCSTART- X X O

Homeobox NNP O
genes NNS O
in IN O
hematopoiesis NN O
and CC O
leukemogenesis NN O
. . O

Homeobox NNP O
genes NNS O
have VBP O
a DT O
strikingly RB O
conserved VBN O
61 CD O
- : O
amino VBP O
acid NN O
sequence NN O
, , O
encoding VBG O
DNA NNP O
- : O
binding JJ O
domain NN O
. . O

Some DT O
homeobox NN O
genes NNS O
, , O
located VBN O
in IN O
four CD O
clusters NNS O
are VBP O
designated VBN O
HOX NNP O
A DT O
through IN O
D NNP O
, , O
while IN O
others NNS O
are VBP O
known VBN O
as IN O
divergent NN O
homeobox NN O
genes NNS O
. . O

Many JJ O
researchers NNS O
have VBP O
demonstrated VBN O
that IN O
hematopoietic JJ O
cells NNS O
express VBP O
many JJ O
homeobox NN O
genes NNS O
. . O

Induced NNP O
over IN O
- : O
and CC O
under IN O
- : O
expression NN O
of IN O
these DT O
genes NNS O
has VBZ O
been VBN O
used VBN O
to TO O
demonstrate VB O
their PRP$ O
affect VBP O
on IN O
some DT O
aspects NNS O
of IN O
hematopoiesis NN O
and CC O
leukemogenesis NN O
. . O

Recently RB O
, , O
knock VB O
- : O
out IN O
mice NNS O
of IN O
homeobox NN O
genes NNS O
by IN O
targeted JJ O
disruption NN O
have VBP O
also RB O
been VBN O
used VBN O
to TO O
examine VB O
their PRP$ O
hematological JJ O
effect NN O
. . O

There EX O
are VBP O
examples NNS O
of IN O
the DT O
aberrant JJ O
expression NN O
of IN O
a DT O
homeobox NN O
gene NN O
causing VBG O
leukemias NNS O
in IN O
humans NNS O
. . O

In IN O
pre NN O
- : O
B NN O
acute JJ O
lymphoblastic JJ O
leukemia NN O
( -LRB- O
ALL NNP O
) -RRB- O
with IN O
t NN O
( -LRB- O
1 CD O
; : O
19 CD O
) -RRB- O
translocation NN O
, , O
a DT O
fusion NN O
protein NN O
is VBZ O
created VBN O
between IN O
E2A NNP O
and CC O
a DT O
homeobox NN O
gene NN O
PBX NNP O
. . O

In IN O
T NNP O
- : O
cell NN O
ALL NNP O
with IN O
t NN O
( -LRB- O
10 CD O
; : O
14 CD O
) -RRB- O
translocation NN O
, , O
the DT O
HOX NNP O
11 CD O
gene NN O
is VBZ O
deregulated VBN O
. . O

In IN O
acute JJ O
myeloid JJ O
leukemia NN O
( -LRB- O
AML NNP O
) -RRB- O
with IN O
t NN O
( -LRB- O
7 CD O
; : O
11 CD O
) -RRB- O
translocation NN O
, , O
the DT O
HOX NNP O
A9 NNP O
gene NN O
is VBZ O
rearranged VBN O
. . O

In IN O
this DT O
review NN O
article NN O
, , O
many JJ O
functions NNS O
of IN O
homeobox NN O
genes NNS O
both CC O
at IN O
the DT O
early JJ O
stem NN O
cell NN O
level NN O
as RB O
well RB O
as IN O
at IN O
the DT O
later JJ O
stages NNS O
of IN O
hematopoietic JJ O
differentiation NN O
, , O
and CC O
the DT O
leukemogenic JJ O
effect NN O
of IN O
altered VBN O
homeobox NN O
genes NNS O
are VBP O
discussed VBN O
. . O

-DOCSTART- X X O

The DT O
myoadipose NN O
flap NN O
: : O
a DT O
new JJ O
composite NN O
. . O

A DT O
prefabricated JJ O
composite JJ O
fat JJ O
flap NN O
consisting VBG O
of IN O
muscle NN O
woven VBN O
into IN O
an DT O
anatomically RB O
distinct JJ O
fat JJ O
pad NN O
was VBD O
studied VBN O
in IN O
a DT O
rabbit NN O
model NN O
. . O

In IN O
17 CD O
rabbits NNS O
, , O
a DT O
2 CD O
- : O
cm NN O
strip NN O
of IN O
latissimus NN O
dorsi NN O
was VBD O
woven VBN O
into IN O
the DT O
parascapular JJ O
fat JJ O
pad NN O
on IN O
one CD O
side NN O
, , O
with IN O
the DT O
contralateral JJ O
fat JJ O
pad NN O
serving VBG O
as IN O
a DT O
control NN O
. . O

At IN O
3 CD O
weeks NNS O
, , O
the DT O
endogenous JJ O
blood NN O
supply NN O
of IN O
both DT O
the DT O
control NN O
and CC O
the DT O
experimental JJ O
fat JJ O
pads NNS O
was VBD O
isolated VBN O
and CC O
ligated VBN O
, , O
and CC O
the DT O
composite JJ O
fat JJ O
/ NN O
muscle NN O
flap NN O
was VBD O
transferred VBN O
to TO O
the DT O
chest NN O
wall NN O
. . O

At IN O
6 CD O
weeks NNS O
, , O
animals NNS O
were VBD O
killed VBN O
, , O
and CC O
flaps NNS O
were VBD O
analyzed VBN O
for IN O
length NN O
, , O
width JJ O
, , O
and CC O
weight NN O
; : O
perfused VBN O
with IN O
fluorescein NN O
or CC O
lead NN O
oxide NN O
; : O
and CC O
examined VBD O
histologically RB O
. . O

Significant JJ O
differences NNS O
were VBD O
found VBN O
between IN O
the DT O
control NN O
and CC O
experimental JJ O
fat JJ O
pads NNS O
with IN O
regard NN O
to TO O
weight NN O
and CC O
length NN O
. . O

Experimental JJ O
flaps NNS O
were VBD O
found VBN O
to TO O
be VB O
perfused VBN O
fully RB O
with IN O
fluorescein NN O
and CC O
lead NN O
oxide NN O
; : O
control NN O
fat JJ O
pads NNS O
were VBD O
found VBN O
not RB O
to TO O
be VB O
perfused VBN O
. . O

The DT O
lead NN O
oxide NN O
group NN O
revealed VBD O
extensive JJ O
growth NN O
of IN O
blood NN O
vessels NNS O
from IN O
the DT O
latissimus NN O
graft NN O
into IN O
the DT O
experimental JJ O
fat JJ O
pad NN O
. . O

No DT O
vessels NNS O
were VBD O
visualized VBN O
in IN O
the DT O
controls NNS O
. . O

Finally RB O
, , O
sections NNS O
of IN O
the DT O
control NN O
and CC O
experimental JJ O
flaps NNS O
were VBD O
analyzed VBN O
histologically RB O
. . O

A DT O
preponderance NN O
of IN O
viable JJ O
fat JJ O
, , O
with IN O
evidence NN O
of IN O
neovascularization NN O
, , O
was VBD O
found VBN O
in IN O
experimental JJ O
flaps NNS O
, , O
compared VBN O
with IN O
the DT O
necrotic JJ O
fat JJ O
that WDT O
characterized VBD O
the DT O
controls NNS O
. . O

We PRP O
conclude VBP O
that IN O
prefabrication NN O
of IN O
a DT O
fat JJ O
flap NN O
is VBZ O
possible JJ O
and CC O
may MD O
have VB O
extensive JJ O
application NN O
in IN O
various JJ O
areas NNS O
of IN O
plastic NN O
surgery NN O
. . O

-DOCSTART- X X O

Store NNP O
- : O
operated VBN O
calcium NN O
entry NN O
promotes VBZ O
shape NN O
change NN O
in IN O
pulmonary JJ O
endothelial JJ O
cells NNS O
expressing VBG O
Trp1 NNP O
. . O

Activation NN O
of IN O
Ca2 NNP O
+ NNP O
entry NN O
is VBZ O
known VBN O
to TO O
produce VB O
endothelial JJ O
cell NN O
shape NN O
change NN O
, , O
leading VBG O
to TO O
increased VB O
permeability NN O
, , O
leukocyte NN O
migration NN O
, , O
and CC O
initiation NN O
of IN O
angiogenesis NN O
in IN O
conduit NN O
- : O
vessel NN O
endothelial NN O
cells NNS O
. . O

The DT O
mode NN O
of IN O
Ca2 NNP O
+ NNP O
entry NN O
regulating NN O
cell NN O
shape NN O
is VBZ O
unknown JJ O
. . O

We PRP O
hypothesized VBD O
that IN O
activation NN O
of IN O
store NN O
- : O
operated VBN O
Ca2 IN O
+ JJ O
channels NNS O
( -LRB- O
SOCs NNS O
) -RRB- O
is VBZ O
sufficient JJ O
to TO O
promote VB O
cell NN O
shape NN O
change NN O
necessary JJ O
for IN O
these DT O
processes NNS O
. . O

SOC JJ O
activation NN O
in IN O
rat NN O
pulmonary NN O
arterial JJ O
endothelial JJ O
cells NNS O
increased VBN O
free JJ O
cytosolic JJ O
Ca2 JJ O
+ NN O
that WDT O
was VBD O
dependent JJ O
on IN O
a DT O
membrane NN O
current JJ O
having VBG O
a DT O
net JJ O
inward JJ O
component NN O
of IN O
5 CD O
. . O
45 CD O
+ NN O
/ RB O
- : O
0 CD O
. . O
90 CD O
pA NN O
/ JJ O
pF NN O
at IN O
- : O
80 CD O
mV NN O
. . O

Changes NNS O
in IN O
endothelial JJ O
cell NN O
shape NN O
accompanied VBN O
SOC NNP O
activation NN O
and CC O
were VBD O
dependent JJ O
on IN O
Ca2 NNP O
+ NNP O
entry NN O
- : O
induced VBN O
reconfiguration NN O
of IN O
peripheral JJ O
( -LRB- O
cortical JJ O
) -RRB- O
filamentous JJ O
actin NN O
( -LRB- O
F NNP O
- : O
actin NN O
) -RRB- O
. . O

Because IN O
the DT O
identity NN O
of IN O
pulmonary JJ O
endothelial JJ O
SOCs NNS O
is VBZ O
unknown JJ O
, , O
but CC O
mammalian JJ O
homologues NNS O
of IN O
the DT O
Drosophila NNP O
melanogaster NN O
transient NN O
receptor NN O
potential JJ O
( -LRB- O
trp NN O
) -RRB- O
gene NN O
have VBP O
been VBN O
proposed VBN O
to TO O
form VB O
Ca2 IN O
+ JJ O
entry NN O
channels NNS O
in IN O
nonexcitable JJ O
cells NNS O
, , O
we PRP O
performed VBD O
RT NNP O
- : O
PCR NN O
using VBG O
Trp NNP O
oligonucleotide NNP O
primers NNS O
in IN O
both DT O
rat NN O
and CC O
human JJ O
pulmonary NN O
arterial NN O
endothelial JJ O
cells NNS O
. . O

Both DT O
cell NN O
types NNS O
were VBD O
found VBN O
to TO O
express VB O
Trp1 NNP O
, , O
but CC O
neither DT O
expressed VBN O
Trp3 NNP O
nor CC O
Trp6 NNP O
. . O

Our PRP$ O
study NN O
indicates VBZ O
that IN O
1 CD O
) -RRB- O
Ca2 IN O
+ JJ O
entry NN O
in IN O
pulmonary JJ O
endothelial JJ O
cells NNS O
through IN O
SOCs JJ O
produces VBZ O
cell NN O
shape NN O
change NN O
that WDT O
is VBZ O
dependent JJ O
on IN O
site NN O
- : O
specific JJ O
rearrangement NN O
of IN O
the DT O
microfilamentous JJ O
cytoskeleton NN O
and CC O
2 CD O
) -RRB- O
Trp1 NNPS O
may MD O
be VB O
a DT O
component NN O
of IN O
pulmonary JJ O
endothelial JJ O
SOCs NNS O
. . O

-DOCSTART- X X O

Brainstem NN O
auditory NN O
- : O
evoked JJ O
potential JJ O
evaluation NN O
in IN O
children NNS O
with IN O
meningitis NNS O
. . O

Brainstem NN O
auditory NN O
- : O
evoked JJ O
potential NN O
( -LRB- O
BAEP NNP O
) -RRB- O
was VBD O
performed VBN O
on IN O
101 CD O
children NNS O
with IN O
meningitis NN O
to TO O
assess VB O
the DT O
incidence NN O
of IN O
hearing VBG O
impairment NN O
. . O

Fifty CD O
- : O
two CD O
( -LRB- O
51 CD O
. . O
5 CD O
% NN O
) -RRB- O
children NNS O
had VBD O
bacterial JJ O
meningitis NN O
, , O
six CD O
( -LRB- O
5 CD O
. . O
9 CD O
% NN O
) -RRB- O
had VBD O
viral JJ O
meningitis NN O
, , O
and CC O
43 CD O
( -LRB- O
42 CD O
. . O
6 CD O
% NN O
) -RRB- O
had VBD O
aseptic JJ O
meningitis NN O
. . O

Fifty CD O
- : O
one CD O
( -LRB- O
50 CD O
. . O
5 CD O
% NN O
) -RRB- O
patients NNS O
were VBD O
assessed VBN O
before IN O
discharge NN O
and CC O
50 CD O
( -LRB- O
49 CD O
. . O
5 CD O
% NN O
) -RRB- O
9 CD O
days NNS O
to TO O
17 CD O
months NNS O
later RB O
( -LRB- O
mean VB O
= SYM O
4 CD O
months NNS O
) -RRB- O
. . O

BAEP NNP O
impairment NN O
was VBD O
found VBN O
in IN O
28 CD O
( -LRB- O
27 CD O
. . O
7 CD O
% NN O
) -RRB- O
of IN O
101 CD O
patients NNS O
; : O
24 CD O
had VBD O
sensorineural JJ O
and CC O
four CD O
had VBD O
conductive JJ O
type NN O
of IN O
hearing NN O
loss NN O
, , O
and CC O
17 CD O
( -LRB- O
60 CD O
. . O
7 CD O
% NN O
) -RRB- O
had VBD O
unilateral JJ O
and CC O
11 CD O
( -LRB- O
39 CD O
. . O
3 CD O
% NN O
) -RRB- O
had VBD O
bilateral JJ O
impairment NN O
. . O

Hearing VBG O
threshold NN O
was VBD O
elevated VBN O
in IN O
22 CD O
( -LRB- O
21 CD O
. . O
8 CD O
% NN O
) -RRB- O
patients NNS O
, , O
and CC O
the DT O
other JJ O
six CD O
had VBD O
increased VBN O
latency RB O
and CC O
interpeak VB O
latencies NNS O
with IN O
normal JJ O
threshold NN O
. . O

Frequency NNP O
of IN O
BAEP NNP O
impairment NN O
or CC O
hearing NN O
loss NN O
associated VBN O
with IN O
bacterial JJ O
meningitis NN O
was VBD O
34 CD O
. . O
6 CD O
% NN O
and CC O
30 CD O
. . O
8 CD O
% NN O
, , O
respectively RB O
; : O
frequency NN O
associated VBN O
with IN O
aseptic JJ O
meningitis NN O
was VBD O
20 CD O
. . O
9 CD O
% NN O
and CC O
13 CD O
. . O
9 CD O
% NN O
, , O
respectively RB O
. . O

One CD O
child NN O
with IN O
viral JJ O
meningitis NN O
( -LRB- O
coxsackie NN O
virus NN O
) -RRB- O
had VBD O
mild JJ O
BAEP NNP O
impairment NN O
. . O

Most JJS O
of IN O
the DT O
BAEP NNP O
impairment NN O
in IN O
the DT O
bacterial JJ O
meningitis NN O
group NN O
was VBD O
associated VBN O
with IN O
H NNP O
. . O
influenzae NNS O
. . O

Prospective JJ O
BAEP NNP O
study NN O
was VBD O
performed VBN O
in IN O
20 CD O
patients NNS O
randomly RB O
at IN O
0 CD O
. . O
3 CD O
to TO O
18 CD O
months NNS O
to TO O
assess VB O
hearing NN O
status NN O
after IN O
antibiotic JJ O
treatment NN O
, , O
10 CD O
with IN O
normal JJ O
and CC O
10 CD O
with IN O
abnormal JJ O
BAEP NNP O
. . O

All PDT O
the DT O
initially RB O
normal JJ O
BAEP NNP O
patients NNS O
remained VBD O
normal JJ O
. . O

Of IN O
the DT O
10 CD O
patients NNS O
with IN O
abnormal JJ O
BAEP NNP O
results NNS O
initially RB O
, , O
four CD O
returned VBD O
to TO O
normal JJ O
, , O
two CD O
improved VBD O
, , O
three CD O
remained VBD O
unchanged JJ O
, , O
and CC O
one CD O
deteriorated VBN O
. . O

The DT O
incidence NN O
of IN O
hearing VBG O
loss NN O
after IN O
bacterial JJ O
and CC O
aseptic JJ O
meningitis NN O
is VBZ O
high JJ O
. . O

BAEP NNP O
is VBZ O
useful JJ O
to TO O
screen NN O
for IN O
possible JJ O
hearing NN O
loss NN O
in IN O
children NNS O
with IN O
meningitis NNS O
, , O
and CC O
follow VB O
- : O
up RP O
BAEP NNP O
is VBZ O
necessary JJ O
for IN O
those DT O
patients NNS O
with IN O
initially RB O
abnormal JJ O
BAEP NNP O
. . O

-DOCSTART- X X O

Hemispheric JJ O
control NN O
of IN O
motor NN O
function NN O
: : O
a DT O
whole JJ O
brain NN O
echo NN O
planar JJ O
fMRI JJ O
study NN O
. . O

The DT O
aim NN O
of IN O
this DT O
study NN O
was VBD O
to TO O
explore VB O
whether IN O
recruitment NN O
of IN O
the DT O
ipsilateral JJ O
motor NN O
cortex NN O
during IN O
non FW O
- : O
dominant JJ O
motor NN O
movement NN O
reflects VBZ O
left VBN O
hemispheric JJ O
control NN O
of IN O
motor NN O
function NN O
or CC O
simply RB O
the DT O
greater JJR O
complexity NN O
or CC O
unfamiliarity NN O
of IN O
the DT O
motor NN O
task NN O
. . O

BOLD NNP O
fMRI NN O
was VBD O
performed VBN O
in IN O
normal JJ O
right JJ O
- : O
handers NNS O
during IN O
two CD O
motor NN O
tasks NNS O
: : O
( -LRB- O
1 CD O
) -RRB- O
sequential JJ O
finger NN O
movements NNS O
( -LRB- O
SM NNP O
task NN O
) -RRB- O
with IN O
the DT O
right NN O
or CC O
left JJ O
hand NN O
; : O
and CC O
( -LRB- O
2 CD O
) -RRB- O
random JJ O
finger NN O
movements NNS O
( -LRB- O
RM NN O
task NN O
) -RRB- O
with IN O
the DT O
right JJ O
hand NN O
. . O

In IN O
all DT O
subjects NNS O
, , O
activation NN O
was VBD O
predominantly RB O
in IN O
the DT O
contralateral JJ O
motor NN O
areas NNS O
( -LRB- O
primary JJ O
sensorimotor NN O
, , O
lateral JJ O
premotor NN O
, , O
parietal NN O
and CC O
supplementary JJ O
motor NN O
regions NNS O
) -RRB- O
and CC O
ipsilateral JJ O
cerebellum NN O
. . O

While IN O
the DT O
ipsilateral JJ O
motor NN O
areas NNS O
were VBD O
also RB O
activated VBN O
, , O
single JJ O
subject JJ O
analysis NN O
revealed VBD O
these DT O
areas NNS O
to TO O
be VB O
more RBR O
extensive JJ O
and CC O
to TO O
be VB O
seen VBN O
in IN O
more JJR O
subjects NNS O
during IN O
the DT O
non FW O
- : O
dominant JJ O
hand NN O
SM NNP O
task NN O
and CC O
dominant JJ O
hand NN O
RM NN O
task NN O
than IN O
during IN O
the DT O
more RBR O
familiar JJ O
dominant JJ O
hand NN O
SM NNP O
task NN O
. . O

Similarly RB O
, , O
group NN O
analysis NN O
also RB O
revealed VBD O
ipsilateral JJ O
activation NN O
in IN O
the DT O
primary JJ O
sensorimotor NN O
and CC O
lateral JJ O
premotor NN O
areas NNS O
, , O
but CC O
only RB O
during IN O
the DT O
non FW O
- : O
dominant JJ O
SM NNP O
task NN O
and CC O
the DT O
dominant JJ O
hand NN O
RM NN O
task NN O
. . O

Non FW O
- : O
dominant JJ O
hand NN O
movements NNS O
, , O
perhaps RB O
because IN O
they PRP O
are VBP O
less JJR O
' '' O
automatic JJ O
' '' O
, , O
appear VBP O
to TO O
require VB O
more JJR O
cortical JJ O
activity NN O
similar JJ O
to TO O
complex JJ O
tasks NNS O
with IN O
the DT O
dominant JJ O
hand NN O
, , O
and CC O
result VBP O
in IN O
greater JJR O
recruitment NN O
of IN O
ipsilateral JJ O
cortical JJ O
motor NN O
areas NNS O
and CC O
striatum NN O
. . O

The DT O
study NN O
also RB O
illustrates VBZ O
how WRB O
potentially RB O
meaningful JJ O
subtleties NNS O
seen VBN O
on IN O
individual JJ O
maps NNS O
may MD O
be VB O
obscured JJ O
with IN O
group NN O
averaging NN O
approaches NNS O
. . O

-DOCSTART- X X O

[ JJ O
The DT O
assessment NN O
of IN O
flow NN O
velocity NN O
in IN O
carotid NN O
and CC O
intracranial JJ O
arteries NNS O
in IN O
three CD O
different JJ O
age NN O
groups NNS O
] SYM O
. . O

In IN O
this DT O
report NN O
we PRP O
assess VBP O
the DT O
systolic JJ O
maximal NN O
flow NN O
velocity NN O
in IN O
carotid NN O
and CC O
intracranial JJ O
arteries NNS O
in IN O
191 CD O
subjects NNS O
with IN O
no DT O
history NN O
of IN O
cerebral JJ O
vascular JJ O
disease NN O
in IN O
3 CD O
age NN O
groups NNS O
: : O
20 CD O
- : O
40 CD O
years NNS O
( -LRB- O
1 CD O
group NN O
) -RRB- O
, , O
41 CD O
- : O
60 CD O
years NNS O
( -LRB- O
2 CD O
group NN O
) -RRB- O
, , O
and CC O
above IN O
60 CD O
years NNS O
( -LRB- O
3 CD O
group NN O
) -RRB- O
. . O

The DT O
subjects NNS O
were VBD O
assessed VBN O
using VBG O
Sonomed NNP O
Transcranial NNP O
Doppler NNP O
Spectrograph NNP O
according VBG O
to TO O
generally RB O
accepted VBN O
principles NNS O
. . O

The DT O
purpose NN O
of IN O
the DT O
study NN O
was VBD O
to TO O
establish VB O
the DT O
mean JJ O
value NN O
of IN O
maximal JJ O
flow NN O
velocity NN O
in IN O
each DT O
particular JJ O
artery NN O
in IN O
three CD O
age NN O
groups NNS O
, , O
and CC O
to TO O
observe VB O
the DT O
changes NNS O
in IN O
this DT O
parameter NN O
with IN O
age NN O
. . O

The DT O
results NNS O
were VBD O
analyzed VBN O
using VBG O
statistical JJ O
methods NNS O
and CC O
a DT O
significant JJ O
decrease NN O
in IN O
blood NN O
flow NN O
, , O
Vmax NNP O
, , O
was VBD O
found VBN O
in IN O
all DT O
investigated VBN O
arteries NNS O
. . O

A DT O
mean JJ O
decrease NN O
of IN O
8 CD O
. . O
02 CD O
% NN O
in IN O
flow NN O
velocity NN O
Vmax NNP O
was VBD O
found VBN O
, , O
when WRB O
comparing VBG O
groups NNS O
2 CD O
and CC O
1 CD O
, , O
and CC O
difference NN O
15 CD O
. . O
99 CD O
% NN O
comparing NN O
3 CD O
and CC O
1 CD O
. . O

-DOCSTART- X X O

Lack NN O
of IN O
developmental JJ O
and CC O
reproductive JJ O
toxicity NN O
of IN O
2 CD O
, , O
3 CD O
, , O
3 CD O
' '' O
, , O
4 CD O
, , O
4 CD O
' '' O
- : O
pentachlorobiphenyl NN O
( -LRB- O
PCB NN O
105 CD O
) -RRB- O
in IN O
ring NN O
- : O
necked JJ O
pheasants NNS O
. . O

Mono NNP O
- : O
ortho NN O
PCBs NNS O
are VBP O
global JJ O
contaminants NNS O
of IN O
wildlife NN O
with IN O
the DT O
potential JJ O
to TO O
produce VB O
toxicity NN O
by IN O
an DT O
aryl NN O
hydrocarbon NN O
receptor NN O
( -LRB- O
AhR NN O
) -RRB- O
- : O
mediated JJ O
mechanism NN O
. . O

To TO O
determine VB O
the DT O
potency NN O
of IN O
2 CD O
, , O
3 CD O
, , O
3 CD O
' '' O
, , O
4 CD O
, , O
4 CD O
' '' O
- : O
pentachlorobiphenyl NN O
( -LRB- O
PCB NN O
105 CD O
) -RRB- O
for IN O
producing VBG O
reproductive JJ O
and CC O
developmental JJ O
toxicity NN O
, , O
adult NN O
ring NN O
- : O
necked JJ O
pheasant JJ O
hens NNS O
( -LRB- O
Phasianus NN O
colchicus NN O
) -RRB- O
were VBD O
orally RB O
dosed VBN O
with IN O
0 CD O
, , O
0 CD O
. . O
06 CD O
, , O
0 CD O
. . O
6 CD O
, , O
or CC O
6 CD O
mg NN O
PCB NNP O
105 CD O
/ IN O
kg JJ O
hen NN O
/ VBD O
week NN O
for IN O
10 CD O
weeks NNS O
to TO O
achieve VB O
cumulative JJ O
doses NNS O
of IN O
0 CD O
, , O
0 CD O
. . O
6 CD O
, , O
6 CD O
, , O
or CC O
60 CD O
mg NN O
PCB NNP O
105 CD O
/ IN O
kg JJ O
hen NN O
after IN O
which WDT O
hens NNS O
were VBD O
bred VBN O
with IN O
untreated JJ O
roosters NNS O
once RB O
per IN O
week NN O
for IN O
8 CD O
weeks NNS O
. . O

Except IN O
at IN O
week NN O
6 CD O
of IN O
the DT O
egg NN O
- : O
laying NN O
period NN O
when WRB O
cumulative JJ O
egg NN O
production NN O
in IN O
the DT O
6 CD O
mg NN O
PCB NNP O
105 CD O
/ IN O
kg JJ O
hen NN O
group NN O
was VBD O
greater JJR O
than IN O
controls NNS O
, , O
fertilized VBN O
egg NN O
production NN O
was VBD O
not RB O
significantly RB O
different JJ O
between IN O
treatment NN O
groups NNS O
. . O

Embryo NN O
mortality NN O
and CC O
chick NN O
mortality NN O
were VBD O
not RB O
significantly RB O
different JJ O
between IN O
treatment NN O
groups NNS O
. . O

Total JJ O
body NN O
and CC O
heart NN O
weights NNS O
of IN O
all DT O
chicks NNS O
1 CD O
day NN O
posthatch NN O
( -LRB- O
dph NN O
) -RRB- O
were VBD O
not RB O
different JJ O
between IN O
groups NNS O
, , O
however RB O
, , O
liver NN O
weights NNS O
of IN O
chicks NNS O
from IN O
the DT O
60 CD O
mg NN O
/ RBR O
kg JJ O
treatment NN O
group NN O
were VBD O
greater JJR O
than IN O
controls NNS O
at IN O
1 CD O
dph NN O
. . O

The DT O
first JJ O
chick NN O
to TO O
hatch NN O
from IN O
each DT O
hen NN O
was VBD O
reared VBN O
to TO O
21 CD O
dph NN O
and CC O
among IN O
these DT O
birds NNS O
, , O
the DT O
total JJ O
body NN O
, , O
liver NN O
, , O
and CC O
heart NN O
weights NNS O
were VBD O
not RB O
different JJ O
between IN O
groups NNS O
. . O

There EX O
were VBD O
no DT O
dose NN O
- : O
related JJ O
malformations NNS O
of IN O
the DT O
beak NN O
or CC O
limbs NNS O
, , O
and CC O
no DT O
signs NNS O
of IN O
subcutaneous JJ O
edema NN O
, , O
ascites NNS O
, , O
or CC O
pericardial JJ O
edema NN O
in IN O
chicks NNS O
at IN O
1 CD O
or CC O
21 CD O
dph NN O
. . O

Hepatic JJ O
microsomal JJ O
monooxygenase NN O
activities NNS O
[ VBP O
ethoxyresorufin VBG O
- : O
O UH O
- : O
dealkylase NN O
( -LRB- O
EROD NNP O
) -RRB- O
, , O
benzyloxyresorufin VBG O
- : O
O UH O
- : O
dealkylase NN O
( -LRB- O
BROD NN O
) -RRB- O
, , O
and CC O
methyloxyresorufin NN O
- : O
O UH O
- : O
dealkylase NN O
( -LRB- O
MROD NNP O
) -RRB- O
] SYM O
were VBD O
significantly RB O
elevated VBN O
in IN O
chicks NNS O
at IN O
1 CD O
dph NN O
from IN O
hens NNS O
given VBN O
a DT O
cumulative JJ O
PCB NN O
105 CD O
dose NN O
of IN O
6 CD O
mg NN O
/ NN O
kg NN O
and CC O
in IN O
chicks NNS O
at IN O
21 CD O
dph NN O
from IN O
hens NNS O
given VBN O
a DT O
cumulative JJ O
PCB NN O
dose NN O
of IN O
60 CD O
mg NN O
/ NN O
kg NN O
. . O

These DT O
results NNS O
indicate VBP O
that IN O
a DT O
cumulative JJ O
PCB NNP O
105 CD O
dose NN O
up IN O
to TO O
60 CD O
mg NN O
/ IN O
kg JJ O
hen NN O
does VBZ O
not RB O
decrease VB O
the DT O
production NN O
of IN O
fertilized VBN O
eggs NNS O
or CC O
increase VB O
embryo NN O
or CC O
chick NN O
mortality NN O
in IN O
ring NN O
- : O
necked JJ O
pheasants NNS O
, , O
but CC O
does VBZ O
increase NN O
chick NN O
hepatic JJ O
monooxygenase NN O
activity NN O
. . O

-DOCSTART- X X O

Glucose NNP O
and CC O
lactate NN O
metabolism NN O
in IN O
C6 DT B-NP
glioma NN O
cells NNS O
: : O
evidence NN O
for IN O
the DT O
preferential JJ O
utilization NN O
of IN O
lactate NN O
for IN O
cell NN O
oxidative JJ O
metabolism NN O
. . O

13C JJ O
and CC O
1H JJ O
nuclear JJ O
magnetic JJ O
resonance NN O
spectroscopy NN O
( -LRB- O
NMR NN O
) -RRB- O
was VBD O
used VBN O
to TO O
investigate VB O
the DT O
metabolism NN O
of IN O
L NNP O
- : O
lactate NN O
and CC O
D LS O
- : O
glucose NN O
in IN O
C6 DT B-NP
glioma NN O
cells NNS O
. . O

The DT O
13C JJ O
enrichment NN O
of IN O
cell NN O
metabolites NNS O
was VBD O
examined VBN O
after IN O
a DT O
4 LS O
- : O
h JJ O
incubation NN O
in IN O
media NNS O
containing VBG O
5 CD O
. . O
5 CD O
mM NN O
glucose NN O
and CC O
11 CD O
mM JJ O
lactate NN O
, , O
each DT O
metabolite NN O
being VBG O
alternatively RB O
labelled VBN O
with IN O
either DT O
[ NN O
1 LS O
- : O
13C JJ O
] NN O
D NNP O
- : O
glucose NN O
or CC O
[ NN O
3 LS O
- : O
13C JJ O
] SYM O
L NNP O
- : O
lactate NN O
. . O

The DT O
results NNS O
indicated VBD O
that IN O
exogenous JJ O
lactate NN O
was VBD O
the DT O
major JJ O
substrate NN O
for IN O
oxidative JJ O
metabolism NN O
. . O

They PRP O
were VBD O
consistent JJ O
with IN O
the DT O
concept NN O
of IN O
the DT O
existence NN O
of IN O
2 CD O
pools NNS O
of IN O
both DT O
lactate NN O
and CC O
pyruvate JJ O
, , O
of IN O
which WDT O
1 CD O
pool NN O
was VBD O
closely RB O
connected VBN O
with IN O
exogenous JJ O
lactate NN O
and CC O
oxidative JJ O
metabolism NN O
, , O
and CC O
the DT O
other JJ O
pool NN O
was VBD O
closely RB O
related VBN O
to TO O
glycolysis NN O
and CC O
disconnected VBD O
from IN O
oxidative JJ O
metabolism NN O
. . O

The DT O
molecular JJ O
basis NN O
of IN O
this DT O
behaviour NN O
could MD O
be VB O
related VBN O
to TO O
different JJ O
locations NNS O
for IN O
the DT O
lactate NN O
dehydrogenase NN O
isoenzymes NNS O
, , O
as IN O
suggested VBN O
by IN O
their PRP$ O
immunohistochemical JJ O
labelling NN O
. . O

-DOCSTART- X X O

Detection NNP O
of IN O
total JJ O
assist VB O
and CC O
sucking VBG O
points NNS O
based VBN O
on IN O
the DT O
pulsatility NN O
of IN O
a DT O
continuous JJ O
flow NN O
artificial JJ O
heart NN O
: : O
in IN O
vivo JJ O
evaluation NN O
. . O

Our PRP$ O
novel NN O
control NN O
strategy NN O
for IN O
a DT O
continuous JJ O
flow NN O
artificial JJ O
heart NN O
by IN O
detecting VBG O
the DT O
total NN O
assist VB O
and CC O
sucking VBG O
points NNS O
based VBN O
on IN O
pump NN O
pulsatility NN O
was VBD O
evaluated VBN O
in IN O
acute JJ O
animal NN O
experiments NNS O
using VBG O
beagle JJ O
dogs NNS O
and CC O
our PRP$ O
mixed JJ O
flow NN O
pump NN O
. . O

The DT O
pump NN O
was VBD O
installed VBN O
as IN O
a DT O
left JJ O
ventricular NN O
( -LRB- O
LV NN O
) -RRB- O
bypass VBZ O
through IN O
a DT O
left JJ O
thoracotomy NN O
. . O

To TO O
change VB O
LV NNP O
contractility NN O
, , O
the DT O
left VBN O
coronary JJ O
arteries NNS O
were VBD O
occluded VBN O
for IN O
30 CD O
min NN O
, , O
followed VBN O
by IN O
a DT O
120 CD O
min NN O
reperfusion NN O
. . O

To TO O
change VB O
LV DT O
end NN O
diastolic JJ O
pressure NN O
( -LRB- O
LVEDP NNP O
) -RRB- O
, , O
dextran JJ O
solution NN O
was VBD O
rapidly RB O
infused VBN O
. . O

To TO O
estimate VB O
the DT O
pump NN O
pulsatility NN O
without IN O
any DT O
specific JJ O
sensor NN O
, , O
we PRP O
calculated VBD O
the DT O
index NN O
of IN O
current JJ O
amplitude NN O
( -LRB- O
ICA NNP O
) -RRB- O
, , O
which WDT O
was VBD O
obtained VBN O
from IN O
the DT O
amplitude NN O
of IN O
the DT O
motor NN O
current JJ O
waveform NN O
divided VBN O
by IN O
the DT O
simultaneous JJ O
mean JJ O
value NN O
. . O

To TO O
investigate VB O
the DT O
basic JJ O
characteristics NNS O
of IN O
the DT O
ICA NNP O
, , O
the DT O
pump NN O
speed NN O
was VBD O
changed VBN O
temporarily RB O
from IN O
2 CD O
, , O
300 CD O
rpm NN O
to TO O
5 CD O
, , O
000 CD O
rpm NN O
. . O

In IN O
92 CD O
% NN O
of IN O
all DT O
measurements NNS O
, , O
the DT O
ICA NNP O
plotted VBD O
against IN O
the DT O
pump NN O
speed NN O
had VBD O
a DT O
peak NN O
point NN O
( -LRB- O
t NN O
- : O
point NN O
) -RRB- O
that IN O
corresponded JJ O
highly RB O
with IN O
the DT O
turning VBG O
point NN O
from IN O
partial JJ O
to TO O
total JJ O
assistance NN O
. . O

The DT O
ICA NNP O
also RB O
had VBD O
a DT O
trough NN O
( -LRB- O
s VBZ O
- : O
point NN O
) -RRB- O
that IN O
corresponded VBN O
with IN O
the DT O
beginning NN O
of IN O
severe JJ O
sucking NN O
in IN O
most JJS O
cases NNS O
. . O

Only RB O
preload VBP O
significantly RB O
influenced VBN O
pump NN O
flow NN O
rate NN O
at IN O
the DT O
t NN O
- : O
point NN O
from IN O
among IN O
preload NN O
( -LRB- O
LVEDP NNP O
) -RRB- O
, , O
afterload NN O
( -LRB- O
SAoP NNP O
) -RRB- O
, , O
and CC O
contractility NN O
( -LRB- O
max NN O
LV NNP O
dP IN O
/ JJ O
dt NN O
) -RRB- O
, , O
by IN O
which WDT O
we PRP O
can MD O
simulate VB O
Starling VBG O
' '' O
s PRP O
law NN O
of IN O
the DT O
natural JJ O
heart NN O
. . O

We PRP O
concluded VBD O
that IN O
a DT O
continuous JJ O
flow NN O
artificial JJ O
heart NN O
could MD O
be VB O
well RB O
controlled VBN O
by IN O
detecting VBG O
the DT O
t NN O
- : O
point NN O
and CC O
s VBZ O
- : O
point NN O
. . O

-DOCSTART- X X O

Tumors NNS O
of IN O
the DT O
retinal JJ O
pigment NN O
epithelium NN O
metastasize NN O
to TO O
inguinal JJ O
lymph NN O
nodes NNS O
and CC O
spleen JJ O
in IN O
tyrosinase NN O
- : O
related JJ O
protein NN O
1 CD O
/ NN O
SV40 IN O
T NNP O
antigen IN O
transgenic JJ O
mice NNS O
. . O

The DT O
pigment NN O
epithelium NN O
of IN O
the DT O
retina NN O
( -LRB- O
RPE NN O
) -RRB- O
is VBZ O
derived VBN O
from IN O
the DT O
optic JJ O
cup NN O
and CC O
is VBZ O
essential JJ O
for IN O
function NN O
and CC O
development NN O
of IN O
the DT O
eye NN O
. . O

We PRP O
produced VBD O
a DT O
transgenic JJ O
mouse NN O
line NN O
that IN O
expresses NNS O
simian JJ O
virus NN O
( -LRB- O
SV40 NN O
) -RRB- O
transforming VBG O
sequences NNS O
under IN O
control NN O
of IN O
the DT O
1 CD O
. . O
4 CD O
kb NN O
tyrosinase NN O
- : O
related JJ O
protein NN O
1 CD O
( -LRB- O
TRP NNP O
- : O
1 CD O
) -RRB- O
promoter NN O
, , O
targeting VBG O
expression NN O
of IN O
T NNP O
antigen NN O
( -LRB- O
Tag NNP O
) -RRB- O
to TO O
the DT O
RPE NNP O
. . O

In IN O
transgenic JJ O
embryos NNS O
, , O
RPE NNP O
cells NNS O
proliferated VBN O
in IN O
the DT O
anterior JJ O
part NN O
of IN O
the DT O
eye NN O
and CC O
near IN O
the DT O
optic JJ O
nerve NN O
. . O

This DT O
resulted VBD O
in IN O
formation NN O
of IN O
tumors NNS O
, , O
which WDT O
were VBD O
pigmented VBN O
and CC O
of IN O
epithelial JJ O
origin NN O
. . O

In IN O
3 CD O
months NNS O
- : O
old JJ O
mice NNS O
, , O
pigmented VBD O
cells NNS O
were VBD O
detected VBN O
in IN O
spleen JJ O
and CC O
inguinal JJ O
lymph NN O
nodes NNS O
. . O

In IN O
spleen JJ O
, , O
tyrosinase NN O
, , O
TRP NNP O
- : O
1 CD O
and CC O
SV40 CD O
Tag NNP O
were VBD O
expressed VBN O
and CC O
tyrosinase NN O
was VBD O
enzymatically RB O
active JJ O
. . O

Pigmented VBN O
regions NNS O
were VBD O
positive JJ O
for IN O
an DT O
epithelial NN O
marker NN O
, , O
cytokeratin NN O
. . O

Cell NN O
lines NNS O
were VBD O
established VBN O
from IN O
tumor NN O
and CC O
metastases NNS O
and CC O
kept VBD O
in IN O
culture NN O
for IN O
more JJR O
than IN O
2 CD O
months NNS O
. . O

These DT O
were VBD O
pigmented JJ O
, , O
and CC O
maintained VBD O
expression NN O
of IN O
tyrosinase NN O
, , O
TRP NNP O
- : O
1 CD O
, , O
cytokeratin NN O
and CC O
SV40 DT O
Tag NNP O
. . O

This DT O
demonstrates VBZ O
that IN O
RPE NNP O
tumor NN O
cells NNS O
metastasize VBP O
to TO O
lymph VB O
node NN O
and CC O
spleen NN O
. . O

In IN O
conclusion NN O
, , O
the DT O
metastasis NN O
from IN O
TRP NNP O
- : O
1 CD O
/ NN O
Tag NNP O
RPE NNP O
tumors NNS O
towards IN O
spleen VBN O
and CC O
lymph NN O
nodes NNS O
serves VBZ O
as IN O
potential JJ O
tool NN O
to TO O
investigate VB O
biology NN O
and CC O
metastasis NN O
of IN O
tumors NNS O
derived VBN O
from IN O
the DT O
pigment NN O
epithelium NN O
. . O

-DOCSTART- X X O

Glucagon NNP O
induces VBZ O
suppression NN O
of IN O
ATP NNP O
- : O
sensitive JJ O
K NNP O
+ NNP O
channel NN O
activity NN O
through IN O
a DT O
Ca2 NNP O
+ NN O
/ NN O
calmodulin NN O
- : O
dependent JJ O
pathway NN O
in IN O
mouse NN O
pancreatic JJ O
beta JJ O
- : O
cells NNS O
. . O

Glucagon NNP O
is VBZ O
known VBN O
to TO O
increase VB O
intracellular JJ O
cAMP JJ O
levels NNS O
and CC O
enhance VB O
glucose NN O
- : O
induced JJ O
electrical JJ O
activity NN O
and CC O
insulin NN O
secretion NN O
in IN O
pancreatic JJ O
beta NN O
- : O
cell NN O
perfused VBN O
with IN O
Krebs NNP O
- : O
Ringer NNP O
bicarbonate CD O
solution NN O
. . O

The DT O
present JJ O
experiments NNS O
were VBD O
aimed VBN O
at IN O
evaluation NN O
of IN O
the DT O
hypothesis NN O
that IN O
changes NNS O
in IN O
beta JJ O
- : O
cells NNS O
ATP VBP O
- : O
sensitive JJ O
K NNP O
+ NNP O
( -LRB- O
K NNP O
( -LRB- O
ATP NN O
) -RRB- O
) -RRB- O
channel NN O
activity NN O
are VBP O
involved VBN O
in IN O
the DT O
glucagon NN O
- : O
induced VBN O
enhancement NN O
of IN O
electrical JJ O
activity NN O
. . O

Channel NNP O
activity NN O
was VBD O
recorded VBN O
using VBG O
the DT O
cell NN O
- : O
attached VBN O
configuration NN O
of IN O
the DT O
patch NN O
- : O
clamp NN O
technique NN O
. . O

Addition NN O
of IN O
glucagon NN O
( -LRB- O
2 CD O
. . O
9 CD O
x NN O
10 CD O
( -LRB- O
- : O
7 CD O
) -RRB- O
m NN O
) -RRB- O
in IN O
the DT O
presence NN O
of IN O
11 CD O
. . O
1 CD O
mm CD O
glucose NN O
caused VBD O
closure NN O
of IN O
K NNP O
( -LRB- O
ATP NNP O
) -RRB- O
channels NNS O
followed VBN O
by IN O
an DT O
increase NN O
in IN O
the DT O
frequency NN O
of IN O
biphasic JJ O
current JJ O
transients NNS O
( -LRB- O
action NN O
currents NNS O
) -RRB- O
due JJ O
to TO O
action NN O
potential JJ O
generation NN O
in IN O
the DT O
cell NN O
. . O

Three CD O
calmodulin NN O
- : O
antagonists NNS O
( -LRB- O
W NNP O
- : O
7 CD O
, , O
chlorpromazine NN O
, , O
and CC O
trifluoperazine NN O
) -RRB- O
restored VBN O
with IN O
similar JJ O
efficacy NN O
K NNP O
( -LRB- O
ATP NNP O
) -RRB- O
channel NN O
activity NN O
in IN O
cells NNS O
being VBG O
exposed VBN O
to TO O
glucagon NN O
. . O

At IN O
2 CD O
. . O
8 CD O
mm CD O
glucose NN O
, , O
glucagon NN O
did VBD O
not RB O
affect VB O
K NNP O
( -LRB- O
ATP NNP O
) -RRB- O
channel NN O
activity NN O
until IN O
Ca2 NNP O
+ , O
was VBD O
released VBN O
from IN O
Nitr NNP O
- : O
5 CD O
by IN O
flash NN O
photolysis NN O
, , O
at IN O
which WDT O
point NN O
channel NN O
activity NN O
was VBD O
transiently RB O
suppressed VBN O
. . O

Similar JJ O
effects NNS O
were VBD O
seen VBN O
when WRB O
db FW O
- : O
cAMP NN O
was VBD O
used VBN O
instead RB O
of IN O
glucagon NN O
. . O

These DT O
results NNS O
support VBP O
the DT O
view NN O
that IN O
glucagon NN O
and CC O
other JJ O
cAMP JJ O
- : O
generating VBG O
agonists NNS O
enhance VB O
glucose NN O
- : O
induced VBN O
beta JJ O
- : O
cell NN O
electrical JJ O
activity NN O
through IN O
a DT O
Ca2 NNP O
+ NNP O
/ , O
calmodulin VBG O
dependent JJ O
- : O
closure NN O
of IN O
K NNP O
( -LRB- O
ATP NNP O
) -RRB- O
channels NNS O
. . O

-DOCSTART- X X O

Requirement NN O
of IN O
estrogen NN O
receptor NN O
expression NN O
and CC O
function NN O
for IN O
[ JJ O
12Val JJ O
] SYM O
K NNP O
- : O
Ras NNP O
- : O
mediated JJ O
NIH3T3 JJ B-NP
cell NN O
transformation NN O
. . O

We PRP O
investigated VBD O
the DT O
biological JJ O
significance NN O
of IN O
estrogen NN O
receptors NNS O
( -LRB- O
ERs NNS O
) -RRB- O
in IN O
NIH3T3 NNP B-NP
cell NN O
transformation NN O
by IN O
the DT O
[ JJ O
12Val JJ O
] SYM O
K NNP O
- : O
Ras NNP O
mutant NN O
. . O

This DT O
mutant NN O
enhanced VBD O
the DT O
steady JJ O
- : O
level NN O
and CC O
transcriptional JJ O
activity NN O
of IN O
ER NNP O
. . O

Coexpression NN O
of IN O
the DT O
progesterone NN O
receptor NN O
with IN O
mutant JJ O
K NNP O
- : O
Ras NNP O
led VBD O
to TO O
suppression NN O
of IN O
tumorigenicity NN O
and CC O
inhibition NN O
of IN O
the DT O
activation NN O
of IN O
ER NNP O
. . O

The DT O
antisense NN O
oligomers NNS O
complementary JJ O
to TO O
the DT O
ER NNP O
suppressed VBD O
proliferation NN O
and CC O
transformed VBD O
phenotypes NNS O
of IN O
K12V NNP B-NP
cells NNS O
. . O

These DT O
observations NNS O
support VBP O
the DT O
importance NN O
of IN O
ER NNP O
in IN O
Ras NNP O
- : O
mediated JJ O
cell NN O
transformation NN O
. . O

-DOCSTART- X X O

Gene NNP O
therapy NN O
for IN O
gliomas NNS O
: : O
p53 NN O
and CC O
E2F NNP O
- : O
1 CD O
proteins NNS O
and CC O
the DT O
target NN O
of IN O
apoptosis NN O
. . O

Current JJ O
therapy NN O
for IN O
glioma NN O
is VBZ O
suboptimal JJ O
. . O

The DT O
transfer NN O
of IN O
apoptosis NN O
genes NNS O
to TO O
tumors NNS O
constitutes VBZ O
one CD O
of IN O
the DT O
most RBS O
promising JJ O
strategies NNS O
for IN O
cancer NN O
gene NN O
therapy NN O
. . O

We PRP O
have VBP O
previously RB O
shown VBN O
that IN O
massive JJ O
apoptosis NN O
occurs VBZ O
when WRB O
wild JJ O
- : O
type NN O
p53 NN O
or CC O
E2F NN O
- : O
1 CD O
expression NN O
is VBZ O
induced VBN O
in IN O
glioma NN O
. . O

However RB O
, , O
the DT O
mechanism NN O
of IN O
action NN O
and CC O
the DT O
efficiency NN O
in IN O
inducing VBG O
apoptosis NN O
of IN O
these DT O
two CD O
proteins NNS O
are VBP O
not RB O
similar JJ O
. . O

Adenovirus NNP O
- : O
mediated VBN O
p53 NN O
gene NN O
transfer NN O
is VBZ O
ineffective JJ O
in IN O
causing VBG O
apoptosis NN O
in IN O
glioma NN O
cells NNS O
that WDT O
retain VBP O
wild JJ O
- : O
type NN O
p53 NN O
genotype NN O
or CC O
overexpress IN O
the DT O
p21 JJ O
protein NN O
. . O

The DT O
p16 NNS O
/ VBD O
Rb NNP O
/ NNP O
E2F NNP O
pathway NN O
is VBZ O
the DT O
most RBS O
frequent JJ O
target NN O
of IN O
genetic JJ O
alterations NNS O
in IN O
gliomas NNP O
, , O
and CC O
therefore RB O
constitutes VBZ O
a DT O
suitable JJ O
target NN O
for IN O
gene NN O
therapy NN O
strategies NNS O
. . O

However RB O
, , O
the DT O
transfer NN O
of IN O
either RB O
the DT O
p16 NNS O
or CC O
Rb NNP O
gene NN O
to TO O
glioma CD O
cells NNS O
results NNS O
in IN O
cytostatic JJ O
effect NN O
. . O

The DT O
E2F NNP O
- : O
1 CD O
protein NN O
is VBZ O
able JJ O
to TO O
induce VB O
generalized JJ O
apoptosis NN O
in IN O
gliomas NNS O
independently RB O
of IN O
the DT O
p53 NN O
, , O
p16 PRP O
or CC O
Rb JJ O
status NN O
. . O

In IN O
addition NN O
, , O
p21 VB O
- : O
or CC O
p16 VB O
- : O
mediated JJ O
growth NN O
arrest NN O
did VBD O
not RB O
protect VB O
glioma NN O
cells NNS O
from IN O
E2F NNP O
- : O
1 LS O
- : O
mediated JJ O
apoptosis NN O
. . O

The DT O
apoptotic JJ O
molecule NN O
bax NN O
is VBZ O
induced VBN O
in IN O
p53 NN O
- : O
mediated JJ O
apoptosis NN O
, , O
but CC O
bax NN O
is VBZ O
not RB O
induced VBN O
in IN O
E2F NNP O
- : O
1 LS O
- : O
mediated JJ O
apoptosis NN O
in IN O
glioma NN O
cells NNS O
. . O

Careful JJ O
selection NN O
of IN O
patients NNS O
may MD O
be VB O
necessary JJ O
before IN O
designing VBG O
therapeutic JJ O
strategies NNS O
using VBG O
either DT O
p53 NN O
or CC O
E2F NN O
- : O
1 CD O
as IN O
a DT O
therapeutic JJ O
tools NNS O
for IN O
glioma NN O
patients NNS O
. . O

-DOCSTART- X X O

Protective JJ O
function NN O
of IN O
von NNP O
Hippel NNP O
- : O
Lindau NNP O
protein NN O
against IN O
impaired JJ O
protein NN O
processing NN O
in IN O
renal JJ O
carcinoma NN O
cells NNS O
. . O

The DT O
absence NN O
of IN O
functional JJ O
von NNP O
Hippel NNP O
- : O
Lindau NNP O
( -LRB- O
VHL NN O
) -RRB- O
tumor NN O
suppressor NN O
gene NN O
leads VBZ O
to TO O
the DT O
development NN O
of IN O
neoplasias NNS O
characteristic JJ O
of IN O
VHL NNP O
disease NN O
, , O
including VBG O
renal JJ O
cell NN O
carcinoma NN O
( -LRB- O
RCC NNP O
) -RRB- O
. . O

Here RB O
, , O
we PRP O
compared VBD O
the DT O
sensitivity NN O
of IN O
RCC NNP O
cells NNS O
lacking VBG O
VHL NNP O
gene NN O
function NN O
with IN O
that DT O
of IN O
RCC NNP O
cells NNS O
expressing VBG O
the DT O
wild JJ O
- : O
type NN O
VHL NN O
gene NN O
( -LRB- O
wtVHL NN O
) -RRB- O
after IN O
exposure NN O
to TO O
various JJ O
stresses VBZ O
. . O

While IN O
the DT O
response NN O
to TO O
most JJS O
treatments NNS O
was VBD O
not RB O
affected VBN O
by IN O
the DT O
VHL NNP O
gene NN O
status NN O
, , O
glucose NN O
deprivation NN O
was VBD O
found VBN O
to TO O
be VB O
much RB O
more RBR O
cytotoxic JJ O
for IN O
RCC NNP O
cells NNS O
lacking VBG O
VHL NNP O
gene NN O
function NN O
than IN O
for IN O
wtVHL JJ O
- : O
expressing VBG O
cells NNS O
. . O

The DT O
heightened JJ O
sensitivity NN O
of IN O
VHL NNP O
- : O
deficient JJ O
cells NNS O
was VBD O
not RB O
attributed VBN O
to TO O
dissimilar JJ O
energy NN O
requirements NNS O
or CC O
to TO O
differences NNS O
in IN O
glucose NN O
uptake NN O
, , O
but CC O
more RBR O
likely JJ O
reflects VBZ O
a DT O
lesser JJR O
ability NN O
of IN O
VHL NNP O
- : O
deficient JJ O
cells NNS O
to TO O
handle VB O
abnormally RB O
processed VBN O
proteins NNS O
arising VBG O
from IN O
impaired JJ O
glycosylation NN O
. . O

In IN O
support NN O
of IN O
this DT O
hypothesis NN O
, , O
other JJ O
treatments NNS O
which WDT O
act VBP O
through IN O
different JJ O
mechanisms NNS O
to TO O
interfere VB O
with IN O
protein NN O
processing NN O
( -LRB- O
i FW O
. . O
e NN O
. . O
, , O
tunicamycin NN O
, , O
brefeldin IN O
A DT O
, , O
and CC O
azetidine JJ O
) -RRB- O
were VBD O
also RB O
found VBN O
to TO O
be VB O
much JJ O
more JJR O
toxic JJ O
for IN O
VHL NNP O
- : O
deficient JJ O
cells NNS O
. . O

Furthermore RB O
, , O
ubiquitination NN O
of IN O
cellular JJ O
proteins NNS O
was VBD O
elevated VBN O
in IN O
VHL NNP O
- : O
deficient JJ O
cells NNS O
, , O
particularly RB O
after IN O
glucose NN O
deprivation NN O
, , O
supporting VBG O
a DT O
role NN O
for IN O
the DT O
VHL NNP O
gene NN O
in IN O
ubiquitin CD O
- : O
mediated JJ O
proteolysis NN O
. . O

Accordingly RB O
, , O
the DT O
rate NN O
of IN O
elimination NN O
of IN O
abnormal JJ O
proteins NNS O
was VBD O
lower RBR O
in IN O
cells NNS O
lacking VBG O
a DT O
functional JJ O
VHL NNP O
gene NN O
than IN O
in IN O
wtVHL JJ O
- : O
expressing VBG O
cells NNS O
. . O

Thus RB O
, , O
pVHL NN O
appears VBZ O
to TO O
participate VB O
in IN O
the DT O
elimination NN O
of IN O
misprocessed JJ O
proteins NNS O
, , O
such JJ O
as IN O
those DT O
arising VBG O
in IN O
the DT O
cell NN O
due JJ O
to TO O
the DT O
unavailability NN O
of IN O
glucose NN O
or CC O
to TO O
other JJ O
stresses VBZ O
. . O

-DOCSTART- X X O

Effect NN O
of IN O
U NNP O
- : O
995 CD O
, , O
a DT O
potent JJ O
shark NN O
cartilage NN O
- : O
derived VBN O
angiogenesis NN O
inhibitor NN O
, , O
on IN O
anti NNS O
- : O
angiogenesis NN O
and CC O
anti NNS O
- : O
tumor NN O
activities NNS O
. . O

BACKGROUND NNP O
: : O
A DT O
potent JJ O
angiogenesis NN O
inhibitor NN O
, , O
U NNP O
- : O
995 CD O
, , O
has VBZ O
been VBN O
purified VBN O
from IN O
the DT O
cartilage NN O
of IN O
the DT O
blue JJ O
shark NN O
( -LRB- O
Prionace NN O
glauca NN O
) -RRB- O
. . O

U NNP O
- : O
995 CD O
is VBZ O
composed VBN O
of IN O
two CD O
single JJ O
peptides NNS O
with IN O
molecular JJ O
mass NN O
of IN O
10 CD O
and CC O
14 CD O
kDa NN O
, , O
respectively RB O
. . O

MATERIALS NNS O
AND CC O
METHODS NNS O
: : O
U NNP O
- : O
995 CD O
was VBD O
designed VBN O
to TO O
study VB O
human JJ O
umbilical JJ O
vein NN O
endothelial NN O
cell NN O
( -LRB- O
HUVEC NNP O
) -RRB- O
migration NN O
and CC O
proliferation NN O
in IN O
vitro NN O
and CC O
angiogenesis NN O
induced VBN O
by IN O
TNF NNP O
alpha NN O
in IN O
chicken NN O
chorioallantoic NN O
membrane FW O
( -LRB- O
CAM NN O
) -RRB- O
. . O

Furthermore RB O
, , O
we PRP O
determined VBD O
the DT O
ability NN O
of IN O
U NNP O
- : O
995 CD O
to TO O
inhibiting VBG O
tumor NN O
cell NN O
growth NN O
and CC O
metastasis NN O
. . O

RESULTS NNS O
: : O
U NNP O
- : O
995 CD O
( -LRB- O
15 CD O
and CC O
30 CD O
micrograms NNS O
/ JJ O
ml NN O
) -RRB- O
markedly NN O
inhibited VBD O
HUVEC NNP O
migration CD O
and CC O
, , O
at IN O
15 CD O
- : O
50 CD O
micrograms NNS O
/ JJ O
ml NN O
produced VBD O
a DT O
dose NN O
- : O
dependent JJ O
decline NN O
in IN O
[ JJ O
3H NNP O
] SYM O
- : O
thymidine NN O
incorporation NN O
. . O

30 CD O
and CC O
50 CD O
micrograms NNS O
/ IN O
ml NN O
of IN O
U NNP O
- : O
995 CD O
, , O
when WRB O
added VBN O
to TO O
TNF NNP O
alpha NN O
- : O
induced VBN O
angiogenesis NN O
caused VBN O
discontinuous JJ O
and CC O
disrupted VBD O
blood NN O
vessels NNS O
. . O

Moreover RB O
, , O
U NNP O
- : O
995 CD O
( -LRB- O
30 CD O
micrograms NNS O
/ JJ O
ml NN O
) -RRB- O
markedly NN O
prevented VBD O
collagenase NN O
- : O
induced VBN O
collagenolysis NN O
. . O

In IN O
addition NN O
, , O
when WRB O
200 CD O
micrograms NNS O
U NNP O
- : O
995 CD O
was VBD O
injected VBN O
i NN O
. . O
p NN O
. . O
into IN O
mice NNS O
it PRP O
suppressed VBD O
sarcoma NN B-NP
- : I-NP
180 CD I-NP
cell NN O
growth NN O
and CC O
B16 CD B-NP
- : I-NP
F10 CD I-NP
mouse NN O
melanoma NN O
cell NN O
metastasis NN O
in IN O
vivo NN O
. . O

CONCLUSIONS NNS O
: : O
These DT O
results NNS O
suggest VBP O
that IN O
the DT O
anti NNS O
- : O
angiogenic JJ O
effects NNS O
of IN O
U NNP O
- : O
995 CD O
may MD O
be VB O
be VB O
due JJ O
to TO O
interference NN O
with IN O
the DT O
proliferation NN O
and CC O
migration NN O
of IN O
HUVECs NNP O
as RB O
well RB O
as IN O
inhibition NN O
of IN O
collagenolysis NN O
, , O
thereby RB O
leading VBG O
to TO O
inhibition NN O
of IN O
both DT O
angiogenesis NN O
and CC O
tumor NN O
cell NN O
growth NN O
. . O

-DOCSTART- X X O

Potential JJ O
roles NNS O
for IN O
focal JJ O
adhesion NN O
kinase NN O
in IN O
development NN O
. . O

Focal NNP O
adhesion NN O
kinase NN O
( -LRB- O
pp125FAK NN O
or CC O
FAK NN O
) -RRB- O
is VBZ O
a DT O
protein NN O
tyrosine NN O
kinase NN O
which WDT O
is VBZ O
associated VBN O
with IN O
intracellular JJ O
signalling NN O
cascades NNS O
which WDT O
are VBP O
initiated VBN O
when WRB O
the DT O
integrin NN O
family NN O
of IN O
cell NN O
adhesion NN O
molecules NNS O
engage VBP O
extracellular JJ O
matrix NN O
molecules NNS O
. . O

In IN O
cultured JJ O
cells NNS O
, , O
this DT O
molecule NN O
is VBZ O
physically RB O
associated VBN O
with IN O
focal JJ O
adhesions NNS O
, , O
which WDT O
are VBP O
well RB O
- : O
defined VBN O
regions NNS O
of IN O
intimate JJ O
cell NN O
- : O
to TO O
- : O
substratum NN O
adhesion NN O
. . O

In IN O
this DT O
location NN O
, , O
it PRP O
interacts VBZ O
with IN O
other JJ O
proteins NNS O
of IN O
the DT O
focal JJ O
adhesion NN O
to TO O
activate VB O
intracellular JJ O
signalling VBG O
events NNS O
associated VBN O
with IN O
cell NN O
adhesion NN O
. . O

The DT O
in IN O
vitro NN O
expression NN O
of IN O
FAK NNP O
and CC O
its PRP$ O
level NN O
of IN O
phosphorylation NN O
appear VBP O
to TO O
be VB O
related VBN O
to TO O
several JJ O
physiological JJ O
phenomena NNS O
, , O
including VBG O
cell NN O
spreading VBG O
, , O
cell NN O
differentiation NN O
, , O
cell NN O
locomotion NN O
and CC O
cell NN O
death NN O
. . O

Because IN O
these DT O
phenomena NNS O
are VBP O
all DT O
of IN O
critical JJ O
importance NN O
during IN O
morphogenesis NN O
, , O
and CC O
because IN O
FAK NNP O
is VBZ O
expressed VBN O
in IN O
embryonic JJ O
cells NNS O
, , O
evidence NN O
has VBZ O
been VBN O
accumulating VBG O
to TO O
indicate VB O
that IN O
FAK NNP O
may MD O
be VB O
an DT O
important JJ O
modulator NN O
of IN O
developmental JJ O
processes NNS O
. . O

In IN O
this DT O
review NN O
, , O
this DT O
evidence NN O
is VBZ O
surveyed VBN O
together RB O
with IN O
evidence NN O
from IN O
analogous JJ O
situations NNS O
, , O
such JJ O
as IN O
tumour JJ O
cell NN O
migration NN O
and CC O
invasiveness NN O
. . O

Although IN O
evidence NN O
suggesting VBG O
a DT O
role NN O
for IN O
FAK NNP O
in IN O
morphogenesis NN O
is VBZ O
accumulating VBG O
, , O
current JJ O
uncertainties NNS O
regarding VBG O
its PRP$ O
cytoplasmic JJ O
location NN O
and CC O
its PRP$ O
molecular JJ O
interactions NNS O
in IN O
vivo RB O
make VB O
it PRP O
difficult JJ O
to TO O
reach VB O
definitive JJ O
conclusions NNS O
regarding VBG O
the DT O
significance NN O
of IN O
its PRP$ O
contributions NNS O
to TO O
developmental JJ O
processes NNS O
. . O

-DOCSTART- X X O

Selective JJ O
inhibition NN O
of IN O
the DT O
renal JJ O
dopamine NN O
subtype NN O
D1A NN O
receptor NN O
induces VBZ O
antinatriuresis NN O
in IN O
conscious JJ O
rats NNS O
. . O

Both DT O
dopamine NN O
D1 IN O
- : O
like IN O
( -LRB- O
D1A NN O
and CC O
D1B NN O
) -RRB- O
and CC O
D2 VB O
- : O
like IN O
( -LRB- O
D2 NN O
, , O
D3 NNP O
, , O
and CC O
D4 NNP O
) -RRB- O
receptor NN O
subfamilies NNS O
are VBP O
present JJ O
in IN O
the DT O
kidney NN O
. . O

Blockade NNP O
of IN O
the DT O
intrarenal JJ O
D1 NNP O
- : O
like IN O
receptor NN O
family NN O
is VBZ O
associated VBN O
with IN O
natriuresis NN O
and CC O
diuresis NN O
. . O

Because IN O
the DT O
D1A NNP O
and CC O
D1B NNP O
receptor NN O
subtypes NNS O
are VBP O
not RB O
distinguishable JJ O
by IN O
currently RB O
available JJ O
dopaminergic JJ O
agents NNS O
, , O
their PRP$ O
functional JJ O
role NN O
remains VBZ O
undefined JJ O
. . O

In IN O
the DT O
present JJ O
study NN O
, , O
the DT O
effect NN O
of IN O
selective JJ O
inhibition NN O
of IN O
the DT O
renal JJ O
D1A NN O
receptor NN O
with IN O
phosphorothioated JJ O
antisense NN O
oligodeoxynucleotide NN O
( -LRB- O
AS IN O
- : O
ODN NN O
) -RRB- O
was VBD O
investigated VBN O
in IN O
conscious JJ O
uninephrectomized JJ O
rats NNS O
. . O

After IN O
renal JJ O
interstitial JJ O
administration NN O
of IN O
Texas NNP O
red JJ O
- : O
labeled VBN O
D1A NN O
receptor NN O
AS IN O
- : O
ODN NN O
, , O
intense JJ O
fluorescent JJ O
signal NN O
was VBD O
localized VBN O
in IN O
the DT O
renal JJ O
tubular JJ O
epithelium NN O
and CC O
vasculature NN O
. . O

In IN O
rats NNS O
on IN O
normal JJ O
salt NN O
intake NN O
, , O
AS IN O
- : O
ODN NNP O
injected VBD O
interstitially RB O
into IN O
the DT O
kidney NN O
reduced VBN O
daily RB O
urinary JJ O
sodium NN O
excretion NN O
( -LRB- O
1 CD O
. . O
4 CD O
+ NN O
/ JJ O
- : O
0 CD O
. . O
04 CD O
versus NN O
0 CD O
. . O
8 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
2 CD O
mEq NN O
/ NN O
d VBD O
, , O
n RB O
= SYM O
5 CD O
, , O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
and CC O
urine JJ O
output NN O
( -LRB- O
16 CD O
. . O
9 CD O
+ NN O
/ NN O
- : O
3 CD O
. . O
8 CD O
versus NN O
12 CD O
. . O
5 CD O
+ NN O
/ NN O
- : O
3 CD O
. . O
6 CD O
mL NN O
/ NN O
d VBD O
, , O
n RB O
= SYM O
5 CD O
, , O
P NNP O
< NNP O
0 CD O
. . O
05 CD O
) -RRB- O
. . O

In IN O
rats NNS O
on IN O
high JJ O
sodium NN O
intake NN O
, , O
continuous JJ O
renal JJ O
interstitial JJ O
administration NN O
of IN O
D1A NNP O
receptor NN O
AS IN O
- : O
ODN VBP O
transiently RB O
decreased VBN O
daily JJ O
urinary NN O
sodium NN O
excretion NN O
( -LRB- O
5 CD O
. . O
4 CD O
+ NN O
/ JJ O
- : O
0 CD O
. . O
5 CD O
versus NN O
4 CD O
. . O
2 CD O
+ NN O
/ NN O
- : O
0 CD O
. . O
3 CD O
mEq NN O
/ NN O
d VBD O
, , O
n RB O
= SYM O
7 CD O
, , O
P NNP O
< NNP O
0 CD O
. . O
01 CD O
) -RRB- O
and CC O
urine JJ O
output NN O
( -LRB- O
27 CD O
. . O
6 CD O
+ NN O
/ IN O
- : O
4 LS O
. . O
5 CD O
versus NN O
18 CD O
. . O
1 CD O
+ NN O
/ IN O
- : O
1 LS O
. . O
8 CD O
mL NN O
/ NN O
d VBD O
, , O
n RB O
= SYM O
7 CD O
, , O
P NNP O
< NNP O
0 CD O
. . O
01 CD O
) -RRB- O
. . O

Neither DT O
vehicle NN O
nor CC O
sense NN O
oligodeoxynucleotide NN O
had VBD O
significant JJ O
effects NNS O
. . O

Systolic JJ O
blood NN O
pressure NN O
remained VBD O
unchanged JJ O
. . O

The DT O
renal JJ O
D1A NN O
receptor NN O
protein NN O
was VBD O
significantly RB O
decreased VBN O
by IN O
35 CD O
% NN O
and CC O
46 CD O
% NN O
at IN O
the DT O
end NN O
of IN O
the DT O
study NN O
in IN O
AS NNP O
- : O
ODN NN O
- : O
treated VBN O
rats NNS O
on IN O
normal JJ O
and CC O
high JJ O
salt NN O
intake NN O
, , O
respectively RB O
, , O
whereas IN O
the DT O
D1B NN O
receptor NN O
and CC O
beta JJ O
- : O
actin NN O
were VBD O
not RB O
affected VBN O
. . O

These DT O
results NNS O
provide VBP O
the DT O
first JJ O
direct JJ O
evidence NN O
that IN O
the DT O
renal JJ O
D1A NN O
receptor NN O
subtype NN O
plays VBZ O
an DT O
important JJ O
role NN O
in IN O
the DT O
control NN O
of IN O
sodium NN O
excretion NN O
. . O

